data_1y7x_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1y7x _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 41' ' ' GLY . 4.8 mt-30 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.332 0.587 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.484 ' O ' ' CD1' ' A' ' 8' ' ' LEU . 36.0 m -125.02 158.97 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.307 -0.871 . . . . 0.0 109.519 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.46 ' C ' ' O ' ' A' ' 6' ' ' VAL . 40.5 t -38.78 106.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.267 -0.896 . . . . 0.0 110.54 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.484 ' CD1' ' O ' ' A' ' 6' ' ' VAL . 3.2 mp -61.09 169.11 2.26 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.549 -0.719 . . . . 0.0 110.694 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 10' ' ' ASN . 48.4 Cg_endo -79.52 63.37 8.72 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.136 1.598 . . . . 0.0 109.85 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 0.5 OUTLIER 64.86 41.95 4.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.504 -0.748 . . . . 0.0 110.824 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 8' ' ' LEU . 14.9 p -118.98 171.34 8.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.121 -0.987 . . . . 0.0 109.759 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.501 ' CB ' ' HA ' ' A' ' 38' ' ' GLU . . . -145.0 161.9 38.24 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.887 -1.133 . . . . 0.0 110.814 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.6 ' CD2' ' CB ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -133.53 156.15 48.31 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.33 -0.856 . . . . 0.0 110.441 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.598 ' CD2' HD11 ' A' ' 36' ' ' LEU . 44.7 m80 -91.93 124.04 35.74 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.131 -0.98 . . . . 0.0 110.631 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.571 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 2.4 mm? -111.42 151.31 28.68 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.341 -0.85 . . . . 0.0 110.303 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.571 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -113.53 117.49 31.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.078 -1.014 . . . . 0.0 109.743 178.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.54 ' CB ' ' HB2' ' A' ' 33' ' ' ASP . . . -79.43 112.02 16.27 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.208 -0.933 . . . . 0.0 110.338 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.468 HD13 ' HB3' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -104.95 101.7 11.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.842 -0.536 . . . . 0.0 109.594 179.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.7 tp -161.91 147.0 13.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.09 -1.006 . . . . 0.0 110.584 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -89.46 101.76 14.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.365 -0.835 . . . . 0.0 109.613 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.477 ' HB2' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 110.216 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.477 HG23 ' HB2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.232 0.539 . . . . 0.0 110.157 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.429 ' O ' ' C ' ' A' ' 31' ' ' ALA . 24.0 m -134.8 82.37 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.156 -0.965 . . . . 0.0 110.074 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.468 ' HB3' HD13 ' A' ' 18' ' ' LEU . . . 40.79 75.27 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.528 -0.732 . . . . 0.0 110.305 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.16 26.93 0.06 OUTLIER Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.692 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.54 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 35.1 m-20 -98.71 149.58 22.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.635 -1.509 . . . . 0.0 110.006 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 3.3 tt0 -151.76 147.03 26.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.02 -1.05 . . . . 0.0 110.436 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.536 ' HA ' ' CG2' ' A' ' 100' ' ' VAL . 7.3 p90 -160.94 171.64 18.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.122 -0.986 . . . . 0.0 111.299 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.598 HD11 ' CD2' ' A' ' 14' ' ' HIS . 15.3 tp -92.0 155.82 17.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.571 -0.706 . . . . 0.0 110.021 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.573 ' CD2' ' HB3' ' A' ' 40' ' ' PRO . 1.0 OUTLIER -134.53 110.56 9.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.126 -0.984 . . . . 0.0 110.219 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.501 ' HA ' ' CB ' ' A' ' 12' ' ' ALA . 11.5 tm-20 -84.41 131.85 34.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.863 . . . . 0.0 110.445 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.615 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 66.57 43.56 91.9 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 55.6 Cg_endo -77.27 23.54 0.53 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.553 1.291 . . . . 0.0 111.218 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.468 ' HA3' ' C ' ' A' ' 6' ' ' VAL . . . -49.99 -44.62 41.52 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.454 ' O ' HD12 ' A' ' 44' ' ' ILE . 35.7 p -91.28 29.64 1.4 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -1.183 . . . . 0.0 110.677 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.483 ' HB3' ' O ' ' A' ' 40' ' ' PRO . 15.3 t80 -88.34 132.57 34.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.131 -0.981 . . . . 0.0 110.108 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.506 ' CG2' ' HD2' ' A' ' 45' ' ' PRO . 4.0 mp -123.31 146.86 50.62 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.34 -0.85 . . . . 0.0 109.534 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.506 ' HD2' ' CG2' ' A' ' 44' ' ' ILE . 44.3 Cg_endo -71.23 103.81 1.45 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.838 1.441 . . . . 0.0 110.669 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 49' ' ' VAL . 5.9 mtm180 -113.56 140.85 47.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.411 -0.806 . . . . 0.0 110.089 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 46' ' ' ARG . 1.1 tttm -41.71 -34.79 0.67 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.147 -0.97 . . . . 0.0 110.538 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 18' ' ' LEU . 1.7 tt0 -53.01 -39.27 63.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.955 . . . . 0.0 110.522 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.479 HG11 ' HA ' ' A' ' 17' ' ' ALA . 1.4 m -144.98 173.3 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.262 -0.899 . . . . 0.0 109.62 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -142.14 139.83 32.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.849 -1.157 . . . . 0.0 110.671 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.482 HG22 ' CD1' ' A' ' 13' ' ' LEU . 6.5 p -55.52 127.69 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.253 -0.904 . . . . 0.0 110.027 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.571 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 2.9 t -106.58 -58.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 110.179 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.464 ' HA ' ' OE1' ' A' ' 53' ' ' GLU . 13.1 mm-40 -140.43 170.57 15.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.404 -0.81 . . . . 0.0 110.199 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.465 HD12 ' HB2' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -132.76 150.49 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.305 -0.872 . . . . 0.0 109.312 179.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.471 HG23 ' HD2' ' A' ' 98' ' ' PRO . 0.5 OUTLIER -141.15 132.67 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.973 -1.08 . . . . 0.0 110.456 -179.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.443 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 15.2 mm-40 -89.92 178.62 6.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.402 -0.811 . . . . 0.0 110.449 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.576 ' CB ' ' HA ' ' A' ' 95' ' ' ALA . . . -102.54 133.53 47.37 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.194 -0.942 . . . . 0.0 110.811 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.491 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 1.3 t 173.61 63.16 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.297 -0.877 . . . . 0.0 111.015 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.569 HG22 ' N ' ' A' ' 60' ' ' ILE . 0.8 OUTLIER -171.18 -31.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.726 -1.234 . . . . 0.0 111.781 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.569 ' N ' HG22 ' A' ' 59' ' ' ILE . 10.1 mt -85.31 179.43 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.619 -1.301 . . . . 0.0 110.432 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -112.17 -153.23 0.52 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.223 -0.923 . . . . 0.0 110.587 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.573 ' HA ' ' CG1' ' A' ' 93' ' ' VAL . 12.9 tt0 -90.86 -12.75 35.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.669 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 4.0 p30 -137.7 -24.89 1.02 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 0.0 111.071 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.454 ' OE1' ' O ' ' A' ' 65' ' ' ALA . 6.1 tp-100 -54.41 133.58 45.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.841 -1.162 . . . . 0.0 110.51 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.498 ' HB2' ' CG1' ' A' ' 108' ' ' VAL . . . -120.95 157.23 30.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.384 -0.822 . . . . 0.0 109.355 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.542 ' HB2' ' CG2' ' A' ' 90' ' ' VAL . 2.8 mt -125.77 113.05 16.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.107 -0.995 . . . . 0.0 110.78 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.46 ' O ' HD22 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -91.68 121.59 33.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.26 -0.9 . . . . 0.0 109.269 178.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.534 ' CD2' ' HA ' ' A' ' 104' ' ' VAL . 6.0 mt -118.46 151.68 37.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.089 -1.007 . . . . 0.0 110.841 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.478 ' HA ' ' CB ' ' A' ' 87' ' ' GLU . 2.0 ttm-85 -121.82 155.28 35.69 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.416 -0.802 . . . . 0.0 109.778 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.506 ' HB2' ' HA ' ' A' ' 84' ' ' THR . . . -65.44 152.64 43.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.173 -0.955 . . . . 0.0 110.855 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.516 ' CB ' ' O ' ' A' ' 101' ' ' PHE . 8.2 tpt180 -114.71 -27.37 7.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.375 -0.828 . . . . 0.0 109.837 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.54 ' O ' ' CB ' ' A' ' 73' ' ' GLU . 29.8 mmmt -108.32 -94.66 0.4 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 0.0 109.684 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.54 ' CB ' ' O ' ' A' ' 72' ' ' LYS . 0.5 OUTLIER 164.39 29.72 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.464 -0.773 . . . . 0.0 110.465 179.597 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.2 m -138.64 -6.96 1.48 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.997 -1.064 . . . . 0.0 110.874 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.558 ' CB ' ' HB2' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -76.91 110.17 11.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.066 -1.021 . . . . 0.0 110.299 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.497 ' HB2' ' N ' ' A' ' 80' ' ' LYS . 3.1 p30 -93.16 132.13 37.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.271 -0.893 . . . . 0.0 110.055 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.547 ' HD2' ' CG ' ' A' ' 86' ' ' GLU . 1.7 mtp180 -80.1 -59.04 2.87 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.063 -1.023 . . . . 0.0 110.409 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -98.5 16.78 20.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.267 -0.896 . . . . 0.0 110.516 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.15 16.03 24.28 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.497 ' N ' ' HB2' ' A' ' 76' ' ' ASP . 40.9 mmtt -115.71 91.66 3.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -1.164 . . . . 0.0 110.248 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.465 ' CB ' HG13 ' A' ' 29' ' ' VAL . 1.7 tm-20 -43.56 101.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.233 -0.917 . . . . 0.0 110.281 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.543 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -100.67 179.24 4.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 0.0 110.223 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.0 m -98.72 -178.59 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.227 -0.921 . . . . 0.0 110.589 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.506 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -58.18 -26.0 62.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.488 -0.757 . . . . 0.0 110.627 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.03 -19.0 73.37 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.547 ' CG ' ' HD2' ' A' ' 77' ' ' ARG . 10.0 tp10 -73.7 143.46 46.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.183 -1.187 . . . . 0.0 110.312 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.478 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 3.9 pt-20 -149.31 155.44 40.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.296 -0.878 . . . . 0.0 110.2 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.573 ' CD1' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -136.88 154.77 50.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.088 -1.008 . . . . 0.0 110.129 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.522 HD23 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -114.87 134.68 54.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.278 -0.889 . . . . 0.0 110.573 -179.482 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.542 ' CG2' ' HB2' ' A' ' 66' ' ' LEU . 3.6 m -99.8 130.14 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.254 -0.904 . . . . 0.0 110.16 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.78 53.9 1.1 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.332 -0.855 . . . . 0.0 110.051 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.36 160.23 19.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 110.456 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.573 ' CG1' ' HA ' ' A' ' 62' ' ' GLN . 90.7 t -109.64 83.89 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.346 -0.846 . . . . 0.0 109.781 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 60' ' ' ILE . . . 87.4 79.53 1.24 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.576 ' HA ' ' CB ' ' A' ' 57' ' ' ALA . . . -162.46 -143.32 0.08 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.28 -1.13 . . . . 0.0 110.599 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 9.3 t80 177.17 104.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.49 ' HB3' HD21 ' A' ' 36' ' ' LEU . 15.6 mt -116.78 88.72 26.37 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.046 -1.034 . . . . 0.0 111.052 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.471 ' HD2' HG23 ' A' ' 55' ' ' ILE . 49.9 Cg_endo -78.24 108.38 2.48 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.892 1.47 . . . . 0.0 109.825 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.461 ' HA ' ' HB2' ' A' ' 36' ' ' LEU . . . -65.2 -171.56 0.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.164 -0.96 . . . . 0.0 110.692 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.536 ' CG2' ' HA ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -110.49 -55.95 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.389 -0.819 . . . . 0.0 109.581 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.558 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 11.8 m-85 -101.5 -14.64 17.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.948 -1.095 . . . . 0.0 109.656 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.573 ' OE1' ' CD1' ' A' ' 88' ' ' TRP . 23.4 tt0 -93.83 123.94 37.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.363 -0.836 . . . . 0.0 110.906 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.33 164.12 11.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.308 -0.87 . . . . 0.0 109.77 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.534 ' HA ' ' CD2' ' A' ' 68' ' ' LEU . 8.4 p -86.65 146.76 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.123 -0.985 . . . . 0.0 110.539 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.559 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 9.4 mp -104.0 -33.29 8.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.366 -0.834 . . . . 0.0 110.142 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.436 ' C ' HD22 ' A' ' 107' ' ' LEU . 0.3 OUTLIER -173.3 -166.55 0.34 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.254 -0.904 . . . . 0.0 110.401 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.565 ' N ' ' CD2' ' A' ' 107' ' ' LEU . 3.3 mm? -121.54 153.44 37.98 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.25 -0.907 . . . . 0.0 110.032 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.498 ' CG1' ' HB2' ' A' ' 65' ' ' ALA . 2.8 p -139.05 107.79 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.08 -1.012 . . . . 0.0 110.987 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -70.17 118.28 12.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.882 . . . . 0.0 110.222 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.219 -0.925 . . . . 0.0 110.42 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.467 ' O ' ' O ' ' A' ' 41' ' ' GLY . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.111 0.481 . . . . 0.0 109.86 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.49 ' O ' HD12 ' A' ' 8' ' ' LEU . 9.0 m -114.14 176.9 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.09 -1.006 . . . . 0.0 110.21 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.493 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 78.0 t -54.81 143.35 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.426 -0.796 . . . . 0.0 110.769 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.541 ' CB ' ' OG1' ' A' ' 11' ' ' THR . 0.1 OUTLIER -96.5 167.2 12.67 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.433 -0.792 . . . . 0.0 110.052 179.644 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.494 ' O ' ' HB2' ' A' ' 10' ' ' ASN . 46.3 Cg_endo -73.94 69.59 4.6 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.989 1.521 . . . . 0.0 109.52 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.517 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 14.6 m-80 60.71 64.48 1.16 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.455 -0.778 . . . . 0.0 110.74 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.541 ' OG1' ' CB ' ' A' ' 8' ' ' LEU . 30.7 p -140.55 172.11 13.17 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.216 -0.927 . . . . 0.0 110.184 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.503 ' O ' HG23 ' A' ' 55' ' ' ILE . . . -144.42 169.33 18.13 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.941 . . . . 0.0 110.017 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.584 ' CD2' ' CB ' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -134.21 147.62 50.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.084 -1.01 . . . . 0.0 110.148 179.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.644 ' CD2' ' CD1' ' A' ' 36' ' ' LEU . 15.0 m-70 -90.26 126.66 35.91 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.039 -1.038 . . . . 0.0 110.395 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.579 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -136.75 155.72 49.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.11 -0.994 . . . . 0.0 110.351 179.37 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -104.82 122.86 46.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.455 -0.778 . . . . 0.0 110.064 -179.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.569 ' CB ' ' HB2' ' A' ' 33' ' ' ASP . . . -82.89 117.82 23.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.934 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.517 HD13 ' CB ' ' A' ' 31' ' ' ALA . 1.4 mm? -106.72 101.06 10.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.742 -0.599 . . . . 0.0 110.635 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.626 ' CD1' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -166.96 165.14 16.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.247 -0.908 . . . . 0.0 110.093 179.409 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -96.25 110.73 22.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 0.0 110.612 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.509 ' CB ' HG22 ' A' ' 29' ' ' VAL . 1.1 t80 . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.317 -0.864 . . . . 0.0 110.087 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.509 HG22 ' CB ' ' A' ' 21' ' ' PHE . 2.0 m . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.233 0.54 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.6 m -129.77 84.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.083 -1.011 . . . . 0.0 110.312 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.517 ' CB ' HD13 ' A' ' 18' ' ' LEU . . . 45.4 69.27 0.46 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.34 -0.85 . . . . 0.0 110.117 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -174.91 27.01 0.08 OUTLIER Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.41 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.569 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 1.5 m-20 -89.47 144.97 25.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.877 -1.366 . . . . 0.0 109.966 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.554 ' HG2' ' CG1' ' A' ' 100' ' ' VAL . 5.7 tt0 -142.57 131.09 22.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -0.99 . . . . 0.0 110.086 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.572 ' CH2' HD12 ' A' ' 15' ' ' LEU . 1.8 p90 -161.37 174.15 13.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.986 -1.071 . . . . 0.0 110.776 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.644 ' CD1' ' CD2' ' A' ' 14' ' ' HIS . 55.9 tp -94.05 162.09 14.02 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.519 -0.738 . . . . 0.0 110.045 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -131.84 110.36 10.77 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.986 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.511 ' OE2' ' N ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER -82.48 142.85 31.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.409 -0.807 . . . . 0.0 110.397 -179.715 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.595 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 55.66 44.42 86.3 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 54.6 Cg_endo -77.82 15.16 1.33 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.663 1.349 . . . . 0.0 111.086 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 7' ' ' VAL . . . -53.27 -29.72 38.12 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.466 ' O ' HD13 ' A' ' 44' ' ' ILE . 48.9 p -103.45 17.19 24.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -1.17 . . . . 0.0 110.518 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.499 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 12.1 t80 -87.44 125.89 34.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.875 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.568 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 3.2 mp -107.47 141.8 23.77 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 109.786 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.57 97.3 0.7 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.957 1.504 . . . . 0.0 110.802 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.88 159.54 22.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.212 -0.93 . . . . 0.0 110.403 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 48' ' ' GLU . 16.0 pttm -48.93 -32.25 8.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.326 -0.859 . . . . 0.0 110.782 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.521 ' N ' ' HG3' ' A' ' 47' ' ' LYS . 2.6 tp10 -43.27 -40.52 3.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.085 -1.009 . . . . 0.0 110.206 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.509 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -150.13 167.92 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 0.0 110.159 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.447 ' O ' HG22 ' A' ' 52' ' ' VAL . 21.0 mt-10 -122.44 124.47 43.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 0.0 109.949 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.469 HG13 HD12 ' A' ' 13' ' ' LEU . 21.7 t -54.58 133.03 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 109.653 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.486 HG21 ' CA ' ' A' ' 15' ' ' LEU . 4.7 t -111.36 -48.89 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.035 -1.041 . . . . 0.0 110.579 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.495 ' C ' ' CD1' ' A' ' 54' ' ' ILE . 0.5 OUTLIER -149.6 168.57 23.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.146 -0.971 . . . . 0.0 109.936 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.497 HD11 ' HB2' ' A' ' 13' ' ' LEU . 1.2 mm -129.94 131.15 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.378 -0.826 . . . . 0.0 108.974 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.503 HG23 ' O ' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -120.84 136.45 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.028 -1.045 . . . . 0.0 111.334 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.507 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 56.8 mm-40 -97.69 176.55 5.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.601 -0.687 . . . . 0.0 109.929 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.52 ' CA ' ' HA ' ' A' ' 95' ' ' ALA . . . -90.84 140.23 30.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.202 -0.936 . . . . 0.0 109.825 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 3.4 t -179.49 38.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.017 -1.052 . . . . 0.0 111.536 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.529 HG12 ' N ' ' A' ' 60' ' ' ILE . 0.6 OUTLIER -159.9 -74.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.536 -1.353 . . . . 0.0 111.827 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.529 ' N ' HG12 ' A' ' 59' ' ' ILE . 77.0 mt -63.31 159.72 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.56 -1.338 . . . . 0.0 110.393 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.36 -166.37 1.08 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.296 -0.878 . . . . 0.0 110.575 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.541 ' HB2' ' CG1' ' A' ' 93' ' ' VAL . 1.7 tt0 -75.61 -70.82 0.41 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.444 -0.785 . . . . 0.0 110.568 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.478 ' HB3' ' CB ' ' A' ' 110' ' ' ALA . 8.5 m120 -60.55 -33.82 73.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.362 -0.836 . . . . 0.0 110.42 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -59.46 141.18 55.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.188 -0.945 . . . . 0.0 110.84 -179.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.484 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . . . -123.03 140.53 52.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.827 . . . . 0.0 109.773 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.418 ' HB2' HD13 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -126.19 108.33 11.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.104 -0.997 . . . . 0.0 110.534 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.486 ' O ' ' CD2' ' A' ' 68' ' ' LEU . 4.8 ttm105 -91.2 135.9 33.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.129 -0.982 . . . . 0.0 109.585 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.521 ' HB3' ' CG ' ' A' ' 102' ' ' GLU . 5.4 mt -133.99 150.18 51.24 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.209 -0.932 . . . . 0.0 110.935 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 13.9 ttm180 -107.02 163.81 12.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.461 -0.775 . . . . 0.0 109.641 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.491 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -80.57 118.5 22.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.177 -0.952 . . . . 0.0 110.478 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.53 -30.37 52.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.144 -0.972 . . . . 0.0 109.133 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -133.75 157.54 45.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.601 -0.687 . . . . 0.0 109.204 179.45 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.513 ' O ' ' HB3' ' A' ' 74' ' ' CYS . 1.0 OUTLIER -84.65 -179.2 7.07 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.023 -1.048 . . . . 0.0 110.802 -179.367 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER 75.05 -16.01 0.61 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.647 -0.658 . . . . 0.0 111.32 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.612 ' CZ2' ' CG ' ' A' ' 77' ' ' ARG . 5.0 t90 -74.37 104.64 5.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.631 -1.293 . . . . 0.0 110.232 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.513 ' O ' ' CD1' ' A' ' 35' ' ' TRP . 7.4 p-10 -84.8 124.48 31.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.085 -1.009 . . . . 0.0 109.68 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.612 ' CG ' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -80.99 -59.9 2.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.205 -0.935 . . . . 0.0 110.507 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -103.92 11.1 35.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 110.232 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.83 10.95 9.6 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -116.17 111.84 20.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -1.162 . . . . 0.0 110.401 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.496 ' OE2' ' CG ' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -71.47 102.77 2.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.194 -0.941 . . . . 0.0 109.711 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -109.35 178.79 4.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.153 -0.967 . . . . 0.0 110.307 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.8 p -77.37 174.37 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 0.0 110.29 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.475 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 14.6 t -69.57 -16.39 63.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.203 -0.935 . . . . 0.0 109.984 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.18 -23.01 78.62 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.476 ' HG3' ' N ' ' A' ' 87' ' ' GLU . 6.5 tp10 -63.09 160.05 16.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -1.134 . . . . 0.0 110.212 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.476 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 10.5 pt-20 -149.9 156.54 41.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 110.169 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.568 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -136.21 148.6 48.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.196 -0.94 . . . . 0.0 109.693 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.523 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -102.06 128.31 48.57 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.315 -0.866 . . . . 0.0 110.45 -179.428 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.523 ' N ' HD22 ' A' ' 89' ' ' LEU . 2.7 t -89.15 124.48 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.589 -0.694 . . . . 0.0 110.073 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.477 ' OG1' ' CD1' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -129.74 33.29 4.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -0.904 . . . . 0.0 109.857 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.63 152.6 37.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.856 . . . . 0.0 109.905 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.541 ' CG1' ' HB2' ' A' ' 62' ' ' GLN . 44.7 t -93.41 109.6 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.181 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 57' ' ' ALA . . . 69.78 76.92 0.47 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.52 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . . . -176.42 -175.23 0.65 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -1.124 . . . . 0.0 110.738 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.497 ' HA ' HG23 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -117.13 -61.86 1.65 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.403 -0.81 . . . . 0.0 110.608 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.533 ' N ' ' HD3' ' A' ' 98' ' ' PRO . 2.9 mm? 58.45 51.87 4.34 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.063 -1.023 . . . . 0.0 109.733 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 97' ' ' LEU . 50.2 Cg_endo -75.47 -2.31 12.41 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.111 1.585 . . . . 0.0 111.329 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.534 ' HA ' ' CB ' ' A' ' 36' ' ' LEU . . . 51.87 -178.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.059 -1.026 . . . . 0.0 110.093 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.554 ' CG1' ' HG2' ' A' ' 34' ' ' GLU . 2.4 t -97.21 -63.93 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.664 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.553 ' CD1' ' N ' ' A' ' 101' ' ' PHE . 7.5 m-30 -94.09 67.66 3.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.966 -1.083 . . . . 0.0 109.385 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.521 ' CG ' ' HB3' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -139.85 144.75 37.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 111.282 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -132.38 121.35 23.33 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.497 ' HA ' HD22 ' A' ' 68' ' ' LEU . 9.0 p -76.89 144.52 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.15 -0.969 . . . . 0.0 111.091 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.523 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -99.17 -26.23 14.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.664 -0.648 . . . . 0.0 109.409 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -177.95 -178.8 0.71 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 110.039 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.35 149.25 44.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.201 -0.937 . . . . 0.0 110.287 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.484 ' CG1' ' CB ' ' A' ' 65' ' ' ALA . 11.0 p -131.81 156.3 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.243 -0.911 . . . . 0.0 110.255 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.511 ' O ' ' C ' ' A' ' 110' ' ' ALA . 7.6 p30 -111.18 113.49 26.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.072 -1.017 . . . . 0.0 110.461 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.511 ' C ' ' O ' ' A' ' 109' ' ' ASP . . . . . . . . 0 N--CA 1.5 2.067 0 CA-C-O 120.956 0.408 . . . . 0.0 111.942 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.531 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.432 0.634 . . . . 0.0 110.735 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.531 HG22 ' N ' ' A' ' 7' ' ' VAL . 33.1 m -74.8 -133.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.214 -0.929 . . . . 0.0 109.257 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.531 ' N ' HG22 ' A' ' 6' ' ' VAL . 21.0 t -105.78 151.76 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.986 -1.071 . . . . 0.0 109.607 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.521 ' CD2' ' OG1' ' A' ' 11' ' ' THR . 5.4 mp -103.64 157.69 33.37 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 110.256 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -74.18 -49.28 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.061 1.558 . . . . 0.0 110.495 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.543 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 5.4 p30 -163.46 27.29 0.09 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.873 . . . . 0.0 110.471 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.521 ' OG1' ' CD2' ' A' ' 8' ' ' LEU . 19.0 p -104.81 151.7 23.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.965 -1.084 . . . . 0.0 111.125 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.53 ' CB ' HD22 ' A' ' 97' ' ' LEU . . . -132.18 165.45 24.06 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.576 ' CD2' ' CD1' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -133.88 153.17 51.94 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.788 -1.195 . . . . 0.0 110.485 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.587 ' CE1' HD23 ' A' ' 36' ' ' LEU . 4.6 m170 -92.15 136.29 33.3 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.504 -0.748 . . . . 0.0 109.105 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.678 ' CD1' ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -139.39 153.37 47.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.013 -1.054 . . . . 0.0 110.6 179.763 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 0.3 OUTLIER -113.52 117.53 31.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.267 -0.896 . . . . 0.0 109.91 -179.615 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.549 ' CB ' ' HB2' ' A' ' 33' ' ' ASP . . . -77.59 119.37 21.05 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.24 -0.913 . . . . 0.0 110.195 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 2.4 mm? -103.04 101.01 10.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.772 -0.58 . . . . 0.0 109.517 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.523 ' CD1' ' N ' ' A' ' 20' ' ' ASP . 2.1 tm? -164.98 144.21 6.79 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.011 -1.055 . . . . 0.0 110.262 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.523 ' N ' ' CD1' ' A' ' 19' ' ' LEU . 2.7 m-20 -85.05 118.72 24.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.667 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.503 ' CB ' HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.168 -0.957 . . . . 0.0 110.766 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.503 HG21 ' CB ' ' A' ' 21' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.448 ' O ' HG21 ' A' ' 30' ' ' VAL . 31.4 m -141.04 89.16 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.074 -1.016 . . . . 0.0 110.451 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 44.24 63.66 1.57 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.384 -0.822 . . . . 0.0 110.163 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.93 21.62 0.1 OUTLIER Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.624 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.549 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 5.3 m-20 -87.1 149.49 24.65 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.676 -1.485 . . . . 0.0 109.557 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 31.6 tt0 -152.68 145.72 24.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.019 -1.051 . . . . 0.0 110.525 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.635 ' CD2' ' CD2' ' A' ' 15' ' ' LEU . 6.7 p90 -167.99 168.93 11.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.211 -0.93 . . . . 0.0 110.616 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.587 HD23 ' CE1' ' A' ' 14' ' ' HIS . 0.5 OUTLIER -91.87 156.28 17.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.205 -0.934 . . . . 0.0 110.959 -178.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.557 ' CE2' ' HB2' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -132.2 111.04 11.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.486 -0.759 . . . . 0.0 109.894 179.604 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.45 ' HA ' ' CB ' ' A' ' 12' ' ' ALA . 4.7 tm-20 -79.17 140.19 37.81 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.568 -0.708 . . . . 0.0 109.64 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.603 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 54.33 44.56 76.12 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 54.5 Cg_endo -76.15 13.15 1.35 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.69 1.363 . . . . 0.0 111.262 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 5' ' ' GLN . . . -49.95 -41.35 36.8 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.8 p -83.16 18.54 1.68 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.173 -1.192 . . . . 0.0 111.231 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.557 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 3.1 t80 -98.72 130.64 45.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.933 -1.105 . . . . 0.0 110.166 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.546 ' CG2' ' HD2' ' A' ' 45' ' ' PRO . 35.1 mm -114.49 146.01 35.01 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.45 -0.781 . . . . 0.0 109.045 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 44' ' ' ILE . 40.3 Cg_endo -66.22 74.58 0.36 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.733 1.386 . . . . 0.0 110.883 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -73.99 139.08 44.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.376 -0.827 . . . . 0.0 109.819 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.491 ' HG3' ' N ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -45.98 -24.2 0.39 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.917 . . . . 0.0 110.387 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -56.64 -36.16 69.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.159 -0.963 . . . . 0.0 110.211 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.534 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 1.2 m -141.35 170.36 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.36 -0.838 . . . . 0.0 110.027 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -127.98 132.69 49.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.992 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.1 m -56.37 127.64 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.875 . . . . 0.0 110.321 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 15' ' ' LEU . 21.8 t -96.54 -60.78 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.363 -0.836 . . . . 0.0 109.975 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.457 ' HG2' HG13 ' A' ' 52' ' ' VAL . 12.1 mm-40 -143.97 175.88 9.69 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.202 -0.936 . . . . 0.0 110.408 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.47 HG23 ' HB2' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -136.74 134.52 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.296 -0.878 . . . . 0.0 108.971 179.349 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -128.61 130.98 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.008 -1.058 . . . . 0.0 111.003 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.474 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 6.1 mm100 -94.91 134.28 37.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.499 -0.751 . . . . 0.0 109.412 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.549 ' CA ' ' HA ' ' A' ' 95' ' ' ALA . . . -49.27 137.26 14.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.081 -1.012 . . . . 0.0 110.804 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 8.7 t -179.51 45.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.309 -0.869 . . . . 0.0 111.587 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.568 ' CG2' ' N ' ' A' ' 60' ' ' ILE . 0.1 OUTLIER -162.48 -53.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.454 -1.404 . . . . 0.0 111.803 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.568 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 21.8 mt -57.37 165.16 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.552 -1.343 . . . . 0.0 109.947 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.451 ' N ' ' CG2' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -93.34 -161.97 0.89 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.339 -0.851 . . . . 0.0 111.057 -179.431 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 0.7 OUTLIER -58.85 -70.25 0.16 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.461 -0.774 . . . . 0.0 110.72 -179.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 15.2 p30 -113.95 26.33 10.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.137 -0.977 . . . . 0.0 110.181 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.448 ' OE1' HD21 ' A' ' 66' ' ' LEU . 1.8 tp-100 -59.84 138.99 57.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 110.4 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.476 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . . . -113.91 130.32 56.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.383 -0.823 . . . . 0.0 109.706 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.448 HD21 ' OE1' ' A' ' 64' ' ' GLN . 42.1 mt -125.04 121.33 34.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 110.275 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.48 ' HA ' HD23 ' A' ' 89' ' ' LEU . 21.1 ttm-85 -96.83 128.25 43.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.347 -0.845 . . . . 0.0 110.177 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.545 ' CD2' ' HA ' ' A' ' 104' ' ' VAL . 31.6 mt -118.16 147.2 43.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 109.992 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.477 ' HB2' HD23 ' A' ' 105' ' ' LEU . 11.7 ttt180 -117.39 146.9 43.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 110.243 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.491 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -67.88 136.49 54.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.345 -0.847 . . . . 0.0 110.807 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -116.12 -8.63 11.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.345 -0.847 . . . . 0.0 109.656 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -141.21 108.68 5.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.338 -0.851 . . . . 0.0 109.727 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 28.2 tt0 -56.59 103.49 0.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.066 -1.021 . . . . 0.0 110.045 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 2.1 t 179.27 -33.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.46 -0.775 . . . . 0.0 109.938 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.524 ' CD1' ' C ' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -75.47 137.2 40.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.418 -0.801 . . . . 0.0 110.11 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 13.6 p-10 -102.18 110.2 22.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.864 . . . . 0.0 110.259 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.521 ' NE ' ' O ' ' A' ' 77' ' ' ARG . 5.4 tpm_? -88.5 -19.93 25.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.177 -0.952 . . . . 0.0 109.309 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.55 -12.67 23.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.465 -0.772 . . . . 0.0 109.638 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 115.16 -5.82 21.72 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 12.4 mmmt -114.89 -70.35 0.8 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.189 -1.183 . . . . 0.0 110.221 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.5 ' CG ' HG13 ' A' ' 29' ' ' VAL . 0.0 OUTLIER 171.36 119.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.364 -0.835 . . . . 0.0 109.789 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.466 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 17.1 mmm180 -111.38 178.5 4.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 110.394 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 29.8 m -110.91 179.24 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 110.345 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.437 HG21 ' N ' ' A' ' 85' ' ' GLY . 3.3 t -56.2 -27.0 53.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 110.093 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.458 ' O ' ' OE2' ' A' ' 87' ' ' GLU . . . -65.23 -23.77 70.1 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.49 ' HG3' ' N ' ' A' ' 87' ' ' GLU . 22.1 tp10 -74.63 158.72 33.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.368 -1.078 . . . . 0.0 110.226 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.49 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -157.4 164.83 37.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.338 -0.851 . . . . 0.0 109.962 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.523 ' CD1' ' C ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -140.93 149.34 41.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.215 -0.928 . . . . 0.0 110.24 -179.749 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.521 HD21 ' N ' ' A' ' 90' ' ' VAL . 1.3 tm? -112.79 124.36 52.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.345 -0.847 . . . . 0.0 109.633 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.521 ' N ' HD21 ' A' ' 89' ' ' LEU . 8.0 p -105.44 132.36 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.173 -0.954 . . . . 0.0 110.847 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.88 56.1 1.84 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.301 -0.875 . . . . 0.0 110.006 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 54.5 m -97.51 119.52 36.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.954 . . . . 0.0 110.332 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 62' ' ' GLN . 18.2 t -50.76 134.2 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.195 -0.941 . . . . 0.0 109.947 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 93' ' ' VAL . . . 48.35 94.97 0.01 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.549 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . . . 178.67 154.79 0.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.088 -1.242 . . . . 0.0 110.949 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.564 ' CD1' HG23 ' A' ' 59' ' ' ILE . 2.5 t80 -134.67 87.18 2.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.488 -0.757 . . . . 0.0 110.15 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.53 HD22 ' CB ' ' A' ' 12' ' ' ALA . 16.9 mt -108.1 87.66 4.07 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.104 -0.998 . . . . 0.0 110.55 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.488 ' O ' ' CB ' ' A' ' 99' ' ' ALA . 47.1 Cg_endo -72.54 -6.19 18.58 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.989 1.52 . . . . 0.0 110.438 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 98' ' ' PRO . . . 68.29 174.91 0.27 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.238 -0.914 . . . . 0.0 110.5 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.538 ' CG2' HD21 ' A' ' 36' ' ' LEU . 4.7 t -94.48 -58.31 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.856 . . . . 0.0 110.052 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.431 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 26.7 m-85 -109.45 53.43 0.69 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.1 -1.0 . . . . 0.0 110.318 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 3.2 tt0 -141.13 157.68 44.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.97 -1.081 . . . . 0.0 110.989 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.422 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 3.5 pt-20 -132.76 140.45 48.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.0 109.663 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.545 ' HA ' ' CD2' ' A' ' 68' ' ' LEU . 15.0 p -76.07 137.43 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.158 -0.964 . . . . 0.0 110.525 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.486 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 1.7 mp -106.51 -19.3 13.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.443 -0.786 . . . . 0.0 110.145 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 37.6 p30 -176.43 162.7 2.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.338 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.442 HD11 HD23 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -120.42 141.99 49.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.361 -0.837 . . . . 0.0 109.778 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.476 ' CG1' ' CB ' ' A' ' 65' ' ' ALA . 12.7 p -139.31 160.59 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.064 -1.023 . . . . 0.0 110.859 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -110.73 116.94 32.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 109.549 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.492 1.656 0 O-C-N 120.98 -1.075 . . . . 0.0 110.687 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.425 ' CD ' HD12 ' A' ' 8' ' ' LEU . 11.2 pt20 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.246 0.546 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.475 ' O ' HD13 ' A' ' 8' ' ' LEU . 15.1 m -100.02 170.14 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 110.643 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.54 ' HA ' ' CA ' ' A' ' 41' ' ' GLY . 23.2 t -46.87 153.0 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.431 -0.793 . . . . 0.0 110.45 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.651 ' CD1' ' N ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -106.5 171.41 4.78 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.283 -0.886 . . . . 0.0 108.863 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 45.8 Cg_endo -72.85 77.96 2.21 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.761 1.4 . . . . 0.0 110.156 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.527 ' HB3' ' CA ' ' A' ' 94' ' ' GLY . 78.2 m-20 58.28 74.21 0.44 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.44 -0.787 . . . . 0.0 110.513 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.495 ' HB ' ' HA ' ' A' ' 56' ' ' GLN . 2.9 p -148.39 169.78 19.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.253 -0.904 . . . . 0.0 110.426 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -147.28 162.95 37.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.455 -0.778 . . . . 0.0 109.768 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.576 HD11 ' CE2' ' A' ' 43' ' ' TYR . 0.8 OUTLIER -133.25 155.78 48.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.006 -1.059 . . . . 0.0 110.833 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.611 ' CD2' ' CD1' ' A' ' 36' ' ' LEU . 4.6 m170 -93.15 123.92 36.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.445 -0.784 . . . . 0.0 109.636 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.648 ' CD1' ' CZ2' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -126.91 155.31 43.24 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.593 -1.317 . . . . 0.0 110.814 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -110.1 117.89 34.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.635 -0.666 . . . . 0.0 109.994 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 33' ' ' ASP . . . -77.04 119.04 20.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 111.006 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 2.7 mm? -109.73 101.22 10.13 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.3 tp -164.42 155.5 15.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.017 -1.052 . . . . 0.0 110.482 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.414 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 12.5 p-10 -97.01 101.84 13.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.146 -0.971 . . . . 0.0 110.261 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.545 ' CD2' ' HE2' ' A' ' 80' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 109.716 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.535 ' CG1' ' HB3' ' A' ' 81' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.162 0.505 . . . . 0.0 109.744 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.454 ' O ' ' C ' ' A' ' 31' ' ' ALA . 30.8 m -137.26 77.9 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.95 -1.094 . . . . 0.0 110.5 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 38.74 70.57 0.2 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.768 -0.583 . . . . 0.0 110.523 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.28 28.94 0.05 OUTLIER Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.849 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.533 ' HB3' ' CB ' ' A' ' 17' ' ' ALA . 18.2 t70 -96.69 149.04 22.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.813 -1.404 . . . . 0.0 109.883 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 36.3 tt0 -146.72 130.35 16.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.326 -0.859 . . . . 0.0 109.819 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.648 ' CZ2' ' CD1' ' A' ' 15' ' ' LEU . 7.6 p90 -154.81 171.28 19.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.126 -0.983 . . . . 0.0 110.955 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.611 ' CD1' ' CD2' ' A' ' 14' ' ' HIS . 0.6 OUTLIER -90.61 155.8 18.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.419 -0.801 . . . . 0.0 110.684 -179.587 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -132.51 110.49 10.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.365 -0.834 . . . . 0.0 110.008 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.46 ' HA ' ' CB ' ' A' ' 12' ' ' ALA . 2.1 tm-20 -95.98 135.51 37.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.38 -0.825 . . . . 0.0 110.065 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.604 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 69.71 45.15 59.93 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 44.1 Cg_endo -72.25 -57.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.854 1.45 . . . . 0.0 110.968 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.54 ' CA ' ' HA ' ' A' ' 7' ' ' VAL . . . 46.03 -89.9 0.01 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 40' ' ' PRO . 1.3 p -73.15 6.05 3.04 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.354 -1.086 . . . . 0.0 111.607 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.576 ' CE2' HD11 ' A' ' 13' ' ' LEU . 9.4 t80 -69.31 110.97 4.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.694 -1.254 . . . . 0.0 109.962 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.424 HD11 ' O ' ' A' ' 42' ' ' THR . 3.2 mt -105.97 139.92 20.73 Favored Pre-proline 0 C--N 1.297 -1.677 0 O-C-N 121.194 -0.941 . . . . 0.0 108.891 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.416 ' HD2' HG22 ' A' ' 44' ' ' ILE . 39.5 Cg_endo -66.4 76.37 0.36 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.762 1.401 . . . . 0.0 110.129 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 49' ' ' VAL . 4.6 mtt180 -73.3 153.08 40.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.516 -0.74 . . . . 0.0 110.185 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -43.13 -33.73 0.94 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.308 -0.87 . . . . 0.0 109.963 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -47.48 -51.44 20.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 109.821 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.528 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -136.06 174.02 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.456 -0.778 . . . . 0.0 109.38 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -134.16 126.63 30.37 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.108 -0.995 . . . . 0.0 110.126 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.4 p -53.84 132.33 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.175 -0.953 . . . . 0.0 108.847 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 14' ' ' HIS . 44.6 t -109.65 -48.96 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.005 . . . . 0.0 111.195 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.57 ' HB2' ' CG ' ' A' ' 14' ' ' HIS . 12.1 mt-10 -138.62 171.92 13.64 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.072 -1.017 . . . . 0.0 110.35 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.495 ' CD1' ' O ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -139.44 146.41 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.349 -0.844 . . . . 0.0 109.18 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.479 HG22 ' O ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -141.84 141.89 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.111 -0.993 . . . . 0.0 110.385 -179.413 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.495 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 1.3 mp0 -112.29 179.8 3.89 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.359 -0.838 . . . . 0.0 110.336 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 94' ' ' GLY . . . -80.34 139.5 36.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.264 -0.898 . . . . 0.0 110.3 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.515 ' O ' HD13 ' A' ' 59' ' ' ILE . 11.8 t -179.93 56.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.362 -0.837 . . . . 0.0 110.054 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.63 HG13 ' CG ' ' A' ' 96' ' ' TYR . 6.3 mm -155.69 -91.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.213 -0.929 . . . . 0.0 111.059 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.541 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 17.5 mm -108.47 -104.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.836 -1.165 . . . . 0.0 110.839 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.524 ' N ' ' HA ' ' A' ' 95' ' ' ALA . 2.0 ttp180 -167.6 -170.24 1.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.777 -1.202 . . . . 0.0 110.496 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.549 ' HB2' ' CG1' ' A' ' 93' ' ' VAL . 6.5 tt0 -68.2 -57.14 6.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.842 . . . . 0.0 110.646 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.547 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 68.9 m-80 -34.52 -60.54 0.42 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.321 0.581 . . . . 0.0 111.112 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.471 ' CB ' HG21 ' A' ' 60' ' ' ILE . 35.6 tp60 -53.6 129.11 31.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.048 -1.033 . . . . 0.0 110.785 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.477 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . . . -108.18 142.39 38.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 109.727 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.502 ' O ' HD21 ' A' ' 89' ' ' LEU . 5.8 mp -124.34 115.03 20.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.604 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.457 ' O ' ' CD1' ' A' ' 105' ' ' LEU . 0.8 OUTLIER -90.67 125.98 35.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 0.0 109.56 179.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.542 ' CB ' ' HG2' ' A' ' 102' ' ' GLU . 13.6 mt -116.58 152.67 33.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.133 -0.98 . . . . 0.0 110.629 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.552 ' HG2' ' CG ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -128.51 144.33 51.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 109.854 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.511 ' HB1' ' CZ3' ' A' ' 75' ' ' TRP . . . -59.16 140.33 56.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.169 -0.957 . . . . 0.0 110.356 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.468 ' C ' ' CG2' ' A' ' 84' ' ' THR . 7.6 tpt180 -107.53 -18.07 13.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.894 . . . . 0.0 110.121 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 2.0 mmmp? -112.51 -98.74 0.42 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.952 . . . . 0.0 110.149 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 72' ' ' LYS . 0.2 OUTLIER 168.09 45.85 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.318 -0.864 . . . . 0.0 109.986 179.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 73' ' ' GLU . 17.2 m -154.89 -19.49 0.12 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.209 -0.932 . . . . 0.0 111.676 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.571 ' CH2' ' OE1' ' A' ' 102' ' ' GLU . 0.3 OUTLIER -73.98 121.37 20.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.686 -1.258 . . . . 0.0 110.851 -179.291 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.501 ' HB2' ' CA ' ' A' ' 81' ' ' GLU . 12.5 t70 -108.87 122.47 47.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 0.0 109.665 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.56 ' CG ' ' CZ2' ' A' ' 75' ' ' TRP . 9.4 mtm180 -55.61 -28.24 54.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -0.874 . . . . 0.0 110.607 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.438 ' HB3' ' OD1' ' A' ' 76' ' ' ASP . 11.4 t70 -89.29 -35.11 16.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.168 -0.957 . . . . 0.0 110.218 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 80' ' ' LYS . . . 148.59 -38.87 0.99 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.545 ' HE2' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -59.31 -133.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.384 -1.068 . . . . 0.0 110.077 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.535 ' HB3' ' CG1' ' A' ' 29' ' ' VAL . 0.4 OUTLIER -141.43 141.81 33.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.898 -1.126 . . . . 0.0 110.067 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.464 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 27.4 mmt-85 -136.22 163.8 29.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.066 -1.021 . . . . 0.0 110.254 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 19.9 m -86.45 -179.12 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.339 -0.85 . . . . 0.0 110.803 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.49 ' CG2' ' O ' ' A' ' 72' ' ' LYS . 0.1 OUTLIER -62.89 -26.62 68.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.45 -0.781 . . . . 0.0 110.418 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.46 -30.87 79.07 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.464 ' CB ' ' HB3' ' A' ' 82' ' ' ARG . 7.9 tp10 -61.43 151.57 32.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.552 ' CG ' ' HG2' ' A' ' 69' ' ' ARG . 5.4 mt-10 -148.52 169.58 19.96 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.184 -0.948 . . . . 0.0 110.151 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.456 ' CB ' ' HG2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -156.0 130.24 8.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.229 -0.919 . . . . 0.0 109.927 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -102.51 136.45 42.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.351 -0.843 . . . . 0.0 109.839 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.538 ' N ' HD22 ' A' ' 89' ' ' LEU . 9.7 p -111.39 135.37 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.901 . . . . 0.0 110.581 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.7 t -141.82 16.44 2.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.437 -0.789 . . . . 0.0 109.53 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.4 m -75.47 170.01 16.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.398 -0.814 . . . . 0.0 109.865 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.549 ' CG1' ' HB2' ' A' ' 62' ' ' GLN . 0.8 OUTLIER -79.14 147.68 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.099 -1.001 . . . . 0.0 109.1 179.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.573 ' O ' ' CB ' ' A' ' 95' ' ' ALA . . . 150.96 -13.3 0.85 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.133 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.573 ' CB ' ' O ' ' A' ' 94' ' ' GLY . . . 77.74 -35.04 0.2 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.361 -1.082 . . . . 0.0 111.674 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.63 ' CG ' HG13 ' A' ' 59' ' ' ILE . 1.0 OUTLIER -146.86 147.61 31.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.08 -1.013 . . . . 0.0 110.385 179.685 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -160.76 59.86 1.23 Allowed Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.401 -0.812 . . . . 0.0 109.883 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.585 ' HG3' ' CE2' ' A' ' 96' ' ' TYR . 53.0 Cg_endo -76.99 143.25 22.8 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.976 1.514 . . . . 0.0 110.787 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -95.04 -151.42 0.33 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.325 -0.859 . . . . 0.0 110.346 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.15 -66.26 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.219 -0.926 . . . . 0.0 110.485 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.552 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 9.1 m-30 -80.57 -22.18 40.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.937 -1.102 . . . . 0.0 110.013 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.571 ' OE1' ' CH2' ' A' ' 75' ' ' TRP . 0.7 OUTLIER -98.34 131.6 44.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.348 -0.845 . . . . 0.0 110.3 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -115.02 161.1 18.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.165 -0.959 . . . . 0.0 110.174 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.535 ' HA ' ' CD2' ' A' ' 68' ' ' LEU . 10.1 p -76.98 146.1 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.114 -0.992 . . . . 0.0 110.685 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.467 HD23 ' CG ' ' A' ' 69' ' ' ARG . 1.5 mp -105.11 -24.67 12.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.413 -0.804 . . . . 0.0 109.709 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -166.04 174.35 9.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.266 -0.896 . . . . 0.0 110.037 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.95 131.19 53.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.23 -0.919 . . . . 0.0 110.064 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.507 HG23 ' N ' ' A' ' 109' ' ' ASP . 14.6 p -125.16 157.14 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.17 -0.956 . . . . 0.0 110.414 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.507 ' N ' HG23 ' A' ' 108' ' ' VAL . 0.6 OUTLIER -111.12 115.54 29.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.161 -0.962 . . . . 0.0 109.739 179.39 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.048 -1.033 . . . . 0.0 110.457 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.475 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 1.3 mt-30 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 7' ' ' VAL . 11.4 m -144.26 83.54 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.743 -1.223 . . . . 0.0 110.885 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.542 ' N ' ' HA3' ' A' ' 41' ' ' GLY . 2.0 t 27.04 99.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 CA-C-O 121.265 0.555 . . . . 0.0 111.682 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.542 ' CD2' ' OG1' ' A' ' 11' ' ' THR . 2.3 mp -61.52 168.76 2.91 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.076 -1.015 . . . . 0.0 110.098 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.456 ' O ' ' OD1' ' A' ' 10' ' ' ASN . 45.0 Cg_endo -72.67 -58.4 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.921 1.485 . . . . 0.0 110.406 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 9' ' ' PRO . 9.6 m120 -162.04 30.87 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.805 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.542 ' OG1' ' CD2' ' A' ' 8' ' ' LEU . 1.1 p -109.9 172.09 7.06 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.312 -0.867 . . . . 0.0 110.22 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.524 ' CB ' HD22 ' A' ' 97' ' ' LEU . . . -144.5 161.32 39.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.213 -0.929 . . . . 0.0 110.659 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.588 ' CD2' ' CD2' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -133.64 155.49 49.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 109.896 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.595 ' CD2' HD13 ' A' ' 36' ' ' LEU . 17.8 m80 -97.66 133.45 42.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 109.812 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.608 ' HB2' ' CZ2' ' A' ' 35' ' ' TRP . 2.5 mm? -120.18 151.9 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.343 -0.848 . . . . 0.0 110.535 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -116.09 117.35 29.84 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.349 178.063 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.574 ' CB ' ' HB3' ' A' ' 33' ' ' ASP . . . -82.62 118.53 23.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.089 -1.007 . . . . 0.0 109.724 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.517 HD12 ' CB ' ' A' ' 31' ' ' ALA . 1.4 mm? -108.15 101.68 10.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.783 -0.573 . . . . 0.0 110.264 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.602 ' CD1' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -164.95 174.91 10.0 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 0.0 110.331 179.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.4 117.22 33.51 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.097 -1.002 . . . . 0.0 109.862 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.551 ' CE2' ' OE1' ' A' ' 81' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.143 -0.973 . . . . 0.0 110.583 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.533 ' CG2' ' HB2' ' A' ' 21' ' ' PHE . 1.4 m . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.426 HG21 ' O ' ' A' ' 30' ' ' VAL . 15.4 m -131.17 82.92 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.886 -1.134 . . . . 0.0 111.03 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.517 ' CB ' HD12 ' A' ' 18' ' ' LEU . . . 47.32 69.65 0.49 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.413 -0.805 . . . . 0.0 110.516 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -175.47 24.72 0.06 OUTLIER Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.694 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.574 ' HB3' ' CB ' ' A' ' 17' ' ' ALA . 11.5 t70 -86.99 143.41 27.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.783 -1.422 . . . . 0.0 110.242 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.45 ' O ' HG21 ' A' ' 100' ' ' VAL . 8.9 tt0 -143.52 134.6 25.64 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.403 -0.811 . . . . 0.0 109.845 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.608 ' CZ2' ' HB2' ' A' ' 15' ' ' LEU . 13.5 p90 -150.26 163.97 36.93 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.994 -1.066 . . . . 0.0 111.237 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.595 HD13 ' CD2' ' A' ' 14' ' ' HIS . 42.0 tp -94.49 152.38 18.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.553 -0.717 . . . . 0.0 109.95 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.502 ' HB3' HD21 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -133.0 110.66 10.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.064 -1.023 . . . . 0.0 110.367 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.537 ' HB2' ' CD2' ' A' ' 97' ' ' LEU . 16.5 tp10 -85.83 138.48 32.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.622 -0.674 . . . . 0.0 109.469 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.619 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 54.36 45.02 76.44 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 51.3 Cg_endo -72.13 4.27 3.4 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.827 1.435 . . . . 0.0 111.057 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.542 ' HA3' ' N ' ' A' ' 7' ' ' VAL . . . -42.0 -27.92 0.43 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.468 ' CG2' HG21 ' A' ' 7' ' ' VAL . 10.8 p -103.19 37.28 2.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.132 -1.217 . . . . 0.0 109.59 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.553 ' CE2' HD11 ' A' ' 15' ' ' LEU . 6.0 t80 -104.25 117.68 34.8 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.527 -0.733 . . . . 0.0 110.021 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.519 ' N ' HD13 ' A' ' 44' ' ' ILE . 3.1 mp -96.47 124.11 52.09 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.235 -0.916 . . . . 0.0 110.318 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.93 127.05 11.11 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.827 1.435 . . . . 0.0 110.335 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -136.82 165.23 26.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.323 -0.86 . . . . 0.0 110.108 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -56.38 -18.83 12.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.732 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.5 ' C ' ' CG1' ' A' ' 49' ' ' VAL . 5.7 tt0 -67.55 -21.62 65.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.419 -0.801 . . . . 0.0 110.444 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.5 ' CG1' ' C ' ' A' ' 48' ' ' GLU . 1.4 m -151.65 173.95 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.026 -1.046 . . . . 0.0 110.38 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.4 137.24 37.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.322 -0.861 . . . . 0.0 110.215 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.432 ' HA ' HD13 ' A' ' 15' ' ' LEU . 97.9 t -57.55 114.55 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 109.526 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.518 HG22 ' HB2' ' A' ' 16' ' ' LYS . 14.4 t -90.96 -60.12 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.946 . . . . 0.0 111.068 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.501 ' C ' ' CD1' ' A' ' 54' ' ' ILE . 5.6 mt-10 -144.82 169.33 18.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.91 -1.119 . . . . 0.0 110.963 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.501 ' CD1' ' C ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -134.44 143.24 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.049 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.577 HD12 ' CD2' ' A' ' 96' ' ' TYR . 0.3 OUTLIER -137.25 130.14 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.963 -1.085 . . . . 0.0 110.605 -179.535 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.525 ' N ' HD13 ' A' ' 55' ' ' ILE . 2.4 mp0 -83.9 171.64 12.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.587 -0.696 . . . . 0.0 109.958 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.574 ' CA ' ' HA ' ' A' ' 95' ' ' ALA . . . -92.53 128.15 38.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.055 -1.028 . . . . 0.0 110.578 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER 172.71 60.98 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.24 -0.913 . . . . 0.0 111.424 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.566 ' CG2' ' N ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -166.43 -51.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.6 -1.313 . . . . 0.0 111.637 179.331 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.566 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 3.5 mt -81.6 142.1 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.815 -1.178 . . . . 0.0 110.56 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.46 -170.39 0.28 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.315 -0.866 . . . . 0.0 110.745 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.545 ' HB2' ' CG1' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -91.55 -35.89 14.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 0.0 110.445 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.476 ' CB ' ' HB2' ' A' ' 110' ' ' ALA . 2.0 m120 -87.72 -29.65 20.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.521 -0.737 . . . . 0.0 110.965 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 109' ' ' ASP . 7.9 tp-100 -58.63 140.59 54.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.085 -1.009 . . . . 0.0 111.476 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.597 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . . . -118.45 141.44 48.55 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.473 ' O ' HD21 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -126.08 117.5 23.31 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.431 -0.793 . . . . 0.0 110.97 -178.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.406 ' HA ' HD21 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -92.37 125.81 37.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 0.0 109.81 179.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.511 ' CD1' ' OE1' ' A' ' 102' ' ' GLU . 3.5 mm? -112.15 134.09 53.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.984 . . . . 0.0 110.576 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.534 ' CB ' HD13 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -125.66 150.95 47.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -0.881 . . . . 0.0 110.057 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.555 ' HB1' ' CZ3' ' A' ' 75' ' ' TRP . . . -70.33 142.0 52.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.39 -0.819 . . . . 0.0 110.519 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -118.49 -24.45 6.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.429 -0.795 . . . . 0.0 109.615 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 74' ' ' CYS . 2.6 ttpt -127.69 109.35 11.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.493 -0.754 . . . . 0.0 109.847 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -47.17 90.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.436 -0.79 . . . . 0.0 110.346 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 72' ' ' LYS . 0.5 OUTLIER -177.46 -32.89 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 110.094 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.6 ' CZ3' ' HB3' ' A' ' 102' ' ' GLU . 2.8 t90 -75.16 114.75 14.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.327 -0.858 . . . . 0.0 110.011 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.468 ' HA ' ' HB2' ' A' ' 82' ' ' ARG . 67.5 m-20 -91.48 113.55 25.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.924 . . . . 0.0 110.357 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.443 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -57.08 -48.9 77.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.329 -0.857 . . . . 0.0 109.851 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -93.49 -16.3 24.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 109.892 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.77 32.96 5.46 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -129.34 47.99 2.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -1.107 . . . . 0.0 109.989 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.551 ' OE1' ' CE2' ' A' ' 21' ' ' PHE . 7.9 mp0 49.04 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.38 -0.825 . . . . 0.0 110.422 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.468 ' HB2' ' HA ' ' A' ' 76' ' ' ASP . 12.8 mmt180 -113.69 -179.96 3.79 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.393 -0.817 . . . . 0.0 110.121 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.485 HG23 ' N ' ' A' ' 84' ' ' THR . 10.9 p -120.87 165.74 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.223 -0.923 . . . . 0.0 110.651 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.53 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -51.2 -20.99 1.78 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.388 -0.82 . . . . 0.0 110.377 179.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.53 -11.58 65.41 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.458 ' OE1' ' CA ' ' A' ' 86' ' ' GLU . 2.1 tp10 -84.48 142.22 30.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.393 -1.063 . . . . 0.0 110.026 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -148.08 158.89 44.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.186 -0.946 . . . . 0.0 110.288 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.45 ' CZ2' ' CG2' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -144.6 134.77 24.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 109.909 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.512 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -95.56 128.7 42.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.14 -0.975 . . . . 0.0 110.055 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.512 ' N ' HD22 ' A' ' 89' ' ' LEU . 5.4 p -108.44 128.61 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 109.995 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.4 HG23 ' CD1' ' A' ' 89' ' ' LEU . 1.1 p -129.51 48.42 2.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -0.88 . . . . 0.0 110.197 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 m -75.83 169.68 17.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.132 -0.98 . . . . 0.0 109.993 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.545 ' CG1' ' HB2' ' A' ' 62' ' ' GLN . 89.7 t -115.14 131.76 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.216 -0.927 . . . . 0.0 110.495 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 60' ' ' ILE . . . 50.01 44.57 41.64 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.574 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . . . -134.33 157.8 45.43 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.222 -1.163 . . . . 0.0 111.036 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.577 ' CD2' HD12 ' A' ' 55' ' ' ILE . 1.3 t80 -121.78 113.85 20.26 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.537 ' CD2' ' HB2' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -126.37 84.9 61.14 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.049 -1.032 . . . . 0.0 111.029 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.525 ' O ' ' NE2' ' A' ' 14' ' ' HIS . 50.0 Cg_endo -77.48 117.44 4.32 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.142 1.601 . . . . 0.0 110.02 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.535 ' HB1' ' CG ' ' A' ' 102' ' ' GLU . . . -74.74 -168.95 0.79 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.026 -1.046 . . . . 0.0 110.431 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.45 HG21 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -113.93 -57.21 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.205 -0.934 . . . . 0.0 110.45 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.499 ' CE2' ' HB3' ' A' ' 74' ' ' CYS . 21.9 m-30 -103.23 -32.14 9.75 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.75 -1.218 . . . . 0.0 110.672 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.6 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -80.07 154.83 27.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.199 -0.938 . . . . 0.0 110.641 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.456 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 6.9 tp10 -128.94 167.73 17.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.458 -0.776 . . . . 0.0 110.2 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 104' ' ' VAL . 10.7 m -72.02 152.31 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.0 110.245 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.562 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 4.7 mp -100.06 -14.57 18.56 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.295 -0.878 . . . . 0.0 109.605 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 1.8 p30 165.25 -168.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.61 -0.681 . . . . 0.0 110.151 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.479 ' CD1' ' CD ' ' A' ' 64' ' ' GLN . 1.0 OUTLIER -127.01 116.08 20.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.464 -0.772 . . . . 0.0 109.416 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.597 ' CG1' ' CB ' ' A' ' 65' ' ' ALA . 2.0 p -115.87 103.71 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.832 -1.168 . . . . 0.0 111.037 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 3.8 t70 -75.61 115.66 15.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.279 -0.888 . . . . 0.0 110.125 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.476 ' HB2' ' CB ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.886 . . . . 0.0 110.586 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.169 0.509 . . . . 0.0 110.261 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.436 ' C ' ' HA2' ' A' ' 41' ' ' GLY . 95.7 t -136.01 135.59 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.166 -0.959 . . . . 0.0 110.131 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.512 ' CG2' ' HA3' ' A' ' 41' ' ' GLY . 79.2 t -60.88 118.7 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 110.829 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.506 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 0.4 OUTLIER -79.16 167.24 36.18 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 109.717 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 42.9 Cg_endo -69.9 -37.12 9.26 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.612 1.322 . . . . 0.0 110.383 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.43 ' CG ' ' HA3' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -170.69 41.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.104 -0.998 . . . . 0.0 110.246 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.444 ' OG1' ' CB ' ' A' ' 8' ' ' LEU . 12.6 p -112.98 160.86 17.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.817 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -146.82 155.35 42.28 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.988 -1.07 . . . . 0.0 110.177 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.58 HD21 ' CD2' ' A' ' 43' ' ' TYR . 0.4 OUTLIER -123.39 154.6 38.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.166 -0.959 . . . . 0.0 110.639 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.569 ' CD2' HD11 ' A' ' 36' ' ' LEU . 7.9 m170 -94.96 127.54 41.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 109.966 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.63 ' CD1' ' CZ2' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -136.1 148.35 48.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.931 -1.105 . . . . 0.0 110.661 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -100.78 121.15 41.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.547 -0.721 . . . . 0.0 110.359 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.538 ' CB ' ' HB2' ' A' ' 33' ' ' ASP . . . -82.46 113.57 20.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 110.028 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.463 ' O ' HD22 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -105.12 99.6 9.21 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.547 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.535 HD11 ' N ' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -167.5 133.33 2.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.356 -0.84 . . . . 0.0 110.079 179.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.535 ' N ' HD11 ' A' ' 19' ' ' LEU . 10.2 t70 -78.26 101.84 7.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.014 -1.054 . . . . 0.0 108.693 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.452 ' HB2' HG23 ' A' ' 29' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.12 -0.988 . . . . 0.0 111.542 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.52 HG13 ' CB ' ' A' ' 81' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 31' ' ' ALA . 27.0 m -132.64 78.54 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.978 -1.077 . . . . 0.0 111.056 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 30' ' ' VAL . . . 35.68 72.29 0.11 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.741 -0.599 . . . . 0.0 111.23 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.56 34.2 0.02 OUTLIER Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.365 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.538 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 3.8 m-20 -93.31 145.62 24.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.893 -1.357 . . . . 0.0 110.36 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 101' ' ' PHE . 14.1 tt0 -140.86 130.18 23.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 0.0 109.396 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.63 ' CZ2' ' CD1' ' A' ' 15' ' ' LEU . 3.7 p90 -157.62 166.95 31.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.97 -1.081 . . . . 0.0 111.286 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.569 HD11 ' CD2' ' A' ' 14' ' ' HIS . 16.2 tp -90.36 155.69 18.77 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.531 -0.731 . . . . 0.0 109.183 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.581 ' CZ ' ' HA ' ' A' ' 40' ' ' PRO . 1.0 OUTLIER -126.42 108.61 11.36 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.099 -1.001 . . . . 0.0 109.841 -179.563 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.545 ' HG3' ' CD1' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -88.44 142.22 27.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.413 -0.804 . . . . 0.0 109.384 179.63 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.611 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 54.52 46.17 74.46 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 47.8 Cg_endo -71.33 18.32 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.861 1.453 . . . . 0.0 112.344 -178.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.513 ' O ' ' OG1' ' A' ' 42' ' ' THR . . . -44.81 156.75 0.25 Allowed Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.513 ' OG1' ' O ' ' A' ' 41' ' ' GLY . 20.3 p 53.45 12.13 0.33 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.662 -0.905 . . . . 0.0 111.583 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.58 ' CD2' HD21 ' A' ' 13' ' ' LEU . 7.0 t80 -75.62 132.37 40.58 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.702 -1.249 . . . . 0.0 109.548 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.413 ' HB ' ' CZ ' ' A' ' 46' ' ' ARG . 50.3 mt -120.52 134.48 24.19 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.054 -1.028 . . . . 0.0 110.492 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.47 ' HB3' HG13 ' A' ' 51' ' ' VAL . 46.7 Cg_endo -73.3 78.46 2.29 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.968 1.509 . . . . 0.0 110.303 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 47' ' ' LYS . 22.8 mtm180 -91.58 151.02 20.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 110.364 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 48' ' ' GLU . 13.7 mttt -42.16 -31.78 0.41 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.238 -0.914 . . . . 0.0 110.287 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -42.9 -51.02 5.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.39 -0.819 . . . . 0.0 109.772 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.503 ' HB ' ' HA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -134.81 173.76 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.381 -0.825 . . . . 0.0 109.389 179.382 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.41 122.74 28.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.19 -0.944 . . . . 0.0 110.407 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.47 HG13 ' HB3' ' A' ' 45' ' ' PRO . 33.7 m -54.27 123.36 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.113 -0.992 . . . . 0.0 108.678 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.49 HG22 ' HA ' ' A' ' 15' ' ' LEU . 57.1 t -99.36 -54.51 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.148 -0.97 . . . . 0.0 110.472 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.498 ' C ' ' CD1' ' A' ' 54' ' ' ILE . 27.6 mm-40 -138.72 174.65 10.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 110.205 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.498 ' CD1' ' C ' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -134.09 144.26 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.405 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -134.26 144.67 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.961 -1.087 . . . . 0.0 111.138 -178.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.443 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 70.9 mm-40 -119.36 168.51 10.87 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.684 -0.635 . . . . 0.0 109.347 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.531 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . . . -89.51 132.51 35.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.154 -0.966 . . . . 0.0 110.43 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.61 ' N ' ' CB ' ' A' ' 95' ' ' ALA . 1.5 t -176.24 71.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.13 -0.981 . . . . 0.0 111.293 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.597 ' CG2' ' HB3' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -176.66 -51.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.825 -1.172 . . . . 0.0 111.732 178.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.585 ' CG2' ' N ' ' A' ' 61' ' ' ARG . 1.0 OUTLIER -108.3 -167.36 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.157 -1.59 . . . . 0.0 110.791 -179.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.585 ' N ' ' CG2' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -123.43 -147.71 0.38 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.461 -0.774 . . . . 0.0 110.115 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.562 ' HB2' ' CG1' ' A' ' 93' ' ' VAL . 11.4 tt0 -89.67 -71.31 0.61 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.206 -0.934 . . . . 0.0 110.919 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.532 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 7.5 p-10 -34.16 -47.66 0.29 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.832 -0.543 . . . . 0.0 111.72 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' A' ' 108' ' ' VAL . 54.0 tp60 -56.23 128.18 34.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.958 -1.089 . . . . 0.0 110.931 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.459 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -108.19 149.17 28.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.342 -0.849 . . . . 0.0 109.303 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.464 ' O ' HD22 ' A' ' 89' ' ' LEU . 1.4 mt -126.27 113.71 17.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.068 -1.02 . . . . 0.0 111.333 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.472 ' HA ' HD22 ' A' ' 89' ' ' LEU . 1.5 ttm-85 -100.03 122.05 42.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.213 -0.929 . . . . 0.0 109.04 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.537 ' CD2' ' HA ' ' A' ' 104' ' ' VAL . 20.1 mt -119.21 145.69 45.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.106 -0.996 . . . . 0.0 111.277 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 2.0 ttp85 -121.03 152.6 38.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.541 -0.725 . . . . 0.0 110.059 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.495 ' HB1' ' O ' ' A' ' 84' ' ' THR . . . -71.7 159.9 33.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -0.929 . . . . 0.0 110.867 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.4 tpm_? -132.0 -34.15 1.3 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.457 -0.777 . . . . 0.0 109.813 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -117.98 107.69 14.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 110.036 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.481 ' O ' ' CB ' ' A' ' 74' ' ' CYS . 0.8 OUTLIER -47.89 99.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.619 179.576 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER 169.71 -24.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.329 -0.857 . . . . 0.0 110.294 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.59 ' CZ3' ' HB2' ' A' ' 102' ' ' GLU . 1.3 t90 -74.72 126.73 31.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -0.923 . . . . 0.0 110.058 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 1.5 m-20 -90.82 110.85 22.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 110.001 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.548 ' HG3' ' CZ2' ' A' ' 75' ' ' TRP . 10.1 mtp180 -59.03 -57.65 12.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.158 -0.964 . . . . 0.0 110.169 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.43 0.23 14.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.33 -0.856 . . . . 0.0 110.274 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.72 9.47 16.57 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -98.51 -11.7 22.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -1.15 . . . . 0.0 109.983 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.52 ' CB ' HG13 ' A' ' 29' ' ' VAL . 2.0 tm-20 61.88 104.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -0.849 . . . . 0.0 110.306 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.467 ' HB2' ' OE1' ' A' ' 86' ' ' GLU . 46.7 mtt180 -123.28 175.04 6.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.333 -0.854 . . . . 0.0 109.918 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.412 ' CG2' ' N ' ' A' ' 84' ' ' THR . 10.8 p -76.83 174.74 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.219 -0.925 . . . . 0.0 110.461 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.495 ' O ' ' HB1' ' A' ' 70' ' ' ALA . 1.9 t -60.61 -10.84 5.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.368 -0.832 . . . . 0.0 110.366 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -76.91 -10.32 86.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.488 ' HG2' ' HB2' ' A' ' 70' ' ' ALA . 9.0 pt-20 -73.22 153.47 40.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.185 -1.185 . . . . 0.0 109.864 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -160.33 161.15 33.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 110.227 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.586 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -149.56 145.87 27.05 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.161 -0.962 . . . . 0.0 110.215 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.517 ' CD1' ' OG1' ' A' ' 91' ' ' THR . 0.3 OUTLIER -106.02 125.19 50.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 0.0 110.321 -179.14 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.584 HG23 ' CE2' ' A' ' 88' ' ' TRP . 22.8 t -93.49 128.07 45.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.467 -0.771 . . . . 0.0 110.765 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.517 ' OG1' ' CD1' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -134.48 30.04 3.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.53 -0.732 . . . . 0.0 109.246 179.383 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.46 130.83 35.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.478 -0.764 . . . . 0.0 110.725 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.562 ' CG1' ' HB2' ' A' ' 62' ' ' GLN . 6.4 t -65.51 113.82 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.374 -0.829 . . . . 0.0 110.033 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.43 ' HA3' ' CG ' ' A' ' 10' ' ' ASN . . . -179.85 -95.37 0.1 OUTLIER Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.293 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.61 ' CB ' ' N ' ' A' ' 58' ' ' THR . . . -150.13 -50.28 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.072 -1.252 . . . . 0.0 111.227 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.597 ' HB3' ' CG2' ' A' ' 59' ' ' ILE . 1.8 p90 176.51 161.37 0.37 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.48 -0.763 . . . . 0.0 110.606 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.545 ' CD1' ' HG3' ' A' ' 38' ' ' GLU . 12.9 mt -155.41 72.73 5.53 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.363 -0.836 . . . . 0.0 110.172 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.529 ' HD3' ' CD2' ' A' ' 96' ' ' TYR . 45.8 Cg_endo -72.35 128.5 13.76 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.883 1.464 . . . . 0.0 110.541 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.69 -163.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.354 -0.841 . . . . 0.0 110.333 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.86 -68.12 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.361 -0.837 . . . . 0.0 109.807 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 34' ' ' GLU . 16.2 m-30 -80.79 -21.2 41.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.258 -0.901 . . . . 0.0 109.935 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.59 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . 3.5 tt0 -87.8 146.11 25.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.378 -0.826 . . . . 0.0 110.411 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.32 170.73 9.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.464 -0.773 . . . . 0.0 110.066 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.537 ' HA ' ' CD2' ' A' ' 68' ' ' LEU . 7.6 p -84.52 136.39 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.114 -0.992 . . . . 0.0 110.461 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.48 ' O ' ' HB3' ' A' ' 106' ' ' ASP . 1.1 mp -93.95 -29.4 15.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 0.0 109.957 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.48 ' HB3' ' O ' ' A' ' 105' ' ' LEU . 15.0 p-10 -178.66 123.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.438 -0.788 . . . . 0.0 110.359 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -77.19 144.98 37.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -0.858 . . . . 0.0 109.73 179.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.518 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 12.9 p -130.87 154.49 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.062 -1.024 . . . . 0.0 110.307 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 47.4 t0 -110.5 123.37 49.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.148 -0.97 . . . . 0.0 110.144 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.18 -0.95 . . . . 0.0 110.407 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.457 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.291 0.567 . . . . 0.0 110.385 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.455 ' O ' HD11 ' A' ' 8' ' ' LEU . 22.0 t -92.36 152.21 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.384 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.452 ' C ' ' O ' ' A' ' 6' ' ' VAL . 54.4 t -41.44 122.54 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.241 -0.912 . . . . 0.0 110.128 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.489 HD11 ' N ' ' A' ' 8' ' ' LEU . 1.7 mp -78.85 159.76 73.08 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 110.366 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -75.48 -82.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.949 1.499 . . . . 0.0 110.164 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 10' ' ' ASN . 11.4 p30 -129.56 54.7 1.81 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.309 -0.87 . . . . 0.0 109.843 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.544 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 1.1 p -132.5 157.47 44.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.145 -0.972 . . . . 0.0 110.111 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 55' ' ' ILE . . . -141.3 162.08 36.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -0.959 . . . . 0.0 109.574 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.545 ' CD2' ' HG3' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -133.54 156.36 47.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.937 -1.102 . . . . 0.0 111.164 -179.492 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.584 ' CD2' HD13 ' A' ' 36' ' ' LEU . 8.9 m170 -96.24 123.32 39.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.438 -0.789 . . . . 0.0 109.882 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.663 ' CD1' ' CZ2' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -125.76 148.86 48.95 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.081 -1.012 . . . . 0.0 109.55 179.278 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -96.98 119.22 35.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 110.714 -178.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.537 ' HA ' ' CG1' ' A' ' 49' ' ' VAL . . . -76.92 115.12 16.42 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.622 0.725 . . . . 0.0 110.258 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 86.8 mt -97.84 100.85 12.23 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.523 HD11 ' N ' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -158.64 144.9 17.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.146 -0.971 . . . . 0.0 110.653 -178.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.523 ' N ' HD11 ' A' ' 19' ' ' LEU . 20.1 p-10 -86.4 102.42 14.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 0.0 109.08 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.544 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 110.818 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.544 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 30' ' ' VAL . 22.8 m -125.96 90.97 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.971 -1.08 . . . . 0.0 110.467 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 42.96 61.57 2.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.0 110.222 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.68 24.14 0.2 Allowed Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.489 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.531 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 1.6 m-20 -88.9 161.15 16.83 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.875 -1.368 . . . . 0.0 110.03 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.515 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 9.9 pt-20 -159.81 130.97 5.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.251 -0.906 . . . . 0.0 110.575 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.663 ' CZ2' ' CD1' ' A' ' 15' ' ' LEU . 6.0 p90 -145.64 170.79 15.77 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.376 -0.827 . . . . 0.0 110.228 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.584 HD13 ' CD2' ' A' ' 14' ' ' HIS . 13.6 tp -90.44 156.07 18.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 110.033 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.598 ' CE1' ' HA ' ' A' ' 40' ' ' PRO . 3.7 t80 -132.76 110.47 10.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -0.872 . . . . 0.0 109.436 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.412 ' HB2' HD12 ' A' ' 97' ' ' LEU . 3.1 tm-20 -91.5 136.5 33.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.298 -0.877 . . . . 0.0 110.094 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.6 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 65.86 46.22 83.59 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 38.7 Cg_endo -66.09 -61.07 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.925 1.487 . . . . 0.0 110.461 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.457 ' O ' ' CB ' ' A' ' 5' ' ' GLN . . . 43.62 -88.62 0.01 OUTLIER Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.577 ' N ' ' O ' ' A' ' 40' ' ' PRO . 1.4 p -70.39 4.35 2.36 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.31 -1.112 . . . . 0.0 111.658 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.561 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 11.1 t80 -68.5 112.26 5.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.609 -1.307 . . . . 0.0 109.976 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.473 HG21 ' HD2' ' A' ' 45' ' ' PRO . 4.1 mm -104.13 141.8 23.27 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.345 -0.847 . . . . 0.0 109.737 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.473 ' HD2' HG21 ' A' ' 44' ' ' ILE . 43.0 Cg_endo -70.18 93.35 0.56 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.93 1.49 . . . . 0.0 110.101 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.404 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -102.78 158.9 15.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.272 -0.892 . . . . 0.0 110.604 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -44.56 -35.61 2.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.431 -0.793 . . . . 0.0 110.104 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -45.28 -48.09 12.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.301 -0.874 . . . . 0.0 110.105 179.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.537 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -147.15 173.3 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.267 -0.895 . . . . 0.0 110.077 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.482 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.2 mt-10 -130.66 127.15 38.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.243 -0.911 . . . . 0.0 110.652 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.7 p -55.06 128.5 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.185 -0.947 . . . . 0.0 109.456 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 50' ' ' GLU . 60.2 t -109.84 -61.04 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -0.95 . . . . 0.0 110.907 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.497 ' C ' ' CD1' ' A' ' 54' ' ' ILE . 2.6 mt-10 -124.46 173.96 8.1 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.192 -0.943 . . . . 0.0 110.774 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 13' ' ' LEU . 1.1 mm -137.01 155.54 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.544 ' O ' ' HB ' ' A' ' 11' ' ' THR . 1.1 mt -146.82 151.12 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.909 -1.12 . . . . 0.0 111.132 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.486 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 87.5 mm-40 -124.21 170.12 11.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.774 -0.579 . . . . 0.0 110.337 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.543 ' CB ' ' HA ' ' A' ' 95' ' ' ALA . . . -86.51 153.85 21.54 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.229 -0.92 . . . . 0.0 110.845 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER 172.65 29.42 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.073 -1.017 . . . . 0.0 112.621 179.004 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.586 ' CG2' ' CB ' ' A' ' 96' ' ' TYR . 2.3 tt -161.88 -35.11 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 119.707 -1.871 . . . . 0.0 113.913 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.495 ' HB ' ' O ' ' A' ' 95' ' ' ALA . 48.6 mt -75.7 152.49 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.078 -1.639 . . . . 0.0 111.188 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.0 -154.73 0.25 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.556 -0.715 . . . . 0.0 110.18 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.526 ' HA ' ' CG1' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -82.27 -69.35 0.63 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 110.93 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.561 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 2.2 m-20 -78.49 -8.17 58.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.105 -0.997 . . . . 0.0 110.665 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 108' ' ' VAL . 5.2 tp-100 -55.32 124.5 17.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.986 -1.071 . . . . 0.0 110.663 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.481 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -108.32 151.04 26.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.308 -0.87 . . . . 0.0 110.232 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.486 ' CB ' ' HB ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -125.69 121.83 34.58 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.196 -0.94 . . . . 0.0 110.418 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.537 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 8.4 mmm180 -93.34 123.91 36.96 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.249 -0.907 . . . . 0.0 110.283 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.527 HD12 ' N ' ' A' ' 104' ' ' VAL . 1.1 mm? -124.99 127.73 47.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.16 -0.963 . . . . 0.0 110.385 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -110.64 165.69 11.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.18 -0.95 . . . . 0.0 110.061 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.485 ' HB2' ' CE3' ' A' ' 75' ' ' TRP . . . -76.36 157.82 32.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.084 -1.01 . . . . 0.0 110.649 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.516 ' CB ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -114.59 -38.44 4.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 0.0 109.553 179.53 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -138.82 131.9 29.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.445 -0.784 . . . . 0.0 109.647 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.46 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 1.1 pt-20 -56.55 84.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.113 -0.992 . . . . 0.0 110.13 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' A' ' 72' ' ' LYS . 1.7 m -162.63 -35.33 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.401 -0.812 . . . . 0.0 110.058 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.579 ' CZ2' ' HG2' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -74.1 118.48 17.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.854 . . . . 0.0 110.073 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -86.86 115.27 24.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.992 . . . . 0.0 110.273 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.579 ' HG2' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -55.48 -55.7 28.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.169 -0.957 . . . . 0.0 110.116 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -105.55 24.22 12.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.245 -0.909 . . . . 0.0 110.066 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.73 -10.25 68.4 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 23.9 pttt -87.45 136.97 32.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.391 -1.064 . . . . 0.0 110.161 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.445 ' CB ' ' CD1' ' A' ' 21' ' ' PHE . 3.6 tm-20 -47.14 118.94 2.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -0.913 . . . . 0.0 110.013 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.515 ' CB ' ' OE1' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -131.35 156.96 44.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.102 -0.999 . . . . 0.0 110.66 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.4 m -86.4 -178.65 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.328 -0.857 . . . . 0.0 110.444 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.441 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 12.5 t -73.61 -6.78 48.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.362 -0.837 . . . . 0.0 109.972 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -77.03 -24.84 65.56 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.515 ' OE1' ' CB ' ' A' ' 82' ' ' ARG . 4.6 pt-20 -57.11 162.0 2.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.045 -1.268 . . . . 0.0 110.058 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.489 ' HG3' ' HA ' ' A' ' 69' ' ' ARG . 6.0 tt0 -159.62 142.49 13.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.185 -0.947 . . . . 0.0 109.877 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.525 ' CZ2' ' HA ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -119.89 148.36 43.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.048 -1.032 . . . . 0.0 110.096 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.542 ' CD1' ' C ' ' A' ' 89' ' ' LEU . 1.2 tm? -113.25 128.61 56.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.533 -0.73 . . . . 0.0 110.07 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.525 ' HA ' ' CZ2' ' A' ' 88' ' ' TRP . 81.4 t -90.77 102.32 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.854 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.36 28.5 8.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.404 -0.81 . . . . 0.0 110.348 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.465 HG23 ' HB2' ' A' ' 95' ' ' ALA . 13.9 t -76.22 169.1 18.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 0.0 109.986 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.526 ' CG1' ' HA ' ' A' ' 62' ' ' GLN . 48.5 t -114.7 107.02 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.187 -0.946 . . . . 0.0 109.985 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.504 ' O ' ' HB3' ' A' ' 95' ' ' ALA . . . 87.79 78.61 1.26 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.543 ' HA ' ' CB ' ' A' ' 57' ' ' ALA . . . 174.37 -158.53 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.58 -0.953 . . . . 0.0 110.611 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.606 ' CG ' ' O ' ' A' ' 96' ' ' TYR . 0.0 OUTLIER 176.21 25.32 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.055 -1.028 . . . . 0.0 111.115 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.535 ' CD1' HD23 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -61.45 110.2 2.88 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.709 -1.244 . . . . 0.0 110.067 179.41 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 96' ' ' TYR . 50.5 Cg_endo -79.32 -92.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.921 1.485 . . . . 0.0 110.796 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 98' ' ' PRO . . . 171.54 -158.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 0.0 110.146 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.527 ' CG2' ' HA ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -113.36 -59.19 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.18 -0.95 . . . . 0.0 110.043 179.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.534 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 17.5 m-30 -99.96 11.8 38.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.069 -1.019 . . . . 0.0 109.457 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.526 ' CD ' ' CH2' ' A' ' 75' ' ' TRP . 6.0 tt0 -96.05 157.59 15.83 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.301 -0.874 . . . . 0.0 110.968 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.06 128.63 22.92 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.552 -0.718 . . . . 0.0 109.355 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.527 ' N ' HD12 ' A' ' 68' ' ' LEU . 6.9 p -75.58 151.64 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.077 -1.015 . . . . 0.0 110.466 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.529 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -104.14 -24.16 13.2 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.434 -0.792 . . . . 0.0 109.611 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.479 ' HB3' ' O ' ' A' ' 105' ' ' LEU . 1.0 OUTLIER 172.67 160.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.449 -0.782 . . . . 0.0 109.861 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.6 mp -96.82 134.94 39.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.095 -1.003 . . . . 0.0 109.649 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.506 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 7.0 p -122.01 157.02 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.061 -1.025 . . . . 0.0 110.755 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.65 131.42 55.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.453 -0.779 . . . . 0.0 109.664 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.141 -0.974 . . . . 0.0 110.667 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 6' ' ' VAL . 48.8 tt0 . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.2 0.524 . . . . 0.0 109.895 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.506 HG12 ' N ' ' A' ' 7' ' ' VAL . 80.6 t -41.57 164.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.362 -0.836 . . . . 0.0 110.467 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.546 ' HA ' ' CA ' ' A' ' 41' ' ' GLY . 33.7 t -37.74 140.89 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.585 -0.697 . . . . 0.0 111.272 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.403 ' HB3' ' OG1' ' A' ' 11' ' ' THR . 2.7 mp -86.76 168.74 17.07 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.436 -0.79 . . . . 0.0 110.057 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.432 ' O ' ' CB ' ' A' ' 10' ' ' ASN . 47.6 Cg_endo -76.1 59.36 5.89 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.1 1.579 . . . . 0.0 109.944 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 3.5 m-80 65.13 46.24 2.79 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.363 -0.835 . . . . 0.0 109.558 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 17.4 p -134.98 162.13 33.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 110.258 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.52 ' CB ' ' HA ' ' A' ' 38' ' ' GLU . . . -133.68 159.84 39.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.104 -0.997 . . . . 0.0 109.766 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.537 ' CD2' ' HG3' ' A' ' 40' ' ' PRO . 1.3 pp -133.04 144.96 50.38 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.97 -1.081 . . . . 0.0 110.52 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.5 ' O ' ' N ' ' A' ' 52' ' ' VAL . 29.8 m80 -89.88 131.25 35.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.411 -0.806 . . . . 0.0 109.245 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.653 ' CD1' ' CZ2' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -133.77 158.4 43.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.956 -1.09 . . . . 0.0 110.502 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -106.72 117.78 34.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.422 -0.798 . . . . 0.0 110.571 -179.158 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.551 ' CB ' ' HB2' ' A' ' 33' ' ' ASP . . . -80.49 111.86 17.29 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.366 -0.834 . . . . 0.0 109.693 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 2.4 mm? -103.03 101.47 11.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.673 -0.642 . . . . 0.0 110.359 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.532 HD13 ' N ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -160.88 144.66 13.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.138 -0.976 . . . . 0.0 110.544 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.532 ' N ' HD13 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -82.61 101.62 10.91 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.424 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.525 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.212 -0.93 . . . . 0.0 111.248 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.525 ' CG2' ' HB2' ' A' ' 21' ' ' PHE . 1.2 m . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 31' ' ' ALA . 16.5 m -127.9 84.59 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.094 -1.004 . . . . 0.0 110.615 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 41.12 70.16 0.28 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.404 -0.81 . . . . 0.0 110.66 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -170.72 22.7 0.08 OUTLIER Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.813 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.551 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 3.2 m-20 -88.43 149.33 23.75 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.811 -1.405 . . . . 0.0 109.829 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 68.1 tt0 -148.34 131.09 16.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.784 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.653 ' CZ2' ' CD1' ' A' ' 15' ' ' LEU . 6.3 p90 -151.97 167.22 29.07 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.448 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 37' ' ' PHE . 16.8 tp -90.84 154.24 19.65 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.549 -0.72 . . . . 0.0 109.846 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.524 ' CG ' ' HB3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -128.46 109.41 11.38 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.144 -0.972 . . . . 0.0 109.555 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.52 ' HA ' ' CB ' ' A' ' 12' ' ' ALA . 5.6 tm-20 -91.92 125.27 36.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.462 -0.774 . . . . 0.0 110.349 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.605 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 62.13 44.83 97.19 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 43.2 Cg_endo -71.08 57.63 2.11 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.681 1.358 . . . . 0.0 109.291 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.546 ' CA ' ' HA ' ' A' ' 7' ' ' VAL . . . -54.21 -14.17 4.29 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.583 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.419 ' C ' HD11 ' A' ' 44' ' ' ILE . 35.4 p -136.79 29.24 2.88 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.693 -1.475 . . . . 0.0 111.109 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.574 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 15.8 t80 -84.24 111.25 19.22 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.944 -1.102 . . . . 0.0 109.709 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.489 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 1.7 mm -103.28 138.87 19.66 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 108.963 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.462 ' HD2' HG21 ' A' ' 44' ' ' ILE . 43.6 Cg_endo -69.8 77.26 1.1 Allowed 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 123.847 1.446 . . . . 0.0 110.782 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.438 ' HD2' ' HB ' ' A' ' 44' ' ' ILE . 1.8 mtt180 -93.7 148.83 21.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 110.118 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 48' ' ' GLU . 0.1 OUTLIER -44.77 -34.33 2.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.915 . . . . 0.0 110.301 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.474 ' HG3' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -41.87 -48.38 4.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.603 -0.686 . . . . 0.0 109.585 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.547 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -136.34 173.82 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.388 -0.82 . . . . 0.0 109.09 178.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.438 ' O ' HG21 ' A' ' 52' ' ' VAL . 34.4 mt-10 -135.38 129.84 33.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.02 -1.05 . . . . 0.0 110.261 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.497 HG22 ' OH ' ' A' ' 43' ' ' TYR . 19.9 t -54.54 131.17 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.106 -0.996 . . . . 0.0 109.088 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.503 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 17.3 t -105.85 -55.55 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.104 -0.997 . . . . 0.0 110.621 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.49 ' C ' ' CD1' ' A' ' 54' ' ' ILE . 12.8 mm-40 -141.04 166.83 23.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.103 -0.998 . . . . 0.0 110.568 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.49 ' CD1' ' C ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -133.17 143.26 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.247 -0.908 . . . . 0.0 108.849 179.232 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.511 ' O ' ' HB ' ' A' ' 11' ' ' THR . 3.1 tt -140.71 152.11 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.996 -1.065 . . . . 0.0 111.179 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -103.61 179.69 4.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.457 -0.777 . . . . 0.0 110.041 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.54 ' CB ' ' HA ' ' A' ' 95' ' ' ALA . . . -101.97 143.1 32.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.188 -0.945 . . . . 0.0 110.536 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 0.8 OUTLIER 174.58 57.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.097 -1.002 . . . . 0.0 111.363 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.571 ' CG2' ' N ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -161.64 -60.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.503 -1.373 . . . . 0.0 111.776 179.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.571 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 1.8 mt -88.82 -144.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 120.169 -1.582 . . . . 0.0 110.377 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.533 ' HA ' ' N ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -165.22 176.66 8.23 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.071 -1.018 . . . . 0.0 110.295 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.5 ' CA ' ' HA ' ' A' ' 93' ' ' VAL . 1.3 tp-100 -68.54 -30.62 69.45 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.139 -0.976 . . . . 0.0 110.217 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.461 ' O ' ' HB1' ' A' ' 110' ' ' ALA . 2.5 m120 -69.51 -56.24 7.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.223 -0.923 . . . . 0.0 110.833 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.482 ' HA ' ' HA ' ' A' ' 109' ' ' ASP . 63.8 tp60 -59.61 140.87 56.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.211 -0.931 . . . . 0.0 110.802 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.557 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . . . -125.27 134.33 52.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.524 -0.735 . . . . 0.0 109.215 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.472 ' O ' HD22 ' A' ' 89' ' ' LEU . 7.9 mp -125.81 118.76 26.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.905 . . . . 0.0 111.028 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.461 ' O ' HD12 ' A' ' 105' ' ' LEU . 8.0 mtt85 -91.7 128.92 37.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.347 -0.846 . . . . 0.0 109.11 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.539 ' CD2' ' HA ' ' A' ' 104' ' ' VAL . 10.7 mt -126.36 153.5 44.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.027 -1.046 . . . . 0.0 110.922 -178.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 14.4 ttp180 -127.24 157.56 39.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.522 -0.736 . . . . 0.0 110.204 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 84' ' ' THR . . . -73.51 141.16 46.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.344 -0.847 . . . . 0.0 111.12 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -107.14 -38.25 6.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.303 -0.873 . . . . 0.0 109.589 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.537 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 9.1 mmtt -98.02 -88.07 0.32 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.356 -0.84 . . . . 0.0 109.922 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.537 ' HB3' ' O ' ' A' ' 72' ' ' LYS . 4.1 pt-20 164.24 -37.25 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.727 0.775 . . . . 0.0 108.948 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.46 ' SG ' ' HA ' ' A' ' 33' ' ' ASP . 1.3 m -56.42 -29.75 61.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.498 -0.751 . . . . 0.0 110.336 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.579 ' CZ2' ' OE1' ' A' ' 102' ' ' GLU . 16.8 t90 -76.98 103.81 7.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.167 -0.958 . . . . 0.0 110.087 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 1.8 p30 -101.92 114.24 28.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 110.123 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.514 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . 4.9 ppt_? -77.22 -22.15 52.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.29 -0.881 . . . . 0.0 110.33 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.427 ' N ' ' HG3' ' A' ' 77' ' ' ARG . 1.9 t0 -95.25 -19.21 20.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 110.236 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.25 24.66 11.11 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.514 ' O ' ' C ' ' A' ' 81' ' ' GLU . 1.4 mttt -137.14 52.63 1.91 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.243 -1.151 . . . . 0.0 110.155 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.514 ' C ' ' O ' ' A' ' 80' ' ' LYS . 2.2 pm0 26.46 94.84 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.259 0.552 . . . . 0.0 111.336 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.516 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 4.4 mpt_? -103.94 179.68 4.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 110.222 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.5 m -103.37 178.47 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -0.916 . . . . 0.0 110.144 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.472 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 2.8 t -59.19 -15.66 16.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 110.203 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.2 -39.17 45.15 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.516 ' CB ' ' HB3' ' A' ' 82' ' ' ARG . 19.4 tp10 -54.09 151.74 6.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -1.127 . . . . 0.0 109.957 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.463 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 19.5 pt-20 -159.36 173.85 15.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.173 -0.954 . . . . 0.0 110.436 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.575 ' CD1' ' OE1' ' A' ' 102' ' ' GLU . 0.6 OUTLIER -161.08 160.82 30.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.898 . . . . 0.0 110.103 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.523 HD23 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -108.34 138.04 45.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.324 -0.86 . . . . 0.0 110.195 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.523 ' N ' HD23 ' A' ' 89' ' ' LEU . 7.3 p -108.61 140.76 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -0.929 . . . . 0.0 110.451 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.4 t -157.55 50.39 0.44 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.393 -0.817 . . . . 0.0 110.261 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.432 HG21 ' N ' ' A' ' 93' ' ' VAL . 1.8 m -75.27 157.9 33.71 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.198 -0.938 . . . . 0.0 110.071 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.5 ' HA ' ' CA ' ' A' ' 62' ' ' GLN . 2.6 t -77.69 72.89 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.244 -0.91 . . . . 0.0 110.122 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.533 ' N ' ' HA ' ' A' ' 61' ' ' ARG . . . 87.86 107.04 0.95 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.54 ' HA ' ' CB ' ' A' ' 57' ' ' ALA . . . 179.88 169.33 1.2 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -1.1 . . . . 0.0 110.385 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.474 ' HB2' ' HB ' ' A' ' 59' ' ' ILE . 2.0 t80 -129.57 88.33 2.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.769 -0.582 . . . . 0.0 110.054 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.516 HD11 ' CG ' ' A' ' 38' ' ' GLU . 17.0 mt -119.12 86.23 31.67 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.157 -0.964 . . . . 0.0 110.479 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.463 ' O ' ' HB2' ' A' ' 99' ' ' ALA . 50.0 Cg_endo -79.69 9.26 3.57 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.884 1.465 . . . . 0.0 110.648 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.55 ' CB ' ' HB3' ' A' ' 102' ' ' GLU . . . 58.07 -175.27 0.08 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.15 -0.969 . . . . 0.0 110.063 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 t -109.44 -55.69 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.078 -1.014 . . . . 0.0 110.532 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.574 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 23.0 m-85 -107.6 9.76 29.29 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.076 -1.015 . . . . 0.0 110.152 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.579 ' OE1' ' CZ2' ' A' ' 75' ' ' TRP . 12.6 tt0 -105.05 153.49 21.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 111.575 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -131.05 167.3 19.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.475 -0.766 . . . . 0.0 110.083 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.539 ' HA ' ' CD2' ' A' ' 68' ' ' LEU . 7.3 p -92.55 143.36 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.107 -0.996 . . . . 0.0 110.692 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -105.02 -19.39 13.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.406 -0.809 . . . . 0.0 110.114 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -169.6 179.71 3.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.221 -0.925 . . . . 0.0 110.324 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.543 ' C ' ' CD2' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -138.99 141.25 38.35 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.125 -0.984 . . . . 0.0 110.612 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.557 ' CG1' ' CB ' ' A' ' 65' ' ' ALA . 8.8 p -139.51 116.7 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.94 -1.1 . . . . 0.0 110.771 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 31.1 t0 -86.81 117.4 25.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.048 -1.033 . . . . 0.0 110.119 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 110.266 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.333 0.587 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.75 -162.78 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.497 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.492 ' HA ' ' HA2' ' A' ' 41' ' ' GLY . 60.5 t -87.9 84.1 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 110.482 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.534 ' CD2' ' OG1' ' A' ' 11' ' ' THR . 0.1 OUTLIER -47.07 160.54 0.34 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.399 -0.813 . . . . 0.0 109.988 179.588 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.02 -47.81 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.861 1.453 . . . . 0.0 110.402 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.455 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 5.4 m120 -162.67 31.95 0.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.195 -0.94 . . . . 0.0 110.142 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.534 ' OG1' ' CD2' ' A' ' 8' ' ' LEU . 14.1 p -104.8 166.62 10.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.31 -0.869 . . . . 0.0 110.171 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.51 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -144.74 160.07 41.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.026 -1.046 . . . . 0.0 110.471 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.522 ' CD1' HD13 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -133.16 151.11 51.98 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.09 -1.006 . . . . 0.0 109.646 179.509 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.45 ' O ' ' HB ' ' A' ' 52' ' ' VAL . 65.7 m80 -95.36 127.21 41.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 0.0 110.582 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.596 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 1.7 mm? -113.95 152.17 31.24 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.517 -0.739 . . . . 0.0 110.277 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.541 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -108.09 115.89 30.95 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.19 -0.944 . . . . 0.0 108.707 178.049 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 33' ' ' ASP . . . -78.6 111.26 14.49 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.941 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 48' ' ' GLU . 51.1 mt -98.11 100.95 12.3 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.251 0.548 . . . . 0.0 109.982 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.47 134.0 7.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 110.129 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -75.68 101.63 5.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.034 -1.042 . . . . 0.0 109.715 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.538 ' CB ' HG21 ' A' ' 29' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.844 . . . . 0.0 110.435 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.538 HG21 ' CB ' ' A' ' 21' ' ' PHE . 1.5 m . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 121.271 0.558 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.456 ' O ' HG23 ' A' ' 30' ' ' VAL . 27.2 m -140.57 83.55 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.165 -0.96 . . . . 0.0 110.188 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.52 70.97 0.37 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.507 -0.745 . . . . 0.0 110.565 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.54 27.92 0.03 OUTLIER Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.34 -1.41 . . . . 0.0 110.892 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.552 ' O ' ' N ' ' A' ' 17' ' ' ALA . 2.2 m-20 -94.13 156.45 16.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.664 -1.492 . . . . 0.0 110.002 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 16.5 tt0 -148.61 145.34 27.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.011 -1.055 . . . . 0.0 110.525 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.553 ' CZ2' ' HB2' ' A' ' 15' ' ' LEU . 12.5 p90 -149.95 166.89 28.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.362 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.479 HD22 ' HB3' ' A' ' 97' ' ' LEU . 53.6 tp -96.47 151.81 19.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.188 -0.945 . . . . 0.0 109.953 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.503 ' HB2' HD23 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -130.77 115.53 16.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.034 -1.041 . . . . 0.0 110.493 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.534 ' CG ' HD23 ' A' ' 97' ' ' LEU . 2.6 tm-20 -96.95 120.99 38.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.536 -0.728 . . . . 0.0 110.326 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.579 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 72.82 46.39 30.15 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 41.6 Cg_endo -66.44 61.29 0.52 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.884 1.465 . . . . 0.0 110.54 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.547 ' C ' ' O ' ' A' ' 40' ' ' PRO . . . -19.0 -92.1 0.01 OUTLIER Glycine 0 N--CA 1.501 2.977 0 N-CA-C 111.491 -0.643 . . . . 0.0 111.491 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.9 p -109.96 49.01 0.86 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.041 -1.27 . . . . 0.0 110.365 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.571 ' CZ ' ' HG ' ' A' ' 15' ' ' LEU . 30.9 t80 -69.83 130.22 41.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.041 -1.037 . . . . 0.0 110.358 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.494 ' CG2' ' HD2' ' A' ' 45' ' ' PRO . 5.5 mt -124.94 145.29 49.61 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.356 -0.84 . . . . 0.0 109.591 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.494 ' HD2' ' CG2' ' A' ' 44' ' ' ILE . 45.8 Cg_endo -71.43 90.8 0.68 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.987 1.519 . . . . 0.0 110.584 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 49' ' ' VAL . 3.9 mtp180 -98.21 152.64 19.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.294 -0.879 . . . . 0.0 110.03 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 46' ' ' ARG . 32.0 tttm -41.49 -31.55 0.27 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.288 -0.883 . . . . 0.0 110.479 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.483 ' O ' HG13 ' A' ' 49' ' ' VAL . 16.7 tt0 -53.82 -41.41 67.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.128 -0.983 . . . . 0.0 109.923 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.518 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 2.1 m -145.7 171.27 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.636 -0.665 . . . . 0.0 109.386 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.21 140.58 47.61 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.684 -1.26 . . . . 0.0 111.125 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.476 ' HA ' HD12 ' A' ' 15' ' ' LEU . 24.9 t -56.53 123.23 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 109.067 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.541 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 7.2 t -105.1 -60.32 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.118 -0.989 . . . . 0.0 110.729 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.47 ' C ' ' CD1' ' A' ' 54' ' ' ILE . 27.1 mm-40 -138.06 162.61 33.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 110.394 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.47 ' CD1' ' C ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -134.49 137.96 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.318 -0.864 . . . . 0.0 109.325 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.51 HG22 ' O ' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -137.37 142.19 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.92 -1.113 . . . . 0.0 111.573 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.493 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 4.0 mm100 -90.67 -179.65 5.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.382 -0.823 . . . . 0.0 109.299 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.538 ' HB3' ' CB ' ' A' ' 95' ' ' ALA . . . -98.41 124.07 42.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.788 -1.195 . . . . 0.0 110.667 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.464 ' O ' HG12 ' A' ' 59' ' ' ILE . 10.1 t -172.12 49.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.443 -0.786 . . . . 0.0 109.818 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.617 HG13 ' CG ' ' A' ' 96' ' ' TYR . 0.7 OUTLIER -150.5 -75.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.083 -1.01 . . . . 0.0 111.533 -179.077 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.569 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 10.0 mt -92.47 125.28 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.905 -1.122 . . . . 0.0 111.534 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.519 ' HA ' ' N ' ' A' ' 94' ' ' GLY . 0.1 OUTLIER -68.66 -165.73 0.07 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.45 -0.781 . . . . 0.0 110.351 179.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.565 ' CA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -91.62 -12.97 32.71 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.142 -0.974 . . . . 0.0 111.023 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.54 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 0.9 OUTLIER -87.66 -54.28 4.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.024 -1.047 . . . . 0.0 109.522 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 108' ' ' VAL . 4.1 tp-100 -57.49 128.39 36.8 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.229 -0.919 . . . . 0.0 110.199 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.501 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . . . -107.8 139.72 41.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.293 -0.879 . . . . 0.0 108.888 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.503 ' O ' HD21 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -120.84 124.72 45.73 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.198 -0.939 . . . . 0.0 110.876 -179.015 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.476 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 1.4 mtm180 -90.3 126.53 35.88 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.395 -0.816 . . . . 0.0 109.055 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.555 ' HB3' ' CG ' ' A' ' 102' ' ' GLU . 14.2 mt -120.01 147.34 44.91 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.216 -0.994 . . . . 0.0 111.702 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.555 ' HA ' ' CB ' ' A' ' 87' ' ' GLU . 12.4 ttm180 -126.44 162.74 24.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.552 -0.717 . . . . 0.0 110.241 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . -78.67 153.28 31.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.22 -0.925 . . . . 0.0 110.619 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.5 ' CZ ' ' HG3' ' A' ' 103' ' ' GLU . 19.8 tpp85 -126.84 -31.14 2.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.886 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 74' ' ' CYS . 20.9 tptm -121.34 128.85 52.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.759 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.518 ' HA ' ' N ' ' A' ' 84' ' ' THR . 6.5 pt-20 -67.06 58.38 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.195 -0.941 . . . . 0.0 110.401 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -149.62 -24.37 0.27 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.367 -0.833 . . . . 0.0 110.977 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.592 ' CZ2' ' HG2' ' A' ' 77' ' ' ARG . 1.2 t90 -73.87 117.34 15.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.972 -1.08 . . . . 0.0 109.72 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -81.53 117.33 21.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.325 -0.859 . . . . 0.0 110.893 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.592 ' HG2' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -81.74 -45.94 14.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.343 -0.848 . . . . 0.0 109.606 179.25 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.68 -1.85 36.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.364 -0.835 . . . . 0.0 110.331 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.3 -35.11 5.02 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -78.94 -103.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.295 -1.121 . . . . 0.0 110.12 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.413 ' OE1' ' HA ' ' A' ' 81' ' ' GLU . 71.8 mm-40 -137.93 127.26 24.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.929 -1.107 . . . . 0.0 109.837 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -131.42 171.97 12.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.235 -0.916 . . . . 0.0 110.4 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.542 ' CG2' ' N ' ' A' ' 84' ' ' THR . 2.3 p -116.01 171.61 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -0.819 . . . . 0.0 110.062 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.542 ' N ' ' CG2' ' A' ' 83' ' ' VAL . 13.6 t -57.13 -164.23 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.25 -0.98 . . . . 0.0 108.563 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 86' ' ' GLU . . . 68.65 -58.89 0.48 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.52 ' O ' ' CB ' ' A' ' 70' ' ' ALA . 1.9 tp10 -43.89 151.38 0.21 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -1.141 . . . . 0.0 109.103 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.555 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 5.8 pt-20 -145.16 160.04 42.06 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.205 -0.934 . . . . 0.0 110.741 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.565 ' CE2' ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -135.43 156.72 48.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.472 -0.768 . . . . 0.0 109.286 179.43 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.565 ' O ' ' CE2' ' A' ' 88' ' ' TRP . 1.1 tt -113.43 160.42 18.45 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.808 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.546 ' N ' HD22 ' A' ' 89' ' ' LEU . 2.4 p -135.7 123.86 37.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.148 -0.97 . . . . 0.0 110.588 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.19 32.27 4.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.453 -0.779 . . . . 0.0 109.474 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.462 ' O ' ' O ' ' A' ' 61' ' ' ARG . 11.8 t -76.02 171.66 14.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.41 -0.806 . . . . 0.0 110.467 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.565 ' HA ' ' CA ' ' A' ' 62' ' ' GLN . 2.3 t -80.49 -172.48 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.393 -0.817 . . . . 0.0 110.207 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.519 ' N ' ' HA ' ' A' ' 61' ' ' ARG . . . -33.61 96.92 0.01 OUTLIER Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.538 ' CB ' ' HB3' ' A' ' 57' ' ' ALA . . . -163.7 148.96 10.9 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.17 -1.194 . . . . 0.0 111.731 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.617 ' CG ' HG13 ' A' ' 59' ' ' ILE . 8.4 t80 -109.03 110.37 21.63 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.534 HD23 ' CG ' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -127.78 66.11 69.79 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.027 -1.045 . . . . 0.0 111.236 -178.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.533 ' HG3' ' CZ ' ' A' ' 96' ' ' TYR . 45.2 Cg_endo -74.03 89.66 1.02 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.005 1.529 . . . . 0.0 109.651 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.539 ' CB ' ' HB3' ' A' ' 102' ' ' GLU . . . -45.63 149.57 0.58 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.286 -0.884 . . . . 0.0 111.232 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.442 HG13 ' OE2' ' A' ' 34' ' ' GLU . 2.3 m -52.16 -69.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.61 -0.681 . . . . 0.0 110.66 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.466 ' HB3' ' HB3' ' A' ' 72' ' ' LYS . 7.0 m-85 -99.73 62.03 1.17 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.821 -1.175 . . . . 0.0 109.674 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.555 ' CG ' ' HB3' ' A' ' 68' ' ' LEU . 4.0 tt0 -140.5 147.99 40.4 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.047 -1.033 . . . . 0.0 110.98 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.5 ' HG3' ' CZ ' ' A' ' 71' ' ' ARG . 1.3 mm-40 -132.15 150.89 52.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.501 -0.749 . . . . 0.0 109.679 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.42 ' C ' HD23 ' A' ' 105' ' ' LEU . 4.8 m -83.66 149.04 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.113 -0.992 . . . . 0.0 110.349 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.536 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -103.19 -10.96 18.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.425 -0.797 . . . . 0.0 109.287 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER 163.58 172.05 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.662 -0.649 . . . . 0.0 109.767 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.2 mp -116.43 123.23 47.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.169 -0.957 . . . . 0.0 109.766 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.501 ' CG1' ' CB ' ' A' ' 65' ' ' ALA . 13.6 p -116.56 155.48 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.029 -1.044 . . . . 0.0 110.681 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -110.05 120.85 43.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.385 -0.822 . . . . 0.0 109.571 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.54 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.296 -0.878 . . . . 0.0 110.937 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.435 ' O ' ' O ' ' A' ' 41' ' ' GLY . 1.2 tt0 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.215 0.531 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.512 ' O ' ' CD1' ' A' ' 8' ' ' LEU . 67.4 t -128.54 147.61 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 109.741 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.533 ' HA ' ' CA ' ' A' ' 41' ' ' GLY . 10.6 t -43.44 120.58 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.074 -1.016 . . . . 0.0 110.098 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.512 ' CD1' ' O ' ' A' ' 6' ' ' VAL . 4.0 mp -76.53 164.84 57.11 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.441 -0.787 . . . . 0.0 110.361 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.481 ' O ' ' HB2' ' A' ' 10' ' ' ASN . 46.2 Cg_endo -75.57 70.31 5.72 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 124.121 1.59 . . . . 0.0 109.914 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.512 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 11.6 m-20 58.42 55.84 4.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.382 -0.824 . . . . 0.0 110.397 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.497 ' HB ' ' HA ' ' A' ' 56' ' ' GLN . 6.2 p -136.38 171.48 14.43 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.066 -1.022 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.536 ' CB ' ' HA ' ' A' ' 38' ' ' GLU . . . -145.37 158.06 43.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.203 -0.936 . . . . 0.0 110.719 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.5 HD21 ' HB3' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -130.49 154.85 47.34 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.391 -0.818 . . . . 0.0 109.268 179.119 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 53' ' ' GLU . 40.7 m80 -94.79 131.63 40.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.975 . . . . 0.0 110.209 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.584 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 1.7 mm? -120.02 140.34 51.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.634 -0.666 . . . . 0.0 109.962 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.55 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 4.8 ttmt -95.82 117.09 29.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.965 -1.084 . . . . 0.0 109.174 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.541 ' HA ' ' CG1' ' A' ' 49' ' ' VAL . . . -81.78 105.73 13.15 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 110.591 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.476 HD13 ' CA ' ' A' ' 31' ' ' ALA . 1.9 mm? -99.08 101.53 12.92 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.0 tp -161.77 148.6 14.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.089 -1.007 . . . . 0.0 110.696 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.64 115.68 22.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.369 -0.832 . . . . 0.0 109.037 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.483 ' HB2' HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 120.982 -1.074 . . . . 0.0 110.988 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.483 HG21 ' HB2' ' A' ' 21' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 121.184 0.516 . . . . 0.0 109.74 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 31' ' ' ALA . 26.9 m -139.06 85.11 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.017 -1.052 . . . . 0.0 110.549 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.476 ' CA ' HD13 ' A' ' 18' ' ' LEU . . . 40.22 76.35 0.07 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.544 -0.722 . . . . 0.0 110.667 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.99 31.8 0.03 OUTLIER Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.359 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 17' ' ' ALA . 13.0 m-20 -99.55 155.56 17.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.934 -1.333 . . . . 0.0 110.377 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 9.8 tt0 -151.51 134.76 15.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.376 -0.827 . . . . 0.0 109.9 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.502 ' CZ2' ' HB2' ' A' ' 15' ' ' LEU . 7.8 p90 -148.29 167.67 24.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.172 -0.955 . . . . 0.0 110.679 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.531 ' CB ' ' HA ' ' A' ' 99' ' ' ALA . 44.5 tp -97.5 153.32 18.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.329 -0.857 . . . . 0.0 109.772 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.5 ' HB3' HD21 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -138.14 110.5 7.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.143 -0.973 . . . . 0.0 109.919 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.536 ' HA ' ' CB ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -97.2 138.17 35.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.334 -0.854 . . . . 0.0 110.44 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.619 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 72.25 40.8 54.85 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 54.0 Cg_endo -78.12 47.9 2.51 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.23 1.121 . . . . 0.0 109.828 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.533 ' CA ' ' HA ' ' A' ' 7' ' ' VAL . . . -42.78 -31.86 1.24 Allowed Glycine 0 N--CA 1.49 2.278 0 O-C-N 121.53 -0.731 . . . . 0.0 111.277 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.7 p -136.46 42.92 2.5 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.82 -1.4 . . . . 0.0 111.02 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.55 ' CZ ' ' HG ' ' A' ' 15' ' ' LEU . 14.7 t80 -79.75 111.99 16.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.106 -0.996 . . . . 0.0 109.654 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.442 HG23 ' HD2' ' A' ' 45' ' ' PRO . 3.6 mp -96.04 133.37 25.31 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 0.0 109.992 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 44' ' ' ILE . 45.4 Cg_endo -73.17 96.82 0.89 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.907 1.477 . . . . 0.0 110.442 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 -104.12 159.41 15.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 110.282 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.86 -28.52 6.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.146 -0.971 . . . . 0.0 110.419 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 18' ' ' LEU . 7.2 tt0 -50.36 -39.85 47.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.17 -0.956 . . . . 0.0 110.077 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.541 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 1.6 m -141.79 173.65 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.426 -0.796 . . . . 0.0 109.998 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -132.61 137.09 46.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.107 -0.996 . . . . 0.0 110.349 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.49 ' HA ' HD11 ' A' ' 15' ' ' LEU . 21.3 t -54.52 132.53 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.971 . . . . 0.0 109.335 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.55 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 97.2 t -118.57 -59.54 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.96 -1.088 . . . . 0.0 110.932 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 14' ' ' HIS . 43.2 mm-40 -137.21 164.53 28.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.058 -1.026 . . . . 0.0 111.273 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.474 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -136.46 137.97 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.48 ' O ' ' HB ' ' A' ' 11' ' ' THR . 0.3 OUTLIER -138.41 137.15 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.806 -1.184 . . . . 0.0 111.466 -178.671 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.497 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 1.3 mp0 -93.03 167.09 12.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.621 -0.674 . . . . 0.0 110.065 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' A' ' 10' ' ' ASN . . . -82.72 140.1 33.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 0.0 110.265 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 4.4 t 179.87 39.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.01 -1.056 . . . . 0.0 111.719 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.566 HD13 ' CE2' ' A' ' 96' ' ' TYR . 0.5 OUTLIER -161.05 -70.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.468 -1.395 . . . . 0.0 111.838 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.487 ' N ' HG12 ' A' ' 59' ' ' ILE . 4.2 mm -41.86 164.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.903 -1.123 . . . . 0.0 110.297 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.43 ' N ' ' CG2' ' A' ' 60' ' ' ILE . 2.6 mpt_? -94.3 -164.12 1.13 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.101 -0.999 . . . . 0.0 110.989 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.548 ' HA ' ' CG1' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -67.05 -68.01 0.41 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 111.352 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.542 ' CB ' ' HB3' ' A' ' 110' ' ' ALA . 52.3 m-20 -113.22 24.6 12.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.924 -1.11 . . . . 0.0 111.23 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -61.95 133.6 55.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.867 -1.146 . . . . 0.0 109.282 178.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.49 ' O ' ' HB ' ' A' ' 108' ' ' VAL . . . -109.51 128.44 55.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.852 -1.155 . . . . 0.0 110.181 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.515 ' CD1' ' HB ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -126.28 127.3 45.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.93 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.486 ' C ' ' CD2' ' A' ' 68' ' ' LEU . 10.8 mtt180 -90.85 130.89 36.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.601 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.535 ' CG ' ' OE2' ' A' ' 102' ' ' GLU . 4.2 mm? -116.78 130.43 56.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 111.035 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 1.9 ttt180 -107.16 156.68 18.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.578 -0.701 . . . . 0.0 109.633 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.474 ' CB ' ' HG2' ' A' ' 86' ' ' GLU . . . -88.66 142.14 27.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.201 -0.937 . . . . 0.0 110.543 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.436 ' O ' HG23 ' A' ' 84' ' ' THR . 3.5 ptm180 -115.05 -17.33 11.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.347 -0.846 . . . . 0.0 109.697 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -132.96 116.4 16.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.49 -0.756 . . . . 0.0 109.988 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.527 ' N ' HG22 ' A' ' 84' ' ' THR . 1.2 tm-20 -62.16 103.32 0.37 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 110.318 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER 167.1 -25.04 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.294 -0.879 . . . . 0.0 110.028 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.57 ' CZ2' ' HB3' ' A' ' 77' ' ' ARG . 1.3 t90 -75.14 105.26 6.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.363 -0.836 . . . . 0.0 110.375 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.408 ' OD1' ' HB3' ' A' ' 35' ' ' TRP . 16.0 p-10 -87.36 109.55 19.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.181 -0.949 . . . . 0.0 109.767 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.57 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -89.77 -13.65 36.24 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.215 -0.928 . . . . 0.0 110.587 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.437 ' OD2' ' NH1' ' A' ' 77' ' ' ARG . 0.2 OUTLIER -124.88 13.33 8.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.986 -1.071 . . . . 0.0 110.267 179.675 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.78 21.23 78.91 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 15.5 mmmt -119.79 -7.31 10.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.174 -1.192 . . . . 0.0 110.012 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.468 ' OE1' ' OD1' ' A' ' 33' ' ' ASP . 25.3 mm-40 60.66 124.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.358 -0.839 . . . . 0.0 110.234 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.511 ' HB3' ' HB3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -141.66 179.52 6.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.303 -0.873 . . . . 0.0 110.356 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.497 ' HA ' ' CB ' ' A' ' 73' ' ' GLU . 6.3 m -96.16 -178.59 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.223 -0.923 . . . . 0.0 111.245 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.527 HG22 ' N ' ' A' ' 73' ' ' GLU . 25.7 p -57.2 -23.07 45.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.467 -0.77 . . . . 0.0 110.545 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.18 -25.7 71.18 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.511 ' HB3' ' HB3' ' A' ' 82' ' ' ARG . 6.1 pt-20 -65.58 153.11 42.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.357 -1.084 . . . . 0.0 110.632 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.12 147.8 18.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.483 -0.76 . . . . 0.0 109.635 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.566 ' NE1' ' CG2' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -134.59 144.76 48.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.997 -1.064 . . . . 0.0 110.381 -179.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.523 ' C ' ' CD1' ' A' ' 89' ' ' LEU . 1.3 tm? -94.65 139.03 31.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.427 -0.796 . . . . 0.0 110.254 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.566 ' CG2' ' NE1' ' A' ' 88' ' ' TRP . 12.1 t -112.98 131.81 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.199 -0.938 . . . . 0.0 110.722 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.467 ' OG1' ' CD1' ' A' ' 89' ' ' LEU . 16.6 m -135.55 45.57 2.44 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.578 -0.701 . . . . 0.0 109.679 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.455 ' O ' HG22 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -82.2 128.67 34.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.899 . . . . 0.0 110.736 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.548 ' CG1' ' HA ' ' A' ' 62' ' ' GLN . 47.2 t -70.31 114.3 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.568 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 60' ' ' ILE . . . 56.96 97.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.511 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . . . 174.88 -176.88 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.108 -1.23 . . . . 0.0 110.606 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.566 ' CE2' HD13 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -147.35 101.99 3.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.3 -0.875 . . . . 0.0 110.499 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.527 HD21 ' CB ' ' A' ' 12' ' ' ALA . 18.7 mt -126.33 71.22 70.91 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.116 -0.99 . . . . 0.0 110.025 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.488 ' HD3' ' CD1' ' A' ' 96' ' ' TYR . 50.5 Cg_endo -81.84 17.29 1.56 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.996 1.524 . . . . 0.0 110.965 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.584 ' CB ' ' CG ' ' A' ' 102' ' ' GLU . . . 43.48 -164.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.12 -0.987 . . . . 0.0 110.674 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.483 ' CG2' ' HA ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -115.92 -44.85 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.191 -0.943 . . . . 0.0 111.656 -178.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.56 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 23.1 m-85 -110.59 40.94 1.88 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.617 -1.302 . . . . 0.0 111.977 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.584 ' CG ' ' CB ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -141.9 165.33 27.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.722 -1.236 . . . . 0.0 110.62 179.18 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -131.26 158.83 39.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.418 -0.801 . . . . 0.0 109.905 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.484 ' CG1' HD11 ' A' ' 68' ' ' LEU . 6.3 m -82.05 142.17 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.058 -1.027 . . . . 0.0 110.451 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.601 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 4.4 mp -90.58 -14.49 32.39 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.371 -0.831 . . . . 0.0 109.271 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 1.0 OUTLIER 163.85 -172.75 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.633 -0.667 . . . . 0.0 109.918 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 107' ' ' LEU . 0.7 OUTLIER -125.8 130.98 52.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.12 -0.987 . . . . 0.0 110.073 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.515 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 24.2 t -123.81 148.89 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.133 -0.979 . . . . 0.0 110.877 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -112.16 113.23 25.37 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.27 -0.894 . . . . 0.0 108.882 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.542 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.491 1.604 0 O-C-N 120.745 -1.222 . . . . 0.0 109.829 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 42' ' ' THR . 1.9 mt-30 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.267 0.556 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 5' ' ' GLN . 8.2 p -45.05 165.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 0.0 109.718 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.8 t -54.08 125.27 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.076 -1.015 . . . . 0.0 110.169 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.497 ' N ' HD13 ' A' ' 8' ' ' LEU . 6.5 mp -71.65 162.95 70.27 Favored Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 109.919 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.69 -89.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.926 1.488 . . . . 0.0 110.17 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.538 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 72.9 m-80 -128.64 25.02 5.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.962 . . . . 0.0 110.015 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 56' ' ' GLN . 27.4 p -104.48 170.6 7.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.316 -0.865 . . . . 0.0 110.077 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.508 ' CB ' ' HA ' ' A' ' 38' ' ' GLU . . . -139.75 161.86 36.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.217 -0.927 . . . . 0.0 110.117 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.582 HD21 ' HB3' ' A' ' 37' ' ' PHE . 0.6 OUTLIER -132.77 155.58 48.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.942 . . . . 0.0 110.021 179.781 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.568 ' CD2' ' CD1' ' A' ' 36' ' ' LEU . 42.9 m80 -90.96 129.16 37.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.165 -0.959 . . . . 0.0 110.555 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.592 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 2.2 mm? -120.11 146.74 45.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.665 -0.647 . . . . 0.0 110.231 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.54 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -110.78 116.28 31.01 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.187 -0.945 . . . . 0.0 108.592 178.044 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.572 ' CB ' ' HB2' ' A' ' 33' ' ' ASP . . . -75.3 115.47 14.97 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.157 -0.964 . . . . 0.0 110.135 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.6 mt -103.26 99.84 9.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.701 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.634 ' CD1' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -167.57 165.99 14.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.026 -1.046 . . . . 0.0 110.559 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.461 ' N ' HD21 ' A' ' 19' ' ' LEU . 11.6 t70 -98.27 103.12 15.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.734 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.57 ' CB ' ' CG2' ' A' ' 29' ' ' VAL . 1.9 t80 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 109.923 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.57 ' CG2' ' CB ' ' A' ' 21' ' ' PHE . 1.3 m . . . . . 0 N--CA 1.495 1.777 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.486 ' O ' HG23 ' A' ' 30' ' ' VAL . 15.4 m -134.91 93.69 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.145 -0.972 . . . . 0.0 110.905 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 42.05 68.35 0.48 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.285 -0.885 . . . . 0.0 110.471 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -166.75 19.35 0.09 OUTLIER Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.294 -1.431 . . . . 0.0 111.043 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.572 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 1.9 m-20 -88.9 148.6 23.75 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.414 -1.639 . . . . 0.0 109.931 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.474 ' CG ' HG11 ' A' ' 100' ' ' VAL . 27.7 tt0 -149.79 132.14 15.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.017 -1.052 . . . . 0.0 110.575 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -148.96 177.16 9.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.37 -0.831 . . . . 0.0 109.877 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.568 ' CD1' ' CD2' ' A' ' 14' ' ' HIS . 8.4 tp -102.94 153.99 19.67 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.157 -0.965 . . . . 0.0 110.227 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.59 ' CZ ' ' HA ' ' A' ' 40' ' ' PRO . 1.0 OUTLIER -130.88 110.46 11.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.433 -0.792 . . . . 0.0 109.68 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.508 ' HA ' ' CB ' ' A' ' 12' ' ' ALA . 8.9 tm-20 -92.01 132.71 36.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.574 -0.704 . . . . 0.0 109.356 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.585 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 60.24 47.05 93.02 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.59 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 37.6 Cg_endo -61.47 75.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.984 1.518 . . . . 0.0 110.467 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . -42.86 110.83 0.3 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 5' ' ' GLN . 3.0 p 38.33 44.21 0.69 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.598 -0.942 . . . . 0.0 111.622 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.55 ' CE2' HD12 ' A' ' 15' ' ' LEU . 13.6 t80 -68.74 122.28 18.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.732 -1.23 . . . . 0.0 109.309 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.432 ' CG2' ' HD2' ' A' ' 45' ' ' PRO . 31.4 mt -111.7 142.16 26.08 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 110.18 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.491 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 45.0 Cg_endo -73.19 96.09 0.87 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.09 1.574 . . . . 0.0 110.353 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.403 ' O ' ' C ' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -106.13 161.8 14.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 110.242 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 46' ' ' ARG . 35.7 mttt -43.26 -31.24 0.59 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.341 -0.85 . . . . 0.0 110.299 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -55.19 -45.66 75.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.266 -0.896 . . . . 0.0 110.605 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.4 m -144.4 165.86 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.232 -0.917 . . . . 0.0 110.031 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -125.76 141.88 51.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.296 -0.877 . . . . 0.0 110.234 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.491 ' CG2' ' HB3' ' A' ' 45' ' ' PRO . 46.6 t -60.18 119.86 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.858 . . . . 0.0 109.832 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.54 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 16.7 t -95.1 -64.02 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 0.0 110.474 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.511 ' HB2' ' ND1' ' A' ' 14' ' ' HIS . 44.8 mm-40 -141.96 175.62 9.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.56 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -134.95 146.06 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.36 -0.838 . . . . 0.0 109.111 179.439 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -140.08 131.74 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.971 -1.081 . . . . 0.0 110.739 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.476 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 2.5 mp0 -86.5 156.01 20.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.49 -0.756 . . . . 0.0 109.835 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.576 ' CB ' ' HA ' ' A' ' 95' ' ' ALA . . . -95.3 142.85 27.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 0.0 110.818 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.496 ' C ' ' CG2' ' A' ' 59' ' ' ILE . 0.1 OUTLIER 168.81 51.69 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.424 -0.797 . . . . 0.0 110.777 179.758 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.573 HD11 ' CD1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -153.48 -28.75 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.728 -1.232 . . . . 0.0 111.419 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 61' ' ' ARG . 0.6 OUTLIER -87.58 168.58 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.644 -1.285 . . . . 0.0 110.844 -179.098 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.499 ' CB ' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -107.23 -177.29 3.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.521 -0.737 . . . . 0.0 110.323 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.593 ' HA ' ' CG1' ' A' ' 93' ' ' VAL . 1.0 OUTLIER -66.46 -72.26 0.17 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.273 -0.892 . . . . 0.0 110.671 -179.747 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.532 ' CB ' ' HB1' ' A' ' 110' ' ' ALA . 1.1 m-80 -77.55 -6.84 55.08 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.314 -0.866 . . . . 0.0 110.207 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.549 ' NE2' ' N ' ' A' ' 108' ' ' VAL . 44.7 tp60 -61.1 129.26 40.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.144 -0.973 . . . . 0.0 110.657 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.415 ' C ' HD21 ' A' ' 66' ' ' LEU . . . -108.67 144.99 35.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.074 -1.016 . . . . 0.0 109.752 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.465 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 1.7 mm? -123.13 114.6 20.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.182 -0.948 . . . . 0.0 110.522 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.443 ' O ' HD11 ' A' ' 105' ' ' LEU . 18.5 mtm180 -97.99 122.04 40.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.297 -0.877 . . . . 0.0 109.881 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.552 ' CD2' ' HA ' ' A' ' 104' ' ' VAL . 13.2 mt -118.88 135.82 54.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.961 . . . . 0.0 110.61 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 29.2 ttt180 -98.22 160.74 14.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.55 -0.719 . . . . 0.0 109.865 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 86' ' ' GLU . . . -75.99 164.16 26.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.261 -0.899 . . . . 0.0 111.193 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 101' ' ' PHE . 1.0 OUTLIER -124.51 -42.6 2.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.66 -0.65 . . . . 0.0 109.493 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.493 ' HB2' ' CD2' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -122.03 138.67 54.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.41 -0.806 . . . . 0.0 109.998 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -69.52 60.55 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.151 -0.968 . . . . 0.0 109.481 179.336 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 72' ' ' LYS . 2.2 t -151.18 -25.63 0.21 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.219 -0.926 . . . . 0.0 111.309 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.584 ' CZ2' ' HB3' ' A' ' 77' ' ' ARG . 1.7 t90 -73.6 116.23 13.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.754 -1.216 . . . . 0.0 110.519 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.464 ' HB3' ' HA ' ' A' ' 81' ' ' GLU . 2.5 p-10 -107.07 109.61 21.51 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.251 -0.905 . . . . 0.0 110.07 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.584 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -88.82 -4.09 58.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.243 -0.911 . . . . 0.0 110.242 179.671 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -117.66 -12.48 10.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.883 . . . . 0.0 110.089 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.18 -46.23 1.13 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -82.55 127.13 33.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -1.161 . . . . 0.0 110.26 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.529 ' CG ' HG12 ' A' ' 29' ' ' VAL . 6.1 tp10 -46.28 119.55 2.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 0.0 110.109 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.43 175.04 5.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 110.317 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.505 ' HA ' ' CG ' ' A' ' 73' ' ' GLU . 13.8 p -106.69 172.84 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 110.306 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.421 HG23 ' C ' ' A' ' 72' ' ' LYS . 40.6 p -60.75 -174.08 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.323 -0.861 . . . . 0.0 109.022 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 87' ' ' GLU . . . 70.8 -56.37 0.99 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.499 ' O ' ' HB1' ' A' ' 70' ' ' ALA . 4.4 tp10 -44.32 153.78 0.14 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.032 -1.275 . . . . 0.0 109.545 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.545 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 13.4 mp0 -145.23 149.8 35.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.741 -1.224 . . . . 0.0 111.385 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.564 ' CZ2' ' HB ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -111.74 163.27 14.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.395 -0.815 . . . . 0.0 108.903 178.606 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.511 ' CD1' ' C ' ' A' ' 89' ' ' LEU . 1.5 tm? -129.32 141.67 51.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.989 -1.069 . . . . 0.0 110.309 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.564 ' HB ' ' CZ2' ' A' ' 88' ' ' TRP . 7.1 p -126.15 139.49 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.61 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.465 ' O ' HG21 ' A' ' 91' ' ' THR . 22.3 m -137.46 40.55 2.42 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.174 -0.954 . . . . 0.0 110.132 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.7 m -82.44 126.71 32.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.169 -0.957 . . . . 0.0 110.376 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.593 ' CG1' ' HA ' ' A' ' 62' ' ' GLN . 3.8 m -58.19 112.56 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.134 -0.979 . . . . 0.0 110.265 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 60' ' ' ILE . . . 71.44 96.6 0.06 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.576 ' HA ' ' CB ' ' A' ' 57' ' ' ALA . . . -169.41 176.03 5.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.324 -1.103 . . . . 0.0 110.826 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.573 ' CD1' HD11 ' A' ' 59' ' ' ILE . 1.0 OUTLIER -129.0 -70.57 0.66 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.495 -0.753 . . . . 0.0 109.514 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.477 ' HA ' HD21 ' A' ' 36' ' ' LEU . 4.8 mt 48.92 78.27 0.41 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.484 -0.76 . . . . 0.0 111.247 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.522 ' O ' ' CB ' ' A' ' 99' ' ' ALA . 48.9 Cg_endo -74.65 -14.79 21.96 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.806 1.424 . . . . 0.0 109.548 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.523 ' CB ' ' HB2' ' A' ' 102' ' ' GLU . . . 72.14 173.46 0.3 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.537 -0.727 . . . . 0.0 111.161 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.489 HG13 ' CD1' ' A' ' 101' ' ' PHE . 94.2 t -99.81 -61.09 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.538 -0.727 . . . . 0.0 109.603 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.572 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 18.0 m-30 -111.43 45.44 1.2 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.335 -0.853 . . . . 0.0 109.992 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 11.4 mt-10 -134.05 144.88 48.93 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.676 -1.265 . . . . 0.0 111.887 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.471 ' O ' HD12 ' A' ' 105' ' ' LEU . 1.3 tt0 -119.37 123.27 43.74 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.552 ' HA ' ' CD2' ' A' ' 68' ' ' LEU . 7.2 p -54.05 149.02 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.218 -0.926 . . . . 0.0 110.779 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.533 ' CD1' ' N ' ' A' ' 69' ' ' ARG . 8.4 mp -103.46 -32.92 9.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.574 -0.704 . . . . 0.0 110.387 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -179.84 148.38 0.31 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.026 -1.046 . . . . 0.0 110.722 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 mp -88.33 125.52 34.73 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.331 -0.856 . . . . 0.0 109.555 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.549 ' N ' ' NE2' ' A' ' 64' ' ' GLN . 74.2 t -116.85 140.53 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.067 -1.021 . . . . 0.0 111.434 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 14.4 t0 -111.29 114.15 27.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 109.496 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.532 ' HB1' ' CB ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.494 1.736 0 O-C-N 120.862 -1.149 . . . . 0.0 110.282 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.2 0.524 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.7 m -66.75 -150.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -0.885 . . . . 0.0 110.079 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.481 HG22 ' HA2' ' A' ' 41' ' ' GLY . 4.0 t -83.32 144.48 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 110.178 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.55 ' CD2' ' HG2' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -100.25 168.74 8.93 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.207 -0.933 . . . . 0.0 109.519 179.667 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 42.8 Cg_endo -70.15 68.94 1.89 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.641 1.337 . . . . 0.0 110.732 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.482 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 4.9 m120 68.67 69.86 0.29 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.555 -0.715 . . . . 0.0 111.227 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' A' ' 8' ' ' LEU . 7.8 p -138.87 159.71 41.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.942 . . . . 0.0 109.921 178.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.534 ' CB ' ' HA ' ' A' ' 38' ' ' GLU . . . -139.04 155.68 47.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.157 -0.964 . . . . 0.0 110.333 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -130.48 156.74 44.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -0.932 . . . . 0.0 110.609 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.505 ' N ' ' CD2' ' A' ' 14' ' ' HIS . 10.5 m170 -93.98 128.2 40.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.597 -0.689 . . . . 0.0 109.424 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.586 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -121.58 153.15 38.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.065 -1.022 . . . . 0.0 110.098 -179.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -110.09 116.52 31.7 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.21 -0.931 . . . . 0.0 109.385 178.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.55 ' HA ' ' CG1' ' A' ' 49' ' ' VAL . . . -76.61 115.93 16.82 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.285 -0.885 . . . . 0.0 110.434 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.455 HD13 ' CB ' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -102.83 99.77 9.73 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.475 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.518 HD11 ' N ' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -167.59 147.31 5.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 110.745 -179.443 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.518 ' N ' HD11 ' A' ' 19' ' ' LEU . 32.4 t70 -85.39 110.82 19.41 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.504 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.081 -1.012 . . . . 0.0 112.054 -177.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.537 ' CG1' ' HB3' ' A' ' 81' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 31' ' ' ALA . 20.1 m -127.63 85.67 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.065 -1.022 . . . . 0.0 110.575 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.455 ' CB ' HD13 ' A' ' 18' ' ' LEU . . . 41.62 71.18 0.22 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.315 -0.866 . . . . 0.0 110.381 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -179.68 28.83 0.05 OUTLIER Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.536 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 17' ' ' ALA . 42.5 m-20 -93.44 147.94 22.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.769 -1.43 . . . . 0.0 110.0 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.457 ' HG2' HG12 ' A' ' 100' ' ' VAL . 15.3 tt0 -143.07 143.56 31.91 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.032 -1.042 . . . . 0.0 110.176 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.544 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 7.1 p90 -159.95 168.83 24.78 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.014 -1.054 . . . . 0.0 111.105 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.474 HD21 ' O ' ' A' ' 98' ' ' PRO . 14.2 tp -97.32 153.29 18.15 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.353 -0.842 . . . . 0.0 109.774 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.601 ' CZ ' ' HA ' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -140.96 109.6 5.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.98 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.543 ' HG2' ' CD2' ' A' ' 97' ' ' LEU . 0.4 OUTLIER -97.77 137.77 36.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.355 -0.84 . . . . 0.0 109.402 179.614 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.595 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 78.73 46.68 8.41 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.601 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 38.1 Cg_endo -63.47 71.32 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.052 1.554 . . . . 0.0 111.041 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.481 ' HA2' HG22 ' A' ' 7' ' ' VAL . . . -46.43 95.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER 46.13 40.44 7.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -1.137 . . . . 0.0 110.413 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.525 ' HB3' ' HB2' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -68.64 131.87 45.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.105 -0.997 . . . . 0.0 109.929 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.529 ' CG2' ' HD2' ' A' ' 45' ' ' PRO . 23.3 mm -121.08 148.22 48.5 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.388 -0.82 . . . . 0.0 109.124 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.529 ' HD2' ' CG2' ' A' ' 44' ' ' ILE . 41.2 Cg_endo -67.85 75.03 0.64 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.689 1.363 . . . . 0.0 110.863 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 49' ' ' VAL . 13.0 ttt85 -66.84 143.47 56.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.424 -0.798 . . . . 0.0 109.895 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -41.25 -33.62 0.4 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.344 -0.848 . . . . 0.0 110.523 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -49.46 -50.89 39.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.157 -0.964 . . . . 0.0 109.95 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.55 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 1.4 m -133.0 173.51 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.353 -0.842 . . . . 0.0 109.408 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.444 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -131.48 132.77 44.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.088 -1.008 . . . . 0.0 110.56 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.491 ' HA ' HD11 ' A' ' 15' ' ' LEU . 9.4 p -54.41 143.53 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.041 -1.037 . . . . 0.0 108.232 178.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.487 ' HB ' ' O ' ' A' ' 14' ' ' HIS . 13.0 t -123.33 -57.5 2.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.666 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.471 ' C ' ' CD1' ' A' ' 54' ' ' ILE . 31.1 mm-40 -135.35 167.36 21.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.393 -0.817 . . . . 0.0 110.092 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -136.77 147.94 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.436 -0.79 . . . . 0.0 109.067 179.359 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.58 HD13 ' CD2' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -142.12 136.08 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.072 -1.017 . . . . 0.0 110.791 -179.21 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.499 ' N ' HD12 ' A' ' 55' ' ' ILE . 90.2 mm-40 -91.91 174.13 7.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.403 -0.811 . . . . 0.0 109.887 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 94' ' ' GLY . . . -97.97 127.45 43.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.95 . . . . 0.0 110.348 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER 172.18 91.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.325 -0.86 . . . . 0.0 110.535 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.6 HD13 ' CE1' ' A' ' 96' ' ' TYR . 0.0 OUTLIER 177.76 -50.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.03 -1.044 . . . . 0.0 110.569 179.605 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.548 ' N ' HG23 ' A' ' 59' ' ' ILE . 15.7 mm -117.97 -93.34 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.788 -1.195 . . . . 0.0 110.33 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.502 ' N ' HG22 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -178.8 -163.34 0.06 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.129 -0.982 . . . . 0.0 111.042 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.52 ' HB3' ' CG1' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -92.51 -72.27 0.6 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.307 -0.871 . . . . 0.0 110.671 -179.353 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 110' ' ' ALA . 3.1 m-20 -41.84 -24.59 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.675 -0.641 . . . . 0.0 111.636 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.527 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -58.47 134.01 56.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.846 -1.159 . . . . 0.0 110.294 -179.51 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.588 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . . . -109.21 138.95 44.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.949 . . . . 0.0 109.285 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.51 ' O ' HD21 ' A' ' 89' ' ' LEU . 2.0 tp -126.25 111.7 14.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -0.991 . . . . 0.0 110.848 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.479 ' O ' HD21 ' A' ' 68' ' ' LEU . 1.1 tpp180 -89.42 123.31 33.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.242 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.521 HD22 ' CA ' ' A' ' 104' ' ' VAL . 13.2 mt -122.57 146.99 46.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.877 . . . . 0.0 111.264 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.506 ' O ' ' CA ' ' A' ' 102' ' ' GLU . 13.5 ttp85 -114.41 165.01 13.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.577 -0.702 . . . . 0.0 109.365 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.516 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -83.59 161.21 21.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.956 -1.09 . . . . 0.0 111.278 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.458 ' HB3' ' O ' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -123.83 -35.91 2.8 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.462 ' HG3' ' CD1' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -125.44 151.25 46.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.511 -0.743 . . . . 0.0 109.463 179.091 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.497 ' N ' ' HB ' ' A' ' 84' ' ' THR . 20.3 tt0 -83.08 95.99 8.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.123 -0.985 . . . . 0.0 109.556 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.77 -27.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.18 -0.95 . . . . 0.0 110.719 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.565 ' CH2' ' OE1' ' A' ' 102' ' ' GLU . 0.8 OUTLIER -74.46 125.8 29.34 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.036 -1.04 . . . . 0.0 110.16 -179.671 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 77' ' ' ARG . 34.9 m-20 -94.73 119.53 33.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 109.536 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 76' ' ' ASP . 5.0 mtm180 -39.6 -55.91 1.77 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.456 -0.778 . . . . 0.0 110.821 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -118.42 -8.1 10.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.1 -1.0 . . . . 0.0 110.396 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.41 -20.52 2.96 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.431 ' O ' ' CG ' ' A' ' 76' ' ' ASP . 4.4 mttp -63.88 -132.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -1.083 . . . . 0.0 109.866 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.537 ' HB3' ' CG1' ' A' ' 29' ' ' VAL . 5.9 mp0 -142.65 120.85 12.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.942 -1.098 . . . . 0.0 110.077 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.456 ' HD3' ' HG2' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -132.51 178.14 7.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.93 . . . . 0.0 110.186 179.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.448 ' HA ' ' HG3' ' A' ' 73' ' ' GLU . 7.7 p -107.86 179.95 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.378 -0.826 . . . . 0.0 110.267 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.497 ' HB ' ' N ' ' A' ' 73' ' ' GLU . 8.8 t -70.24 -15.53 62.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 110.343 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -86.75 8.37 75.89 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.492 ' O ' ' HB1' ' A' ' 70' ' ' ALA . 13.6 tp10 -91.14 162.96 14.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.24 -1.153 . . . . 0.0 109.888 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.484 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 12.5 pt-20 -153.5 156.95 39.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.949 -1.094 . . . . 0.0 110.359 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.577 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -139.51 147.53 41.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.762 179.894 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.535 HD12 ' N ' ' A' ' 90' ' ' VAL . 2.7 tm? -103.41 146.97 27.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -0.852 . . . . 0.0 109.493 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.535 ' N ' HD12 ' A' ' 89' ' ' LEU . 20.5 t -104.47 117.42 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.146 -0.971 . . . . 0.0 110.224 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.44 HG23 HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -123.69 -0.18 8.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.576 -0.702 . . . . 0.0 109.909 179.71 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.52 171.41 15.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.425 -0.797 . . . . 0.0 110.112 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.52 ' CG1' ' HB3' ' A' ' 62' ' ' GLN . 11.1 t -86.43 166.6 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.131 -0.98 . . . . 0.0 110.019 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 57' ' ' ALA . . . 144.02 -28.18 2.0 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.529 ' O ' HG23 ' A' ' 59' ' ' ILE . . . 58.34 14.25 2.8 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.337 -1.096 . . . . 0.0 110.921 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.6 ' CE1' HD13 ' A' ' 59' ' ' ILE . 6.7 t80 179.99 85.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.088 -1.008 . . . . 0.0 110.674 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.543 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 69.3 mt -129.45 81.63 69.54 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 109.54 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.474 ' O ' HD21 ' A' ' 36' ' ' LEU . 44.3 Cg_endo -71.8 141.48 37.42 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.076 1.566 . . . . 0.0 110.774 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -85.19 -164.85 1.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.41 -0.806 . . . . 0.0 109.941 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.457 HG12 ' HG2' ' A' ' 34' ' ' GLU . 18.7 t -109.47 -62.75 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.215 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.487 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 14.8 m-85 -97.6 -33.06 11.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.278 -0.889 . . . . 0.0 110.189 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.565 ' OE1' ' CH2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -80.95 154.03 27.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 110.243 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -128.79 172.18 11.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.91 . . . . 0.0 110.45 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.521 ' CA ' HD22 ' A' ' 68' ' ' LEU . 7.5 p -93.28 142.69 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.903 . . . . 0.0 110.644 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.34 -19.81 13.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.477 -0.764 . . . . 0.0 109.608 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -174.63 156.24 2.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.497 -0.752 . . . . 0.0 109.944 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.457 ' HA ' HD12 ' A' ' 66' ' ' LEU . 3.3 mp -107.54 146.09 32.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.899 . . . . 0.0 110.356 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.588 ' CG1' ' CB ' ' A' ' 65' ' ' ALA . 8.9 p -134.41 159.52 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.139 -0.976 . . . . 0.0 109.848 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.431 ' N ' HG21 ' A' ' 108' ' ' VAL . 8.2 p-10 -110.36 125.71 53.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.122 -0.986 . . . . 0.0 110.114 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.468 ' HB2' ' HB3' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.216 -0.928 . . . . 0.0 110.408 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.462 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 1.8 mt-30 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.269 0.557 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 8' ' ' LEU . 14.2 t -90.63 143.35 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.22 -0.925 . . . . 0.0 109.471 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.455 ' C ' ' O ' ' A' ' 6' ' ' VAL . 40.7 t -39.4 95.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.436 -0.79 . . . . 0.0 110.102 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 6' ' ' VAL . 0.9 OUTLIER -45.55 165.84 0.16 Allowed Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.451 -0.781 . . . . 0.0 110.167 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.69 -56.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 124.165 1.613 . . . . 0.0 110.648 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.553 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -166.75 26.01 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.084 -1.01 . . . . 0.0 110.588 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 7.2 p -103.58 171.76 7.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.171 -0.956 . . . . 0.0 109.655 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.516 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -141.42 160.4 40.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.858 -1.151 . . . . 0.0 110.689 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.609 ' CD2' ' CD2' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -129.59 155.18 46.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.103 -0.998 . . . . 0.0 109.927 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.613 ' N ' ' CD2' ' A' ' 14' ' ' HIS . 5.2 m170 -92.74 126.51 37.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 110.321 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.609 ' CD2' ' CD2' ' A' ' 13' ' ' LEU . 2.6 mm? -112.19 151.51 29.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.671 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.588 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 9.0 ttmt -119.58 117.0 27.2 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.953 -1.092 . . . . 0.0 109.362 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 33' ' ' ASP . . . -77.93 120.33 22.64 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.271 -0.893 . . . . 0.0 110.335 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.441 ' O ' HD23 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -99.29 101.76 13.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.629 -0.669 . . . . 0.0 109.731 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.462 HD12 ' N ' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -159.04 141.04 13.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.327 -0.858 . . . . 0.0 110.04 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.462 ' N ' HD12 ' A' ' 19' ' ' LEU . 4.1 m-20 -90.07 103.6 16.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.856 . . . . 0.0 110.258 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.491 ' CB ' HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.393 -0.817 . . . . 0.0 110.042 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.491 HG23 ' CB ' ' A' ' 21' ' ' PHE . 1.5 m . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.187 0.517 . . . . 0.0 109.752 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 30' ' ' VAL . 29.6 m -137.37 80.88 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.9 . . . . 0.0 110.026 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.91 68.62 0.64 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.891 . . . . 0.0 110.18 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.14 29.54 0.04 OUTLIER Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.362 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 38.1 m-20 -83.99 146.72 27.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.789 -1.418 . . . . 0.0 109.473 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 4.8 tt0 -144.22 147.34 33.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.099 -1.001 . . . . 0.0 111.056 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.596 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 11.5 p90 -156.7 164.41 38.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.465 -0.772 . . . . 0.0 110.188 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.567 HD23 ' CD2' ' A' ' 14' ' ' HIS . 0.2 OUTLIER -96.74 149.46 21.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.244 -0.91 . . . . 0.0 110.394 -179.796 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.534 ' CE1' ' HA ' ' A' ' 40' ' ' PRO . 2.9 t80 -131.55 110.74 11.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.233 -0.917 . . . . 0.0 110.502 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.496 ' HA ' ' CB ' ' A' ' 12' ' ' ALA . 2.3 tm-20 -85.75 125.12 32.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.652 -0.655 . . . . 0.0 110.001 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.583 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 74.63 44.85 24.81 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 55.9 Cg_endo -77.88 32.96 0.44 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.494 1.26 . . . . 0.0 111.222 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 5' ' ' GLN . . . -54.39 -59.53 9.95 Favored Glycine 0 N--CA 1.487 2.096 0 O-C-N 120.53 -1.356 . . . . 0.0 109.976 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 75.5 p -78.87 12.35 2.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -1.174 . . . . 0.0 111.501 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.576 ' CE2' ' HG ' ' A' ' 15' ' ' LEU . 3.2 t80 -72.99 130.6 40.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.851 -1.156 . . . . 0.0 110.078 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.449 HG22 ' HD2' ' A' ' 45' ' ' PRO . 1.9 mt -118.66 143.11 32.81 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.982 . . . . 0.0 109.798 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.449 ' HD2' HG22 ' A' ' 44' ' ' ILE . 46.0 Cg_endo -72.58 107.17 2.24 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.971 1.511 . . . . 0.0 110.458 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 49' ' ' VAL . 1.2 mtt-85 -114.91 148.73 38.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.306 -0.871 . . . . 0.0 110.229 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 46' ' ' ARG . 0.3 OUTLIER -40.44 -45.95 2.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.353 -0.842 . . . . 0.0 110.847 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.466 ' O ' HG11 ' A' ' 49' ' ' VAL . 3.0 mt-10 -42.53 -39.06 2.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.407 -0.808 . . . . 0.0 110.875 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.513 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 1.6 m -145.96 174.09 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.15 -0.969 . . . . 0.0 110.549 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 49' ' ' VAL . 1.6 mm-40 -139.39 139.61 37.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.255 -0.903 . . . . 0.0 110.395 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.445 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . 5.0 m -55.23 130.98 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.147 -0.971 . . . . 0.0 110.223 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.588 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 3.7 t -104.12 -58.7 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.312 -0.867 . . . . 0.0 110.351 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.489 ' C ' ' CD1' ' A' ' 54' ' ' ILE . 3.7 mt-10 -143.36 171.06 14.64 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.097 -1.002 . . . . 0.0 110.4 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.489 ' CD1' ' C ' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -132.23 135.96 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.781 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -129.91 143.86 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.913 -1.117 . . . . 0.0 111.694 -178.588 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.435 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 93.1 mm-40 -91.84 158.78 16.13 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.644 -0.66 . . . . 0.0 109.383 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 10' ' ' ASN . . . -102.35 132.85 48.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.175 -0.953 . . . . 0.0 110.193 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 3.7 t 178.5 55.02 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.132 -0.98 . . . . 0.0 111.584 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.554 ' CG2' ' N ' ' A' ' 60' ' ' ILE . 0.2 OUTLIER -157.42 -51.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.462 -1.398 . . . . 0.0 111.599 179.341 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.554 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 13.9 mm -70.05 157.42 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.616 -1.302 . . . . 0.0 110.644 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.43 179.58 5.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.35 -0.844 . . . . 0.0 110.004 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.566 ' HA ' ' CG1' ' A' ' 93' ' ' VAL . 4.4 mt-30 -83.42 -27.07 29.81 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.151 -0.968 . . . . 0.0 110.714 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.544 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 3.1 m120 -94.4 -34.94 12.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.129 -0.982 . . . . 0.0 110.526 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.429 ' NE2' ' O ' ' A' ' 108' ' ' VAL . 40.6 tp60 -58.69 129.3 41.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.115 -0.991 . . . . 0.0 111.146 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.554 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . . . -108.3 143.5 37.09 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.55 ' O ' HD11 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -126.72 120.47 29.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.081 -1.012 . . . . 0.0 110.578 -179.194 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -89.69 141.87 28.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.489 -0.757 . . . . 0.0 109.462 179.591 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -125.41 125.74 43.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.15 -0.969 . . . . 0.0 111.081 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -105.41 159.31 16.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.461 -0.774 . . . . 0.0 109.615 179.433 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 86' ' ' GLU . . . -69.3 151.33 46.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.212 -0.93 . . . . 0.0 110.878 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -116.01 -30.16 6.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.434 -0.791 . . . . 0.0 109.589 179.322 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.456 ' C ' ' CD ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -149.43 130.21 14.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.304 -0.873 . . . . 0.0 109.802 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.44 ' N ' ' HD3' ' A' ' 72' ' ' LYS . 0.3 OUTLIER -56.57 90.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.176 -0.953 . . . . 0.0 109.903 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 72' ' ' LYS . 37.5 t -176.0 -29.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.384 -0.822 . . . . 0.0 110.442 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.577 ' CE3' ' HG2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -73.89 120.88 20.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.147 -0.971 . . . . 0.0 110.005 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.423 ' OD2' ' O ' ' A' ' 79' ' ' GLY . 3.5 m-20 -80.02 113.85 18.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.354 -0.841 . . . . 0.0 110.051 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.468 ' HB2' ' OE2' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -55.65 -54.7 40.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 110.355 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.68 -13.94 12.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.363 -0.836 . . . . 0.0 110.411 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.423 ' O ' ' OD2' ' A' ' 76' ' ' ASP . . . 143.42 -22.03 2.22 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.8 mmtt -85.77 157.51 20.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.524 -0.986 . . . . 0.0 109.741 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.478 ' HA ' ' OE1' ' A' ' 81' ' ' GLU . 37.8 mm-40 -69.37 126.5 29.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 110.161 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.451 ' HD2' ' OE1' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -122.2 175.23 6.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.493 -0.754 . . . . 0.0 110.702 -179.541 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' A' ' 84' ' ' THR . 4.8 p -119.35 171.8 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.417 -0.802 . . . . 0.0 110.423 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.486 ' N ' ' CG2' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -54.78 -170.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.105 -0.997 . . . . 0.0 108.789 178.746 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 86' ' ' GLU . . . 70.77 -55.88 0.98 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.611 ' HG3' ' N ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -44.76 156.37 0.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.171 -1.193 . . . . 0.0 109.11 179.335 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.611 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 12.9 pt-20 -155.61 145.06 21.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.656 -1.278 . . . . 0.0 111.148 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -112.3 160.39 17.71 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.55 HD11 ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -115.33 127.72 55.61 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.966 -1.084 . . . . 0.0 111.221 -178.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.538 ' N ' HD12 ' A' ' 89' ' ' LEU . 25.0 t -92.64 108.3 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.394 -0.816 . . . . 0.0 109.705 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.0 m -128.19 46.12 2.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.967 . . . . 0.0 110.829 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.453 ' CG2' ' ND2' ' A' ' 10' ' ' ASN . 53.2 m -107.8 131.3 54.61 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.15 -0.969 . . . . 0.0 110.149 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.566 ' CG1' ' HA ' ' A' ' 62' ' ' GLN . 27.5 m -66.9 150.29 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.253 -0.904 . . . . 0.0 110.477 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.469 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 41.08 82.03 0.02 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.536 ' HA ' ' CB ' ' A' ' 57' ' ' ALA . . . -159.63 147.08 16.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -1.151 . . . . 0.0 110.207 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.567 ' CG ' ' O ' ' A' ' 96' ' ' TYR . 14.9 t80 -133.49 59.27 1.74 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.379 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.55 99.91 52.51 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 120.911 -1.118 . . . . 0.0 109.783 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.512 ' O ' ' CB ' ' A' ' 99' ' ' ALA . 47.3 Cg_endo -77.56 18.08 0.87 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 124.111 1.585 . . . . 0.0 111.854 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' A' ' 98' ' ' PRO . . . 70.1 -178.59 0.22 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.81 -1.181 . . . . 0.0 110.426 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.525 HG21 ' CD2' ' A' ' 36' ' ' LEU . 2.6 t -102.57 -61.72 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 109.793 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.53 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 22.0 m-85 -107.73 47.92 0.87 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.27 -0.894 . . . . 0.0 109.925 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.577 ' HG2' ' CE3' ' A' ' 75' ' ' TRP . 17.8 mt-10 -138.85 158.67 43.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.904 -1.122 . . . . 0.0 111.611 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -132.49 167.53 19.81 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.606 -0.684 . . . . 0.0 109.395 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 67' ' ' ARG . 3.8 m -90.75 146.89 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.937 -1.102 . . . . 0.0 110.263 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.551 ' O ' ' CB ' ' A' ' 106' ' ' ASP . 0.8 OUTLIER -102.28 -11.24 18.86 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.405 -0.809 . . . . 0.0 109.351 179.315 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 0.5 OUTLIER 162.46 127.71 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.61 -0.682 . . . . 0.0 110.098 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.1 mp -76.45 121.86 23.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 109.598 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.554 ' CG1' ' CB ' ' A' ' 65' ' ' ALA . 9.1 p -111.31 153.98 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.094 -1.004 . . . . 0.0 110.467 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.421 ' N ' HG23 ' A' ' 108' ' ' VAL . 1.5 t0 -110.91 120.17 41.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -0.874 . . . . 0.0 109.821 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.007 -1.058 . . . . 0.0 110.216 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 2.4 mt-30 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.332 0.587 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.0 t -77.26 155.89 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.932 . . . . 0.0 110.37 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 74.9 t -45.21 106.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.321 -0.862 . . . . 0.0 110.217 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.408 HD11 ' CA ' ' A' ' 41' ' ' GLY . 3.5 mp -49.83 164.72 0.34 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.7 -57.13 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.992 1.522 . . . . 0.0 110.498 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -163.41 31.11 0.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -0.904 . . . . 0.0 110.011 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.481 HG21 ' HA ' ' A' ' 56' ' ' GLN . 55.2 p -112.62 171.82 7.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.316 -0.865 . . . . 0.0 110.37 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -137.74 165.96 25.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.177 -0.952 . . . . 0.0 110.029 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.547 ' CD1' HD21 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -133.95 155.63 49.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.149 -0.969 . . . . 0.0 111.032 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.477 ' C ' HD21 ' A' ' 15' ' ' LEU . 52.8 m80 -99.06 132.74 44.14 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.288 -0.883 . . . . 0.0 110.474 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.608 ' CD1' ' CZ2' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -137.06 156.76 48.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.997 -1.064 . . . . 0.0 109.984 178.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 3.4 mtpt -107.94 123.56 48.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.358 -0.839 . . . . 0.0 110.742 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.53 ' CB ' ' HB2' ' A' ' 33' ' ' ASP . . . -82.1 119.68 24.33 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.314 -0.866 . . . . 0.0 110.157 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.53 HD12 ' CB ' ' A' ' 31' ' ' ALA . 2.8 mm? -101.06 101.18 11.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.581 -0.699 . . . . 0.0 109.865 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.443 HD23 ' OE2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -160.99 147.15 14.74 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.102 -0.999 . . . . 0.0 110.502 -179.679 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.423 ' N ' HD12 ' A' ' 19' ' ' LEU . 5.9 t70 -88.75 113.26 24.12 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.504 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.081 -1.012 . . . . 0.0 111.733 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.504 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 30' ' ' VAL . 16.7 m -130.99 85.61 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.961 -1.087 . . . . 0.0 110.98 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.53 ' CB ' HD12 ' A' ' 18' ' ' LEU . . . 42.16 68.76 0.43 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.409 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.88 23.51 0.09 OUTLIER Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.445 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.53 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 10.5 m-20 -85.72 154.22 21.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.818 -1.401 . . . . 0.0 109.734 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 78.7 tt0 -155.93 138.71 15.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 110.312 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.608 ' CZ2' ' CD1' ' A' ' 15' ' ' LEU . 3.8 p90 -157.77 177.14 11.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.164 -0.96 . . . . 0.0 110.523 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 99' ' ' ALA . 39.7 tp -90.43 165.56 13.76 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.433 -0.792 . . . . 0.0 110.824 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -135.73 110.84 8.91 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.58 -0.7 . . . . 0.0 109.467 179.554 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.499 ' CG ' HD22 ' A' ' 97' ' ' LEU . 13.3 tm-20 -86.22 131.31 34.26 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.193 -0.942 . . . . 0.0 110.441 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.597 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 54.98 45.99 79.15 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.617 ' O ' ' N ' ' A' ' 42' ' ' THR . 39.5 Cg_endo -67.03 -60.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.918 1.483 . . . . 0.0 110.338 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 5' ' ' GLN . . . 37.83 -86.81 0.01 OUTLIER Glycine 0 N--CA 1.497 2.72 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.617 ' N ' ' O ' ' A' ' 40' ' ' PRO . 1.2 p -54.4 -7.65 0.17 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.337 -1.096 . . . . 0.0 112.008 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.455 ' CE1' HD13 ' A' ' 15' ' ' LEU . 6.6 t80 -67.37 130.09 41.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.61 -1.307 . . . . 0.0 110.096 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.474 HG21 ' HD2' ' A' ' 45' ' ' PRO . 34.1 mt -119.56 147.78 44.4 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.51 -0.744 . . . . 0.0 109.639 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.474 ' HD2' HG21 ' A' ' 44' ' ' ILE . 40.4 Cg_endo -68.48 87.62 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.841 1.442 . . . . 0.0 110.462 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 49' ' ' VAL . 18.3 mmt85 -95.91 157.73 15.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.402 -0.811 . . . . 0.0 110.112 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -53.66 -19.84 4.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.177 -0.952 . . . . 0.0 110.107 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.489 ' C ' ' CG1' ' A' ' 49' ' ' VAL . 1.8 tp10 -62.65 -36.51 83.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.283 -0.885 . . . . 0.0 109.752 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.489 ' CG1' ' C ' ' A' ' 48' ' ' GLU . 0.9 OUTLIER -150.05 173.92 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.393 -0.817 . . . . 0.0 109.521 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.45 ' O ' HG21 ' A' ' 52' ' ' VAL . 6.3 mt-10 -130.88 125.59 33.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.043 -1.036 . . . . 0.0 110.507 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 p -54.21 124.84 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.098 -1.001 . . . . 0.0 109.139 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.513 ' CG1' ' HG2' ' A' ' 53' ' ' GLU . 47.1 t -104.37 -61.79 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.106 -0.996 . . . . 0.0 111.1 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.513 ' HG2' ' CG1' ' A' ' 52' ' ' VAL . 4.5 mm-40 -134.84 174.09 10.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.071 -1.018 . . . . 0.0 110.612 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.488 HD13 ' HB2' ' A' ' 13' ' ' LEU . 1.1 mm -135.24 131.76 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.469 ' O ' ' HB ' ' A' ' 11' ' ' THR . 0.3 OUTLIER -121.13 137.31 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.106 -0.996 . . . . 0.0 111.269 -178.583 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.481 ' HA ' HG21 ' A' ' 11' ' ' THR . 6.8 mp0 -95.37 169.24 10.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.505 -0.747 . . . . 0.0 110.543 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 94' ' ' GLY . . . -96.85 118.99 34.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.821 . . . . 0.0 110.282 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.542 ' N ' ' HB1' ' A' ' 95' ' ' ALA . 8.1 t -176.91 78.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.053 -1.03 . . . . 0.0 110.726 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.577 ' CG2' ' N ' ' A' ' 60' ' ' ILE . 0.1 OUTLIER -179.12 -59.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.944 -1.098 . . . . 0.0 111.104 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.577 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 1.7 mt -92.75 -139.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 120.295 -1.503 . . . . 0.0 109.695 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.7 mtt85 -155.53 -162.02 1.26 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.077 -1.014 . . . . 0.0 110.092 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.557 ' HB3' ' CG1' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -83.06 -72.28 0.46 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.944 . . . . 0.0 111.109 -179.171 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.552 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 9.6 p30 -45.41 -41.1 8.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -0.918 . . . . 0.0 111.304 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.85 136.87 51.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.877 -1.139 . . . . 0.0 111.14 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.479 ' C ' ' CD2' ' A' ' 66' ' ' LEU . . . -121.96 142.65 50.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.515 -0.741 . . . . 0.0 109.296 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.479 ' CD2' ' C ' ' A' ' 65' ' ' ALA . 4.4 mm? -125.85 112.8 16.43 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.962 -1.086 . . . . 0.0 110.668 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.487 ' O ' ' HG3' ' A' ' 67' ' ' ARG . 3.5 ptp180 -90.91 126.98 36.21 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.031 -1.043 . . . . 0.0 110.362 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.539 ' CD2' ' HA ' ' A' ' 104' ' ' VAL . 17.2 mt -123.02 137.82 54.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.363 -0.836 . . . . 0.0 110.678 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -98.79 154.09 18.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.313 -0.867 . . . . 0.0 109.953 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.573 ' HA ' ' CZ3' ' A' ' 75' ' ' TRP . . . -67.92 140.35 56.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.378 -0.826 . . . . 0.0 111.6 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 101' ' ' PHE . 15.1 tpp85 -104.38 -38.46 6.82 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 101' ' ' PHE . 2.0 mmtt -113.81 155.96 24.75 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -86.82 27.76 0.96 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.988 -1.07 . . . . 0.0 110.275 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.6 -20.97 4.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.211 -0.93 . . . . 0.0 110.689 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.58 ' HB2' ' CD2' ' A' ' 101' ' ' PHE . 13.7 t90 -73.99 107.27 6.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.155 -0.965 . . . . 0.0 110.426 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 82' ' ' ARG . 8.3 m-20 -112.75 122.96 49.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.353 -0.842 . . . . 0.0 110.157 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.5 ' NH2' ' OD2' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -88.01 -20.41 25.85 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.265 -0.897 . . . . 0.0 110.256 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.5 ' OD2' ' NH2' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -96.16 6.98 47.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.208 -0.933 . . . . 0.0 110.032 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.07 9.33 86.83 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.449 ' O ' ' HB3' ' A' ' 76' ' ' ASP . 2.0 mmmt -117.88 135.61 53.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -1.189 . . . . 0.0 110.406 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.75 125.77 7.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -0.865 . . . . 0.0 110.159 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.504 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 1.5 mtt-85 -137.36 142.88 41.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.89 . . . . 0.0 110.115 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.4 p -78.62 170.72 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.912 . . . . 0.0 110.215 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.469 ' CG2' ' O ' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -55.44 -17.51 5.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.513 -0.742 . . . . 0.0 110.384 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.74 -12.2 78.1 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.473 ' OE2' ' CZ3' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -67.3 170.97 6.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.969 -1.312 . . . . 0.0 109.848 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -159.59 145.61 16.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.15 -0.969 . . . . 0.0 110.277 179.66 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.58 ' CZ2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -132.08 133.69 44.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.22 -0.925 . . . . 0.0 110.016 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.566 ' CD2' ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -107.06 138.72 42.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 110.018 179.737 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.58 HG22 ' CZ2' ' A' ' 88' ' ' TRP . 63.5 t -93.91 101.35 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.343 -0.848 . . . . 0.0 110.137 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.516 ' HB ' ' CD1' ' A' ' 89' ' ' LEU . 1.5 t -119.64 0.2 10.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.596 -0.69 . . . . 0.0 109.717 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 93' ' ' VAL . 98.9 m -88.06 114.44 24.68 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.429 -0.794 . . . . 0.0 110.259 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.557 ' CG1' ' HB3' ' A' ' 62' ' ' GLN . 16.6 m -41.31 124.7 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.453 -0.78 . . . . 0.0 109.753 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' A' ' 96' ' ' TYR . . . -174.93 34.78 0.1 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.542 ' HB1' ' N ' ' A' ' 58' ' ' THR . . . 45.58 -80.83 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.758 -0.848 . . . . 0.0 111.627 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.599 ' N ' ' O ' ' A' ' 94' ' ' GLY . 3.8 t80 -125.12 159.76 30.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.625 -1.297 . . . . 0.0 110.06 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.499 HD22 ' CG ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -173.28 69.07 0.36 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.131 -0.98 . . . . 0.0 110.555 -179.441 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.465 ' HG2' HG13 ' A' ' 55' ' ' ILE . 45.1 Cg_endo -74.89 145.27 31.68 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.839 1.441 . . . . 0.0 109.938 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.52 ' HB1' ' CG ' ' A' ' 102' ' ' GLU . . . -104.95 -141.67 0.37 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.038 -1.039 . . . . 0.0 111.15 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.508 ' CG2' ' HA ' ' A' ' 35' ' ' TRP . 0.9 OUTLIER -121.29 -58.42 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.136 -0.978 . . . . 0.0 111.819 -178.826 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.58 ' CD2' ' HB2' ' A' ' 75' ' ' TRP . 9.7 m-30 -111.35 55.6 0.66 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.161 -1.587 . . . . 0.0 111.492 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.52 ' CG ' ' HB1' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -141.2 143.83 34.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.592 -1.317 . . . . 0.0 110.815 179.218 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.407 ' O ' ' CD1' ' A' ' 105' ' ' LEU . 12.5 tp10 -118.56 128.31 54.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.586 -0.696 . . . . 0.0 110.171 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.539 ' HA ' ' CD2' ' A' ' 68' ' ' LEU . 4.9 p -65.28 148.53 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.389 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 1.6 mp -105.19 -45.56 4.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.354 -0.841 . . . . 0.0 109.944 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.11 133.14 2.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.878 . . . . 0.0 109.963 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.558 ' CD2' ' C ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -76.06 142.65 41.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.939 . . . . 0.0 111.119 -179.499 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.473 ' CG1' ' CB ' ' A' ' 65' ' ' ALA . 3.4 p -128.03 149.88 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.993 -1.067 . . . . 0.0 109.709 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.2 119.58 39.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.058 -1.026 . . . . 0.0 110.544 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.028 -1.045 . . . . 0.0 109.862 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.513 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.35 0.595 . . . . 0.0 110.071 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 8' ' ' LEU . 3.5 t -123.29 160.09 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.243 -0.91 . . . . 0.0 109.954 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.471 ' O ' ' O ' ' A' ' 8' ' ' LEU . 10.6 t -57.06 81.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.374 -0.828 . . . . 0.0 110.837 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.621 ' CD1' ' N ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -45.62 171.38 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.43 -0.794 . . . . 0.0 110.113 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.502 ' HD2' ' HB2' ' A' ' 8' ' ' LEU . 51.3 Cg_endo -75.44 -99.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.524 1.276 . . . . 0.0 111.955 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.539 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 0.8 OUTLIER -112.38 83.94 1.89 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.761 -1.212 . . . . 0.0 110.934 -178.711 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.531 ' CG2' ' C ' ' A' ' 10' ' ' ASN . 1.7 p -156.16 169.6 24.13 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.204 -0.935 . . . . 0.0 110.17 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.497 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -145.9 167.37 23.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 108.883 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.572 HD21 ' CD2' ' A' ' 43' ' ' TYR . 0.2 OUTLIER -134.55 153.75 51.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.826 -1.171 . . . . 0.0 111.137 179.859 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.643 ' CD2' ' CD1' ' A' ' 36' ' ' LEU . 14.3 m-70 -98.5 135.63 39.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -0.858 . . . . 0.0 109.261 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.689 ' CD1' ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -139.11 165.53 26.91 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.128 -0.983 . . . . 0.0 110.172 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 1.6 tttt -114.51 120.91 41.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 111.108 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.527 ' CB ' ' HB2' ' A' ' 33' ' ' ASP . . . -81.56 112.53 18.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.416 -0.802 . . . . 0.0 109.696 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.462 ' O ' HD22 ' A' ' 19' ' ' LEU . 0.7 OUTLIER -100.47 101.6 12.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.395 -0.816 . . . . 0.0 110.124 -179.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.481 HD11 ' N ' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -162.27 139.18 8.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 110.208 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.481 ' N ' HD11 ' A' ' 19' ' ' LEU . 33.9 p-10 -78.83 101.53 7.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.687 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.535 ' CB ' HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.27 -0.894 . . . . 0.0 110.53 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.535 HG21 ' CB ' ' A' ' 21' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.409 ' O ' ' C ' ' A' ' 31' ' ' ALA . 29.1 m -138.59 88.58 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.024 -1.047 . . . . 0.0 110.676 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.438 ' CB ' ' CD1' ' A' ' 18' ' ' LEU . . . 41.55 65.32 0.86 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.372 -0.83 . . . . 0.0 110.55 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -175.17 26.02 0.07 OUTLIER Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.501 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.527 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 10.0 m-20 -86.7 154.53 20.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.893 -1.357 . . . . 0.0 109.833 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 3.8 tt0 -153.59 131.27 11.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.251 -0.906 . . . . 0.0 110.176 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.631 ' CD2' ' CD2' ' A' ' 15' ' ' LEU . 6.8 p90 -151.94 165.17 35.43 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.062 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.643 ' CD1' ' CD2' ' A' ' 14' ' ' HIS . 51.6 tp -91.44 161.86 14.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -0.834 . . . . 0.0 110.173 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.601 ' CE2' ' HB2' ' A' ' 43' ' ' TYR . 0.9 OUTLIER -136.78 111.99 9.09 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.366 -0.834 . . . . 0.0 109.89 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.445 ' HG3' HD23 ' A' ' 97' ' ' LEU . 2.4 tm-20 -84.31 140.68 31.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.683 -0.635 . . . . 0.0 109.803 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.609 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 59.05 40.77 95.97 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 49.2 Cg_endo -75.2 -51.14 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.375 1.197 . . . . 0.0 109.535 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.535 ' CA ' HD11 ' A' ' 8' ' ' LEU . . . 41.63 -94.08 0.01 OUTLIER Glycine 0 N--CA 1.486 1.967 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 40' ' ' PRO . 1.8 t -78.23 19.9 0.42 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.425 -1.044 . . . . 0.0 112.05 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.601 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 1.6 t80 -67.61 111.05 3.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.675 -1.266 . . . . 0.0 109.006 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.475 HG22 HD13 ' A' ' 44' ' ' ILE . 51.1 mm -90.11 142.14 28.42 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.295 -0.878 . . . . 0.0 110.609 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.495 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 48.3 Cg_endo -74.74 106.5 2.27 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.184 1.623 . . . . 0.0 110.467 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.428 ' O ' ' N ' ' A' ' 48' ' ' GLU . 0.7 OUTLIER -84.95 147.85 26.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 109.789 179.699 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -43.71 -25.82 0.2 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.163 -0.96 . . . . 0.0 109.933 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -62.15 -46.45 88.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -0.863 . . . . 0.0 110.51 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -124.03 173.17 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.183 -0.948 . . . . 0.0 110.418 -179.656 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.464 ' O ' HG21 ' A' ' 52' ' ' VAL . 3.0 mm-40 -135.1 137.12 42.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 110.22 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.495 ' CG2' ' HB3' ' A' ' 45' ' ' PRO . 12.2 t -56.98 138.79 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 109.234 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 16' ' ' LYS . 39.4 t -121.86 -51.27 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.031 -1.043 . . . . 0.0 110.799 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.501 ' HG3' ' HB2' ' A' ' 14' ' ' HIS . 0.7 OUTLIER -145.6 166.89 24.45 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.977 -1.077 . . . . 0.0 110.147 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.468 HD12 ' O ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -134.29 131.24 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.335 -0.853 . . . . 0.0 109.245 179.185 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 12' ' ' ALA . 8.0 tt -117.03 145.93 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.061 -1.024 . . . . 0.0 111.44 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.431 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 14.4 mp0 -105.79 -179.51 3.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.618 -0.676 . . . . 0.0 109.837 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.572 ' CA ' ' HA ' ' A' ' 95' ' ' ALA . . . -97.16 136.06 38.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.159 -0.963 . . . . 0.0 111.17 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 4.7 t 176.23 57.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.443 -0.786 . . . . 0.0 111.134 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.597 HG21 ' CG ' ' A' ' 96' ' ' TYR . 0.5 OUTLIER -173.77 -48.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.507 -1.371 . . . . 0.0 112.33 179.389 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.558 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 70.7 mt -75.69 172.63 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.577 -1.327 . . . . 0.0 110.333 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.498 ' N ' HG22 ' A' ' 60' ' ' ILE . 29.7 mtt-85 -117.81 -174.31 2.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.035 -1.04 . . . . 0.0 110.256 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.541 ' HB2' ' CG1' ' A' ' 93' ' ' VAL . 5.6 tt0 -79.16 -30.22 43.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.17 -0.956 . . . . 0.0 110.96 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 7.2 p30 -105.94 -21.87 13.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.009 -1.057 . . . . 0.0 110.625 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 109' ' ' ASP . 5.5 tp-100 -58.39 135.0 57.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.873 -1.142 . . . . 0.0 110.699 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.573 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . . . -112.96 135.47 53.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.487 -0.758 . . . . 0.0 109.324 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.468 HD21 HG12 ' A' ' 60' ' ' ILE . 1.3 mp -124.82 117.23 23.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.192 -0.942 . . . . 0.0 111.173 -179.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.482 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 1.7 ttp180 -96.34 126.13 41.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 108.965 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.581 ' CD2' ' CG1' ' A' ' 104' ' ' VAL . 17.8 mt -118.89 133.18 56.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.01 -1.056 . . . . 0.0 110.582 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 5.4 ttt85 -114.85 150.63 35.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -0.847 . . . . 0.0 110.13 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.544 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . . . -70.32 123.45 21.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.83 . . . . 0.0 110.752 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -81.8 -38.67 25.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.947 . . . . 0.0 108.931 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.636 ' CG ' ' CD2' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -136.35 143.25 43.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.535 -0.728 . . . . 0.0 109.239 179.099 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 74' ' ' CYS . 0.0 OUTLIER -55.46 -161.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.983 . . . . 0.0 110.58 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 7.3 m 78.88 -40.97 0.27 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.587 -0.696 . . . . 0.0 110.54 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.585 ' CD1' ' HB2' ' A' ' 35' ' ' TRP . 20.6 t90 -73.38 104.36 4.36 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.769 -1.207 . . . . 0.0 110.099 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.412 ' OD1' ' HA ' ' A' ' 81' ' ' GLU . 65.1 m-20 -84.1 113.72 21.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.853 . . . . 0.0 110.136 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.453 ' HB2' ' CZ2' ' A' ' 75' ' ' TRP . 21.8 tpt180 -87.45 -8.55 56.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.316 -0.865 . . . . 0.0 110.489 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.02 3.04 9.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 110.199 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.69 -2.9 64.98 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.85 144.27 48.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -1.114 . . . . 0.0 110.047 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.475 ' HB2' ' CG1' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -46.16 110.67 0.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -0.929 . . . . 0.0 110.408 -179.762 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.35 179.44 3.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.212 -0.93 . . . . 0.0 109.947 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' A' ' 86' ' ' GLU . 12.5 p -116.85 172.87 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.995 -1.066 . . . . 0.0 110.503 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.499 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 7.5 t -57.55 -16.35 9.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.303 -0.873 . . . . 0.0 109.96 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.38 -14.25 74.34 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 83' ' ' VAL . 5.1 tp10 -75.63 147.75 39.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.406 -1.055 . . . . 0.0 109.67 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 68' ' ' LEU . 4.8 tt0 -157.38 162.44 39.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.212 -0.93 . . . . 0.0 109.981 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.567 ' CZ2' ' HB ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -153.34 142.04 20.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.17 -0.956 . . . . 0.0 110.232 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.52 HD21 ' N ' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -100.25 119.42 38.35 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.497 -0.752 . . . . 0.0 109.98 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.567 ' HB ' ' CZ2' ' A' ' 88' ' ' TRP . 5.3 p -97.99 150.72 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 110.749 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.1 t -148.98 51.06 0.97 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.453 -0.779 . . . . 0.0 109.903 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.46 HG23 ' OD1' ' A' ' 10' ' ' ASN . 9.2 m -82.95 139.82 33.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -0.917 . . . . 0.0 110.459 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.541 ' CG1' ' HB2' ' A' ' 62' ' ' GLN . 8.1 t -75.4 128.75 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.168 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 60' ' ' ILE . . . 48.69 84.32 0.02 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.572 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . . . -177.61 151.46 0.74 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.111 -1.229 . . . . 0.0 110.953 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.597 ' CG ' HG21 ' A' ' 59' ' ' ILE . 1.2 t80 -116.88 112.57 21.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.021 -1.049 . . . . 0.0 110.419 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.452 ' HG ' ' CD2' ' A' ' 36' ' ' LEU . 1.0 OUTLIER -124.94 76.71 66.62 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.183 -0.948 . . . . 0.0 110.249 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.427 ' HD3' ' CD1' ' A' ' 96' ' ' TYR . 52.8 Cg_endo -77.18 6.67 4.15 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.009 1.531 . . . . 0.0 110.967 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.589 ' CB ' ' CG ' ' A' ' 102' ' ' GLU . . . 52.41 -161.47 0.1 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.002 -1.062 . . . . 0.0 110.084 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.441 HG21 ' ND1' ' A' ' 14' ' ' HIS . 3.4 t -115.0 -62.01 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.07 -1.019 . . . . 0.0 111.19 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.636 ' CD2' ' CG ' ' A' ' 72' ' ' LYS . 4.5 m-30 -93.71 -29.65 15.3 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.767 -1.208 . . . . 0.0 111.214 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.589 ' CG ' ' CB ' ' A' ' 99' ' ' ALA . 8.6 pt-20 -80.37 161.15 25.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.965 -1.084 . . . . 0.0 110.899 -178.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.482 ' O ' HD22 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -136.05 164.18 28.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.364 -0.835 . . . . 0.0 110.018 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.581 ' CG1' ' CD2' ' A' ' 68' ' ' LEU . 3.9 m -76.25 139.85 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.909 . . . . 0.0 110.43 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.552 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -94.0 -10.34 33.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.329 -0.857 . . . . 0.0 109.145 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER 166.35 -174.66 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.548 -0.72 . . . . 0.0 109.871 179.677 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.504 ' N ' HD11 ' A' ' 107' ' ' LEU . 4.4 mp -133.54 127.47 33.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.3 -0.875 . . . . 0.0 109.762 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.573 ' CG1' ' CB ' ' A' ' 65' ' ' ALA . 9.4 p -124.51 113.72 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.951 -1.093 . . . . 0.0 111.004 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.495 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -70.01 134.95 48.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.184 -0.947 . . . . 0.0 109.941 179.405 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.423 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.466 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 7.1 tt0 . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 121.091 0.472 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.519 ' C ' ' HA3' ' A' ' 41' ' ' GLY . 7.1 p -118.4 139.51 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.157 -0.964 . . . . 0.0 109.991 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.449 ' C ' ' O ' ' A' ' 6' ' ' VAL . 2.2 p -38.85 120.45 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.31 -0.869 . . . . 0.0 111.118 -178.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.555 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -67.99 171.54 5.41 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.817 -0.552 . . . . 0.0 109.766 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.555 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 38.1 Cg_endo -64.67 73.8 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.593 1.312 . . . . 0.0 109.969 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.52 ' OD1' ' CG2' ' A' ' 92' ' ' THR . 9.2 m-20 64.1 33.29 12.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.873 -0.517 . . . . 0.0 111.558 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.497 ' OG1' ' HB2' ' A' ' 8' ' ' LEU . 1.2 p -106.16 169.07 8.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.76 -1.213 . . . . 0.0 109.369 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.528 ' CB ' ' HA ' ' A' ' 38' ' ' GLU . . . -148.75 158.67 44.32 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.008 -1.057 . . . . 0.0 110.496 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.622 ' CD1' ' CD2' ' A' ' 15' ' ' LEU . 1.4 pp -127.57 156.94 41.44 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.294 -0.879 . . . . 0.0 110.896 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.621 ' N ' ' CD2' ' A' ' 14' ' ' HIS . 6.6 m170 -93.39 127.17 38.89 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.526 -0.734 . . . . 0.0 110.622 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.622 ' CD2' ' CD1' ' A' ' 13' ' ' LEU . 1.1 mm? -114.21 144.66 42.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.487 -0.758 . . . . 0.0 110.151 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.513 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 4.2 tttp -107.75 116.54 32.13 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.241 -0.983 . . . . 0.0 109.339 178.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.52 ' HA ' ' CG1' ' A' ' 49' ' ' VAL . . . -79.39 120.85 24.39 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 110.074 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 70.6 mt -105.98 101.21 10.72 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.883 -0.511 . . . . 0.0 109.638 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.525 HD13 ' N ' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -164.04 144.1 8.14 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.074 -1.016 . . . . 0.0 110.608 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.525 ' N ' HD13 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -84.9 103.4 13.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.343 -0.848 . . . . 0.0 109.146 178.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.479 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 110.542 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.485 HG21 ' O ' ' A' ' 29' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.447 ' O ' ' C ' ' A' ' 31' ' ' ALA . 23.1 m -131.53 90.31 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.997 -1.064 . . . . 0.0 110.686 -179.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 39.98 58.34 2.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.468 -0.77 . . . . 0.0 110.74 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.91 28.05 0.22 Allowed Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.58 -1.295 . . . . 0.0 110.04 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 17' ' ' ALA . 7.4 m-20 -91.98 148.35 22.27 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.08 -1.247 . . . . 0.0 110.075 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 5.3 tt0 -147.63 131.7 17.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.016 -1.053 . . . . 0.0 110.603 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.551 ' CZ2' ' HB2' ' A' ' 15' ' ' LEU . 10.3 p90 -140.64 172.92 12.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.188 -0.945 . . . . 0.0 110.3 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.521 HD23 ' CD1' ' A' ' 97' ' ' LEU . 17.1 tp -106.16 156.78 18.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.488 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.492 ' N ' ' HG ' ' A' ' 36' ' ' LEU . 1.5 t80 -142.89 115.52 8.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -0.913 . . . . 0.0 110.913 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.528 ' HA ' ' CB ' ' A' ' 12' ' ' ALA . 4.3 tm-20 -84.53 141.58 30.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.532 -0.73 . . . . 0.0 109.273 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.612 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 63.43 47.73 84.76 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 47.1 Cg_endo -68.99 7.06 0.85 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 124.187 1.625 . . . . 0.0 112.071 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.519 ' HA3' ' C ' ' A' ' 6' ' ' VAL . . . -49.67 -57.03 10.05 Favored Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.321 -1.418 . . . . 0.0 109.56 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 61.4 p -71.93 -4.45 28.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.479 -1.012 . . . . 0.0 110.789 -179.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.531 ' CE1' ' HG ' ' A' ' 15' ' ' LEU . 4.3 t80 -82.67 111.5 18.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.042 -1.036 . . . . 0.0 109.732 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.523 ' CG2' ' HD2' ' A' ' 45' ' ' PRO . 18.2 mm -102.48 144.56 28.86 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.255 -0.903 . . . . 0.0 109.787 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.523 ' HD2' ' CG2' ' A' ' 44' ' ' ILE . 42.2 Cg_endo -67.8 96.3 0.43 Allowed 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.033 1.543 . . . . 0.0 111.474 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.1 147.71 23.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 109.482 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.453 ' HG3' ' N ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -50.72 -30.95 15.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.161 -0.962 . . . . 0.0 110.474 -179.572 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.473 ' O ' HG11 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -52.25 -25.49 9.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.129 -0.982 . . . . 0.0 110.668 -179.796 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.52 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 1.5 m -149.18 173.29 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.885 . . . . 0.0 109.615 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.74 134.79 45.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.052 -1.03 . . . . 0.0 110.595 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.455 ' HA ' HD12 ' A' ' 15' ' ' LEU . 9.0 t -54.79 130.78 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 109.128 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.543 HG21 ' CA ' ' A' ' 15' ' ' LEU . 5.3 t -104.54 -62.24 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.366 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.497 ' C ' ' CD1' ' A' ' 54' ' ' ILE . 2.4 mm-40 -146.29 173.72 12.0 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.547 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.515 HD13 ' CB ' ' A' ' 13' ' ' LEU . 1.3 mm -133.68 145.88 32.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.452 HD12 HG23 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -136.71 139.05 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.914 -1.116 . . . . 0.0 110.923 -178.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.476 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 2.8 mp0 -88.75 159.63 17.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.574 -0.704 . . . . 0.0 109.939 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.534 ' CB ' ' HA ' ' A' ' 95' ' ' ALA . . . -94.84 138.06 33.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.286 -0.884 . . . . 0.0 110.222 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 1.7 t 178.48 58.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.988 -1.07 . . . . 0.0 111.903 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.574 ' CG2' ' N ' ' A' ' 60' ' ' ILE . 0.6 OUTLIER -166.04 -52.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.605 -1.31 . . . . 0.0 111.201 178.81 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.574 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 10.5 mt -62.45 161.23 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.655 -1.278 . . . . 0.0 109.552 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 1.0 OUTLIER -96.38 -168.43 1.73 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.1 -1.0 . . . . 0.0 110.818 -179.37 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.584 ' HA ' ' CG1' ' A' ' 93' ' ' VAL . 7.5 tt0 -89.03 -17.5 29.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.323 -0.861 . . . . 0.0 111.116 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 2.4 p-10 -115.96 -36.34 4.17 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 110.266 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.469 ' NE2' ' HB3' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -55.54 132.05 47.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 111.175 -179.596 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.526 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . . . -109.9 149.71 29.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.384 -0.823 . . . . 0.0 109.381 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.597 ' CB ' ' CG1' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -119.01 123.9 45.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.831 -1.168 . . . . 0.0 110.948 -179.469 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.468 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 7.9 ttt180 -91.5 120.91 32.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 109.255 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.527 HD11 ' N ' ' A' ' 104' ' ' VAL . 2.5 mm? -112.66 137.49 50.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.186 -0.946 . . . . 0.0 111.256 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.516 ' CB ' HD11 ' A' ' 105' ' ' LEU . 7.5 ttt180 -128.12 150.53 49.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.539 -0.725 . . . . 0.0 109.466 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.497 ' HB1' ' HG2' ' A' ' 86' ' ' GLU . . . -62.84 136.76 58.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.053 -1.029 . . . . 0.0 110.603 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.458 ' HG3' ' HD2' ' A' ' 72' ' ' LYS . 34.8 tpt85 -107.52 -26.3 10.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.252 -0.905 . . . . 0.0 110.022 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.613 ' HG3' ' CD2' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -143.83 34.7 1.26 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.22 -0.925 . . . . 0.0 110.332 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.57 ' O ' ' CB ' ' A' ' 74' ' ' CYS . 1.1 pt-20 38.76 -162.13 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.585 -0.697 . . . . 0.0 110.447 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.57 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER 77.43 -35.21 0.21 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.382 -0.824 . . . . 0.0 111.156 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.565 ' CZ2' ' HB2' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -73.87 113.13 10.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.91 -1.119 . . . . 0.0 109.665 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 79' ' ' GLY . 11.0 t0 -78.17 109.96 12.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.345 -0.847 . . . . 0.0 110.839 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.565 ' HB2' ' CZ2' ' A' ' 75' ' ' TRP . 1.4 tpm_? -88.68 -41.8 12.37 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.281 -0.887 . . . . 0.0 109.79 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -102.95 -9.07 20.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.356 -0.84 . . . . 0.0 110.128 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.518 ' N ' ' OD1' ' A' ' 76' ' ' ASP . . . 103.56 -4.6 47.21 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 81' ' ' GLU . 2.1 mttt -103.63 2.13 32.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -1.167 . . . . 0.0 110.132 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.466 ' OE2' ' OD2' ' A' ' 33' ' ' ASP . 43.5 mm-40 57.32 110.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 110.083 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.423 ' HB2' ' CD ' ' A' ' 86' ' ' GLU . 1.5 mmm-85 -113.8 179.87 3.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.465 -0.772 . . . . 0.0 110.641 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.8 p -87.56 169.91 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.415 -0.803 . . . . 0.0 110.653 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.507 HG23 ' N ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -48.55 -23.03 0.86 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.304 -0.873 . . . . 0.0 110.138 179.754 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.66 -34.58 90.29 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.497 ' HG2' ' HB1' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -50.19 162.51 0.21 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.171 -1.193 . . . . 0.0 109.727 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.441 ' HB3' ' HG3' ' A' ' 69' ' ' ARG . 7.8 pt-20 -159.13 151.22 21.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.145 -0.972 . . . . 0.0 110.655 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.505 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -133.0 148.44 52.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.431 -0.793 . . . . 0.0 109.106 179.579 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 90' ' ' VAL . 1.1 tt -109.3 162.23 14.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.176 -0.952 . . . . 0.0 110.15 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.597 ' CG1' ' CB ' ' A' ' 66' ' ' LEU . 14.3 p -137.0 117.78 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.156 -0.965 . . . . 0.0 110.556 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.66 38.27 3.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.396 -0.815 . . . . 0.0 109.789 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.52 ' CG2' ' OD1' ' A' ' 10' ' ' ASN . 2.2 m -88.62 133.78 34.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.848 . . . . 0.0 110.568 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.584 ' CG1' ' HA ' ' A' ' 62' ' ' GLN . 76.5 t -76.8 147.46 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.317 -0.865 . . . . 0.0 109.871 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . 44.97 82.35 0.03 OUTLIER Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.534 ' HA ' ' CB ' ' A' ' 57' ' ' ALA . . . -165.31 145.84 7.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.33 -1.1 . . . . 0.0 110.393 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.573 ' O ' ' CD1' ' A' ' 96' ' ' TYR . 3.2 t80 -124.81 -13.59 6.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.598 -0.689 . . . . 0.0 110.859 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.521 ' CD1' HD23 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -40.87 98.93 0.19 Allowed Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.151 -0.968 . . . . 0.0 110.185 -179.708 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' A' ' 99' ' ' ALA . 50.2 Cg_endo -86.88 11.63 3.21 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.169 1.615 . . . . 0.0 111.018 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 36' ' ' LEU . . . 67.99 -158.97 0.21 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.027 -1.046 . . . . 0.0 110.111 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.93 -55.45 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.061 -1.025 . . . . 0.0 110.897 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.613 ' CD2' ' HG3' ' A' ' 72' ' ' LYS . 7.5 m-85 -98.68 -4.54 33.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.869 -1.145 . . . . 0.0 110.159 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.55 ' HG2' ' CH2' ' A' ' 75' ' ' TRP . 6.9 mt-10 -91.05 121.93 33.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.293 -0.88 . . . . 0.0 110.733 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.471 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -102.19 143.32 32.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.411 -0.806 . . . . 0.0 109.975 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.527 ' N ' HD11 ' A' ' 68' ' ' LEU . 3.6 m -71.39 134.08 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.062 -1.024 . . . . 0.0 110.426 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.599 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 3.0 mp -84.83 -16.02 42.78 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.447 -0.783 . . . . 0.0 109.168 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 3.2 p30 160.85 -165.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.469 ' HB3' ' NE2' ' A' ' 64' ' ' GLN . 3.4 mp -123.1 109.76 14.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.35 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.526 ' CG1' ' CB ' ' A' ' 65' ' ' ALA . 10.0 p -97.19 161.55 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.474 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 110' ' ' ALA . 8.8 p-10 -104.65 131.78 51.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.852 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.496 1.833 0 O-C-N 121.476 -0.765 . . . . 0.0 110.942 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.461 ' O ' ' O ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.428 0.632 . . . . 0.0 110.757 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.496 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 55.6 t -97.82 157.5 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.381 -0.825 . . . . 0.0 109.524 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.514 ' HA ' ' CA ' ' A' ' 41' ' ' GLY . 48.7 t -38.06 102.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.51 -0.744 . . . . 0.0 110.766 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.471 ' HB3' ' OG1' ' A' ' 11' ' ' THR . 1.6 mp -47.73 137.49 9.91 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 110.288 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.474 ' O ' HG23 ' A' ' 11' ' ' THR . 48.4 Cg_endo -73.87 85.05 1.38 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.986 1.519 . . . . 0.0 110.618 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.523 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 9.4 m-20 56.64 48.36 16.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.214 -0.929 . . . . 0.0 110.578 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.482 HG21 ' O ' ' A' ' 10' ' ' ASN . 61.3 p -143.56 170.89 14.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.079 -1.013 . . . . 0.0 110.696 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -146.31 159.79 42.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.495 -0.753 . . . . 0.0 110.107 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.577 HD21 ' CD2' ' A' ' 43' ' ' TYR . 0.2 OUTLIER -133.3 152.71 51.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 109.983 179.493 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.512 ' C ' ' CD1' ' A' ' 15' ' ' LEU . 32.2 m80 -92.71 133.85 35.61 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.157 -0.964 . . . . 0.0 111.521 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.603 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -124.21 153.85 41.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.419 -0.801 . . . . 0.0 109.274 178.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.54 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 8.5 ttmt -107.65 117.1 33.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.984 -1.073 . . . . 0.0 109.277 178.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.562 ' HA ' ' CG1' ' A' ' 49' ' ' VAL . . . -78.6 110.84 14.09 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.318 -0.864 . . . . 0.0 110.123 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 48' ' ' GLU . 82.6 mt -98.53 101.13 12.46 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.365 0.602 . . . . 0.0 109.72 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.419 HD22 ' O ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -163.87 136.54 5.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.202 -0.936 . . . . 0.0 110.081 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -78.43 104.36 8.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 0.0 109.702 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.448 ' O ' ' O ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.147 -0.97 . . . . 0.0 110.587 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.494 HG12 ' HG2' ' A' ' 81' ' ' GLU . 2.0 m . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 121.231 0.539 . . . . 0.0 109.653 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.413 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 35.7 m -142.0 84.93 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 110.482 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.55 67.37 0.82 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.482 -0.761 . . . . 0.0 110.481 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -179.26 26.44 0.05 OUTLIER Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.592 -1.289 . . . . 0.0 110.587 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 17' ' ' ALA . 15.7 m-20 -87.99 150.42 23.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.821 -1.4 . . . . 0.0 110.217 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 80.4 tt0 -145.3 130.8 18.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.134 -0.979 . . . . 0.0 110.052 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 8.0 p90 -143.03 166.01 25.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.042 -1.036 . . . . 0.0 110.715 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.477 HD12 ' CD2' ' A' ' 14' ' ' HIS . 56.2 tp -90.17 153.72 20.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.454 -0.779 . . . . 0.0 109.942 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.588 ' CE1' ' HA ' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -119.98 109.62 15.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.763 -1.211 . . . . 0.0 110.38 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.536 ' HB2' ' CD2' ' A' ' 97' ' ' LEU . 0.4 OUTLIER -90.71 127.0 36.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.422 -0.799 . . . . 0.0 110.186 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.57 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 57.98 46.86 92.03 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.588 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 37.8 Cg_endo -62.85 -21.65 73.26 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.87 1.458 . . . . 0.0 110.095 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.514 ' CA ' ' HA ' ' A' ' 7' ' ' VAL . . . 30.97 -92.09 0.01 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.495 ' N ' ' O ' ' A' ' 40' ' ' PRO . 30.2 p -86.21 34.78 0.63 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.38 -1.07 . . . . 0.0 111.666 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.577 ' CD2' HD21 ' A' ' 13' ' ' LEU . 14.4 t80 -69.45 111.36 5.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.772 -1.205 . . . . 0.0 109.592 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.443 HD11 ' O ' ' A' ' 42' ' ' THR . 2.5 mp -103.57 142.58 24.88 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 109.839 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.96 109.6 2.59 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.007 1.53 . . . . 0.0 110.801 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 49' ' ' VAL . 80.4 mtt180 -111.85 143.81 42.2 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.364 -0.835 . . . . 0.0 110.015 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 46' ' ' ARG . 14.4 pttp -43.55 -38.28 2.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.099 -1.0 . . . . 0.0 110.094 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 8.8 mt-10 -44.89 -43.83 9.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.171 -0.956 . . . . 0.0 110.231 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.562 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 1.6 m -136.49 173.33 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.326 -0.859 . . . . 0.0 109.99 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -136.06 139.82 43.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.098 -1.001 . . . . 0.0 110.526 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.1 t -54.74 130.58 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.186 -0.946 . . . . 0.0 109.587 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.54 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 16.9 t -109.73 -62.39 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.267 -0.896 . . . . 0.0 110.396 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.491 ' HB2' ' ND1' ' A' ' 14' ' ' HIS . 3.2 mt-10 -139.03 173.08 11.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.035 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.503 HD11 ' HB2' ' A' ' 13' ' ' LEU . 1.4 mm -131.72 150.55 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.483 HG23 HD13 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -143.55 144.95 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.84 -1.163 . . . . 0.0 110.883 -179.025 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.427 ' HA ' ' CG2' ' A' ' 11' ' ' THR . 13.6 mp0 -115.88 169.77 8.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.524 -0.735 . . . . 0.0 109.767 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 10' ' ' ASN . . . -89.11 139.09 30.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 110.078 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.465 ' O ' HG12 ' A' ' 59' ' ' ILE . 2.6 t -169.97 51.4 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 110.261 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.609 ' HB ' ' CD1' ' A' ' 96' ' ' TYR . 7.1 mm -146.83 -82.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.085 -1.009 . . . . 0.0 110.631 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.483 ' N ' HG23 ' A' ' 59' ' ' ILE . 13.3 mt -111.88 -102.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.803 -1.186 . . . . 0.0 110.704 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.501 ' N ' ' HA ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER -175.99 -144.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.848 -1.158 . . . . 0.0 110.822 -179.633 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.569 ' HB2' ' CG1' ' A' ' 93' ' ' VAL . 6.1 tt0 -87.98 -66.41 0.92 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.511 -0.743 . . . . 0.0 110.884 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.502 ' C ' ' O ' ' A' ' 62' ' ' GLN . 3.3 m-20 -31.25 -58.7 0.24 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.299 0.571 . . . . 0.0 110.786 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 2.8 tp-100 -59.87 129.22 40.79 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.224 -0.923 . . . . 0.0 109.66 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.469 ' O ' ' OE1' ' A' ' 64' ' ' GLN . . . -108.15 146.73 32.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.969 -1.082 . . . . 0.0 110.264 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.491 HD23 ' OE1' ' A' ' 64' ' ' GLN . 4.0 mm? -121.27 116.34 24.67 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.134 -0.979 . . . . 0.0 109.89 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.509 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 16.3 ttp180 -90.14 132.47 35.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.064 -1.022 . . . . 0.0 110.01 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 98' ' ' PRO . 12.6 mt -124.14 143.27 50.58 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.522 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.492 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 2.5 ttt180 -117.62 138.88 51.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.714 -0.616 . . . . 0.0 109.577 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -58.33 152.67 17.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.223 -0.923 . . . . 0.0 110.359 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.457 ' C ' ' CG2' ' A' ' 84' ' ' THR . 8.8 ttt180 -143.48 -11.79 0.7 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.158 -0.964 . . . . 0.0 111.778 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.59 ' HG2' ' CE1' ' A' ' 101' ' ' PHE . 5.4 tppt? -114.57 -4.92 12.78 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.635 -1.29 . . . . 0.0 111.021 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 7.8 tt0 54.55 69.64 0.7 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.892 -1.13 . . . . 0.0 109.689 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 2.6 t -172.81 -31.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.308 -0.87 . . . . 0.0 110.261 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.573 ' CB ' ' HB2' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -74.16 126.76 31.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.146 -0.972 . . . . 0.0 110.118 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.514 ' HB3' ' N ' ' A' ' 81' ' ' GLU . 39.3 p-10 -101.08 110.34 22.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.156 -0.965 . . . . 0.0 109.905 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.567 ' HB2' ' CZ2' ' A' ' 75' ' ' TRP . 2.3 tpm_? -80.05 -38.08 32.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.391 -0.818 . . . . 0.0 110.032 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.35 24.05 13.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.878 . . . . 0.0 110.108 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.92 9.71 80.23 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 81' ' ' GLU . 30.4 mtpt -130.12 87.97 2.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -1.076 . . . . 0.0 110.038 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.514 ' N ' ' HB3' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -43.2 118.48 1.32 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.918 . . . . 0.0 109.58 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.539 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 1.4 ttm180 -117.23 179.67 3.97 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 0.0 110.779 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 84' ' ' THR . 7.4 p -82.51 172.36 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.507 -0.745 . . . . 0.0 110.628 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.463 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 45.7 p -52.65 -26.39 13.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.353 -0.842 . . . . 0.0 109.99 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -55.96 -43.71 87.83 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.539 ' CB ' ' HB3' ' A' ' 82' ' ' ARG . 12.4 tp10 -55.96 153.52 8.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.403 -1.057 . . . . 0.0 109.527 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.492 ' HB3' ' HG3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -159.47 156.18 27.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.064 -1.022 . . . . 0.0 110.602 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.486 ' CZ2' HG21 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -142.58 151.12 41.22 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.283 -0.886 . . . . 0.0 109.604 179.679 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.554 HD21 ' N ' ' A' ' 90' ' ' VAL . 1.8 tt -102.21 154.01 19.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.325 -0.86 . . . . 0.0 109.901 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.554 ' N ' HD21 ' A' ' 89' ' ' LEU . 49.4 t -114.2 107.95 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.385 -0.822 . . . . 0.0 110.396 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.9 m -121.47 25.85 9.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.923 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.2 t -76.85 171.36 14.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.381 -0.824 . . . . 0.0 110.403 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.569 ' CG1' ' HB2' ' A' ' 62' ' ' GLN . 3.9 t -92.22 75.81 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 0.0 110.027 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.47 ' HA2' ' HB3' ' A' ' 10' ' ' ASN . . . -128.01 -85.82 0.5 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.501 ' HA ' ' N ' ' A' ' 61' ' ' ARG . . . -177.18 -38.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.362 -1.081 . . . . 0.0 109.707 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.609 ' CD1' ' HB ' ' A' ' 59' ' ' ILE . 3.4 p90 179.92 40.81 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.697 -0.627 . . . . 0.0 109.94 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.536 ' CD2' ' HB2' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -41.68 103.97 0.33 Allowed Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.281 -0.887 . . . . 0.0 110.155 -179.73 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.517 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 46.7 Cg_endo -72.09 -98.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.08 1.569 . . . . 0.0 110.277 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.542 ' CB ' ' HG2' ' A' ' 102' ' ' GLU . . . 169.11 -156.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.769 -1.207 . . . . 0.0 110.156 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.31 -32.03 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 110.806 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.59 ' CE1' ' HG2' ' A' ' 72' ' ' LYS . 1.7 m-85 -130.48 -6.86 4.19 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.75 -1.219 . . . . 0.0 110.897 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.562 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 1.2 pt-20 -110.86 157.73 19.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.013 -1.055 . . . . 0.0 110.675 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.57 166.06 13.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.355 -0.841 . . . . 0.0 109.846 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.478 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 11.5 p -95.63 152.61 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.142 -0.974 . . . . 0.0 110.469 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.575 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 0.8 OUTLIER -102.55 -34.71 9.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.367 -0.833 . . . . 0.0 109.508 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -164.97 -163.88 0.74 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.557 -0.715 . . . . 0.0 109.63 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.638 ' CD1' ' N ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -136.93 163.71 30.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 110.578 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 64' ' ' GLN . 33.7 t -138.95 150.48 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.843 . . . . 0.0 110.169 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 1.7 p-10 -111.67 115.13 28.61 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.882 -1.136 . . . . 0.0 109.81 178.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.493 1.687 0 O-C-N 120.981 -1.074 . . . . 0.0 110.595 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.337 0.589 . . . . 0.0 110.384 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.479 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 41.5 t -113.47 160.04 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 0.0 109.718 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.487 ' CA ' ' HA3' ' A' ' 41' ' ' GLY . 21.5 t -35.56 99.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.65 -0.656 . . . . 0.0 110.855 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.544 ' CD2' ' OG1' ' A' ' 11' ' ' THR . 2.5 mp -47.45 147.23 2.96 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.458 -0.776 . . . . 0.0 110.865 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 10' ' ' ASN . 50.4 Cg_endo -76.98 69.0 7.17 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.134 1.597 . . . . 0.0 110.462 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.491 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 0.9 OUTLIER 67.68 49.0 1.0 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.21 -0.931 . . . . 0.0 110.741 179.792 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.544 ' OG1' ' CD2' ' A' ' 8' ' ' LEU . 33.1 p -137.13 171.35 14.62 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.278 -0.889 . . . . 0.0 109.792 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.519 ' CB ' HD23 ' A' ' 97' ' ' LEU . . . -144.3 161.97 37.59 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.954 -1.091 . . . . 0.0 110.785 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.549 ' CD2' ' CB ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -134.04 152.2 51.74 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.244 -0.91 . . . . 0.0 110.419 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.635 ' CD2' ' CD1' ' A' ' 36' ' ' LEU . 9.1 m170 -88.03 128.19 35.4 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.143 -0.973 . . . . 0.0 110.727 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.568 HD13 ' CE2' ' A' ' 43' ' ' TYR . 2.7 mm? -115.99 148.0 40.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.497 -0.752 . . . . 0.0 110.579 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.56 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 1.7 ttmt -114.16 116.85 29.75 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.239 -0.984 . . . . 0.0 108.889 177.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.553 ' CB ' ' HB3' ' A' ' 33' ' ' ASP . . . -80.43 121.95 26.37 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.954 -1.091 . . . . 0.0 109.936 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 69.3 mt -98.66 99.89 11.05 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.493 0.663 . . . . 0.0 109.711 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.504 HD11 ' N ' ' A' ' 20' ' ' ASP . 0.4 OUTLIER -166.73 130.06 1.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.503 -0.748 . . . . 0.0 109.669 -179.797 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.504 ' N ' HD11 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -71.62 101.34 2.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.083 -1.011 . . . . 0.0 110.019 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.527 ' CB ' HG23 ' A' ' 29' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.903 . . . . 0.0 109.969 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.527 HG23 ' CB ' ' A' ' 21' ' ' PHE . 1.7 m . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' A' ' 30' ' ' VAL . 29.6 m -138.85 90.18 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.135 -0.978 . . . . 0.0 110.545 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 46.75 51.61 12.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.864 . . . . 0.0 110.436 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -176.7 25.37 0.06 OUTLIER Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.152 -1.499 . . . . 0.0 111.061 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.553 ' HB3' ' CB ' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -66.66 149.84 49.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.508 -1.584 . . . . 0.0 109.011 179.091 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.635 ' CG ' ' CZ ' ' A' ' 101' ' ' PHE . 1.2 pm0 -148.47 138.66 22.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.557 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.403 ' CA ' HG23 ' A' ' 100' ' ' VAL . 10.1 p90 -158.86 164.68 35.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.335 -0.853 . . . . 0.0 109.816 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.635 ' CD1' ' CD2' ' A' ' 14' ' ' HIS . 60.6 tp -90.82 156.14 18.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.004 -1.06 . . . . 0.0 109.66 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.549 ' CE2' ' HB2' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -126.1 114.13 17.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.055 -1.028 . . . . 0.0 110.183 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 4.1 tt0 -84.77 129.38 34.83 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.275 0.559 . . . . 0.0 109.983 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.61 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 64.77 44.33 94.95 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 55.8 Cg_endo -77.48 17.74 0.89 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.604 1.318 . . . . 0.0 110.875 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.487 ' HA3' ' CA ' ' A' ' 7' ' ' VAL . . . -49.21 -41.99 31.59 Favored Glycine 0 N--CA 1.488 2.114 0 O-C-N 120.755 -1.216 . . . . 0.0 110.367 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.8 p -93.73 19.74 8.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.038 -1.272 . . . . 0.0 110.974 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.568 ' CE2' HD13 ' A' ' 15' ' ' LEU . 21.8 t80 -85.45 133.36 34.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.124 -0.985 . . . . 0.0 110.019 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.466 HG23 ' N ' ' A' ' 45' ' ' PRO . 1.5 mp -119.73 145.31 39.02 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.359 -0.838 . . . . 0.0 109.006 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.466 ' N ' HG23 ' A' ' 44' ' ' ILE . 40.9 Cg_endo -66.89 109.53 1.71 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.869 1.457 . . . . 0.0 110.713 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -111.59 149.58 31.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.462 -0.774 . . . . 0.0 110.246 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -53.07 -29.1 28.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.859 . . . . 0.0 110.312 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.486 ' C ' ' CG1' ' A' ' 49' ' ' VAL . 20.4 tt0 -59.81 -21.69 61.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.173 -0.954 . . . . 0.0 110.512 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.9 m -150.92 170.8 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.292 -0.88 . . . . 0.0 110.33 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -131.54 138.0 48.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.198 -0.939 . . . . 0.0 110.099 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.6 t -58.63 125.55 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.716 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.56 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 2.8 t -102.27 -63.32 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.276 -0.89 . . . . 0.0 110.291 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.494 ' O ' HD11 ' A' ' 54' ' ' ILE . 3.4 mt-10 -144.01 166.49 24.82 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.18 -0.95 . . . . 0.0 110.252 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.494 HD11 ' O ' ' A' ' 53' ' ' GLU . 2.6 mm -128.71 148.65 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.6 HD11 ' CZ ' ' A' ' 96' ' ' TYR . 0.5 OUTLIER -141.6 130.39 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.591 -1.318 . . . . 0.0 111.59 -178.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.433 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 23.1 mp0 -94.8 176.0 6.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.589 -0.694 . . . . 0.0 109.708 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.6 ' CB ' ' CB ' ' A' ' 95' ' ' ALA . . . -102.02 144.61 30.4 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.159 -0.963 . . . . 0.0 110.63 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.518 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER 170.61 59.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.156 -0.965 . . . . 0.0 111.984 179.53 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.538 HG23 ' HB3' ' A' ' 96' ' ' TYR . 1.2 tt -172.71 -60.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.277 -1.515 . . . . 0.0 112.649 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 95' ' ' ALA . 18.8 mm -80.81 169.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.36 -1.463 . . . . 0.0 110.835 -178.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -109.33 -159.7 0.69 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.474 -0.766 . . . . 0.0 110.326 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.56 ' HB2' ' CG1' ' A' ' 93' ' ' VAL . 2.9 tt0 -91.14 -68.64 0.78 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.327 -0.858 . . . . 0.0 110.295 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.544 ' CA ' ' HB1' ' A' ' 110' ' ' ALA . 2.1 m-20 -38.23 -50.97 1.46 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.75 -0.594 . . . . 0.0 110.97 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.486 ' NE2' ' O ' ' A' ' 108' ' ' VAL . 7.9 tp60 -59.69 137.4 58.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.082 -1.011 . . . . 0.0 110.852 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.5 ' HB1' ' CG1' ' A' ' 108' ' ' VAL . . . -127.41 148.95 50.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.412 -0.805 . . . . 0.0 110.069 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.443 ' HB2' ' HB ' ' A' ' 90' ' ' VAL . 2.6 mp -127.05 118.13 23.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.318 -0.864 . . . . 0.0 110.152 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.558 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -91.66 128.26 37.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.002 -1.061 . . . . 0.0 110.029 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.482 HD22 ' HA ' ' A' ' 104' ' ' VAL . 15.6 mt -120.33 139.85 52.15 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.05 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -120.02 157.54 28.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.483 -0.761 . . . . 0.0 109.754 179.329 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.521 ' HB2' ' CA ' ' A' ' 84' ' ' THR . . . -68.95 124.58 24.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 111.353 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -84.33 -23.09 30.37 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.491 ' HG2' ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -156.73 146.56 20.89 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.552 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 74' ' ' CYS . 1.9 pt-20 -56.96 -156.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.036 -1.04 . . . . 0.0 110.341 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 6.6 m 77.34 -43.45 0.42 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.525 -0.734 . . . . 0.0 110.889 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.613 ' CZ3' ' HG3' ' A' ' 86' ' ' GLU . 8.3 t90 -74.15 110.94 8.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.793 -1.192 . . . . 0.0 110.353 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 76' ' ' ASP . 2.4 p30 -91.2 127.05 36.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.205 -0.934 . . . . 0.0 110.003 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.403 ' CD ' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -86.08 -40.5 15.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 110.039 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.01 -28.79 25.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.166 -0.959 . . . . 0.0 110.275 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 80' ' ' LYS . . . 139.86 -52.29 0.71 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -61.05 -131.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -1.179 . . . . 0.0 109.741 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.465 ' OE2' HG21 ' A' ' 29' ' ' VAL . 15.0 mm-40 -136.97 121.78 18.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.826 -1.171 . . . . 0.0 110.464 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.36 173.26 8.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.535 -0.728 . . . . 0.0 109.888 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.5 p -88.87 173.03 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 0.0 110.568 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.521 ' CA ' ' HB2' ' A' ' 70' ' ' ALA . 10.1 t -67.45 -12.53 60.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.863 . . . . 0.0 110.006 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.49 -14.65 55.2 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.613 ' HG3' ' CZ3' ' A' ' 75' ' ' TRP . 8.4 pt-20 -79.25 166.42 22.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.417 -1.049 . . . . 0.0 109.526 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.472 ' HA ' ' OE2' ' A' ' 102' ' ' GLU . 5.8 pt-20 -157.9 153.55 26.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.808 -1.183 . . . . 0.0 110.774 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.578 ' CE2' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -128.38 144.24 51.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.392 -0.817 . . . . 0.0 109.716 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.558 ' HG ' ' HA ' ' A' ' 67' ' ' ARG . 1.4 tt -106.2 158.42 16.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.211 -0.931 . . . . 0.0 110.123 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.578 HG23 ' CE2' ' A' ' 88' ' ' TRP . 16.6 t -122.23 136.65 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 0.0 110.571 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.492 ' CG2' ' O ' ' A' ' 90' ' ' VAL . 61.0 p -155.72 60.26 0.61 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 109.641 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.532 ' CG2' ' HB2' ' A' ' 95' ' ' ALA . 14.6 t -85.29 167.93 15.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.399 -0.813 . . . . 0.0 110.627 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.56 ' CG1' ' HB2' ' A' ' 62' ' ' GLN . 3.3 t -108.18 67.17 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.385 -0.822 . . . . 0.0 109.768 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 60' ' ' ILE . . . 110.04 62.85 0.52 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.6 ' CB ' ' CB ' ' A' ' 57' ' ' ALA . . . -174.72 -153.14 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.332 -1.099 . . . . 0.0 110.426 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.6 ' CZ ' HD11 ' A' ' 55' ' ' ILE . 2.3 p90 176.46 119.11 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.519 HD23 ' CB ' ' A' ' 12' ' ' ALA . 2.6 mp -106.19 95.65 11.7 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 111.457 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.488 ' O ' ' O ' ' A' ' 99' ' ' ALA . 47.0 Cg_endo -74.94 87.19 1.34 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.9 1.474 . . . . 0.0 108.887 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.56 ' CB ' ' HB2' ' A' ' 102' ' ' GLU . . . -50.05 -172.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.404 -0.81 . . . . 0.0 111.261 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.403 HG23 ' CA ' ' A' ' 35' ' ' TRP . 2.5 t -99.47 -66.33 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.433 -0.792 . . . . 0.0 110.496 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.635 ' CZ ' ' CG ' ' A' ' 34' ' ' GLU . 21.5 m-30 -100.15 22.23 11.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.936 -1.102 . . . . 0.0 110.57 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.56 ' HB2' ' CB ' ' A' ' 99' ' ' ALA . 2.4 mm-40 -111.56 120.29 41.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.964 -1.085 . . . . 0.0 110.397 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -100.13 156.26 17.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.352 -0.843 . . . . 0.0 110.188 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.482 ' HA ' HD22 ' A' ' 68' ' ' LEU . 3.5 m -81.87 138.39 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 110.26 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.592 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 3.0 mp -97.14 -9.58 27.62 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.318 -0.864 . . . . 0.0 109.197 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.57 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 0.4 OUTLIER 159.94 -160.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.791 -0.568 . . . . 0.0 109.622 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.573 ' CD2' ' C ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -138.42 150.13 46.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.941 . . . . 0.0 110.341 178.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.5 ' CG1' ' HB1' ' A' ' 65' ' ' ALA . 14.7 p -134.07 140.66 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.128 -0.982 . . . . 0.0 110.167 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.17 117.84 35.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.881 -1.137 . . . . 0.0 110.003 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.544 ' HB1' ' CA ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 110.014 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.242 0.544 . . . . 0.0 110.151 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.482 ' O ' ' CD1' ' A' ' 8' ' ' LEU . 9.8 p -126.61 147.24 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.163 -0.961 . . . . 0.0 110.089 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.468 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 83.4 t -41.18 107.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 110.337 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.534 ' CD2' ' OG1' ' A' ' 11' ' ' THR . 5.4 mp -63.24 163.94 16.21 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.391 -0.818 . . . . 0.0 110.079 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.411 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 47.3 Cg_endo -73.19 -56.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.913 1.48 . . . . 0.0 110.451 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.535 ' HB3' ' CG2' ' A' ' 92' ' ' THR . 63.2 m-80 -158.42 31.77 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 110.174 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.534 ' OG1' ' CD2' ' A' ' 8' ' ' LEU . 43.9 p -106.41 171.56 7.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.342 -0.849 . . . . 0.0 110.2 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.505 ' CB ' ' HA ' ' A' ' 38' ' ' GLU . . . -147.24 162.46 38.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.193 -0.942 . . . . 0.0 109.93 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.539 ' HG ' ' CD2' ' A' ' 15' ' ' LEU . 0.6 OUTLIER -130.25 155.79 45.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.021 . . . . 0.0 110.642 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.603 ' N ' ' CD2' ' A' ' 14' ' ' HIS . 2.4 m170 -96.93 129.16 44.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.341 -0.849 . . . . 0.0 109.08 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.619 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -126.2 162.28 25.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.703 -1.248 . . . . 0.0 109.48 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.542 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 1.2 ttpt -113.44 118.58 34.91 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.576 -0.85 . . . . 0.0 111.029 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.58 ' CB ' ' HB2' ' A' ' 33' ' ' ASP . . . -73.9 113.18 10.77 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.922 0.868 . . . . 0.0 108.782 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -106.95 106.73 17.4 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.486 0.66 . . . . 0.0 110.655 -178.677 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.517 ' CD1' ' HG3' ' A' ' 48' ' ' GLU . 5.1 tp -166.72 146.2 5.6 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.564 -0.71 . . . . 0.0 109.903 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.3 105.0 15.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 109.827 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.508 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.212 -0.93 . . . . 0.0 110.318 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.508 ' CG2' ' HB2' ' A' ' 21' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 121.226 0.536 . . . . 0.0 109.65 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.433 ' O ' ' C ' ' A' ' 31' ' ' ALA . 27.0 m -132.41 81.37 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.07 -1.019 . . . . 0.0 109.764 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 41.31 67.47 0.54 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.617 -0.677 . . . . 0.0 110.295 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -168.47 20.26 0.08 OUTLIER Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.114 -1.517 . . . . 0.0 111.263 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.58 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 1.3 m-20 -88.34 150.6 23.13 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.437 -1.625 . . . . 0.0 109.406 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.473 ' HB2' ' HG3' ' A' ' 16' ' ' LYS . 16.5 tt0 -151.46 139.07 19.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.089 -1.007 . . . . 0.0 110.461 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.584 ' CZ2' ' CD1' ' A' ' 15' ' ' LEU . 8.7 p90 -154.44 177.63 10.96 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.147 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.592 HD21 ' CE1' ' A' ' 14' ' ' HIS . 0.5 OUTLIER -90.33 158.69 17.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 0.0 110.969 -179.062 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.495 ' CE2' ' HB2' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -141.99 110.77 6.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.386 -0.821 . . . . 0.0 109.565 179.252 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.505 ' HA ' ' CB ' ' A' ' 12' ' ' ALA . 4.1 tm-20 -93.94 149.44 21.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.205 -0.934 . . . . 0.0 111.001 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.588 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 55.91 45.52 86.2 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 41.8 Cg_endo -70.68 -60.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.757 1.398 . . . . 0.0 109.844 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.468 ' HA3' ' HA ' ' A' ' 7' ' ' VAL . . . 41.87 -89.92 0.01 OUTLIER Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 40' ' ' PRO . 19.8 p -66.9 1.32 1.95 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.33 -1.1 . . . . 0.0 111.559 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.495 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 6.8 t80 -68.78 124.15 22.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.643 -1.286 . . . . 0.0 110.408 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 45' ' ' PRO . 6.2 mt -115.52 145.59 34.78 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 109.064 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.494 ' N ' HG23 ' A' ' 44' ' ' ILE . 42.6 Cg_endo -67.57 109.19 1.78 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.764 1.402 . . . . 0.0 110.751 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -102.37 144.64 30.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.4 -0.812 . . . . 0.0 109.999 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.538 ' O ' ' CD2' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -37.34 -45.66 0.7 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.572 -0.705 . . . . 0.0 111.062 -179.582 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 18' ' ' LEU . 11.4 tt0 -49.07 -49.07 43.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -0.964 . . . . 0.0 110.98 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.498 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -133.44 142.58 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.915 -1.115 . . . . 0.0 110.741 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -108.62 137.51 46.45 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.323 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 51' ' ' VAL . 31.3 m -54.01 145.29 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.168 -0.957 . . . . 0.0 109.252 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.542 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 31.7 t -117.48 -58.65 3.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.048 -1.033 . . . . 0.0 110.407 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.447 ' C ' HD13 ' A' ' 54' ' ' ILE . 1.9 mt-10 -136.09 172.85 12.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.144 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.515 HD11 ' HB2' ' A' ' 13' ' ' LEU . 1.2 mm -136.18 130.73 48.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.322 -0.861 . . . . 0.0 108.828 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.503 HG13 ' CG ' ' A' ' 98' ' ' PRO . 0.4 OUTLIER -125.85 144.93 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.214 -0.929 . . . . 0.0 111.162 -178.591 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.474 ' N ' HD12 ' A' ' 55' ' ' ILE . 40.7 mm-40 -100.4 174.28 6.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.468 -0.77 . . . . 0.0 109.779 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.546 ' CA ' ' HA ' ' A' ' 95' ' ' ALA . . . -102.25 125.68 49.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.132 -0.98 . . . . 0.0 109.96 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 3.2 t 179.29 63.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.012 -1.055 . . . . 0.0 111.872 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.547 HG22 ' CD1' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -169.68 -37.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.549 -1.344 . . . . 0.0 111.323 179.107 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.478 HD11 ' CD2' ' A' ' 66' ' ' LEU . 9.4 mm -78.1 158.41 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.785 -1.197 . . . . 0.0 110.44 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.485 ' HB2' ' CB ' ' A' ' 64' ' ' GLN . 9.1 mtt180 -62.8 -168.84 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.283 -0.886 . . . . 0.0 110.413 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.555 ' HA ' ' CG1' ' A' ' 93' ' ' VAL . 0.8 OUTLIER -91.63 -19.92 22.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.0 110.701 -179.435 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 2.7 p30 -127.97 -19.2 4.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.905 -1.122 . . . . 0.0 110.907 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.485 ' CB ' ' HB2' ' A' ' 61' ' ' ARG . 6.4 tp-100 -51.34 126.88 18.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.031 -1.043 . . . . 0.0 111.646 -179.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.514 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . . . -108.54 142.37 39.06 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.493 ' O ' HD21 ' A' ' 89' ' ' LEU . 1.8 mp -127.59 115.04 18.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.837 -1.165 . . . . 0.0 111.882 -178.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.477 ' HA ' HD21 ' A' ' 89' ' ' LEU . 4.3 ttm180 -91.36 119.6 31.51 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.507 ' CD2' ' HA ' ' A' ' 104' ' ' VAL . 21.6 mt -113.74 161.25 17.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 111.396 -178.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 15.7 mtp180 -126.57 161.88 26.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.371 -0.83 . . . . 0.0 110.179 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.568 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . . . -82.63 152.37 25.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.202 -0.936 . . . . 0.0 111.415 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.505 ' HG3' ' N ' ' A' ' 72' ' ' LYS . 9.4 ptt180 -125.31 -27.7 3.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.453 -0.779 . . . . 0.0 109.819 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.505 ' N ' ' HG3' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -124.49 118.46 26.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.283 -0.885 . . . . 0.0 109.762 179.575 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.513 ' N ' ' HB ' ' A' ' 84' ' ' THR . 4.3 pt-20 -54.51 106.82 0.23 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.202 -0.937 . . . . 0.0 110.723 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.507 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER 168.5 -43.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.285 -0.884 . . . . 0.0 110.151 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.606 ' HB3' ' HB2' ' A' ' 101' ' ' PHE . 2.7 t90 -74.98 104.43 5.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.284 -0.885 . . . . 0.0 110.182 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.482 ' OD2' ' N ' ' A' ' 80' ' ' LYS . 3.4 t70 -96.82 122.04 39.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -0.978 . . . . 0.0 110.226 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.437 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -85.03 -0.38 54.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.886 . . . . 0.0 110.365 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.55 -4.99 8.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.954 . . . . 0.0 110.365 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 101.21 -47.25 1.21 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.482 ' N ' ' OD2' ' A' ' 76' ' ' ASP . 9.1 mmtp -69.54 98.63 1.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -1.14 . . . . 0.0 110.012 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 80' ' ' LYS . 0.9 OUTLIER -34.17 135.15 0.16 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.718 -0.614 . . . . 0.0 110.913 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.16 179.77 7.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 110.533 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.452 HG22 ' N ' ' A' ' 84' ' ' THR . 10.8 p -77.84 174.02 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.4 -0.813 . . . . 0.0 110.553 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.513 ' HB ' ' N ' ' A' ' 73' ' ' GLU . 2.3 t -73.95 -3.52 29.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.815 . . . . 0.0 110.099 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.88 -13.35 78.84 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 8.3 pt-20 -70.79 172.24 9.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -1.083 . . . . 0.0 110.058 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.409 ' HB3' ' HG2' ' A' ' 69' ' ' ARG . 5.4 pm0 -159.06 172.59 17.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 110.444 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.549 ' CD1' ' C ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -155.96 153.66 29.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.342 -0.849 . . . . 0.0 109.795 -179.825 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.52 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -122.25 124.97 45.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.117 -0.99 . . . . 0.0 109.954 179.558 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.52 ' N ' HD22 ' A' ' 89' ' ' LEU . 4.5 p -105.6 138.92 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.429 -0.795 . . . . 0.0 110.263 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.7 t -141.93 49.78 1.56 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.272 -0.892 . . . . 0.0 110.415 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.535 ' CG2' ' HB3' ' A' ' 10' ' ' ASN . 51.6 m -91.28 138.66 31.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -0.937 . . . . 0.0 110.281 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.555 ' CG1' ' HA ' ' A' ' 62' ' ' GLN . 17.5 t -71.13 140.39 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.147 -0.971 . . . . 0.0 110.15 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 93' ' ' VAL . . . 43.27 80.75 0.04 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.546 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . . . -156.38 154.01 29.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -1.149 . . . . 0.0 110.861 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.547 ' CD1' HG22 ' A' ' 59' ' ' ILE . 4.9 t80 -117.69 25.69 10.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.502 -0.749 . . . . 0.0 109.961 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 96' ' ' TYR . 2.0 mm? -34.34 91.87 0.05 OUTLIER Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.827 -0.546 . . . . 0.0 111.408 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.518 ' N ' ' O ' ' A' ' 96' ' ' TYR . 48.5 Cg_endo -91.32 115.8 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.827 1.435 . . . . 0.0 110.395 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -69.76 171.92 8.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.213 -0.929 . . . . 0.0 110.32 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.484 HG21 ' CD2' ' A' ' 36' ' ' LEU . 1.7 t -99.33 -58.5 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.352 -0.843 . . . . 0.0 109.447 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.606 ' HB2' ' HB3' ' A' ' 75' ' ' TRP . 22.8 m-30 -117.6 38.9 3.46 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.156 -0.965 . . . . 0.0 109.257 178.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.478 ' OE2' ' CH2' ' A' ' 75' ' ' TRP . 13.6 tt0 -132.11 133.23 44.07 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.124 -0.985 . . . . 0.0 110.879 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -105.08 171.22 7.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.389 -0.819 . . . . 0.0 110.193 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.507 ' HA ' ' CD2' ' A' ' 68' ' ' LEU . 7.7 p -101.31 144.56 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.172 -0.955 . . . . 0.0 110.306 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.593 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 1.6 mm? -103.14 -40.07 6.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -0.968 . . . . 0.0 110.118 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.431 ' C ' HD12 ' A' ' 107' ' ' LEU . 1.8 p30 -161.29 171.58 18.11 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.868 . . . . 0.0 109.963 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.589 ' N ' ' CD2' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -121.96 142.55 50.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.175 -0.953 . . . . 0.0 110.367 -179.855 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.514 ' CG1' ' CB ' ' A' ' 65' ' ' ALA . 12.6 p -125.49 157.84 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.398 -0.814 . . . . 0.0 109.499 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.405 ' O ' ' CG ' ' A' ' 109' ' ' ASP . 8.6 p-10 -110.91 121.27 44.93 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.92 -1.113 . . . . 0.0 110.704 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 109.951 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.581 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.505 ' O ' ' O ' ' A' ' 5' ' ' GLN . 12.0 p -38.0 165.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.349 -0.844 . . . . 0.0 111.927 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.517 ' CA ' ' HA3' ' A' ' 41' ' ' GLY . 43.7 t -30.83 150.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 CA-C-O 121.586 0.708 . . . . 0.0 111.973 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.484 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.0 mp -106.29 171.23 4.96 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.569 -0.707 . . . . 0.0 109.634 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 44.5 Cg_endo -71.35 -39.44 3.8 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.72 1.379 . . . . 0.0 110.401 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 3.1 m-20 172.19 37.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.338 -0.851 . . . . 0.0 109.681 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.535 ' CB ' ' HA ' ' A' ' 56' ' ' GLN . 69.9 p -114.58 162.72 16.38 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.329 -0.857 . . . . 0.0 110.957 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.526 ' CB ' ' HG ' ' A' ' 97' ' ' LEU . . . -135.57 161.13 36.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.378 -0.826 . . . . 0.0 109.96 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.535 ' CD1' HD12 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -133.28 153.65 51.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.167 -0.958 . . . . 0.0 110.553 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.559 ' CD2' HD13 ' A' ' 36' ' ' LEU . 30.7 m80 -96.58 136.35 37.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.0 109.642 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.672 ' CD1' ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -135.67 167.18 21.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.126 -0.984 . . . . 0.0 110.561 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 3.2 ttmt -119.04 117.58 29.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.17 -0.956 . . . . 0.0 110.049 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.551 ' CB ' ' HB2' ' A' ' 33' ' ' ASP . . . -75.76 117.54 17.61 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.311 -0.868 . . . . 0.0 109.864 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 48' ' ' GLU . 61.4 mt -108.62 100.94 10.13 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.188 0.518 . . . . 0.0 109.963 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.3 tp -163.79 144.74 8.83 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.157 -0.964 . . . . 0.0 110.294 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -85.2 110.78 19.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.379 -0.826 . . . . 0.0 109.061 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.52 ' CB ' HG21 ' A' ' 29' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 O-C-N 121.103 -0.998 . . . . 0.0 111.103 -178.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.553 ' CG1' ' HB3' ' A' ' 81' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.193 0.521 . . . . 0.0 109.794 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 30' ' ' VAL . 25.2 m -133.39 81.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 0.0 110.336 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 42.36 66.87 0.67 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 110.189 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.52 20.18 0.09 OUTLIER Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.373 -1.394 . . . . 0.0 110.895 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.551 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -89.09 152.39 21.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.478 -1.601 . . . . 0.0 108.984 179.191 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 23.0 tt0 -155.23 140.12 17.25 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.907 -1.12 . . . . 0.0 110.498 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.602 ' CE2' HD22 ' A' ' 15' ' ' LEU . 5.2 p90 -162.94 172.78 14.56 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.661 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.559 HD13 ' CD2' ' A' ' 14' ' ' HIS . 16.9 tp -90.53 159.93 16.23 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.394 0.616 . . . . 0.0 110.733 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.59 ' CD1' ' HB3' ' A' ' 40' ' ' PRO . 0.6 OUTLIER -135.38 114.77 12.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.321 -0.862 . . . . 0.0 109.952 179.629 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.495 ' CG ' HD21 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -86.96 135.47 33.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.515 -0.741 . . . . 0.0 110.369 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.596 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 54.02 44.31 72.77 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 52.9 Cg_endo -77.03 42.76 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.492 1.259 . . . . 0.0 110.959 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.581 ' HA2' ' O ' ' A' ' 5' ' ' GLN . . . -65.1 -25.12 70.77 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.6 p -101.63 12.95 36.32 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.831 -1.394 . . . . 0.0 109.77 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.441 ' HB3' ' HB2' ' A' ' 40' ' ' PRO . 16.6 t80 -86.88 122.53 30.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.393 -0.817 . . . . 0.0 109.556 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.448 HG23 ' HD2' ' A' ' 45' ' ' PRO . 3.7 mp -116.98 145.25 35.17 Favored Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.224 -0.922 . . . . 0.0 109.508 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.472 ' HB3' HG23 ' A' ' 51' ' ' VAL . 43.0 Cg_endo -69.56 83.44 0.66 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.874 1.46 . . . . 0.0 110.172 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -95.72 152.93 18.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.414 -0.804 . . . . 0.0 110.697 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -41.55 -42.97 2.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.352 -0.843 . . . . 0.0 110.69 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -42.55 -47.94 5.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.856 . . . . 0.0 110.434 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.545 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 1.2 m -136.15 173.85 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.313 -0.867 . . . . 0.0 110.332 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -133.16 142.02 48.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.388 -0.82 . . . . 0.0 110.206 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.472 HG23 ' HB3' ' A' ' 45' ' ' PRO . 47.7 t -62.56 130.36 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.229 -0.919 . . . . 0.0 109.833 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.481 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 28.2 t -107.82 -61.32 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 110.588 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.422 ' CD ' ' O ' ' A' ' 52' ' ' VAL . 7.8 mm-40 -139.89 168.08 20.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.168 -0.958 . . . . 0.0 110.293 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.466 HD12 ' HB2' ' A' ' 13' ' ' LEU . 1.4 mm -128.89 152.48 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.319 -0.863 . . . . 0.0 109.191 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.473 ' O ' ' HB ' ' A' ' 11' ' ' THR . 0.3 OUTLIER -149.65 152.25 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.952 -1.092 . . . . 0.0 110.697 -179.698 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.535 ' HA ' ' CB ' ' A' ' 11' ' ' THR . 0.2 OUTLIER -123.94 177.89 5.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.432 -0.792 . . . . 0.0 110.078 179.542 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.529 ' HB3' ' CB ' ' A' ' 95' ' ' ALA . . . -87.25 130.02 34.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.186 -0.946 . . . . 0.0 110.727 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 1.5 t 177.41 52.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 111.018 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.565 HD12 ' CD2' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -157.09 -59.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.608 -1.308 . . . . 0.0 111.591 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.553 HG13 HG22 ' A' ' 59' ' ' ILE . 2.3 mt -92.51 -174.46 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 120.14 -1.6 . . . . 0.0 110.8 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.548 ' O ' ' CA ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -101.25 169.43 8.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.4 -0.812 . . . . 0.0 110.114 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.525 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.5 OUTLIER -67.3 -72.69 0.16 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.203 -0.935 . . . . 0.0 111.974 -179.006 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.53 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 5.7 p30 -39.62 -24.1 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.297 -0.877 . . . . 0.0 112.07 -178.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.508 ' HG2' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -57.22 167.98 0.81 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.609 -1.307 . . . . 0.0 112.206 -178.775 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.522 ' CB ' HG12 ' A' ' 108' ' ' VAL . . . -150.35 131.25 14.22 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.541 ' HG ' ' CG1' ' A' ' 90' ' ' VAL . 2.5 pp -129.3 127.42 41.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.513 -1.367 . . . . 0.0 112.395 -178.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.529 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . 12.5 ttt180 -103.64 130.01 51.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.784 -0.572 . . . . 0.0 109.553 178.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.445 HD21 ' HA ' ' A' ' 104' ' ' VAL . 35.2 mt -117.76 149.53 40.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.18 -0.95 . . . . 0.0 111.007 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.424 ' C ' ' HG2' ' A' ' 102' ' ' GLU . 22.7 ttp180 -114.53 139.89 49.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.537 -0.727 . . . . 0.0 109.883 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.456 ' HB3' ' HA ' ' A' ' 84' ' ' THR . . . -60.45 147.6 40.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.144 -0.973 . . . . 0.0 110.376 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -107.05 -44.1 4.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 109.874 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.582 ' HD2' ' CE2' ' A' ' 101' ' ' PHE . 15.2 ptpt -122.41 134.79 54.6 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.269 -0.894 . . . . 0.0 109.809 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.5 ' N ' ' HB ' ' A' ' 84' ' ' THR . 2.4 pt-20 -57.16 96.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.205 -0.935 . . . . 0.0 110.644 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.52 -42.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 110.443 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.581 ' CB ' ' HB2' ' A' ' 101' ' ' PHE . 2.5 t90 -74.64 120.34 20.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.214 -0.929 . . . . 0.0 110.701 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -117.19 110.21 17.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -0.923 . . . . 0.0 109.401 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.556 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -59.38 -23.06 62.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 110.219 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.452 ' OD2' ' HE2' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -88.57 -21.44 24.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 110.14 179.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.26 16.37 27.69 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.452 ' HE2' ' OD2' ' A' ' 78' ' ' ASP . 25.1 mttm -110.39 -137.89 0.37 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.218 -1.166 . . . . 0.0 110.147 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.553 ' HB3' ' CG1' ' A' ' 29' ' ' VAL . 7.9 mp0 -134.98 105.42 6.36 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.03 -1.043 . . . . 0.0 110.327 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.75 179.54 5.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.224 -0.922 . . . . 0.0 110.68 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.3 p -91.67 174.45 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.422 -0.799 . . . . 0.0 110.79 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.5 ' HB ' ' N ' ' A' ' 73' ' ' GLU . 4.6 t -72.01 -6.53 42.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.318 -0.864 . . . . 0.0 110.361 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.03 -19.27 70.29 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.455 ' O ' ' HB1' ' A' ' 70' ' ' ALA . 8.0 tp10 -66.94 160.61 25.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.462 -1.022 . . . . 0.0 110.053 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.432 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 6.1 pt-20 -154.87 168.12 27.98 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.38 -0.825 . . . . 0.0 110.05 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.592 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -147.5 143.94 28.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.127 -0.983 . . . . 0.0 109.979 179.587 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -115.46 124.46 51.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.108 -0.995 . . . . 0.0 110.208 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.541 ' CG1' ' HG ' ' A' ' 66' ' ' LEU . 8.5 p -107.05 132.37 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.313 -0.867 . . . . 0.0 110.518 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.494 HG21 HD12 ' A' ' 89' ' ' LEU . 3.5 p -115.4 29.37 8.05 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.488 0.661 . . . . 0.0 109.25 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 93' ' ' VAL . 20.1 m -74.65 171.81 13.21 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.417 -0.802 . . . . 0.0 109.55 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 62' ' ' GLN . 1.5 t -47.37 172.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.99 -1.069 . . . . 0.0 109.006 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.548 ' CA ' ' O ' ' A' ' 61' ' ' ARG . . . -45.24 -88.87 0.01 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.529 ' CB ' ' HB3' ' A' ' 57' ' ' ALA . . . 60.84 -167.79 0.18 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.569 -0.959 . . . . 0.0 110.213 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.565 ' CD2' HD12 ' A' ' 59' ' ' ILE . 1.0 OUTLIER -120.76 -65.46 1.14 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.711 -0.618 . . . . 0.0 109.827 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.526 ' HG ' ' CB ' ' A' ' 12' ' ' ALA . 0.3 OUTLIER 46.23 71.37 1.59 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.559 -0.713 . . . . 0.0 110.695 179.584 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -78.15 120.53 5.0 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.939 1.494 . . . . 0.0 110.092 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.512 ' HB3' ' CB ' ' A' ' 102' ' ' GLU . . . -73.55 138.82 45.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.21 -0.931 . . . . 0.0 110.275 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.498 HG23 ' HA ' ' A' ' 35' ' ' TRP . 30.5 m -69.65 -51.72 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.157 -0.965 . . . . 0.0 110.754 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.582 ' CE2' ' HD2' ' A' ' 72' ' ' LYS . 19.5 m-30 -112.78 26.4 10.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.732 -1.23 . . . . 0.0 110.464 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.548 ' CD ' ' CZ2' ' A' ' 75' ' ' TRP . 1.1 tt0 -121.63 141.95 50.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.011 -1.056 . . . . 0.0 110.464 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.03 152.26 36.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.418 -0.801 . . . . 0.0 110.333 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.445 ' HA ' HD21 ' A' ' 68' ' ' LEU . 12.4 p -94.45 133.06 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.259 -0.9 . . . . 0.0 110.075 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.472 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -102.76 -21.98 13.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.308 -0.87 . . . . 0.0 110.209 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -174.44 136.31 0.46 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.937 . . . . 0.0 110.396 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.4 pp -99.1 153.25 19.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.89 . . . . 0.0 109.965 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.522 HG12 ' CB ' ' A' ' 65' ' ' ALA . 2.5 p -130.93 147.25 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.083 -1.01 . . . . 0.0 110.605 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -107.19 126.29 52.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.857 . . . . 0.0 110.004 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.927 . . . . 0.0 110.526 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.68 -5.5 28.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -1.157 . . . . 0.0 110.196 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 52.91 178.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.232 -0.918 . . . . 0.0 110.376 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.465 ' HB3' HG13 ' A' ' 44' ' ' ILE . 4.9 ptp -49.79 140.06 12.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.853 . . . . 0.0 110.059 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 41' ' ' GLY . 4.8 mt-30 -112.6 -155.72 0.57 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -0.909 . . . . 0.0 110.239 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.484 ' O ' ' CD1' ' A' ' 8' ' ' LEU . 36.0 m -125.02 158.97 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.307 -0.871 . . . . 0.0 109.519 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.46 ' C ' ' O ' ' A' ' 6' ' ' VAL . 40.5 t -38.78 106.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.267 -0.896 . . . . 0.0 110.54 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.484 ' CD1' ' O ' ' A' ' 6' ' ' VAL . 3.2 mp -61.09 169.11 2.26 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.549 -0.719 . . . . 0.0 110.694 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 10' ' ' ASN . 48.4 Cg_endo -79.52 63.37 8.72 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.136 1.598 . . . . 0.0 109.85 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 0.5 OUTLIER 64.86 41.95 4.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.504 -0.748 . . . . 0.0 110.824 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 8' ' ' LEU . 14.9 p -118.98 171.34 8.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.121 -0.987 . . . . 0.0 109.759 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.501 ' CB ' ' HA ' ' A' ' 38' ' ' GLU . . . -145.0 161.9 38.24 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.887 -1.133 . . . . 0.0 110.814 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.6 ' CD2' ' CB ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -133.53 156.15 48.31 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.33 -0.856 . . . . 0.0 110.441 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.598 ' CD2' HD11 ' A' ' 36' ' ' LEU . 44.7 m80 -91.93 124.04 35.74 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.131 -0.98 . . . . 0.0 110.631 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.571 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 2.4 mm? -111.42 151.31 28.68 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.341 -0.85 . . . . 0.0 110.303 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.571 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -113.53 117.49 31.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.078 -1.014 . . . . 0.0 109.743 178.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.54 ' CB ' ' HB2' ' A' ' 33' ' ' ASP . . . -79.43 112.02 16.27 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.208 -0.933 . . . . 0.0 110.338 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.468 HD13 ' HB3' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -104.95 101.7 11.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.842 -0.536 . . . . 0.0 109.594 179.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.7 tp -161.91 147.0 13.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.09 -1.006 . . . . 0.0 110.584 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -89.46 101.76 14.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.365 -0.835 . . . . 0.0 109.613 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.477 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -112.9 100.13 8.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 110.216 -179.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.521 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 0.7 OUTLIER -101.8 114.59 28.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.721 -0.612 . . . . 0.0 109.983 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER -122.26 136.08 54.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 110.459 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 2.8 ttmm -81.05 -9.44 59.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.887 . . . . 0.0 109.961 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -62.28 -27.45 69.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 110.365 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.83 -2.14 6.38 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -130.49 122.99 28.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.161 -1.199 . . . . 0.0 110.019 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.521 ' HB2' ' HA ' ' A' ' 22' ' ' GLU . 12.6 ptpt -151.35 144.32 24.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -0.884 . . . . 0.0 110.43 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.477 HG23 ' HB2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -113.22 155.85 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.137 -0.977 . . . . 0.0 110.157 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.429 ' O ' ' C ' ' A' ' 31' ' ' ALA . 24.0 m -134.8 82.37 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.156 -0.965 . . . . 0.0 110.074 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.468 ' HB3' HD13 ' A' ' 18' ' ' LEU . . . 40.79 75.27 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.528 -0.732 . . . . 0.0 110.305 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.16 26.93 0.06 OUTLIER Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.692 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.54 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 35.1 m-20 -98.71 149.58 22.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.635 -1.509 . . . . 0.0 110.006 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 3.3 tt0 -151.76 147.03 26.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.02 -1.05 . . . . 0.0 110.436 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.536 ' HA ' ' CG2' ' A' ' 100' ' ' VAL . 7.3 p90 -160.94 171.64 18.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.122 -0.986 . . . . 0.0 111.299 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.598 HD11 ' CD2' ' A' ' 14' ' ' HIS . 15.3 tp -92.0 155.82 17.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.571 -0.706 . . . . 0.0 110.021 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.573 ' CD2' ' HB3' ' A' ' 40' ' ' PRO . 1.0 OUTLIER -134.53 110.56 9.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.126 -0.984 . . . . 0.0 110.219 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.501 ' HA ' ' CB ' ' A' ' 12' ' ' ALA . 11.5 tm-20 -84.41 131.85 34.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.863 . . . . 0.0 110.445 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.615 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 66.57 43.56 91.9 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 55.6 Cg_endo -77.27 23.54 0.53 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.553 1.291 . . . . 0.0 111.218 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.468 ' HA3' ' C ' ' A' ' 6' ' ' VAL . . . -49.99 -44.62 41.52 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.454 ' O ' HD12 ' A' ' 44' ' ' ILE . 35.7 p -91.28 29.64 1.4 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -1.183 . . . . 0.0 110.677 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.483 ' HB3' ' O ' ' A' ' 40' ' ' PRO . 15.3 t80 -88.34 132.57 34.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.131 -0.981 . . . . 0.0 110.108 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.506 ' CG2' ' HD2' ' A' ' 45' ' ' PRO . 4.0 mp -123.31 146.86 50.62 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.34 -0.85 . . . . 0.0 109.534 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.506 ' HD2' ' CG2' ' A' ' 44' ' ' ILE . 44.3 Cg_endo -71.23 103.81 1.45 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.838 1.441 . . . . 0.0 110.669 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 49' ' ' VAL . 5.9 mtm180 -113.56 140.85 47.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.411 -0.806 . . . . 0.0 110.089 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 46' ' ' ARG . 1.1 tttm -41.71 -34.79 0.67 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.147 -0.97 . . . . 0.0 110.538 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 18' ' ' LEU . 1.7 tt0 -53.01 -39.27 63.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.955 . . . . 0.0 110.522 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.479 HG11 ' HA ' ' A' ' 17' ' ' ALA . 1.4 m -144.98 173.3 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.262 -0.899 . . . . 0.0 109.62 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -142.14 139.83 32.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.849 -1.157 . . . . 0.0 110.671 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.482 HG22 ' CD1' ' A' ' 13' ' ' LEU . 6.5 p -55.52 127.69 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.253 -0.904 . . . . 0.0 110.027 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.571 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 2.9 t -106.58 -58.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 110.179 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.464 ' HA ' ' OE1' ' A' ' 53' ' ' GLU . 13.1 mm-40 -140.43 170.57 15.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.404 -0.81 . . . . 0.0 110.199 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.465 HD12 ' HB2' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -132.76 150.49 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.305 -0.872 . . . . 0.0 109.312 179.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.471 HG23 ' HD2' ' A' ' 98' ' ' PRO . 0.5 OUTLIER -141.15 132.67 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.973 -1.08 . . . . 0.0 110.456 -179.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.443 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 15.2 mm-40 -89.92 178.62 6.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.402 -0.811 . . . . 0.0 110.449 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.576 ' CB ' ' HA ' ' A' ' 95' ' ' ALA . . . -102.54 133.53 47.37 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.194 -0.942 . . . . 0.0 110.811 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.491 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 1.3 t 173.61 63.16 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.297 -0.877 . . . . 0.0 111.015 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.569 HG22 ' N ' ' A' ' 60' ' ' ILE . 0.8 OUTLIER -171.18 -31.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.726 -1.234 . . . . 0.0 111.781 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.569 ' N ' HG22 ' A' ' 59' ' ' ILE . 10.1 mt -85.31 179.43 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.619 -1.301 . . . . 0.0 110.432 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -112.17 -153.23 0.52 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.223 -0.923 . . . . 0.0 110.587 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.573 ' HA ' ' CG1' ' A' ' 93' ' ' VAL . 12.9 tt0 -90.86 -12.75 35.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.669 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 4.0 p30 -137.7 -24.89 1.02 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 0.0 111.071 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.454 ' OE1' ' O ' ' A' ' 65' ' ' ALA . 6.1 tp-100 -54.41 133.58 45.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.841 -1.162 . . . . 0.0 110.51 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.498 ' HB2' ' CG1' ' A' ' 108' ' ' VAL . . . -120.95 157.23 30.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.384 -0.822 . . . . 0.0 109.355 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.542 ' HB2' ' CG2' ' A' ' 90' ' ' VAL . 2.8 mt -125.77 113.05 16.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.107 -0.995 . . . . 0.0 110.78 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.46 ' O ' HD22 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -91.68 121.59 33.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.26 -0.9 . . . . 0.0 109.269 178.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.534 ' CD2' ' HA ' ' A' ' 104' ' ' VAL . 6.0 mt -118.46 151.68 37.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.089 -1.007 . . . . 0.0 110.841 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.478 ' HA ' ' CB ' ' A' ' 87' ' ' GLU . 2.0 ttm-85 -121.82 155.28 35.69 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.416 -0.802 . . . . 0.0 109.778 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.506 ' HB2' ' HA ' ' A' ' 84' ' ' THR . . . -65.44 152.64 43.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.173 -0.955 . . . . 0.0 110.855 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.516 ' CB ' ' O ' ' A' ' 101' ' ' PHE . 8.2 tpt180 -114.71 -27.37 7.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.375 -0.828 . . . . 0.0 109.837 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.54 ' O ' ' CB ' ' A' ' 73' ' ' GLU . 29.8 mmmt -108.32 -94.66 0.4 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 0.0 109.684 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.54 ' CB ' ' O ' ' A' ' 72' ' ' LYS . 0.5 OUTLIER 164.39 29.72 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.464 -0.773 . . . . 0.0 110.465 179.597 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.2 m -138.64 -6.96 1.48 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.997 -1.064 . . . . 0.0 110.874 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.558 ' CB ' ' HB2' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -76.91 110.17 11.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.066 -1.021 . . . . 0.0 110.299 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.497 ' HB2' ' N ' ' A' ' 80' ' ' LYS . 3.1 p30 -93.16 132.13 37.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.271 -0.893 . . . . 0.0 110.055 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.547 ' HD2' ' CG ' ' A' ' 86' ' ' GLU . 1.7 mtp180 -80.1 -59.04 2.87 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.063 -1.023 . . . . 0.0 110.409 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -98.5 16.78 20.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.267 -0.896 . . . . 0.0 110.516 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.15 16.03 24.28 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.497 ' N ' ' HB2' ' A' ' 76' ' ' ASP . 40.9 mmtt -115.71 91.66 3.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -1.164 . . . . 0.0 110.248 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.465 ' CB ' HG13 ' A' ' 29' ' ' VAL . 1.7 tm-20 -43.56 101.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.233 -0.917 . . . . 0.0 110.281 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.543 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -100.67 179.24 4.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 0.0 110.223 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.0 m -98.72 -178.59 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.227 -0.921 . . . . 0.0 110.589 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.506 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -58.18 -26.0 62.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.488 -0.757 . . . . 0.0 110.627 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.03 -19.0 73.37 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.547 ' CG ' ' HD2' ' A' ' 77' ' ' ARG . 10.0 tp10 -73.7 143.46 46.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.183 -1.187 . . . . 0.0 110.312 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.478 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 3.9 pt-20 -149.31 155.44 40.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.296 -0.878 . . . . 0.0 110.2 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.573 ' CD1' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -136.88 154.77 50.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.088 -1.008 . . . . 0.0 110.129 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.522 HD23 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -114.87 134.68 54.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.278 -0.889 . . . . 0.0 110.573 -179.482 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.542 ' CG2' ' HB2' ' A' ' 66' ' ' LEU . 3.6 m -99.8 130.14 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.254 -0.904 . . . . 0.0 110.16 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.78 53.9 1.1 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.332 -0.855 . . . . 0.0 110.051 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.36 160.23 19.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 110.456 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.573 ' CG1' ' HA ' ' A' ' 62' ' ' GLN . 90.7 t -109.64 83.89 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.346 -0.846 . . . . 0.0 109.781 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 60' ' ' ILE . . . 87.4 79.53 1.24 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.576 ' HA ' ' CB ' ' A' ' 57' ' ' ALA . . . -162.46 -143.32 0.08 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.28 -1.13 . . . . 0.0 110.599 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 9.3 t80 177.17 104.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.49 ' HB3' HD21 ' A' ' 36' ' ' LEU . 15.6 mt -116.78 88.72 26.37 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.046 -1.034 . . . . 0.0 111.052 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.471 ' HD2' HG23 ' A' ' 55' ' ' ILE . 49.9 Cg_endo -78.24 108.38 2.48 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.892 1.47 . . . . 0.0 109.825 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.461 ' HA ' ' HB2' ' A' ' 36' ' ' LEU . . . -65.2 -171.56 0.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.164 -0.96 . . . . 0.0 110.692 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.536 ' CG2' ' HA ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -110.49 -55.95 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.389 -0.819 . . . . 0.0 109.581 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.558 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 11.8 m-85 -101.5 -14.64 17.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.948 -1.095 . . . . 0.0 109.656 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.573 ' OE1' ' CD1' ' A' ' 88' ' ' TRP . 23.4 tt0 -93.83 123.94 37.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.363 -0.836 . . . . 0.0 110.906 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.33 164.12 11.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.308 -0.87 . . . . 0.0 109.77 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.534 ' HA ' ' CD2' ' A' ' 68' ' ' LEU . 8.4 p -86.65 146.76 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.123 -0.985 . . . . 0.0 110.539 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.559 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 9.4 mp -104.0 -33.29 8.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.366 -0.834 . . . . 0.0 110.142 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.436 ' C ' HD22 ' A' ' 107' ' ' LEU . 0.3 OUTLIER -173.3 -166.55 0.34 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.254 -0.904 . . . . 0.0 110.401 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.565 ' N ' ' CD2' ' A' ' 107' ' ' LEU . 3.3 mm? -121.54 153.44 37.98 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.25 -0.907 . . . . 0.0 110.032 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.498 ' CG1' ' HB2' ' A' ' 65' ' ' ALA . 2.8 p -139.05 107.79 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.08 -1.012 . . . . 0.0 110.987 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -70.17 118.28 12.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.882 . . . . 0.0 110.222 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . -75.8 166.4 23.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.219 -0.925 . . . . 0.0 110.42 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.7 p -86.86 131.21 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 0.0 110.292 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.2 mp -97.34 -28.97 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.214 -0.929 . . . . 0.0 110.216 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.137 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.37 172.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.184 -1.186 . . . . 0.0 110.102 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -96.79 12.09 33.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.145 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.473 ' HB3' HG13 ' A' ' 44' ' ' ILE . 0.6 OUTLIER -125.9 -164.91 1.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.95 . . . . 0.0 110.701 -179.555 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.467 ' O ' ' O ' ' A' ' 41' ' ' GLY . 0.8 OUTLIER -147.57 -163.97 1.89 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.341 -0.85 . . . . 0.0 109.86 179.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.49 ' O ' HD12 ' A' ' 8' ' ' LEU . 9.0 m -114.14 176.9 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.09 -1.006 . . . . 0.0 110.21 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.493 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 78.0 t -54.81 143.35 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.426 -0.796 . . . . 0.0 110.769 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.541 ' CB ' ' OG1' ' A' ' 11' ' ' THR . 0.1 OUTLIER -96.5 167.2 12.67 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.433 -0.792 . . . . 0.0 110.052 179.644 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.494 ' O ' ' HB2' ' A' ' 10' ' ' ASN . 46.3 Cg_endo -73.94 69.59 4.6 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.989 1.521 . . . . 0.0 109.52 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.517 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 14.6 m-80 60.71 64.48 1.16 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.455 -0.778 . . . . 0.0 110.74 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.541 ' OG1' ' CB ' ' A' ' 8' ' ' LEU . 30.7 p -140.55 172.11 13.17 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.216 -0.927 . . . . 0.0 110.184 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.503 ' O ' HG23 ' A' ' 55' ' ' ILE . . . -144.42 169.33 18.13 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.941 . . . . 0.0 110.017 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.584 ' CD2' ' CB ' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -134.21 147.62 50.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.084 -1.01 . . . . 0.0 110.148 179.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.644 ' CD2' ' CD1' ' A' ' 36' ' ' LEU . 15.0 m-70 -90.26 126.66 35.91 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.039 -1.038 . . . . 0.0 110.395 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.579 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -136.75 155.72 49.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.11 -0.994 . . . . 0.0 110.351 179.37 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -104.82 122.86 46.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.455 -0.778 . . . . 0.0 110.064 -179.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.569 ' CB ' ' HB2' ' A' ' 33' ' ' ASP . . . -82.89 117.82 23.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.934 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.517 HD13 ' CB ' ' A' ' 31' ' ' ALA . 1.4 mm? -106.72 101.06 10.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.742 -0.599 . . . . 0.0 110.635 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.626 ' CD1' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -166.96 165.14 16.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.247 -0.908 . . . . 0.0 110.093 179.409 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -96.25 110.73 22.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 0.0 110.612 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.509 ' CB ' HG22 ' A' ' 29' ' ' VAL . 1.1 t80 -121.21 123.88 43.33 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.317 -0.864 . . . . 0.0 110.087 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.442 ' OE2' ' HD2' ' A' ' 28' ' ' LYS . 26.2 tt0 -130.9 114.83 15.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.932 . . . . 0.0 110.209 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -102.69 135.88 43.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.343 -0.848 . . . . 0.0 110.035 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.82 -23.94 66.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -0.926 . . . . 0.0 110.392 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -66.07 -9.85 34.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 110.162 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.7 -45.57 1.17 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.462 ' O ' ' CB ' ' A' ' 28' ' ' LYS . 31.9 t70 -50.61 159.9 0.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -1.138 . . . . 0.0 110.277 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.0 OUTLIER 172.59 120.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 109.972 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.509 HG22 ' CB ' ' A' ' 21' ' ' PHE . 2.0 m -110.2 148.74 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.25 -0.906 . . . . 0.0 110.041 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.6 m -129.77 84.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.083 -1.011 . . . . 0.0 110.312 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.517 ' CB ' HD13 ' A' ' 18' ' ' LEU . . . 45.4 69.27 0.46 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.34 -0.85 . . . . 0.0 110.117 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -174.91 27.01 0.08 OUTLIER Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.41 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.569 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 1.5 m-20 -89.47 144.97 25.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.877 -1.366 . . . . 0.0 109.966 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.554 ' HG2' ' CG1' ' A' ' 100' ' ' VAL . 5.7 tt0 -142.57 131.09 22.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -0.99 . . . . 0.0 110.086 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.572 ' CH2' HD12 ' A' ' 15' ' ' LEU . 1.8 p90 -161.37 174.15 13.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.986 -1.071 . . . . 0.0 110.776 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.644 ' CD1' ' CD2' ' A' ' 14' ' ' HIS . 55.9 tp -94.05 162.09 14.02 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.519 -0.738 . . . . 0.0 110.045 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -131.84 110.36 10.77 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.986 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.511 ' OE2' ' N ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER -82.48 142.85 31.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.409 -0.807 . . . . 0.0 110.397 -179.715 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.595 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 55.66 44.42 86.3 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 54.6 Cg_endo -77.82 15.16 1.33 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.663 1.349 . . . . 0.0 111.086 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 7' ' ' VAL . . . -53.27 -29.72 38.12 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.466 ' O ' HD13 ' A' ' 44' ' ' ILE . 48.9 p -103.45 17.19 24.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -1.17 . . . . 0.0 110.518 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.499 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 12.1 t80 -87.44 125.89 34.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.875 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.568 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 3.2 mp -107.47 141.8 23.77 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 109.786 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.57 97.3 0.7 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.957 1.504 . . . . 0.0 110.802 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.88 159.54 22.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.212 -0.93 . . . . 0.0 110.403 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 48' ' ' GLU . 16.0 pttm -48.93 -32.25 8.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.326 -0.859 . . . . 0.0 110.782 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.521 ' N ' ' HG3' ' A' ' 47' ' ' LYS . 2.6 tp10 -43.27 -40.52 3.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.085 -1.009 . . . . 0.0 110.206 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.509 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -150.13 167.92 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 0.0 110.159 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.447 ' O ' HG22 ' A' ' 52' ' ' VAL . 21.0 mt-10 -122.44 124.47 43.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 0.0 109.949 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.469 HG13 HD12 ' A' ' 13' ' ' LEU . 21.7 t -54.58 133.03 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 109.653 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.486 HG21 ' CA ' ' A' ' 15' ' ' LEU . 4.7 t -111.36 -48.89 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.035 -1.041 . . . . 0.0 110.579 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.495 ' C ' ' CD1' ' A' ' 54' ' ' ILE . 0.5 OUTLIER -149.6 168.57 23.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.146 -0.971 . . . . 0.0 109.936 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.497 HD11 ' HB2' ' A' ' 13' ' ' LEU . 1.2 mm -129.94 131.15 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.378 -0.826 . . . . 0.0 108.974 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.503 HG23 ' O ' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -120.84 136.45 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.028 -1.045 . . . . 0.0 111.334 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.507 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 56.8 mm-40 -97.69 176.55 5.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.601 -0.687 . . . . 0.0 109.929 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.52 ' CA ' ' HA ' ' A' ' 95' ' ' ALA . . . -90.84 140.23 30.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.202 -0.936 . . . . 0.0 109.825 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 3.4 t -179.49 38.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.017 -1.052 . . . . 0.0 111.536 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.529 HG12 ' N ' ' A' ' 60' ' ' ILE . 0.6 OUTLIER -159.9 -74.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.536 -1.353 . . . . 0.0 111.827 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.529 ' N ' HG12 ' A' ' 59' ' ' ILE . 77.0 mt -63.31 159.72 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.56 -1.338 . . . . 0.0 110.393 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.36 -166.37 1.08 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.296 -0.878 . . . . 0.0 110.575 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.541 ' HB2' ' CG1' ' A' ' 93' ' ' VAL . 1.7 tt0 -75.61 -70.82 0.41 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.444 -0.785 . . . . 0.0 110.568 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.478 ' HB3' ' CB ' ' A' ' 110' ' ' ALA . 8.5 m120 -60.55 -33.82 73.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.362 -0.836 . . . . 0.0 110.42 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -59.46 141.18 55.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.188 -0.945 . . . . 0.0 110.84 -179.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.484 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . . . -123.03 140.53 52.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.827 . . . . 0.0 109.773 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.418 ' HB2' HD13 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -126.19 108.33 11.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.104 -0.997 . . . . 0.0 110.534 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.486 ' O ' ' CD2' ' A' ' 68' ' ' LEU . 4.8 ttm105 -91.2 135.9 33.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.129 -0.982 . . . . 0.0 109.585 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.521 ' HB3' ' CG ' ' A' ' 102' ' ' GLU . 5.4 mt -133.99 150.18 51.24 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.209 -0.932 . . . . 0.0 110.935 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 13.9 ttm180 -107.02 163.81 12.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.461 -0.775 . . . . 0.0 109.641 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.491 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -80.57 118.5 22.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.177 -0.952 . . . . 0.0 110.478 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.53 -30.37 52.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.144 -0.972 . . . . 0.0 109.133 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -133.75 157.54 45.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.601 -0.687 . . . . 0.0 109.204 179.45 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.513 ' O ' ' HB3' ' A' ' 74' ' ' CYS . 1.0 OUTLIER -84.65 -179.2 7.07 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.023 -1.048 . . . . 0.0 110.802 -179.367 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER 75.05 -16.01 0.61 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.647 -0.658 . . . . 0.0 111.32 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.612 ' CZ2' ' CG ' ' A' ' 77' ' ' ARG . 5.0 t90 -74.37 104.64 5.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.631 -1.293 . . . . 0.0 110.232 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.513 ' O ' ' CD1' ' A' ' 35' ' ' TRP . 7.4 p-10 -84.8 124.48 31.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.085 -1.009 . . . . 0.0 109.68 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.612 ' CG ' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -80.99 -59.9 2.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.205 -0.935 . . . . 0.0 110.507 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -103.92 11.1 35.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 110.232 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.83 10.95 9.6 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -116.17 111.84 20.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -1.162 . . . . 0.0 110.401 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.496 ' OE2' ' CG ' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -71.47 102.77 2.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.194 -0.941 . . . . 0.0 109.711 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -109.35 178.79 4.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.153 -0.967 . . . . 0.0 110.307 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.8 p -77.37 174.37 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 0.0 110.29 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.475 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 14.6 t -69.57 -16.39 63.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.203 -0.935 . . . . 0.0 109.984 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.18 -23.01 78.62 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.476 ' HG3' ' N ' ' A' ' 87' ' ' GLU . 6.5 tp10 -63.09 160.05 16.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -1.134 . . . . 0.0 110.212 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.476 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 10.5 pt-20 -149.9 156.54 41.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 110.169 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.568 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -136.21 148.6 48.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.196 -0.94 . . . . 0.0 109.693 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.523 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -102.06 128.31 48.57 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.315 -0.866 . . . . 0.0 110.45 -179.428 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.523 ' N ' HD22 ' A' ' 89' ' ' LEU . 2.7 t -89.15 124.48 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.589 -0.694 . . . . 0.0 110.073 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.477 ' OG1' ' CD1' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -129.74 33.29 4.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -0.904 . . . . 0.0 109.857 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.63 152.6 37.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.856 . . . . 0.0 109.905 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.541 ' CG1' ' HB2' ' A' ' 62' ' ' GLN . 44.7 t -93.41 109.6 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.181 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 57' ' ' ALA . . . 69.78 76.92 0.47 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.52 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . . . -176.42 -175.23 0.65 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -1.124 . . . . 0.0 110.738 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.497 ' HA ' HG23 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -117.13 -61.86 1.65 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.403 -0.81 . . . . 0.0 110.608 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.533 ' N ' ' HD3' ' A' ' 98' ' ' PRO . 2.9 mm? 58.45 51.87 4.34 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.063 -1.023 . . . . 0.0 109.733 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 97' ' ' LEU . 50.2 Cg_endo -75.47 -2.31 12.41 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.111 1.585 . . . . 0.0 111.329 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.534 ' HA ' ' CB ' ' A' ' 36' ' ' LEU . . . 51.87 -178.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.059 -1.026 . . . . 0.0 110.093 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.554 ' CG1' ' HG2' ' A' ' 34' ' ' GLU . 2.4 t -97.21 -63.93 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.664 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.553 ' CD1' ' N ' ' A' ' 101' ' ' PHE . 7.5 m-30 -94.09 67.66 3.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.966 -1.083 . . . . 0.0 109.385 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.521 ' CG ' ' HB3' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -139.85 144.75 37.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 111.282 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -132.38 121.35 23.33 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.497 ' HA ' HD22 ' A' ' 68' ' ' LEU . 9.0 p -76.89 144.52 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.15 -0.969 . . . . 0.0 111.091 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.523 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -99.17 -26.23 14.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.664 -0.648 . . . . 0.0 109.409 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -177.95 -178.8 0.71 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 110.039 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.35 149.25 44.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.201 -0.937 . . . . 0.0 110.287 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.484 ' CG1' ' CB ' ' A' ' 65' ' ' ALA . 11.0 p -131.81 156.3 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.243 -0.911 . . . . 0.0 110.255 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.511 ' O ' ' C ' ' A' ' 110' ' ' ALA . 7.6 p30 -111.18 113.49 26.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.072 -1.017 . . . . 0.0 110.461 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.511 ' C ' ' O ' ' A' ' 109' ' ' ASP . . . 26.06 45.29 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 120.956 0.408 . . . . 0.0 111.942 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 110' ' ' ALA . 51.5 t -157.08 154.22 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.949 -1.094 . . . . 0.0 110.528 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.4 mm -129.41 114.19 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.407 -0.808 . . . . 0.0 110.036 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.245 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 3' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 0.1 OUTLIER 65.23 -69.95 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -1.097 . . . . 0.0 110.311 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.461 ' N ' ' O ' ' A' ' 1' ' ' GLY . 0.1 OUTLIER -76.67 -172.01 2.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.234 -0.916 . . . . 0.0 110.179 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.462 ' HG3' ' CD1' ' A' ' 44' ' ' ILE . 20.3 ttm -68.27 161.6 26.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.27 -0.894 . . . . 0.0 109.901 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.531 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 0.4 OUTLIER -112.21 135.01 53.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.133 -0.979 . . . . 0.0 110.735 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.531 HG22 ' N ' ' A' ' 7' ' ' VAL . 33.1 m -74.8 -133.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.214 -0.929 . . . . 0.0 109.257 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.531 ' N ' HG22 ' A' ' 6' ' ' VAL . 21.0 t -105.78 151.76 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.986 -1.071 . . . . 0.0 109.607 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.521 ' CD2' ' OG1' ' A' ' 11' ' ' THR . 5.4 mp -103.64 157.69 33.37 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 110.256 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -74.18 -49.28 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.061 1.558 . . . . 0.0 110.495 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.543 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 5.4 p30 -163.46 27.29 0.09 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.873 . . . . 0.0 110.471 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.521 ' OG1' ' CD2' ' A' ' 8' ' ' LEU . 19.0 p -104.81 151.7 23.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.965 -1.084 . . . . 0.0 111.125 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.53 ' CB ' HD22 ' A' ' 97' ' ' LEU . . . -132.18 165.45 24.06 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.576 ' CD2' ' CD1' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -133.88 153.17 51.94 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.788 -1.195 . . . . 0.0 110.485 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.587 ' CE1' HD23 ' A' ' 36' ' ' LEU . 4.6 m170 -92.15 136.29 33.3 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.504 -0.748 . . . . 0.0 109.105 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.678 ' CD1' ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -139.39 153.37 47.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.013 -1.054 . . . . 0.0 110.6 179.763 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 0.3 OUTLIER -113.52 117.53 31.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.267 -0.896 . . . . 0.0 109.91 -179.615 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.549 ' CB ' ' HB2' ' A' ' 33' ' ' ASP . . . -77.59 119.37 21.05 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.24 -0.913 . . . . 0.0 110.195 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 2.4 mm? -103.04 101.01 10.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.772 -0.58 . . . . 0.0 109.517 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.523 ' CD1' ' N ' ' A' ' 20' ' ' ASP . 2.1 tm? -164.98 144.21 6.79 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.011 -1.055 . . . . 0.0 110.262 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.523 ' N ' ' CD1' ' A' ' 19' ' ' LEU . 2.7 m-20 -85.05 118.72 24.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.667 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.503 ' CB ' HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -140.59 144.65 35.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.168 -0.957 . . . . 0.0 110.766 -179.431 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.506 ' CB ' ' HE2' ' A' ' 28' ' ' LYS . 12.6 pt-20 -108.78 131.35 55.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 109.782 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -82.58 167.46 18.31 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.216 -0.928 . . . . 0.0 110.429 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.01 -17.9 24.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.342 -0.849 . . . . 0.0 110.25 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -79.46 -17.11 54.9 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.202 -0.936 . . . . 0.0 110.233 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 129.52 -30.15 3.67 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -64.27 -156.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.186 -1.185 . . . . 0.0 110.088 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.506 ' HE2' ' CB ' ' A' ' 22' ' ' GLU . 1.8 ttmm 174.92 131.14 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.142 -0.974 . . . . 0.0 110.153 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.503 HG21 ' CB ' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -92.56 141.72 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.082 -1.011 . . . . 0.0 109.209 179.557 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 30' ' ' VAL . 31.4 m -141.04 89.16 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.074 -1.016 . . . . 0.0 110.451 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 44.24 63.66 1.57 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.384 -0.822 . . . . 0.0 110.163 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.93 21.62 0.1 OUTLIER Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.624 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.549 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 5.3 m-20 -87.1 149.49 24.65 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.676 -1.485 . . . . 0.0 109.557 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 31.6 tt0 -152.68 145.72 24.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.019 -1.051 . . . . 0.0 110.525 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.635 ' CD2' ' CD2' ' A' ' 15' ' ' LEU . 6.7 p90 -167.99 168.93 11.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.211 -0.93 . . . . 0.0 110.616 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.587 HD23 ' CE1' ' A' ' 14' ' ' HIS . 0.5 OUTLIER -91.87 156.28 17.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.205 -0.934 . . . . 0.0 110.959 -178.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.557 ' CE2' ' HB2' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -132.2 111.04 11.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.486 -0.759 . . . . 0.0 109.894 179.604 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.45 ' HA ' ' CB ' ' A' ' 12' ' ' ALA . 4.7 tm-20 -79.17 140.19 37.81 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.568 -0.708 . . . . 0.0 109.64 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.603 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 54.33 44.56 76.12 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 54.5 Cg_endo -76.15 13.15 1.35 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.69 1.363 . . . . 0.0 111.262 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 5' ' ' GLN . . . -49.95 -41.35 36.8 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.8 p -83.16 18.54 1.68 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.173 -1.192 . . . . 0.0 111.231 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.557 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 3.1 t80 -98.72 130.64 45.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.933 -1.105 . . . . 0.0 110.166 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.546 ' CG2' ' HD2' ' A' ' 45' ' ' PRO . 35.1 mm -114.49 146.01 35.01 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.45 -0.781 . . . . 0.0 109.045 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 44' ' ' ILE . 40.3 Cg_endo -66.22 74.58 0.36 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.733 1.386 . . . . 0.0 110.883 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -73.99 139.08 44.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.376 -0.827 . . . . 0.0 109.819 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.491 ' HG3' ' N ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -45.98 -24.2 0.39 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.917 . . . . 0.0 110.387 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -56.64 -36.16 69.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.159 -0.963 . . . . 0.0 110.211 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.534 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 1.2 m -141.35 170.36 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.36 -0.838 . . . . 0.0 110.027 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -127.98 132.69 49.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.992 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.1 m -56.37 127.64 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.875 . . . . 0.0 110.321 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 15' ' ' LEU . 21.8 t -96.54 -60.78 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.363 -0.836 . . . . 0.0 109.975 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.457 ' HG2' HG13 ' A' ' 52' ' ' VAL . 12.1 mm-40 -143.97 175.88 9.69 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.202 -0.936 . . . . 0.0 110.408 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.47 HG23 ' HB2' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -136.74 134.52 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.296 -0.878 . . . . 0.0 108.971 179.349 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -128.61 130.98 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.008 -1.058 . . . . 0.0 111.003 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.474 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 6.1 mm100 -94.91 134.28 37.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.499 -0.751 . . . . 0.0 109.412 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.549 ' CA ' ' HA ' ' A' ' 95' ' ' ALA . . . -49.27 137.26 14.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.081 -1.012 . . . . 0.0 110.804 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 8.7 t -179.51 45.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.309 -0.869 . . . . 0.0 111.587 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.568 ' CG2' ' N ' ' A' ' 60' ' ' ILE . 0.1 OUTLIER -162.48 -53.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.454 -1.404 . . . . 0.0 111.803 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.568 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 21.8 mt -57.37 165.16 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.552 -1.343 . . . . 0.0 109.947 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.451 ' N ' ' CG2' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -93.34 -161.97 0.89 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.339 -0.851 . . . . 0.0 111.057 -179.431 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 0.7 OUTLIER -58.85 -70.25 0.16 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.461 -0.774 . . . . 0.0 110.72 -179.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 15.2 p30 -113.95 26.33 10.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.137 -0.977 . . . . 0.0 110.181 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.448 ' OE1' HD21 ' A' ' 66' ' ' LEU . 1.8 tp-100 -59.84 138.99 57.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 110.4 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.476 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . . . -113.91 130.32 56.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.383 -0.823 . . . . 0.0 109.706 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.448 HD21 ' OE1' ' A' ' 64' ' ' GLN . 42.1 mt -125.04 121.33 34.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 110.275 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.48 ' HA ' HD23 ' A' ' 89' ' ' LEU . 21.1 ttm-85 -96.83 128.25 43.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.347 -0.845 . . . . 0.0 110.177 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.545 ' CD2' ' HA ' ' A' ' 104' ' ' VAL . 31.6 mt -118.16 147.2 43.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 109.992 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.477 ' HB2' HD23 ' A' ' 105' ' ' LEU . 11.7 ttt180 -117.39 146.9 43.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 110.243 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.491 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -67.88 136.49 54.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.345 -0.847 . . . . 0.0 110.807 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -116.12 -8.63 11.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.345 -0.847 . . . . 0.0 109.656 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -141.21 108.68 5.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.338 -0.851 . . . . 0.0 109.727 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 28.2 tt0 -56.59 103.49 0.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.066 -1.021 . . . . 0.0 110.045 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 2.1 t 179.27 -33.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.46 -0.775 . . . . 0.0 109.938 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.524 ' C ' ' CD1' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -75.47 137.2 40.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.418 -0.801 . . . . 0.0 110.11 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 13.6 p-10 -102.18 110.2 22.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.864 . . . . 0.0 110.259 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.521 ' O ' ' NE ' ' A' ' 77' ' ' ARG . 5.4 tpm_? -88.5 -19.93 25.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.177 -0.952 . . . . 0.0 109.309 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.55 -12.67 23.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.465 -0.772 . . . . 0.0 109.638 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 115.16 -5.82 21.72 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 12.4 mmmt -114.89 -70.35 0.8 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.189 -1.183 . . . . 0.0 110.221 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.5 ' CG ' HG13 ' A' ' 29' ' ' VAL . 0.0 OUTLIER 171.36 119.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.364 -0.835 . . . . 0.0 109.789 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.466 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 17.1 mmm180 -111.38 178.5 4.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 110.394 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 29.8 m -110.91 179.24 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 110.345 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.437 HG21 ' N ' ' A' ' 85' ' ' GLY . 3.3 t -56.2 -27.0 53.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 110.093 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.458 ' O ' ' OE2' ' A' ' 87' ' ' GLU . . . -65.23 -23.77 70.1 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.49 ' HG3' ' N ' ' A' ' 87' ' ' GLU . 22.1 tp10 -74.63 158.72 33.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.368 -1.078 . . . . 0.0 110.226 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.49 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -157.4 164.83 37.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.338 -0.851 . . . . 0.0 109.962 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.523 ' CD1' ' C ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -140.93 149.34 41.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.215 -0.928 . . . . 0.0 110.24 -179.749 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.521 HD21 ' N ' ' A' ' 90' ' ' VAL . 1.3 tm? -112.79 124.36 52.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.345 -0.847 . . . . 0.0 109.633 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.521 ' N ' HD21 ' A' ' 89' ' ' LEU . 8.0 p -105.44 132.36 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.173 -0.954 . . . . 0.0 110.847 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.88 56.1 1.84 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.301 -0.875 . . . . 0.0 110.006 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 54.5 m -97.51 119.52 36.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.954 . . . . 0.0 110.332 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 62' ' ' GLN . 18.2 t -50.76 134.2 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.195 -0.941 . . . . 0.0 109.947 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 93' ' ' VAL . . . 48.35 94.97 0.01 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.549 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . . . 178.67 154.79 0.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.088 -1.242 . . . . 0.0 110.949 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.564 ' CD1' HG23 ' A' ' 59' ' ' ILE . 2.5 t80 -134.67 87.18 2.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.488 -0.757 . . . . 0.0 110.15 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.53 HD22 ' CB ' ' A' ' 12' ' ' ALA . 16.9 mt -108.1 87.66 4.07 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.104 -0.998 . . . . 0.0 110.55 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.488 ' O ' ' CB ' ' A' ' 99' ' ' ALA . 47.1 Cg_endo -72.54 -6.19 18.58 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.989 1.52 . . . . 0.0 110.438 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 98' ' ' PRO . . . 68.29 174.91 0.27 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.238 -0.914 . . . . 0.0 110.5 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.538 ' CG2' HD21 ' A' ' 36' ' ' LEU . 4.7 t -94.48 -58.31 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.856 . . . . 0.0 110.052 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.431 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 26.7 m-85 -109.45 53.43 0.69 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.1 -1.0 . . . . 0.0 110.318 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 3.2 tt0 -141.13 157.68 44.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.97 -1.081 . . . . 0.0 110.989 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.422 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 3.5 pt-20 -132.76 140.45 48.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.0 109.663 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.545 ' HA ' ' CD2' ' A' ' 68' ' ' LEU . 15.0 p -76.07 137.43 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.158 -0.964 . . . . 0.0 110.525 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.486 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 1.7 mp -106.51 -19.3 13.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.443 -0.786 . . . . 0.0 110.145 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 37.6 p30 -176.43 162.7 2.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.338 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.442 HD11 HD23 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -120.42 141.99 49.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.361 -0.837 . . . . 0.0 109.778 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.476 ' CG1' ' CB ' ' A' ' 65' ' ' ALA . 12.7 p -139.31 160.59 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.064 -1.023 . . . . 0.0 110.859 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -110.73 116.94 32.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 109.549 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . -62.36 -21.29 65.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.98 -1.075 . . . . 0.0 110.687 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.502 ' N ' ' OD1' ' A' ' 63' ' ' ASN . 5.0 t 44.16 -122.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.153 -0.967 . . . . 0.0 109.912 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 21.2 mt -107.13 -70.86 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.775 -1.203 . . . . 0.0 110.174 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.257 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 3' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 4' ' ' MET . 1.7 t 49.55 -91.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -1.161 . . . . 0.0 110.169 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.478 ' N ' ' O ' ' A' ' 1' ' ' GLY . 35.0 m170 49.57 -93.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -0.95 . . . . 0.0 110.187 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.517 ' HG3' ' N ' ' A' ' 5' ' ' GLN . 6.2 tpt -133.64 -102.68 0.25 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.104 -0.998 . . . . 0.0 110.217 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.517 ' N ' ' HG3' ' A' ' 4' ' ' MET . 11.2 pt20 -167.18 -170.62 1.54 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.012 -1.055 . . . . 0.0 110.485 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.475 ' O ' HD13 ' A' ' 8' ' ' LEU . 15.1 m -100.02 170.14 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 110.643 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.54 ' HA ' ' CA ' ' A' ' 41' ' ' GLY . 23.2 t -46.87 153.0 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.431 -0.793 . . . . 0.0 110.45 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.651 ' CD1' ' N ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -106.5 171.41 4.78 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.283 -0.886 . . . . 0.0 108.863 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 45.8 Cg_endo -72.85 77.96 2.21 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.761 1.4 . . . . 0.0 110.156 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.527 ' HB3' ' CA ' ' A' ' 94' ' ' GLY . 78.2 m-20 58.28 74.21 0.44 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.44 -0.787 . . . . 0.0 110.513 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.495 ' HB ' ' HA ' ' A' ' 56' ' ' GLN . 2.9 p -148.39 169.78 19.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.253 -0.904 . . . . 0.0 110.426 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -147.28 162.95 37.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.455 -0.778 . . . . 0.0 109.768 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.576 HD11 ' CE2' ' A' ' 43' ' ' TYR . 0.8 OUTLIER -133.25 155.78 48.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.006 -1.059 . . . . 0.0 110.833 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.611 ' CD2' ' CD1' ' A' ' 36' ' ' LEU . 4.6 m170 -93.15 123.92 36.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.445 -0.784 . . . . 0.0 109.636 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.648 ' CD1' ' CZ2' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -126.91 155.31 43.24 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.593 -1.317 . . . . 0.0 110.814 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -110.1 117.89 34.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.635 -0.666 . . . . 0.0 109.994 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 33' ' ' ASP . . . -77.04 119.04 20.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 111.006 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 2.7 mm? -109.73 101.22 10.13 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.3 tp -164.42 155.5 15.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.017 -1.052 . . . . 0.0 110.482 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.414 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 12.5 p-10 -97.01 101.84 13.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.146 -0.971 . . . . 0.0 110.261 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.545 ' CD2' ' HE2' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -123.67 126.4 46.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 109.716 179.569 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.497 ' HA ' ' CB ' ' A' ' 28' ' ' LYS . 8.2 tm-20 -149.72 112.59 4.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.045 -1.034 . . . . 0.0 110.833 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.98 165.98 16.51 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.518 -0.739 . . . . 0.0 109.423 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.11 1.41 55.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.97 -1.081 . . . . 0.0 109.92 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.68 -32.47 14.73 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.243 -0.911 . . . . 0.0 110.202 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.85 -50.66 0.52 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -56.98 99.31 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.303 -1.116 . . . . 0.0 110.221 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.497 ' CB ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -153.44 104.72 2.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 110.101 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.535 ' CG1' ' HB3' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -112.5 161.38 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.032 -1.043 . . . . 0.0 109.744 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.454 ' O ' ' C ' ' A' ' 31' ' ' ALA . 30.8 m -137.26 77.9 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.95 -1.094 . . . . 0.0 110.5 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 38.74 70.57 0.2 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.768 -0.583 . . . . 0.0 110.523 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.28 28.94 0.05 OUTLIER Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.849 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.533 ' HB3' ' CB ' ' A' ' 17' ' ' ALA . 18.2 t70 -96.69 149.04 22.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.813 -1.404 . . . . 0.0 109.883 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 36.3 tt0 -146.72 130.35 16.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.326 -0.859 . . . . 0.0 109.819 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.648 ' CZ2' ' CD1' ' A' ' 15' ' ' LEU . 7.6 p90 -154.81 171.28 19.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.126 -0.983 . . . . 0.0 110.955 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.611 ' CD1' ' CD2' ' A' ' 14' ' ' HIS . 0.6 OUTLIER -90.61 155.8 18.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.419 -0.801 . . . . 0.0 110.684 -179.587 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -132.51 110.49 10.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.365 -0.834 . . . . 0.0 110.008 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.46 ' HA ' ' CB ' ' A' ' 12' ' ' ALA . 2.1 tm-20 -95.98 135.51 37.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.38 -0.825 . . . . 0.0 110.065 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.604 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 69.71 45.15 59.93 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 44.1 Cg_endo -72.25 -57.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.854 1.45 . . . . 0.0 110.968 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.54 ' CA ' ' HA ' ' A' ' 7' ' ' VAL . . . 46.03 -89.9 0.01 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 40' ' ' PRO . 1.3 p -73.15 6.05 3.04 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.354 -1.086 . . . . 0.0 111.607 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.576 ' CE2' HD11 ' A' ' 13' ' ' LEU . 9.4 t80 -69.31 110.97 4.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.694 -1.254 . . . . 0.0 109.962 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.477 HG12 ' HB3' ' A' ' 3' ' ' HIS . 3.2 mt -105.97 139.92 20.73 Favored Pre-proline 0 C--N 1.297 -1.677 0 O-C-N 121.194 -0.941 . . . . 0.0 108.891 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.48 ' HD3' ' SD ' ' A' ' 4' ' ' MET . 39.5 Cg_endo -66.4 76.37 0.36 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.762 1.401 . . . . 0.0 110.129 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 49' ' ' VAL . 4.6 mtt180 -73.3 153.08 40.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.516 -0.74 . . . . 0.0 110.185 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -43.13 -33.73 0.94 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.308 -0.87 . . . . 0.0 109.963 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -47.48 -51.44 20.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 109.821 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.528 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -136.06 174.02 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.456 -0.778 . . . . 0.0 109.38 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -134.16 126.63 30.37 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.108 -0.995 . . . . 0.0 110.126 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.4 p -53.84 132.33 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.175 -0.953 . . . . 0.0 108.847 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 14' ' ' HIS . 44.6 t -109.65 -48.96 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.005 . . . . 0.0 111.195 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.57 ' HB2' ' CG ' ' A' ' 14' ' ' HIS . 12.1 mt-10 -138.62 171.92 13.64 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.072 -1.017 . . . . 0.0 110.35 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.495 ' CD1' ' O ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -139.44 146.41 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.349 -0.844 . . . . 0.0 109.18 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.479 HG22 ' O ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -141.84 141.89 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.111 -0.993 . . . . 0.0 110.385 -179.413 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.495 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 1.3 mp0 -112.29 179.8 3.89 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.359 -0.838 . . . . 0.0 110.336 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 94' ' ' GLY . . . -80.34 139.5 36.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.264 -0.898 . . . . 0.0 110.3 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.515 ' O ' HD13 ' A' ' 59' ' ' ILE . 11.8 t -179.93 56.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.362 -0.837 . . . . 0.0 110.054 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.63 HG13 ' CG ' ' A' ' 96' ' ' TYR . 6.3 mm -155.69 -91.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.213 -0.929 . . . . 0.0 111.059 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.541 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 17.5 mm -108.47 -104.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.836 -1.165 . . . . 0.0 110.839 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.524 ' N ' ' HA ' ' A' ' 95' ' ' ALA . 2.0 ttp180 -167.6 -170.24 1.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.777 -1.202 . . . . 0.0 110.496 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.549 ' HB2' ' CG1' ' A' ' 93' ' ' VAL . 6.5 tt0 -68.2 -57.14 6.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.842 . . . . 0.0 110.646 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.547 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 68.9 m-80 -34.52 -60.54 0.42 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.321 0.581 . . . . 0.0 111.112 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.471 ' CB ' HG21 ' A' ' 60' ' ' ILE . 35.6 tp60 -53.6 129.11 31.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.048 -1.033 . . . . 0.0 110.785 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.477 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . . . -108.18 142.39 38.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 109.727 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.502 ' O ' HD21 ' A' ' 89' ' ' LEU . 5.8 mp -124.34 115.03 20.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.604 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.457 ' O ' ' CD1' ' A' ' 105' ' ' LEU . 0.8 OUTLIER -90.67 125.98 35.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 0.0 109.56 179.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.542 ' CB ' ' HG2' ' A' ' 102' ' ' GLU . 13.6 mt -116.58 152.67 33.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.133 -0.98 . . . . 0.0 110.629 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.552 ' HG2' ' CG ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -128.51 144.33 51.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 109.854 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.511 ' HB1' ' CZ3' ' A' ' 75' ' ' TRP . . . -59.16 140.33 56.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.169 -0.957 . . . . 0.0 110.356 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.468 ' C ' ' CG2' ' A' ' 84' ' ' THR . 7.6 tpt180 -107.53 -18.07 13.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.894 . . . . 0.0 110.121 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 2.0 mmmp? -112.51 -98.74 0.42 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.952 . . . . 0.0 110.149 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 72' ' ' LYS . 0.2 OUTLIER 168.09 45.85 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.318 -0.864 . . . . 0.0 109.986 179.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 73' ' ' GLU . 17.2 m -154.89 -19.49 0.12 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.209 -0.932 . . . . 0.0 111.676 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.571 ' CH2' ' OE1' ' A' ' 102' ' ' GLU . 0.3 OUTLIER -73.98 121.37 20.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.686 -1.258 . . . . 0.0 110.851 -179.291 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.501 ' HB2' ' CA ' ' A' ' 81' ' ' GLU . 12.5 t70 -108.87 122.47 47.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 0.0 109.665 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.56 ' CG ' ' CZ2' ' A' ' 75' ' ' TRP . 9.4 mtm180 -55.61 -28.24 54.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -0.874 . . . . 0.0 110.607 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.438 ' HB3' ' OD1' ' A' ' 76' ' ' ASP . 11.4 t70 -89.29 -35.11 16.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.168 -0.957 . . . . 0.0 110.218 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 80' ' ' LYS . . . 148.59 -38.87 0.99 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.545 ' HE2' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -59.31 -133.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.384 -1.068 . . . . 0.0 110.077 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.535 ' HB3' ' CG1' ' A' ' 29' ' ' VAL . 0.4 OUTLIER -141.43 141.81 33.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.898 -1.126 . . . . 0.0 110.067 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.464 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 27.4 mmt-85 -136.22 163.8 29.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.066 -1.021 . . . . 0.0 110.254 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 19.9 m -86.45 -179.12 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.339 -0.85 . . . . 0.0 110.803 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.49 ' CG2' ' O ' ' A' ' 72' ' ' LYS . 0.1 OUTLIER -62.89 -26.62 68.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.45 -0.781 . . . . 0.0 110.418 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.46 -30.87 79.07 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.464 ' CB ' ' HB3' ' A' ' 82' ' ' ARG . 7.9 tp10 -61.43 151.57 32.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.552 ' CG ' ' HG2' ' A' ' 69' ' ' ARG . 5.4 mt-10 -148.52 169.58 19.96 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.184 -0.948 . . . . 0.0 110.151 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.456 ' CB ' ' HG2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -156.0 130.24 8.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.229 -0.919 . . . . 0.0 109.927 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -102.51 136.45 42.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.351 -0.843 . . . . 0.0 109.839 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.538 ' N ' HD22 ' A' ' 89' ' ' LEU . 9.7 p -111.39 135.37 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.901 . . . . 0.0 110.581 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.7 t -141.82 16.44 2.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.437 -0.789 . . . . 0.0 109.53 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.4 m -75.47 170.01 16.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.398 -0.814 . . . . 0.0 109.865 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.549 ' CG1' ' HB2' ' A' ' 62' ' ' GLN . 0.8 OUTLIER -79.14 147.68 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.099 -1.001 . . . . 0.0 109.1 179.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.573 ' O ' ' CB ' ' A' ' 95' ' ' ALA . . . 150.96 -13.3 0.85 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.133 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.573 ' CB ' ' O ' ' A' ' 94' ' ' GLY . . . 77.74 -35.04 0.2 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.361 -1.082 . . . . 0.0 111.674 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.63 ' CG ' HG13 ' A' ' 59' ' ' ILE . 1.0 OUTLIER -146.86 147.61 31.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.08 -1.013 . . . . 0.0 110.385 179.685 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -160.76 59.86 1.23 Allowed Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.401 -0.812 . . . . 0.0 109.883 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.585 ' HG3' ' CE2' ' A' ' 96' ' ' TYR . 53.0 Cg_endo -76.99 143.25 22.8 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.976 1.514 . . . . 0.0 110.787 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -95.04 -151.42 0.33 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.325 -0.859 . . . . 0.0 110.346 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.15 -66.26 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.219 -0.926 . . . . 0.0 110.485 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.552 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 9.1 m-30 -80.57 -22.18 40.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.937 -1.102 . . . . 0.0 110.013 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.571 ' OE1' ' CH2' ' A' ' 75' ' ' TRP . 0.7 OUTLIER -98.34 131.6 44.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.348 -0.845 . . . . 0.0 110.3 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -115.02 161.1 18.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.165 -0.959 . . . . 0.0 110.174 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.535 ' HA ' ' CD2' ' A' ' 68' ' ' LEU . 10.1 p -76.98 146.1 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.114 -0.992 . . . . 0.0 110.685 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.467 HD23 ' CG ' ' A' ' 69' ' ' ARG . 1.5 mp -105.11 -24.67 12.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.413 -0.804 . . . . 0.0 109.709 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -166.04 174.35 9.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.266 -0.896 . . . . 0.0 110.037 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.95 131.19 53.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.23 -0.919 . . . . 0.0 110.064 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.507 HG23 ' N ' ' A' ' 109' ' ' ASP . 14.6 p -125.16 157.14 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.17 -0.956 . . . . 0.0 110.414 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.507 ' N ' HG23 ' A' ' 108' ' ' VAL . 0.6 OUTLIER -111.12 115.54 29.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.161 -0.962 . . . . 0.0 109.739 179.39 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . -53.09 -177.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.048 -1.033 . . . . 0.0 110.457 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.7 m -65.07 -143.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.322 -0.861 . . . . 0.0 110.244 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.416 ' O ' ' C ' ' A' ' 113' ' ' LEU . 57.1 mt -127.83 122.58 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 110.479 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 112' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.164 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 0.4 OUTLIER -145.43 -178.32 6.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -1.117 . . . . 0.0 110.14 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.51 ' O ' ' HG2' ' A' ' 4' ' ' MET . 97.2 m-70 54.59 -160.02 0.17 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.132 -0.98 . . . . 0.0 110.214 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.51 ' HG2' ' O ' ' A' ' 3' ' ' HIS . 0.0 OUTLIER 51.76 171.81 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.461 -0.774 . . . . 0.0 110.735 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.475 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 1.3 mt-30 -80.3 -156.72 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.497 -0.752 . . . . 0.0 109.385 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 7' ' ' VAL . 11.4 m -144.26 83.54 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.743 -1.223 . . . . 0.0 110.885 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.542 ' N ' ' HA3' ' A' ' 41' ' ' GLY . 2.0 t 27.04 99.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 CA-C-O 121.265 0.555 . . . . 0.0 111.682 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.542 ' CD2' ' OG1' ' A' ' 11' ' ' THR . 2.3 mp -61.52 168.76 2.91 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.076 -1.015 . . . . 0.0 110.098 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.456 ' O ' ' OD1' ' A' ' 10' ' ' ASN . 45.0 Cg_endo -72.67 -58.4 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.921 1.485 . . . . 0.0 110.406 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 9' ' ' PRO . 9.6 m120 -162.04 30.87 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.805 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.542 ' OG1' ' CD2' ' A' ' 8' ' ' LEU . 1.1 p -109.9 172.09 7.06 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.312 -0.867 . . . . 0.0 110.22 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.524 ' CB ' HD22 ' A' ' 97' ' ' LEU . . . -144.5 161.32 39.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.213 -0.929 . . . . 0.0 110.659 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.588 ' CD2' ' CD2' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -133.64 155.49 49.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 109.896 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.595 ' CD2' HD13 ' A' ' 36' ' ' LEU . 17.8 m80 -97.66 133.45 42.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 109.812 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.608 ' HB2' ' CZ2' ' A' ' 35' ' ' TRP . 2.5 mm? -120.18 151.9 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.343 -0.848 . . . . 0.0 110.535 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -116.09 117.35 29.84 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.349 178.063 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.574 ' CB ' ' HB3' ' A' ' 33' ' ' ASP . . . -82.62 118.53 23.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.089 -1.007 . . . . 0.0 109.724 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.517 HD12 ' CB ' ' A' ' 31' ' ' ALA . 1.4 mm? -108.15 101.68 10.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.783 -0.573 . . . . 0.0 110.264 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.602 ' CD1' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -164.95 174.91 10.0 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 0.0 110.331 179.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.4 117.22 33.51 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.097 -1.002 . . . . 0.0 109.862 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.551 ' CE2' ' OE1' ' A' ' 81' ' ' GLU . 0.5 OUTLIER -125.48 94.02 4.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.143 -0.973 . . . . 0.0 110.583 -179.713 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.548 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 0.6 OUTLIER -103.93 119.88 39.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.576 -0.703 . . . . 0.0 110.135 179.396 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.16 161.66 19.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.295 -0.878 . . . . 0.0 110.275 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.486 ' CG ' ' O ' ' A' ' 24' ' ' LYS . 22.9 tttm -82.71 4.5 24.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 0.0 110.286 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -89.64 5.76 44.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.167 -0.958 . . . . 0.0 110.326 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.62 9.51 86.32 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -122.51 110.56 15.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -1.125 . . . . 0.0 110.019 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.548 ' HB2' ' HA ' ' A' ' 22' ' ' GLU . 6.9 ptpt -138.83 149.23 44.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.23 -0.919 . . . . 0.0 110.741 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.533 ' CG2' ' HB2' ' A' ' 21' ' ' PHE . 1.4 m -112.71 147.01 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -0.942 . . . . 0.0 109.123 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.426 HG21 ' O ' ' A' ' 30' ' ' VAL . 15.4 m -131.17 82.92 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.886 -1.134 . . . . 0.0 111.03 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.517 ' CB ' HD12 ' A' ' 18' ' ' LEU . . . 47.32 69.65 0.49 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.413 -0.805 . . . . 0.0 110.516 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -175.47 24.72 0.06 OUTLIER Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.694 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.574 ' HB3' ' CB ' ' A' ' 17' ' ' ALA . 11.5 t70 -86.99 143.41 27.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.783 -1.422 . . . . 0.0 110.242 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.45 ' O ' HG21 ' A' ' 100' ' ' VAL . 8.9 tt0 -143.52 134.6 25.64 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.403 -0.811 . . . . 0.0 109.845 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.608 ' CZ2' ' HB2' ' A' ' 15' ' ' LEU . 13.5 p90 -150.26 163.97 36.93 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.994 -1.066 . . . . 0.0 111.237 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.595 HD13 ' CD2' ' A' ' 14' ' ' HIS . 42.0 tp -94.49 152.38 18.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.553 -0.717 . . . . 0.0 109.95 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.502 ' HB3' HD21 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -133.0 110.66 10.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.064 -1.023 . . . . 0.0 110.367 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.537 ' HB2' ' CD2' ' A' ' 97' ' ' LEU . 16.5 tp10 -85.83 138.48 32.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.622 -0.674 . . . . 0.0 109.469 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.619 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 54.36 45.02 76.44 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 51.3 Cg_endo -72.13 4.27 3.4 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.827 1.435 . . . . 0.0 111.057 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.542 ' HA3' ' N ' ' A' ' 7' ' ' VAL . . . -42.0 -27.92 0.43 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.468 ' CG2' HG21 ' A' ' 7' ' ' VAL . 10.8 p -103.19 37.28 2.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.132 -1.217 . . . . 0.0 109.59 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.553 ' CE2' HD11 ' A' ' 15' ' ' LEU . 6.0 t80 -104.25 117.68 34.8 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.527 -0.733 . . . . 0.0 110.021 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.519 ' N ' HD13 ' A' ' 44' ' ' ILE . 3.1 mp -96.47 124.11 52.09 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.235 -0.916 . . . . 0.0 110.318 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.93 127.05 11.11 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.827 1.435 . . . . 0.0 110.335 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -136.82 165.23 26.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.323 -0.86 . . . . 0.0 110.108 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -56.38 -18.83 12.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.732 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.5 ' C ' ' CG1' ' A' ' 49' ' ' VAL . 5.7 tt0 -67.55 -21.62 65.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.419 -0.801 . . . . 0.0 110.444 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.5 ' CG1' ' C ' ' A' ' 48' ' ' GLU . 1.4 m -151.65 173.95 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.026 -1.046 . . . . 0.0 110.38 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.4 137.24 37.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.322 -0.861 . . . . 0.0 110.215 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.432 ' HA ' HD13 ' A' ' 15' ' ' LEU . 97.9 t -57.55 114.55 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 109.526 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.518 HG22 ' HB2' ' A' ' 16' ' ' LYS . 14.4 t -90.96 -60.12 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.946 . . . . 0.0 111.068 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.501 ' C ' ' CD1' ' A' ' 54' ' ' ILE . 5.6 mt-10 -144.82 169.33 18.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.91 -1.119 . . . . 0.0 110.963 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.501 ' CD1' ' C ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -134.44 143.24 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.049 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.577 HD12 ' CD2' ' A' ' 96' ' ' TYR . 0.3 OUTLIER -137.25 130.14 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.963 -1.085 . . . . 0.0 110.605 -179.535 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.525 ' N ' HD13 ' A' ' 55' ' ' ILE . 2.4 mp0 -83.9 171.64 12.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.587 -0.696 . . . . 0.0 109.958 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.574 ' CA ' ' HA ' ' A' ' 95' ' ' ALA . . . -92.53 128.15 38.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.055 -1.028 . . . . 0.0 110.578 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER 172.71 60.98 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.24 -0.913 . . . . 0.0 111.424 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.566 ' CG2' ' N ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -166.43 -51.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.6 -1.313 . . . . 0.0 111.637 179.331 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.566 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 3.5 mt -81.6 142.1 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.815 -1.178 . . . . 0.0 110.56 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.46 -170.39 0.28 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.315 -0.866 . . . . 0.0 110.745 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.545 ' HB2' ' CG1' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -91.55 -35.89 14.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 0.0 110.445 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.476 ' CB ' ' HB2' ' A' ' 110' ' ' ALA . 2.0 m120 -87.72 -29.65 20.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.521 -0.737 . . . . 0.0 110.965 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 109' ' ' ASP . 7.9 tp-100 -58.63 140.59 54.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.085 -1.009 . . . . 0.0 111.476 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.597 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . . . -118.45 141.44 48.55 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.473 ' O ' HD21 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -126.08 117.5 23.31 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.431 -0.793 . . . . 0.0 110.97 -178.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.406 ' HA ' HD21 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -92.37 125.81 37.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 0.0 109.81 179.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.511 ' CD1' ' OE1' ' A' ' 102' ' ' GLU . 3.5 mm? -112.15 134.09 53.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.984 . . . . 0.0 110.576 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.534 ' CB ' HD13 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -125.66 150.95 47.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -0.881 . . . . 0.0 110.057 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.555 ' HB1' ' CZ3' ' A' ' 75' ' ' TRP . . . -70.33 142.0 52.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.39 -0.819 . . . . 0.0 110.519 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -118.49 -24.45 6.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.429 -0.795 . . . . 0.0 109.615 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 74' ' ' CYS . 2.6 ttpt -127.69 109.35 11.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.493 -0.754 . . . . 0.0 109.847 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -47.17 90.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.436 -0.79 . . . . 0.0 110.346 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 72' ' ' LYS . 0.5 OUTLIER -177.46 -32.89 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 110.094 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.6 ' CZ3' ' HB3' ' A' ' 102' ' ' GLU . 2.8 t90 -75.16 114.75 14.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.327 -0.858 . . . . 0.0 110.011 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.468 ' HA ' ' HB2' ' A' ' 82' ' ' ARG . 67.5 m-20 -91.48 113.55 25.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.924 . . . . 0.0 110.357 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.443 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -57.08 -48.9 77.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.329 -0.857 . . . . 0.0 109.851 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -93.49 -16.3 24.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 109.892 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.77 32.96 5.46 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -129.34 47.99 2.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -1.107 . . . . 0.0 109.989 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.551 ' OE1' ' CE2' ' A' ' 21' ' ' PHE . 7.9 mp0 49.04 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.38 -0.825 . . . . 0.0 110.422 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.468 ' HB2' ' HA ' ' A' ' 76' ' ' ASP . 12.8 mmt180 -113.69 -179.96 3.79 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.393 -0.817 . . . . 0.0 110.121 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.485 HG23 ' N ' ' A' ' 84' ' ' THR . 10.9 p -120.87 165.74 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.223 -0.923 . . . . 0.0 110.651 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.53 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -51.2 -20.99 1.78 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.388 -0.82 . . . . 0.0 110.377 179.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.53 -11.58 65.41 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.458 ' OE1' ' CA ' ' A' ' 86' ' ' GLU . 2.1 tp10 -84.48 142.22 30.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.393 -1.063 . . . . 0.0 110.026 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -148.08 158.89 44.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.186 -0.946 . . . . 0.0 110.288 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.45 ' CZ2' ' CG2' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -144.6 134.77 24.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 109.909 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.512 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -95.56 128.7 42.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.14 -0.975 . . . . 0.0 110.055 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.512 ' N ' HD22 ' A' ' 89' ' ' LEU . 5.4 p -108.44 128.61 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 109.995 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.4 HG23 ' CD1' ' A' ' 89' ' ' LEU . 1.1 p -129.51 48.42 2.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -0.88 . . . . 0.0 110.197 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 m -75.83 169.68 17.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.132 -0.98 . . . . 0.0 109.993 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.545 ' CG1' ' HB2' ' A' ' 62' ' ' GLN . 89.7 t -115.14 131.76 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.216 -0.927 . . . . 0.0 110.495 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 60' ' ' ILE . . . 50.01 44.57 41.64 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.574 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . . . -134.33 157.8 45.43 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.222 -1.163 . . . . 0.0 111.036 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.577 ' CD2' HD12 ' A' ' 55' ' ' ILE . 1.3 t80 -121.78 113.85 20.26 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.537 ' CD2' ' HB2' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -126.37 84.9 61.14 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.049 -1.032 . . . . 0.0 111.029 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.525 ' O ' ' NE2' ' A' ' 14' ' ' HIS . 50.0 Cg_endo -77.48 117.44 4.32 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.142 1.601 . . . . 0.0 110.02 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.535 ' HB1' ' CG ' ' A' ' 102' ' ' GLU . . . -74.74 -168.95 0.79 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.026 -1.046 . . . . 0.0 110.431 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.45 HG21 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -113.93 -57.21 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.205 -0.934 . . . . 0.0 110.45 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.499 ' CE2' ' HB3' ' A' ' 74' ' ' CYS . 21.9 m-30 -103.23 -32.14 9.75 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.75 -1.218 . . . . 0.0 110.672 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.6 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -80.07 154.83 27.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.199 -0.938 . . . . 0.0 110.641 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.456 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 6.9 tp10 -128.94 167.73 17.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.458 -0.776 . . . . 0.0 110.2 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 104' ' ' VAL . 10.7 m -72.02 152.31 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.0 110.245 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.562 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 4.7 mp -100.06 -14.57 18.56 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.295 -0.878 . . . . 0.0 109.605 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 1.8 p30 165.25 -168.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.61 -0.681 . . . . 0.0 110.151 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.479 ' CD1' ' CD ' ' A' ' 64' ' ' GLN . 1.0 OUTLIER -127.01 116.08 20.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.464 -0.772 . . . . 0.0 109.416 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.597 ' CG1' ' CB ' ' A' ' 65' ' ' ALA . 2.0 p -115.87 103.71 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.832 -1.168 . . . . 0.0 111.037 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 3.8 t70 -75.61 115.66 15.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.279 -0.888 . . . . 0.0 110.125 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.476 ' HB2' ' CB ' ' A' ' 63' ' ' ASN . . . -49.86 132.05 22.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.886 . . . . 0.0 110.586 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.459 ' HB ' ' O ' ' A' ' 110' ' ' ALA . 21.2 t 59.35 98.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.382 -0.824 . . . . 0.0 110.513 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 2.5 mp -46.37 119.69 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.159 -0.963 . . . . 0.0 110.038 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.438 ' C ' HD11 ' A' ' 113' ' ' LEU . 3.4 tm? . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.954 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' A' ' 3' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 50.09 -90.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.298 -1.119 . . . . 0.0 110.302 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.498 ' N ' ' O ' ' A' ' 1' ' ' GLY . 51.5 m-70 -108.64 -151.74 0.48 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.135 -0.978 . . . . 0.0 110.579 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 0.0 OUTLIER 64.09 -175.26 0.16 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.309 -0.87 . . . . 0.0 110.391 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.47 -164.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.192 -0.943 . . . . 0.0 110.261 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.436 ' C ' ' HA2' ' A' ' 41' ' ' GLY . 95.7 t -136.01 135.59 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.166 -0.959 . . . . 0.0 110.131 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.512 ' CG2' ' HA3' ' A' ' 41' ' ' GLY . 79.2 t -60.88 118.7 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 110.829 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.506 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 0.4 OUTLIER -79.16 167.24 36.18 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 109.717 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 42.9 Cg_endo -69.9 -37.12 9.26 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.612 1.322 . . . . 0.0 110.383 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.43 ' CG ' ' HA3' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -170.69 41.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.104 -0.998 . . . . 0.0 110.246 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.444 ' OG1' ' CB ' ' A' ' 8' ' ' LEU . 12.6 p -112.98 160.86 17.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.817 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -146.82 155.35 42.28 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.988 -1.07 . . . . 0.0 110.177 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.58 HD21 ' CD2' ' A' ' 43' ' ' TYR . 0.4 OUTLIER -123.39 154.6 38.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.166 -0.959 . . . . 0.0 110.639 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.569 ' CD2' HD11 ' A' ' 36' ' ' LEU . 7.9 m170 -94.96 127.54 41.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 109.966 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.63 ' CD1' ' CZ2' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -136.1 148.35 48.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.931 -1.105 . . . . 0.0 110.661 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -100.78 121.15 41.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.547 -0.721 . . . . 0.0 110.359 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.538 ' CB ' ' HB2' ' A' ' 33' ' ' ASP . . . -82.46 113.57 20.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 110.028 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.463 ' O ' HD22 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -105.12 99.6 9.21 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.547 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.535 HD11 ' N ' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -167.5 133.33 2.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.356 -0.84 . . . . 0.0 110.079 179.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.535 ' N ' HD11 ' A' ' 19' ' ' LEU . 10.2 t70 -78.26 101.84 7.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.014 -1.054 . . . . 0.0 108.693 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -123.51 135.9 54.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.12 -0.988 . . . . 0.0 111.542 -178.516 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -130.18 128.58 42.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.604 -0.685 . . . . 0.0 109.186 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.443 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 4.7 t0 -85.31 170.24 12.97 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.148 -0.97 . . . . 0.0 110.89 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -61.79 -31.0 71.18 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.451 -0.78 . . . . 0.0 110.098 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -61.34 -17.11 52.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.311 -0.868 . . . . 0.0 110.138 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.64 -70.7 0.41 Allowed Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.632 -1.271 . . . . 0.0 109.942 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -132.01 156.55 46.03 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.152 -1.205 . . . . 0.0 111.251 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 21' ' ' PHE . 2.7 tptt -134.47 -95.5 0.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.533 -0.729 . . . . 0.0 109.321 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.52 HG13 ' CB ' ' A' ' 81' ' ' GLU . 0.6 OUTLIER -112.68 151.79 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.917 -1.114 . . . . 0.0 109.225 179.132 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 31' ' ' ALA . 27.0 m -132.64 78.54 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.978 -1.077 . . . . 0.0 111.056 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 30' ' ' VAL . . . 35.68 72.29 0.11 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.741 -0.599 . . . . 0.0 111.23 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.56 34.2 0.02 OUTLIER Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.365 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.538 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 3.8 m-20 -93.31 145.62 24.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.893 -1.357 . . . . 0.0 110.36 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 101' ' ' PHE . 14.1 tt0 -140.86 130.18 23.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 0.0 109.396 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.63 ' CZ2' ' CD1' ' A' ' 15' ' ' LEU . 3.7 p90 -157.62 166.95 31.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.97 -1.081 . . . . 0.0 111.286 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.569 HD11 ' CD2' ' A' ' 14' ' ' HIS . 16.2 tp -90.36 155.69 18.77 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.531 -0.731 . . . . 0.0 109.183 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.581 ' CZ ' ' HA ' ' A' ' 40' ' ' PRO . 1.0 OUTLIER -126.42 108.61 11.36 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.099 -1.001 . . . . 0.0 109.841 -179.563 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.545 ' HG3' ' CD1' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -88.44 142.22 27.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.413 -0.804 . . . . 0.0 109.384 179.63 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.611 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 54.52 46.17 74.46 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 47.8 Cg_endo -71.33 18.32 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.861 1.453 . . . . 0.0 112.344 -178.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.513 ' O ' ' OG1' ' A' ' 42' ' ' THR . . . -44.81 156.75 0.25 Allowed Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.513 ' OG1' ' O ' ' A' ' 41' ' ' GLY . 20.3 p 53.45 12.13 0.33 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.662 -0.905 . . . . 0.0 111.583 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.58 ' CD2' HD21 ' A' ' 13' ' ' LEU . 7.0 t80 -75.62 132.37 40.58 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.702 -1.249 . . . . 0.0 109.548 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.413 ' HB ' ' CZ ' ' A' ' 46' ' ' ARG . 50.3 mt -120.52 134.48 24.19 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.054 -1.028 . . . . 0.0 110.492 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.47 ' HB3' HG13 ' A' ' 51' ' ' VAL . 46.7 Cg_endo -73.3 78.46 2.29 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.968 1.509 . . . . 0.0 110.303 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 47' ' ' LYS . 22.8 mtm180 -91.58 151.02 20.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 110.364 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 48' ' ' GLU . 13.7 mttt -42.16 -31.78 0.41 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.238 -0.914 . . . . 0.0 110.287 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -42.9 -51.02 5.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.39 -0.819 . . . . 0.0 109.772 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.503 ' HB ' ' HA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -134.81 173.76 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.381 -0.825 . . . . 0.0 109.389 179.382 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.41 122.74 28.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.19 -0.944 . . . . 0.0 110.407 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.47 HG13 ' HB3' ' A' ' 45' ' ' PRO . 33.7 m -54.27 123.36 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.113 -0.992 . . . . 0.0 108.678 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.49 HG22 ' HA ' ' A' ' 15' ' ' LEU . 57.1 t -99.36 -54.51 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.148 -0.97 . . . . 0.0 110.472 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.498 ' C ' ' CD1' ' A' ' 54' ' ' ILE . 27.6 mm-40 -138.72 174.65 10.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 110.205 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.498 ' CD1' ' C ' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -134.09 144.26 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.405 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -134.26 144.67 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.961 -1.087 . . . . 0.0 111.138 -178.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.443 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 70.9 mm-40 -119.36 168.51 10.87 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.684 -0.635 . . . . 0.0 109.347 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.531 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . . . -89.51 132.51 35.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.154 -0.966 . . . . 0.0 110.43 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.61 ' N ' ' CB ' ' A' ' 95' ' ' ALA . 1.5 t -176.24 71.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.13 -0.981 . . . . 0.0 111.293 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.597 ' CG2' ' HB3' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -176.66 -51.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.825 -1.172 . . . . 0.0 111.732 178.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.585 ' CG2' ' N ' ' A' ' 61' ' ' ARG . 1.0 OUTLIER -108.3 -167.36 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.157 -1.59 . . . . 0.0 110.791 -179.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.585 ' N ' ' CG2' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -123.43 -147.71 0.38 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.461 -0.774 . . . . 0.0 110.115 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.562 ' HB2' ' CG1' ' A' ' 93' ' ' VAL . 11.4 tt0 -89.67 -71.31 0.61 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.206 -0.934 . . . . 0.0 110.919 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.532 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 7.5 p-10 -34.16 -47.66 0.29 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.832 -0.543 . . . . 0.0 111.72 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' A' ' 108' ' ' VAL . 54.0 tp60 -56.23 128.18 34.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.958 -1.089 . . . . 0.0 110.931 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.459 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -108.19 149.17 28.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.342 -0.849 . . . . 0.0 109.303 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.464 ' O ' HD22 ' A' ' 89' ' ' LEU . 1.4 mt -126.27 113.71 17.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.068 -1.02 . . . . 0.0 111.333 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.472 ' HA ' HD22 ' A' ' 89' ' ' LEU . 1.5 ttm-85 -100.03 122.05 42.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.213 -0.929 . . . . 0.0 109.04 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.537 ' CD2' ' HA ' ' A' ' 104' ' ' VAL . 20.1 mt -119.21 145.69 45.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.106 -0.996 . . . . 0.0 111.277 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 2.0 ttp85 -121.03 152.6 38.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.541 -0.725 . . . . 0.0 110.059 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.495 ' HB1' ' O ' ' A' ' 84' ' ' THR . . . -71.7 159.9 33.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -0.929 . . . . 0.0 110.867 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.4 tpm_? -132.0 -34.15 1.3 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.457 -0.777 . . . . 0.0 109.813 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -117.98 107.69 14.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 110.036 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.481 ' O ' ' CB ' ' A' ' 74' ' ' CYS . 0.8 OUTLIER -47.89 99.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.619 179.576 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER 169.71 -24.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.329 -0.857 . . . . 0.0 110.294 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.59 ' CZ3' ' HB2' ' A' ' 102' ' ' GLU . 1.3 t90 -74.72 126.73 31.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -0.923 . . . . 0.0 110.058 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 1.5 m-20 -90.82 110.85 22.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 110.001 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.548 ' HG3' ' CZ2' ' A' ' 75' ' ' TRP . 10.1 mtp180 -59.03 -57.65 12.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.158 -0.964 . . . . 0.0 110.169 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.43 0.23 14.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.33 -0.856 . . . . 0.0 110.274 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.72 9.47 16.57 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.443 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -98.51 -11.7 22.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -1.15 . . . . 0.0 109.983 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.52 ' CB ' HG13 ' A' ' 29' ' ' VAL . 2.0 tm-20 61.88 104.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -0.849 . . . . 0.0 110.306 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.467 ' HB2' ' OE1' ' A' ' 86' ' ' GLU . 46.7 mtt180 -123.28 175.04 6.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.333 -0.854 . . . . 0.0 109.918 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.412 ' CG2' ' N ' ' A' ' 84' ' ' THR . 10.8 p -76.83 174.74 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.219 -0.925 . . . . 0.0 110.461 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.495 ' O ' ' HB1' ' A' ' 70' ' ' ALA . 1.9 t -60.61 -10.84 5.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.368 -0.832 . . . . 0.0 110.366 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -76.91 -10.32 86.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.488 ' HG2' ' HB2' ' A' ' 70' ' ' ALA . 9.0 pt-20 -73.22 153.47 40.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.185 -1.185 . . . . 0.0 109.864 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -160.33 161.15 33.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 110.227 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.586 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -149.56 145.87 27.05 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.161 -0.962 . . . . 0.0 110.215 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.517 ' CD1' ' OG1' ' A' ' 91' ' ' THR . 0.3 OUTLIER -106.02 125.19 50.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 0.0 110.321 -179.14 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.584 HG23 ' CE2' ' A' ' 88' ' ' TRP . 22.8 t -93.49 128.07 45.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.467 -0.771 . . . . 0.0 110.765 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.517 ' OG1' ' CD1' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -134.48 30.04 3.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.53 -0.732 . . . . 0.0 109.246 179.383 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.46 130.83 35.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.478 -0.764 . . . . 0.0 110.725 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.562 ' CG1' ' HB2' ' A' ' 62' ' ' GLN . 6.4 t -65.51 113.82 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.374 -0.829 . . . . 0.0 110.033 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.43 ' HA3' ' CG ' ' A' ' 10' ' ' ASN . . . -179.85 -95.37 0.1 OUTLIER Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.293 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.61 ' CB ' ' N ' ' A' ' 58' ' ' THR . . . -150.13 -50.28 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.072 -1.252 . . . . 0.0 111.227 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.597 ' HB3' ' CG2' ' A' ' 59' ' ' ILE . 1.8 p90 176.51 161.37 0.37 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.48 -0.763 . . . . 0.0 110.606 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.545 ' CD1' ' HG3' ' A' ' 38' ' ' GLU . 12.9 mt -155.41 72.73 5.53 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.363 -0.836 . . . . 0.0 110.172 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.529 ' HD3' ' CD2' ' A' ' 96' ' ' TYR . 45.8 Cg_endo -72.35 128.5 13.76 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.883 1.464 . . . . 0.0 110.541 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.69 -163.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.354 -0.841 . . . . 0.0 110.333 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.86 -68.12 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.361 -0.837 . . . . 0.0 109.807 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 34' ' ' GLU . 16.2 m-30 -80.79 -21.2 41.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.258 -0.901 . . . . 0.0 109.935 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.59 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . 3.5 tt0 -87.8 146.11 25.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.378 -0.826 . . . . 0.0 110.411 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.32 170.73 9.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.464 -0.773 . . . . 0.0 110.066 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.537 ' HA ' ' CD2' ' A' ' 68' ' ' LEU . 7.6 p -84.52 136.39 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.114 -0.992 . . . . 0.0 110.461 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.48 ' O ' ' HB3' ' A' ' 106' ' ' ASP . 1.1 mp -93.95 -29.4 15.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 0.0 109.957 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.48 ' HB3' ' O ' ' A' ' 105' ' ' LEU . 15.0 p-10 -178.66 123.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.438 -0.788 . . . . 0.0 110.359 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -77.19 144.98 37.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -0.858 . . . . 0.0 109.73 179.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.518 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 12.9 p -130.87 154.49 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.062 -1.024 . . . . 0.0 110.307 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 47.4 t0 -110.5 123.37 49.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.148 -0.97 . . . . 0.0 110.144 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . -69.33 -177.63 1.18 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.18 -0.95 . . . . 0.0 110.407 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.48 ' O ' ' CG2' ' A' ' 112' ' ' ILE . 26.1 t 50.81 75.51 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.92 . . . . 0.0 110.126 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.48 ' CG2' ' O ' ' A' ' 111' ' ' VAL . 3.2 pt -158.91 154.6 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.235 -0.916 . . . . 0.0 110.264 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.403 ' C ' HD11 ' A' ' 113' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.218 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 51.54 -178.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -1.131 . . . . 0.0 109.943 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.421 ' O ' ' O ' ' A' ' 4' ' ' MET . 25.2 m170 -95.68 134.43 38.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.258 -0.901 . . . . 0.0 109.906 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.52 ' CA ' HD11 ' A' ' 44' ' ' ILE . 4.9 ttt 62.42 139.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.958 . . . . 0.0 109.842 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.457 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -145.52 161.27 40.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.169 -0.957 . . . . 0.0 110.385 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.455 ' O ' HD11 ' A' ' 8' ' ' LEU . 22.0 t -92.36 152.21 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.384 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.452 ' C ' ' O ' ' A' ' 6' ' ' VAL . 54.4 t -41.44 122.54 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.241 -0.912 . . . . 0.0 110.128 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.489 ' N ' HD11 ' A' ' 8' ' ' LEU . 1.7 mp -78.85 159.76 73.08 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 110.366 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -75.48 -82.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.949 1.499 . . . . 0.0 110.164 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 10' ' ' ASN . 11.4 p30 -129.56 54.7 1.81 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.309 -0.87 . . . . 0.0 109.843 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.544 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 1.1 p -132.5 157.47 44.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.145 -0.972 . . . . 0.0 110.111 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 55' ' ' ILE . . . -141.3 162.08 36.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -0.959 . . . . 0.0 109.574 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.545 ' CD2' ' HG3' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -133.54 156.36 47.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.937 -1.102 . . . . 0.0 111.164 -179.492 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.584 ' CD2' HD13 ' A' ' 36' ' ' LEU . 8.9 m170 -96.24 123.32 39.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.438 -0.789 . . . . 0.0 109.882 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.663 ' CD1' ' CZ2' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -125.76 148.86 48.95 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.081 -1.012 . . . . 0.0 109.55 179.278 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -96.98 119.22 35.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 110.714 -178.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.537 ' HA ' ' CG1' ' A' ' 49' ' ' VAL . . . -76.92 115.12 16.42 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.622 0.725 . . . . 0.0 110.258 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 86.8 mt -97.84 100.85 12.23 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.523 HD11 ' N ' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -158.64 144.9 17.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.146 -0.971 . . . . 0.0 110.653 -178.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.523 ' N ' HD11 ' A' ' 19' ' ' LEU . 20.1 p-10 -86.4 102.42 14.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 0.0 109.08 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.544 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -122.55 143.01 50.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 110.818 -178.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -100.05 134.51 42.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.418 -0.801 . . . . 0.0 110.092 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.419 ' OD1' ' OE2' ' A' ' 81' ' ' GLU . 2.9 t70 -98.62 147.06 25.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.252 -0.905 . . . . 0.0 110.312 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.5 ' HG3' ' N ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -60.84 -18.65 57.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.921 . . . . 0.0 110.201 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.5 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 4.6 t0 -83.29 -29.08 28.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.148 -0.97 . . . . 0.0 110.15 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.02 -17.49 9.93 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 28' ' ' LYS . 30.2 t70 -58.47 -46.15 87.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.254 -1.145 . . . . 0.0 110.116 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 27' ' ' ASP . 2.1 ttpt 57.88 120.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.456 -0.778 . . . . 0.0 110.434 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.544 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -80.77 134.74 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.202 -0.936 . . . . 0.0 108.804 179.509 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 30' ' ' VAL . 22.8 m -125.96 90.97 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.971 -1.08 . . . . 0.0 110.467 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 42.96 61.57 2.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.0 110.222 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.68 24.14 0.2 Allowed Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.489 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.531 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 1.6 m-20 -88.9 161.15 16.83 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.875 -1.368 . . . . 0.0 110.03 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.515 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 9.9 pt-20 -159.81 130.97 5.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.251 -0.906 . . . . 0.0 110.575 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.663 ' CZ2' ' CD1' ' A' ' 15' ' ' LEU . 6.0 p90 -145.64 170.79 15.77 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.376 -0.827 . . . . 0.0 110.228 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.584 HD13 ' CD2' ' A' ' 14' ' ' HIS . 13.6 tp -90.44 156.07 18.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 110.033 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.598 ' CE1' ' HA ' ' A' ' 40' ' ' PRO . 3.7 t80 -132.76 110.47 10.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -0.872 . . . . 0.0 109.436 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.412 ' HB2' HD12 ' A' ' 97' ' ' LEU . 3.1 tm-20 -91.5 136.5 33.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.298 -0.877 . . . . 0.0 110.094 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.6 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 65.86 46.22 83.59 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 38.7 Cg_endo -66.09 -61.07 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.925 1.487 . . . . 0.0 110.461 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.457 ' O ' ' CB ' ' A' ' 5' ' ' GLN . . . 43.62 -88.62 0.01 OUTLIER Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.577 ' N ' ' O ' ' A' ' 40' ' ' PRO . 1.4 p -70.39 4.35 2.36 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.31 -1.112 . . . . 0.0 111.658 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.561 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 11.1 t80 -68.5 112.26 5.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.609 -1.307 . . . . 0.0 109.976 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.52 HD11 ' CA ' ' A' ' 4' ' ' MET . 4.1 mm -104.13 141.8 23.27 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.345 -0.847 . . . . 0.0 109.737 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.473 ' HD2' HG21 ' A' ' 44' ' ' ILE . 43.0 Cg_endo -70.18 93.35 0.56 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.93 1.49 . . . . 0.0 110.101 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.404 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -102.78 158.9 15.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.272 -0.892 . . . . 0.0 110.604 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -44.56 -35.61 2.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.431 -0.793 . . . . 0.0 110.104 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -45.28 -48.09 12.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.301 -0.874 . . . . 0.0 110.105 179.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.537 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -147.15 173.3 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.267 -0.895 . . . . 0.0 110.077 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.482 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.2 mt-10 -130.66 127.15 38.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.243 -0.911 . . . . 0.0 110.652 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.7 p -55.06 128.5 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.185 -0.947 . . . . 0.0 109.456 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 50' ' ' GLU . 60.2 t -109.84 -61.04 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -0.95 . . . . 0.0 110.907 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.497 ' C ' ' CD1' ' A' ' 54' ' ' ILE . 2.6 mt-10 -124.46 173.96 8.1 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.192 -0.943 . . . . 0.0 110.774 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 13' ' ' LEU . 1.1 mm -137.01 155.54 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.544 ' O ' ' HB ' ' A' ' 11' ' ' THR . 1.1 mt -146.82 151.12 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.909 -1.12 . . . . 0.0 111.132 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.486 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 87.5 mm-40 -124.21 170.12 11.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.774 -0.579 . . . . 0.0 110.337 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.543 ' CB ' ' HA ' ' A' ' 95' ' ' ALA . . . -86.51 153.85 21.54 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.229 -0.92 . . . . 0.0 110.845 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER 172.65 29.42 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.073 -1.017 . . . . 0.0 112.621 179.004 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.586 ' CG2' ' CB ' ' A' ' 96' ' ' TYR . 2.3 tt -161.88 -35.11 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 119.707 -1.871 . . . . 0.0 113.913 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.495 ' HB ' ' O ' ' A' ' 95' ' ' ALA . 48.6 mt -75.7 152.49 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.078 -1.639 . . . . 0.0 111.188 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.0 -154.73 0.25 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.556 -0.715 . . . . 0.0 110.18 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.526 ' HA ' ' CG1' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -82.27 -69.35 0.63 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 110.93 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.561 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 2.2 m-20 -78.49 -8.17 58.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.105 -0.997 . . . . 0.0 110.665 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 108' ' ' VAL . 5.2 tp-100 -55.32 124.5 17.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.986 -1.071 . . . . 0.0 110.663 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.481 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -108.32 151.04 26.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.308 -0.87 . . . . 0.0 110.232 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.486 ' CB ' ' HB ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -125.69 121.83 34.58 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.196 -0.94 . . . . 0.0 110.418 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.537 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 8.4 mmm180 -93.34 123.91 36.96 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.249 -0.907 . . . . 0.0 110.283 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.527 HD12 ' N ' ' A' ' 104' ' ' VAL . 1.1 mm? -124.99 127.73 47.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.16 -0.963 . . . . 0.0 110.385 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -110.64 165.69 11.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.18 -0.95 . . . . 0.0 110.061 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.485 ' HB2' ' CE3' ' A' ' 75' ' ' TRP . . . -76.36 157.82 32.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.084 -1.01 . . . . 0.0 110.649 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.516 ' CB ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -114.59 -38.44 4.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 0.0 109.553 179.53 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -138.82 131.9 29.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.445 -0.784 . . . . 0.0 109.647 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.46 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 1.1 pt-20 -56.55 84.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.113 -0.992 . . . . 0.0 110.13 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' A' ' 72' ' ' LYS . 1.7 m -162.63 -35.33 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.401 -0.812 . . . . 0.0 110.058 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.579 ' CZ2' ' HG2' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -74.1 118.48 17.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.854 . . . . 0.0 110.073 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -86.86 115.27 24.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.992 . . . . 0.0 110.273 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.579 ' HG2' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -55.48 -55.7 28.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.169 -0.957 . . . . 0.0 110.116 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -105.55 24.22 12.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.245 -0.909 . . . . 0.0 110.066 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.73 -10.25 68.4 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 23.9 pttt -87.45 136.97 32.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.391 -1.064 . . . . 0.0 110.161 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.445 ' CB ' ' CD1' ' A' ' 21' ' ' PHE . 3.6 tm-20 -47.14 118.94 2.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -0.913 . . . . 0.0 110.013 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.515 ' CB ' ' OE1' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -131.35 156.96 44.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.102 -0.999 . . . . 0.0 110.66 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.4 m -86.4 -178.65 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.328 -0.857 . . . . 0.0 110.444 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.441 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 12.5 t -73.61 -6.78 48.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.362 -0.837 . . . . 0.0 109.972 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -77.03 -24.84 65.56 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.515 ' OE1' ' CB ' ' A' ' 82' ' ' ARG . 4.6 pt-20 -57.11 162.0 2.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.045 -1.268 . . . . 0.0 110.058 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.489 ' HG3' ' HA ' ' A' ' 69' ' ' ARG . 6.0 tt0 -159.62 142.49 13.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.185 -0.947 . . . . 0.0 109.877 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.525 ' CZ2' ' HA ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -119.89 148.36 43.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.048 -1.032 . . . . 0.0 110.096 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.542 ' C ' ' CD1' ' A' ' 89' ' ' LEU . 1.2 tm? -113.25 128.61 56.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.533 -0.73 . . . . 0.0 110.07 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.525 ' HA ' ' CZ2' ' A' ' 88' ' ' TRP . 81.4 t -90.77 102.32 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.854 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.36 28.5 8.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.404 -0.81 . . . . 0.0 110.348 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.465 HG23 ' HB2' ' A' ' 95' ' ' ALA . 13.9 t -76.22 169.1 18.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 0.0 109.986 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.526 ' CG1' ' HA ' ' A' ' 62' ' ' GLN . 48.5 t -114.7 107.02 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.187 -0.946 . . . . 0.0 109.985 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.504 ' O ' ' HB3' ' A' ' 95' ' ' ALA . . . 87.79 78.61 1.26 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.543 ' HA ' ' CB ' ' A' ' 57' ' ' ALA . . . 174.37 -158.53 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.58 -0.953 . . . . 0.0 110.611 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.606 ' O ' ' CG ' ' A' ' 96' ' ' TYR . 0.0 OUTLIER 176.21 25.32 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.055 -1.028 . . . . 0.0 111.115 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.535 ' CD1' HD23 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -61.45 110.2 2.88 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.709 -1.244 . . . . 0.0 110.067 179.41 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 96' ' ' TYR . 50.5 Cg_endo -79.32 -92.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.921 1.485 . . . . 0.0 110.796 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 98' ' ' PRO . . . 171.54 -158.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 0.0 110.146 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.527 ' CG2' ' HA ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -113.36 -59.19 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.18 -0.95 . . . . 0.0 110.043 179.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.534 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 17.5 m-30 -99.96 11.8 38.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.069 -1.019 . . . . 0.0 109.457 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.526 ' CD ' ' CH2' ' A' ' 75' ' ' TRP . 6.0 tt0 -96.05 157.59 15.83 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.301 -0.874 . . . . 0.0 110.968 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.06 128.63 22.92 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.552 -0.718 . . . . 0.0 109.355 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.527 ' N ' HD12 ' A' ' 68' ' ' LEU . 6.9 p -75.58 151.64 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.077 -1.015 . . . . 0.0 110.466 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.529 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -104.14 -24.16 13.2 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.434 -0.792 . . . . 0.0 109.611 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.479 ' HB3' ' O ' ' A' ' 105' ' ' LEU . 1.0 OUTLIER 172.67 160.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.449 -0.782 . . . . 0.0 109.861 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.6 mp -96.82 134.94 39.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.095 -1.003 . . . . 0.0 109.649 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.506 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 7.0 p -122.01 157.02 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.061 -1.025 . . . . 0.0 110.755 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.65 131.42 55.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.453 -0.779 . . . . 0.0 109.664 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . -90.37 34.56 0.87 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.141 -0.974 . . . . 0.0 110.667 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.3 t -73.44 177.84 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 109.749 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 113' ' ' LEU . 49.7 mt 50.31 32.41 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.097 -1.002 . . . . 0.0 110.021 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.452 ' OXT' ' HG ' ' A' ' 113' ' ' LEU . 31.3 tp . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 118.091 -0.957 . . . . 0.0 110.347 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.65 -164.89 1.92 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.291 -1.123 . . . . 0.0 109.944 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -141.17 32.2 1.74 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.104 -0.997 . . . . 0.0 110.36 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.531 ' CB ' HD13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -91.04 -103.84 0.1 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.333 -0.854 . . . . 0.0 109.955 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 6' ' ' VAL . 48.8 tt0 -105.03 66.85 0.77 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.034 -1.041 . . . . 0.0 109.895 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.506 HG12 ' N ' ' A' ' 7' ' ' VAL . 80.6 t -41.57 164.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.362 -0.836 . . . . 0.0 110.467 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.546 ' HA ' ' CA ' ' A' ' 41' ' ' GLY . 33.7 t -37.74 140.89 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.585 -0.697 . . . . 0.0 111.272 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.403 ' HB3' ' OG1' ' A' ' 11' ' ' THR . 2.7 mp -86.76 168.74 17.07 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.436 -0.79 . . . . 0.0 110.057 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.432 ' O ' ' CB ' ' A' ' 10' ' ' ASN . 47.6 Cg_endo -76.1 59.36 5.89 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.1 1.579 . . . . 0.0 109.944 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 3.5 m-80 65.13 46.24 2.79 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.363 -0.835 . . . . 0.0 109.558 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 17.4 p -134.98 162.13 33.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 110.258 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.52 ' CB ' ' HA ' ' A' ' 38' ' ' GLU . . . -133.68 159.84 39.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.104 -0.997 . . . . 0.0 109.766 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.537 ' CD2' ' HG3' ' A' ' 40' ' ' PRO . 1.3 pp -133.04 144.96 50.38 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.97 -1.081 . . . . 0.0 110.52 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.5 ' O ' ' N ' ' A' ' 52' ' ' VAL . 29.8 m80 -89.88 131.25 35.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.411 -0.806 . . . . 0.0 109.245 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.653 ' CD1' ' CZ2' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -133.77 158.4 43.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.956 -1.09 . . . . 0.0 110.502 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -106.72 117.78 34.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.422 -0.798 . . . . 0.0 110.571 -179.158 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.551 ' CB ' ' HB2' ' A' ' 33' ' ' ASP . . . -80.49 111.86 17.29 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.366 -0.834 . . . . 0.0 109.693 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 2.4 mm? -103.03 101.47 11.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.673 -0.642 . . . . 0.0 110.359 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.532 HD13 ' N ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -160.88 144.66 13.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.138 -0.976 . . . . 0.0 110.544 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.532 ' N ' HD13 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -82.61 101.62 10.91 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.424 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.525 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -111.01 137.75 48.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.212 -0.93 . . . . 0.0 111.248 -178.355 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.516 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 8.2 tt0 -120.61 118.89 31.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.639 -0.663 . . . . 0.0 110.079 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 27' ' ' ASP . 8.0 t0 -113.09 127.74 56.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.209 -0.932 . . . . 0.0 110.379 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -59.71 -33.19 71.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 110.563 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -121.07 -30.51 4.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.149 -0.969 . . . . 0.0 110.468 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.442 ' C ' ' HB3' ' A' ' 23' ' ' ASP . . . -87.44 39.15 3.11 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 23' ' ' ASP . 4.1 m-20 50.34 -139.83 0.86 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -1.163 . . . . 0.0 110.054 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.516 ' HB2' ' HA ' ' A' ' 22' ' ' GLU . 10.2 ptpt -156.01 150.8 26.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -0.999 . . . . 0.0 110.146 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.525 ' CG2' ' HB2' ' A' ' 21' ' ' PHE . 1.2 m -110.62 148.07 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.065 -1.022 . . . . 0.0 109.105 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 31' ' ' ALA . 16.5 m -127.9 84.59 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.094 -1.004 . . . . 0.0 110.615 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 41.12 70.16 0.28 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.404 -0.81 . . . . 0.0 110.66 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -170.72 22.7 0.08 OUTLIER Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.813 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.551 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 3.2 m-20 -88.43 149.33 23.75 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.811 -1.405 . . . . 0.0 109.829 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 68.1 tt0 -148.34 131.09 16.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.784 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.653 ' CZ2' ' CD1' ' A' ' 15' ' ' LEU . 6.3 p90 -151.97 167.22 29.07 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.448 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 37' ' ' PHE . 16.8 tp -90.84 154.24 19.65 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.549 -0.72 . . . . 0.0 109.846 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.524 ' CG ' ' HB3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -128.46 109.41 11.38 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.144 -0.972 . . . . 0.0 109.555 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.52 ' HA ' ' CB ' ' A' ' 12' ' ' ALA . 5.6 tm-20 -91.92 125.27 36.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.462 -0.774 . . . . 0.0 110.349 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.605 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 62.13 44.83 97.19 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 43.2 Cg_endo -71.08 57.63 2.11 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.681 1.358 . . . . 0.0 109.291 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.546 ' CA ' ' HA ' ' A' ' 7' ' ' VAL . . . -54.21 -14.17 4.29 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.583 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.419 ' C ' HD11 ' A' ' 44' ' ' ILE . 35.4 p -136.79 29.24 2.88 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.693 -1.475 . . . . 0.0 111.109 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.574 ' CZ ' HD11 ' A' ' 15' ' ' LEU . 15.8 t80 -84.24 111.25 19.22 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.944 -1.102 . . . . 0.0 109.709 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 4' ' ' MET . 1.7 mm -103.28 138.87 19.66 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 108.963 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.462 ' HD2' HG21 ' A' ' 44' ' ' ILE . 43.6 Cg_endo -69.8 77.26 1.1 Allowed 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 123.847 1.446 . . . . 0.0 110.782 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.438 ' HD2' ' HB ' ' A' ' 44' ' ' ILE . 1.8 mtt180 -93.7 148.83 21.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 110.118 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 48' ' ' GLU . 0.1 OUTLIER -44.77 -34.33 2.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.915 . . . . 0.0 110.301 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.474 ' HG3' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -41.87 -48.38 4.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.603 -0.686 . . . . 0.0 109.585 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.547 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -136.34 173.82 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.388 -0.82 . . . . 0.0 109.09 178.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.438 ' O ' HG21 ' A' ' 52' ' ' VAL . 34.4 mt-10 -135.38 129.84 33.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.02 -1.05 . . . . 0.0 110.261 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.497 HG22 ' OH ' ' A' ' 43' ' ' TYR . 19.9 t -54.54 131.17 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.106 -0.996 . . . . 0.0 109.088 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.503 ' CG2' ' HA ' ' A' ' 15' ' ' LEU . 17.3 t -105.85 -55.55 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.104 -0.997 . . . . 0.0 110.621 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.49 ' C ' ' CD1' ' A' ' 54' ' ' ILE . 12.8 mm-40 -141.04 166.83 23.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.103 -0.998 . . . . 0.0 110.568 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.49 ' CD1' ' C ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -133.17 143.26 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.247 -0.908 . . . . 0.0 108.849 179.232 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.511 ' O ' ' HB ' ' A' ' 11' ' ' THR . 3.1 tt -140.71 152.11 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.996 -1.065 . . . . 0.0 111.179 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -103.61 179.69 4.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.457 -0.777 . . . . 0.0 110.041 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.54 ' CB ' ' HA ' ' A' ' 95' ' ' ALA . . . -101.97 143.1 32.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.188 -0.945 . . . . 0.0 110.536 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 0.8 OUTLIER 174.58 57.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.097 -1.002 . . . . 0.0 111.363 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.571 ' CG2' ' N ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -161.64 -60.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.503 -1.373 . . . . 0.0 111.776 179.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.571 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 1.8 mt -88.82 -144.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 120.169 -1.582 . . . . 0.0 110.377 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.533 ' HA ' ' N ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -165.22 176.66 8.23 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.071 -1.018 . . . . 0.0 110.295 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.5 ' CA ' ' HA ' ' A' ' 93' ' ' VAL . 1.3 tp-100 -68.54 -30.62 69.45 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.139 -0.976 . . . . 0.0 110.217 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.461 ' O ' ' HB1' ' A' ' 110' ' ' ALA . 2.5 m120 -69.51 -56.24 7.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.223 -0.923 . . . . 0.0 110.833 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.482 ' HA ' ' HA ' ' A' ' 109' ' ' ASP . 63.8 tp60 -59.61 140.87 56.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.211 -0.931 . . . . 0.0 110.802 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.557 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . . . -125.27 134.33 52.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.524 -0.735 . . . . 0.0 109.215 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.472 ' O ' HD22 ' A' ' 89' ' ' LEU . 7.9 mp -125.81 118.76 26.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.905 . . . . 0.0 111.028 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.461 ' O ' HD12 ' A' ' 105' ' ' LEU . 8.0 mtt85 -91.7 128.92 37.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.347 -0.846 . . . . 0.0 109.11 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.539 ' CD2' ' HA ' ' A' ' 104' ' ' VAL . 10.7 mt -126.36 153.5 44.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.027 -1.046 . . . . 0.0 110.922 -178.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 14.4 ttp180 -127.24 157.56 39.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.522 -0.736 . . . . 0.0 110.204 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 84' ' ' THR . . . -73.51 141.16 46.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.344 -0.847 . . . . 0.0 111.12 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -107.14 -38.25 6.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.303 -0.873 . . . . 0.0 109.589 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.537 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 9.1 mmtt -98.02 -88.07 0.32 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.356 -0.84 . . . . 0.0 109.922 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.537 ' HB3' ' O ' ' A' ' 72' ' ' LYS . 4.1 pt-20 164.24 -37.25 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.727 0.775 . . . . 0.0 108.948 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.46 ' SG ' ' HA ' ' A' ' 33' ' ' ASP . 1.3 m -56.42 -29.75 61.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.498 -0.751 . . . . 0.0 110.336 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.579 ' CZ2' ' OE1' ' A' ' 102' ' ' GLU . 16.8 t90 -76.98 103.81 7.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.167 -0.958 . . . . 0.0 110.087 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 1.8 p30 -101.92 114.24 28.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 110.123 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.514 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . 4.9 ppt_? -77.22 -22.15 52.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.29 -0.881 . . . . 0.0 110.33 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.427 ' N ' ' HG3' ' A' ' 77' ' ' ARG . 1.9 t0 -95.25 -19.21 20.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 110.236 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.25 24.66 11.11 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.514 ' O ' ' C ' ' A' ' 81' ' ' GLU . 1.4 mttt -137.14 52.63 1.91 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.243 -1.151 . . . . 0.0 110.155 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.514 ' C ' ' O ' ' A' ' 80' ' ' LYS . 2.2 pm0 26.46 94.84 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.259 0.552 . . . . 0.0 111.336 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.516 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 4.4 mpt_? -103.94 179.68 4.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 110.222 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.5 m -103.37 178.47 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -0.916 . . . . 0.0 110.144 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.472 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 2.8 t -59.19 -15.66 16.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 110.203 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.2 -39.17 45.15 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.516 ' CB ' ' HB3' ' A' ' 82' ' ' ARG . 19.4 tp10 -54.09 151.74 6.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -1.127 . . . . 0.0 109.957 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.463 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 19.5 pt-20 -159.36 173.85 15.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.173 -0.954 . . . . 0.0 110.436 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.575 ' CD1' ' OE1' ' A' ' 102' ' ' GLU . 0.6 OUTLIER -161.08 160.82 30.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.898 . . . . 0.0 110.103 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.523 HD23 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -108.34 138.04 45.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.324 -0.86 . . . . 0.0 110.195 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.523 ' N ' HD23 ' A' ' 89' ' ' LEU . 7.3 p -108.61 140.76 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -0.929 . . . . 0.0 110.451 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.4 t -157.55 50.39 0.44 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.393 -0.817 . . . . 0.0 110.261 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.432 HG21 ' N ' ' A' ' 93' ' ' VAL . 1.8 m -75.27 157.9 33.71 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.198 -0.938 . . . . 0.0 110.071 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.5 ' HA ' ' CA ' ' A' ' 62' ' ' GLN . 2.6 t -77.69 72.89 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.244 -0.91 . . . . 0.0 110.122 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.533 ' N ' ' HA ' ' A' ' 61' ' ' ARG . . . 87.86 107.04 0.95 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.54 ' HA ' ' CB ' ' A' ' 57' ' ' ALA . . . 179.88 169.33 1.2 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -1.1 . . . . 0.0 110.385 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.474 ' HB2' ' HB ' ' A' ' 59' ' ' ILE . 2.0 t80 -129.57 88.33 2.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.769 -0.582 . . . . 0.0 110.054 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.516 HD11 ' CG ' ' A' ' 38' ' ' GLU . 17.0 mt -119.12 86.23 31.67 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.157 -0.964 . . . . 0.0 110.479 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.463 ' O ' ' HB2' ' A' ' 99' ' ' ALA . 50.0 Cg_endo -79.69 9.26 3.57 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.884 1.465 . . . . 0.0 110.648 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.55 ' CB ' ' HB3' ' A' ' 102' ' ' GLU . . . 58.07 -175.27 0.08 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.15 -0.969 . . . . 0.0 110.063 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 t -109.44 -55.69 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.078 -1.014 . . . . 0.0 110.532 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.574 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 23.0 m-85 -107.6 9.76 29.29 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.076 -1.015 . . . . 0.0 110.152 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.579 ' OE1' ' CZ2' ' A' ' 75' ' ' TRP . 12.6 tt0 -105.05 153.49 21.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 111.575 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -131.05 167.3 19.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.475 -0.766 . . . . 0.0 110.083 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.539 ' HA ' ' CD2' ' A' ' 68' ' ' LEU . 7.3 p -92.55 143.36 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.107 -0.996 . . . . 0.0 110.692 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -105.02 -19.39 13.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.406 -0.809 . . . . 0.0 110.114 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -169.6 179.71 3.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.221 -0.925 . . . . 0.0 110.324 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.543 ' C ' ' CD2' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -138.99 141.25 38.35 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.125 -0.984 . . . . 0.0 110.612 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.557 ' CG1' ' CB ' ' A' ' 65' ' ' ALA . 8.8 p -139.51 116.7 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.94 -1.1 . . . . 0.0 110.771 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 31.1 t0 -86.81 117.4 25.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.048 -1.033 . . . . 0.0 110.119 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 63' ' ' ASN . . . -67.42 158.87 30.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 110.266 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.2 m -67.42 -152.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 110.415 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.6 pt -101.78 153.76 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.268 -0.895 . . . . 0.0 110.394 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.5 tt . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.189 -179.951 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 1' ' ' GLY . 0.1 OUTLIER 43.26 -166.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -1.133 . . . . 0.0 110.164 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.407 ' CG ' ' H ' ' A' ' 4' ' ' MET . 19.1 t60 -151.06 -164.1 1.93 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.316 -0.865 . . . . 0.0 110.019 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.407 ' H ' ' CG ' ' A' ' 3' ' ' HIS . 3.9 ttt -67.81 160.47 28.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.147 -0.971 . . . . 0.0 109.947 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -123.39 155.54 37.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.327 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.75 -162.78 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.497 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.492 ' HA ' ' HA2' ' A' ' 41' ' ' GLY . 60.5 t -87.9 84.1 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 110.482 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.534 ' CD2' ' OG1' ' A' ' 11' ' ' THR . 0.1 OUTLIER -47.07 160.54 0.34 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.399 -0.813 . . . . 0.0 109.988 179.588 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.02 -47.81 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.861 1.453 . . . . 0.0 110.402 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.455 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 5.4 m120 -162.67 31.95 0.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.195 -0.94 . . . . 0.0 110.142 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.534 ' OG1' ' CD2' ' A' ' 8' ' ' LEU . 14.1 p -104.8 166.62 10.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.31 -0.869 . . . . 0.0 110.171 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.51 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -144.74 160.07 41.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.026 -1.046 . . . . 0.0 110.471 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.522 ' CD1' HD13 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -133.16 151.11 51.98 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.09 -1.006 . . . . 0.0 109.646 179.509 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.45 ' O ' ' HB ' ' A' ' 52' ' ' VAL . 65.7 m80 -95.36 127.21 41.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 0.0 110.582 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.596 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 1.7 mm? -113.95 152.17 31.24 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.517 -0.739 . . . . 0.0 110.277 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.541 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -108.09 115.89 30.95 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.19 -0.944 . . . . 0.0 108.707 178.049 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 33' ' ' ASP . . . -78.6 111.26 14.49 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.941 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 48' ' ' GLU . 51.1 mt -98.11 100.95 12.3 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.251 0.548 . . . . 0.0 109.982 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.47 134.0 7.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 110.129 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -75.68 101.63 5.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.034 -1.042 . . . . 0.0 109.715 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.538 ' CB ' HG21 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -125.67 80.74 1.92 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.844 . . . . 0.0 110.435 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.49 ' OE2' ' CG1' ' A' ' 30' ' ' VAL . 0.7 OUTLIER -100.88 114.53 28.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.0 109.691 179.558 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.51 177.31 8.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 110.515 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -54.91 -16.4 2.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.425 -0.797 . . . . 0.0 110.462 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -61.9 -36.0 80.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.135 -0.978 . . . . 0.0 110.092 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.13 -20.78 46.0 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.98 73.59 1.47 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.144 -1.21 . . . . 0.0 110.643 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 21' ' ' PHE . 20.5 tptp -107.67 -119.06 0.25 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.313 -0.867 . . . . 0.0 109.72 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.538 HG21 ' CB ' ' A' ' 21' ' ' PHE . 1.5 m -109.1 140.03 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 120.724 -1.235 . . . . 0.0 109.55 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.49 ' CG1' ' OE2' ' A' ' 22' ' ' GLU . 27.2 m -140.57 83.55 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.165 -0.96 . . . . 0.0 110.188 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.52 70.97 0.37 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.507 -0.745 . . . . 0.0 110.565 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.54 27.92 0.03 OUTLIER Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.34 -1.41 . . . . 0.0 110.892 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.552 ' O ' ' N ' ' A' ' 17' ' ' ALA . 2.2 m-20 -94.13 156.45 16.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.664 -1.492 . . . . 0.0 110.002 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 16.5 tt0 -148.61 145.34 27.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.011 -1.055 . . . . 0.0 110.525 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.553 ' CZ2' ' HB2' ' A' ' 15' ' ' LEU . 12.5 p90 -149.95 166.89 28.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.362 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.479 HD22 ' HB3' ' A' ' 97' ' ' LEU . 53.6 tp -96.47 151.81 19.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.188 -0.945 . . . . 0.0 109.953 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.503 ' HB2' HD23 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -130.77 115.53 16.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.034 -1.041 . . . . 0.0 110.493 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.534 ' CG ' HD23 ' A' ' 97' ' ' LEU . 2.6 tm-20 -96.95 120.99 38.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.536 -0.728 . . . . 0.0 110.326 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.579 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 72.82 46.39 30.15 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 41.6 Cg_endo -66.44 61.29 0.52 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.884 1.465 . . . . 0.0 110.54 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.547 ' C ' ' O ' ' A' ' 40' ' ' PRO . . . -19.0 -92.1 0.01 OUTLIER Glycine 0 N--CA 1.501 2.977 0 N-CA-C 111.491 -0.643 . . . . 0.0 111.491 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.9 p -109.96 49.01 0.86 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.041 -1.27 . . . . 0.0 110.365 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.571 ' CZ ' ' HG ' ' A' ' 15' ' ' LEU . 30.9 t80 -69.83 130.22 41.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.041 -1.037 . . . . 0.0 110.358 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.494 ' CG2' ' HD2' ' A' ' 45' ' ' PRO . 5.5 mt -124.94 145.29 49.61 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.356 -0.84 . . . . 0.0 109.591 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.494 ' HD2' ' CG2' ' A' ' 44' ' ' ILE . 45.8 Cg_endo -71.43 90.8 0.68 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.987 1.519 . . . . 0.0 110.584 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 49' ' ' VAL . 3.9 mtp180 -98.21 152.64 19.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.294 -0.879 . . . . 0.0 110.03 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 46' ' ' ARG . 32.0 tttm -41.49 -31.55 0.27 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.288 -0.883 . . . . 0.0 110.479 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.483 ' O ' HG13 ' A' ' 49' ' ' VAL . 16.7 tt0 -53.82 -41.41 67.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.128 -0.983 . . . . 0.0 109.923 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.518 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 2.1 m -145.7 171.27 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.636 -0.665 . . . . 0.0 109.386 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.21 140.58 47.61 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.684 -1.26 . . . . 0.0 111.125 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.476 ' HA ' HD12 ' A' ' 15' ' ' LEU . 24.9 t -56.53 123.23 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 109.067 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.541 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 7.2 t -105.1 -60.32 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.118 -0.989 . . . . 0.0 110.729 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.47 ' C ' ' CD1' ' A' ' 54' ' ' ILE . 27.1 mm-40 -138.06 162.61 33.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 110.394 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.47 ' CD1' ' C ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -134.49 137.96 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.318 -0.864 . . . . 0.0 109.325 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.51 HG22 ' O ' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -137.37 142.19 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.92 -1.113 . . . . 0.0 111.573 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.493 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 4.0 mm100 -90.67 -179.65 5.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.382 -0.823 . . . . 0.0 109.299 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.538 ' HB3' ' CB ' ' A' ' 95' ' ' ALA . . . -98.41 124.07 42.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.788 -1.195 . . . . 0.0 110.667 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.464 ' O ' HG12 ' A' ' 59' ' ' ILE . 10.1 t -172.12 49.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.443 -0.786 . . . . 0.0 109.818 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.617 HG13 ' CG ' ' A' ' 96' ' ' TYR . 0.7 OUTLIER -150.5 -75.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.083 -1.01 . . . . 0.0 111.533 -179.077 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.569 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 10.0 mt -92.47 125.28 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.905 -1.122 . . . . 0.0 111.534 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.519 ' HA ' ' N ' ' A' ' 94' ' ' GLY . 0.1 OUTLIER -68.66 -165.73 0.07 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.45 -0.781 . . . . 0.0 110.351 179.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.565 ' CA ' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -91.62 -12.97 32.71 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.142 -0.974 . . . . 0.0 111.023 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.54 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 0.9 OUTLIER -87.66 -54.28 4.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.024 -1.047 . . . . 0.0 109.522 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 108' ' ' VAL . 4.1 tp-100 -57.49 128.39 36.8 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.229 -0.919 . . . . 0.0 110.199 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.501 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . . . -107.8 139.72 41.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.293 -0.879 . . . . 0.0 108.888 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.503 ' O ' HD21 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -120.84 124.72 45.73 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.198 -0.939 . . . . 0.0 110.876 -179.015 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.476 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 1.4 mtm180 -90.3 126.53 35.88 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.395 -0.816 . . . . 0.0 109.055 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.555 ' HB3' ' CG ' ' A' ' 102' ' ' GLU . 14.2 mt -120.01 147.34 44.91 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.216 -0.994 . . . . 0.0 111.702 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.555 ' HA ' ' CB ' ' A' ' 87' ' ' GLU . 12.4 ttm180 -126.44 162.74 24.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.552 -0.717 . . . . 0.0 110.241 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . -78.67 153.28 31.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.22 -0.925 . . . . 0.0 110.619 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.5 ' CZ ' ' HG3' ' A' ' 103' ' ' GLU . 19.8 tpp85 -126.84 -31.14 2.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.886 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 74' ' ' CYS . 20.9 tptm -121.34 128.85 52.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.759 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.518 ' HA ' ' N ' ' A' ' 84' ' ' THR . 6.5 pt-20 -67.06 58.38 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.195 -0.941 . . . . 0.0 110.401 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -149.62 -24.37 0.27 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.367 -0.833 . . . . 0.0 110.977 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.592 ' CZ2' ' HG2' ' A' ' 77' ' ' ARG . 1.2 t90 -73.87 117.34 15.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.972 -1.08 . . . . 0.0 109.72 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -81.53 117.33 21.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.325 -0.859 . . . . 0.0 110.893 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.592 ' HG2' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -81.74 -45.94 14.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.343 -0.848 . . . . 0.0 109.606 179.25 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.68 -1.85 36.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.364 -0.835 . . . . 0.0 110.331 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.3 -35.11 5.02 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -78.94 -103.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.295 -1.121 . . . . 0.0 110.12 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.413 ' OE1' ' HA ' ' A' ' 81' ' ' GLU . 71.8 mm-40 -137.93 127.26 24.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.929 -1.107 . . . . 0.0 109.837 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -131.42 171.97 12.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.235 -0.916 . . . . 0.0 110.4 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.542 ' CG2' ' N ' ' A' ' 84' ' ' THR . 2.3 p -116.01 171.61 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -0.819 . . . . 0.0 110.062 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.542 ' N ' ' CG2' ' A' ' 83' ' ' VAL . 13.6 t -57.13 -164.23 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.25 -0.98 . . . . 0.0 108.563 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 86' ' ' GLU . . . 68.65 -58.89 0.48 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.52 ' O ' ' CB ' ' A' ' 70' ' ' ALA . 1.9 tp10 -43.89 151.38 0.21 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -1.141 . . . . 0.0 109.103 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.555 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 5.8 pt-20 -145.16 160.04 42.06 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.205 -0.934 . . . . 0.0 110.741 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.565 ' CE2' ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -135.43 156.72 48.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.472 -0.768 . . . . 0.0 109.286 179.43 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.565 ' O ' ' CE2' ' A' ' 88' ' ' TRP . 1.1 tt -113.43 160.42 18.45 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.808 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.546 ' N ' HD22 ' A' ' 89' ' ' LEU . 2.4 p -135.7 123.86 37.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.148 -0.97 . . . . 0.0 110.588 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.19 32.27 4.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.453 -0.779 . . . . 0.0 109.474 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.462 ' O ' ' O ' ' A' ' 61' ' ' ARG . 11.8 t -76.02 171.66 14.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.41 -0.806 . . . . 0.0 110.467 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.565 ' HA ' ' CA ' ' A' ' 62' ' ' GLN . 2.3 t -80.49 -172.48 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.393 -0.817 . . . . 0.0 110.207 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.519 ' N ' ' HA ' ' A' ' 61' ' ' ARG . . . -33.61 96.92 0.01 OUTLIER Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.538 ' CB ' ' HB3' ' A' ' 57' ' ' ALA . . . -163.7 148.96 10.9 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.17 -1.194 . . . . 0.0 111.731 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.617 ' CG ' HG13 ' A' ' 59' ' ' ILE . 8.4 t80 -109.03 110.37 21.63 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.534 HD23 ' CG ' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -127.78 66.11 69.79 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.027 -1.045 . . . . 0.0 111.236 -178.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.533 ' HG3' ' CZ ' ' A' ' 96' ' ' TYR . 45.2 Cg_endo -74.03 89.66 1.02 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.005 1.529 . . . . 0.0 109.651 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.539 ' CB ' ' HB3' ' A' ' 102' ' ' GLU . . . -45.63 149.57 0.58 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.286 -0.884 . . . . 0.0 111.232 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.442 HG13 ' OE2' ' A' ' 34' ' ' GLU . 2.3 m -52.16 -69.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.61 -0.681 . . . . 0.0 110.66 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.466 ' HB3' ' HB3' ' A' ' 72' ' ' LYS . 7.0 m-85 -99.73 62.03 1.17 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.821 -1.175 . . . . 0.0 109.674 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.555 ' CG ' ' HB3' ' A' ' 68' ' ' LEU . 4.0 tt0 -140.5 147.99 40.4 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.047 -1.033 . . . . 0.0 110.98 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.5 ' HG3' ' CZ ' ' A' ' 71' ' ' ARG . 1.3 mm-40 -132.15 150.89 52.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.501 -0.749 . . . . 0.0 109.679 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.42 ' C ' HD23 ' A' ' 105' ' ' LEU . 4.8 m -83.66 149.04 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.113 -0.992 . . . . 0.0 110.349 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.536 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -103.19 -10.96 18.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.425 -0.797 . . . . 0.0 109.287 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER 163.58 172.05 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.662 -0.649 . . . . 0.0 109.767 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.2 mp -116.43 123.23 47.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.169 -0.957 . . . . 0.0 109.766 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.501 ' CG1' ' CB ' ' A' ' 65' ' ' ALA . 13.6 p -116.56 155.48 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.029 -1.044 . . . . 0.0 110.681 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -110.05 120.85 43.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.385 -0.822 . . . . 0.0 109.571 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.54 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . -59.11 131.06 49.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.296 -0.878 . . . . 0.0 110.937 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.511 HG13 ' N ' ' A' ' 112' ' ' ILE . 40.7 t 56.02 160.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.855 . . . . 0.0 110.782 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.511 ' N ' HG13 ' A' ' 111' ' ' VAL . 3.5 mp -149.41 -69.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.499 -0.751 . . . . 0.0 109.908 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.113 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 t -114.41 -25.45 8.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.188 -1.184 . . . . 0.0 110.167 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -99.83 -80.9 0.47 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.874 . . . . 0.0 110.143 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 44.5 ttm -45.99 160.53 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.451 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.435 ' O ' ' O ' ' A' ' 41' ' ' GLY . 1.2 tt0 -118.06 -174.15 2.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.886 . . . . 0.0 109.905 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.512 ' O ' ' CD1' ' A' ' 8' ' ' LEU . 67.4 t -128.54 147.61 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 109.741 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.533 ' HA ' ' CA ' ' A' ' 41' ' ' GLY . 10.6 t -43.44 120.58 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.074 -1.016 . . . . 0.0 110.098 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.512 ' CD1' ' O ' ' A' ' 6' ' ' VAL . 4.0 mp -76.53 164.84 57.11 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.441 -0.787 . . . . 0.0 110.361 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.481 ' O ' ' HB2' ' A' ' 10' ' ' ASN . 46.2 Cg_endo -75.57 70.31 5.72 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 124.121 1.59 . . . . 0.0 109.914 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.512 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 11.6 m-20 58.42 55.84 4.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.382 -0.824 . . . . 0.0 110.397 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.497 ' HB ' ' HA ' ' A' ' 56' ' ' GLN . 6.2 p -136.38 171.48 14.43 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.066 -1.022 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.536 ' CB ' ' HA ' ' A' ' 38' ' ' GLU . . . -145.37 158.06 43.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.203 -0.936 . . . . 0.0 110.719 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.5 HD21 ' HB3' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -130.49 154.85 47.34 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.391 -0.818 . . . . 0.0 109.268 179.119 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 53' ' ' GLU . 40.7 m80 -94.79 131.63 40.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.975 . . . . 0.0 110.209 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.584 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 1.7 mm? -120.02 140.34 51.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.634 -0.666 . . . . 0.0 109.962 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.55 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 4.8 ttmt -95.82 117.09 29.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.965 -1.084 . . . . 0.0 109.174 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.541 ' HA ' ' CG1' ' A' ' 49' ' ' VAL . . . -81.78 105.73 13.15 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 110.591 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.476 HD13 ' CA ' ' A' ' 31' ' ' ALA . 1.9 mm? -99.08 101.53 12.92 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.0 tp -161.77 148.6 14.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.089 -1.007 . . . . 0.0 110.696 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.64 115.68 22.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.369 -0.832 . . . . 0.0 109.037 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -134.34 70.04 1.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.982 -1.074 . . . . 0.0 110.988 -179.055 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 1.5 tt0 -92.94 111.61 23.28 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.878 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 27' ' ' ASP . 0.7 OUTLIER -125.61 152.08 45.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.503 -0.748 . . . . 0.0 110.413 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.01 4.32 54.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.137 -0.977 . . . . 0.0 109.894 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.465 ' OD1' ' HB3' ' A' ' 23' ' ' ASP . 3.6 p-10 -100.92 -36.47 9.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 0.0 110.618 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.78 -40.51 0.08 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 23' ' ' ASP . 2.1 m-20 -68.79 131.6 45.42 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.21 -1.17 . . . . 0.0 109.857 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -166.49 63.18 0.1 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.237 -0.915 . . . . 0.0 110.86 -179.199 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.483 HG21 ' HB2' ' A' ' 21' ' ' PHE . 1.0 OUTLIER -108.07 160.88 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.18 -0.95 . . . . 0.0 109.74 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 31' ' ' ALA . 26.9 m -139.06 85.11 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.017 -1.052 . . . . 0.0 110.549 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.476 ' CA ' HD13 ' A' ' 18' ' ' LEU . . . 40.22 76.35 0.07 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.544 -0.722 . . . . 0.0 110.667 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.99 31.8 0.03 OUTLIER Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.359 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 17' ' ' ALA . 13.0 m-20 -99.55 155.56 17.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.934 -1.333 . . . . 0.0 110.377 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 9.8 tt0 -151.51 134.76 15.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.376 -0.827 . . . . 0.0 109.9 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.502 ' CZ2' ' HB2' ' A' ' 15' ' ' LEU . 7.8 p90 -148.29 167.67 24.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.172 -0.955 . . . . 0.0 110.679 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.531 ' CB ' ' HA ' ' A' ' 99' ' ' ALA . 44.5 tp -97.5 153.32 18.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.329 -0.857 . . . . 0.0 109.772 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.5 ' HB3' HD21 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -138.14 110.5 7.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.143 -0.973 . . . . 0.0 109.919 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.536 ' HA ' ' CB ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -97.2 138.17 35.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.334 -0.854 . . . . 0.0 110.44 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.619 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 72.25 40.8 54.85 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 54.0 Cg_endo -78.12 47.9 2.51 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.23 1.121 . . . . 0.0 109.828 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.533 ' CA ' ' HA ' ' A' ' 7' ' ' VAL . . . -42.78 -31.86 1.24 Allowed Glycine 0 N--CA 1.49 2.278 0 O-C-N 121.53 -0.731 . . . . 0.0 111.277 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.7 p -136.46 42.92 2.5 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.82 -1.4 . . . . 0.0 111.02 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.55 ' CZ ' ' HG ' ' A' ' 15' ' ' LEU . 14.7 t80 -79.75 111.99 16.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.106 -0.996 . . . . 0.0 109.654 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.442 HG23 ' HD2' ' A' ' 45' ' ' PRO . 3.6 mp -96.04 133.37 25.31 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 0.0 109.992 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 44' ' ' ILE . 45.4 Cg_endo -73.17 96.82 0.89 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.907 1.477 . . . . 0.0 110.442 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 -104.12 159.41 15.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 110.282 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.86 -28.52 6.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.146 -0.971 . . . . 0.0 110.419 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 18' ' ' LEU . 7.2 tt0 -50.36 -39.85 47.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.17 -0.956 . . . . 0.0 110.077 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.541 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 1.6 m -141.79 173.65 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.426 -0.796 . . . . 0.0 109.998 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -132.61 137.09 46.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.107 -0.996 . . . . 0.0 110.349 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.49 ' HA ' HD11 ' A' ' 15' ' ' LEU . 21.3 t -54.52 132.53 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.971 . . . . 0.0 109.335 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.55 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 97.2 t -118.57 -59.54 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.96 -1.088 . . . . 0.0 110.932 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 14' ' ' HIS . 43.2 mm-40 -137.21 164.53 28.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.058 -1.026 . . . . 0.0 111.273 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.474 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -136.46 137.97 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.48 ' O ' ' HB ' ' A' ' 11' ' ' THR . 0.3 OUTLIER -138.41 137.15 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.806 -1.184 . . . . 0.0 111.466 -178.671 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.497 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 1.3 mp0 -93.03 167.09 12.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.621 -0.674 . . . . 0.0 110.065 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' A' ' 10' ' ' ASN . . . -82.72 140.1 33.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 0.0 110.265 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 4.4 t 179.87 39.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.01 -1.056 . . . . 0.0 111.719 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.566 HD13 ' CE2' ' A' ' 96' ' ' TYR . 0.5 OUTLIER -161.05 -70.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.468 -1.395 . . . . 0.0 111.838 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.487 ' N ' HG12 ' A' ' 59' ' ' ILE . 4.2 mm -41.86 164.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.903 -1.123 . . . . 0.0 110.297 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.43 ' N ' ' CG2' ' A' ' 60' ' ' ILE . 2.6 mpt_? -94.3 -164.12 1.13 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.101 -0.999 . . . . 0.0 110.989 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.548 ' HA ' ' CG1' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -67.05 -68.01 0.41 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 111.352 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.542 ' CB ' ' HB3' ' A' ' 110' ' ' ALA . 52.3 m-20 -113.22 24.6 12.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.924 -1.11 . . . . 0.0 111.23 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -61.95 133.6 55.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.867 -1.146 . . . . 0.0 109.282 178.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.49 ' O ' ' HB ' ' A' ' 108' ' ' VAL . . . -109.51 128.44 55.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.852 -1.155 . . . . 0.0 110.181 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.515 ' CD1' ' HB ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -126.28 127.3 45.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.93 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.486 ' C ' ' CD2' ' A' ' 68' ' ' LEU . 10.8 mtt180 -90.85 130.89 36.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.601 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.535 ' CG ' ' OE2' ' A' ' 102' ' ' GLU . 4.2 mm? -116.78 130.43 56.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 111.035 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 1.9 ttt180 -107.16 156.68 18.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.578 -0.701 . . . . 0.0 109.633 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.474 ' CB ' ' HG2' ' A' ' 86' ' ' GLU . . . -88.66 142.14 27.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.201 -0.937 . . . . 0.0 110.543 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.436 ' O ' HG23 ' A' ' 84' ' ' THR . 3.5 ptm180 -115.05 -17.33 11.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.347 -0.846 . . . . 0.0 109.697 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -132.96 116.4 16.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.49 -0.756 . . . . 0.0 109.988 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.527 ' N ' HG22 ' A' ' 84' ' ' THR . 1.2 tm-20 -62.16 103.32 0.37 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 110.318 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER 167.1 -25.04 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.294 -0.879 . . . . 0.0 110.028 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.57 ' CZ2' ' HB3' ' A' ' 77' ' ' ARG . 1.3 t90 -75.14 105.26 6.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.363 -0.836 . . . . 0.0 110.375 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.408 ' OD1' ' HB3' ' A' ' 35' ' ' TRP . 16.0 p-10 -87.36 109.55 19.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.181 -0.949 . . . . 0.0 109.767 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.57 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -89.77 -13.65 36.24 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.215 -0.928 . . . . 0.0 110.587 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.437 ' OD2' ' NH1' ' A' ' 77' ' ' ARG . 0.2 OUTLIER -124.88 13.33 8.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.986 -1.071 . . . . 0.0 110.267 179.675 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.78 21.23 78.91 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 15.5 mmmt -119.79 -7.31 10.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.174 -1.192 . . . . 0.0 110.012 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.468 ' OE1' ' OD1' ' A' ' 33' ' ' ASP . 25.3 mm-40 60.66 124.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.358 -0.839 . . . . 0.0 110.234 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.511 ' HB3' ' HB3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -141.66 179.52 6.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.303 -0.873 . . . . 0.0 110.356 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.497 ' HA ' ' CB ' ' A' ' 73' ' ' GLU . 6.3 m -96.16 -178.59 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.223 -0.923 . . . . 0.0 111.245 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.527 HG22 ' N ' ' A' ' 73' ' ' GLU . 25.7 p -57.2 -23.07 45.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.467 -0.77 . . . . 0.0 110.545 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.18 -25.7 71.18 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.511 ' HB3' ' HB3' ' A' ' 82' ' ' ARG . 6.1 pt-20 -65.58 153.11 42.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.357 -1.084 . . . . 0.0 110.632 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.12 147.8 18.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.483 -0.76 . . . . 0.0 109.635 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.566 ' NE1' ' CG2' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -134.59 144.76 48.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.997 -1.064 . . . . 0.0 110.381 -179.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.523 ' C ' ' CD1' ' A' ' 89' ' ' LEU . 1.3 tm? -94.65 139.03 31.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.427 -0.796 . . . . 0.0 110.254 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.566 ' CG2' ' NE1' ' A' ' 88' ' ' TRP . 12.1 t -112.98 131.81 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.199 -0.938 . . . . 0.0 110.722 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.467 ' OG1' ' CD1' ' A' ' 89' ' ' LEU . 16.6 m -135.55 45.57 2.44 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.578 -0.701 . . . . 0.0 109.679 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.455 ' O ' HG22 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -82.2 128.67 34.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.899 . . . . 0.0 110.736 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.548 ' CG1' ' HA ' ' A' ' 62' ' ' GLN . 47.2 t -70.31 114.3 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.568 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 60' ' ' ILE . . . 56.96 97.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.511 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . . . 174.88 -176.88 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.108 -1.23 . . . . 0.0 110.606 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.566 ' CE2' HD13 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -147.35 101.99 3.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.3 -0.875 . . . . 0.0 110.499 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.527 HD21 ' CB ' ' A' ' 12' ' ' ALA . 18.7 mt -126.33 71.22 70.91 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.116 -0.99 . . . . 0.0 110.025 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.488 ' HD3' ' CD1' ' A' ' 96' ' ' TYR . 50.5 Cg_endo -81.84 17.29 1.56 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.996 1.524 . . . . 0.0 110.965 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.584 ' CB ' ' CG ' ' A' ' 102' ' ' GLU . . . 43.48 -164.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.12 -0.987 . . . . 0.0 110.674 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.483 ' CG2' ' HA ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -115.92 -44.85 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.191 -0.943 . . . . 0.0 111.656 -178.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.56 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 23.1 m-85 -110.59 40.94 1.88 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.617 -1.302 . . . . 0.0 111.977 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.584 ' CG ' ' CB ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -141.9 165.33 27.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.722 -1.236 . . . . 0.0 110.62 179.18 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -131.26 158.83 39.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.418 -0.801 . . . . 0.0 109.905 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.484 ' CG1' HD11 ' A' ' 68' ' ' LEU . 6.3 m -82.05 142.17 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.058 -1.027 . . . . 0.0 110.451 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.601 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 4.4 mp -90.58 -14.49 32.39 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.371 -0.831 . . . . 0.0 109.271 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 1.0 OUTLIER 163.85 -172.75 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.633 -0.667 . . . . 0.0 109.918 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 107' ' ' LEU . 0.7 OUTLIER -125.8 130.98 52.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.12 -0.987 . . . . 0.0 110.073 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.515 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 24.2 t -123.81 148.89 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.133 -0.979 . . . . 0.0 110.877 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -112.16 113.23 25.37 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.27 -0.894 . . . . 0.0 108.882 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.542 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . . . -63.4 105.68 0.79 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.745 -1.222 . . . . 0.0 109.829 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.1 p -114.22 4.36 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 110.186 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.467 HG21 HD12 ' A' ' 112' ' ' ILE . 38.6 mm -52.49 89.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.408 -0.807 . . . . 0.0 110.369 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 111' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.175 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.54 87.96 2.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -1.178 . . . . 0.0 110.106 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -174.16 131.52 0.39 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.329 -0.857 . . . . 0.0 110.185 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.5 mtp -78.63 158.79 28.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.344 -0.847 . . . . 0.0 109.996 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 42' ' ' THR . 1.9 mt-30 -142.43 104.06 4.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.131 -0.981 . . . . 0.0 110.625 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 5' ' ' GLN . 8.2 p -45.05 165.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 0.0 109.718 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.8 t -54.08 125.27 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.076 -1.015 . . . . 0.0 110.169 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.497 ' N ' HD13 ' A' ' 8' ' ' LEU . 6.5 mp -71.65 162.95 70.27 Favored Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 109.919 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.69 -89.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.926 1.488 . . . . 0.0 110.17 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.538 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 72.9 m-80 -128.64 25.02 5.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.962 . . . . 0.0 110.015 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 56' ' ' GLN . 27.4 p -104.48 170.6 7.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.316 -0.865 . . . . 0.0 110.077 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.508 ' CB ' ' HA ' ' A' ' 38' ' ' GLU . . . -139.75 161.86 36.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.217 -0.927 . . . . 0.0 110.117 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.582 HD21 ' HB3' ' A' ' 37' ' ' PHE . 0.6 OUTLIER -132.77 155.58 48.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.942 . . . . 0.0 110.021 179.781 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.568 ' CD2' ' CD1' ' A' ' 36' ' ' LEU . 42.9 m80 -90.96 129.16 37.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.165 -0.959 . . . . 0.0 110.555 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.592 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 2.2 mm? -120.11 146.74 45.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.665 -0.647 . . . . 0.0 110.231 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.54 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -110.78 116.28 31.01 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.187 -0.945 . . . . 0.0 108.592 178.044 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.572 ' CB ' ' HB2' ' A' ' 33' ' ' ASP . . . -75.3 115.47 14.97 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.157 -0.964 . . . . 0.0 110.135 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.6 mt -103.26 99.84 9.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.701 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.634 ' CD1' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -167.57 165.99 14.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.026 -1.046 . . . . 0.0 110.559 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.461 ' N ' HD21 ' A' ' 19' ' ' LEU . 11.6 t70 -98.27 103.12 15.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.734 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.57 ' CB ' ' CG2' ' A' ' 29' ' ' VAL . 1.9 t80 -101.01 101.78 12.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 109.923 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -85.48 118.98 25.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.395 -0.816 . . . . 0.0 110.146 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.446 ' OD2' ' HB2' ' A' ' 25' ' ' ASP . 2.4 t70 -118.62 132.73 56.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.917 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 tttp -71.98 -23.54 61.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 110.161 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.446 ' HB2' ' OD2' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -68.83 -31.08 69.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 109.885 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 127.41 -6.43 7.12 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.48 44.39 0.96 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.149 -1.206 . . . . 0.0 110.28 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -68.82 123.55 21.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 110.111 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.57 ' CG2' ' CB ' ' A' ' 21' ' ' PHE . 1.3 m -109.83 150.0 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.211 -0.931 . . . . 0.0 109.474 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.486 ' O ' HG23 ' A' ' 30' ' ' VAL . 15.4 m -134.91 93.69 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.145 -0.972 . . . . 0.0 110.905 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 42.05 68.35 0.48 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.285 -0.885 . . . . 0.0 110.471 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -166.75 19.35 0.09 OUTLIER Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.294 -1.431 . . . . 0.0 111.043 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.572 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 1.9 m-20 -88.9 148.6 23.75 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.414 -1.639 . . . . 0.0 109.931 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.474 ' CG ' HG11 ' A' ' 100' ' ' VAL . 27.7 tt0 -149.79 132.14 15.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.017 -1.052 . . . . 0.0 110.575 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -148.96 177.16 9.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.37 -0.831 . . . . 0.0 109.877 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.568 ' CD1' ' CD2' ' A' ' 14' ' ' HIS . 8.4 tp -102.94 153.99 19.67 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.157 -0.965 . . . . 0.0 110.227 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.59 ' CZ ' ' HA ' ' A' ' 40' ' ' PRO . 1.0 OUTLIER -130.88 110.46 11.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.433 -0.792 . . . . 0.0 109.68 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.508 ' HA ' ' CB ' ' A' ' 12' ' ' ALA . 8.9 tm-20 -92.01 132.71 36.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.574 -0.704 . . . . 0.0 109.356 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.585 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 60.24 47.05 93.02 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.59 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 37.6 Cg_endo -61.47 75.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.984 1.518 . . . . 0.0 110.467 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . -42.86 110.83 0.3 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 5' ' ' GLN . 3.0 p 38.33 44.21 0.69 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.598 -0.942 . . . . 0.0 111.622 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.55 ' CE2' HD12 ' A' ' 15' ' ' LEU . 13.6 t80 -68.74 122.28 18.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.732 -1.23 . . . . 0.0 109.309 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.432 ' CG2' ' HD2' ' A' ' 45' ' ' PRO . 31.4 mt -111.7 142.16 26.08 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 110.18 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.491 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 45.0 Cg_endo -73.19 96.09 0.87 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.09 1.574 . . . . 0.0 110.353 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.403 ' O ' ' C ' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -106.13 161.8 14.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 110.242 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 46' ' ' ARG . 35.7 mttt -43.26 -31.24 0.59 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.341 -0.85 . . . . 0.0 110.299 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -55.19 -45.66 75.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.266 -0.896 . . . . 0.0 110.605 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.4 m -144.4 165.86 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.232 -0.917 . . . . 0.0 110.031 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -125.76 141.88 51.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.296 -0.877 . . . . 0.0 110.234 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.491 ' CG2' ' HB3' ' A' ' 45' ' ' PRO . 46.6 t -60.18 119.86 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.858 . . . . 0.0 109.832 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.54 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 16.7 t -95.1 -64.02 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 0.0 110.474 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.511 ' HB2' ' ND1' ' A' ' 14' ' ' HIS . 44.8 mm-40 -141.96 175.62 9.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.56 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -134.95 146.06 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.36 -0.838 . . . . 0.0 109.111 179.439 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -140.08 131.74 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.971 -1.081 . . . . 0.0 110.739 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.476 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 2.5 mp0 -86.5 156.01 20.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.49 -0.756 . . . . 0.0 109.835 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.576 ' CB ' ' HA ' ' A' ' 95' ' ' ALA . . . -95.3 142.85 27.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 0.0 110.818 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.496 ' C ' ' CG2' ' A' ' 59' ' ' ILE . 0.1 OUTLIER 168.81 51.69 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.424 -0.797 . . . . 0.0 110.777 179.758 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.573 HD11 ' CD1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -153.48 -28.75 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.728 -1.232 . . . . 0.0 111.419 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 61' ' ' ARG . 0.6 OUTLIER -87.58 168.58 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.644 -1.285 . . . . 0.0 110.844 -179.098 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.499 ' CB ' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -107.23 -177.29 3.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.521 -0.737 . . . . 0.0 110.323 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.593 ' HA ' ' CG1' ' A' ' 93' ' ' VAL . 1.0 OUTLIER -66.46 -72.26 0.17 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.273 -0.892 . . . . 0.0 110.671 -179.747 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.532 ' CB ' ' HB1' ' A' ' 110' ' ' ALA . 1.1 m-80 -77.55 -6.84 55.08 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.314 -0.866 . . . . 0.0 110.207 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.549 ' NE2' ' N ' ' A' ' 108' ' ' VAL . 44.7 tp60 -61.1 129.26 40.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.144 -0.973 . . . . 0.0 110.657 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.415 ' C ' HD21 ' A' ' 66' ' ' LEU . . . -108.67 144.99 35.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.074 -1.016 . . . . 0.0 109.752 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.465 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 1.7 mm? -123.13 114.6 20.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.182 -0.948 . . . . 0.0 110.522 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.443 ' O ' HD11 ' A' ' 105' ' ' LEU . 18.5 mtm180 -97.99 122.04 40.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.297 -0.877 . . . . 0.0 109.881 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.552 ' CD2' ' HA ' ' A' ' 104' ' ' VAL . 13.2 mt -118.88 135.82 54.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.961 . . . . 0.0 110.61 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 29.2 ttt180 -98.22 160.74 14.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.55 -0.719 . . . . 0.0 109.865 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 86' ' ' GLU . . . -75.99 164.16 26.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.261 -0.899 . . . . 0.0 111.193 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 101' ' ' PHE . 1.0 OUTLIER -124.51 -42.6 2.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.66 -0.65 . . . . 0.0 109.493 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.493 ' HB2' ' CD2' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -122.03 138.67 54.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.41 -0.806 . . . . 0.0 109.998 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -69.52 60.55 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.151 -0.968 . . . . 0.0 109.481 179.336 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 72' ' ' LYS . 2.2 t -151.18 -25.63 0.21 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.219 -0.926 . . . . 0.0 111.309 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.584 ' CZ2' ' HB3' ' A' ' 77' ' ' ARG . 1.7 t90 -73.6 116.23 13.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.754 -1.216 . . . . 0.0 110.519 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.464 ' HB3' ' HA ' ' A' ' 81' ' ' GLU . 2.5 p-10 -107.07 109.61 21.51 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.251 -0.905 . . . . 0.0 110.07 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.584 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -88.82 -4.09 58.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.243 -0.911 . . . . 0.0 110.242 179.671 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -117.66 -12.48 10.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.883 . . . . 0.0 110.089 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.18 -46.23 1.13 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -82.55 127.13 33.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -1.161 . . . . 0.0 110.26 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.529 ' CG ' HG12 ' A' ' 29' ' ' VAL . 6.1 tp10 -46.28 119.55 2.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 0.0 110.109 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.43 175.04 5.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 110.317 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.505 ' HA ' ' CG ' ' A' ' 73' ' ' GLU . 13.8 p -106.69 172.84 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 110.306 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.421 HG23 ' C ' ' A' ' 72' ' ' LYS . 40.6 p -60.75 -174.08 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.323 -0.861 . . . . 0.0 109.022 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 87' ' ' GLU . . . 70.8 -56.37 0.99 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.499 ' O ' ' HB1' ' A' ' 70' ' ' ALA . 4.4 tp10 -44.32 153.78 0.14 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.032 -1.275 . . . . 0.0 109.545 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.545 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 13.4 mp0 -145.23 149.8 35.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.741 -1.224 . . . . 0.0 111.385 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.564 ' CZ2' ' HB ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -111.74 163.27 14.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.395 -0.815 . . . . 0.0 108.903 178.606 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.511 ' CD1' ' C ' ' A' ' 89' ' ' LEU . 1.5 tm? -129.32 141.67 51.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.989 -1.069 . . . . 0.0 110.309 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.564 ' HB ' ' CZ2' ' A' ' 88' ' ' TRP . 7.1 p -126.15 139.49 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.61 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.465 ' O ' HG21 ' A' ' 91' ' ' THR . 22.3 m -137.46 40.55 2.42 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.174 -0.954 . . . . 0.0 110.132 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.7 m -82.44 126.71 32.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.169 -0.957 . . . . 0.0 110.376 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.593 ' CG1' ' HA ' ' A' ' 62' ' ' GLN . 3.8 m -58.19 112.56 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.134 -0.979 . . . . 0.0 110.265 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 60' ' ' ILE . . . 71.44 96.6 0.06 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.576 ' HA ' ' CB ' ' A' ' 57' ' ' ALA . . . -169.41 176.03 5.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.324 -1.103 . . . . 0.0 110.826 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.573 ' CD1' HD11 ' A' ' 59' ' ' ILE . 1.0 OUTLIER -129.0 -70.57 0.66 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.495 -0.753 . . . . 0.0 109.514 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.477 ' HA ' HD21 ' A' ' 36' ' ' LEU . 4.8 mt 48.92 78.27 0.41 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.484 -0.76 . . . . 0.0 111.247 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.522 ' O ' ' CB ' ' A' ' 99' ' ' ALA . 48.9 Cg_endo -74.65 -14.79 21.96 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.806 1.424 . . . . 0.0 109.548 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.523 ' CB ' ' HB2' ' A' ' 102' ' ' GLU . . . 72.14 173.46 0.3 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.537 -0.727 . . . . 0.0 111.161 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.489 HG13 ' CD1' ' A' ' 101' ' ' PHE . 94.2 t -99.81 -61.09 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.538 -0.727 . . . . 0.0 109.603 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.572 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 18.0 m-30 -111.43 45.44 1.2 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.335 -0.853 . . . . 0.0 109.992 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 11.4 mt-10 -134.05 144.88 48.93 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.676 -1.265 . . . . 0.0 111.887 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.471 ' O ' HD12 ' A' ' 105' ' ' LEU . 1.3 tt0 -119.37 123.27 43.74 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.552 ' HA ' ' CD2' ' A' ' 68' ' ' LEU . 7.2 p -54.05 149.02 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.218 -0.926 . . . . 0.0 110.779 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.533 ' CD1' ' N ' ' A' ' 69' ' ' ARG . 8.4 mp -103.46 -32.92 9.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.574 -0.704 . . . . 0.0 110.387 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -179.84 148.38 0.31 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.026 -1.046 . . . . 0.0 110.722 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 mp -88.33 125.52 34.73 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.331 -0.856 . . . . 0.0 109.555 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.549 ' N ' ' NE2' ' A' ' 64' ' ' GLN . 74.2 t -116.85 140.53 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.067 -1.021 . . . . 0.0 111.434 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 14.4 t0 -111.29 114.15 27.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 109.496 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.532 ' HB1' ' CB ' ' A' ' 63' ' ' ASN . . . -84.22 177.31 8.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.862 -1.149 . . . . 0.0 110.282 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.431 ' O ' ' CG ' ' A' ' 63' ' ' ASN . 19.6 m -61.81 -145.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.255 -0.903 . . . . 0.0 110.599 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.409 HG23 HD13 ' A' ' 112' ' ' ILE . 15.7 mm -109.08 146.53 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.9 . . . . 0.0 110.279 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.179 179.991 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.427 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.3 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 0.3 OUTLIER 65.31 146.25 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.25 -1.147 . . . . 0.0 110.048 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -58.32 101.27 0.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.16 -0.962 . . . . 0.0 110.28 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.531 ' HA ' ' CD1' ' A' ' 44' ' ' ILE . 14.9 ttt -131.28 150.1 52.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.177 -0.952 . . . . 0.0 110.154 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.427 ' HB3' ' O ' ' A' ' 4' ' ' MET . 14.2 pt20 -176.76 142.5 0.41 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.179 -0.951 . . . . 0.0 110.392 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.7 m -66.75 -150.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -0.885 . . . . 0.0 110.079 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.481 HG22 ' HA2' ' A' ' 41' ' ' GLY . 4.0 t -83.32 144.48 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 110.178 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.55 ' CD2' ' HG2' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -100.25 168.74 8.93 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.207 -0.933 . . . . 0.0 109.519 179.667 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 42.8 Cg_endo -70.15 68.94 1.89 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.641 1.337 . . . . 0.0 110.732 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.482 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 4.9 m120 68.67 69.86 0.29 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.555 -0.715 . . . . 0.0 111.227 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' A' ' 8' ' ' LEU . 7.8 p -138.87 159.71 41.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.942 . . . . 0.0 109.921 178.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.534 ' CB ' ' HA ' ' A' ' 38' ' ' GLU . . . -139.04 155.68 47.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.157 -0.964 . . . . 0.0 110.333 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -130.48 156.74 44.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -0.932 . . . . 0.0 110.609 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.505 ' N ' ' CD2' ' A' ' 14' ' ' HIS . 10.5 m170 -93.98 128.2 40.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.597 -0.689 . . . . 0.0 109.424 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.586 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -121.58 153.15 38.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.065 -1.022 . . . . 0.0 110.098 -179.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -110.09 116.52 31.7 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.21 -0.931 . . . . 0.0 109.385 178.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.55 ' HA ' ' CG1' ' A' ' 49' ' ' VAL . . . -76.61 115.93 16.82 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.285 -0.885 . . . . 0.0 110.434 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.455 HD13 ' CB ' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -102.83 99.77 9.73 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.475 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.518 HD11 ' N ' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -167.59 147.31 5.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 110.745 -179.443 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.518 ' N ' HD11 ' A' ' 19' ' ' LEU . 32.4 t70 -85.39 110.82 19.41 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.508 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 0.4 OUTLIER -129.17 144.41 51.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.081 -1.012 . . . . 0.0 112.054 -177.893 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.06 123.13 46.05 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.95 144.7 29.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.977 -1.077 . . . . 0.0 110.88 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -74.04 -33.05 63.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.413 -0.805 . . . . 0.0 109.507 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.94 -25.06 4.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.439 -0.788 . . . . 0.0 110.226 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.455 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -88.76 27.51 7.18 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.4 OUTLIER 61.63 -84.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -1.175 . . . . 0.0 110.4 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.508 ' CG ' ' O ' ' A' ' 21' ' ' PHE . 1.9 ttmm 178.13 142.44 0.1 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.373 -0.829 . . . . 0.0 110.344 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.537 ' CG1' ' HB3' ' A' ' 81' ' ' GLU . 0.8 OUTLIER -100.66 139.97 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.203 -0.935 . . . . 0.0 109.333 179.658 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 31' ' ' ALA . 20.1 m -127.63 85.67 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.065 -1.022 . . . . 0.0 110.575 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.455 ' CB ' HD13 ' A' ' 18' ' ' LEU . . . 41.62 71.18 0.22 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.315 -0.866 . . . . 0.0 110.381 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -179.68 28.83 0.05 OUTLIER Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.536 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 17' ' ' ALA . 42.5 m-20 -93.44 147.94 22.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.769 -1.43 . . . . 0.0 110.0 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.457 ' HG2' HG12 ' A' ' 100' ' ' VAL . 15.3 tt0 -143.07 143.56 31.91 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.032 -1.042 . . . . 0.0 110.176 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.544 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 7.1 p90 -159.95 168.83 24.78 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.014 -1.054 . . . . 0.0 111.105 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.474 HD21 ' O ' ' A' ' 98' ' ' PRO . 14.2 tp -97.32 153.29 18.15 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.353 -0.842 . . . . 0.0 109.774 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.601 ' CZ ' ' HA ' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -140.96 109.6 5.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.98 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.543 ' HG2' ' CD2' ' A' ' 97' ' ' LEU . 0.4 OUTLIER -97.77 137.77 36.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.355 -0.84 . . . . 0.0 109.402 179.614 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.595 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 78.73 46.68 8.41 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.601 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 38.1 Cg_endo -63.47 71.32 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.052 1.554 . . . . 0.0 111.041 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.481 ' HA2' HG22 ' A' ' 7' ' ' VAL . . . -46.43 95.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER 46.13 40.44 7.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -1.137 . . . . 0.0 110.413 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.525 ' HB3' ' HB2' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -68.64 131.87 45.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.105 -0.997 . . . . 0.0 109.929 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.531 ' CD1' ' HA ' ' A' ' 4' ' ' MET . 23.3 mm -121.08 148.22 48.5 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.388 -0.82 . . . . 0.0 109.124 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.529 ' HD2' ' CG2' ' A' ' 44' ' ' ILE . 41.2 Cg_endo -67.85 75.03 0.64 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.689 1.363 . . . . 0.0 110.863 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 49' ' ' VAL . 13.0 ttt85 -66.84 143.47 56.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.424 -0.798 . . . . 0.0 109.895 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -41.25 -33.62 0.4 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.344 -0.848 . . . . 0.0 110.523 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -49.46 -50.89 39.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.157 -0.964 . . . . 0.0 109.95 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.55 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 1.4 m -133.0 173.51 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.353 -0.842 . . . . 0.0 109.408 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.444 ' O ' HG23 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -131.48 132.77 44.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.088 -1.008 . . . . 0.0 110.56 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.491 ' HA ' HD11 ' A' ' 15' ' ' LEU . 9.4 p -54.41 143.53 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.041 -1.037 . . . . 0.0 108.232 178.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.487 ' HB ' ' O ' ' A' ' 14' ' ' HIS . 13.0 t -123.33 -57.5 2.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.666 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.471 ' C ' ' CD1' ' A' ' 54' ' ' ILE . 31.1 mm-40 -135.35 167.36 21.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.393 -0.817 . . . . 0.0 110.092 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -136.77 147.94 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.436 -0.79 . . . . 0.0 109.067 179.359 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.58 HD13 ' CD2' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -142.12 136.08 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.072 -1.017 . . . . 0.0 110.791 -179.21 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.499 ' N ' HD12 ' A' ' 55' ' ' ILE . 90.2 mm-40 -91.91 174.13 7.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.403 -0.811 . . . . 0.0 109.887 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 94' ' ' GLY . . . -97.97 127.45 43.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.95 . . . . 0.0 110.348 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER 172.18 91.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.325 -0.86 . . . . 0.0 110.535 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.6 HD13 ' CE1' ' A' ' 96' ' ' TYR . 0.0 OUTLIER 177.76 -50.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.03 -1.044 . . . . 0.0 110.569 179.605 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.548 ' N ' HG23 ' A' ' 59' ' ' ILE . 15.7 mm -117.97 -93.34 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.788 -1.195 . . . . 0.0 110.33 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.502 ' N ' HG22 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -178.8 -163.34 0.06 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.129 -0.982 . . . . 0.0 111.042 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.52 ' HB3' ' CG1' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -92.51 -72.27 0.6 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.307 -0.871 . . . . 0.0 110.671 -179.353 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 110' ' ' ALA . 3.1 m-20 -41.84 -24.59 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.675 -0.641 . . . . 0.0 111.636 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.527 ' HG2' ' CG2' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -58.47 134.01 56.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.846 -1.159 . . . . 0.0 110.294 -179.51 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.588 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . . . -109.21 138.95 44.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.949 . . . . 0.0 109.285 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.51 ' O ' HD21 ' A' ' 89' ' ' LEU . 2.0 tp -126.25 111.7 14.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -0.991 . . . . 0.0 110.848 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.479 ' O ' HD21 ' A' ' 68' ' ' LEU . 1.1 tpp180 -89.42 123.31 33.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.242 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.521 HD22 ' CA ' ' A' ' 104' ' ' VAL . 13.2 mt -122.57 146.99 46.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.877 . . . . 0.0 111.264 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.506 ' O ' ' CA ' ' A' ' 102' ' ' GLU . 13.5 ttp85 -114.41 165.01 13.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.577 -0.702 . . . . 0.0 109.365 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.516 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -83.59 161.21 21.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.956 -1.09 . . . . 0.0 111.278 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.458 ' HB3' ' O ' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -123.83 -35.91 2.8 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.462 ' HG3' ' CD1' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -125.44 151.25 46.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.511 -0.743 . . . . 0.0 109.463 179.091 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.497 ' N ' ' HB ' ' A' ' 84' ' ' THR . 20.3 tt0 -83.08 95.99 8.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.123 -0.985 . . . . 0.0 109.556 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.77 -27.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.18 -0.95 . . . . 0.0 110.719 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.565 ' CH2' ' OE1' ' A' ' 102' ' ' GLU . 0.8 OUTLIER -74.46 125.8 29.34 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.036 -1.04 . . . . 0.0 110.16 -179.671 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 77' ' ' ARG . 34.9 m-20 -94.73 119.53 33.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 109.536 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 76' ' ' ASP . 5.0 mtm180 -39.6 -55.91 1.77 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.456 -0.778 . . . . 0.0 110.821 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -118.42 -8.1 10.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.1 -1.0 . . . . 0.0 110.396 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.41 -20.52 2.96 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.431 ' O ' ' CG ' ' A' ' 76' ' ' ASP . 4.4 mttp -63.88 -132.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -1.083 . . . . 0.0 109.866 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.537 ' HB3' ' CG1' ' A' ' 29' ' ' VAL . 5.9 mp0 -142.65 120.85 12.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.942 -1.098 . . . . 0.0 110.077 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.456 ' HD3' ' HG2' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -132.51 178.14 7.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.93 . . . . 0.0 110.186 179.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.455 ' HB ' ' HA2' ' A' ' 26' ' ' GLY . 7.7 p -107.86 179.95 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.378 -0.826 . . . . 0.0 110.267 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.497 ' HB ' ' N ' ' A' ' 73' ' ' GLU . 8.8 t -70.24 -15.53 62.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 110.343 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -86.75 8.37 75.89 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.492 ' O ' ' HB1' ' A' ' 70' ' ' ALA . 13.6 tp10 -91.14 162.96 14.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.24 -1.153 . . . . 0.0 109.888 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.484 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 12.5 pt-20 -153.5 156.95 39.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.949 -1.094 . . . . 0.0 110.359 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.577 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -139.51 147.53 41.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.762 179.894 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.535 HD12 ' N ' ' A' ' 90' ' ' VAL . 2.7 tm? -103.41 146.97 27.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -0.852 . . . . 0.0 109.493 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.535 ' N ' HD12 ' A' ' 89' ' ' LEU . 20.5 t -104.47 117.42 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.146 -0.971 . . . . 0.0 110.224 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.44 HG23 HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -123.69 -0.18 8.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.576 -0.702 . . . . 0.0 109.909 179.71 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.52 171.41 15.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.425 -0.797 . . . . 0.0 110.112 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.52 ' CG1' ' HB3' ' A' ' 62' ' ' GLN . 11.1 t -86.43 166.6 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.131 -0.98 . . . . 0.0 110.019 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 57' ' ' ALA . . . 144.02 -28.18 2.0 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.529 ' O ' HG23 ' A' ' 59' ' ' ILE . . . 58.34 14.25 2.8 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.337 -1.096 . . . . 0.0 110.921 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.6 ' CE1' HD13 ' A' ' 59' ' ' ILE . 6.7 t80 179.99 85.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.088 -1.008 . . . . 0.0 110.674 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.543 ' CD2' ' HG2' ' A' ' 38' ' ' GLU . 69.3 mt -129.45 81.63 69.54 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 109.54 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.474 ' O ' HD21 ' A' ' 36' ' ' LEU . 44.3 Cg_endo -71.8 141.48 37.42 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.076 1.566 . . . . 0.0 110.774 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -85.19 -164.85 1.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.41 -0.806 . . . . 0.0 109.941 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.457 HG12 ' HG2' ' A' ' 34' ' ' GLU . 18.7 t -109.47 -62.75 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.215 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.487 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 14.8 m-85 -97.6 -33.06 11.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.278 -0.889 . . . . 0.0 110.189 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.565 ' OE1' ' CH2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -80.95 154.03 27.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 110.243 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -128.79 172.18 11.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.91 . . . . 0.0 110.45 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.521 ' CA ' HD22 ' A' ' 68' ' ' LEU . 7.5 p -93.28 142.69 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.903 . . . . 0.0 110.644 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.34 -19.81 13.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.477 -0.764 . . . . 0.0 109.608 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -174.63 156.24 2.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.497 -0.752 . . . . 0.0 109.944 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.457 ' HA ' HD12 ' A' ' 66' ' ' LEU . 3.3 mp -107.54 146.09 32.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.899 . . . . 0.0 110.356 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.588 ' CG1' ' CB ' ' A' ' 65' ' ' ALA . 8.9 p -134.41 159.52 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.139 -0.976 . . . . 0.0 109.848 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.431 ' N ' HG21 ' A' ' 108' ' ' VAL . 8.2 p-10 -110.36 125.71 53.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.122 -0.986 . . . . 0.0 110.114 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.468 ' HB2' ' HB3' ' A' ' 63' ' ' ASN . . . -43.03 148.01 0.29 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.216 -0.928 . . . . 0.0 110.408 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 111' ' ' VAL . 13.9 p -157.41 44.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.258 -0.901 . . . . 0.0 110.377 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.421 ' O ' ' C ' ' A' ' 113' ' ' LEU . 1.9 tt -121.17 150.73 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.298 -0.876 . . . . 0.0 110.257 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 112' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.21 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 50.31 42.38 25.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.344 -1.092 . . . . 0.0 110.328 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.466 ' O ' ' HB3' ' A' ' 4' ' ' MET . 0.3 OUTLIER -171.92 110.77 0.28 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.177 -0.952 . . . . 0.0 110.194 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.466 ' HB3' ' O ' ' A' ' 3' ' ' HIS . 15.3 ttt 62.32 153.37 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.361 -0.837 . . . . 0.0 110.333 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.462 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 1.8 mt-30 -130.83 176.05 8.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.357 -0.839 . . . . 0.0 109.867 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 8' ' ' LEU . 14.2 t -90.63 143.35 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.22 -0.925 . . . . 0.0 109.471 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.455 ' C ' ' O ' ' A' ' 6' ' ' VAL . 40.7 t -39.4 95.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.436 -0.79 . . . . 0.0 110.102 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 6' ' ' VAL . 0.9 OUTLIER -45.55 165.84 0.16 Allowed Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.451 -0.781 . . . . 0.0 110.167 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.69 -56.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 124.165 1.613 . . . . 0.0 110.648 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.553 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -166.75 26.01 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.084 -1.01 . . . . 0.0 110.588 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 7.2 p -103.58 171.76 7.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.171 -0.956 . . . . 0.0 109.655 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.516 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -141.42 160.4 40.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.858 -1.151 . . . . 0.0 110.689 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.609 ' CD2' ' CD2' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -129.59 155.18 46.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.103 -0.998 . . . . 0.0 109.927 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.613 ' N ' ' CD2' ' A' ' 14' ' ' HIS . 5.2 m170 -92.74 126.51 37.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 110.321 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.609 ' CD2' ' CD2' ' A' ' 13' ' ' LEU . 2.6 mm? -112.19 151.51 29.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.671 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.588 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 9.0 ttmt -119.58 117.0 27.2 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.953 -1.092 . . . . 0.0 109.362 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 33' ' ' ASP . . . -77.93 120.33 22.64 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.271 -0.893 . . . . 0.0 110.335 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.441 ' O ' HD23 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -99.29 101.76 13.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.629 -0.669 . . . . 0.0 109.731 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.462 HD12 ' N ' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -159.04 141.04 13.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.327 -0.858 . . . . 0.0 110.04 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.462 ' N ' HD12 ' A' ' 19' ' ' LEU . 4.1 m-20 -90.07 103.6 16.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.856 . . . . 0.0 110.258 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.491 ' CB ' HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -128.96 104.48 7.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.393 -0.817 . . . . 0.0 110.042 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -122.92 116.42 23.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.269 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -86.63 177.28 7.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -0.882 . . . . 0.0 110.345 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.5 tttp -79.96 -2.35 43.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.145 -0.972 . . . . 0.0 110.149 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -62.75 -30.54 71.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.195 -0.941 . . . . 0.0 110.188 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 27' ' ' ASP . . . 145.01 -30.09 1.8 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 26' ' ' GLY . 0.2 OUTLIER 170.91 141.84 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.297 -1.119 . . . . 0.0 109.939 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.464 ' HA ' ' HE2' ' A' ' 28' ' ' LYS . 1.0 OUTLIER -137.9 -99.73 0.19 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.098 -1.001 . . . . 0.0 110.427 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.491 HG23 ' CB ' ' A' ' 21' ' ' PHE . 1.5 m -112.08 137.41 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.035 -1.041 . . . . 0.0 109.752 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 30' ' ' VAL . 29.6 m -137.37 80.88 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.9 . . . . 0.0 110.026 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.91 68.62 0.64 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.891 . . . . 0.0 110.18 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.14 29.54 0.04 OUTLIER Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.362 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' A' ' 16' ' ' LYS . 38.1 m-20 -83.99 146.72 27.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.789 -1.418 . . . . 0.0 109.473 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 4.8 tt0 -144.22 147.34 33.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.099 -1.001 . . . . 0.0 111.056 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.596 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 11.5 p90 -156.7 164.41 38.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.465 -0.772 . . . . 0.0 110.188 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.567 HD23 ' CD2' ' A' ' 14' ' ' HIS . 0.2 OUTLIER -96.74 149.46 21.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.244 -0.91 . . . . 0.0 110.394 -179.796 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.534 ' CE1' ' HA ' ' A' ' 40' ' ' PRO . 2.9 t80 -131.55 110.74 11.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.233 -0.917 . . . . 0.0 110.502 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.496 ' HA ' ' CB ' ' A' ' 12' ' ' ALA . 2.3 tm-20 -85.75 125.12 32.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.652 -0.655 . . . . 0.0 110.001 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.583 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 74.63 44.85 24.81 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 55.9 Cg_endo -77.88 32.96 0.44 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.494 1.26 . . . . 0.0 111.222 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 5' ' ' GLN . . . -54.39 -59.53 9.95 Favored Glycine 0 N--CA 1.487 2.096 0 O-C-N 120.53 -1.356 . . . . 0.0 109.976 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 75.5 p -78.87 12.35 2.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -1.174 . . . . 0.0 111.501 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.576 ' CE2' ' HG ' ' A' ' 15' ' ' LEU . 3.2 t80 -72.99 130.6 40.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.851 -1.156 . . . . 0.0 110.078 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.449 HG22 ' HD2' ' A' ' 45' ' ' PRO . 1.9 mt -118.66 143.11 32.81 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.982 . . . . 0.0 109.798 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.449 ' HD2' HG22 ' A' ' 44' ' ' ILE . 46.0 Cg_endo -72.58 107.17 2.24 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.971 1.511 . . . . 0.0 110.458 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 49' ' ' VAL . 1.2 mtt-85 -114.91 148.73 38.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.306 -0.871 . . . . 0.0 110.229 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 46' ' ' ARG . 0.3 OUTLIER -40.44 -45.95 2.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.353 -0.842 . . . . 0.0 110.847 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.466 ' O ' HG11 ' A' ' 49' ' ' VAL . 3.0 mt-10 -42.53 -39.06 2.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.407 -0.808 . . . . 0.0 110.875 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.513 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 1.6 m -145.96 174.09 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.15 -0.969 . . . . 0.0 110.549 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 49' ' ' VAL . 1.6 mm-40 -139.39 139.61 37.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.255 -0.903 . . . . 0.0 110.395 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.445 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . 5.0 m -55.23 130.98 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.147 -0.971 . . . . 0.0 110.223 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.588 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 3.7 t -104.12 -58.7 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.312 -0.867 . . . . 0.0 110.351 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.489 ' C ' ' CD1' ' A' ' 54' ' ' ILE . 3.7 mt-10 -143.36 171.06 14.64 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.097 -1.002 . . . . 0.0 110.4 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.489 ' CD1' ' C ' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -132.23 135.96 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.781 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -129.91 143.86 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.913 -1.117 . . . . 0.0 111.694 -178.588 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.435 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 93.1 mm-40 -91.84 158.78 16.13 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.644 -0.66 . . . . 0.0 109.383 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 10' ' ' ASN . . . -102.35 132.85 48.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.175 -0.953 . . . . 0.0 110.193 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 3.7 t 178.5 55.02 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.132 -0.98 . . . . 0.0 111.584 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.554 ' CG2' ' N ' ' A' ' 60' ' ' ILE . 0.2 OUTLIER -157.42 -51.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.462 -1.398 . . . . 0.0 111.599 179.341 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.554 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 13.9 mm -70.05 157.42 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.616 -1.302 . . . . 0.0 110.644 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.43 179.58 5.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.35 -0.844 . . . . 0.0 110.004 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.566 ' HA ' ' CG1' ' A' ' 93' ' ' VAL . 4.4 mt-30 -83.42 -27.07 29.81 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.151 -0.968 . . . . 0.0 110.714 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.544 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 3.1 m120 -94.4 -34.94 12.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.129 -0.982 . . . . 0.0 110.526 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.429 ' NE2' ' O ' ' A' ' 108' ' ' VAL . 40.6 tp60 -58.69 129.3 41.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.115 -0.991 . . . . 0.0 111.146 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.554 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . . . -108.3 143.5 37.09 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.55 ' O ' HD11 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -126.72 120.47 29.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.081 -1.012 . . . . 0.0 110.578 -179.194 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -89.69 141.87 28.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.489 -0.757 . . . . 0.0 109.462 179.591 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -125.41 125.74 43.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.15 -0.969 . . . . 0.0 111.081 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -105.41 159.31 16.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.461 -0.774 . . . . 0.0 109.615 179.433 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 86' ' ' GLU . . . -69.3 151.33 46.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.212 -0.93 . . . . 0.0 110.878 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -116.01 -30.16 6.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.434 -0.791 . . . . 0.0 109.589 179.322 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.456 ' C ' ' CD ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -149.43 130.21 14.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.304 -0.873 . . . . 0.0 109.802 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.44 ' N ' ' HD3' ' A' ' 72' ' ' LYS . 0.3 OUTLIER -56.57 90.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.176 -0.953 . . . . 0.0 109.903 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 72' ' ' LYS . 37.5 t -176.0 -29.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.384 -0.822 . . . . 0.0 110.442 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.577 ' CE3' ' HG2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -73.89 120.88 20.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.147 -0.971 . . . . 0.0 110.005 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.423 ' OD2' ' O ' ' A' ' 79' ' ' GLY . 3.5 m-20 -80.02 113.85 18.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.354 -0.841 . . . . 0.0 110.051 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.468 ' HB2' ' OE2' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -55.65 -54.7 40.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 110.355 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.68 -13.94 12.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.363 -0.836 . . . . 0.0 110.411 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.423 ' O ' ' OD2' ' A' ' 76' ' ' ASP . . . 143.42 -22.03 2.22 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.8 mmtt -85.77 157.51 20.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.524 -0.986 . . . . 0.0 109.741 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.478 ' HA ' ' OE1' ' A' ' 81' ' ' GLU . 37.8 mm-40 -69.37 126.5 29.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 110.161 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.451 ' HD2' ' OE1' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -122.2 175.23 6.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.493 -0.754 . . . . 0.0 110.702 -179.541 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' A' ' 84' ' ' THR . 4.8 p -119.35 171.8 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.417 -0.802 . . . . 0.0 110.423 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.486 ' N ' ' CG2' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -54.78 -170.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.105 -0.997 . . . . 0.0 108.789 178.746 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 86' ' ' GLU . . . 70.77 -55.88 0.98 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.611 ' HG3' ' N ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -44.76 156.37 0.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.171 -1.193 . . . . 0.0 109.11 179.335 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.611 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 12.9 pt-20 -155.61 145.06 21.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.656 -1.278 . . . . 0.0 111.148 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -112.3 160.39 17.71 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.55 HD11 ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -115.33 127.72 55.61 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.966 -1.084 . . . . 0.0 111.221 -178.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.538 ' N ' HD12 ' A' ' 89' ' ' LEU . 25.0 t -92.64 108.3 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.394 -0.816 . . . . 0.0 109.705 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.0 m -128.19 46.12 2.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.967 . . . . 0.0 110.829 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.453 ' CG2' ' ND2' ' A' ' 10' ' ' ASN . 53.2 m -107.8 131.3 54.61 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.15 -0.969 . . . . 0.0 110.149 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.566 ' CG1' ' HA ' ' A' ' 62' ' ' GLN . 27.5 m -66.9 150.29 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.253 -0.904 . . . . 0.0 110.477 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.469 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 41.08 82.03 0.02 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.536 ' HA ' ' CB ' ' A' ' 57' ' ' ALA . . . -159.63 147.08 16.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -1.151 . . . . 0.0 110.207 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.567 ' CG ' ' O ' ' A' ' 96' ' ' TYR . 14.9 t80 -133.49 59.27 1.74 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.379 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.55 99.91 52.51 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 120.911 -1.118 . . . . 0.0 109.783 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.512 ' O ' ' CB ' ' A' ' 99' ' ' ALA . 47.3 Cg_endo -77.56 18.08 0.87 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 124.111 1.585 . . . . 0.0 111.854 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' A' ' 98' ' ' PRO . . . 70.1 -178.59 0.22 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.81 -1.181 . . . . 0.0 110.426 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.525 HG21 ' CD2' ' A' ' 36' ' ' LEU . 2.6 t -102.57 -61.72 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 109.793 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.53 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 22.0 m-85 -107.73 47.92 0.87 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.27 -0.894 . . . . 0.0 109.925 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.577 ' HG2' ' CE3' ' A' ' 75' ' ' TRP . 17.8 mt-10 -138.85 158.67 43.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.904 -1.122 . . . . 0.0 111.611 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -132.49 167.53 19.81 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.606 -0.684 . . . . 0.0 109.395 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 67' ' ' ARG . 3.8 m -90.75 146.89 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.937 -1.102 . . . . 0.0 110.263 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.551 ' O ' ' CB ' ' A' ' 106' ' ' ASP . 0.8 OUTLIER -102.28 -11.24 18.86 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.405 -0.809 . . . . 0.0 109.351 179.315 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 0.5 OUTLIER 162.46 127.71 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.61 -0.682 . . . . 0.0 110.098 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.1 mp -76.45 121.86 23.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 109.598 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.554 ' CG1' ' CB ' ' A' ' 65' ' ' ALA . 9.1 p -111.31 153.98 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.094 -1.004 . . . . 0.0 110.467 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.421 ' N ' HG23 ' A' ' 108' ' ' VAL . 1.5 t0 -110.91 120.17 41.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -0.874 . . . . 0.0 109.821 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . -50.16 -82.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.007 -1.058 . . . . 0.0 110.216 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.6 p -162.72 135.33 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.379 -0.826 . . . . 0.0 110.019 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.428 ' O ' ' C ' ' A' ' 113' ' ' LEU . 3.8 mt -130.44 -140.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.216 -0.928 . . . . 0.0 109.712 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.449 HD13 ' O ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.004 -1.06 . . . . 0.0 110.303 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.519 ' O ' ' CD2' ' A' ' 3' ' ' HIS . 0.3 OUTLIER -77.68 -41.0 39.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.283 -1.128 . . . . 0.0 110.116 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.519 ' CD2' ' O ' ' A' ' 2' ' ' SER . 1.6 m170 -151.5 164.59 36.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.203 -0.936 . . . . 0.0 109.999 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.511 ' HG3' ' CD1' ' A' ' 44' ' ' ILE . 0.5 OUTLIER 57.22 111.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.261 -0.9 . . . . 0.0 110.187 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 2.4 mt-30 -95.33 146.44 24.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.251 -0.906 . . . . 0.0 110.188 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.0 t -77.26 155.89 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.932 . . . . 0.0 110.37 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 74.9 t -45.21 106.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.321 -0.862 . . . . 0.0 110.217 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.408 HD11 ' CA ' ' A' ' 41' ' ' GLY . 3.5 mp -49.83 164.72 0.34 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.7 -57.13 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.992 1.522 . . . . 0.0 110.498 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -163.41 31.11 0.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -0.904 . . . . 0.0 110.011 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.481 HG21 ' HA ' ' A' ' 56' ' ' GLN . 55.2 p -112.62 171.82 7.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.316 -0.865 . . . . 0.0 110.37 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -137.74 165.96 25.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.177 -0.952 . . . . 0.0 110.029 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.547 ' CD1' HD21 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -133.95 155.63 49.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.149 -0.969 . . . . 0.0 111.032 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.477 ' C ' HD21 ' A' ' 15' ' ' LEU . 52.8 m80 -99.06 132.74 44.14 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.288 -0.883 . . . . 0.0 110.474 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.608 ' CD1' ' CZ2' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -137.06 156.76 48.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.997 -1.064 . . . . 0.0 109.984 178.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 3.4 mtpt -107.94 123.56 48.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.358 -0.839 . . . . 0.0 110.742 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.53 ' CB ' ' HB2' ' A' ' 33' ' ' ASP . . . -82.1 119.68 24.33 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.314 -0.866 . . . . 0.0 110.157 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.53 HD12 ' CB ' ' A' ' 31' ' ' ALA . 2.8 mm? -101.06 101.18 11.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.581 -0.699 . . . . 0.0 109.865 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.443 HD23 ' OE2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -160.99 147.15 14.74 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.102 -0.999 . . . . 0.0 110.502 -179.679 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.423 ' N ' HD12 ' A' ' 19' ' ' LEU . 5.9 t70 -88.75 113.26 24.12 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.504 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -130.6 142.89 50.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.081 -1.012 . . . . 0.0 111.733 -178.27 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -102.16 123.69 46.45 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.442 -0.786 . . . . 0.0 109.548 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -89.33 164.36 14.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.077 -1.014 . . . . 0.0 110.669 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -32.57 59.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.384 -0.822 . . . . 0.0 110.065 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -65.77 -27.85 68.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 110.215 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.85 26.41 5.02 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' A' ' 28' ' ' LYS . 0.4 OUTLIER -103.27 -43.04 5.55 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.204 -1.174 . . . . 0.0 110.126 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 27' ' ' ASP . 37.5 tttt 58.08 133.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.635 -0.666 . . . . 0.0 110.888 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.504 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -95.35 147.4 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.223 -0.923 . . . . 0.0 109.027 179.207 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 30' ' ' VAL . 16.7 m -130.99 85.61 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.961 -1.087 . . . . 0.0 110.98 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.53 ' CB ' HD12 ' A' ' 18' ' ' LEU . . . 42.16 68.76 0.43 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.409 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.88 23.51 0.09 OUTLIER Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.445 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.53 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 10.5 m-20 -85.72 154.22 21.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.818 -1.401 . . . . 0.0 109.734 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 78.7 tt0 -155.93 138.71 15.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 110.312 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.608 ' CZ2' ' CD1' ' A' ' 15' ' ' LEU . 3.8 p90 -157.77 177.14 11.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.164 -0.96 . . . . 0.0 110.523 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 99' ' ' ALA . 39.7 tp -90.43 165.56 13.76 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.433 -0.792 . . . . 0.0 110.824 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -135.73 110.84 8.91 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.58 -0.7 . . . . 0.0 109.467 179.554 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.499 ' CG ' HD22 ' A' ' 97' ' ' LEU . 13.3 tm-20 -86.22 131.31 34.26 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.193 -0.942 . . . . 0.0 110.441 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.597 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 54.98 45.99 79.15 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.617 ' O ' ' N ' ' A' ' 42' ' ' THR . 39.5 Cg_endo -67.03 -60.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.918 1.483 . . . . 0.0 110.338 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 5' ' ' GLN . . . 37.83 -86.81 0.01 OUTLIER Glycine 0 N--CA 1.497 2.72 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.617 ' N ' ' O ' ' A' ' 40' ' ' PRO . 1.2 p -54.4 -7.65 0.17 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.337 -1.096 . . . . 0.0 112.008 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.455 ' CE1' HD13 ' A' ' 15' ' ' LEU . 6.6 t80 -67.37 130.09 41.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.61 -1.307 . . . . 0.0 110.096 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.511 ' CD1' ' HG3' ' A' ' 4' ' ' MET . 34.1 mt -119.56 147.78 44.4 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.51 -0.744 . . . . 0.0 109.639 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.474 ' HD2' HG21 ' A' ' 44' ' ' ILE . 40.4 Cg_endo -68.48 87.62 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.841 1.442 . . . . 0.0 110.462 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 49' ' ' VAL . 18.3 mmt85 -95.91 157.73 15.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.402 -0.811 . . . . 0.0 110.112 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -53.66 -19.84 4.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.177 -0.952 . . . . 0.0 110.107 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.489 ' C ' ' CG1' ' A' ' 49' ' ' VAL . 1.8 tp10 -62.65 -36.51 83.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.283 -0.885 . . . . 0.0 109.752 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.489 ' CG1' ' C ' ' A' ' 48' ' ' GLU . 0.9 OUTLIER -150.05 173.92 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.393 -0.817 . . . . 0.0 109.521 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.45 ' O ' HG21 ' A' ' 52' ' ' VAL . 6.3 mt-10 -130.88 125.59 33.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.043 -1.036 . . . . 0.0 110.507 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 p -54.21 124.84 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.098 -1.001 . . . . 0.0 109.139 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.513 ' CG1' ' HG2' ' A' ' 53' ' ' GLU . 47.1 t -104.37 -61.79 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.106 -0.996 . . . . 0.0 111.1 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.513 ' HG2' ' CG1' ' A' ' 52' ' ' VAL . 4.5 mm-40 -134.84 174.09 10.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.071 -1.018 . . . . 0.0 110.612 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.488 HD13 ' HB2' ' A' ' 13' ' ' LEU . 1.1 mm -135.24 131.76 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.469 ' O ' ' HB ' ' A' ' 11' ' ' THR . 0.3 OUTLIER -121.13 137.31 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.106 -0.996 . . . . 0.0 111.269 -178.583 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.481 ' HA ' HG21 ' A' ' 11' ' ' THR . 6.8 mp0 -95.37 169.24 10.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.505 -0.747 . . . . 0.0 110.543 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 94' ' ' GLY . . . -96.85 118.99 34.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.821 . . . . 0.0 110.282 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.542 ' N ' ' HB1' ' A' ' 95' ' ' ALA . 8.1 t -176.91 78.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.053 -1.03 . . . . 0.0 110.726 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.577 ' CG2' ' N ' ' A' ' 60' ' ' ILE . 0.1 OUTLIER -179.12 -59.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.944 -1.098 . . . . 0.0 111.104 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.577 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 1.7 mt -92.75 -139.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 120.295 -1.503 . . . . 0.0 109.695 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.7 mtt85 -155.53 -162.02 1.26 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.077 -1.014 . . . . 0.0 110.092 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.557 ' HB3' ' CG1' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -83.06 -72.28 0.46 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.944 . . . . 0.0 111.109 -179.171 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.552 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 9.6 p30 -45.41 -41.1 8.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -0.918 . . . . 0.0 111.304 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.85 136.87 51.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.877 -1.139 . . . . 0.0 111.14 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.479 ' C ' ' CD2' ' A' ' 66' ' ' LEU . . . -121.96 142.65 50.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.515 -0.741 . . . . 0.0 109.296 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.479 ' CD2' ' C ' ' A' ' 65' ' ' ALA . 4.4 mm? -125.85 112.8 16.43 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.962 -1.086 . . . . 0.0 110.668 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.487 ' O ' ' HG3' ' A' ' 67' ' ' ARG . 3.5 ptp180 -90.91 126.98 36.21 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.031 -1.043 . . . . 0.0 110.362 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.539 ' CD2' ' HA ' ' A' ' 104' ' ' VAL . 17.2 mt -123.02 137.82 54.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.363 -0.836 . . . . 0.0 110.678 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -98.79 154.09 18.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.313 -0.867 . . . . 0.0 109.953 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.573 ' HA ' ' CZ3' ' A' ' 75' ' ' TRP . . . -67.92 140.35 56.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.378 -0.826 . . . . 0.0 111.6 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 101' ' ' PHE . 15.1 tpp85 -104.38 -38.46 6.82 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 101' ' ' PHE . 2.0 mmtt -113.81 155.96 24.75 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.453 ' OE2' ' OD1' ' A' ' 27' ' ' ASP . 12.5 pt-20 -86.82 27.76 0.96 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.988 -1.07 . . . . 0.0 110.275 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.6 -20.97 4.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.211 -0.93 . . . . 0.0 110.689 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.58 ' HB2' ' CD2' ' A' ' 101' ' ' PHE . 13.7 t90 -73.99 107.27 6.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.155 -0.965 . . . . 0.0 110.426 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 82' ' ' ARG . 8.3 m-20 -112.75 122.96 49.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.353 -0.842 . . . . 0.0 110.157 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.5 ' NH2' ' OD2' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -88.01 -20.41 25.85 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.265 -0.897 . . . . 0.0 110.256 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.5 ' OD2' ' NH2' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -96.16 6.98 47.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.208 -0.933 . . . . 0.0 110.032 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.07 9.33 86.83 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.449 ' O ' ' HB3' ' A' ' 76' ' ' ASP . 2.0 mmmt -117.88 135.61 53.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -1.189 . . . . 0.0 110.406 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.75 125.77 7.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -0.865 . . . . 0.0 110.159 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.504 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 1.5 mtt-85 -137.36 142.88 41.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.89 . . . . 0.0 110.115 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.4 p -78.62 170.72 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.912 . . . . 0.0 110.215 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.469 ' CG2' ' O ' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -55.44 -17.51 5.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.513 -0.742 . . . . 0.0 110.384 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.74 -12.2 78.1 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.473 ' OE2' ' CZ3' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -67.3 170.97 6.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.969 -1.312 . . . . 0.0 109.848 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -159.59 145.61 16.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.15 -0.969 . . . . 0.0 110.277 179.66 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.58 ' CZ2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -132.08 133.69 44.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.22 -0.925 . . . . 0.0 110.016 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.566 ' CD2' ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -107.06 138.72 42.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 110.018 179.737 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.58 HG22 ' CZ2' ' A' ' 88' ' ' TRP . 63.5 t -93.91 101.35 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.343 -0.848 . . . . 0.0 110.137 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.516 ' HB ' ' CD1' ' A' ' 89' ' ' LEU . 1.5 t -119.64 0.2 10.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.596 -0.69 . . . . 0.0 109.717 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 93' ' ' VAL . 98.9 m -88.06 114.44 24.68 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.429 -0.794 . . . . 0.0 110.259 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.557 ' CG1' ' HB3' ' A' ' 62' ' ' GLN . 16.6 m -41.31 124.7 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.453 -0.78 . . . . 0.0 109.753 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' A' ' 96' ' ' TYR . . . -174.93 34.78 0.1 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.542 ' HB1' ' N ' ' A' ' 58' ' ' THR . . . 45.58 -80.83 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.758 -0.848 . . . . 0.0 111.627 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.599 ' N ' ' O ' ' A' ' 94' ' ' GLY . 3.8 t80 -125.12 159.76 30.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.625 -1.297 . . . . 0.0 110.06 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.499 HD22 ' CG ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -173.28 69.07 0.36 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.131 -0.98 . . . . 0.0 110.555 -179.441 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.465 ' HG2' HG13 ' A' ' 55' ' ' ILE . 45.1 Cg_endo -74.89 145.27 31.68 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.839 1.441 . . . . 0.0 109.938 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.52 ' HB1' ' CG ' ' A' ' 102' ' ' GLU . . . -104.95 -141.67 0.37 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.038 -1.039 . . . . 0.0 111.15 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.508 ' CG2' ' HA ' ' A' ' 35' ' ' TRP . 0.9 OUTLIER -121.29 -58.42 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.136 -0.978 . . . . 0.0 111.819 -178.826 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.58 ' CD2' ' HB2' ' A' ' 75' ' ' TRP . 9.7 m-30 -111.35 55.6 0.66 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.161 -1.587 . . . . 0.0 111.492 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.52 ' CG ' ' HB1' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -141.2 143.83 34.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.592 -1.317 . . . . 0.0 110.815 179.218 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.407 ' O ' ' CD1' ' A' ' 105' ' ' LEU . 12.5 tp10 -118.56 128.31 54.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.586 -0.696 . . . . 0.0 110.171 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.539 ' HA ' ' CD2' ' A' ' 68' ' ' LEU . 4.9 p -65.28 148.53 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.389 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 1.6 mp -105.19 -45.56 4.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.354 -0.841 . . . . 0.0 109.944 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.11 133.14 2.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.878 . . . . 0.0 109.963 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.558 ' CD2' ' C ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -76.06 142.65 41.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.939 . . . . 0.0 111.119 -179.499 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.473 ' CG1' ' CB ' ' A' ' 65' ' ' ALA . 3.4 p -128.03 149.88 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.993 -1.067 . . . . 0.0 109.709 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.2 119.58 39.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.058 -1.026 . . . . 0.0 110.544 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . -81.82 -173.59 4.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.028 -1.045 . . . . 0.0 109.862 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 86.8 t -74.78 -89.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.169 -0.957 . . . . 0.0 110.439 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.473 HG13 ' N ' ' A' ' 113' ' ' LEU . 3.0 pt -119.86 -24.81 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.083 -1.011 . . . . 0.0 110.039 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.473 ' N ' HG13 ' A' ' 112' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.142 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.561 ' O ' ' CD2' ' A' ' 3' ' ' HIS . 79.8 p -63.27 -49.24 74.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -1.112 . . . . 0.0 110.086 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.561 ' CD2' ' O ' ' A' ' 2' ' ' SER . 1.5 m-70 174.49 -33.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.168 -0.958 . . . . 0.0 110.41 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.457 ' HA ' HD11 ' A' ' 44' ' ' ILE . 1.5 mtt -98.31 137.63 36.75 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.179 -0.951 . . . . 0.0 110.462 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.513 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -97.4 -173.94 2.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.311 -0.868 . . . . 0.0 110.071 179.714 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 8' ' ' LEU . 3.5 t -123.29 160.09 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.243 -0.91 . . . . 0.0 109.954 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.471 ' O ' ' O ' ' A' ' 8' ' ' LEU . 10.6 t -57.06 81.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.374 -0.828 . . . . 0.0 110.837 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.621 ' CD1' ' N ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -45.62 171.38 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.43 -0.794 . . . . 0.0 110.113 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.502 ' HD2' ' HB2' ' A' ' 8' ' ' LEU . 51.3 Cg_endo -75.44 -99.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.524 1.276 . . . . 0.0 111.955 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.539 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 0.8 OUTLIER -112.38 83.94 1.89 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.761 -1.212 . . . . 0.0 110.934 -178.711 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.531 ' CG2' ' C ' ' A' ' 10' ' ' ASN . 1.7 p -156.16 169.6 24.13 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.204 -0.935 . . . . 0.0 110.17 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.497 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -145.9 167.37 23.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 108.883 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.572 HD21 ' CD2' ' A' ' 43' ' ' TYR . 0.2 OUTLIER -134.55 153.75 51.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.826 -1.171 . . . . 0.0 111.137 179.859 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.643 ' CD2' ' CD1' ' A' ' 36' ' ' LEU . 14.3 m-70 -98.5 135.63 39.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -0.858 . . . . 0.0 109.261 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.689 ' CD1' ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -139.11 165.53 26.91 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.128 -0.983 . . . . 0.0 110.172 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 1.6 tttt -114.51 120.91 41.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 111.108 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.527 ' CB ' ' HB2' ' A' ' 33' ' ' ASP . . . -81.56 112.53 18.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.416 -0.802 . . . . 0.0 109.696 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.462 ' O ' HD22 ' A' ' 19' ' ' LEU . 0.7 OUTLIER -100.47 101.6 12.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.395 -0.816 . . . . 0.0 110.124 -179.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.481 HD11 ' N ' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -162.27 139.18 8.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 110.208 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.481 ' N ' HD11 ' A' ' 19' ' ' LEU . 33.9 p-10 -78.83 101.53 7.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.687 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.535 ' CB ' HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -121.62 104.91 9.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.27 -0.894 . . . . 0.0 110.53 -179.46 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 2.3 pt-20 -119.79 115.89 24.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.401 -0.812 . . . . 0.0 109.819 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.75 175.17 6.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.176 -0.952 . . . . 0.0 110.44 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -65.24 -13.44 58.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.426 -0.796 . . . . 0.0 110.176 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.4 -25.87 68.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 110.057 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.78 -66.44 0.48 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -148.13 134.22 19.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.304 -1.115 . . . . 0.0 110.168 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.3 tptt -125.15 -90.47 0.55 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.126 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.535 HG21 ' CB ' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -106.63 143.32 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.681 -1.262 . . . . 0.0 109.416 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.409 ' O ' ' C ' ' A' ' 31' ' ' ALA . 29.1 m -138.59 88.58 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.024 -1.047 . . . . 0.0 110.676 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.438 ' CB ' ' CD1' ' A' ' 18' ' ' LEU . . . 41.55 65.32 0.86 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.372 -0.83 . . . . 0.0 110.55 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -175.17 26.02 0.07 OUTLIER Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.501 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.527 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 10.0 m-20 -86.7 154.53 20.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.893 -1.357 . . . . 0.0 109.833 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 3.8 tt0 -153.59 131.27 11.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.251 -0.906 . . . . 0.0 110.176 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.631 ' CD2' ' CD2' ' A' ' 15' ' ' LEU . 6.8 p90 -151.94 165.17 35.43 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.062 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.643 ' CD1' ' CD2' ' A' ' 14' ' ' HIS . 51.6 tp -91.44 161.86 14.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -0.834 . . . . 0.0 110.173 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.601 ' CE2' ' HB2' ' A' ' 43' ' ' TYR . 0.9 OUTLIER -136.78 111.99 9.09 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.366 -0.834 . . . . 0.0 109.89 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.445 ' HG3' HD23 ' A' ' 97' ' ' LEU . 2.4 tm-20 -84.31 140.68 31.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.683 -0.635 . . . . 0.0 109.803 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.609 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 59.05 40.77 95.97 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 49.2 Cg_endo -75.2 -51.14 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.375 1.197 . . . . 0.0 109.535 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.535 ' CA ' HD11 ' A' ' 8' ' ' LEU . . . 41.63 -94.08 0.01 OUTLIER Glycine 0 N--CA 1.486 1.967 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 40' ' ' PRO . 1.8 t -78.23 19.9 0.42 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.425 -1.044 . . . . 0.0 112.05 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.601 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 1.6 t80 -67.61 111.05 3.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.675 -1.266 . . . . 0.0 109.006 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.475 HG22 HD13 ' A' ' 44' ' ' ILE . 51.1 mm -90.11 142.14 28.42 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.295 -0.878 . . . . 0.0 110.609 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.495 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 48.3 Cg_endo -74.74 106.5 2.27 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.184 1.623 . . . . 0.0 110.467 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.428 ' O ' ' N ' ' A' ' 48' ' ' GLU . 0.7 OUTLIER -84.95 147.85 26.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 109.789 179.699 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -43.71 -25.82 0.2 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.163 -0.96 . . . . 0.0 109.933 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -62.15 -46.45 88.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -0.863 . . . . 0.0 110.51 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -124.03 173.17 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.183 -0.948 . . . . 0.0 110.418 -179.656 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.464 ' O ' HG21 ' A' ' 52' ' ' VAL . 3.0 mm-40 -135.1 137.12 42.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 110.22 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.495 ' CG2' ' HB3' ' A' ' 45' ' ' PRO . 12.2 t -56.98 138.79 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 109.234 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 16' ' ' LYS . 39.4 t -121.86 -51.27 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.031 -1.043 . . . . 0.0 110.799 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.501 ' HG3' ' HB2' ' A' ' 14' ' ' HIS . 0.7 OUTLIER -145.6 166.89 24.45 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.977 -1.077 . . . . 0.0 110.147 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.468 HD12 ' O ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -134.29 131.24 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.335 -0.853 . . . . 0.0 109.245 179.185 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 12' ' ' ALA . 8.0 tt -117.03 145.93 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.061 -1.024 . . . . 0.0 111.44 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.431 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 14.4 mp0 -105.79 -179.51 3.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.618 -0.676 . . . . 0.0 109.837 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.572 ' CA ' ' HA ' ' A' ' 95' ' ' ALA . . . -97.16 136.06 38.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.159 -0.963 . . . . 0.0 111.17 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 4.7 t 176.23 57.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.443 -0.786 . . . . 0.0 111.134 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.597 HG21 ' CG ' ' A' ' 96' ' ' TYR . 0.5 OUTLIER -173.77 -48.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.507 -1.371 . . . . 0.0 112.33 179.389 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.558 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 70.7 mt -75.69 172.63 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.577 -1.327 . . . . 0.0 110.333 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.498 ' N ' HG22 ' A' ' 60' ' ' ILE . 29.7 mtt-85 -117.81 -174.31 2.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.035 -1.04 . . . . 0.0 110.256 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.541 ' HB2' ' CG1' ' A' ' 93' ' ' VAL . 5.6 tt0 -79.16 -30.22 43.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.17 -0.956 . . . . 0.0 110.96 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 7.2 p30 -105.94 -21.87 13.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.009 -1.057 . . . . 0.0 110.625 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 109' ' ' ASP . 5.5 tp-100 -58.39 135.0 57.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.873 -1.142 . . . . 0.0 110.699 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.573 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . . . -112.96 135.47 53.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.487 -0.758 . . . . 0.0 109.324 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.468 HD21 HG12 ' A' ' 60' ' ' ILE . 1.3 mp -124.82 117.23 23.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.192 -0.942 . . . . 0.0 111.173 -179.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.482 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 1.7 ttp180 -96.34 126.13 41.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 108.965 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.581 ' CD2' ' CG1' ' A' ' 104' ' ' VAL . 17.8 mt -118.89 133.18 56.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.01 -1.056 . . . . 0.0 110.582 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 5.4 ttt85 -114.85 150.63 35.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -0.847 . . . . 0.0 110.13 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.544 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . . . -70.32 123.45 21.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.83 . . . . 0.0 110.752 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -81.8 -38.67 25.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.947 . . . . 0.0 108.931 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.636 ' CG ' ' CD2' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -136.35 143.25 43.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.535 -0.728 . . . . 0.0 109.239 179.099 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 74' ' ' CYS . 0.0 OUTLIER -55.46 -161.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.983 . . . . 0.0 110.58 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 7.3 m 78.88 -40.97 0.27 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.587 -0.696 . . . . 0.0 110.54 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.585 ' CD1' ' HB2' ' A' ' 35' ' ' TRP . 20.6 t90 -73.38 104.36 4.36 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.769 -1.207 . . . . 0.0 110.099 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.412 ' OD1' ' HA ' ' A' ' 81' ' ' GLU . 65.1 m-20 -84.1 113.72 21.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.853 . . . . 0.0 110.136 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.453 ' HB2' ' CZ2' ' A' ' 75' ' ' TRP . 21.8 tpt180 -87.45 -8.55 56.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.316 -0.865 . . . . 0.0 110.489 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.02 3.04 9.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 110.199 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.69 -2.9 64.98 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.85 144.27 48.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -1.114 . . . . 0.0 110.047 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.475 ' HB2' ' CG1' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -46.16 110.67 0.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -0.929 . . . . 0.0 110.408 -179.762 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.35 179.44 3.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.212 -0.93 . . . . 0.0 109.947 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' A' ' 86' ' ' GLU . 12.5 p -116.85 172.87 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.995 -1.066 . . . . 0.0 110.503 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.499 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 7.5 t -57.55 -16.35 9.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.303 -0.873 . . . . 0.0 109.96 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.38 -14.25 74.34 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 83' ' ' VAL . 5.1 tp10 -75.63 147.75 39.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.406 -1.055 . . . . 0.0 109.67 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 68' ' ' LEU . 4.8 tt0 -157.38 162.44 39.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.212 -0.93 . . . . 0.0 109.981 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.567 ' CZ2' ' HB ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -153.34 142.04 20.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.17 -0.956 . . . . 0.0 110.232 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.52 HD21 ' N ' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -100.25 119.42 38.35 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.497 -0.752 . . . . 0.0 109.98 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.567 ' HB ' ' CZ2' ' A' ' 88' ' ' TRP . 5.3 p -97.99 150.72 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 110.749 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.1 t -148.98 51.06 0.97 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.453 -0.779 . . . . 0.0 109.903 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.46 HG23 ' OD1' ' A' ' 10' ' ' ASN . 9.2 m -82.95 139.82 33.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -0.917 . . . . 0.0 110.459 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.541 ' CG1' ' HB2' ' A' ' 62' ' ' GLN . 8.1 t -75.4 128.75 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.168 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 60' ' ' ILE . . . 48.69 84.32 0.02 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.572 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . . . -177.61 151.46 0.74 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.111 -1.229 . . . . 0.0 110.953 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.597 ' CG ' HG21 ' A' ' 59' ' ' ILE . 1.2 t80 -116.88 112.57 21.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.021 -1.049 . . . . 0.0 110.419 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.452 ' HG ' ' CD2' ' A' ' 36' ' ' LEU . 1.0 OUTLIER -124.94 76.71 66.62 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.183 -0.948 . . . . 0.0 110.249 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.427 ' HD3' ' CD1' ' A' ' 96' ' ' TYR . 52.8 Cg_endo -77.18 6.67 4.15 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.009 1.531 . . . . 0.0 110.967 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.589 ' CB ' ' CG ' ' A' ' 102' ' ' GLU . . . 52.41 -161.47 0.1 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.002 -1.062 . . . . 0.0 110.084 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.441 HG21 ' ND1' ' A' ' 14' ' ' HIS . 3.4 t -115.0 -62.01 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.07 -1.019 . . . . 0.0 111.19 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.636 ' CD2' ' CG ' ' A' ' 72' ' ' LYS . 4.5 m-30 -93.71 -29.65 15.3 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.767 -1.208 . . . . 0.0 111.214 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.589 ' CG ' ' CB ' ' A' ' 99' ' ' ALA . 8.6 pt-20 -80.37 161.15 25.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.965 -1.084 . . . . 0.0 110.899 -178.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.482 ' O ' HD22 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -136.05 164.18 28.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.364 -0.835 . . . . 0.0 110.018 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.581 ' CG1' ' CD2' ' A' ' 68' ' ' LEU . 3.9 m -76.25 139.85 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.909 . . . . 0.0 110.43 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.552 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -94.0 -10.34 33.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.329 -0.857 . . . . 0.0 109.145 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER 166.35 -174.66 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.548 -0.72 . . . . 0.0 109.871 179.677 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.504 ' N ' HD11 ' A' ' 107' ' ' LEU . 4.4 mp -133.54 127.47 33.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.3 -0.875 . . . . 0.0 109.762 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.573 ' CG1' ' CB ' ' A' ' 65' ' ' ALA . 9.4 p -124.51 113.72 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.951 -1.093 . . . . 0.0 111.004 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.495 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -70.01 134.95 48.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.184 -0.947 . . . . 0.0 109.941 179.405 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . -88.68 53.59 2.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.423 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.405 HG23 ' CB ' ' A' ' 63' ' ' ASN . 55.3 t -153.43 120.47 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 110.178 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.2 tt -118.49 141.56 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.227 -0.921 . . . . 0.0 110.146 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.144 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.3 m -87.63 139.54 30.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.208 -1.172 . . . . 0.0 110.19 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.474 ' O ' ' O ' ' A' ' 4' ' ' MET . 0.5 OUTLIER -44.38 131.67 6.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.344 -0.848 . . . . 0.0 110.367 -179.828 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.474 ' O ' ' O ' ' A' ' 3' ' ' HIS . 0.0 OUTLIER 58.48 120.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.186 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.466 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 7.1 tt0 -117.84 168.17 10.72 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.211 -0.931 . . . . 0.0 110.205 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.519 ' C ' ' HA3' ' A' ' 41' ' ' GLY . 7.1 p -118.4 139.51 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.157 -0.964 . . . . 0.0 109.991 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.449 ' C ' ' O ' ' A' ' 6' ' ' VAL . 2.2 p -38.85 120.45 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.31 -0.869 . . . . 0.0 111.118 -178.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.555 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -67.99 171.54 5.41 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.817 -0.552 . . . . 0.0 109.766 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.555 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 38.1 Cg_endo -64.67 73.8 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.593 1.312 . . . . 0.0 109.969 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.52 ' OD1' ' CG2' ' A' ' 92' ' ' THR . 9.2 m-20 64.1 33.29 12.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.873 -0.517 . . . . 0.0 111.558 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.497 ' OG1' ' HB2' ' A' ' 8' ' ' LEU . 1.2 p -106.16 169.07 8.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.76 -1.213 . . . . 0.0 109.369 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.528 ' CB ' ' HA ' ' A' ' 38' ' ' GLU . . . -148.75 158.67 44.32 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.008 -1.057 . . . . 0.0 110.496 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.622 ' CD1' ' CD2' ' A' ' 15' ' ' LEU . 1.4 pp -127.57 156.94 41.44 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.294 -0.879 . . . . 0.0 110.896 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.621 ' N ' ' CD2' ' A' ' 14' ' ' HIS . 6.6 m170 -93.39 127.17 38.89 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.526 -0.734 . . . . 0.0 110.622 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.622 ' CD2' ' CD1' ' A' ' 13' ' ' LEU . 1.1 mm? -114.21 144.66 42.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.487 -0.758 . . . . 0.0 110.151 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.513 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 4.2 tttp -107.75 116.54 32.13 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.241 -0.983 . . . . 0.0 109.339 178.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.52 ' HA ' ' CG1' ' A' ' 49' ' ' VAL . . . -79.39 120.85 24.39 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 110.074 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 70.6 mt -105.98 101.21 10.72 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.883 -0.511 . . . . 0.0 109.638 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.525 HD13 ' N ' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -164.04 144.1 8.14 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.074 -1.016 . . . . 0.0 110.608 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.525 ' N ' HD13 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -84.9 103.4 13.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.343 -0.848 . . . . 0.0 109.146 178.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.482 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -115.39 111.66 21.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 110.542 -179.067 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.496 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 7.8 tt0 -91.98 126.71 37.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.349 -0.844 . . . . 0.0 110.272 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -108.88 146.59 33.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.143 -0.973 . . . . 0.0 110.109 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.08 3.48 20.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.286 -0.884 . . . . 0.0 110.435 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.61 1.65 46.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.221 -0.925 . . . . 0.0 110.356 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.34 -17.76 54.65 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -101.0 90.41 4.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.334 -1.098 . . . . 0.0 109.72 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.496 ' HB2' ' HA ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -107.31 164.46 12.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.24 -0.913 . . . . 0.0 110.463 -179.547 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.485 HG21 ' O ' ' A' ' 29' ' ' VAL . 0.8 OUTLIER -110.73 141.87 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.215 -0.928 . . . . 0.0 109.032 179.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.447 ' O ' ' C ' ' A' ' 31' ' ' ALA . 23.1 m -131.53 90.31 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.997 -1.064 . . . . 0.0 110.686 -179.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 39.98 58.34 2.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.468 -0.77 . . . . 0.0 110.74 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.91 28.05 0.22 Allowed Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.58 -1.295 . . . . 0.0 110.04 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 17' ' ' ALA . 7.4 m-20 -91.98 148.35 22.27 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.08 -1.247 . . . . 0.0 110.075 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 5.3 tt0 -147.63 131.7 17.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.016 -1.053 . . . . 0.0 110.603 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.551 ' CZ2' ' HB2' ' A' ' 15' ' ' LEU . 10.3 p90 -140.64 172.92 12.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.188 -0.945 . . . . 0.0 110.3 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.521 HD23 ' CD1' ' A' ' 97' ' ' LEU . 17.1 tp -106.16 156.78 18.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.488 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.492 ' N ' ' HG ' ' A' ' 36' ' ' LEU . 1.5 t80 -142.89 115.52 8.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -0.913 . . . . 0.0 110.913 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.528 ' HA ' ' CB ' ' A' ' 12' ' ' ALA . 4.3 tm-20 -84.53 141.58 30.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.532 -0.73 . . . . 0.0 109.273 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.612 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 63.43 47.73 84.76 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 47.1 Cg_endo -68.99 7.06 0.85 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 124.187 1.625 . . . . 0.0 112.071 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.519 ' HA3' ' C ' ' A' ' 6' ' ' VAL . . . -49.67 -57.03 10.05 Favored Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.321 -1.418 . . . . 0.0 109.56 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 61.4 p -71.93 -4.45 28.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.479 -1.012 . . . . 0.0 110.789 -179.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.531 ' CE1' ' HG ' ' A' ' 15' ' ' LEU . 4.3 t80 -82.67 111.5 18.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.042 -1.036 . . . . 0.0 109.732 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.523 ' CG2' ' HD2' ' A' ' 45' ' ' PRO . 18.2 mm -102.48 144.56 28.86 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.255 -0.903 . . . . 0.0 109.787 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.523 ' HD2' ' CG2' ' A' ' 44' ' ' ILE . 42.2 Cg_endo -67.8 96.3 0.43 Allowed 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.033 1.543 . . . . 0.0 111.474 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.1 147.71 23.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 109.482 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.453 ' HG3' ' N ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -50.72 -30.95 15.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.161 -0.962 . . . . 0.0 110.474 -179.572 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.473 ' O ' HG11 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -52.25 -25.49 9.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.129 -0.982 . . . . 0.0 110.668 -179.796 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.52 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 1.5 m -149.18 173.29 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.885 . . . . 0.0 109.615 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.74 134.79 45.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.052 -1.03 . . . . 0.0 110.595 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.455 ' HA ' HD12 ' A' ' 15' ' ' LEU . 9.0 t -54.79 130.78 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 109.128 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.543 HG21 ' CA ' ' A' ' 15' ' ' LEU . 5.3 t -104.54 -62.24 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.366 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.497 ' C ' ' CD1' ' A' ' 54' ' ' ILE . 2.4 mm-40 -146.29 173.72 12.0 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.547 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.515 HD13 ' CB ' ' A' ' 13' ' ' LEU . 1.3 mm -133.68 145.88 32.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.452 HD12 HG23 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -136.71 139.05 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.914 -1.116 . . . . 0.0 110.923 -178.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.476 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 2.8 mp0 -88.75 159.63 17.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.574 -0.704 . . . . 0.0 109.939 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.534 ' CB ' ' HA ' ' A' ' 95' ' ' ALA . . . -94.84 138.06 33.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.286 -0.884 . . . . 0.0 110.222 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 1.7 t 178.48 58.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.988 -1.07 . . . . 0.0 111.903 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.574 ' CG2' ' N ' ' A' ' 60' ' ' ILE . 0.6 OUTLIER -166.04 -52.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.605 -1.31 . . . . 0.0 111.201 178.81 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.574 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 10.5 mt -62.45 161.23 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.655 -1.278 . . . . 0.0 109.552 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 1.0 OUTLIER -96.38 -168.43 1.73 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.1 -1.0 . . . . 0.0 110.818 -179.37 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.584 ' HA ' ' CG1' ' A' ' 93' ' ' VAL . 7.5 tt0 -89.03 -17.5 29.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.323 -0.861 . . . . 0.0 111.116 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 2.4 p-10 -115.96 -36.34 4.17 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 110.266 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.469 ' NE2' ' HB3' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -55.54 132.05 47.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 111.175 -179.596 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.526 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . . . -109.9 149.71 29.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.384 -0.823 . . . . 0.0 109.381 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.597 ' CB ' ' CG1' ' A' ' 90' ' ' VAL . 0.7 OUTLIER -119.01 123.9 45.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.831 -1.168 . . . . 0.0 110.948 -179.469 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.468 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 7.9 ttt180 -91.5 120.91 32.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 109.255 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.527 HD11 ' N ' ' A' ' 104' ' ' VAL . 2.5 mm? -112.66 137.49 50.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.186 -0.946 . . . . 0.0 111.256 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.516 ' CB ' HD11 ' A' ' 105' ' ' LEU . 7.5 ttt180 -128.12 150.53 49.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.539 -0.725 . . . . 0.0 109.466 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.497 ' HB1' ' HG2' ' A' ' 86' ' ' GLU . . . -62.84 136.76 58.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.053 -1.029 . . . . 0.0 110.603 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.458 ' HG3' ' HD2' ' A' ' 72' ' ' LYS . 34.8 tpt85 -107.52 -26.3 10.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.252 -0.905 . . . . 0.0 110.022 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.613 ' HG3' ' CD2' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -143.83 34.7 1.26 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.22 -0.925 . . . . 0.0 110.332 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.57 ' O ' ' CB ' ' A' ' 74' ' ' CYS . 1.1 pt-20 38.76 -162.13 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.585 -0.697 . . . . 0.0 110.447 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.57 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER 77.43 -35.21 0.21 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.382 -0.824 . . . . 0.0 111.156 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.565 ' CZ2' ' HB2' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -73.87 113.13 10.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.91 -1.119 . . . . 0.0 109.665 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 79' ' ' GLY . 11.0 t0 -78.17 109.96 12.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.345 -0.847 . . . . 0.0 110.839 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.565 ' HB2' ' CZ2' ' A' ' 75' ' ' TRP . 1.4 tpm_? -88.68 -41.8 12.37 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.281 -0.887 . . . . 0.0 109.79 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -102.95 -9.07 20.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.356 -0.84 . . . . 0.0 110.128 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.518 ' N ' ' OD1' ' A' ' 76' ' ' ASP . . . 103.56 -4.6 47.21 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 81' ' ' GLU . 2.1 mttt -103.63 2.13 32.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -1.167 . . . . 0.0 110.132 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.466 ' OE2' ' OD2' ' A' ' 33' ' ' ASP . 43.5 mm-40 57.32 110.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 110.083 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.423 ' HB2' ' CD ' ' A' ' 86' ' ' GLU . 1.5 mmm-85 -113.8 179.87 3.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.465 -0.772 . . . . 0.0 110.641 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.8 p -87.56 169.91 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.415 -0.803 . . . . 0.0 110.653 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.507 HG23 ' N ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -48.55 -23.03 0.86 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.304 -0.873 . . . . 0.0 110.138 179.754 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.66 -34.58 90.29 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.497 ' HG2' ' HB1' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -50.19 162.51 0.21 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.171 -1.193 . . . . 0.0 109.727 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.441 ' HB3' ' HG3' ' A' ' 69' ' ' ARG . 7.8 pt-20 -159.13 151.22 21.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.145 -0.972 . . . . 0.0 110.655 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.505 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -133.0 148.44 52.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.431 -0.793 . . . . 0.0 109.106 179.579 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 90' ' ' VAL . 1.1 tt -109.3 162.23 14.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.176 -0.952 . . . . 0.0 110.15 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.597 ' CG1' ' CB ' ' A' ' 66' ' ' LEU . 14.3 p -137.0 117.78 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.156 -0.965 . . . . 0.0 110.556 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.66 38.27 3.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.396 -0.815 . . . . 0.0 109.789 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.52 ' CG2' ' OD1' ' A' ' 10' ' ' ASN . 2.2 m -88.62 133.78 34.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.848 . . . . 0.0 110.568 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.584 ' CG1' ' HA ' ' A' ' 62' ' ' GLN . 76.5 t -76.8 147.46 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.317 -0.865 . . . . 0.0 109.871 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . 44.97 82.35 0.03 OUTLIER Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.534 ' HA ' ' CB ' ' A' ' 57' ' ' ALA . . . -165.31 145.84 7.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.33 -1.1 . . . . 0.0 110.393 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.573 ' O ' ' CD1' ' A' ' 96' ' ' TYR . 3.2 t80 -124.81 -13.59 6.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.598 -0.689 . . . . 0.0 110.859 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.521 ' CD1' HD23 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -40.87 98.93 0.19 Allowed Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.151 -0.968 . . . . 0.0 110.185 -179.708 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' A' ' 99' ' ' ALA . 50.2 Cg_endo -86.88 11.63 3.21 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.169 1.615 . . . . 0.0 111.018 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 36' ' ' LEU . . . 67.99 -158.97 0.21 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.027 -1.046 . . . . 0.0 110.111 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.93 -55.45 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.061 -1.025 . . . . 0.0 110.897 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.613 ' CD2' ' HG3' ' A' ' 72' ' ' LYS . 7.5 m-85 -98.68 -4.54 33.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.869 -1.145 . . . . 0.0 110.159 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.55 ' HG2' ' CH2' ' A' ' 75' ' ' TRP . 6.9 mt-10 -91.05 121.93 33.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.293 -0.88 . . . . 0.0 110.733 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.471 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -102.19 143.32 32.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.411 -0.806 . . . . 0.0 109.975 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.527 ' N ' HD11 ' A' ' 68' ' ' LEU . 3.6 m -71.39 134.08 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.062 -1.024 . . . . 0.0 110.426 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.599 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 3.0 mp -84.83 -16.02 42.78 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.447 -0.783 . . . . 0.0 109.168 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 3.2 p30 160.85 -165.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.469 ' HB3' ' NE2' ' A' ' 64' ' ' GLN . 3.4 mp -123.1 109.76 14.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.35 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.526 ' CG1' ' CB ' ' A' ' 65' ' ' ALA . 10.0 p -97.19 161.55 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.474 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 110' ' ' ALA . 8.8 p-10 -104.65 131.78 51.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.852 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . -38.4 148.73 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.476 -0.765 . . . . 0.0 110.942 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.12 79.73 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -0.866 . . . . 0.0 109.951 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -60.04 163.49 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.9 . . . . 0.0 110.09 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.458 ' C ' ' CD1' ' A' ' 113' ' ' LEU . 3.1 tm? . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.048 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 0.7 OUTLIER -137.95 -163.3 1.42 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.269 -1.136 . . . . 0.0 110.18 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.469 ' O ' ' O ' ' A' ' 4' ' ' MET . 2.6 m170 58.93 149.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 110.144 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.469 ' O ' ' O ' ' A' ' 3' ' ' HIS . 1.1 mtp 54.12 107.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.302 -0.874 . . . . 0.0 110.058 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.461 ' O ' ' O ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -99.29 164.76 11.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.143 -0.973 . . . . 0.0 110.757 -179.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.496 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 55.6 t -97.82 157.5 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.381 -0.825 . . . . 0.0 109.524 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.514 ' HA ' ' CA ' ' A' ' 41' ' ' GLY . 48.7 t -38.06 102.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.51 -0.744 . . . . 0.0 110.766 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.471 ' HB3' ' OG1' ' A' ' 11' ' ' THR . 1.6 mp -47.73 137.49 9.91 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 110.288 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.474 ' O ' HG23 ' A' ' 11' ' ' THR . 48.4 Cg_endo -73.87 85.05 1.38 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.986 1.519 . . . . 0.0 110.618 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.523 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 9.4 m-20 56.64 48.36 16.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.214 -0.929 . . . . 0.0 110.578 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.482 HG21 ' O ' ' A' ' 10' ' ' ASN . 61.3 p -143.56 170.89 14.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.079 -1.013 . . . . 0.0 110.696 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -146.31 159.79 42.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.495 -0.753 . . . . 0.0 110.107 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.577 HD21 ' CD2' ' A' ' 43' ' ' TYR . 0.2 OUTLIER -133.3 152.71 51.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 109.983 179.493 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.512 ' C ' ' CD1' ' A' ' 15' ' ' LEU . 32.2 m80 -92.71 133.85 35.61 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.157 -0.964 . . . . 0.0 111.521 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.603 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -124.21 153.85 41.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.419 -0.801 . . . . 0.0 109.274 178.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.54 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 8.5 ttmt -107.65 117.1 33.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.984 -1.073 . . . . 0.0 109.277 178.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.562 ' HA ' ' CG1' ' A' ' 49' ' ' VAL . . . -78.6 110.84 14.09 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.318 -0.864 . . . . 0.0 110.123 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 48' ' ' GLU . 82.6 mt -98.53 101.13 12.46 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.365 0.602 . . . . 0.0 109.72 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.419 HD22 ' O ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -163.87 136.54 5.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.202 -0.936 . . . . 0.0 110.081 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -78.43 104.36 8.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 0.0 109.702 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.448 ' O ' ' O ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -127.36 126.3 42.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.147 -0.97 . . . . 0.0 110.587 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -120.32 126.05 49.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.385 -0.822 . . . . 0.0 110.02 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.48 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -67.05 167.39 11.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.188 -0.945 . . . . 0.0 110.439 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.68 -24.85 23.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.328 -0.857 . . . . 0.0 110.229 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.76 -27.07 68.47 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.396 -0.815 . . . . 0.0 110.197 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 22' ' ' GLU . . . 146.01 -54.29 0.55 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.415 ' HA ' ' CB ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -155.7 148.58 24.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.223 -1.163 . . . . 0.0 110.238 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . 5.3 tptp -147.14 -73.66 0.21 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 110.459 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.494 HG12 ' HG2' ' A' ' 81' ' ' GLU . 2.0 m -103.54 139.79 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.206 -0.934 . . . . 0.0 109.653 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.413 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 35.7 m -142.0 84.93 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 110.482 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.55 67.37 0.82 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.482 -0.761 . . . . 0.0 110.481 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -179.26 26.44 0.05 OUTLIER Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.592 -1.289 . . . . 0.0 110.587 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 17' ' ' ALA . 15.7 m-20 -87.99 150.42 23.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.821 -1.4 . . . . 0.0 110.217 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 80.4 tt0 -145.3 130.8 18.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.134 -0.979 . . . . 0.0 110.052 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 8.0 p90 -143.03 166.01 25.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.042 -1.036 . . . . 0.0 110.715 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.477 HD12 ' CD2' ' A' ' 14' ' ' HIS . 56.2 tp -90.17 153.72 20.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.454 -0.779 . . . . 0.0 109.942 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.588 ' CE1' ' HA ' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -119.98 109.62 15.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.763 -1.211 . . . . 0.0 110.38 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.536 ' HB2' ' CD2' ' A' ' 97' ' ' LEU . 0.4 OUTLIER -90.71 127.0 36.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.422 -0.799 . . . . 0.0 110.186 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.57 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 57.98 46.86 92.03 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.588 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 37.8 Cg_endo -62.85 -21.65 73.26 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.87 1.458 . . . . 0.0 110.095 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.514 ' CA ' ' HA ' ' A' ' 7' ' ' VAL . . . 30.97 -92.09 0.01 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.495 ' N ' ' O ' ' A' ' 40' ' ' PRO . 30.2 p -86.21 34.78 0.63 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.38 -1.07 . . . . 0.0 111.666 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.577 ' CD2' HD21 ' A' ' 13' ' ' LEU . 14.4 t80 -69.45 111.36 5.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.772 -1.205 . . . . 0.0 109.592 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.443 HD11 ' O ' ' A' ' 42' ' ' THR . 2.5 mp -103.57 142.58 24.88 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 109.839 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.96 109.6 2.59 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.007 1.53 . . . . 0.0 110.801 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 49' ' ' VAL . 80.4 mtt180 -111.85 143.81 42.2 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.364 -0.835 . . . . 0.0 110.015 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 46' ' ' ARG . 14.4 pttp -43.55 -38.28 2.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.099 -1.0 . . . . 0.0 110.094 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 8.8 mt-10 -44.89 -43.83 9.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.171 -0.956 . . . . 0.0 110.231 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.562 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 1.6 m -136.49 173.33 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.326 -0.859 . . . . 0.0 109.99 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -136.06 139.82 43.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.098 -1.001 . . . . 0.0 110.526 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.1 t -54.74 130.58 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.186 -0.946 . . . . 0.0 109.587 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.54 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 16.9 t -109.73 -62.39 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.267 -0.896 . . . . 0.0 110.396 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.491 ' HB2' ' ND1' ' A' ' 14' ' ' HIS . 3.2 mt-10 -139.03 173.08 11.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.035 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.503 HD11 ' HB2' ' A' ' 13' ' ' LEU . 1.4 mm -131.72 150.55 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.483 HD13 HG23 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -143.55 144.95 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.84 -1.163 . . . . 0.0 110.883 -179.025 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.427 ' HA ' ' CG2' ' A' ' 11' ' ' THR . 13.6 mp0 -115.88 169.77 8.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.524 -0.735 . . . . 0.0 109.767 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 10' ' ' ASN . . . -89.11 139.09 30.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 110.078 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.465 ' O ' HG12 ' A' ' 59' ' ' ILE . 2.6 t -169.97 51.4 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 110.261 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.609 ' HB ' ' CD1' ' A' ' 96' ' ' TYR . 7.1 mm -146.83 -82.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.085 -1.009 . . . . 0.0 110.631 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.483 ' N ' HG23 ' A' ' 59' ' ' ILE . 13.3 mt -111.88 -102.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.803 -1.186 . . . . 0.0 110.704 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.501 ' N ' ' HA ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER -175.99 -144.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.848 -1.158 . . . . 0.0 110.822 -179.633 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.569 ' HB2' ' CG1' ' A' ' 93' ' ' VAL . 6.1 tt0 -87.98 -66.41 0.92 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.511 -0.743 . . . . 0.0 110.884 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.502 ' C ' ' O ' ' A' ' 62' ' ' GLN . 3.3 m-20 -31.25 -58.7 0.24 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.299 0.571 . . . . 0.0 110.786 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 2.8 tp-100 -59.87 129.22 40.79 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.224 -0.923 . . . . 0.0 109.66 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.469 ' O ' ' OE1' ' A' ' 64' ' ' GLN . . . -108.15 146.73 32.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.969 -1.082 . . . . 0.0 110.264 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.491 HD23 ' OE1' ' A' ' 64' ' ' GLN . 4.0 mm? -121.27 116.34 24.67 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.134 -0.979 . . . . 0.0 109.89 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.509 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 16.3 ttp180 -90.14 132.47 35.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.064 -1.022 . . . . 0.0 110.01 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 98' ' ' PRO . 12.6 mt -124.14 143.27 50.58 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.522 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.492 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 2.5 ttt180 -117.62 138.88 51.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.714 -0.616 . . . . 0.0 109.577 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -58.33 152.67 17.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.223 -0.923 . . . . 0.0 110.359 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.457 ' C ' ' CG2' ' A' ' 84' ' ' THR . 8.8 ttt180 -143.48 -11.79 0.7 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.158 -0.964 . . . . 0.0 111.778 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.59 ' HG2' ' CE1' ' A' ' 101' ' ' PHE . 5.4 tppt? -114.57 -4.92 12.78 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.635 -1.29 . . . . 0.0 111.021 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.523 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 7.8 tt0 54.55 69.64 0.7 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.892 -1.13 . . . . 0.0 109.689 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 2.6 t -172.81 -31.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.308 -0.87 . . . . 0.0 110.261 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.573 ' CB ' ' HB2' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -74.16 126.76 31.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.146 -0.972 . . . . 0.0 110.118 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.514 ' HB3' ' N ' ' A' ' 81' ' ' GLU . 39.3 p-10 -101.08 110.34 22.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.156 -0.965 . . . . 0.0 109.905 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.567 ' HB2' ' CZ2' ' A' ' 75' ' ' TRP . 2.3 tpm_? -80.05 -38.08 32.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.391 -0.818 . . . . 0.0 110.032 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.35 24.05 13.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.878 . . . . 0.0 110.108 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.92 9.71 80.23 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 81' ' ' GLU . 30.4 mtpt -130.12 87.97 2.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -1.076 . . . . 0.0 110.038 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.514 ' N ' ' HB3' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -43.2 118.48 1.32 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.918 . . . . 0.0 109.58 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.539 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 1.4 ttm180 -117.23 179.67 3.97 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 0.0 110.779 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 84' ' ' THR . 7.4 p -82.51 172.36 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.507 -0.745 . . . . 0.0 110.628 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.463 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 45.7 p -52.65 -26.39 13.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.353 -0.842 . . . . 0.0 109.99 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -55.96 -43.71 87.83 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.539 ' CB ' ' HB3' ' A' ' 82' ' ' ARG . 12.4 tp10 -55.96 153.52 8.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.403 -1.057 . . . . 0.0 109.527 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.492 ' HB3' ' HG3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -159.47 156.18 27.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.064 -1.022 . . . . 0.0 110.602 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.486 ' CZ2' HG21 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -142.58 151.12 41.22 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.283 -0.886 . . . . 0.0 109.604 179.679 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.554 HD21 ' N ' ' A' ' 90' ' ' VAL . 1.8 tt -102.21 154.01 19.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.325 -0.86 . . . . 0.0 109.901 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.554 ' N ' HD21 ' A' ' 89' ' ' LEU . 49.4 t -114.2 107.95 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.385 -0.822 . . . . 0.0 110.396 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.9 m -121.47 25.85 9.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.923 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.2 t -76.85 171.36 14.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.381 -0.824 . . . . 0.0 110.403 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.569 ' CG1' ' HB2' ' A' ' 62' ' ' GLN . 3.9 t -92.22 75.81 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 0.0 110.027 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.47 ' HA2' ' HB3' ' A' ' 10' ' ' ASN . . . -128.01 -85.82 0.5 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.501 ' HA ' ' N ' ' A' ' 61' ' ' ARG . . . -177.18 -38.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.362 -1.081 . . . . 0.0 109.707 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.609 ' CD1' ' HB ' ' A' ' 59' ' ' ILE . 3.4 p90 179.92 40.81 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.697 -0.627 . . . . 0.0 109.94 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.536 ' CD2' ' HB2' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -41.68 103.97 0.33 Allowed Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.281 -0.887 . . . . 0.0 110.155 -179.73 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.517 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 46.7 Cg_endo -72.09 -98.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.08 1.569 . . . . 0.0 110.277 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.542 ' CB ' ' HG2' ' A' ' 102' ' ' GLU . . . 169.11 -156.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.769 -1.207 . . . . 0.0 110.156 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.31 -32.03 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 110.806 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.59 ' CE1' ' HG2' ' A' ' 72' ' ' LYS . 1.7 m-85 -130.48 -6.86 4.19 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.75 -1.219 . . . . 0.0 110.897 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.562 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 1.2 pt-20 -110.86 157.73 19.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.013 -1.055 . . . . 0.0 110.675 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.57 166.06 13.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.355 -0.841 . . . . 0.0 109.846 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.478 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 11.5 p -95.63 152.61 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.142 -0.974 . . . . 0.0 110.469 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.575 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 0.8 OUTLIER -102.55 -34.71 9.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.367 -0.833 . . . . 0.0 109.508 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -164.97 -163.88 0.74 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.557 -0.715 . . . . 0.0 109.63 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.638 ' CD1' ' N ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -136.93 163.71 30.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 110.578 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 64' ' ' GLN . 33.7 t -138.95 150.48 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.843 . . . . 0.0 110.169 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 1.7 p-10 -111.67 115.13 28.61 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.882 -1.136 . . . . 0.0 109.81 178.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' A' ' 63' ' ' ASN . . . -78.02 177.2 8.48 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.981 -1.074 . . . . 0.0 110.595 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 112' ' ' ILE . 0.9 OUTLIER -119.44 160.49 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.335 -0.853 . . . . 0.0 109.843 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.446 ' N ' HG13 ' A' ' 111' ' ' VAL . 23.5 mm -72.11 137.4 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.292 -0.88 . . . . 0.0 110.271 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.265 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.436 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.11 -69.04 0.34 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -1.193 . . . . 0.0 110.227 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.457 ' O ' ' HB3' ' A' ' 4' ' ' MET . 77.5 m80 -92.47 125.42 37.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.176 -0.952 . . . . 0.0 110.262 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.504 ' CG ' ' N ' ' A' ' 5' ' ' GLN . 5.6 ttp 57.33 168.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.933 . . . . 0.0 110.074 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.504 ' N ' ' CG ' ' A' ' 4' ' ' MET . 0.0 OUTLIER 176.49 -173.91 0.1 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.148 -0.97 . . . . 0.0 110.384 179.807 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.479 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 41.5 t -113.47 160.04 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 0.0 109.718 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.487 ' CA ' ' HA3' ' A' ' 41' ' ' GLY . 21.5 t -35.56 99.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.65 -0.656 . . . . 0.0 110.855 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.544 ' CD2' ' OG1' ' A' ' 11' ' ' THR . 2.5 mp -47.45 147.23 2.96 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.458 -0.776 . . . . 0.0 110.865 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 10' ' ' ASN . 50.4 Cg_endo -76.98 69.0 7.17 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.134 1.597 . . . . 0.0 110.462 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.491 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 0.9 OUTLIER 67.68 49.0 1.0 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.21 -0.931 . . . . 0.0 110.741 179.792 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.544 ' OG1' ' CD2' ' A' ' 8' ' ' LEU . 33.1 p -137.13 171.35 14.62 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.278 -0.889 . . . . 0.0 109.792 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.519 ' CB ' HD23 ' A' ' 97' ' ' LEU . . . -144.3 161.97 37.59 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.954 -1.091 . . . . 0.0 110.785 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.549 ' CD2' ' CB ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -134.04 152.2 51.74 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.244 -0.91 . . . . 0.0 110.419 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.635 ' CD2' ' CD1' ' A' ' 36' ' ' LEU . 9.1 m170 -88.03 128.19 35.4 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.143 -0.973 . . . . 0.0 110.727 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.568 HD13 ' CE2' ' A' ' 43' ' ' TYR . 2.7 mm? -115.99 148.0 40.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.497 -0.752 . . . . 0.0 110.579 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.56 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 1.7 ttmt -114.16 116.85 29.75 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.239 -0.984 . . . . 0.0 108.889 177.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.553 ' CB ' ' HB3' ' A' ' 33' ' ' ASP . . . -80.43 121.95 26.37 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.954 -1.091 . . . . 0.0 109.936 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 69.3 mt -98.66 99.89 11.05 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.493 0.663 . . . . 0.0 109.711 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.504 HD11 ' N ' ' A' ' 20' ' ' ASP . 0.4 OUTLIER -166.73 130.06 1.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.503 -0.748 . . . . 0.0 109.669 -179.797 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.504 ' N ' HD11 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -71.62 101.34 2.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.083 -1.011 . . . . 0.0 110.019 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.527 ' CB ' HG23 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -129.51 71.38 1.44 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.903 . . . . 0.0 109.969 -179.88 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.442 ' HA ' ' HB3' ' A' ' 28' ' ' LYS . 4.7 tt0 -102.39 114.92 29.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.273 -0.892 . . . . 0.0 110.381 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -81.36 177.39 9.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 110.064 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.7 4.01 12.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 110.35 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.95 -25.44 68.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.317 -0.865 . . . . 0.0 110.166 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.16 -37.75 1.89 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.57 96.56 0.05 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.297 -1.119 . . . . 0.0 110.472 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.442 ' HB3' ' HA ' ' A' ' 22' ' ' GLU . 3.1 tptt -99.67 -107.71 0.21 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.166 -0.959 . . . . 0.0 109.892 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.527 HG23 ' CB ' ' A' ' 21' ' ' PHE . 1.7 m -112.03 137.04 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.767 -1.208 . . . . 0.0 109.189 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' A' ' 30' ' ' VAL . 29.6 m -138.85 90.18 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.135 -0.978 . . . . 0.0 110.545 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 46.75 51.61 12.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.864 . . . . 0.0 110.436 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -176.7 25.37 0.06 OUTLIER Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.152 -1.499 . . . . 0.0 111.061 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.553 ' HB3' ' CB ' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -66.66 149.84 49.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.508 -1.584 . . . . 0.0 109.011 179.091 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.635 ' CG ' ' CZ ' ' A' ' 101' ' ' PHE . 1.2 pm0 -148.47 138.66 22.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.557 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.403 ' CA ' HG23 ' A' ' 100' ' ' VAL . 10.1 p90 -158.86 164.68 35.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.335 -0.853 . . . . 0.0 109.816 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.635 ' CD1' ' CD2' ' A' ' 14' ' ' HIS . 60.6 tp -90.82 156.14 18.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.004 -1.06 . . . . 0.0 109.66 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.549 ' CE2' ' HB2' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -126.1 114.13 17.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.055 -1.028 . . . . 0.0 110.183 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 4.1 tt0 -84.77 129.38 34.83 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.275 0.559 . . . . 0.0 109.983 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.61 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 64.77 44.33 94.95 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 55.8 Cg_endo -77.48 17.74 0.89 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.604 1.318 . . . . 0.0 110.875 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.487 ' HA3' ' CA ' ' A' ' 7' ' ' VAL . . . -49.21 -41.99 31.59 Favored Glycine 0 N--CA 1.488 2.114 0 O-C-N 120.755 -1.216 . . . . 0.0 110.367 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.8 p -93.73 19.74 8.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.038 -1.272 . . . . 0.0 110.974 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.568 ' CE2' HD13 ' A' ' 15' ' ' LEU . 21.8 t80 -85.45 133.36 34.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.124 -0.985 . . . . 0.0 110.019 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.466 HG23 ' N ' ' A' ' 45' ' ' PRO . 1.5 mp -119.73 145.31 39.02 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.359 -0.838 . . . . 0.0 109.006 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.466 ' N ' HG23 ' A' ' 44' ' ' ILE . 40.9 Cg_endo -66.89 109.53 1.71 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.869 1.457 . . . . 0.0 110.713 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -111.59 149.58 31.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.462 -0.774 . . . . 0.0 110.246 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -53.07 -29.1 28.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.859 . . . . 0.0 110.312 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.486 ' C ' ' CG1' ' A' ' 49' ' ' VAL . 20.4 tt0 -59.81 -21.69 61.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.173 -0.954 . . . . 0.0 110.512 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.9 m -150.92 170.8 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.292 -0.88 . . . . 0.0 110.33 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -131.54 138.0 48.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.198 -0.939 . . . . 0.0 110.099 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.6 t -58.63 125.55 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.716 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.56 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 2.8 t -102.27 -63.32 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.276 -0.89 . . . . 0.0 110.291 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.494 ' O ' HD11 ' A' ' 54' ' ' ILE . 3.4 mt-10 -144.01 166.49 24.82 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.18 -0.95 . . . . 0.0 110.252 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.494 HD11 ' O ' ' A' ' 53' ' ' GLU . 2.6 mm -128.71 148.65 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.6 HD11 ' CZ ' ' A' ' 96' ' ' TYR . 0.5 OUTLIER -141.6 130.39 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.591 -1.318 . . . . 0.0 111.59 -178.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.433 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 23.1 mp0 -94.8 176.0 6.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.589 -0.694 . . . . 0.0 109.708 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.6 ' CB ' ' CB ' ' A' ' 95' ' ' ALA . . . -102.02 144.61 30.4 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.159 -0.963 . . . . 0.0 110.63 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.518 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER 170.61 59.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.156 -0.965 . . . . 0.0 111.984 179.53 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.538 HG23 ' HB3' ' A' ' 96' ' ' TYR . 1.2 tt -172.71 -60.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.277 -1.515 . . . . 0.0 112.649 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 95' ' ' ALA . 18.8 mm -80.81 169.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.36 -1.463 . . . . 0.0 110.835 -178.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -109.33 -159.7 0.69 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.474 -0.766 . . . . 0.0 110.326 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.56 ' HB2' ' CG1' ' A' ' 93' ' ' VAL . 2.9 tt0 -91.14 -68.64 0.78 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.327 -0.858 . . . . 0.0 110.295 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.544 ' CA ' ' HB1' ' A' ' 110' ' ' ALA . 2.1 m-20 -38.23 -50.97 1.46 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.75 -0.594 . . . . 0.0 110.97 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.486 ' NE2' ' O ' ' A' ' 108' ' ' VAL . 7.9 tp60 -59.69 137.4 58.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.082 -1.011 . . . . 0.0 110.852 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.5 ' HB1' ' CG1' ' A' ' 108' ' ' VAL . . . -127.41 148.95 50.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.412 -0.805 . . . . 0.0 110.069 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.443 ' HB2' ' HB ' ' A' ' 90' ' ' VAL . 2.6 mp -127.05 118.13 23.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.318 -0.864 . . . . 0.0 110.152 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.558 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -91.66 128.26 37.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.002 -1.061 . . . . 0.0 110.029 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.482 HD22 ' HA ' ' A' ' 104' ' ' VAL . 15.6 mt -120.33 139.85 52.15 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.05 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -120.02 157.54 28.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.483 -0.761 . . . . 0.0 109.754 179.329 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.521 ' HB2' ' CA ' ' A' ' 84' ' ' THR . . . -68.95 124.58 24.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 111.353 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -84.33 -23.09 30.37 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.491 ' HG2' ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -156.73 146.56 20.89 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.552 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 74' ' ' CYS . 1.9 pt-20 -56.96 -156.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.036 -1.04 . . . . 0.0 110.341 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 6.6 m 77.34 -43.45 0.42 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.525 -0.734 . . . . 0.0 110.889 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.613 ' CZ3' ' HG3' ' A' ' 86' ' ' GLU . 8.3 t90 -74.15 110.94 8.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.793 -1.192 . . . . 0.0 110.353 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 2.4 p30 -91.2 127.05 36.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.205 -0.934 . . . . 0.0 110.003 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.403 ' CD ' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -86.08 -40.5 15.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 110.039 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.01 -28.79 25.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.166 -0.959 . . . . 0.0 110.275 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 80' ' ' LYS . . . 139.86 -52.29 0.71 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -61.05 -131.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -1.179 . . . . 0.0 109.741 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.465 ' OE2' HG21 ' A' ' 29' ' ' VAL . 15.0 mm-40 -136.97 121.78 18.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.826 -1.171 . . . . 0.0 110.464 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.36 173.26 8.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.535 -0.728 . . . . 0.0 109.888 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.5 p -88.87 173.03 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 0.0 110.568 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.521 ' CA ' ' HB2' ' A' ' 70' ' ' ALA . 10.1 t -67.45 -12.53 60.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.863 . . . . 0.0 110.006 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.49 -14.65 55.2 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.613 ' HG3' ' CZ3' ' A' ' 75' ' ' TRP . 8.4 pt-20 -79.25 166.42 22.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.417 -1.049 . . . . 0.0 109.526 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.472 ' HA ' ' OE2' ' A' ' 102' ' ' GLU . 5.8 pt-20 -157.9 153.55 26.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.808 -1.183 . . . . 0.0 110.774 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.578 ' CE2' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -128.38 144.24 51.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.392 -0.817 . . . . 0.0 109.716 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.558 ' HG ' ' HA ' ' A' ' 67' ' ' ARG . 1.4 tt -106.2 158.42 16.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.211 -0.931 . . . . 0.0 110.123 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.578 HG23 ' CE2' ' A' ' 88' ' ' TRP . 16.6 t -122.23 136.65 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 0.0 110.571 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.492 ' CG2' ' O ' ' A' ' 90' ' ' VAL . 61.0 p -155.72 60.26 0.61 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 109.641 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.532 ' CG2' ' HB2' ' A' ' 95' ' ' ALA . 14.6 t -85.29 167.93 15.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.399 -0.813 . . . . 0.0 110.627 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.56 ' CG1' ' HB2' ' A' ' 62' ' ' GLN . 3.3 t -108.18 67.17 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.385 -0.822 . . . . 0.0 109.768 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 60' ' ' ILE . . . 110.04 62.85 0.52 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.6 ' CB ' ' CB ' ' A' ' 57' ' ' ALA . . . -174.72 -153.14 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.332 -1.099 . . . . 0.0 110.426 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.6 ' CZ ' HD11 ' A' ' 55' ' ' ILE . 2.3 p90 176.46 119.11 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.519 HD23 ' CB ' ' A' ' 12' ' ' ALA . 2.6 mp -106.19 95.65 11.7 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 111.457 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.488 ' O ' ' O ' ' A' ' 99' ' ' ALA . 47.0 Cg_endo -74.94 87.19 1.34 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.9 1.474 . . . . 0.0 108.887 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.56 ' CB ' ' HB2' ' A' ' 102' ' ' GLU . . . -50.05 -172.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.404 -0.81 . . . . 0.0 111.261 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.403 HG23 ' CA ' ' A' ' 35' ' ' TRP . 2.5 t -99.47 -66.33 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.433 -0.792 . . . . 0.0 110.496 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.635 ' CZ ' ' CG ' ' A' ' 34' ' ' GLU . 21.5 m-30 -100.15 22.23 11.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.936 -1.102 . . . . 0.0 110.57 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.56 ' HB2' ' CB ' ' A' ' 99' ' ' ALA . 2.4 mm-40 -111.56 120.29 41.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.964 -1.085 . . . . 0.0 110.397 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -100.13 156.26 17.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.352 -0.843 . . . . 0.0 110.188 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.482 ' HA ' HD22 ' A' ' 68' ' ' LEU . 3.5 m -81.87 138.39 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 110.26 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.592 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 3.0 mp -97.14 -9.58 27.62 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.318 -0.864 . . . . 0.0 109.197 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.57 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 0.4 OUTLIER 159.94 -160.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.791 -0.568 . . . . 0.0 109.622 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.573 ' C ' ' CD2' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -138.42 150.13 46.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.941 . . . . 0.0 110.341 178.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.5 ' CG1' ' HB1' ' A' ' 65' ' ' ALA . 14.7 p -134.07 140.66 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.128 -0.982 . . . . 0.0 110.167 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.17 117.84 35.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.881 -1.137 . . . . 0.0 110.003 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.544 ' HB1' ' CA ' ' A' ' 63' ' ' ASN . . . -54.21 -78.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 110.014 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.3 t -142.35 147.1 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.357 -0.839 . . . . 0.0 110.273 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.0 mt -112.83 170.93 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.346 -0.846 . . . . 0.0 109.679 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.093 -1.004 . . . . 0.0 110.126 179.877 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 84.8 p -115.22 83.67 1.96 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.331 -1.099 . . . . 0.0 110.206 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -164.38 128.4 2.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.907 . . . . 0.0 110.335 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.459 ' HG2' ' N ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -112.49 152.83 28.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 110.213 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.459 ' N ' ' HG2' ' A' ' 4' ' ' MET . 0.5 OUTLIER -122.22 -170.71 2.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.151 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.482 ' O ' ' CD1' ' A' ' 8' ' ' LEU . 9.8 p -126.61 147.24 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.163 -0.961 . . . . 0.0 110.089 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.468 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 83.4 t -41.18 107.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 110.337 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.534 ' CD2' ' OG1' ' A' ' 11' ' ' THR . 5.4 mp -63.24 163.94 16.21 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.391 -0.818 . . . . 0.0 110.079 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.411 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 47.3 Cg_endo -73.19 -56.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.913 1.48 . . . . 0.0 110.451 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.535 ' HB3' ' CG2' ' A' ' 92' ' ' THR . 63.2 m-80 -158.42 31.77 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 110.174 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.534 ' OG1' ' CD2' ' A' ' 8' ' ' LEU . 43.9 p -106.41 171.56 7.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.342 -0.849 . . . . 0.0 110.2 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.505 ' CB ' ' HA ' ' A' ' 38' ' ' GLU . . . -147.24 162.46 38.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.193 -0.942 . . . . 0.0 109.93 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.539 ' HG ' ' CD2' ' A' ' 15' ' ' LEU . 0.6 OUTLIER -130.25 155.79 45.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.021 . . . . 0.0 110.642 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.603 ' N ' ' CD2' ' A' ' 14' ' ' HIS . 2.4 m170 -96.93 129.16 44.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.341 -0.849 . . . . 0.0 109.08 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.619 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -126.2 162.28 25.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.703 -1.248 . . . . 0.0 109.48 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.542 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 1.2 ttpt -113.44 118.58 34.91 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.576 -0.85 . . . . 0.0 111.029 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.58 ' CB ' ' HB2' ' A' ' 33' ' ' ASP . . . -73.9 113.18 10.77 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.922 0.868 . . . . 0.0 108.782 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -106.95 106.73 17.4 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.486 0.66 . . . . 0.0 110.655 -178.677 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.517 ' CD1' ' HG3' ' A' ' 48' ' ' GLU . 5.1 tp -166.72 146.2 5.6 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.564 -0.71 . . . . 0.0 109.903 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.3 105.0 15.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 109.827 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.508 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -125.14 118.52 26.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.212 -0.93 . . . . 0.0 110.318 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.54 114.98 27.25 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.141 -0.975 . . . . 0.0 110.149 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.35 145.41 48.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.158 -0.964 . . . . 0.0 110.224 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -80.57 -9.04 59.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.909 . . . . 0.0 110.207 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.2 -14.08 59.6 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.266 -0.896 . . . . 0.0 110.169 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.27 -5.42 30.12 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.18 29.09 1.11 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.117 -1.225 . . . . 0.0 110.027 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.6 ttpp -66.78 116.0 7.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.356 -0.84 . . . . 0.0 110.37 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.508 ' CG2' ' HB2' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -109.0 146.76 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.262 -0.899 . . . . 0.0 109.65 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.433 ' O ' ' C ' ' A' ' 31' ' ' ALA . 27.0 m -132.41 81.37 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.07 -1.019 . . . . 0.0 109.764 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 41.31 67.47 0.54 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.617 -0.677 . . . . 0.0 110.295 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -168.47 20.26 0.08 OUTLIER Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.114 -1.517 . . . . 0.0 111.263 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.58 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 1.3 m-20 -88.34 150.6 23.13 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.437 -1.625 . . . . 0.0 109.406 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.473 ' HB2' ' HG3' ' A' ' 16' ' ' LYS . 16.5 tt0 -151.46 139.07 19.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.089 -1.007 . . . . 0.0 110.461 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.584 ' CZ2' ' CD1' ' A' ' 15' ' ' LEU . 8.7 p90 -154.44 177.63 10.96 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.147 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.592 HD21 ' CE1' ' A' ' 14' ' ' HIS . 0.5 OUTLIER -90.33 158.69 17.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 0.0 110.969 -179.062 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.495 ' CE2' ' HB2' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -141.99 110.77 6.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.386 -0.821 . . . . 0.0 109.565 179.252 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.505 ' HA ' ' CB ' ' A' ' 12' ' ' ALA . 4.1 tm-20 -93.94 149.44 21.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.205 -0.934 . . . . 0.0 111.001 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.588 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 55.91 45.52 86.2 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 41.8 Cg_endo -70.68 -60.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.757 1.398 . . . . 0.0 109.844 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.468 ' HA3' ' HA ' ' A' ' 7' ' ' VAL . . . 41.87 -89.92 0.01 OUTLIER Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 40' ' ' PRO . 19.8 p -66.9 1.32 1.95 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.33 -1.1 . . . . 0.0 111.559 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.495 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 6.8 t80 -68.78 124.15 22.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.643 -1.286 . . . . 0.0 110.408 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 45' ' ' PRO . 6.2 mt -115.52 145.59 34.78 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 109.064 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.494 ' N ' HG23 ' A' ' 44' ' ' ILE . 42.6 Cg_endo -67.57 109.19 1.78 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.764 1.402 . . . . 0.0 110.751 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -102.37 144.64 30.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.4 -0.812 . . . . 0.0 109.999 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.538 ' O ' ' CD2' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -37.34 -45.66 0.7 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.572 -0.705 . . . . 0.0 111.062 -179.582 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 18' ' ' LEU . 11.4 tt0 -49.07 -49.07 43.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -0.964 . . . . 0.0 110.98 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.498 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -133.44 142.58 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.915 -1.115 . . . . 0.0 110.741 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -108.62 137.51 46.45 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.323 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 51' ' ' VAL . 31.3 m -54.01 145.29 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.168 -0.957 . . . . 0.0 109.252 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.542 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 31.7 t -117.48 -58.65 3.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.048 -1.033 . . . . 0.0 110.407 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.447 ' C ' HD13 ' A' ' 54' ' ' ILE . 1.9 mt-10 -136.09 172.85 12.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.144 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.515 HD11 ' HB2' ' A' ' 13' ' ' LEU . 1.2 mm -136.18 130.73 48.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.322 -0.861 . . . . 0.0 108.828 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.503 HG13 ' CG ' ' A' ' 98' ' ' PRO . 0.4 OUTLIER -125.85 144.93 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.214 -0.929 . . . . 0.0 111.162 -178.591 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.474 ' N ' HD12 ' A' ' 55' ' ' ILE . 40.7 mm-40 -100.4 174.28 6.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.468 -0.77 . . . . 0.0 109.779 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.546 ' CA ' ' HA ' ' A' ' 95' ' ' ALA . . . -102.25 125.68 49.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.132 -0.98 . . . . 0.0 109.96 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 3.2 t 179.29 63.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.012 -1.055 . . . . 0.0 111.872 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.547 HG22 ' CD1' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -169.68 -37.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.549 -1.344 . . . . 0.0 111.323 179.107 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.478 HD11 ' CD2' ' A' ' 66' ' ' LEU . 9.4 mm -78.1 158.41 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.785 -1.197 . . . . 0.0 110.44 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.485 ' HB2' ' CB ' ' A' ' 64' ' ' GLN . 9.1 mtt180 -62.8 -168.84 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.283 -0.886 . . . . 0.0 110.413 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.555 ' HA ' ' CG1' ' A' ' 93' ' ' VAL . 0.8 OUTLIER -91.63 -19.92 22.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.0 110.701 -179.435 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 2.7 p30 -127.97 -19.2 4.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.905 -1.122 . . . . 0.0 110.907 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.485 ' CB ' ' HB2' ' A' ' 61' ' ' ARG . 6.4 tp-100 -51.34 126.88 18.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.031 -1.043 . . . . 0.0 111.646 -179.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.514 ' CB ' ' CG1' ' A' ' 108' ' ' VAL . . . -108.54 142.37 39.06 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.493 ' O ' HD21 ' A' ' 89' ' ' LEU . 1.8 mp -127.59 115.04 18.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.837 -1.165 . . . . 0.0 111.882 -178.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.477 ' HA ' HD21 ' A' ' 89' ' ' LEU . 4.3 ttm180 -91.36 119.6 31.51 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.507 ' CD2' ' HA ' ' A' ' 104' ' ' VAL . 21.6 mt -113.74 161.25 17.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 111.396 -178.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 15.7 mtp180 -126.57 161.88 26.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.371 -0.83 . . . . 0.0 110.179 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.568 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . . . -82.63 152.37 25.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.202 -0.936 . . . . 0.0 111.415 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.505 ' HG3' ' N ' ' A' ' 72' ' ' LYS . 9.4 ptt180 -125.31 -27.7 3.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.453 -0.779 . . . . 0.0 109.819 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.505 ' N ' ' HG3' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -124.49 118.46 26.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.283 -0.885 . . . . 0.0 109.762 179.575 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.513 ' N ' ' HB ' ' A' ' 84' ' ' THR . 4.3 pt-20 -54.51 106.82 0.23 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.202 -0.937 . . . . 0.0 110.723 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.507 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER 168.5 -43.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.285 -0.884 . . . . 0.0 110.151 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.606 ' HB3' ' HB2' ' A' ' 101' ' ' PHE . 2.7 t90 -74.98 104.43 5.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.284 -0.885 . . . . 0.0 110.182 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.482 ' OD2' ' N ' ' A' ' 80' ' ' LYS . 3.4 t70 -96.82 122.04 39.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -0.978 . . . . 0.0 110.226 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.437 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -85.03 -0.38 54.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.886 . . . . 0.0 110.365 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.55 -4.99 8.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.954 . . . . 0.0 110.365 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 101.21 -47.25 1.21 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.482 ' N ' ' OD2' ' A' ' 76' ' ' ASP . 9.1 mmtp -69.54 98.63 1.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -1.14 . . . . 0.0 110.012 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 80' ' ' LYS . 0.9 OUTLIER -34.17 135.15 0.16 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.718 -0.614 . . . . 0.0 110.913 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.16 179.77 7.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 110.533 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.452 HG22 ' N ' ' A' ' 84' ' ' THR . 10.8 p -77.84 174.02 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.4 -0.813 . . . . 0.0 110.553 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.513 ' HB ' ' N ' ' A' ' 73' ' ' GLU . 2.3 t -73.95 -3.52 29.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.815 . . . . 0.0 110.099 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.88 -13.35 78.84 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 8.3 pt-20 -70.79 172.24 9.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -1.083 . . . . 0.0 110.058 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.409 ' HB3' ' HG2' ' A' ' 69' ' ' ARG . 5.4 pm0 -159.06 172.59 17.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 110.444 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.549 ' CD1' ' C ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -155.96 153.66 29.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.342 -0.849 . . . . 0.0 109.795 -179.825 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.52 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -122.25 124.97 45.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.117 -0.99 . . . . 0.0 109.954 179.558 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.52 ' N ' HD22 ' A' ' 89' ' ' LEU . 4.5 p -105.6 138.92 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.429 -0.795 . . . . 0.0 110.263 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.7 t -141.93 49.78 1.56 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.272 -0.892 . . . . 0.0 110.415 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.535 ' CG2' ' HB3' ' A' ' 10' ' ' ASN . 51.6 m -91.28 138.66 31.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -0.937 . . . . 0.0 110.281 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.555 ' CG1' ' HA ' ' A' ' 62' ' ' GLN . 17.5 t -71.13 140.39 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.147 -0.971 . . . . 0.0 110.15 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 93' ' ' VAL . . . 43.27 80.75 0.04 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.546 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . . . -156.38 154.01 29.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -1.149 . . . . 0.0 110.861 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.547 ' CD1' HG22 ' A' ' 59' ' ' ILE . 4.9 t80 -117.69 25.69 10.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.502 -0.749 . . . . 0.0 109.961 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 96' ' ' TYR . 2.0 mm? -34.34 91.87 0.05 OUTLIER Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.827 -0.546 . . . . 0.0 111.408 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.518 ' N ' ' O ' ' A' ' 96' ' ' TYR . 48.5 Cg_endo -91.32 115.8 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.827 1.435 . . . . 0.0 110.395 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -69.76 171.92 8.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.213 -0.929 . . . . 0.0 110.32 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.484 HG21 ' CD2' ' A' ' 36' ' ' LEU . 1.7 t -99.33 -58.5 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.352 -0.843 . . . . 0.0 109.447 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.606 ' HB2' ' HB3' ' A' ' 75' ' ' TRP . 22.8 m-30 -117.6 38.9 3.46 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.156 -0.965 . . . . 0.0 109.257 178.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.478 ' OE2' ' CH2' ' A' ' 75' ' ' TRP . 13.6 tt0 -132.11 133.23 44.07 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.124 -0.985 . . . . 0.0 110.879 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -105.08 171.22 7.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.389 -0.819 . . . . 0.0 110.193 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.507 ' HA ' ' CD2' ' A' ' 68' ' ' LEU . 7.7 p -101.31 144.56 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.172 -0.955 . . . . 0.0 110.306 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.593 ' N ' ' CD2' ' A' ' 105' ' ' LEU . 1.6 mm? -103.14 -40.07 6.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -0.968 . . . . 0.0 110.118 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.431 ' C ' HD12 ' A' ' 107' ' ' LEU . 1.8 p30 -161.29 171.58 18.11 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.868 . . . . 0.0 109.963 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.589 ' N ' ' CD2' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -121.96 142.55 50.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.175 -0.953 . . . . 0.0 110.367 -179.855 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.514 ' CG1' ' CB ' ' A' ' 65' ' ' ALA . 12.6 p -125.49 157.84 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.398 -0.814 . . . . 0.0 109.499 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.405 ' O ' ' CG ' ' A' ' 109' ' ' ASP . 8.6 p-10 -110.91 121.27 44.93 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.92 -1.113 . . . . 0.0 110.704 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . -75.93 172.2 13.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 109.951 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.6 m -129.4 -29.54 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.951 -1.093 . . . . 0.0 110.876 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.445 HG21 ' O ' ' A' ' 112' ' ' ILE . 0.6 OUTLIER -144.94 27.89 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.928 -1.108 . . . . 0.0 110.69 -179.7 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.34 -179.978 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.3 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.422 ' OG ' ' HG3' ' A' ' 45' ' ' PRO . 74.6 m 45.47 -165.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.259 -1.142 . . . . 0.0 110.424 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.472 ' O ' ' CB ' ' A' ' 4' ' ' MET . 0.4 OUTLIER 60.28 13.55 4.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 0.0 110.161 -179.798 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.472 ' CB ' ' O ' ' A' ' 3' ' ' HIS . 0.2 OUTLIER 67.46 128.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.902 . . . . 0.0 110.368 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.581 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 0.6 OUTLIER -133.38 86.01 2.26 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.282 -0.886 . . . . 0.0 109.836 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.505 ' O ' ' O ' ' A' ' 5' ' ' GLN . 12.0 p -38.0 165.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.349 -0.844 . . . . 0.0 111.927 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.517 ' CA ' ' HA3' ' A' ' 41' ' ' GLY . 43.7 t -30.83 150.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 CA-C-O 121.586 0.708 . . . . 0.0 111.973 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 8' ' ' LEU . 6.0 mp -106.29 171.23 4.96 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.569 -0.707 . . . . 0.0 109.634 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 44.5 Cg_endo -71.35 -39.44 3.8 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.72 1.379 . . . . 0.0 110.401 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 3.1 m-20 172.19 37.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.338 -0.851 . . . . 0.0 109.681 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.535 ' CB ' ' HA ' ' A' ' 56' ' ' GLN . 69.9 p -114.58 162.72 16.38 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.329 -0.857 . . . . 0.0 110.957 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.526 ' CB ' ' HG ' ' A' ' 97' ' ' LEU . . . -135.57 161.13 36.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.378 -0.826 . . . . 0.0 109.96 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.535 ' CD1' HD12 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -133.28 153.65 51.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.167 -0.958 . . . . 0.0 110.553 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.559 ' CD2' HD13 ' A' ' 36' ' ' LEU . 30.7 m80 -96.58 136.35 37.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.0 109.642 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.672 ' CD1' ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -135.67 167.18 21.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.126 -0.984 . . . . 0.0 110.561 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 3.2 ttmt -119.04 117.58 29.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.17 -0.956 . . . . 0.0 110.049 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.551 ' CB ' ' HB2' ' A' ' 33' ' ' ASP . . . -75.76 117.54 17.61 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.311 -0.868 . . . . 0.0 109.864 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 48' ' ' GLU . 61.4 mt -108.62 100.94 10.13 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.188 0.518 . . . . 0.0 109.963 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.3 tp -163.79 144.74 8.83 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.157 -0.964 . . . . 0.0 110.294 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -85.2 110.78 19.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.379 -0.826 . . . . 0.0 109.061 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.52 ' CB ' HG21 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -128.23 112.55 14.63 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.103 -0.998 . . . . 0.0 111.103 -178.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.424 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 25.5 tt0 -94.26 113.84 25.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.348 -0.845 . . . . 0.0 109.265 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.87 163.82 19.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.363 -0.836 . . . . 0.0 110.503 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.78 -31.45 18.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.297 -0.877 . . . . 0.0 110.234 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.35 -11.5 10.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.347 -0.846 . . . . 0.0 110.33 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.457 ' O ' ' CB ' ' A' ' 27' ' ' ASP . . . -87.1 5.06 85.85 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER 66.17 10.73 7.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.329 -1.101 . . . . 0.0 110.372 179.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 27' ' ' ASP . 29.6 ttpt 55.94 112.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.275 -0.891 . . . . 0.0 110.391 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.553 ' CG1' ' HB3' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -90.15 150.08 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.154 -0.967 . . . . 0.0 109.794 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 30' ' ' VAL . 25.2 m -133.39 81.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 0.0 110.336 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 42.36 66.87 0.67 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 110.189 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.52 20.18 0.09 OUTLIER Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.373 -1.394 . . . . 0.0 110.895 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.551 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -89.09 152.39 21.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.478 -1.601 . . . . 0.0 108.984 179.191 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 23.0 tt0 -155.23 140.12 17.25 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.907 -1.12 . . . . 0.0 110.498 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.602 ' CE2' HD22 ' A' ' 15' ' ' LEU . 5.2 p90 -162.94 172.78 14.56 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.661 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.559 HD13 ' CD2' ' A' ' 14' ' ' HIS . 16.9 tp -90.53 159.93 16.23 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.394 0.616 . . . . 0.0 110.733 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.59 ' CD1' ' HB3' ' A' ' 40' ' ' PRO . 0.6 OUTLIER -135.38 114.77 12.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.321 -0.862 . . . . 0.0 109.952 179.629 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.495 ' CG ' HD21 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -86.96 135.47 33.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.515 -0.741 . . . . 0.0 110.369 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.596 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 54.02 44.31 72.77 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 52.9 Cg_endo -77.03 42.76 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.492 1.259 . . . . 0.0 110.959 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.581 ' HA2' ' O ' ' A' ' 5' ' ' GLN . . . -65.1 -25.12 70.77 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.6 p -101.63 12.95 36.32 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.831 -1.394 . . . . 0.0 109.77 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.441 ' HB3' ' HB2' ' A' ' 40' ' ' PRO . 16.6 t80 -86.88 122.53 30.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.393 -0.817 . . . . 0.0 109.556 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.448 HG23 ' HD2' ' A' ' 45' ' ' PRO . 3.7 mp -116.98 145.25 35.17 Favored Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.224 -0.922 . . . . 0.0 109.508 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.472 ' HB3' HG23 ' A' ' 51' ' ' VAL . 43.0 Cg_endo -69.56 83.44 0.66 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.874 1.46 . . . . 0.0 110.172 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -95.72 152.93 18.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.414 -0.804 . . . . 0.0 110.697 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -41.55 -42.97 2.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.352 -0.843 . . . . 0.0 110.69 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -42.55 -47.94 5.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.856 . . . . 0.0 110.434 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.545 ' CG1' ' HA ' ' A' ' 17' ' ' ALA . 1.2 m -136.15 173.85 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.313 -0.867 . . . . 0.0 110.332 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -133.16 142.02 48.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.388 -0.82 . . . . 0.0 110.206 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.472 HG23 ' HB3' ' A' ' 45' ' ' PRO . 47.7 t -62.56 130.36 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.229 -0.919 . . . . 0.0 109.833 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.481 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 28.2 t -107.82 -61.32 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 110.588 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.422 ' CD ' ' O ' ' A' ' 52' ' ' VAL . 7.8 mm-40 -139.89 168.08 20.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.168 -0.958 . . . . 0.0 110.293 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.466 HD12 ' HB2' ' A' ' 13' ' ' LEU . 1.4 mm -128.89 152.48 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.319 -0.863 . . . . 0.0 109.191 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.473 ' O ' ' HB ' ' A' ' 11' ' ' THR . 0.3 OUTLIER -149.65 152.25 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.952 -1.092 . . . . 0.0 110.697 -179.698 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.535 ' HA ' ' CB ' ' A' ' 11' ' ' THR . 0.2 OUTLIER -123.94 177.89 5.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.432 -0.792 . . . . 0.0 110.078 179.542 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.529 ' HB3' ' CB ' ' A' ' 95' ' ' ALA . . . -87.25 130.02 34.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.186 -0.946 . . . . 0.0 110.727 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 1.5 t 177.41 52.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 111.018 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.565 HD12 ' CD2' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -157.09 -59.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.608 -1.308 . . . . 0.0 111.591 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.553 HG13 HG22 ' A' ' 59' ' ' ILE . 2.3 mt -92.51 -174.46 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 120.14 -1.6 . . . . 0.0 110.8 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.548 ' O ' ' CA ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -101.25 169.43 8.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.4 -0.812 . . . . 0.0 110.114 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.525 ' HA ' ' HA ' ' A' ' 93' ' ' VAL . 0.5 OUTLIER -67.3 -72.69 0.16 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.203 -0.935 . . . . 0.0 111.974 -179.006 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.53 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 5.7 p30 -39.62 -24.1 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.297 -0.877 . . . . 0.0 112.07 -178.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.508 ' HG2' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -57.22 167.98 0.81 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.609 -1.307 . . . . 0.0 112.206 -178.775 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.522 ' CB ' HG12 ' A' ' 108' ' ' VAL . . . -150.35 131.25 14.22 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.541 ' HG ' ' CG1' ' A' ' 90' ' ' VAL . 2.5 pp -129.3 127.42 41.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.513 -1.367 . . . . 0.0 112.395 -178.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.529 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . 12.5 ttt180 -103.64 130.01 51.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.784 -0.572 . . . . 0.0 109.553 178.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.445 HD21 ' HA ' ' A' ' 104' ' ' VAL . 35.2 mt -117.76 149.53 40.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.18 -0.95 . . . . 0.0 111.007 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.424 ' C ' ' HG2' ' A' ' 102' ' ' GLU . 22.7 ttp180 -114.53 139.89 49.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.537 -0.727 . . . . 0.0 109.883 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.456 ' HB3' ' HA ' ' A' ' 84' ' ' THR . . . -60.45 147.6 40.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.144 -0.973 . . . . 0.0 110.376 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -107.05 -44.1 4.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 109.874 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.582 ' HD2' ' CE2' ' A' ' 101' ' ' PHE . 15.2 ptpt -122.41 134.79 54.6 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.269 -0.894 . . . . 0.0 109.809 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.5 ' N ' ' HB ' ' A' ' 84' ' ' THR . 2.4 pt-20 -57.16 96.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.205 -0.935 . . . . 0.0 110.644 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.52 -42.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 110.443 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.581 ' CB ' ' HB2' ' A' ' 101' ' ' PHE . 2.5 t90 -74.64 120.34 20.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.214 -0.929 . . . . 0.0 110.701 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -117.19 110.21 17.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -0.923 . . . . 0.0 109.401 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.556 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -59.38 -23.06 62.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 110.219 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.452 ' OD2' ' HE2' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -88.57 -21.44 24.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 110.14 179.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.26 16.37 27.69 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.452 ' HE2' ' OD2' ' A' ' 78' ' ' ASP . 25.1 mttm -110.39 -137.89 0.37 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.218 -1.166 . . . . 0.0 110.147 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.553 ' HB3' ' CG1' ' A' ' 29' ' ' VAL . 7.9 mp0 -134.98 105.42 6.36 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.03 -1.043 . . . . 0.0 110.327 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.75 179.54 5.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.224 -0.922 . . . . 0.0 110.68 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.3 p -91.67 174.45 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.422 -0.799 . . . . 0.0 110.79 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.5 ' HB ' ' N ' ' A' ' 73' ' ' GLU . 4.6 t -72.01 -6.53 42.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.318 -0.864 . . . . 0.0 110.361 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.03 -19.27 70.29 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.455 ' O ' ' HB1' ' A' ' 70' ' ' ALA . 8.0 tp10 -66.94 160.61 25.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.462 -1.022 . . . . 0.0 110.053 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.432 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 6.1 pt-20 -154.87 168.12 27.98 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.38 -0.825 . . . . 0.0 110.05 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.592 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -147.5 143.94 28.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.127 -0.983 . . . . 0.0 109.979 179.587 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -115.46 124.46 51.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.108 -0.995 . . . . 0.0 110.208 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.541 ' CG1' ' HG ' ' A' ' 66' ' ' LEU . 8.5 p -107.05 132.37 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.313 -0.867 . . . . 0.0 110.518 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.494 HG21 HD12 ' A' ' 89' ' ' LEU . 3.5 p -115.4 29.37 8.05 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.488 0.661 . . . . 0.0 109.25 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 93' ' ' VAL . 20.1 m -74.65 171.81 13.21 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.417 -0.802 . . . . 0.0 109.55 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 62' ' ' GLN . 1.5 t -47.37 172.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.99 -1.069 . . . . 0.0 109.006 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.548 ' CA ' ' O ' ' A' ' 61' ' ' ARG . . . -45.24 -88.87 0.01 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.529 ' CB ' ' HB3' ' A' ' 57' ' ' ALA . . . 60.84 -167.79 0.18 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.569 -0.959 . . . . 0.0 110.213 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.565 ' CD2' HD12 ' A' ' 59' ' ' ILE . 1.0 OUTLIER -120.76 -65.46 1.14 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.711 -0.618 . . . . 0.0 109.827 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.526 ' HG ' ' CB ' ' A' ' 12' ' ' ALA . 0.3 OUTLIER 46.23 71.37 1.59 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.559 -0.713 . . . . 0.0 110.695 179.584 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -78.15 120.53 5.0 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.939 1.494 . . . . 0.0 110.092 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.512 ' HB3' ' CB ' ' A' ' 102' ' ' GLU . . . -73.55 138.82 45.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.21 -0.931 . . . . 0.0 110.275 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.498 HG23 ' HA ' ' A' ' 35' ' ' TRP . 30.5 m -69.65 -51.72 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.157 -0.965 . . . . 0.0 110.754 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.582 ' CE2' ' HD2' ' A' ' 72' ' ' LYS . 19.5 m-30 -112.78 26.4 10.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.732 -1.23 . . . . 0.0 110.464 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.548 ' CD ' ' CZ2' ' A' ' 75' ' ' TRP . 1.1 tt0 -121.63 141.95 50.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.011 -1.056 . . . . 0.0 110.464 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.03 152.26 36.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.418 -0.801 . . . . 0.0 110.333 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.445 ' HA ' HD21 ' A' ' 68' ' ' LEU . 12.4 p -94.45 133.06 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.259 -0.9 . . . . 0.0 110.075 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.472 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -102.76 -21.98 13.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.308 -0.87 . . . . 0.0 110.209 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -174.44 136.31 0.46 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.937 . . . . 0.0 110.396 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.4 pp -99.1 153.25 19.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.89 . . . . 0.0 109.965 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.522 HG12 ' CB ' ' A' ' 65' ' ' ALA . 2.5 p -130.93 147.25 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.083 -1.01 . . . . 0.0 110.605 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -107.19 126.29 52.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.857 . . . . 0.0 110.004 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . -66.96 139.13 57.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.927 . . . . 0.0 110.526 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 111' ' ' VAL . 47.7 t -141.89 91.45 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.414 -0.804 . . . . 0.0 109.811 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 71.8 mt -125.81 142.69 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.197 -0.939 . . . . 0.0 110.33 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.458 ' C ' ' CD1' ' A' ' 113' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.168 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 41' ' ' GLY . 4.8 mt-30 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.332 0.587 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.492 ' C ' ' HA3' ' A' ' 41' ' ' GLY . 36.0 m -125.02 158.97 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.307 -0.871 . . . . 0.0 109.519 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.46 ' C ' ' O ' ' A' ' 6' ' ' VAL . 40.5 t -38.78 106.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.267 -0.896 . . . . 0.0 110.54 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.618 HD23 ' OG1' ' A' ' 11' ' ' THR . 3.2 mp -61.09 169.11 2.26 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.549 -0.719 . . . . 0.0 110.694 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 10' ' ' ASN . 48.4 Cg_endo -79.52 63.37 8.72 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.136 1.598 . . . . 0.0 109.85 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.732 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER 64.86 41.95 4.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.504 -0.748 . . . . 0.0 110.824 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.618 ' OG1' HD23 ' A' ' 8' ' ' LEU . 14.9 p -118.98 171.34 8.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.121 -0.987 . . . . 0.0 109.759 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.662 ' CB ' HD22 ' A' ' 97' ' ' LEU . . . -145.0 161.9 38.24 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.887 -1.133 . . . . 0.0 110.814 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.012 HD11 HD11 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -133.53 156.15 48.31 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.33 -0.856 . . . . 0.0 110.441 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.584 ' CD2' HD13 ' A' ' 36' ' ' LEU . 44.7 m80 -91.93 124.04 35.74 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.131 -0.98 . . . . 0.0 110.631 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.012 HD11 HD11 ' A' ' 13' ' ' LEU . 2.4 mm? -111.42 151.31 28.68 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.341 -0.85 . . . . 0.0 110.303 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.641 ' HB2' HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -113.53 117.49 31.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.078 -1.014 . . . . 0.0 109.743 178.756 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.039 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -79.43 112.02 16.27 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.208 -0.933 . . . . 0.0 110.338 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.728 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -104.95 101.7 11.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.842 -0.536 . . . . 0.0 109.594 179.743 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.414 HD13 ' HG3' ' A' ' 48' ' ' GLU . 7.7 tp -161.91 147.0 13.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.09 -1.006 . . . . 0.0 110.584 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -89.46 101.76 14.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.365 -0.835 . . . . 0.0 109.613 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.92 ' HB2' HG22 ' A' ' 29' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 110.216 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.92 HG22 ' HB2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.232 0.539 . . . . 0.0 110.157 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 30' ' ' VAL . 24.0 m -134.8 82.37 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.156 -0.965 . . . . 0.0 110.074 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.728 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 40.79 75.27 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.528 -0.732 . . . . 0.0 110.305 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.16 26.93 0.06 OUTLIER Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.692 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 1.039 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 35.1 m-20 -98.71 149.58 22.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.635 -1.509 . . . . 0.0 110.006 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.822 ' OE2' HG11 ' A' ' 52' ' ' VAL . 3.3 tt0 -151.76 147.03 26.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.02 -1.05 . . . . 0.0 110.436 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.563 ' HA ' ' CG2' ' A' ' 100' ' ' VAL . 7.3 p90 -160.94 171.64 18.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.122 -0.986 . . . . 0.0 111.299 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.614 HD22 ' O ' ' A' ' 98' ' ' PRO . 15.3 tp -92.0 155.82 17.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.571 -0.706 . . . . 0.0 110.021 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.666 ' HB2' HD23 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -134.53 110.56 9.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.126 -0.984 . . . . 0.0 110.219 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.628 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 11.5 tm-20 -84.41 131.85 34.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.863 . . . . 0.0 110.445 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.615 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 66.57 43.56 91.9 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.641 ' HG3' HD23 ' A' ' 13' ' ' LEU . 55.6 Cg_endo -77.27 23.54 0.53 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.553 1.291 . . . . 0.0 111.218 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.492 ' HA3' ' C ' ' A' ' 6' ' ' VAL . . . -49.99 -44.62 41.52 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.422 ' O ' HD12 ' A' ' 44' ' ' ILE . 35.7 p -91.28 29.64 1.4 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -1.183 . . . . 0.0 110.677 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.506 ' HB3' ' O ' ' A' ' 40' ' ' PRO . 15.3 t80 -88.34 132.57 34.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.131 -0.981 . . . . 0.0 110.108 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.727 HG23 ' HD2' ' A' ' 45' ' ' PRO . 4.0 mp -123.31 146.86 50.62 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.34 -0.85 . . . . 0.0 109.534 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.727 ' HD2' HG23 ' A' ' 44' ' ' ILE . 44.3 Cg_endo -71.23 103.81 1.45 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.838 1.441 . . . . 0.0 110.669 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 49' ' ' VAL . 5.9 mtm180 -113.56 140.85 47.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.411 -0.806 . . . . 0.0 110.089 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 46' ' ' ARG . 1.1 tttm -41.71 -34.79 0.67 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.147 -0.97 . . . . 0.0 110.538 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.448 ' HB3' HG13 ' A' ' 49' ' ' VAL . 1.7 tt0 -53.01 -39.27 63.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.955 . . . . 0.0 110.522 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.4 m -144.98 173.3 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.262 -0.899 . . . . 0.0 109.62 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -142.14 139.83 32.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.849 -1.157 . . . . 0.0 110.671 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.846 HG23 ' CD1' ' A' ' 13' ' ' LEU . 6.5 p -55.52 127.69 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.253 -0.904 . . . . 0.0 110.027 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.822 HG11 ' OE2' ' A' ' 34' ' ' GLU . 2.9 t -106.58 -58.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 110.179 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.767 ' O ' HD13 ' A' ' 54' ' ' ILE . 13.1 mm-40 -140.43 170.57 15.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.404 -0.81 . . . . 0.0 110.199 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.767 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -132.76 150.49 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.305 -0.872 . . . . 0.0 109.312 179.612 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.517 HG21 ' HD2' ' A' ' 98' ' ' PRO . 0.5 OUTLIER -141.15 132.67 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.973 -1.08 . . . . 0.0 110.456 -179.529 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.48 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 15.2 mm-40 -89.92 178.62 6.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.402 -0.811 . . . . 0.0 110.449 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -102.54 133.53 47.37 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.194 -0.942 . . . . 0.0 110.811 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 1.3 t 173.61 63.16 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.297 -0.877 . . . . 0.0 111.015 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.912 HG22 ' O ' ' A' ' 95' ' ' ALA . 0.8 OUTLIER -171.18 -31.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.726 -1.234 . . . . 0.0 111.781 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.655 HG22 ' H ' ' A' ' 61' ' ' ARG . 10.1 mt -85.31 179.43 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.619 -1.301 . . . . 0.0 110.432 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.655 ' H ' HG22 ' A' ' 60' ' ' ILE . 1.2 mmt180 -112.17 -153.23 0.52 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.223 -0.923 . . . . 0.0 110.587 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 1.029 ' HA ' HG13 ' A' ' 93' ' ' VAL . 12.9 tt0 -90.86 -12.75 35.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.669 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 4.0 p30 -137.7 -24.89 1.02 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 0.0 111.071 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.454 ' OE1' ' O ' ' A' ' 65' ' ' ALA . 6.1 tp-100 -54.41 133.58 45.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.841 -1.162 . . . . 0.0 110.51 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.015 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -120.95 157.23 30.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.384 -0.822 . . . . 0.0 109.355 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 65' ' ' ALA . 2.8 mt -125.77 113.05 16.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.107 -0.995 . . . . 0.0 110.78 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.469 ' C ' HD23 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -91.68 121.59 33.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.26 -0.9 . . . . 0.0 109.269 178.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.869 ' CD2' HG23 ' A' ' 104' ' ' VAL . 6.0 mt -118.46 151.68 37.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.089 -1.007 . . . . 0.0 110.841 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 2.0 ttm-85 -121.82 155.28 35.69 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.416 -0.802 . . . . 0.0 109.778 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -65.44 152.64 43.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.173 -0.955 . . . . 0.0 110.855 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.516 ' CB ' ' O ' ' A' ' 101' ' ' PHE . 8.2 tpt180 -114.71 -27.37 7.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.375 -0.828 . . . . 0.0 109.837 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.661 ' O ' HG23 ' A' ' 84' ' ' THR . 29.8 mmmt -108.32 -94.66 0.4 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 0.0 109.684 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.54 ' CB ' ' O ' ' A' ' 72' ' ' LYS . 0.5 OUTLIER 164.39 29.72 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.464 -0.773 . . . . 0.0 110.465 179.597 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.2 m -138.64 -6.96 1.48 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.997 -1.064 . . . . 0.0 110.874 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.572 ' CB ' ' HB2' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -76.91 110.17 11.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.066 -1.021 . . . . 0.0 110.299 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.512 ' HB2' ' N ' ' A' ' 80' ' ' LYS . 3.1 p30 -93.16 132.13 37.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.271 -0.893 . . . . 0.0 110.055 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.569 ' HD2' ' CG ' ' A' ' 86' ' ' GLU . 1.7 mtp180 -80.1 -59.04 2.87 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.063 -1.023 . . . . 0.0 110.409 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -98.5 16.78 20.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.267 -0.896 . . . . 0.0 110.516 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.15 16.03 24.28 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.512 ' N ' ' HB2' ' A' ' 76' ' ' ASP . 40.9 mmtt -115.71 91.66 3.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -1.164 . . . . 0.0 110.248 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.438 ' HG3' ' CG1' ' A' ' 29' ' ' VAL . 1.7 tm-20 -43.56 101.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.233 -0.917 . . . . 0.0 110.281 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.548 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -100.67 179.24 4.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 0.0 110.223 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.739 HG23 ' H ' ' A' ' 85' ' ' GLY . 11.0 m -98.72 -178.59 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.227 -0.921 . . . . 0.0 110.589 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 72' ' ' LYS . 0.1 OUTLIER -58.18 -26.0 62.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.488 -0.757 . . . . 0.0 110.627 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.739 ' H ' HG23 ' A' ' 83' ' ' VAL . . . -69.03 -19.0 73.37 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.569 ' CG ' ' HD2' ' A' ' 77' ' ' ARG . 10.0 tp10 -73.7 143.46 46.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.183 -1.187 . . . . 0.0 110.312 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.461 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 3.9 pt-20 -149.31 155.44 40.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.296 -0.878 . . . . 0.0 110.2 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.87 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -136.88 154.77 50.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.088 -1.008 . . . . 0.0 110.129 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.024 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -114.87 134.68 54.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.278 -0.889 . . . . 0.0 110.573 -179.482 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 1.024 ' N ' HD22 ' A' ' 89' ' ' LEU . 3.6 m -99.8 130.14 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.254 -0.904 . . . . 0.0 110.16 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.565 HG23 HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -120.78 53.9 1.1 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.332 -0.855 . . . . 0.0 110.051 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.498 HG22 ' OD1' ' A' ' 10' ' ' ASN . 0.2 OUTLIER -85.36 160.23 19.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 110.456 -179.702 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.029 HG13 ' HA ' ' A' ' 62' ' ' GLN . 90.7 t -109.64 83.89 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.346 -0.846 . . . . 0.0 109.781 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 60' ' ' ILE . . . 87.4 79.53 1.24 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.912 ' O ' HG22 ' A' ' 59' ' ' ILE . . . -162.46 -143.32 0.08 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.28 -1.13 . . . . 0.0 110.599 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.533 ' O ' HD23 ' A' ' 97' ' ' LEU . 9.3 t80 177.17 104.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.662 HD22 ' CB ' ' A' ' 12' ' ' ALA . 15.6 mt -116.78 88.72 26.37 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.046 -1.034 . . . . 0.0 111.052 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.614 ' O ' HD22 ' A' ' 36' ' ' LEU . 49.9 Cg_endo -78.24 108.38 2.48 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.892 1.47 . . . . 0.0 109.825 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.49 ' HA ' ' HB2' ' A' ' 36' ' ' LEU . . . -65.2 -171.56 0.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.164 -0.96 . . . . 0.0 110.692 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.563 ' CG2' ' HA ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -110.49 -55.95 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.389 -0.819 . . . . 0.0 109.581 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.572 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 11.8 m-85 -101.5 -14.64 17.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.948 -1.095 . . . . 0.0 109.656 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.573 ' OE1' ' CD1' ' A' ' 88' ' ' TRP . 23.4 tt0 -93.83 123.94 37.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.363 -0.836 . . . . 0.0 110.906 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.33 164.12 11.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.308 -0.87 . . . . 0.0 109.77 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.869 HG23 ' CD2' ' A' ' 68' ' ' LEU . 8.4 p -86.65 146.76 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.123 -0.985 . . . . 0.0 110.539 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 104' ' ' VAL . 9.4 mp -104.0 -33.29 8.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.366 -0.834 . . . . 0.0 110.142 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.923 ' C ' HD22 ' A' ' 107' ' ' LEU . 0.3 OUTLIER -173.3 -166.55 0.34 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.254 -0.904 . . . . 0.0 110.401 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.923 HD22 ' C ' ' A' ' 106' ' ' ASP . 3.3 mm? -121.54 153.44 37.98 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.25 -0.907 . . . . 0.0 110.032 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.015 HG13 ' HB3' ' A' ' 65' ' ' ALA . 2.8 p -139.05 107.79 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.08 -1.012 . . . . 0.0 110.987 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -70.17 118.28 12.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.882 . . . . 0.0 110.222 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.219 -0.925 . . . . 0.0 110.42 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.467 ' O ' ' O ' ' A' ' 41' ' ' GLY . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.111 0.481 . . . . 0.0 109.86 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.502 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 9.0 m -114.14 176.9 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.09 -1.006 . . . . 0.0 110.21 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.506 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 78.0 t -54.81 143.35 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.426 -0.796 . . . . 0.0 110.769 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.58 HD13 ' N ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -96.5 167.2 12.67 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.433 -0.792 . . . . 0.0 110.052 179.644 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.496 ' O ' ' HB2' ' A' ' 10' ' ' ASN . 46.3 Cg_endo -73.94 69.59 4.6 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.989 1.521 . . . . 0.0 109.52 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 1.043 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 14.6 m-80 60.71 64.48 1.16 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.455 -0.778 . . . . 0.0 110.74 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.55 ' HB ' ' HA ' ' A' ' 56' ' ' GLN . 30.7 p -140.55 172.11 13.17 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.216 -0.927 . . . . 0.0 110.184 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.565 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -144.42 169.33 18.13 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.941 . . . . 0.0 110.017 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.948 HD23 ' CB ' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -134.21 147.62 50.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.084 -1.01 . . . . 0.0 110.148 179.521 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.82 ' CE1' HD13 ' A' ' 36' ' ' LEU . 11.7 m80 -90.26 126.66 35.91 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.039 -1.038 . . . . 0.0 110.395 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.952 HD21 ' HB2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -136.75 155.72 49.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.11 -0.994 . . . . 0.0 110.351 179.37 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.476 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -104.82 122.86 46.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.455 -0.778 . . . . 0.0 110.064 -179.712 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.066 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -82.89 117.82 23.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.934 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.876 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 1.4 mm? -106.72 101.06 10.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.742 -0.599 . . . . 0.0 110.635 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.817 ' C ' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -166.96 165.14 16.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.247 -0.908 . . . . 0.0 110.093 179.409 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.505 ' N ' HD22 ' A' ' 19' ' ' LEU . 80.7 m-20 -96.25 110.73 22.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 0.0 110.612 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.914 ' CB ' HG22 ' A' ' 29' ' ' VAL . 1.1 t80 . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.317 -0.864 . . . . 0.0 110.087 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.914 HG22 ' CB ' ' A' ' 21' ' ' PHE . 2.0 m . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.233 0.54 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 30' ' ' VAL . 18.6 m -129.77 84.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.083 -1.011 . . . . 0.0 110.312 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.876 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 45.4 69.27 0.46 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.34 -0.85 . . . . 0.0 110.117 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -174.91 27.01 0.08 OUTLIER Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.41 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 1.066 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 1.5 m-20 -89.47 144.97 25.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.877 -1.366 . . . . 0.0 109.966 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.071 ' HG2' HG11 ' A' ' 100' ' ' VAL . 5.7 tt0 -142.57 131.09 22.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -0.99 . . . . 0.0 110.086 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.617 ' CH2' HD12 ' A' ' 15' ' ' LEU . 1.8 p90 -161.37 174.15 13.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.986 -1.071 . . . . 0.0 110.776 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.82 HD13 ' CE1' ' A' ' 14' ' ' HIS . 55.9 tp -94.05 162.09 14.02 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.519 -0.738 . . . . 0.0 110.045 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.952 ' HB2' HD21 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -131.84 110.36 10.77 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.986 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.639 ' HG2' HD11 ' A' ' 97' ' ' LEU . 0.6 OUTLIER -82.48 142.85 31.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.409 -0.807 . . . . 0.0 110.397 -179.715 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.596 ' N ' ' HD3' ' A' ' 40' ' ' PRO . . . 55.66 44.42 86.3 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.948 ' CB ' HD23 ' A' ' 13' ' ' LEU . 54.6 Cg_endo -77.82 15.16 1.33 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.663 1.349 . . . . 0.0 111.086 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 7' ' ' VAL . . . -53.27 -29.72 38.12 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.429 ' O ' ' CD1' ' A' ' 44' ' ' ILE . 48.9 p -103.45 17.19 24.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -1.17 . . . . 0.0 110.518 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.588 ' C ' HD12 ' A' ' 44' ' ' ILE . 12.1 t80 -87.44 125.89 34.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.875 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.803 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.2 mp -107.47 141.8 23.77 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 109.786 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.531 ' HD2' HG23 ' A' ' 44' ' ' ILE . 43.9 Cg_endo -70.57 97.3 0.7 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.957 1.504 . . . . 0.0 110.802 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.88 159.54 22.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.212 -0.93 . . . . 0.0 110.403 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.529 ' HG3' ' N ' ' A' ' 48' ' ' GLU . 16.0 pttm -48.93 -32.25 8.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.326 -0.859 . . . . 0.0 110.782 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.529 ' N ' ' HG3' ' A' ' 47' ' ' LYS . 2.6 tp10 -43.27 -40.52 3.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.085 -1.009 . . . . 0.0 110.206 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -150.13 167.92 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 0.0 110.159 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -122.44 124.47 43.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 0.0 109.949 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.518 HG13 HD13 ' A' ' 13' ' ' LEU . 21.7 t -54.58 133.03 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 109.653 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.934 HG23 ' HA ' ' A' ' 15' ' ' LEU . 4.7 t -111.36 -48.89 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.035 -1.041 . . . . 0.0 110.579 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.908 ' C ' HD13 ' A' ' 54' ' ' ILE . 0.5 OUTLIER -149.6 168.57 23.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.146 -0.971 . . . . 0.0 109.936 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.908 HD13 ' C ' ' A' ' 53' ' ' GLU . 1.2 mm -129.94 131.15 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.378 -0.826 . . . . 0.0 108.974 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.665 HD13 ' N ' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -120.84 136.45 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.028 -1.045 . . . . 0.0 111.334 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.665 ' N ' HD13 ' A' ' 55' ' ' ILE . 56.8 mm-40 -97.69 176.55 5.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.601 -0.687 . . . . 0.0 109.929 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.043 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -90.84 140.23 30.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.202 -0.936 . . . . 0.0 109.825 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 3.4 t -179.49 38.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.017 -1.052 . . . . 0.0 111.536 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.731 HG21 ' CG ' ' A' ' 96' ' ' TYR . 0.6 OUTLIER -159.9 -74.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.536 -1.353 . . . . 0.0 111.827 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.718 ' H ' HG23 ' A' ' 59' ' ' ILE . 77.0 mt -63.31 159.72 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.56 -1.338 . . . . 0.0 110.393 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.36 -166.37 1.08 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.296 -0.878 . . . . 0.0 110.575 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.929 ' HB2' HG13 ' A' ' 93' ' ' VAL . 1.7 tt0 -75.61 -70.82 0.41 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.444 -0.785 . . . . 0.0 110.568 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.843 ' HB3' ' HB2' ' A' ' 110' ' ' ALA . 31.1 m-20 -60.55 -33.82 73.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.362 -0.836 . . . . 0.0 110.42 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -59.46 141.18 55.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.188 -0.945 . . . . 0.0 110.84 -179.774 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.962 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -123.03 140.53 52.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.827 . . . . 0.0 109.773 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.716 HD12 HD21 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -126.19 108.33 11.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.104 -0.997 . . . . 0.0 110.534 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 1.022 ' O ' HD23 ' A' ' 68' ' ' LEU . 4.8 ttm105 -91.2 135.9 33.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.129 -0.982 . . . . 0.0 109.585 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.022 HD23 ' O ' ' A' ' 67' ' ' ARG . 5.4 mt -133.99 150.18 51.24 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.209 -0.932 . . . . 0.0 110.935 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 13.9 ttm180 -107.02 163.81 12.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.461 -0.775 . . . . 0.0 109.641 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -80.57 118.5 22.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.177 -0.952 . . . . 0.0 110.478 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.53 -30.37 52.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.144 -0.972 . . . . 0.0 109.133 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -133.75 157.54 45.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.601 -0.687 . . . . 0.0 109.204 179.45 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.518 ' O ' ' HB3' ' A' ' 74' ' ' CYS . 1.0 OUTLIER -84.65 -179.2 7.07 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.023 -1.048 . . . . 0.0 110.802 -179.367 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER 75.05 -16.01 0.61 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.647 -0.658 . . . . 0.0 111.32 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.612 ' CZ2' ' CG ' ' A' ' 77' ' ' ARG . 5.0 t90 -74.37 104.64 5.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.631 -1.293 . . . . 0.0 110.232 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.513 ' O ' ' CD1' ' A' ' 35' ' ' TRP . 7.4 p-10 -84.8 124.48 31.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.085 -1.009 . . . . 0.0 109.68 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.612 ' CG ' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -80.99 -59.9 2.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.205 -0.935 . . . . 0.0 110.507 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -103.92 11.1 35.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 110.232 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.83 10.95 9.6 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -116.17 111.84 20.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -1.162 . . . . 0.0 110.401 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.496 ' OE2' ' CG ' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -71.47 102.77 2.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.194 -0.941 . . . . 0.0 109.711 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -109.35 178.79 4.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.153 -0.967 . . . . 0.0 110.307 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.633 HG13 ' H ' ' A' ' 85' ' ' GLY . 8.8 p -77.37 174.37 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 0.0 110.29 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.715 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 14.6 t -69.57 -16.39 63.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.203 -0.935 . . . . 0.0 109.984 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.633 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -72.18 -23.01 78.62 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' A' ' 87' ' ' GLU . 6.5 tp10 -63.09 160.05 16.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -1.134 . . . . 0.0 110.212 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.457 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 10.5 pt-20 -149.9 156.54 41.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 110.169 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.568 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -136.21 148.6 48.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.196 -0.94 . . . . 0.0 109.693 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.963 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -102.06 128.31 48.57 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.315 -0.866 . . . . 0.0 110.45 -179.428 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.963 ' N ' HD22 ' A' ' 89' ' ' LEU . 2.7 t -89.15 124.48 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.589 -0.694 . . . . 0.0 110.073 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.477 ' OG1' ' CD1' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -129.74 33.29 4.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -0.904 . . . . 0.0 109.857 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.63 152.6 37.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.856 . . . . 0.0 109.905 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.929 HG13 ' HB2' ' A' ' 62' ' ' GLN . 44.7 t -93.41 109.6 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.181 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.899 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 69.78 76.92 0.47 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -176.42 -175.23 0.65 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -1.124 . . . . 0.0 110.738 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.731 ' CG ' HG21 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -117.13 -61.86 1.65 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.403 -0.81 . . . . 0.0 110.608 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.639 HD11 ' HG2' ' A' ' 38' ' ' GLU . 2.9 mm? 58.45 51.87 4.34 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.063 -1.023 . . . . 0.0 109.733 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 97' ' ' LEU . 50.2 Cg_endo -75.47 -2.31 12.41 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.111 1.585 . . . . 0.0 111.329 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.559 ' HA ' ' CB ' ' A' ' 36' ' ' LEU . . . 51.87 -178.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.059 -1.026 . . . . 0.0 110.093 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 1.071 HG11 ' HG2' ' A' ' 34' ' ' GLU . 2.4 t -97.21 -63.93 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.664 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.556 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 7.5 m-30 -94.09 67.66 3.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.966 -1.083 . . . . 0.0 109.385 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -139.85 144.75 37.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 111.282 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -132.38 121.35 23.33 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.793 ' HB ' HD22 ' A' ' 68' ' ' LEU . 9.0 p -76.89 144.52 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.15 -0.969 . . . . 0.0 111.091 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.761 ' N ' HD22 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -99.17 -26.23 14.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.664 -0.648 . . . . 0.0 109.409 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -177.95 -178.8 0.71 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 110.039 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.35 149.25 44.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.201 -0.937 . . . . 0.0 110.287 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.962 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 11.0 p -131.81 156.3 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.243 -0.911 . . . . 0.0 110.255 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.511 ' O ' ' C ' ' A' ' 110' ' ' ALA . 7.6 p30 -111.18 113.49 26.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.072 -1.017 . . . . 0.0 110.461 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.843 ' HB2' ' HB3' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.5 2.067 0 CA-C-O 120.956 0.408 . . . . 0.0 111.942 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.531 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.432 0.634 . . . . 0.0 110.735 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.537 HG23 ' N ' ' A' ' 7' ' ' VAL . 33.1 m -74.8 -133.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.214 -0.929 . . . . 0.0 109.257 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.537 ' N ' HG23 ' A' ' 6' ' ' VAL . 21.0 t -105.78 151.76 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.986 -1.071 . . . . 0.0 109.607 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.883 HD23 ' OG1' ' A' ' 11' ' ' THR . 5.4 mp -103.64 157.69 33.37 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 110.256 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -74.18 -49.28 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.061 1.558 . . . . 0.0 110.495 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 1.082 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 5.4 p30 -163.46 27.29 0.09 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.873 . . . . 0.0 110.471 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.883 ' OG1' HD23 ' A' ' 8' ' ' LEU . 19.0 p -104.81 151.7 23.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.965 -1.084 . . . . 0.0 111.125 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.779 ' HB3' HD22 ' A' ' 97' ' ' LEU . . . -132.18 165.45 24.06 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.929 ' CD2' HD12 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -133.88 153.17 51.94 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.788 -1.195 . . . . 0.0 110.485 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.819 ' C ' HD13 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -92.15 136.29 33.3 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.504 -0.748 . . . . 0.0 109.105 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.953 HD13 ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -139.39 153.37 47.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.013 -1.054 . . . . 0.0 110.6 179.763 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 0.3 OUTLIER -113.52 117.53 31.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.267 -0.896 . . . . 0.0 109.91 -179.615 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.095 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -77.59 119.37 21.05 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.24 -0.913 . . . . 0.0 110.195 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.594 HD13 ' HB1' ' A' ' 31' ' ' ALA . 2.4 mm? -103.04 101.01 10.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.772 -0.58 . . . . 0.0 109.517 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.027 HD13 ' N ' ' A' ' 20' ' ' ASP . 2.1 tm? -164.98 144.21 6.79 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.011 -1.055 . . . . 0.0 110.262 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 1.027 ' N ' HD13 ' A' ' 19' ' ' LEU . 2.7 m-20 -85.05 118.72 24.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.667 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.679 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.168 -0.957 . . . . 0.0 110.766 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.679 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.654 ' O ' HG23 ' A' ' 30' ' ' VAL . 31.4 m -141.04 89.16 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.074 -1.016 . . . . 0.0 110.451 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.594 ' HB1' HD13 ' A' ' 18' ' ' LEU . . . 44.24 63.66 1.57 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.384 -0.822 . . . . 0.0 110.163 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.93 21.62 0.1 OUTLIER Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.624 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 1.095 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 5.3 m-20 -87.1 149.49 24.65 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.676 -1.485 . . . . 0.0 109.557 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.598 ' OE2' HG11 ' A' ' 52' ' ' VAL . 31.6 tt0 -152.68 145.72 24.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.019 -1.051 . . . . 0.0 110.525 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.703 ' CZ3' ' HB2' ' A' ' 17' ' ' ALA . 6.7 p90 -167.99 168.93 11.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.211 -0.93 . . . . 0.0 110.616 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.682 HD11 ' ND1' ' A' ' 14' ' ' HIS . 0.5 OUTLIER -91.87 156.28 17.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.205 -0.934 . . . . 0.0 110.959 -178.843 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -132.2 111.04 11.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.486 -0.759 . . . . 0.0 109.894 179.604 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.584 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 4.7 tm-20 -79.17 140.19 37.81 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.568 -0.708 . . . . 0.0 109.64 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.612 ' N ' ' HD3' ' A' ' 40' ' ' PRO . . . 54.33 44.56 76.12 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 39' ' ' GLY . 54.5 Cg_endo -76.15 13.15 1.35 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.69 1.363 . . . . 0.0 111.262 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.599 ' HA3' HD13 ' A' ' 8' ' ' LEU . . . -49.95 -41.35 36.8 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.8 p -83.16 18.54 1.68 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.173 -1.192 . . . . 0.0 111.231 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.566 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 3.1 t80 -98.72 130.64 45.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.933 -1.105 . . . . 0.0 110.166 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.547 ' CG2' ' HD2' ' A' ' 45' ' ' PRO . 35.1 mm -114.49 146.01 35.01 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.45 -0.781 . . . . 0.0 109.045 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 44' ' ' ILE . 40.3 Cg_endo -66.22 74.58 0.36 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.733 1.386 . . . . 0.0 110.883 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -73.99 139.08 44.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.376 -0.827 . . . . 0.0 109.819 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.493 ' HG3' ' N ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -45.98 -24.2 0.39 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.917 . . . . 0.0 110.387 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.493 ' N ' ' HG3' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -56.64 -36.16 69.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.159 -0.963 . . . . 0.0 110.211 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.2 m -141.35 170.36 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.36 -0.838 . . . . 0.0 110.027 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -127.98 132.69 49.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.992 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.1 m -56.37 127.64 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.875 . . . . 0.0 110.321 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.827 HG23 ' HA ' ' A' ' 15' ' ' LEU . 21.8 t -96.54 -60.78 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.363 -0.836 . . . . 0.0 109.975 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.855 ' O ' HD13 ' A' ' 54' ' ' ILE . 12.1 mm-40 -143.97 175.88 9.69 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.202 -0.936 . . . . 0.0 110.408 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.855 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -136.74 134.52 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.296 -0.878 . . . . 0.0 108.971 179.349 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.649 HD13 ' N ' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -128.61 130.98 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.008 -1.058 . . . . 0.0 111.003 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.649 ' N ' HD13 ' A' ' 55' ' ' ILE . 6.1 mm100 -94.91 134.28 37.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.499 -0.751 . . . . 0.0 109.412 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.082 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -49.27 137.26 14.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.081 -1.012 . . . . 0.0 110.804 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 8.7 t -179.51 45.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.309 -0.869 . . . . 0.0 111.587 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.648 HG21 ' CD1' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -162.48 -53.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.454 -1.404 . . . . 0.0 111.803 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.568 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 21.8 mt -57.37 165.16 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.552 -1.343 . . . . 0.0 109.947 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.451 ' N ' ' CG2' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -93.34 -161.97 0.89 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.339 -0.851 . . . . 0.0 111.057 -179.431 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.877 ' HA ' HG13 ' A' ' 93' ' ' VAL . 0.7 OUTLIER -58.85 -70.25 0.16 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.461 -0.774 . . . . 0.0 110.72 -179.621 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 15.2 p30 -113.95 26.33 10.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.137 -0.977 . . . . 0.0 110.181 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.442 ' OE1' ' O ' ' A' ' 65' ' ' ALA . 1.8 tp-100 -59.84 138.99 57.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 110.4 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.977 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -113.91 130.32 56.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.383 -0.823 . . . . 0.0 109.706 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.618 HD21 HD12 ' A' ' 107' ' ' LEU . 42.1 mt -125.04 121.33 34.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 110.275 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.599 ' O ' HD12 ' A' ' 105' ' ' LEU . 21.1 ttm-85 -96.83 128.25 43.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.347 -0.845 . . . . 0.0 110.177 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.593 HD23 ' HA ' ' A' ' 104' ' ' VAL . 31.6 mt -118.16 147.2 43.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 109.992 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 11.7 ttt180 -117.39 146.9 43.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 110.243 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.505 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -67.88 136.49 54.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.345 -0.847 . . . . 0.0 110.807 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -116.12 -8.63 11.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.345 -0.847 . . . . 0.0 109.656 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -141.21 108.68 5.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.338 -0.851 . . . . 0.0 109.727 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.716 ' HG3' HG12 ' A' ' 83' ' ' VAL . 28.2 tt0 -56.59 103.49 0.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.066 -1.021 . . . . 0.0 110.045 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 2.1 t 179.27 -33.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.46 -0.775 . . . . 0.0 109.938 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.524 ' CD1' ' C ' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -75.47 137.2 40.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.418 -0.801 . . . . 0.0 110.11 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 13.6 p-10 -102.18 110.2 22.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.864 . . . . 0.0 110.259 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.521 ' NE ' ' O ' ' A' ' 77' ' ' ARG . 5.4 tpm_? -88.5 -19.93 25.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.177 -0.952 . . . . 0.0 109.309 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.55 -12.67 23.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.465 -0.772 . . . . 0.0 109.638 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 115.16 -5.82 21.72 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.434 ' O ' ' CB ' ' A' ' 81' ' ' GLU . 12.4 mmmt -114.89 -70.35 0.8 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.189 -1.183 . . . . 0.0 110.221 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER 171.36 119.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.364 -0.835 . . . . 0.0 109.789 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.49 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 17.1 mmm180 -111.38 178.5 4.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 110.394 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.716 HG12 ' HG3' ' A' ' 73' ' ' GLU . 29.8 m -110.91 179.24 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 110.345 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.446 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 3.3 t -56.2 -27.0 53.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 110.093 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.458 ' O ' ' OE2' ' A' ' 87' ' ' GLU . . . -65.23 -23.77 70.1 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.49 ' CB ' ' HB3' ' A' ' 82' ' ' ARG . 22.1 tp10 -74.63 158.72 33.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.368 -1.078 . . . . 0.0 110.226 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.477 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -157.4 164.83 37.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.338 -0.851 . . . . 0.0 109.962 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.523 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -140.93 149.34 41.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.215 -0.928 . . . . 0.0 110.24 -179.749 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.791 HD13 ' C ' ' A' ' 89' ' ' LEU . 1.3 tm? -112.79 124.36 52.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.345 -0.847 . . . . 0.0 109.633 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.597 ' N ' HD22 ' A' ' 89' ' ' LEU . 8.0 p -105.44 132.36 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.173 -0.954 . . . . 0.0 110.847 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.48 ' OG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -135.88 56.1 1.84 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.301 -0.875 . . . . 0.0 110.006 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 54.5 m -97.51 119.52 36.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.954 . . . . 0.0 110.332 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.877 HG13 ' HA ' ' A' ' 62' ' ' GLN . 18.2 t -50.76 134.2 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.195 -0.941 . . . . 0.0 109.947 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.749 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 48.35 94.97 0.01 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.581 ' O ' HG22 ' A' ' 59' ' ' ILE . . . 178.67 154.79 0.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.088 -1.242 . . . . 0.0 110.949 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.648 ' CD1' HG21 ' A' ' 59' ' ' ILE . 2.5 t80 -134.67 87.18 2.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.488 -0.757 . . . . 0.0 110.15 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.779 HD22 ' HB3' ' A' ' 12' ' ' ALA . 16.9 mt -108.1 87.66 4.07 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.104 -0.998 . . . . 0.0 110.55 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.709 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 47.1 Cg_endo -72.54 -6.19 18.58 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.989 1.52 . . . . 0.0 110.438 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 98' ' ' PRO . . . 68.29 174.91 0.27 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.238 -0.914 . . . . 0.0 110.5 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.459 HG21 ' CA ' ' A' ' 35' ' ' TRP . 4.7 t -94.48 -58.31 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.856 . . . . 0.0 110.052 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 26.7 m-85 -109.45 53.43 0.69 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.1 -1.0 . . . . 0.0 110.318 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 3.2 tt0 -141.13 157.68 44.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.97 -1.081 . . . . 0.0 110.989 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 3.5 pt-20 -132.76 140.45 48.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.0 109.663 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.593 ' HA ' HD23 ' A' ' 68' ' ' LEU . 15.0 p -76.07 137.43 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.158 -0.964 . . . . 0.0 110.525 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.736 ' H ' HD12 ' A' ' 105' ' ' LEU . 1.7 mp -106.51 -19.3 13.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.443 -0.786 . . . . 0.0 110.145 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 37.6 p30 -176.43 162.7 2.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.338 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.618 HD12 HD21 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -120.42 141.99 49.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.361 -0.837 . . . . 0.0 109.778 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.977 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 12.7 p -139.31 160.59 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.064 -1.023 . . . . 0.0 110.859 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -110.73 116.94 32.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 109.549 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.492 1.656 0 O-C-N 120.98 -1.075 . . . . 0.0 110.687 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.246 0.546 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.471 ' O ' HD13 ' A' ' 8' ' ' LEU . 15.1 m -100.02 170.14 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 110.643 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.923 ' C ' HD13 ' A' ' 8' ' ' LEU . 23.2 t -46.87 153.0 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.431 -0.793 . . . . 0.0 110.45 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.923 HD13 ' C ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -106.5 171.41 4.78 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.283 -0.886 . . . . 0.0 108.863 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 45.8 Cg_endo -72.85 77.96 2.21 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.761 1.4 . . . . 0.0 110.156 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.549 ' HB3' ' CA ' ' A' ' 94' ' ' GLY . 78.2 m-20 58.28 74.21 0.44 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.44 -0.787 . . . . 0.0 110.513 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.496 ' HB ' ' HA ' ' A' ' 56' ' ' GLN . 2.9 p -148.39 169.78 19.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.253 -0.904 . . . . 0.0 110.426 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.665 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -147.28 162.95 37.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.455 -0.778 . . . . 0.0 109.768 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.931 HD23 ' HG3' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -133.25 155.78 48.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.006 -1.059 . . . . 0.0 110.833 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.82 ' CD2' HD21 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -93.15 123.92 36.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.445 -0.784 . . . . 0.0 109.636 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.835 HD21 ' HB2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -126.91 155.31 43.24 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.593 -1.317 . . . . 0.0 110.814 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -110.1 117.89 34.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.635 -0.666 . . . . 0.0 109.994 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.031 ' HB3' ' HB3' ' A' ' 33' ' ' ASP . . . -77.04 119.04 20.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 111.006 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 2.7 mm? -109.73 101.22 10.13 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.498 HD13 ' HG3' ' A' ' 48' ' ' GLU . 5.3 tp -164.42 155.5 15.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.017 -1.052 . . . . 0.0 110.482 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.414 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 12.5 p-10 -97.01 101.84 13.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.146 -0.971 . . . . 0.0 110.261 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.942 ' HB2' HG22 ' A' ' 29' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 109.716 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.942 HG22 ' HB2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.162 0.505 . . . . 0.0 109.744 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.564 ' O ' HG23 ' A' ' 30' ' ' VAL . 30.8 m -137.26 77.9 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.95 -1.094 . . . . 0.0 110.5 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 38.74 70.57 0.2 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.768 -0.583 . . . . 0.0 110.523 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.28 28.94 0.05 OUTLIER Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.849 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 1.031 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 18.2 t70 -96.69 149.04 22.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.813 -1.404 . . . . 0.0 109.883 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 36.3 tt0 -146.72 130.35 16.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.326 -0.859 . . . . 0.0 109.819 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.735 ' CZ2' HD12 ' A' ' 15' ' ' LEU . 7.6 p90 -154.81 171.28 19.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.126 -0.983 . . . . 0.0 110.955 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.82 HD21 ' CD2' ' A' ' 14' ' ' HIS . 0.6 OUTLIER -90.61 155.8 18.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.419 -0.801 . . . . 0.0 110.684 -179.587 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.835 ' HB2' HD21 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -132.51 110.49 10.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.365 -0.834 . . . . 0.0 110.008 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.506 ' HB2' HD11 ' A' ' 97' ' ' LEU . 2.1 tm-20 -95.98 135.51 37.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.38 -0.825 . . . . 0.0 110.065 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.604 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 69.71 45.15 59.93 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.931 ' HG3' HD23 ' A' ' 13' ' ' LEU . 44.1 Cg_endo -72.25 -57.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.854 1.45 . . . . 0.0 110.968 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.522 ' CA ' ' HA ' ' A' ' 7' ' ' VAL . . . 46.03 -89.9 0.01 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 40' ' ' PRO . 1.3 p -73.15 6.05 3.04 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.354 -1.086 . . . . 0.0 111.607 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.65 ' CE1' HD13 ' A' ' 15' ' ' LEU . 9.4 t80 -69.31 110.97 4.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.694 -1.254 . . . . 0.0 109.962 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.437 HG23 ' HD2' ' A' ' 45' ' ' PRO . 3.2 mt -105.97 139.92 20.73 Favored Pre-proline 0 C--N 1.297 -1.677 0 O-C-N 121.194 -0.941 . . . . 0.0 108.891 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.437 ' HD2' HG23 ' A' ' 44' ' ' ILE . 39.5 Cg_endo -66.4 76.37 0.36 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.762 1.401 . . . . 0.0 110.129 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 49' ' ' VAL . 4.6 mtt180 -73.3 153.08 40.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.516 -0.74 . . . . 0.0 110.185 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -43.13 -33.73 0.94 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.308 -0.87 . . . . 0.0 109.963 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.498 ' HG3' HD13 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -47.48 -51.44 20.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 109.821 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -136.06 174.02 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.456 -0.778 . . . . 0.0 109.38 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -134.16 126.63 30.37 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.108 -0.995 . . . . 0.0 110.126 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.822 HG23 HD13 ' A' ' 13' ' ' LEU . 12.4 p -53.84 132.33 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.175 -0.953 . . . . 0.0 108.847 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.545 HG23 ' HA ' ' A' ' 15' ' ' LEU . 44.6 t -109.65 -48.96 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.005 . . . . 0.0 111.195 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 1.043 ' O ' HD13 ' A' ' 54' ' ' ILE . 12.1 mt-10 -138.62 171.92 13.64 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.072 -1.017 . . . . 0.0 110.35 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 1.043 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -139.44 146.41 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.349 -0.844 . . . . 0.0 109.18 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.808 HD13 ' N ' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -141.84 141.89 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.111 -0.993 . . . . 0.0 110.385 -179.413 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.808 ' N ' HD13 ' A' ' 55' ' ' ILE . 8.4 mp0 -112.29 179.8 3.89 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.359 -0.838 . . . . 0.0 110.336 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.58 ' HB1' ' O ' ' A' ' 94' ' ' GLY . . . -80.34 139.5 36.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.264 -0.898 . . . . 0.0 110.3 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 58' ' ' THR . 11.8 t -179.93 56.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.362 -0.837 . . . . 0.0 110.054 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.805 HG22 ' N ' ' A' ' 60' ' ' ILE . 6.3 mm -155.69 -91.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.213 -0.929 . . . . 0.0 111.059 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.805 ' N ' HG22 ' A' ' 59' ' ' ILE . 17.5 mm -108.47 -104.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.836 -1.165 . . . . 0.0 110.839 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.644 ' N ' HG22 ' A' ' 60' ' ' ILE . 2.0 ttp180 -167.6 -170.24 1.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.777 -1.202 . . . . 0.0 110.496 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 1.009 ' HB2' HG13 ' A' ' 93' ' ' VAL . 50.1 tt0 -68.2 -57.14 6.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.842 . . . . 0.0 110.646 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.548 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 68.9 m-80 -34.52 -60.54 0.42 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.321 0.581 . . . . 0.0 111.112 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.434 ' OE1' HD23 ' A' ' 107' ' ' LEU . 4.0 tp-100 -53.6 129.11 31.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.048 -1.033 . . . . 0.0 110.785 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.022 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -108.18 142.39 38.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 109.727 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 65' ' ' ALA . 5.8 mp -124.34 115.03 20.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.604 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.837 ' O ' HD12 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -90.67 125.98 35.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 0.0 109.56 179.479 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 104' ' ' VAL . 13.6 mt -116.58 152.67 33.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.133 -0.98 . . . . 0.0 110.629 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.832 ' HB2' HD21 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -128.51 144.33 51.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 109.854 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.52 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -59.16 140.33 56.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.169 -0.957 . . . . 0.0 110.356 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.468 ' C ' ' CG2' ' A' ' 84' ' ' THR . 7.6 tpt180 -107.53 -18.07 13.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.894 . . . . 0.0 110.121 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.708 ' O ' HG23 ' A' ' 84' ' ' THR . 2.0 mmmp? -112.51 -98.74 0.42 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.952 . . . . 0.0 110.149 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 0.2 OUTLIER 168.09 45.85 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.318 -0.864 . . . . 0.0 109.986 179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 73' ' ' GLU . 17.2 m -154.89 -19.49 0.12 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.209 -0.932 . . . . 0.0 111.676 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.571 ' CB ' ' HB2' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -73.98 121.37 20.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.686 -1.258 . . . . 0.0 110.851 -179.291 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.516 ' HB2' ' CA ' ' A' ' 81' ' ' GLU . 12.5 t70 -108.87 122.47 47.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 0.0 109.665 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.56 ' CG ' ' CZ2' ' A' ' 75' ' ' TRP . 9.4 mtm180 -55.61 -28.24 54.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -0.874 . . . . 0.0 110.607 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.444 ' HB3' ' OD1' ' A' ' 76' ' ' ASP . 11.4 t70 -89.29 -35.11 16.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.168 -0.957 . . . . 0.0 110.218 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 80' ' ' LYS . . . 148.59 -38.87 0.99 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.561 ' HE2' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -59.31 -133.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.384 -1.068 . . . . 0.0 110.077 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.81 ' CG ' HG12 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -141.43 141.81 33.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.898 -1.126 . . . . 0.0 110.067 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.476 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 27.4 mmt-85 -136.22 163.8 29.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.066 -1.021 . . . . 0.0 110.254 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 19.9 m -86.45 -179.12 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.339 -0.85 . . . . 0.0 110.803 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 72' ' ' LYS . 0.1 OUTLIER -62.89 -26.62 68.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.45 -0.781 . . . . 0.0 110.418 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.493 ' H ' HG23 ' A' ' 83' ' ' VAL . . . -64.46 -30.87 79.07 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.476 ' CB ' ' HB3' ' A' ' 82' ' ' ARG . 7.9 tp10 -61.43 151.57 32.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.568 ' CG ' ' HG2' ' A' ' 69' ' ' ARG . 5.4 mt-10 -148.52 169.58 19.96 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.184 -0.948 . . . . 0.0 110.151 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.466 ' HB2' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -156.0 130.24 8.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.229 -0.919 . . . . 0.0 109.927 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.008 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -102.51 136.45 42.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.351 -0.843 . . . . 0.0 109.839 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 1.008 ' N ' HD22 ' A' ' 89' ' ' LEU . 9.7 p -111.39 135.37 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.901 . . . . 0.0 110.581 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.7 t -141.82 16.44 2.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.437 -0.789 . . . . 0.0 109.53 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.4 m -75.47 170.01 16.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.398 -0.814 . . . . 0.0 109.865 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.009 HG13 ' HB2' ' A' ' 62' ' ' GLN . 0.8 OUTLIER -79.14 147.68 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.099 -1.001 . . . . 0.0 109.1 179.524 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.797 ' O ' ' HB3' ' A' ' 95' ' ' ALA . . . 150.96 -13.3 0.85 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.133 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.797 ' HB3' ' O ' ' A' ' 94' ' ' GLY . . . 77.74 -35.04 0.2 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.361 -1.082 . . . . 0.0 111.674 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.655 ' CG ' HG13 ' A' ' 59' ' ' ILE . 1.0 OUTLIER -146.86 147.61 31.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.08 -1.013 . . . . 0.0 110.385 179.685 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.63 ' HB3' HG21 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -160.76 59.86 1.23 Allowed Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.401 -0.812 . . . . 0.0 109.883 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.586 ' HG3' ' CE2' ' A' ' 96' ' ' TYR . 53.0 Cg_endo -76.99 143.25 22.8 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.976 1.514 . . . . 0.0 110.787 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -95.04 -151.42 0.33 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.325 -0.859 . . . . 0.0 110.346 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.15 -66.26 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.219 -0.926 . . . . 0.0 110.485 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.571 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 9.1 m-30 -80.57 -22.18 40.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.937 -1.102 . . . . 0.0 110.013 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.571 ' OE1' ' CH2' ' A' ' 75' ' ' TRP . 0.7 OUTLIER -98.34 131.6 44.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.348 -0.845 . . . . 0.0 110.3 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -115.02 161.1 18.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.165 -0.959 . . . . 0.0 110.174 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.648 ' HA ' HD23 ' A' ' 68' ' ' LEU . 10.1 p -76.98 146.1 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.114 -0.992 . . . . 0.0 110.685 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.837 HD12 ' O ' ' A' ' 67' ' ' ARG . 1.5 mp -105.11 -24.67 12.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.413 -0.804 . . . . 0.0 109.709 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -166.04 174.35 9.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.266 -0.896 . . . . 0.0 110.037 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.434 HD23 ' OE1' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -121.95 131.19 53.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.23 -0.919 . . . . 0.0 110.064 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.022 HG13 ' HB3' ' A' ' 65' ' ' ALA . 14.6 p -125.16 157.14 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.17 -0.956 . . . . 0.0 110.414 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 0.6 OUTLIER -111.12 115.54 29.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.161 -0.962 . . . . 0.0 109.739 179.39 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.048 -1.033 . . . . 0.0 110.457 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.51 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 1.3 mt-30 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 7' ' ' VAL . 11.4 m -144.26 83.54 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.743 -1.223 . . . . 0.0 110.885 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.616 HG22 HG23 ' A' ' 42' ' ' THR . 2.0 t 27.04 99.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 CA-C-O 121.265 0.555 . . . . 0.0 111.682 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.011 HD23 ' OG1' ' A' ' 11' ' ' THR . 2.3 mp -61.52 168.76 2.91 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.076 -1.015 . . . . 0.0 110.098 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.456 ' O ' ' OD1' ' A' ' 10' ' ' ASN . 45.0 Cg_endo -72.67 -58.4 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.921 1.485 . . . . 0.0 110.406 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 9.6 m120 -162.04 30.87 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.805 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 1.011 ' OG1' HD23 ' A' ' 8' ' ' LEU . 1.1 p -109.9 172.09 7.06 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.312 -0.867 . . . . 0.0 110.22 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.743 ' HB2' HD21 ' A' ' 97' ' ' LEU . . . -144.5 161.32 39.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.213 -0.929 . . . . 0.0 110.659 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.11 ' CD2' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -133.64 155.49 49.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 109.896 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.697 ' C ' HD22 ' A' ' 15' ' ' LEU . 17.8 m80 -97.66 133.45 42.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 109.812 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.11 HD21 ' CD2' ' A' ' 13' ' ' LEU . 2.5 mm? -120.18 151.9 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.343 -0.848 . . . . 0.0 110.535 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -116.09 117.35 29.84 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.349 178.063 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.08 ' HB3' ' HB3' ' A' ' 33' ' ' ASP . . . -82.62 118.53 23.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.089 -1.007 . . . . 0.0 109.724 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.873 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 1.4 mm? -108.15 101.68 10.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.783 -0.573 . . . . 0.0 110.264 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.855 HD13 ' C ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -164.95 174.91 10.0 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 0.0 110.331 179.614 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.4 117.22 33.51 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.097 -1.002 . . . . 0.0 109.862 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.931 ' HB2' HG22 ' A' ' 29' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.143 -0.973 . . . . 0.0 110.583 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.931 HG22 ' HB2' ' A' ' 21' ' ' PHE . 1.4 m . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 30' ' ' VAL . 15.4 m -131.17 82.92 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.886 -1.134 . . . . 0.0 111.03 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.873 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 47.32 69.65 0.49 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.413 -0.805 . . . . 0.0 110.516 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -175.47 24.72 0.06 OUTLIER Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.694 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 1.08 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 11.5 t70 -86.99 143.41 27.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.783 -1.422 . . . . 0.0 110.242 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.76 ' HG2' HG11 ' A' ' 100' ' ' VAL . 8.9 tt0 -143.52 134.6 25.64 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.403 -0.811 . . . . 0.0 109.845 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.631 ' CZ2' ' HB2' ' A' ' 15' ' ' LEU . 13.5 p90 -150.26 163.97 36.93 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.994 -1.066 . . . . 0.0 111.237 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.533 HD13 ' CD2' ' A' ' 14' ' ' HIS . 42.0 tp -94.49 152.38 18.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.553 -0.717 . . . . 0.0 109.95 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.671 ' HB3' HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -133.0 110.66 10.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.064 -1.023 . . . . 0.0 110.367 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.95 ' OE1' HD11 ' A' ' 97' ' ' LEU . 16.5 tp10 -85.83 138.48 32.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.622 -0.674 . . . . 0.0 109.469 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.619 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 54.36 45.02 76.44 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 51.3 Cg_endo -72.13 4.27 3.4 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.827 1.435 . . . . 0.0 111.057 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.542 ' HA3' ' N ' ' A' ' 7' ' ' VAL . . . -42.0 -27.92 0.43 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.616 HG23 HG22 ' A' ' 7' ' ' VAL . 10.8 p -103.19 37.28 2.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.132 -1.217 . . . . 0.0 109.59 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.5 ' N ' ' O ' ' A' ' 40' ' ' PRO . 6.0 t80 -104.25 117.68 34.8 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.527 -0.733 . . . . 0.0 110.021 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.468 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.1 mp -96.47 124.11 52.09 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.235 -0.916 . . . . 0.0 110.318 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.93 127.05 11.11 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.827 1.435 . . . . 0.0 110.335 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -136.82 165.23 26.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.323 -0.86 . . . . 0.0 110.108 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -56.38 -18.83 12.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.732 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.5 ' C ' ' CG1' ' A' ' 49' ' ' VAL . 5.7 tt0 -67.55 -21.62 65.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.419 -0.801 . . . . 0.0 110.444 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.5 ' CG1' ' C ' ' A' ' 48' ' ' GLU . 1.4 m -151.65 173.95 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.026 -1.046 . . . . 0.0 110.38 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.4 137.24 37.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.322 -0.861 . . . . 0.0 110.215 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -57.55 114.55 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 109.526 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.567 HG11 ' OE2' ' A' ' 34' ' ' GLU . 14.4 t -90.96 -60.12 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.946 . . . . 0.0 111.068 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.931 ' C ' HD13 ' A' ' 54' ' ' ILE . 5.6 mt-10 -144.82 169.33 18.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.91 -1.119 . . . . 0.0 110.963 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.931 HD13 ' C ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -134.44 143.24 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.049 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.581 HD13 ' N ' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -137.25 130.14 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.963 -1.085 . . . . 0.0 110.605 -179.535 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.581 ' N ' HD13 ' A' ' 55' ' ' ILE . 2.4 mp0 -83.9 171.64 12.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.587 -0.696 . . . . 0.0 109.958 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.595 ' CA ' ' HA ' ' A' ' 95' ' ' ALA . . . -92.53 128.15 38.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.055 -1.028 . . . . 0.0 110.578 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER 172.71 60.98 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.24 -0.913 . . . . 0.0 111.424 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.566 ' CG2' ' N ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -166.43 -51.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.6 -1.313 . . . . 0.0 111.637 179.331 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.636 HD12 ' O ' ' A' ' 95' ' ' ALA . 3.5 mt -81.6 142.1 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.815 -1.178 . . . . 0.0 110.56 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.46 -170.39 0.28 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.315 -0.866 . . . . 0.0 110.745 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.795 ' HB2' HG13 ' A' ' 93' ' ' VAL . 1.1 tm0? -91.55 -35.89 14.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 0.0 110.445 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.589 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 13.0 m-20 -87.72 -29.65 20.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.521 -0.737 . . . . 0.0 110.965 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 109' ' ' ASP . 7.9 tp-100 -58.63 140.59 54.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.085 -1.009 . . . . 0.0 111.476 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.072 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -118.45 141.44 48.55 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 90' ' ' VAL . 0.5 OUTLIER -126.08 117.5 23.31 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.431 -0.793 . . . . 0.0 110.97 -178.939 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.544 ' HB3' HD22 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -92.37 125.81 37.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 0.0 109.81 179.328 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.749 HD12 ' OE1' ' A' ' 102' ' ' GLU . 3.5 mm? -112.15 134.09 53.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.984 . . . . 0.0 110.576 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.542 ' CB ' HD11 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -125.66 150.95 47.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -0.881 . . . . 0.0 110.057 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.585 ' CB ' ' HA ' ' A' ' 84' ' ' THR . . . -70.33 142.0 52.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.39 -0.819 . . . . 0.0 110.519 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.452 ' C ' HG23 ' A' ' 84' ' ' THR . 7.8 tpp180 -118.49 -24.45 6.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.429 -0.795 . . . . 0.0 109.615 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 74' ' ' CYS . 2.6 ttpt -127.69 109.35 11.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.493 -0.754 . . . . 0.0 109.847 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -47.17 90.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.436 -0.79 . . . . 0.0 110.346 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 72' ' ' LYS . 0.5 OUTLIER -177.46 -32.89 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 110.094 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.619 ' CZ3' ' HB3' ' A' ' 102' ' ' GLU . 2.8 t90 -75.16 114.75 14.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.327 -0.858 . . . . 0.0 110.011 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.481 ' OD1' ' HA ' ' A' ' 81' ' ' GLU . 67.5 m-20 -91.48 113.55 25.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.924 . . . . 0.0 110.357 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.436 ' HD2' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -57.08 -48.9 77.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.329 -0.857 . . . . 0.0 109.851 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -93.49 -16.3 24.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 109.892 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.77 32.96 5.46 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -129.34 47.99 2.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -1.107 . . . . 0.0 109.989 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.551 ' OE1' ' CE2' ' A' ' 21' ' ' PHE . 7.9 mp0 49.04 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.38 -0.825 . . . . 0.0 110.422 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.476 ' HB2' ' HA ' ' A' ' 76' ' ' ASP . 12.8 mmt180 -113.69 -179.96 3.79 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.393 -0.817 . . . . 0.0 110.121 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.498 HG22 ' N ' ' A' ' 84' ' ' THR . 10.9 p -120.87 165.74 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.223 -0.923 . . . . 0.0 110.651 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.585 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -51.2 -20.99 1.78 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.388 -0.82 . . . . 0.0 110.377 179.726 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.441 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -69.53 -11.58 65.41 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.462 ' HA ' ' OE1' ' A' ' 86' ' ' GLU . 2.1 tp10 -84.48 142.22 30.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.393 -1.063 . . . . 0.0 110.026 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -148.08 158.89 44.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.186 -0.946 . . . . 0.0 110.288 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.584 ' CZ2' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -144.6 134.77 24.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 109.909 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.016 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -95.56 128.7 42.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.14 -0.975 . . . . 0.0 110.055 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 1.016 ' N ' HD22 ' A' ' 89' ' ' LEU . 5.4 p -108.44 128.61 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 109.995 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.538 HG23 HD11 ' A' ' 89' ' ' LEU . 1.1 p -129.51 48.42 2.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -0.88 . . . . 0.0 110.197 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 m -75.83 169.68 17.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.132 -0.98 . . . . 0.0 109.993 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.795 HG13 ' HB2' ' A' ' 62' ' ' GLN . 89.7 t -115.14 131.76 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.216 -0.927 . . . . 0.0 110.495 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 60' ' ' ILE . . . 50.01 44.57 41.64 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.636 ' O ' HD12 ' A' ' 60' ' ' ILE . . . -134.33 157.8 45.43 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.222 -1.163 . . . . 0.0 111.036 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.544 ' CD2' HD11 ' A' ' 55' ' ' ILE . 1.3 t80 -121.78 113.85 20.26 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.95 HD11 ' OE1' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -126.37 84.9 61.14 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.049 -1.032 . . . . 0.0 111.029 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.525 ' O ' ' NE2' ' A' ' 14' ' ' HIS . 50.0 Cg_endo -77.48 117.44 4.32 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.142 1.601 . . . . 0.0 110.02 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.66 ' HB1' ' HG3' ' A' ' 102' ' ' GLU . . . -74.74 -168.95 0.79 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.026 -1.046 . . . . 0.0 110.431 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.76 HG11 ' HG2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -113.93 -57.21 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.205 -0.934 . . . . 0.0 110.45 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.509 ' CE2' ' HB3' ' A' ' 74' ' ' CYS . 21.9 m-30 -103.23 -32.14 9.75 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.75 -1.218 . . . . 0.0 110.672 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.749 ' OE1' HD12 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -80.07 154.83 27.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.199 -0.938 . . . . 0.0 110.641 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.582 ' C ' HD13 ' A' ' 68' ' ' LEU . 6.9 tp10 -128.94 167.73 17.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.458 -0.776 . . . . 0.0 110.2 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.454 ' C ' HD12 ' A' ' 105' ' ' LEU . 10.7 m -72.02 152.31 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.0 110.245 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.562 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 4.7 mp -100.06 -14.57 18.56 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.295 -0.878 . . . . 0.0 109.605 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.599 ' O ' HD22 ' A' ' 107' ' ' LEU . 1.8 p30 165.25 -168.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.61 -0.681 . . . . 0.0 110.151 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.599 HD22 ' O ' ' A' ' 106' ' ' ASP . 1.0 OUTLIER -127.01 116.08 20.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.464 -0.772 . . . . 0.0 109.416 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.072 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 2.0 p -115.87 103.71 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.832 -1.168 . . . . 0.0 111.037 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 3.8 t70 -75.61 115.66 15.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.279 -0.888 . . . . 0.0 110.125 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.886 . . . . 0.0 110.586 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.169 0.509 . . . . 0.0 110.261 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.462 ' C ' ' HA2' ' A' ' 41' ' ' GLY . 95.7 t -136.01 135.59 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.166 -0.959 . . . . 0.0 110.131 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.517 ' CG2' ' HA3' ' A' ' 41' ' ' GLY . 79.2 t -60.88 118.7 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 110.829 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.509 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 0.4 OUTLIER -79.16 167.24 36.18 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 109.717 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 42.9 Cg_endo -69.9 -37.12 9.26 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.612 1.322 . . . . 0.0 110.383 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.434 ' CG ' ' HA3' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -170.69 41.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.104 -0.998 . . . . 0.0 110.246 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.444 ' OG1' ' CB ' ' A' ' 8' ' ' LEU . 12.6 p -112.98 160.86 17.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.817 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.746 ' CB ' HD11 ' A' ' 36' ' ' LEU . . . -146.82 155.35 42.28 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.988 -1.07 . . . . 0.0 110.177 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.776 ' CD1' HD22 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -123.39 154.6 38.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.166 -0.959 . . . . 0.0 110.639 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.773 ' NE2' HD12 ' A' ' 55' ' ' ILE . 7.9 m170 -94.96 127.54 41.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 109.966 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.868 HD21 ' HB2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -136.1 148.35 48.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.931 -1.105 . . . . 0.0 110.661 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.492 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -100.78 121.15 41.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.547 -0.721 . . . . 0.0 110.359 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.069 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -82.46 113.57 20.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 110.028 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.456 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -105.12 99.6 9.21 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.547 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.456 ' CD2' ' O ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -167.5 133.33 2.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.356 -0.84 . . . . 0.0 110.079 179.565 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -78.26 101.84 7.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.014 -1.054 . . . . 0.0 108.693 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.788 ' HB2' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.12 -0.988 . . . . 0.0 111.542 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.886 HG12 ' CB ' ' A' ' 81' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.523 ' O ' HG23 ' A' ' 30' ' ' VAL . 27.0 m -132.64 78.54 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.978 -1.077 . . . . 0.0 111.056 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 30' ' ' VAL . . . 35.68 72.29 0.11 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.741 -0.599 . . . . 0.0 111.23 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.56 34.2 0.02 OUTLIER Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.365 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 1.069 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 3.8 m-20 -93.31 145.62 24.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.893 -1.357 . . . . 0.0 110.36 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 101' ' ' PHE . 14.1 tt0 -140.86 130.18 23.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 0.0 109.396 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.658 ' CH2' HD12 ' A' ' 15' ' ' LEU . 3.7 p90 -157.62 166.95 31.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.97 -1.081 . . . . 0.0 111.286 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.746 HD11 ' CB ' ' A' ' 12' ' ' ALA . 16.2 tp -90.36 155.69 18.77 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.531 -0.731 . . . . 0.0 109.183 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.868 ' HB2' HD21 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -126.42 108.61 11.36 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.099 -1.001 . . . . 0.0 109.841 -179.563 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.617 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -88.44 142.22 27.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.413 -0.804 . . . . 0.0 109.384 179.63 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.611 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 54.52 46.17 74.46 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.617 ' HG3' HD23 ' A' ' 13' ' ' LEU . 47.8 Cg_endo -71.33 18.32 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.861 1.453 . . . . 0.0 112.344 -178.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.517 ' HA3' ' CG2' ' A' ' 7' ' ' VAL . . . -44.81 156.75 0.25 Allowed Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 41' ' ' GLY . 20.3 p 53.45 12.13 0.33 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.662 -0.905 . . . . 0.0 111.583 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.543 ' HE2' HG12 ' A' ' 51' ' ' VAL . 7.0 t80 -75.62 132.37 40.58 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.702 -1.249 . . . . 0.0 109.548 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.422 ' HB ' ' CZ ' ' A' ' 46' ' ' ARG . 50.3 mt -120.52 134.48 24.19 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.054 -1.028 . . . . 0.0 110.492 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.3 78.46 2.29 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.968 1.509 . . . . 0.0 110.303 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 47' ' ' LYS . 22.8 mtm180 -91.58 151.02 20.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 110.364 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 48' ' ' GLU . 13.7 mttt -42.16 -31.78 0.41 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.238 -0.914 . . . . 0.0 110.287 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -42.9 -51.02 5.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.39 -0.819 . . . . 0.0 109.772 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -134.81 173.76 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.381 -0.825 . . . . 0.0 109.389 179.382 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.41 122.74 28.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.19 -0.944 . . . . 0.0 110.407 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.543 HG12 ' HE2' ' A' ' 43' ' ' TYR . 33.7 m -54.27 123.36 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.113 -0.992 . . . . 0.0 108.678 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.781 HG12 ' HG2' ' A' ' 53' ' ' GLU . 57.1 t -99.36 -54.51 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.148 -0.97 . . . . 0.0 110.472 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.934 ' O ' HD13 ' A' ' 54' ' ' ILE . 27.6 mm-40 -138.72 174.65 10.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 110.205 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.934 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -134.09 144.26 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.405 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.773 HD12 ' NE2' ' A' ' 14' ' ' HIS . 0.2 OUTLIER -134.26 144.67 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.961 -1.087 . . . . 0.0 111.138 -178.73 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.433 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 70.9 mm-40 -119.36 168.51 10.87 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.684 -0.635 . . . . 0.0 109.347 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.617 ' HB1' ' HB3' ' A' ' 95' ' ' ALA . . . -89.51 132.51 35.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.154 -0.966 . . . . 0.0 110.43 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.61 ' N ' ' CB ' ' A' ' 95' ' ' ALA . 1.5 t -176.24 71.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.13 -0.981 . . . . 0.0 111.293 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.771 HD13 ' C ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -176.66 -51.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.825 -1.172 . . . . 0.0 111.732 178.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.768 HG23 ' N ' ' A' ' 61' ' ' ARG . 1.0 OUTLIER -108.3 -167.36 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.157 -1.59 . . . . 0.0 110.791 -179.719 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.768 ' N ' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -123.43 -147.71 0.38 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.461 -0.774 . . . . 0.0 110.115 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.947 ' HB2' HG13 ' A' ' 93' ' ' VAL . 11.4 tt0 -89.67 -71.31 0.61 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.206 -0.934 . . . . 0.0 110.919 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 7.5 p-10 -34.16 -47.66 0.29 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.832 -0.543 . . . . 0.0 111.72 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.491 ' HG2' ' CG1' ' A' ' 60' ' ' ILE . 8.3 tp-100 -56.23 128.18 34.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.958 -1.089 . . . . 0.0 110.931 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.99 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -108.19 149.17 28.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.342 -0.849 . . . . 0.0 109.303 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.451 ' O ' HD22 ' A' ' 89' ' ' LEU . 1.4 mt -126.27 113.71 17.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.068 -1.02 . . . . 0.0 111.333 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.72 ' O ' HD12 ' A' ' 105' ' ' LEU . 1.5 ttm-85 -100.03 122.05 42.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.213 -0.929 . . . . 0.0 109.04 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.553 HD23 ' HA ' ' A' ' 104' ' ' VAL . 20.1 mt -119.21 145.69 45.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.106 -0.996 . . . . 0.0 111.277 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.886 ' CB ' HD21 ' A' ' 105' ' ' LEU . 2.0 ttp85 -121.03 152.6 38.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.541 -0.725 . . . . 0.0 110.059 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.559 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -71.7 159.9 33.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -0.929 . . . . 0.0 110.867 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 101' ' ' PHE . 4.4 tpm_? -132.0 -34.15 1.3 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.457 -0.777 . . . . 0.0 109.813 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -117.98 107.69 14.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 110.036 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.481 ' O ' ' CB ' ' A' ' 74' ' ' CYS . 0.8 OUTLIER -47.89 99.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.619 179.576 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER 169.71 -24.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.329 -0.857 . . . . 0.0 110.294 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.608 ' CZ3' ' HB2' ' A' ' 102' ' ' GLU . 1.3 t90 -74.72 126.73 31.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -0.923 . . . . 0.0 110.058 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 1.5 m-20 -90.82 110.85 22.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 110.001 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.574 ' HG3' ' CZ2' ' A' ' 75' ' ' TRP . 10.1 mtp180 -59.03 -57.65 12.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.158 -0.964 . . . . 0.0 110.169 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.43 0.23 14.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.33 -0.856 . . . . 0.0 110.274 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.72 9.47 16.57 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -98.51 -11.7 22.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -1.15 . . . . 0.0 109.983 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.886 ' CB ' HG12 ' A' ' 29' ' ' VAL . 2.0 tm-20 61.88 104.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -0.849 . . . . 0.0 110.306 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.492 ' HB3' ' HB3' ' A' ' 86' ' ' GLU . 46.7 mtt180 -123.28 175.04 6.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.333 -0.854 . . . . 0.0 109.918 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.679 HG13 ' H ' ' A' ' 85' ' ' GLY . 10.8 p -76.83 174.74 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.219 -0.925 . . . . 0.0 110.461 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.599 ' N ' HG22 ' A' ' 83' ' ' VAL . 1.9 t -60.61 -10.84 5.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.368 -0.832 . . . . 0.0 110.366 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.679 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -76.91 -10.32 86.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.502 ' HG2' ' CB ' ' A' ' 70' ' ' ALA . 9.0 pt-20 -73.22 153.47 40.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.185 -1.185 . . . . 0.0 109.864 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -160.33 161.15 33.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 110.227 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.887 ' CZ2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -149.56 145.87 27.05 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.161 -0.962 . . . . 0.0 110.215 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.887 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -106.02 125.19 50.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 0.0 110.321 -179.14 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.887 HG22 ' CZ2' ' A' ' 88' ' ' TRP . 22.8 t -93.49 128.07 45.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.467 -0.771 . . . . 0.0 110.765 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.517 ' OG1' ' CD1' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -134.48 30.04 3.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.53 -0.732 . . . . 0.0 109.246 179.383 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.46 130.83 35.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.478 -0.764 . . . . 0.0 110.725 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.947 HG13 ' HB2' ' A' ' 62' ' ' GLN . 6.4 t -65.51 113.82 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.374 -0.829 . . . . 0.0 110.033 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.434 ' HA3' ' CG ' ' A' ' 10' ' ' ASN . . . -179.85 -95.37 0.1 OUTLIER Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.293 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.661 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -150.13 -50.28 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.072 -1.252 . . . . 0.0 111.227 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.603 ' HB3' ' CG2' ' A' ' 59' ' ' ILE . 1.8 p90 176.51 161.37 0.37 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.48 -0.763 . . . . 0.0 110.606 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.614 ' HB2' HG11 ' A' ' 90' ' ' VAL . 12.9 mt -155.41 72.73 5.53 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.363 -0.836 . . . . 0.0 110.172 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.563 ' HD3' ' CD2' ' A' ' 96' ' ' TYR . 45.8 Cg_endo -72.35 128.5 13.76 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.883 1.464 . . . . 0.0 110.541 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.444 ' HB2' ' OE1' ' A' ' 102' ' ' GLU . . . -66.69 -163.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.354 -0.841 . . . . 0.0 110.333 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.86 -68.12 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.361 -0.837 . . . . 0.0 109.807 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 34' ' ' GLU . 16.2 m-30 -80.79 -21.2 41.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.258 -0.901 . . . . 0.0 109.935 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.608 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . 3.5 tt0 -87.8 146.11 25.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.378 -0.826 . . . . 0.0 110.411 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.32 170.73 9.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.464 -0.773 . . . . 0.0 110.066 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.553 ' HA ' HD23 ' A' ' 68' ' ' LEU . 7.6 p -84.52 136.39 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.114 -0.992 . . . . 0.0 110.461 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.886 HD21 ' CB ' ' A' ' 69' ' ' ARG . 1.1 mp -93.95 -29.4 15.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 0.0 109.957 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 105' ' ' LEU . 15.0 p-10 -178.66 123.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.438 -0.788 . . . . 0.0 110.359 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -77.19 144.98 37.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -0.858 . . . . 0.0 109.73 179.73 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.99 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 12.9 p -130.87 154.49 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.062 -1.024 . . . . 0.0 110.307 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 47.4 t0 -110.5 123.37 49.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.148 -0.97 . . . . 0.0 110.144 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.18 -0.95 . . . . 0.0 110.407 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.55 ' OE1' HD11 ' A' ' 8' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.291 0.567 . . . . 0.0 110.385 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.479 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 22.0 t -92.36 152.21 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.384 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.466 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 54.4 t -41.44 122.54 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.241 -0.912 . . . . 0.0 110.128 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.898 HD22 ' HG2' ' A' ' 40' ' ' PRO . 1.7 mp -78.85 159.76 73.08 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 110.366 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -75.48 -82.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.949 1.499 . . . . 0.0 110.164 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.727 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 11.4 p30 -129.56 54.7 1.81 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.309 -0.87 . . . . 0.0 109.843 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.874 ' OG1' HD23 ' A' ' 8' ' ' LEU . 1.1 p -132.5 157.47 44.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.145 -0.972 . . . . 0.0 110.111 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.755 ' CB ' HD11 ' A' ' 36' ' ' LEU . . . -141.3 162.08 36.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -0.959 . . . . 0.0 109.574 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.789 HD23 ' HG3' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -133.54 156.36 47.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.937 -1.102 . . . . 0.0 111.164 -179.492 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.667 ' NE2' HD12 ' A' ' 55' ' ' ILE . 8.9 m170 -96.24 123.32 39.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.438 -0.789 . . . . 0.0 109.882 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.854 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -125.76 148.86 48.95 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.081 -1.012 . . . . 0.0 109.55 179.278 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.499 ' HG3' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -96.98 119.22 35.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 110.714 -178.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.992 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -76.92 115.12 16.42 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.622 0.725 . . . . 0.0 110.258 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 86.8 mt -97.84 100.85 12.23 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.672 HD13 ' N ' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -158.64 144.9 17.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.146 -0.971 . . . . 0.0 110.653 -178.928 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.672 ' N ' HD13 ' A' ' 19' ' ' LEU . 20.1 p-10 -86.4 102.42 14.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 0.0 109.08 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.805 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 110.818 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.805 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.579 ' O ' HG23 ' A' ' 30' ' ' VAL . 22.8 m -125.96 90.97 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.971 -1.08 . . . . 0.0 110.467 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 42.96 61.57 2.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.0 110.222 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.68 24.14 0.2 Allowed Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.489 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.992 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 1.6 m-20 -88.9 161.15 16.83 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.875 -1.368 . . . . 0.0 110.03 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.499 ' HB3' ' HG3' ' A' ' 16' ' ' LYS . 9.9 pt-20 -159.81 130.97 5.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.251 -0.906 . . . . 0.0 110.575 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.689 ' CZ2' HD12 ' A' ' 15' ' ' LEU . 6.0 p90 -145.64 170.79 15.77 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.376 -0.827 . . . . 0.0 110.228 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.755 HD11 ' CB ' ' A' ' 12' ' ' ALA . 13.6 tp -90.44 156.07 18.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 110.033 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.782 ' HB2' HD21 ' A' ' 15' ' ' LEU . 3.7 t80 -132.76 110.47 10.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -0.872 . . . . 0.0 109.436 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.573 ' HB2' HD13 ' A' ' 97' ' ' LEU . 3.1 tm-20 -91.5 136.5 33.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.298 -0.877 . . . . 0.0 110.094 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.6 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 65.86 46.22 83.59 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.898 ' HG2' HD22 ' A' ' 8' ' ' LEU . 38.7 Cg_endo -66.09 -61.07 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.925 1.487 . . . . 0.0 110.461 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 6' ' ' VAL . . . 43.62 -88.62 0.01 OUTLIER Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.577 ' N ' ' O ' ' A' ' 40' ' ' PRO . 1.4 p -70.39 4.35 2.36 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.31 -1.112 . . . . 0.0 111.658 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.697 ' CE2' HD11 ' A' ' 13' ' ' LEU . 11.1 t80 -68.5 112.26 5.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.609 -1.307 . . . . 0.0 109.976 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.422 HG23 ' HD2' ' A' ' 45' ' ' PRO . 4.1 mm -104.13 141.8 23.27 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.345 -0.847 . . . . 0.0 109.737 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.422 ' HD2' HG23 ' A' ' 44' ' ' ILE . 43.0 Cg_endo -70.18 93.35 0.56 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.93 1.49 . . . . 0.0 110.101 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.404 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -102.78 158.9 15.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.272 -0.892 . . . . 0.0 110.604 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -44.56 -35.61 2.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.431 -0.793 . . . . 0.0 110.104 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -45.28 -48.09 12.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.301 -0.874 . . . . 0.0 110.105 179.796 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.554 HG21 ' HH2' ' A' ' 35' ' ' TRP . 0.9 OUTLIER -147.15 173.3 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.267 -0.895 . . . . 0.0 110.077 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.409 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.2 mt-10 -130.66 127.15 38.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.243 -0.911 . . . . 0.0 110.652 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.662 HG23 ' CD1' ' A' ' 13' ' ' LEU . 8.7 p -55.06 128.5 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.185 -0.947 . . . . 0.0 109.456 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.638 HG12 ' HG2' ' A' ' 53' ' ' GLU . 60.2 t -109.84 -61.04 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -0.95 . . . . 0.0 110.907 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 1.007 ' O ' HD13 ' A' ' 54' ' ' ILE . 2.6 mt-10 -124.46 173.96 8.1 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.192 -0.943 . . . . 0.0 110.774 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 1.007 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.1 mm -137.01 155.54 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.667 HD12 ' NE2' ' A' ' 14' ' ' HIS . 1.1 mt -146.82 151.12 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.909 -1.12 . . . . 0.0 111.132 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.479 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 87.5 mm-40 -124.21 170.12 11.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.774 -0.579 . . . . 0.0 110.337 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -86.51 153.85 21.54 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.229 -0.92 . . . . 0.0 110.845 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.523 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER 172.65 29.42 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.073 -1.017 . . . . 0.0 112.621 179.004 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.836 HG22 ' HB3' ' A' ' 96' ' ' TYR . 2.3 tt -161.88 -35.11 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 119.707 -1.871 . . . . 0.0 113.913 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.545 HG23 ' CG ' ' A' ' 64' ' ' GLN . 48.6 mt -75.7 152.49 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.078 -1.639 . . . . 0.0 111.188 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.0 -154.73 0.25 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.556 -0.715 . . . . 0.0 110.18 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.996 ' HA ' HG13 ' A' ' 93' ' ' VAL . 0.7 OUTLIER -82.27 -69.35 0.63 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 110.93 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.561 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 2.2 m-20 -78.49 -8.17 58.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.105 -0.997 . . . . 0.0 110.665 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.545 ' CG ' HG23 ' A' ' 60' ' ' ILE . 5.2 tp-100 -55.32 124.5 17.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.986 -1.071 . . . . 0.0 110.663 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.976 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -108.32 151.04 26.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.308 -0.87 . . . . 0.0 110.232 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.531 HD13 ' HA ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -125.69 121.83 34.58 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.196 -0.94 . . . . 0.0 110.418 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.73 ' HA ' HD22 ' A' ' 89' ' ' LEU . 8.4 mmm180 -93.34 123.91 36.96 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.249 -0.907 . . . . 0.0 110.283 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.629 HD13 ' C ' ' A' ' 103' ' ' GLU . 1.1 mm? -124.99 127.73 47.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.16 -0.963 . . . . 0.0 110.385 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -110.64 165.69 11.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.18 -0.95 . . . . 0.0 110.061 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -76.36 157.82 32.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.084 -1.01 . . . . 0.0 110.649 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.516 ' CB ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -114.59 -38.44 4.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 0.0 109.553 179.53 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -138.82 131.9 29.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.445 -0.784 . . . . 0.0 109.647 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.46 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 1.1 pt-20 -56.55 84.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.113 -0.992 . . . . 0.0 110.13 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' A' ' 72' ' ' LYS . 1.7 m -162.63 -35.33 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.401 -0.812 . . . . 0.0 110.058 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.603 ' CZ2' ' HG2' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -74.1 118.48 17.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.854 . . . . 0.0 110.073 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.406 ' HB3' ' C ' ' A' ' 79' ' ' GLY . 35.7 m-20 -86.86 115.27 24.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.992 . . . . 0.0 110.273 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.603 ' HG2' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -55.48 -55.7 28.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.169 -0.957 . . . . 0.0 110.116 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -105.55 24.22 12.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.245 -0.909 . . . . 0.0 110.066 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.406 ' C ' ' HB3' ' A' ' 76' ' ' ASP . . . 86.73 -10.25 68.4 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 23.9 pttt -87.45 136.97 32.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.391 -1.064 . . . . 0.0 110.161 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.445 ' CB ' ' CD1' ' A' ' 21' ' ' PHE . 3.6 tm-20 -47.14 118.94 2.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -0.913 . . . . 0.0 110.013 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.515 ' CB ' ' OE1' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -131.35 156.96 44.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.102 -0.999 . . . . 0.0 110.66 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.751 HG23 ' H ' ' A' ' 85' ' ' GLY . 23.4 m -86.4 -178.65 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.328 -0.857 . . . . 0.0 110.444 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.824 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 12.5 t -73.61 -6.78 48.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.362 -0.837 . . . . 0.0 109.972 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.751 ' H ' HG23 ' A' ' 83' ' ' VAL . . . -77.03 -24.84 65.56 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.515 ' OE1' ' CB ' ' A' ' 82' ' ' ARG . 4.6 pt-20 -57.11 162.0 2.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.045 -1.268 . . . . 0.0 110.058 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.484 ' CG ' ' O ' ' A' ' 68' ' ' LEU . 6.0 tt0 -159.62 142.49 13.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.185 -0.947 . . . . 0.0 109.877 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.63 ' CZ2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -119.89 148.36 43.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.048 -1.032 . . . . 0.0 110.096 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.031 HD12 HG23 ' A' ' 91' ' ' THR . 1.2 tm? -113.25 128.61 56.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.533 -0.73 . . . . 0.0 110.07 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.847 ' N ' HD13 ' A' ' 89' ' ' LEU . 81.4 t -90.77 102.32 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.854 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . 1.031 HG23 HD12 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -109.36 28.5 8.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.404 -0.81 . . . . 0.0 110.348 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.461 HG21 ' HB3' ' A' ' 95' ' ' ALA . 13.9 t -76.22 169.1 18.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 0.0 109.986 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.996 HG13 ' HA ' ' A' ' 62' ' ' GLN . 48.5 t -114.7 107.02 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.187 -0.946 . . . . 0.0 109.985 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.661 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 87.79 78.61 1.26 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 94' ' ' GLY . . . 174.37 -158.53 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.58 -0.953 . . . . 0.0 110.611 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.836 ' HB3' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER 176.21 25.32 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.055 -1.028 . . . . 0.0 111.115 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.697 ' HB2' HD21 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -61.45 110.2 2.88 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.709 -1.244 . . . . 0.0 110.067 179.41 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.665 ' O ' ' HB2' ' A' ' 99' ' ' ALA . 50.5 Cg_endo -79.32 -92.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.921 1.485 . . . . 0.0 110.796 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' A' ' 98' ' ' PRO . . . 171.54 -158.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 0.0 110.146 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.548 ' CG2' ' HA ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -113.36 -59.19 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.18 -0.95 . . . . 0.0 110.043 179.768 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.545 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 17.5 m-30 -99.96 11.8 38.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.069 -1.019 . . . . 0.0 109.457 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 99' ' ' ALA . 6.0 tt0 -96.05 157.59 15.83 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.301 -0.874 . . . . 0.0 110.968 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.629 ' C ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -140.06 128.63 22.92 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.552 -0.718 . . . . 0.0 109.355 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.686 ' C ' HD13 ' A' ' 105' ' ' LEU . 6.9 p -75.58 151.64 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.077 -1.015 . . . . 0.0 110.466 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.749 ' N ' HD22 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -104.14 -24.16 13.2 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.434 -0.792 . . . . 0.0 109.611 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 105' ' ' LEU . 1.0 OUTLIER 172.67 160.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.449 -0.782 . . . . 0.0 109.861 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.6 mp -96.82 134.94 39.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.095 -1.003 . . . . 0.0 109.649 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.976 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 7.0 p -122.01 157.02 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.061 -1.025 . . . . 0.0 110.755 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.65 131.42 55.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.453 -0.779 . . . . 0.0 109.664 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.141 -0.974 . . . . 0.0 110.667 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 6' ' ' VAL . 48.8 tt0 . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.2 0.524 . . . . 0.0 109.895 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.509 ' C ' ' HA2' ' A' ' 41' ' ' GLY . 80.6 t -41.57 164.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.362 -0.836 . . . . 0.0 110.467 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.535 ' HA ' ' CA ' ' A' ' 41' ' ' GLY . 33.7 t -37.74 140.89 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.585 -0.697 . . . . 0.0 111.272 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.628 HD23 ' OG1' ' A' ' 11' ' ' THR . 2.7 mp -86.76 168.74 17.07 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.436 -0.79 . . . . 0.0 110.057 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.432 ' O ' ' CB ' ' A' ' 10' ' ' ASN . 47.6 Cg_endo -76.1 59.36 5.89 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.1 1.579 . . . . 0.0 109.944 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.763 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 3.7 m120 65.13 46.24 2.79 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.363 -0.835 . . . . 0.0 109.558 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.628 ' OG1' HD23 ' A' ' 8' ' ' LEU . 17.4 p -134.98 162.13 33.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 110.258 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.776 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -133.68 159.84 39.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.104 -0.997 . . . . 0.0 109.766 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.932 ' CD1' HD22 ' A' ' 15' ' ' LEU . 1.3 pp -133.04 144.96 50.38 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.97 -1.081 . . . . 0.0 110.52 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.678 ' HD2' HG22 ' A' ' 100' ' ' VAL . 29.8 m80 -89.88 131.25 35.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.411 -0.806 . . . . 0.0 109.245 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.031 ' HA ' HG23 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -133.77 158.4 43.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.956 -1.09 . . . . 0.0 110.502 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -106.72 117.78 34.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.422 -0.798 . . . . 0.0 110.571 -179.158 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.04 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -80.49 111.86 17.29 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.366 -0.834 . . . . 0.0 109.693 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.725 HD13 ' HB1' ' A' ' 31' ' ' ALA . 2.4 mm? -103.03 101.47 11.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.673 -0.642 . . . . 0.0 110.359 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.582 HD13 ' H ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -160.88 144.66 13.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.138 -0.976 . . . . 0.0 110.544 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.582 ' H ' HD13 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -82.61 101.62 10.91 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.424 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.88 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.212 -0.93 . . . . 0.0 111.248 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.9 HG11 ' HB2' ' A' ' 81' ' ' GLU . 1.2 m . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 30' ' ' VAL . 16.5 m -127.9 84.59 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.094 -1.004 . . . . 0.0 110.615 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.725 ' HB1' HD13 ' A' ' 18' ' ' LEU . . . 41.12 70.16 0.28 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.404 -0.81 . . . . 0.0 110.66 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -170.72 22.7 0.08 OUTLIER Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.813 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 1.04 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 3.2 m-20 -88.43 149.33 23.75 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.811 -1.405 . . . . 0.0 109.829 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 68.1 tt0 -148.34 131.09 16.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.784 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.75 ' CZ3' ' HB2' ' A' ' 17' ' ' ALA . 6.3 p90 -151.97 167.22 29.07 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.448 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.658 HD13 ' NE2' ' A' ' 14' ' ' HIS . 16.8 tp -90.84 154.24 19.65 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.549 -0.72 . . . . 0.0 109.846 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.832 ' HB2' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -128.46 109.41 11.38 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.144 -0.972 . . . . 0.0 109.555 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.62 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 5.6 tm-20 -91.92 125.27 36.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.462 -0.774 . . . . 0.0 110.349 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.605 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 62.13 44.83 97.19 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.66 ' HG3' HD23 ' A' ' 13' ' ' LEU . 43.2 Cg_endo -71.08 57.63 2.11 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.681 1.358 . . . . 0.0 109.291 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.535 ' CA ' ' HA ' ' A' ' 7' ' ' VAL . . . -54.21 -14.17 4.29 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.583 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.4 p -136.79 29.24 2.88 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.693 -1.475 . . . . 0.0 111.109 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.791 ' HE2' HG22 ' A' ' 51' ' ' VAL . 15.8 t80 -84.24 111.25 19.22 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.944 -1.102 . . . . 0.0 109.709 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.701 HD13 ' C ' ' A' ' 43' ' ' TYR . 1.7 mm -103.28 138.87 19.66 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 108.963 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.44 ' HD2' HG22 ' A' ' 44' ' ' ILE . 43.6 Cg_endo -69.8 77.26 1.1 Allowed 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 123.847 1.446 . . . . 0.0 110.782 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.435 ' HD2' ' HB ' ' A' ' 44' ' ' ILE . 1.8 mtt180 -93.7 148.83 21.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 110.118 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 48' ' ' GLU . 0.1 OUTLIER -44.77 -34.33 2.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.915 . . . . 0.0 110.301 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.453 ' HG3' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -41.87 -48.38 4.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.603 -0.686 . . . . 0.0 109.585 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.599 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -136.34 173.82 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.388 -0.82 . . . . 0.0 109.09 178.903 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -135.38 129.84 33.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.02 -1.05 . . . . 0.0 110.261 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.791 HG22 ' HE2' ' A' ' 43' ' ' TYR . 19.9 t -54.54 131.17 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.106 -0.996 . . . . 0.0 109.088 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 1.031 HG23 ' HA ' ' A' ' 15' ' ' LEU . 17.3 t -105.85 -55.55 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.104 -0.997 . . . . 0.0 110.621 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.886 ' C ' HD13 ' A' ' 54' ' ' ILE . 12.8 mm-40 -141.04 166.83 23.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.103 -0.998 . . . . 0.0 110.568 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.886 HD13 ' C ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -133.17 143.26 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.247 -0.908 . . . . 0.0 108.849 179.232 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.776 HG22 ' O ' ' A' ' 12' ' ' ALA . 3.1 tt -140.71 152.11 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.996 -1.065 . . . . 0.0 111.179 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -103.61 179.69 4.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.457 -0.777 . . . . 0.0 110.041 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.763 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -101.97 143.1 32.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.188 -0.945 . . . . 0.0 110.536 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.552 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.8 OUTLIER 174.58 57.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.097 -1.002 . . . . 0.0 111.363 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.728 HG22 HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -161.64 -60.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.503 -1.373 . . . . 0.0 111.776 179.305 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.728 HG13 HG22 ' A' ' 59' ' ' ILE . 1.8 mt -88.82 -144.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 120.169 -1.582 . . . . 0.0 110.377 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.579 ' HA ' ' N ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -165.22 176.66 8.23 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.071 -1.018 . . . . 0.0 110.295 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.805 ' HB2' HG13 ' A' ' 93' ' ' VAL . 17.1 tp60 -68.54 -30.62 69.45 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.139 -0.976 . . . . 0.0 110.217 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 2.5 m120 -69.51 -56.24 7.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.223 -0.923 . . . . 0.0 110.833 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.613 ' HB3' HG22 ' A' ' 60' ' ' ILE . 63.8 tp60 -59.61 140.87 56.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.211 -0.931 . . . . 0.0 110.802 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.072 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -125.27 134.33 52.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.524 -0.735 . . . . 0.0 109.215 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.751 ' O ' HG12 ' A' ' 90' ' ' VAL . 7.9 mp -125.81 118.76 26.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.905 . . . . 0.0 111.028 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.562 ' O ' HD12 ' A' ' 105' ' ' LEU . 8.0 mtt85 -91.7 128.92 37.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.347 -0.846 . . . . 0.0 109.11 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 104' ' ' VAL . 10.7 mt -126.36 153.5 44.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.027 -1.046 . . . . 0.0 110.922 -178.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.481 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 14.4 ttp180 -127.24 157.56 39.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.522 -0.736 . . . . 0.0 110.204 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.51 ' HB2' ' HZ3' ' A' ' 75' ' ' TRP . . . -73.51 141.16 46.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.344 -0.847 . . . . 0.0 111.12 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -107.14 -38.25 6.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.303 -0.873 . . . . 0.0 109.589 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.531 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 9.1 mmtt -98.02 -88.07 0.32 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.356 -0.84 . . . . 0.0 109.922 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' A' ' 72' ' ' LYS . 4.1 pt-20 164.24 -37.25 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.727 0.775 . . . . 0.0 108.948 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' ' 33' ' ' ASP . 1.3 m -56.42 -29.75 61.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.498 -0.751 . . . . 0.0 110.336 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.602 ' HA ' ' HB3' ' A' ' 35' ' ' TRP . 16.8 t90 -76.98 103.81 7.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.167 -0.958 . . . . 0.0 110.087 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 76' ' ' ASP . 1.8 p30 -101.92 114.24 28.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 110.123 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.529 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . 4.9 ppt_? -77.22 -22.15 52.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.29 -0.881 . . . . 0.0 110.33 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.412 ' N ' ' HG3' ' A' ' 77' ' ' ARG . 1.9 t0 -95.25 -19.21 20.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 110.236 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.25 24.66 11.11 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.514 ' O ' ' C ' ' A' ' 81' ' ' GLU . 1.4 mttt -137.14 52.63 1.91 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.243 -1.151 . . . . 0.0 110.155 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.9 ' HB2' HG11 ' A' ' 29' ' ' VAL . 2.2 pm0 26.46 94.84 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.259 0.552 . . . . 0.0 111.336 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.523 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 4.4 mpt_? -103.94 179.68 4.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 110.222 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.534 HG23 ' H ' ' A' ' 85' ' ' GLY . 27.5 m -103.37 178.47 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -0.916 . . . . 0.0 110.144 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 70' ' ' ALA . 2.8 t -59.19 -15.66 16.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 110.203 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.534 ' H ' HG23 ' A' ' 83' ' ' VAL . . . -74.2 -39.17 45.15 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.523 ' CB ' ' HB3' ' A' ' 82' ' ' ARG . 19.4 tp10 -54.09 151.74 6.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -1.127 . . . . 0.0 109.957 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 19.5 pt-20 -159.36 173.85 15.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.173 -0.954 . . . . 0.0 110.436 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.575 ' CD1' ' OE1' ' A' ' 102' ' ' GLU . 0.6 OUTLIER -161.08 160.82 30.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.898 . . . . 0.0 110.103 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.012 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -108.34 138.04 45.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.324 -0.86 . . . . 0.0 110.195 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 1.012 ' N ' HD22 ' A' ' 89' ' ' LEU . 7.3 p -108.61 140.76 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -0.929 . . . . 0.0 110.451 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.4 t -157.55 50.39 0.44 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.393 -0.817 . . . . 0.0 110.261 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 m -75.27 157.9 33.71 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.198 -0.938 . . . . 0.0 110.071 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.805 HG13 ' HB2' ' A' ' 62' ' ' GLN . 2.6 t -77.69 72.89 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.244 -0.91 . . . . 0.0 110.122 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.597 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 87.86 107.04 0.95 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.604 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . . . 179.88 169.33 1.2 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -1.1 . . . . 0.0 110.385 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.489 ' HB2' ' HB ' ' A' ' 59' ' ' ILE . 2.0 t80 -129.57 88.33 2.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.769 -0.582 . . . . 0.0 110.054 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.651 HD22 ' CB ' ' A' ' 12' ' ' ALA . 17.0 mt -119.12 86.23 31.67 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.157 -0.964 . . . . 0.0 110.479 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.473 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 50.0 Cg_endo -79.69 9.26 3.57 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.884 1.465 . . . . 0.0 110.648 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.558 ' CB ' ' HB3' ' A' ' 102' ' ' GLU . . . 58.07 -175.27 0.08 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.15 -0.969 . . . . 0.0 110.063 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.678 HG22 ' HD2' ' A' ' 14' ' ' HIS . 2.8 t -109.44 -55.69 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.078 -1.014 . . . . 0.0 110.532 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.588 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 23.0 m-85 -107.6 9.76 29.29 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.076 -1.015 . . . . 0.0 110.152 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.579 ' OE1' ' CZ2' ' A' ' 75' ' ' TRP . 12.6 tt0 -105.05 153.49 21.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 111.575 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -131.05 167.3 19.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.475 -0.766 . . . . 0.0 110.083 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.726 ' HA ' HD23 ' A' ' 68' ' ' LEU . 7.3 p -92.55 143.36 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.107 -0.996 . . . . 0.0 110.692 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.562 HD12 ' O ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -105.02 -19.39 13.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.406 -0.809 . . . . 0.0 110.114 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -169.6 179.71 3.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.221 -0.925 . . . . 0.0 110.324 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.875 HD22 ' O ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -138.99 141.25 38.35 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.125 -0.984 . . . . 0.0 110.612 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.072 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 8.8 p -139.51 116.7 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.94 -1.1 . . . . 0.0 110.771 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 31.1 t0 -86.81 117.4 25.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.048 -1.033 . . . . 0.0 110.119 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 110.266 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.333 0.587 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.75 -162.78 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.497 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.458 ' HA ' ' HA2' ' A' ' 41' ' ' GLY . 60.5 t -87.9 84.1 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 110.482 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.808 HD23 ' OG1' ' A' ' 11' ' ' THR . 0.1 OUTLIER -47.07 160.54 0.34 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.399 -0.813 . . . . 0.0 109.988 179.588 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.02 -47.81 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.861 1.453 . . . . 0.0 110.402 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.759 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 5.4 m120 -162.67 31.95 0.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.195 -0.94 . . . . 0.0 110.142 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.808 ' OG1' HD23 ' A' ' 8' ' ' LEU . 14.1 p -104.8 166.62 10.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.31 -0.869 . . . . 0.0 110.171 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.783 ' HB2' HD21 ' A' ' 97' ' ' LEU . . . -144.74 160.07 41.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.026 -1.046 . . . . 0.0 110.471 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.846 HD11 HD11 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -133.16 151.11 51.98 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.09 -1.006 . . . . 0.0 109.646 179.509 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.724 ' CE1' HD13 ' A' ' 36' ' ' LEU . 65.7 m80 -95.36 127.21 41.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 0.0 110.582 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.847 ' N ' HD22 ' A' ' 15' ' ' LEU . 1.7 mm? -113.95 152.17 31.24 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.517 -0.739 . . . . 0.0 110.277 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.54 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -108.09 115.89 30.95 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.19 -0.944 . . . . 0.0 108.707 178.049 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.769 ' HA ' HG12 ' A' ' 49' ' ' VAL . . . -78.6 111.26 14.49 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.941 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 48' ' ' GLU . 51.1 mt -98.11 100.95 12.3 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.251 0.548 . . . . 0.0 109.982 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.68 HD13 ' N ' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -159.47 134.0 7.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 110.129 -179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.68 ' N ' HD13 ' A' ' 19' ' ' LEU . 9.5 m-20 -75.68 101.63 5.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.034 -1.042 . . . . 0.0 109.715 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.817 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.844 . . . . 0.0 110.435 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.817 HG22 ' CB ' ' A' ' 21' ' ' PHE . 1.5 m . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 121.271 0.558 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 30' ' ' VAL . 27.2 m -140.57 83.55 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.165 -0.96 . . . . 0.0 110.188 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.52 70.97 0.37 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.507 -0.745 . . . . 0.0 110.565 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.54 27.92 0.03 OUTLIER Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.34 -1.41 . . . . 0.0 110.892 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.552 ' O ' ' N ' ' A' ' 17' ' ' ALA . 2.2 m-20 -94.13 156.45 16.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.664 -1.492 . . . . 0.0 110.002 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 16.5 tt0 -148.61 145.34 27.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.011 -1.055 . . . . 0.0 110.525 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.572 ' CZ2' ' HB2' ' A' ' 15' ' ' LEU . 12.5 p90 -149.95 166.89 28.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.362 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.724 HD13 ' CE1' ' A' ' 14' ' ' HIS . 53.6 tp -96.47 151.81 19.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.188 -0.945 . . . . 0.0 109.953 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.805 ' HB3' HD23 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -130.77 115.53 16.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.034 -1.041 . . . . 0.0 110.493 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.508 ' HB2' ' CD2' ' A' ' 97' ' ' LEU . 2.6 tm-20 -96.95 120.99 38.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.536 -0.728 . . . . 0.0 110.326 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.579 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 72.82 46.39 30.15 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 41.6 Cg_endo -66.44 61.29 0.52 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.884 1.465 . . . . 0.0 110.54 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.547 ' C ' ' O ' ' A' ' 40' ' ' PRO . . . -19.0 -92.1 0.01 OUTLIER Glycine 0 N--CA 1.501 2.977 0 N-CA-C 111.491 -0.643 . . . . 0.0 111.491 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.9 p -109.96 49.01 0.86 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.041 -1.27 . . . . 0.0 110.365 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.664 ' OH ' HD12 ' A' ' 15' ' ' LEU . 30.9 t80 -69.83 130.22 41.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.041 -1.037 . . . . 0.0 110.358 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.66 HG23 ' HD2' ' A' ' 45' ' ' PRO . 5.5 mt -124.94 145.29 49.61 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.356 -0.84 . . . . 0.0 109.591 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.66 ' HD2' HG23 ' A' ' 44' ' ' ILE . 45.8 Cg_endo -71.43 90.8 0.68 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.987 1.519 . . . . 0.0 110.584 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 49' ' ' VAL . 3.9 mtp180 -98.21 152.64 19.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.294 -0.879 . . . . 0.0 110.03 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 46' ' ' ARG . 32.0 tttm -41.49 -31.55 0.27 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.288 -0.883 . . . . 0.0 110.479 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 18' ' ' LEU . 16.7 tt0 -53.82 -41.41 67.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.128 -0.983 . . . . 0.0 109.923 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.769 HG12 ' HA ' ' A' ' 17' ' ' ALA . 2.1 m -145.7 171.27 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.636 -0.665 . . . . 0.0 109.386 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.21 140.58 47.61 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.684 -1.26 . . . . 0.0 111.125 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.554 HG23 ' HB3' ' A' ' 45' ' ' PRO . 24.9 t -56.53 123.23 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 109.067 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.54 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 7.2 t -105.1 -60.32 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.118 -0.989 . . . . 0.0 110.729 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.888 ' O ' HD13 ' A' ' 54' ' ' ILE . 27.1 mm-40 -138.06 162.61 33.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 110.394 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.888 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -134.49 137.96 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.318 -0.864 . . . . 0.0 109.325 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.804 HD13 ' O ' ' A' ' 96' ' ' TYR . 1.0 OUTLIER -137.37 142.19 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.92 -1.113 . . . . 0.0 111.573 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.526 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 4.0 mm100 -90.67 -179.65 5.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.382 -0.823 . . . . 0.0 109.299 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.84 ' HB1' ' O ' ' A' ' 94' ' ' GLY . . . -98.41 124.07 42.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.788 -1.195 . . . . 0.0 110.667 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.458 ' O ' HG12 ' A' ' 59' ' ' ILE . 10.1 t -172.12 49.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.443 -0.786 . . . . 0.0 109.818 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.813 HG22 ' N ' ' A' ' 60' ' ' ILE . 0.7 OUTLIER -150.5 -75.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.083 -1.01 . . . . 0.0 111.533 -179.077 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.813 ' N ' HG22 ' A' ' 59' ' ' ILE . 10.0 mt -92.47 125.28 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.905 -1.122 . . . . 0.0 111.534 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.569 ' HA ' ' N ' ' A' ' 94' ' ' GLY . 0.1 OUTLIER -68.66 -165.73 0.07 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.45 -0.781 . . . . 0.0 110.351 179.564 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.788 ' HB3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -91.62 -12.97 32.71 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.142 -0.974 . . . . 0.0 111.023 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.626 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 0.9 OUTLIER -87.66 -54.28 4.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.024 -1.047 . . . . 0.0 109.522 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.447 ' HB3' ' HG2' ' A' ' 61' ' ' ARG . 4.1 tp-100 -57.49 128.39 36.8 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.229 -0.919 . . . . 0.0 110.199 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.978 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -107.8 139.72 41.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.293 -0.879 . . . . 0.0 108.888 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.616 ' O ' HG12 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -120.84 124.72 45.73 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.198 -0.939 . . . . 0.0 110.876 -179.015 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.759 ' O ' HD23 ' A' ' 68' ' ' LEU . 1.4 mtm180 -90.3 126.53 35.88 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.395 -0.816 . . . . 0.0 109.055 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.759 HD23 ' O ' ' A' ' 67' ' ' ARG . 14.2 mt -120.01 147.34 44.91 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.216 -0.994 . . . . 0.0 111.702 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.662 ' HB2' HD21 ' A' ' 105' ' ' LEU . 12.4 ttm180 -126.44 162.74 24.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.552 -0.717 . . . . 0.0 110.241 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . -78.67 153.28 31.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.22 -0.925 . . . . 0.0 110.619 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.503 ' CZ ' ' HG3' ' A' ' 103' ' ' GLU . 19.8 tpp85 -126.84 -31.14 2.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.886 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 20.9 tptm -121.34 128.85 52.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.759 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.486 ' HA ' ' N ' ' A' ' 84' ' ' THR . 6.5 pt-20 -67.06 58.38 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.195 -0.941 . . . . 0.0 110.401 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -149.62 -24.37 0.27 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.367 -0.833 . . . . 0.0 110.977 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.604 ' CZ2' ' HG2' ' A' ' 77' ' ' ARG . 1.2 t90 -73.87 117.34 15.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.972 -1.08 . . . . 0.0 109.72 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.437 ' HA ' ' HB2' ' A' ' 82' ' ' ARG . 6.1 m-20 -81.53 117.33 21.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.325 -0.859 . . . . 0.0 110.893 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.604 ' HG2' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -81.74 -45.94 14.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.343 -0.848 . . . . 0.0 109.606 179.25 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.68 -1.85 36.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.364 -0.835 . . . . 0.0 110.331 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.3 -35.11 5.02 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -78.94 -103.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.295 -1.121 . . . . 0.0 110.12 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.451 ' CD ' HG21 ' A' ' 29' ' ' VAL . 71.8 mm-40 -137.93 127.26 24.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.929 -1.107 . . . . 0.0 109.837 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.437 ' HB2' ' HA ' ' A' ' 76' ' ' ASP . 18.5 mmt180 -131.42 171.97 12.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.235 -0.916 . . . . 0.0 110.4 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.612 HG22 ' N ' ' A' ' 84' ' ' THR . 2.3 p -116.01 171.61 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -0.819 . . . . 0.0 110.062 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.612 ' N ' HG22 ' A' ' 83' ' ' VAL . 13.6 t -57.13 -164.23 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.25 -0.98 . . . . 0.0 108.563 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 86' ' ' GLU . . . 68.65 -58.89 0.48 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.52 ' O ' ' CB ' ' A' ' 70' ' ' ALA . 1.9 tp10 -43.89 151.38 0.21 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -1.141 . . . . 0.0 109.103 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.545 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 5.8 pt-20 -145.16 160.04 42.06 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.205 -0.934 . . . . 0.0 110.741 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.565 ' CE2' ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -135.43 156.72 48.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.472 -0.768 . . . . 0.0 109.286 179.43 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.882 HD23 ' H ' ' A' ' 90' ' ' VAL . 1.1 tt -113.43 160.42 18.45 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.808 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.882 ' H ' HD23 ' A' ' 89' ' ' LEU . 2.4 p -135.7 123.86 37.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.148 -0.97 . . . . 0.0 110.588 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.19 32.27 4.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.453 -0.779 . . . . 0.0 109.474 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.462 ' O ' ' O ' ' A' ' 61' ' ' ARG . 11.8 t -76.02 171.66 14.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.41 -0.806 . . . . 0.0 110.467 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.788 HG22 ' HB3' ' A' ' 62' ' ' GLN . 2.3 t -80.49 -172.48 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.393 -0.817 . . . . 0.0 110.207 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.84 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . -33.61 96.92 0.01 OUTLIER Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . . . -163.7 148.96 10.9 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.17 -1.194 . . . . 0.0 111.731 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.804 ' O ' HD13 ' A' ' 55' ' ' ILE . 8.4 t80 -109.03 110.37 21.63 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.783 HD21 ' HB2' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -127.78 66.11 69.79 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.027 -1.045 . . . . 0.0 111.236 -178.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.522 ' HG3' ' CZ ' ' A' ' 96' ' ' TYR . 45.2 Cg_endo -74.03 89.66 1.02 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.005 1.529 . . . . 0.0 109.651 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 1.026 ' HB3' ' HB3' ' A' ' 102' ' ' GLU . . . -45.63 149.57 0.58 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.286 -0.884 . . . . 0.0 111.232 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.752 HG23 ' H ' ' A' ' 101' ' ' PHE . 2.3 m -52.16 -69.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.61 -0.681 . . . . 0.0 110.66 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.752 ' H ' HG23 ' A' ' 100' ' ' VAL . 7.0 m-85 -99.73 62.03 1.17 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.821 -1.175 . . . . 0.0 109.674 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 1.026 ' HB3' ' HB3' ' A' ' 99' ' ' ALA . 4.0 tt0 -140.5 147.99 40.4 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.047 -1.033 . . . . 0.0 110.98 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.503 ' HG3' ' CZ ' ' A' ' 71' ' ' ARG . 1.3 mm-40 -132.15 150.89 52.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.501 -0.749 . . . . 0.0 109.679 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.686 ' C ' HD23 ' A' ' 105' ' ' LEU . 4.8 m -83.66 149.04 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.113 -0.992 . . . . 0.0 110.349 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.703 ' N ' HD23 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -103.19 -10.96 18.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.425 -0.797 . . . . 0.0 109.287 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER 163.58 172.05 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.662 -0.649 . . . . 0.0 109.767 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.2 mp -116.43 123.23 47.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.169 -0.957 . . . . 0.0 109.766 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.978 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 13.6 p -116.56 155.48 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.029 -1.044 . . . . 0.0 110.681 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -110.05 120.85 43.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.385 -0.822 . . . . 0.0 109.571 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.296 -0.878 . . . . 0.0 110.937 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.435 ' O ' ' O ' ' A' ' 41' ' ' GLY . 1.2 tt0 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.215 0.531 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.512 ' O ' ' CD1' ' A' ' 8' ' ' LEU . 67.4 t -128.54 147.61 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 109.741 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.513 ' HA ' ' CA ' ' A' ' 41' ' ' GLY . 10.6 t -43.44 120.58 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.074 -1.016 . . . . 0.0 110.098 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.536 HD23 ' OG1' ' A' ' 11' ' ' THR . 4.0 mp -76.53 164.84 57.11 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.441 -0.787 . . . . 0.0 110.361 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 10' ' ' ASN . 46.2 Cg_endo -75.57 70.31 5.72 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 124.121 1.59 . . . . 0.0 109.914 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 1.045 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 11.6 m-20 58.42 55.84 4.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.382 -0.824 . . . . 0.0 110.397 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.536 ' OG1' HD23 ' A' ' 8' ' ' LEU . 6.2 p -136.38 171.48 14.43 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.066 -1.022 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.581 ' HB2' HD22 ' A' ' 97' ' ' LEU . . . -145.37 158.06 43.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.203 -0.936 . . . . 0.0 110.719 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.822 ' CD2' HD21 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -130.49 154.85 47.34 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.391 -0.818 . . . . 0.0 109.268 179.119 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.635 ' O ' HD13 ' A' ' 15' ' ' LEU . 40.7 m80 -94.79 131.63 40.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.975 . . . . 0.0 110.209 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.828 ' N ' HD22 ' A' ' 15' ' ' LEU . 1.7 mm? -120.02 140.34 51.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.634 -0.666 . . . . 0.0 109.962 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.563 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 4.8 ttmt -95.82 117.09 29.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.965 -1.084 . . . . 0.0 109.174 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.84 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -81.78 105.73 13.15 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 110.591 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.664 HD13 ' CA ' ' A' ' 31' ' ' ALA . 1.9 mm? -99.08 101.53 12.92 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.48 HD13 ' CG ' ' A' ' 48' ' ' GLU . 5.0 tp -161.77 148.6 14.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.089 -1.007 . . . . 0.0 110.696 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.64 115.68 22.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.369 -0.832 . . . . 0.0 109.037 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.943 ' HB2' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 120.982 -1.074 . . . . 0.0 110.988 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.943 HG22 ' HB2' ' A' ' 21' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 121.184 0.516 . . . . 0.0 109.74 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.617 ' O ' HG23 ' A' ' 30' ' ' VAL . 26.9 m -139.06 85.11 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.017 -1.052 . . . . 0.0 110.549 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.664 ' CA ' HD13 ' A' ' 18' ' ' LEU . . . 40.22 76.35 0.07 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.544 -0.722 . . . . 0.0 110.667 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.99 31.8 0.03 OUTLIER Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.359 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.84 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 13.0 m-20 -99.55 155.56 17.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.934 -1.333 . . . . 0.0 110.377 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.652 ' OE2' HG11 ' A' ' 52' ' ' VAL . 9.8 tt0 -151.51 134.76 15.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.376 -0.827 . . . . 0.0 109.9 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.538 ' CZ3' ' HB2' ' A' ' 17' ' ' ALA . 7.8 p90 -148.29 167.67 24.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.172 -0.955 . . . . 0.0 110.679 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.554 HD21 ' HA ' ' A' ' 97' ' ' LEU . 44.5 tp -97.5 153.32 18.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.329 -0.857 . . . . 0.0 109.772 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.529 ' HB3' HD23 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -138.14 110.5 7.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.143 -0.973 . . . . 0.0 109.919 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.557 ' HB3' HD22 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -97.2 138.17 35.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.334 -0.854 . . . . 0.0 110.44 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.619 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 72.25 40.8 54.85 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 54.0 Cg_endo -78.12 47.9 2.51 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.23 1.121 . . . . 0.0 109.828 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.513 ' CA ' ' HA ' ' A' ' 7' ' ' VAL . . . -42.78 -31.86 1.24 Allowed Glycine 0 N--CA 1.49 2.278 0 O-C-N 121.53 -0.731 . . . . 0.0 111.277 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.621 ' O ' HD12 ' A' ' 44' ' ' ILE . 6.7 p -136.46 42.92 2.5 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.82 -1.4 . . . . 0.0 111.02 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.558 ' CZ ' ' HG ' ' A' ' 15' ' ' LEU . 14.7 t80 -79.75 111.99 16.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.106 -0.996 . . . . 0.0 109.654 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.621 HD12 ' O ' ' A' ' 42' ' ' THR . 3.6 mp -96.04 133.37 25.31 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 0.0 109.992 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.17 96.82 0.89 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.907 1.477 . . . . 0.0 110.442 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 -104.12 159.41 15.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 110.282 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.86 -28.52 6.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.146 -0.971 . . . . 0.0 110.419 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.48 ' CG ' HD13 ' A' ' 19' ' ' LEU . 7.2 tt0 -50.36 -39.85 47.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.17 -0.956 . . . . 0.0 110.077 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.77 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.6 m -141.79 173.65 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.426 -0.796 . . . . 0.0 109.998 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.52 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.7 mt-10 -132.61 137.09 46.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.107 -0.996 . . . . 0.0 110.349 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 51' ' ' VAL . 21.3 t -54.52 132.53 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.971 . . . . 0.0 109.335 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.939 HG12 ' HG2' ' A' ' 53' ' ' GLU . 97.2 t -118.57 -59.54 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.96 -1.088 . . . . 0.0 110.932 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.939 ' HG2' HG12 ' A' ' 52' ' ' VAL . 43.2 mm-40 -137.21 164.53 28.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.058 -1.026 . . . . 0.0 111.273 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.774 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -136.46 137.97 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.832 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.569 HD13 ' N ' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -138.41 137.15 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.806 -1.184 . . . . 0.0 111.466 -178.671 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.569 ' N ' HD13 ' A' ' 55' ' ' ILE . 1.3 mp0 -93.03 167.09 12.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.621 -0.674 . . . . 0.0 110.065 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.045 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -82.72 140.1 33.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 0.0 110.265 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 4.4 t 179.87 39.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.01 -1.056 . . . . 0.0 111.719 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.835 HG23 ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER -161.05 -70.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.468 -1.395 . . . . 0.0 111.838 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.711 ' H ' HG23 ' A' ' 59' ' ' ILE . 4.2 mm -41.86 164.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.903 -1.123 . . . . 0.0 110.297 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.43 ' N ' ' CG2' ' A' ' 60' ' ' ILE . 2.6 mpt_? -94.3 -164.12 1.13 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.101 -0.999 . . . . 0.0 110.989 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.983 ' HA ' HG13 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -67.05 -68.01 0.41 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 111.352 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.647 ' CB ' ' HB3' ' A' ' 110' ' ' ALA . 52.3 m-20 -113.22 24.6 12.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.924 -1.11 . . . . 0.0 111.23 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -61.95 133.6 55.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.867 -1.146 . . . . 0.0 109.282 178.744 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.5 ' O ' ' HB ' ' A' ' 108' ' ' VAL . . . -109.51 128.44 55.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.852 -1.155 . . . . 0.0 110.181 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.659 ' O ' HD22 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -126.28 127.3 45.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.93 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.796 ' C ' HD22 ' A' ' 68' ' ' LEU . 10.8 mtt180 -90.85 130.89 36.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.601 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.963 HD12 ' OE1' ' A' ' 102' ' ' GLU . 4.2 mm? -116.78 130.43 56.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 111.035 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 1.9 ttt180 -107.16 156.68 18.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.578 -0.701 . . . . 0.0 109.633 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -88.66 142.14 27.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.201 -0.937 . . . . 0.0 110.543 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -115.05 -17.33 11.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.347 -0.846 . . . . 0.0 109.697 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -132.96 116.4 16.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.49 -0.756 . . . . 0.0 109.988 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.67 ' HG3' HG12 ' A' ' 83' ' ' VAL . 1.2 tm-20 -62.16 103.32 0.37 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 110.318 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER 167.1 -25.04 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.294 -0.879 . . . . 0.0 110.028 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.579 ' CZ2' ' HB3' ' A' ' 77' ' ' ARG . 1.3 t90 -75.14 105.26 6.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.363 -0.836 . . . . 0.0 110.375 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.412 ' OD1' ' HB3' ' A' ' 35' ' ' TRP . 16.0 p-10 -87.36 109.55 19.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.181 -0.949 . . . . 0.0 109.767 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.579 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -89.77 -13.65 36.24 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.215 -0.928 . . . . 0.0 110.587 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.437 ' OD2' ' NH1' ' A' ' 77' ' ' ARG . 0.2 OUTLIER -124.88 13.33 8.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.986 -1.071 . . . . 0.0 110.267 179.675 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.78 21.23 78.91 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 15.5 mmmt -119.79 -7.31 10.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.174 -1.192 . . . . 0.0 110.012 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.487 ' HB3' HG11 ' A' ' 29' ' ' VAL . 25.3 mm-40 60.66 124.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.358 -0.839 . . . . 0.0 110.234 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -141.66 179.52 6.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.303 -0.873 . . . . 0.0 110.356 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.856 HG23 ' H ' ' A' ' 85' ' ' GLY . 6.3 m -96.16 -178.59 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.223 -0.923 . . . . 0.0 111.245 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.555 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 25.7 p -57.2 -23.07 45.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.467 -0.77 . . . . 0.0 110.545 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.856 ' H ' HG23 ' A' ' 83' ' ' VAL . . . -65.18 -25.7 71.18 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 82' ' ' ARG . 6.1 pt-20 -65.58 153.11 42.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.357 -1.084 . . . . 0.0 110.632 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.12 147.8 18.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.483 -0.76 . . . . 0.0 109.635 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.898 ' CE2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -134.59 144.76 48.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.997 -1.064 . . . . 0.0 110.381 -179.8 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.796 HD13 ' C ' ' A' ' 89' ' ' LEU . 1.3 tm? -94.65 139.03 31.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.427 -0.796 . . . . 0.0 110.254 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.898 HG22 ' CE2' ' A' ' 88' ' ' TRP . 12.1 t -112.98 131.81 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.199 -0.938 . . . . 0.0 110.722 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.757 ' OG1' HD11 ' A' ' 89' ' ' LEU . 16.6 m -135.55 45.57 2.44 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.578 -0.701 . . . . 0.0 109.679 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.543 ' OG1' HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -82.2 128.67 34.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.899 . . . . 0.0 110.736 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.983 HG13 ' HA ' ' A' ' 62' ' ' GLN . 47.2 t -70.31 114.3 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.568 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.623 ' O ' ' HB2' ' A' ' 95' ' ' ALA . . . 56.96 97.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.835 ' O ' HG23 ' A' ' 59' ' ' ILE . . . 174.88 -176.88 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.108 -1.23 . . . . 0.0 110.606 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.77 ' CD2' HG21 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -147.35 101.99 3.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.3 -0.875 . . . . 0.0 110.499 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.581 HD22 ' HB2' ' A' ' 12' ' ' ALA . 18.7 mt -126.33 71.22 70.91 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.116 -0.99 . . . . 0.0 110.025 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.482 ' HD3' ' CD1' ' A' ' 96' ' ' TYR . 50.5 Cg_endo -81.84 17.29 1.56 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.996 1.524 . . . . 0.0 110.965 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.92 ' HB3' ' CG ' ' A' ' 102' ' ' GLU . . . 43.48 -164.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.12 -0.987 . . . . 0.0 110.674 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.53 ' CG2' ' HA ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -115.92 -44.85 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.191 -0.943 . . . . 0.0 111.656 -178.816 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.567 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 23.1 m-85 -110.59 40.94 1.88 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.617 -1.302 . . . . 0.0 111.977 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.963 ' OE1' HD12 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -141.9 165.33 27.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.722 -1.236 . . . . 0.0 110.62 179.18 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.538 ' C ' HD13 ' A' ' 68' ' ' LEU . 1.9 tt0 -131.26 158.83 39.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.418 -0.801 . . . . 0.0 109.905 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.734 HG12 HD11 ' A' ' 68' ' ' LEU . 6.3 m -82.05 142.17 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.058 -1.027 . . . . 0.0 110.451 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.601 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 4.4 mp -90.58 -14.49 32.39 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.371 -0.831 . . . . 0.0 109.271 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 1.0 OUTLIER 163.85 -172.75 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.633 -0.667 . . . . 0.0 109.918 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 0.7 OUTLIER -125.8 130.98 52.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.12 -0.987 . . . . 0.0 110.073 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.739 HG21 ' NH1' ' A' ' 67' ' ' ARG . 24.2 t -123.81 148.89 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.133 -0.979 . . . . 0.0 110.877 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -112.16 113.23 25.37 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.27 -0.894 . . . . 0.0 108.882 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.647 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.491 1.604 0 O-C-N 120.745 -1.222 . . . . 0.0 109.829 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.623 ' OE1' HD11 ' A' ' 8' ' ' LEU . 1.9 mt-30 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.267 0.556 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 5' ' ' GLN . 8.2 p -45.05 165.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 0.0 109.718 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.482 HG13 ' HA2' ' A' ' 41' ' ' GLY . 13.8 t -54.08 125.27 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.076 -1.015 . . . . 0.0 110.169 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.623 HD11 ' OE1' ' A' ' 5' ' ' GLN . 6.5 mp -71.65 162.95 70.27 Favored Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 109.919 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.69 -89.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.926 1.488 . . . . 0.0 110.17 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.795 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 72.9 m-80 -128.64 25.02 5.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.962 . . . . 0.0 110.015 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.842 HG22 ' H ' ' A' ' 57' ' ' ALA . 27.4 p -104.48 170.6 7.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.316 -0.865 . . . . 0.0 110.077 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.585 ' HB2' ' HA ' ' A' ' 38' ' ' GLU . . . -139.75 161.86 36.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.217 -0.927 . . . . 0.0 110.117 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.056 ' CD2' HD21 ' A' ' 15' ' ' LEU . 0.6 OUTLIER -132.77 155.58 48.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.942 . . . . 0.0 110.021 179.781 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.689 ' C ' HD22 ' A' ' 15' ' ' LEU . 42.9 m80 -90.96 129.16 37.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.165 -0.959 . . . . 0.0 110.555 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.056 HD21 ' CD2' ' A' ' 13' ' ' LEU . 2.2 mm? -120.11 146.74 45.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.665 -0.647 . . . . 0.0 110.231 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.541 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -110.78 116.28 31.01 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.187 -0.945 . . . . 0.0 108.592 178.044 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.057 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -75.3 115.47 14.97 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.157 -0.964 . . . . 0.0 110.135 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.624 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.6 mt -103.26 99.84 9.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.701 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.809 ' C ' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -167.57 165.99 14.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.026 -1.046 . . . . 0.0 110.559 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.523 ' N ' HD22 ' A' ' 19' ' ' LEU . 11.6 t70 -98.27 103.12 15.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.734 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.989 ' CB ' HG22 ' A' ' 29' ' ' VAL . 1.9 t80 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 109.923 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.989 HG22 ' CB ' ' A' ' 21' ' ' PHE . 1.3 m . . . . . 0 N--CA 1.495 1.777 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.47 ' O ' HG23 ' A' ' 30' ' ' VAL . 15.4 m -134.91 93.69 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.145 -0.972 . . . . 0.0 110.905 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.624 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 42.05 68.35 0.48 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.285 -0.885 . . . . 0.0 110.471 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -166.75 19.35 0.09 OUTLIER Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.294 -1.431 . . . . 0.0 111.043 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 1.057 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 1.9 m-20 -88.9 148.6 23.75 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.414 -1.639 . . . . 0.0 109.931 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.464 ' HG3' ' HG3' ' A' ' 16' ' ' LYS . 27.7 tt0 -149.79 132.14 15.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.017 -1.052 . . . . 0.0 110.575 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -148.96 177.16 9.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.37 -0.831 . . . . 0.0 109.877 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.568 ' CD1' ' CD2' ' A' ' 14' ' ' HIS . 8.4 tp -102.94 153.99 19.67 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.157 -0.965 . . . . 0.0 110.227 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.622 ' CZ ' ' HA ' ' A' ' 40' ' ' PRO . 1.0 OUTLIER -130.88 110.46 11.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.433 -0.792 . . . . 0.0 109.68 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.591 ' HG3' HD11 ' A' ' 97' ' ' LEU . 8.9 tm-20 -92.01 132.71 36.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.574 -0.704 . . . . 0.0 109.356 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.585 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 60.24 47.05 93.02 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.622 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 37.6 Cg_endo -61.47 75.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.984 1.518 . . . . 0.0 110.467 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.482 ' HA2' HG13 ' A' ' 7' ' ' VAL . . . -42.86 110.83 0.3 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 5' ' ' GLN . 3.0 p 38.33 44.21 0.69 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.598 -0.942 . . . . 0.0 111.622 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.616 ' OH ' HD12 ' A' ' 15' ' ' LEU . 13.6 t80 -68.74 122.28 18.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.732 -1.23 . . . . 0.0 109.309 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.446 HG23 ' HD2' ' A' ' 45' ' ' PRO . 31.4 mt -111.7 142.16 26.08 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 110.18 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.821 ' HB3' HG23 ' A' ' 51' ' ' VAL . 45.0 Cg_endo -73.19 96.09 0.87 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.09 1.574 . . . . 0.0 110.353 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.403 ' O ' ' C ' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -106.13 161.8 14.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 110.242 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 46' ' ' ARG . 35.7 mttt -43.26 -31.24 0.59 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.341 -0.85 . . . . 0.0 110.299 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.474 ' HB3' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -55.19 -45.66 75.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.266 -0.896 . . . . 0.0 110.605 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.601 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.4 m -144.4 165.86 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.232 -0.917 . . . . 0.0 110.031 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -125.76 141.88 51.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.296 -0.877 . . . . 0.0 110.234 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.821 HG23 ' HB3' ' A' ' 45' ' ' PRO . 46.6 t -60.18 119.86 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.858 . . . . 0.0 109.832 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.833 HG12 ' HG2' ' A' ' 53' ' ' GLU . 16.7 t -95.1 -64.02 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 0.0 110.474 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.833 ' HG2' HG12 ' A' ' 52' ' ' VAL . 44.8 mm-40 -141.96 175.62 9.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.56 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.816 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -134.95 146.06 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.36 -0.838 . . . . 0.0 109.111 179.439 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -140.08 131.74 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.971 -1.081 . . . . 0.0 110.739 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.499 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 2.5 mp0 -86.5 156.01 20.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.49 -0.756 . . . . 0.0 109.835 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.037 ' HB1' ' HA ' ' A' ' 95' ' ' ALA . . . -95.3 142.85 27.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 0.0 110.818 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.62 HG22 ' C ' ' A' ' 57' ' ' ALA . 0.1 OUTLIER 168.81 51.69 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.424 -0.797 . . . . 0.0 110.777 179.758 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.9 HD13 ' CD1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -153.48 -28.75 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.728 -1.232 . . . . 0.0 111.419 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.731 HD12 ' O ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER -87.58 168.58 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.644 -1.285 . . . . 0.0 110.844 -179.098 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.522 ' CB ' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -107.23 -177.29 3.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.521 -0.737 . . . . 0.0 110.323 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.956 ' HA ' HG12 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -66.46 -72.26 0.17 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.273 -0.892 . . . . 0.0 110.671 -179.747 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.536 ' CB ' ' HB3' ' A' ' 110' ' ' ALA . 1.1 m-80 -77.55 -6.84 55.08 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.314 -0.866 . . . . 0.0 110.207 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.522 ' HB2' ' CB ' ' A' ' 61' ' ' ARG . 5.3 tp-100 -61.1 129.26 40.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.144 -0.973 . . . . 0.0 110.657 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.632 ' O ' HD22 ' A' ' 66' ' ' LEU . . . -108.67 144.99 35.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.074 -1.016 . . . . 0.0 109.752 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.672 ' HB2' HG13 ' A' ' 90' ' ' VAL . 1.7 mm? -123.13 114.6 20.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.182 -0.948 . . . . 0.0 110.522 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.819 ' HG2' HD23 ' A' ' 89' ' ' LEU . 18.5 mtm180 -97.99 122.04 40.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.297 -0.877 . . . . 0.0 109.881 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.777 HD23 ' HA ' ' A' ' 104' ' ' VAL . 13.2 mt -118.88 135.82 54.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.961 . . . . 0.0 110.61 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.852 ' HB2' HD11 ' A' ' 105' ' ' LEU . 29.2 ttt180 -98.22 160.74 14.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.55 -0.719 . . . . 0.0 109.865 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.514 ' HB2' ' HZ3' ' A' ' 75' ' ' TRP . . . -75.99 164.16 26.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.261 -0.899 . . . . 0.0 111.193 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 101' ' ' PHE . 1.0 OUTLIER -124.51 -42.6 2.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.66 -0.65 . . . . 0.0 109.493 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.501 ' HB2' ' CD2' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -122.03 138.67 54.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.41 -0.806 . . . . 0.0 109.998 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.528 ' HG3' HG23 ' A' ' 83' ' ' VAL . 0.6 OUTLIER -69.52 60.55 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.151 -0.968 . . . . 0.0 109.481 179.336 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 72' ' ' LYS . 2.2 t -151.18 -25.63 0.21 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.219 -0.926 . . . . 0.0 111.309 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.595 ' CZ2' ' HB3' ' A' ' 77' ' ' ARG . 1.7 t90 -73.6 116.23 13.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.754 -1.216 . . . . 0.0 110.519 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.488 ' HB3' ' HA ' ' A' ' 81' ' ' GLU . 2.5 p-10 -107.07 109.61 21.51 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.251 -0.905 . . . . 0.0 110.07 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.595 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -88.82 -4.09 58.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.243 -0.911 . . . . 0.0 110.242 179.671 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -117.66 -12.48 10.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.883 . . . . 0.0 110.089 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.18 -46.23 1.13 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.403 ' O ' ' HD2' ' A' ' 82' ' ' ARG . 11.4 mtmt -82.55 127.13 33.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -1.161 . . . . 0.0 110.26 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.591 ' CG ' HG11 ' A' ' 29' ' ' VAL . 6.1 tp10 -46.28 119.55 2.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 0.0 110.109 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.403 ' HD2' ' O ' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -101.43 175.04 5.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 110.317 -179.858 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.584 HG22 ' N ' ' A' ' 84' ' ' THR . 13.8 p -106.69 172.84 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 110.306 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.584 ' N ' HG22 ' A' ' 83' ' ' VAL . 40.6 p -60.75 -174.08 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.323 -0.861 . . . . 0.0 109.022 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 87' ' ' GLU . . . 70.8 -56.37 0.99 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 4.4 tp10 -44.32 153.78 0.14 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.032 -1.275 . . . . 0.0 109.545 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.54 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 13.4 mp0 -145.23 149.8 35.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.741 -1.224 . . . . 0.0 111.385 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.572 ' CZ2' ' HB ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -111.74 163.27 14.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.395 -0.815 . . . . 0.0 108.903 178.606 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.819 HD23 ' HG2' ' A' ' 67' ' ' ARG . 1.5 tm? -129.32 141.67 51.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.989 -1.069 . . . . 0.0 110.309 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.824 HG21 HD12 ' A' ' 97' ' ' LEU . 7.1 p -126.15 139.49 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.61 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 91' ' ' THR . 22.3 m -137.46 40.55 2.42 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.174 -0.954 . . . . 0.0 110.132 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.7 m -82.44 126.71 32.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.169 -0.957 . . . . 0.0 110.376 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.956 HG12 ' HA ' ' A' ' 62' ' ' GLN . 3.8 m -58.19 112.56 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.134 -0.979 . . . . 0.0 110.265 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 60' ' ' ILE . . . 71.44 96.6 0.06 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 1.037 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . . . -169.41 176.03 5.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.324 -1.103 . . . . 0.0 110.826 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.9 ' CD1' HD13 ' A' ' 59' ' ' ILE . 1.0 OUTLIER -129.0 -70.57 0.66 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.495 -0.753 . . . . 0.0 109.514 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.824 HD12 HG21 ' A' ' 90' ' ' VAL . 4.8 mt 48.92 78.27 0.41 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.484 -0.76 . . . . 0.0 111.247 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.739 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 48.9 Cg_endo -74.65 -14.79 21.96 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.806 1.424 . . . . 0.0 109.548 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.739 ' HB3' ' O ' ' A' ' 98' ' ' PRO . . . 72.14 173.46 0.3 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.537 -0.727 . . . . 0.0 111.161 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.531 HG12 ' CD1' ' A' ' 101' ' ' PHE . 94.2 t -99.81 -61.09 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.538 -0.727 . . . . 0.0 109.603 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.586 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 18.0 m-30 -111.43 45.44 1.2 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.335 -0.853 . . . . 0.0 109.992 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 11.4 mt-10 -134.05 144.88 48.93 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.676 -1.265 . . . . 0.0 111.887 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.45 ' O ' HD12 ' A' ' 105' ' ' LEU . 1.3 tt0 -119.37 123.27 43.74 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.777 ' HA ' HD23 ' A' ' 68' ' ' LEU . 7.2 p -54.05 149.02 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.218 -0.926 . . . . 0.0 110.779 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.852 HD11 ' HB2' ' A' ' 69' ' ' ARG . 8.4 mp -103.46 -32.92 9.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.574 -0.704 . . . . 0.0 110.387 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -179.84 148.38 0.31 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.026 -1.046 . . . . 0.0 110.722 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 mp -88.33 125.52 34.73 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.331 -0.856 . . . . 0.0 109.555 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 64' ' ' GLN . 74.2 t -116.85 140.53 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.067 -1.021 . . . . 0.0 111.434 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 14.4 t0 -111.29 114.15 27.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 109.496 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.536 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.494 1.736 0 O-C-N 120.862 -1.149 . . . . 0.0 110.282 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.2 0.524 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.497 HG23 ' N ' ' A' ' 7' ' ' VAL . 6.7 m -66.75 -150.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -0.885 . . . . 0.0 110.079 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.738 ' C ' HD13 ' A' ' 8' ' ' LEU . 4.0 t -83.32 144.48 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 110.178 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.749 HD22 ' H ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -100.25 168.74 8.93 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.207 -0.933 . . . . 0.0 109.519 179.667 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 42.8 Cg_endo -70.15 68.94 1.89 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.641 1.337 . . . . 0.0 110.732 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.837 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 4.9 m120 68.67 69.86 0.29 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.555 -0.715 . . . . 0.0 111.227 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.482 ' OG1' ' HB2' ' A' ' 8' ' ' LEU . 7.8 p -138.87 159.71 41.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.942 . . . . 0.0 109.921 178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.573 ' CB ' HD22 ' A' ' 97' ' ' LEU . . . -139.04 155.68 47.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.157 -0.964 . . . . 0.0 110.333 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.977 HD13 HD11 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -130.48 156.74 44.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -0.932 . . . . 0.0 110.609 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.994 ' C ' HD13 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -93.98 128.2 40.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.597 -0.689 . . . . 0.0 109.424 179.625 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.994 HD13 ' C ' ' A' ' 14' ' ' HIS . 0.1 OUTLIER -121.58 153.15 38.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.065 -1.022 . . . . 0.0 110.098 -179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -110.09 116.52 31.7 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.21 -0.931 . . . . 0.0 109.385 178.915 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.986 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -76.61 115.93 16.82 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.285 -0.885 . . . . 0.0 110.434 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.741 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -102.83 99.77 9.73 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.475 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.627 HD13 ' H ' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -167.59 147.31 5.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 110.745 -179.443 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.627 ' H ' HD13 ' A' ' 19' ' ' LEU . 32.4 t70 -85.39 110.82 19.41 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.727 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.081 -1.012 . . . . 0.0 112.054 -177.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.727 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 30' ' ' VAL . 20.1 m -127.63 85.67 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.065 -1.022 . . . . 0.0 110.575 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.741 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 41.62 71.18 0.22 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.315 -0.866 . . . . 0.0 110.381 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -179.68 28.83 0.05 OUTLIER Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.536 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.986 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 42.5 m-20 -93.44 147.94 22.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.769 -1.43 . . . . 0.0 110.0 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.473 ' HG2' HG11 ' A' ' 100' ' ' VAL . 15.3 tt0 -143.07 143.56 31.91 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.032 -1.042 . . . . 0.0 110.176 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.563 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 7.1 p90 -159.95 168.83 24.78 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.014 -1.054 . . . . 0.0 111.105 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.869 HD22 ' O ' ' A' ' 98' ' ' PRO . 14.2 tp -97.32 153.29 18.15 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.353 -0.842 . . . . 0.0 109.774 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.602 ' CZ ' ' HA ' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -140.96 109.6 5.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.98 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.816 ' HG2' HD22 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -97.77 137.77 36.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.355 -0.84 . . . . 0.0 109.402 179.614 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.595 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 78.73 46.68 8.41 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.602 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 38.1 Cg_endo -63.47 71.32 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.052 1.554 . . . . 0.0 111.041 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.552 ' HA2' HG22 ' A' ' 7' ' ' VAL . . . -46.43 95.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER 46.13 40.44 7.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -1.137 . . . . 0.0 110.413 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.561 ' HB3' ' HB2' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -68.64 131.87 45.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.105 -0.997 . . . . 0.0 109.929 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.714 HG23 ' HD2' ' A' ' 45' ' ' PRO . 23.3 mm -121.08 148.22 48.5 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.388 -0.82 . . . . 0.0 109.124 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.714 ' HD2' HG23 ' A' ' 44' ' ' ILE . 41.2 Cg_endo -67.85 75.03 0.64 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.689 1.363 . . . . 0.0 110.863 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 49' ' ' VAL . 13.0 ttt85 -66.84 143.47 56.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.424 -0.798 . . . . 0.0 109.895 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -41.25 -33.62 0.4 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.344 -0.848 . . . . 0.0 110.523 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -49.46 -50.89 39.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.157 -0.964 . . . . 0.0 109.95 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.675 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.4 m -133.0 173.51 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.353 -0.842 . . . . 0.0 109.408 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.48 132.77 44.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.088 -1.008 . . . . 0.0 110.56 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.732 ' HA ' HD12 ' A' ' 15' ' ' LEU . 9.4 p -54.41 143.53 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.041 -1.037 . . . . 0.0 108.232 178.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.714 HG23 ' HA ' ' A' ' 15' ' ' LEU . 13.0 t -123.33 -57.5 2.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.666 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.959 ' O ' HD13 ' A' ' 54' ' ' ILE . 31.1 mm-40 -135.35 167.36 21.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.393 -0.817 . . . . 0.0 110.092 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.959 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -136.77 147.94 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.436 -0.79 . . . . 0.0 109.067 179.359 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.556 HD13 ' H ' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -142.12 136.08 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.072 -1.017 . . . . 0.0 110.791 -179.21 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.556 ' H ' HD13 ' A' ' 55' ' ' ILE . 90.2 mm-40 -91.91 174.13 7.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.403 -0.811 . . . . 0.0 109.887 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.837 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -97.97 127.45 43.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.95 . . . . 0.0 110.348 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER 172.18 91.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.325 -0.86 . . . . 0.0 110.535 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.804 HD13 ' CE1' ' A' ' 96' ' ' TYR . 0.0 OUTLIER 177.76 -50.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.03 -1.044 . . . . 0.0 110.569 179.605 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.622 HG22 ' N ' ' A' ' 61' ' ' ARG . 15.7 mm -117.97 -93.34 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.788 -1.195 . . . . 0.0 110.33 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.622 ' N ' HG22 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -178.8 -163.34 0.06 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.129 -0.982 . . . . 0.0 111.042 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.829 ' HB3' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -92.51 -72.27 0.6 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.307 -0.871 . . . . 0.0 110.671 -179.353 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.783 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 3.1 m-20 -41.84 -24.59 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.675 -0.641 . . . . 0.0 111.636 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.967 ' OE1' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -58.47 134.01 56.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.846 -1.159 . . . . 0.0 110.294 -179.51 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.078 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -109.21 138.95 44.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.949 . . . . 0.0 109.285 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.967 HD13 ' OE1' ' A' ' 64' ' ' GLN . 2.0 tp -126.25 111.7 14.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -0.991 . . . . 0.0 110.848 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.614 ' O ' HD12 ' A' ' 105' ' ' LEU . 1.1 tpp180 -89.42 123.31 33.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.242 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.603 HD23 ' HA ' ' A' ' 104' ' ' VAL . 13.2 mt -122.57 146.99 46.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.877 . . . . 0.0 111.264 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 13.5 ttp85 -114.41 165.01 13.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.577 -0.702 . . . . 0.0 109.365 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.879 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -83.59 161.21 21.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.956 -1.09 . . . . 0.0 111.278 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.486 ' HB3' ' O ' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -123.83 -35.91 2.8 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.791 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.479 ' HG3' ' CD1' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -125.44 151.25 46.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.511 -0.743 . . . . 0.0 109.463 179.091 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.514 ' OE1' HG23 ' A' ' 83' ' ' VAL . 20.3 tt0 -83.08 95.99 8.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.123 -0.985 . . . . 0.0 109.556 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.77 -27.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.18 -0.95 . . . . 0.0 110.719 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.577 ' HZ3' ' HB2' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -74.46 125.8 29.34 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.036 -1.04 . . . . 0.0 110.16 -179.671 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 77' ' ' ARG . 34.9 m-20 -94.73 119.53 33.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 109.536 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 76' ' ' ASP . 5.0 mtm180 -39.6 -55.91 1.77 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.456 -0.778 . . . . 0.0 110.821 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -118.42 -8.1 10.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.1 -1.0 . . . . 0.0 110.396 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.41 -20.52 2.96 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.431 ' O ' ' CG ' ' A' ' 76' ' ' ASP . 4.4 mttp -63.88 -132.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -1.083 . . . . 0.0 109.866 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.536 ' HB3' ' CG1' ' A' ' 29' ' ' VAL . 5.9 mp0 -142.65 120.85 12.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.942 -1.098 . . . . 0.0 110.077 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.468 ' HD3' ' HG2' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -132.51 178.14 7.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.93 . . . . 0.0 110.186 179.823 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.917 HG13 ' H ' ' A' ' 85' ' ' GLY . 7.7 p -107.86 179.95 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.378 -0.826 . . . . 0.0 110.267 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.879 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 8.8 t -70.24 -15.53 62.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 110.343 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.917 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -86.75 8.37 75.89 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.468 ' HG2' ' HD3' ' A' ' 82' ' ' ARG . 13.6 tp10 -91.14 162.96 14.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.24 -1.153 . . . . 0.0 109.888 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.468 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 12.5 pt-20 -153.5 156.95 39.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.949 -1.094 . . . . 0.0 110.359 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.577 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -139.51 147.53 41.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.762 179.894 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.951 HD13 ' N ' ' A' ' 90' ' ' VAL . 2.7 tm? -103.41 146.97 27.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -0.852 . . . . 0.0 109.493 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.951 ' N ' HD13 ' A' ' 89' ' ' LEU . 20.5 t -104.47 117.42 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.146 -0.971 . . . . 0.0 110.224 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.69 -0.18 8.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.576 -0.702 . . . . 0.0 109.909 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.52 171.41 15.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.425 -0.797 . . . . 0.0 110.112 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.829 HG13 ' HB3' ' A' ' 62' ' ' GLN . 11.1 t -86.43 166.6 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.131 -0.98 . . . . 0.0 110.019 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.781 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 144.02 -28.18 2.0 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 59' ' ' ILE . . . 58.34 14.25 2.8 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.337 -1.096 . . . . 0.0 110.921 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.804 ' CE1' HD13 ' A' ' 59' ' ' ILE . 6.7 t80 179.99 85.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.088 -1.008 . . . . 0.0 110.674 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.816 HD22 ' HG2' ' A' ' 38' ' ' GLU . 69.3 mt -129.45 81.63 69.54 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 109.54 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.869 ' O ' HD22 ' A' ' 36' ' ' LEU . 44.3 Cg_endo -71.8 141.48 37.42 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.076 1.566 . . . . 0.0 110.774 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -85.19 -164.85 1.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.41 -0.806 . . . . 0.0 109.941 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.473 HG11 ' HG2' ' A' ' 34' ' ' GLU . 18.7 t -109.47 -62.75 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.215 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.515 ' HB2' ' HB2' ' A' ' 75' ' ' TRP . 14.8 m-85 -97.6 -33.06 11.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.278 -0.889 . . . . 0.0 110.189 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.565 ' OE1' ' CH2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -80.95 154.03 27.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 110.243 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -128.79 172.18 11.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.91 . . . . 0.0 110.45 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.603 ' HA ' HD23 ' A' ' 68' ' ' LEU . 7.5 p -93.28 142.69 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.903 . . . . 0.0 110.644 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.711 ' H ' HD12 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -106.34 -19.81 13.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.477 -0.764 . . . . 0.0 109.608 179.755 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -174.63 156.24 2.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.497 -0.752 . . . . 0.0 109.944 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.437 HD23 HD11 ' A' ' 66' ' ' LEU . 3.3 mp -107.54 146.09 32.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.899 . . . . 0.0 110.356 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.078 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 8.9 p -134.41 159.52 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.139 -0.976 . . . . 0.0 109.848 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 110' ' ' ALA . 8.2 p-10 -110.36 125.71 53.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.122 -0.986 . . . . 0.0 110.114 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.783 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.216 -0.928 . . . . 0.0 110.408 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.462 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 1.8 mt-30 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.269 0.557 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 8' ' ' LEU . 14.2 t -90.63 143.35 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.22 -0.925 . . . . 0.0 109.471 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.455 ' C ' ' O ' ' A' ' 6' ' ' VAL . 40.7 t -39.4 95.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.436 -0.79 . . . . 0.0 110.102 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 6' ' ' VAL . 0.9 OUTLIER -45.55 165.84 0.16 Allowed Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.451 -0.781 . . . . 0.0 110.167 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.69 -56.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 124.165 1.613 . . . . 0.0 110.648 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.775 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 2.0 m-20 -166.75 26.01 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.084 -1.01 . . . . 0.0 110.588 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 7.2 p -103.58 171.76 7.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.171 -0.956 . . . . 0.0 109.655 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.834 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -141.42 160.4 40.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.858 -1.151 . . . . 0.0 110.689 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.097 ' CD2' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -129.59 155.18 46.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.103 -0.998 . . . . 0.0 109.927 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.62 ' CE1' HD21 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -92.74 126.51 37.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 110.321 -179.278 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.097 HD21 ' CD2' ' A' ' 13' ' ' LEU . 2.6 mm? -112.19 151.51 29.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.671 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.607 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 9.0 ttmt -119.58 117.0 27.2 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.953 -1.092 . . . . 0.0 109.362 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.962 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -77.93 120.33 22.64 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.271 -0.893 . . . . 0.0 110.335 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.499 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 0.5 OUTLIER -99.29 101.76 13.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.629 -0.669 . . . . 0.0 109.731 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.63 HD13 ' H ' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -159.04 141.04 13.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.327 -0.858 . . . . 0.0 110.04 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.63 ' H ' HD13 ' A' ' 19' ' ' LEU . 4.1 m-20 -90.07 103.6 16.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.856 . . . . 0.0 110.258 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.636 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.393 -0.817 . . . . 0.0 110.042 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.636 HG22 ' CB ' ' A' ' 21' ' ' PHE . 1.5 m . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.187 0.517 . . . . 0.0 109.752 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 30' ' ' VAL . 29.6 m -137.37 80.88 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.9 . . . . 0.0 110.026 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.499 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 47.91 68.62 0.64 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.891 . . . . 0.0 110.18 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.14 29.54 0.04 OUTLIER Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.362 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.962 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 38.1 m-20 -83.99 146.72 27.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.789 -1.418 . . . . 0.0 109.473 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.619 ' OE1' HG11 ' A' ' 100' ' ' VAL . 4.8 tt0 -144.22 147.34 33.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.099 -1.001 . . . . 0.0 111.056 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.619 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 11.5 p90 -156.7 164.41 38.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.465 -0.772 . . . . 0.0 110.188 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.62 HD21 ' CE1' ' A' ' 14' ' ' HIS . 0.2 OUTLIER -96.74 149.46 21.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.244 -0.91 . . . . 0.0 110.394 -179.796 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.57 ' HB3' HD23 ' A' ' 13' ' ' LEU . 2.9 t80 -131.55 110.74 11.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.233 -0.917 . . . . 0.0 110.502 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.594 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 2.3 tm-20 -85.75 125.12 32.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.652 -0.655 . . . . 0.0 110.001 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.594 ' N ' ' HD3' ' A' ' 40' ' ' PRO . . . 74.63 44.85 24.81 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.594 ' HD3' ' N ' ' A' ' 39' ' ' GLY . 55.9 Cg_endo -77.88 32.96 0.44 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.494 1.26 . . . . 0.0 111.222 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 5' ' ' GLN . . . -54.39 -59.53 9.95 Favored Glycine 0 N--CA 1.487 2.096 0 O-C-N 120.53 -1.356 . . . . 0.0 109.976 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 75.5 p -78.87 12.35 2.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -1.174 . . . . 0.0 111.501 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.615 ' OH ' HD12 ' A' ' 15' ' ' LEU . 3.2 t80 -72.99 130.6 40.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.851 -1.156 . . . . 0.0 110.078 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.518 HG23 ' HD2' ' A' ' 45' ' ' PRO . 1.9 mt -118.66 143.11 32.81 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.982 . . . . 0.0 109.798 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.518 ' HD2' HG23 ' A' ' 44' ' ' ILE . 46.0 Cg_endo -72.58 107.17 2.24 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.971 1.511 . . . . 0.0 110.458 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 49' ' ' VAL . 1.2 mtt-85 -114.91 148.73 38.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.306 -0.871 . . . . 0.0 110.229 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 46' ' ' ARG . 0.3 OUTLIER -40.44 -45.95 2.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.353 -0.842 . . . . 0.0 110.847 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.426 ' C ' ' CG1' ' A' ' 49' ' ' VAL . 3.0 mt-10 -42.53 -39.06 2.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.407 -0.808 . . . . 0.0 110.875 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.63 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.6 m -145.96 174.09 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.15 -0.969 . . . . 0.0 110.549 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 49' ' ' VAL . 1.6 mm-40 -139.39 139.61 37.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.255 -0.903 . . . . 0.0 110.395 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.446 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . 5.0 m -55.23 130.98 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.147 -0.971 . . . . 0.0 110.223 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.607 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 3.7 t -104.12 -58.7 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.312 -0.867 . . . . 0.0 110.351 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.888 ' C ' HD13 ' A' ' 54' ' ' ILE . 3.7 mt-10 -143.36 171.06 14.64 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.097 -1.002 . . . . 0.0 110.4 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.888 HD13 ' C ' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -132.23 135.96 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.781 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.834 HG22 ' O ' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -129.91 143.86 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.913 -1.117 . . . . 0.0 111.694 -178.588 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.468 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 93.1 mm-40 -91.84 158.78 16.13 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.644 -0.66 . . . . 0.0 109.383 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.775 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -102.35 132.85 48.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.175 -0.953 . . . . 0.0 110.193 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 3.7 t 178.5 55.02 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.132 -0.98 . . . . 0.0 111.584 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.591 HG22 ' O ' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -157.42 -51.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.462 -1.398 . . . . 0.0 111.599 179.341 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.554 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 13.9 mm -70.05 157.42 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.616 -1.302 . . . . 0.0 110.644 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.438 ' O ' HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -90.43 179.58 5.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.35 -0.844 . . . . 0.0 110.004 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.981 ' HA ' HG12 ' A' ' 93' ' ' VAL . 4.4 mt-30 -83.42 -27.07 29.81 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.151 -0.968 . . . . 0.0 110.714 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.711 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 3.1 m120 -94.4 -34.94 12.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.129 -0.982 . . . . 0.0 110.526 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -58.69 129.3 41.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.115 -0.991 . . . . 0.0 111.146 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.103 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -108.3 143.5 37.09 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.557 ' O ' HD13 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -126.72 120.47 29.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.081 -1.012 . . . . 0.0 110.578 -179.194 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.705 ' O ' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -89.69 141.87 28.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.489 -0.757 . . . . 0.0 109.462 179.591 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.705 HD22 ' O ' ' A' ' 67' ' ' ARG . 1.8 mm? -125.41 125.74 43.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.15 -0.969 . . . . 0.0 111.081 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.9 ' HB2' HD11 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -105.41 159.31 16.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.461 -0.774 . . . . 0.0 109.615 179.433 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.3 151.33 46.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.212 -0.93 . . . . 0.0 110.878 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -116.01 -30.16 6.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.434 -0.791 . . . . 0.0 109.589 179.322 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -149.43 130.21 14.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.304 -0.873 . . . . 0.0 109.802 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.46 ' N ' ' HD3' ' A' ' 72' ' ' LYS . 0.3 OUTLIER -56.57 90.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.176 -0.953 . . . . 0.0 109.903 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 72' ' ' LYS . 37.5 t -176.0 -29.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.384 -0.822 . . . . 0.0 110.442 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.584 ' CE3' ' HG2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -73.89 120.88 20.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.147 -0.971 . . . . 0.0 110.005 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.423 ' OD2' ' O ' ' A' ' 79' ' ' GLY . 3.5 m-20 -80.02 113.85 18.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.354 -0.841 . . . . 0.0 110.051 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.477 ' HB2' ' OE2' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -55.65 -54.7 40.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 110.355 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.68 -13.94 12.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.363 -0.836 . . . . 0.0 110.411 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.423 ' O ' ' OD2' ' A' ' 76' ' ' ASP . . . 143.42 -22.03 2.22 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.8 mmtt -85.77 157.51 20.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.524 -0.986 . . . . 0.0 109.741 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.521 ' HB3' HG11 ' A' ' 29' ' ' VAL . 37.8 mm-40 -69.37 126.5 29.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 110.161 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.473 ' HD2' ' OE1' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -122.2 175.23 6.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.493 -0.754 . . . . 0.0 110.702 -179.541 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.633 HG22 ' N ' ' A' ' 84' ' ' THR . 4.8 p -119.35 171.8 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.417 -0.802 . . . . 0.0 110.423 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.633 ' N ' HG22 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -54.78 -170.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.105 -0.997 . . . . 0.0 108.789 178.746 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 86' ' ' GLU . . . 70.77 -55.88 0.98 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.626 ' HG3' ' N ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -44.76 156.37 0.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.171 -1.193 . . . . 0.0 109.11 179.335 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.626 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 12.9 pt-20 -155.61 145.06 21.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.656 -1.278 . . . . 0.0 111.148 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -112.3 160.39 17.71 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 90' ' ' VAL . 0.1 OUTLIER -115.33 127.72 55.61 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.966 -1.084 . . . . 0.0 111.221 -178.88 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.64 ' N ' HD12 ' A' ' 89' ' ' LEU . 25.0 t -92.64 108.3 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.394 -0.816 . . . . 0.0 109.705 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.0 m -128.19 46.12 2.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.967 . . . . 0.0 110.829 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 53.2 m -107.8 131.3 54.61 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.15 -0.969 . . . . 0.0 110.149 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.981 HG12 ' HA ' ' A' ' 62' ' ' GLN . 27.5 m -66.9 150.29 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.253 -0.904 . . . . 0.0 110.477 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.618 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 41.08 82.03 0.02 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.712 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . . . -159.63 147.08 16.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -1.151 . . . . 0.0 110.207 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.567 ' O ' ' CG ' ' A' ' 96' ' ' TYR . 14.9 t80 -133.49 59.27 1.74 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.379 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.685 HD21 ' HB1' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -117.55 99.91 52.51 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 120.911 -1.118 . . . . 0.0 109.783 178.888 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.727 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 47.3 Cg_endo -77.56 18.08 0.87 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 124.111 1.585 . . . . 0.0 111.854 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 98' ' ' PRO . . . 70.1 -178.59 0.22 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.81 -1.181 . . . . 0.0 110.426 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.619 HG11 ' OE1' ' A' ' 34' ' ' GLU . 2.6 t -102.57 -61.72 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 109.793 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.537 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 22.0 m-85 -107.73 47.92 0.87 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.27 -0.894 . . . . 0.0 109.925 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.646 ' HB2' HD12 ' A' ' 68' ' ' LEU . 17.8 mt-10 -138.85 158.67 43.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.904 -1.122 . . . . 0.0 111.611 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.63 ' O ' HD13 ' A' ' 68' ' ' LEU . 9.9 mt-10 -132.49 167.53 19.81 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.606 -0.684 . . . . 0.0 109.395 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.521 ' C ' HD13 ' A' ' 105' ' ' LEU . 3.8 m -90.75 146.89 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.937 -1.102 . . . . 0.0 110.263 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.9 HD11 ' HB2' ' A' ' 69' ' ' ARG . 0.8 OUTLIER -102.28 -11.24 18.86 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.405 -0.809 . . . . 0.0 109.351 179.315 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 0.5 OUTLIER 162.46 127.71 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.61 -0.682 . . . . 0.0 110.098 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.1 mp -76.45 121.86 23.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 109.598 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.103 HG13 ' HB3' ' A' ' 65' ' ' ALA . 9.1 p -111.31 153.98 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.094 -1.004 . . . . 0.0 110.467 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -110.91 120.17 41.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -0.874 . . . . 0.0 109.821 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.007 -1.058 . . . . 0.0 110.216 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 2.4 mt-30 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.332 0.587 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.0 t -77.26 155.89 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.932 . . . . 0.0 110.37 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 74.9 t -45.21 106.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.321 -0.862 . . . . 0.0 110.217 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.761 HD23 ' OG1' ' A' ' 11' ' ' THR . 3.5 mp -49.83 164.72 0.34 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.7 -57.13 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.992 1.522 . . . . 0.0 110.498 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.68 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 3.2 m120 -163.41 31.11 0.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -0.904 . . . . 0.0 110.011 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.761 ' OG1' HD23 ' A' ' 8' ' ' LEU . 55.2 p -112.62 171.82 7.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.316 -0.865 . . . . 0.0 110.37 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -137.74 165.96 25.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.177 -0.952 . . . . 0.0 110.029 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.855 HD23 ' CG ' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -133.95 155.63 49.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.149 -0.969 . . . . 0.0 111.032 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.628 ' C ' HD23 ' A' ' 15' ' ' LEU . 52.8 m80 -99.06 132.74 44.14 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.288 -0.883 . . . . 0.0 110.474 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.856 HD21 ' HB2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -137.06 156.76 48.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.997 -1.064 . . . . 0.0 109.984 178.898 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 3.4 mtpt -107.94 123.56 48.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.358 -0.839 . . . . 0.0 110.742 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.087 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -82.1 119.68 24.33 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.314 -0.866 . . . . 0.0 110.157 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.861 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 2.8 mm? -101.06 101.18 11.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.581 -0.699 . . . . 0.0 109.865 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.487 HD13 ' HA ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -160.99 147.15 14.74 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.102 -0.999 . . . . 0.0 110.502 -179.679 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -88.75 113.26 24.12 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.672 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.081 -1.012 . . . . 0.0 111.733 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.672 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 30' ' ' VAL . 16.7 m -130.99 85.61 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.961 -1.087 . . . . 0.0 110.98 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.861 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 42.16 68.76 0.43 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.409 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.88 23.51 0.09 OUTLIER Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.445 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 1.087 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 10.5 m-20 -85.72 154.22 21.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.818 -1.401 . . . . 0.0 109.734 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 78.7 tt0 -155.93 138.71 15.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 110.312 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.667 ' CH2' HD12 ' A' ' 15' ' ' LEU . 3.8 p90 -157.77 177.14 11.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.164 -0.96 . . . . 0.0 110.523 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.654 HD22 ' O ' ' A' ' 98' ' ' PRO . 39.7 tp -90.43 165.56 13.76 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.433 -0.792 . . . . 0.0 110.824 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.856 ' HB2' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -135.73 110.84 8.91 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.58 -0.7 . . . . 0.0 109.467 179.554 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -86.22 131.31 34.26 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.193 -0.942 . . . . 0.0 110.441 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.597 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 54.98 45.99 79.15 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.855 ' CG ' HD23 ' A' ' 13' ' ' LEU . 39.5 Cg_endo -67.03 -60.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.918 1.483 . . . . 0.0 110.338 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 5' ' ' GLN . . . 37.83 -86.81 0.01 OUTLIER Glycine 0 N--CA 1.497 2.72 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.617 ' N ' ' O ' ' A' ' 40' ' ' PRO . 1.2 p -54.4 -7.65 0.17 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.337 -1.096 . . . . 0.0 112.008 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.599 ' CD2' HD21 ' A' ' 13' ' ' LEU . 6.6 t80 -67.37 130.09 41.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.61 -1.307 . . . . 0.0 110.096 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.695 HG23 ' HD2' ' A' ' 45' ' ' PRO . 34.1 mt -119.56 147.78 44.4 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.51 -0.744 . . . . 0.0 109.639 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.695 ' HD2' HG23 ' A' ' 44' ' ' ILE . 40.4 Cg_endo -68.48 87.62 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.841 1.442 . . . . 0.0 110.462 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 49' ' ' VAL . 18.3 mmt85 -95.91 157.73 15.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.402 -0.811 . . . . 0.0 110.112 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -53.66 -19.84 4.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.177 -0.952 . . . . 0.0 110.107 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.489 ' C ' ' CG1' ' A' ' 49' ' ' VAL . 1.8 tp10 -62.65 -36.51 83.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.283 -0.885 . . . . 0.0 109.752 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.489 ' CG1' ' C ' ' A' ' 48' ' ' GLU . 0.9 OUTLIER -150.05 173.92 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.393 -0.817 . . . . 0.0 109.521 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 52' ' ' VAL . 6.3 mt-10 -130.88 125.59 33.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.043 -1.036 . . . . 0.0 110.507 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 51' ' ' VAL . 2.6 p -54.21 124.84 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.098 -1.001 . . . . 0.0 109.139 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.877 HG12 ' HG2' ' A' ' 53' ' ' GLU . 47.1 t -104.37 -61.79 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.106 -0.996 . . . . 0.0 111.1 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.95 ' O ' HD13 ' A' ' 54' ' ' ILE . 4.5 mm-40 -134.84 174.09 10.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.071 -1.018 . . . . 0.0 110.612 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.95 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.1 mm -135.24 131.76 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.486 HG13 ' HG2' ' A' ' 98' ' ' PRO . 0.3 OUTLIER -121.13 137.31 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.106 -0.996 . . . . 0.0 111.269 -178.583 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.495 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 6.8 mp0 -95.37 169.24 10.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.505 -0.747 . . . . 0.0 110.543 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.888 ' HB1' ' HB3' ' A' ' 95' ' ' ALA . . . -96.85 118.99 34.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.821 . . . . 0.0 110.282 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 58' ' ' THR . 8.1 t -176.91 78.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.053 -1.03 . . . . 0.0 110.726 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.79 HG21 ' CD1' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -179.12 -59.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.944 -1.098 . . . . 0.0 111.104 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.697 HG13 HG22 ' A' ' 59' ' ' ILE . 1.7 mt -92.75 -139.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 120.295 -1.503 . . . . 0.0 109.695 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.503 ' H ' HG22 ' A' ' 60' ' ' ILE . 14.7 mtt85 -155.53 -162.02 1.26 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.077 -1.014 . . . . 0.0 110.092 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.834 ' CB ' HG12 ' A' ' 93' ' ' VAL . 2.2 mt-30 -83.06 -72.28 0.46 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.944 . . . . 0.0 111.109 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.563 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 9.6 p30 -45.41 -41.1 8.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -0.918 . . . . 0.0 111.304 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.85 136.87 51.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.877 -1.139 . . . . 0.0 111.14 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.989 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -121.96 142.65 50.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.515 -0.741 . . . . 0.0 109.296 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.936 HD22 ' C ' ' A' ' 65' ' ' ALA . 4.4 mm? -125.85 112.8 16.43 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.962 -1.086 . . . . 0.0 110.668 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.494 ' O ' ' HG3' ' A' ' 67' ' ' ARG . 3.5 ptp180 -90.91 126.98 36.21 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.031 -1.043 . . . . 0.0 110.362 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.789 HD23 ' HA ' ' A' ' 104' ' ' VAL . 17.2 mt -123.02 137.82 54.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.363 -0.836 . . . . 0.0 110.678 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -98.79 154.09 18.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.313 -0.867 . . . . 0.0 109.953 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.905 ' HB2' ' HG3' ' A' ' 86' ' ' GLU . . . -67.92 140.35 56.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.378 -0.826 . . . . 0.0 111.6 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 101' ' ' PHE . 15.1 tpp85 -104.38 -38.46 6.82 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.5 ' HB2' ' HB3' ' A' ' 101' ' ' PHE . 2.0 mmtt -113.81 155.96 24.75 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -86.82 27.76 0.96 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.988 -1.07 . . . . 0.0 110.275 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.6 -20.97 4.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.211 -0.93 . . . . 0.0 110.689 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.6 ' HB2' ' CD2' ' A' ' 101' ' ' PHE . 13.7 t90 -73.99 107.27 6.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.155 -0.965 . . . . 0.0 110.426 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 82' ' ' ARG . 8.3 m-20 -112.75 122.96 49.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.353 -0.842 . . . . 0.0 110.157 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.5 ' NH2' ' OD2' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -88.01 -20.41 25.85 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.265 -0.897 . . . . 0.0 110.256 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.5 ' OD2' ' NH2' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -96.16 6.98 47.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.208 -0.933 . . . . 0.0 110.032 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.07 9.33 86.83 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 76' ' ' ASP . 2.0 mmmt -117.88 135.61 53.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -1.189 . . . . 0.0 110.406 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.75 125.77 7.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -0.865 . . . . 0.0 110.159 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.504 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 1.5 mtt-85 -137.36 142.88 41.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.89 . . . . 0.0 110.115 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.556 HG13 ' H ' ' A' ' 85' ' ' GLY . 11.4 p -78.62 170.72 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.912 . . . . 0.0 110.215 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.754 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -55.44 -17.51 5.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.513 -0.742 . . . . 0.0 110.384 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.556 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -72.74 -12.2 78.1 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.905 ' HG3' ' HB2' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -67.3 170.97 6.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.969 -1.312 . . . . 0.0 109.848 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -159.59 145.61 16.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.15 -0.969 . . . . 0.0 110.277 179.66 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.596 ' CZ2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -132.08 133.69 44.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.22 -0.925 . . . . 0.0 110.016 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.073 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -107.06 138.72 42.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 110.018 179.737 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 1.073 ' N ' HD22 ' A' ' 89' ' ' LEU . 63.5 t -93.91 101.35 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.343 -0.848 . . . . 0.0 110.137 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.868 ' HB ' HD11 ' A' ' 89' ' ' LEU . 1.5 t -119.64 0.2 10.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.596 -0.69 . . . . 0.0 109.717 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 93' ' ' VAL . 98.9 m -88.06 114.44 24.68 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.429 -0.794 . . . . 0.0 110.259 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.834 HG12 ' CB ' ' A' ' 62' ' ' GLN . 16.6 m -41.31 124.7 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.453 -0.78 . . . . 0.0 109.753 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' A' ' 96' ' ' TYR . . . -174.93 34.78 0.1 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.888 ' HB3' ' HB1' ' A' ' 57' ' ' ALA . . . 45.58 -80.83 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.758 -0.848 . . . . 0.0 111.627 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.79 ' CD1' HG21 ' A' ' 59' ' ' ILE . 3.8 t80 -125.12 159.76 30.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.625 -1.297 . . . . 0.0 110.06 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -173.28 69.07 0.36 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.131 -0.98 . . . . 0.0 110.555 -179.441 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.654 ' O ' HD22 ' A' ' 36' ' ' LEU . 45.1 Cg_endo -74.89 145.27 31.68 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.839 1.441 . . . . 0.0 109.938 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.786 ' HB3' ' CG ' ' A' ' 102' ' ' GLU . . . -104.95 -141.67 0.37 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.038 -1.039 . . . . 0.0 111.15 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.512 ' CG2' ' HA ' ' A' ' 35' ' ' TRP . 0.9 OUTLIER -121.29 -58.42 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.136 -0.978 . . . . 0.0 111.819 -178.826 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.6 ' CD2' ' HB2' ' A' ' 75' ' ' TRP . 9.7 m-30 -111.35 55.6 0.66 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.161 -1.587 . . . . 0.0 111.492 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.786 ' CG ' ' HB3' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -141.2 143.83 34.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.592 -1.317 . . . . 0.0 110.815 179.218 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.407 ' O ' ' CD1' ' A' ' 105' ' ' LEU . 12.5 tp10 -118.56 128.31 54.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.586 -0.696 . . . . 0.0 110.171 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.789 ' HA ' HD23 ' A' ' 68' ' ' LEU . 4.9 p -65.28 148.53 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.389 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 1.6 mp -105.19 -45.56 4.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.354 -0.841 . . . . 0.0 109.944 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.11 133.14 2.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.878 . . . . 0.0 109.963 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.855 ' C ' HD22 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -76.06 142.65 41.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.939 . . . . 0.0 111.119 -179.499 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.989 HG13 ' HB3' ' A' ' 65' ' ' ALA . 3.4 p -128.03 149.88 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.993 -1.067 . . . . 0.0 109.709 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.2 119.58 39.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.058 -1.026 . . . . 0.0 110.544 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.028 -1.045 . . . . 0.0 109.862 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.513 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.35 0.595 . . . . 0.0 110.071 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.522 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 3.5 t -123.29 160.09 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.243 -0.91 . . . . 0.0 109.954 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.471 ' O ' ' O ' ' A' ' 8' ' ' LEU . 10.6 t -57.06 81.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.374 -0.828 . . . . 0.0 110.837 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.798 ' C ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -45.62 171.38 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.43 -0.794 . . . . 0.0 110.113 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.632 ' N ' HD22 ' A' ' 8' ' ' LEU . 51.3 Cg_endo -75.44 -99.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.524 1.276 . . . . 0.0 111.955 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.963 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 0.8 OUTLIER -112.38 83.94 1.89 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.761 -1.212 . . . . 0.0 110.934 -178.711 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.744 HG23 HD23 ' A' ' 8' ' ' LEU . 1.7 p -156.16 169.6 24.13 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.204 -0.935 . . . . 0.0 110.17 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.909 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -145.9 167.37 23.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 108.883 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.813 HD23 ' HG3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -134.55 153.75 51.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.826 -1.171 . . . . 0.0 111.137 179.859 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.897 ' CE1' HD13 ' A' ' 36' ' ' LEU . 7.8 m80 -98.5 135.63 39.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -0.858 . . . . 0.0 109.261 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.951 HD13 ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -139.11 165.53 26.91 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.128 -0.983 . . . . 0.0 110.172 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 1.6 tttt -114.51 120.91 41.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 111.108 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.0 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -81.56 112.53 18.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.416 -0.802 . . . . 0.0 109.696 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.809 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -100.47 101.6 12.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.395 -0.816 . . . . 0.0 110.124 -179.871 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.581 HD23 ' HG3' ' A' ' 48' ' ' GLU . 0.1 OUTLIER -162.27 139.18 8.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 110.208 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.577 ' H ' HD13 ' A' ' 19' ' ' LEU . 33.9 p-10 -78.83 101.53 7.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.687 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.883 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.27 -0.894 . . . . 0.0 110.53 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.883 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.613 ' O ' HG23 ' A' ' 30' ' ' VAL . 29.1 m -138.59 88.58 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.024 -1.047 . . . . 0.0 110.676 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.809 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 41.55 65.32 0.86 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.372 -0.83 . . . . 0.0 110.55 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -175.17 26.02 0.07 OUTLIER Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.501 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 1.0 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 10.0 m-20 -86.7 154.53 20.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.893 -1.357 . . . . 0.0 109.833 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.724 ' OE2' HG21 ' A' ' 52' ' ' VAL . 3.8 tt0 -153.59 131.27 11.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.251 -0.906 . . . . 0.0 110.176 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.776 ' CZ3' ' HB2' ' A' ' 17' ' ' ALA . 6.8 p90 -151.94 165.17 35.43 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.062 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.897 HD13 ' CE1' ' A' ' 14' ' ' HIS . 51.6 tp -91.44 161.86 14.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -0.834 . . . . 0.0 110.173 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.612 ' CE2' ' HB2' ' A' ' 43' ' ' TYR . 0.9 OUTLIER -136.78 111.99 9.09 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.366 -0.834 . . . . 0.0 109.89 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.648 ' HB2' HD21 ' A' ' 97' ' ' LEU . 2.4 tm-20 -84.31 140.68 31.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.683 -0.635 . . . . 0.0 109.803 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.609 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 59.05 40.77 95.97 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.813 ' HG3' HD23 ' A' ' 13' ' ' LEU . 49.2 Cg_endo -75.2 -51.14 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.375 1.197 . . . . 0.0 109.535 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.588 ' N ' HD12 ' A' ' 8' ' ' LEU . . . 41.63 -94.08 0.01 OUTLIER Glycine 0 N--CA 1.486 1.967 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 40' ' ' PRO . 1.8 t -78.23 19.9 0.42 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.425 -1.044 . . . . 0.0 112.05 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.612 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 1.6 t80 -67.61 111.05 3.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.675 -1.266 . . . . 0.0 109.006 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.457 HG23 ' HD2' ' A' ' 45' ' ' PRO . 51.1 mm -90.11 142.14 28.42 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.295 -0.878 . . . . 0.0 110.609 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.653 ' HB3' HG23 ' A' ' 51' ' ' VAL . 48.3 Cg_endo -74.74 106.5 2.27 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.184 1.623 . . . . 0.0 110.467 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.428 ' O ' ' N ' ' A' ' 48' ' ' GLU . 0.7 OUTLIER -84.95 147.85 26.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 109.789 179.699 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -43.71 -25.82 0.2 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.163 -0.96 . . . . 0.0 109.933 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.581 ' HG3' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -62.15 -46.45 88.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -0.863 . . . . 0.0 110.51 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.641 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -124.03 173.17 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.183 -0.948 . . . . 0.0 110.418 -179.656 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.416 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.0 mm-40 -135.1 137.12 42.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 110.22 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.653 HG23 ' HB3' ' A' ' 45' ' ' PRO . 12.2 t -56.98 138.79 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 109.234 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.724 HG21 ' OE2' ' A' ' 34' ' ' GLU . 39.4 t -121.86 -51.27 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.031 -1.043 . . . . 0.0 110.799 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.822 ' O ' HD13 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -145.6 166.89 24.45 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.977 -1.077 . . . . 0.0 110.147 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.822 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -134.29 131.24 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.335 -0.853 . . . . 0.0 109.245 179.185 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.909 HG22 ' O ' ' A' ' 12' ' ' ALA . 8.0 tt -117.03 145.93 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.061 -1.024 . . . . 0.0 111.44 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.452 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 3.9 mp0 -105.79 -179.51 3.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.618 -0.676 . . . . 0.0 109.837 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.963 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -97.16 136.06 38.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.159 -0.963 . . . . 0.0 111.17 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 4.7 t 176.23 57.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.443 -0.786 . . . . 0.0 111.134 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.621 HG21 ' CG ' ' A' ' 96' ' ' TYR . 0.5 OUTLIER -173.77 -48.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.507 -1.371 . . . . 0.0 112.33 179.389 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.602 HG22 ' N ' ' A' ' 61' ' ' ARG . 70.7 mt -75.69 172.63 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.577 -1.327 . . . . 0.0 110.333 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.602 ' N ' HG22 ' A' ' 60' ' ' ILE . 29.7 mtt-85 -117.81 -174.31 2.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.035 -1.04 . . . . 0.0 110.256 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.798 ' CA ' HG13 ' A' ' 93' ' ' VAL . 41.7 tt0 -79.16 -30.22 43.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.17 -0.956 . . . . 0.0 110.96 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 7.2 p30 -105.94 -21.87 13.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.009 -1.057 . . . . 0.0 110.625 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 109' ' ' ASP . 5.5 tp-100 -58.39 135.0 57.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.873 -1.142 . . . . 0.0 110.699 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.106 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -112.96 135.47 53.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.487 -0.758 . . . . 0.0 109.324 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.592 ' O ' HD22 ' A' ' 89' ' ' LEU . 1.3 mp -124.82 117.23 23.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.192 -0.942 . . . . 0.0 111.173 -179.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.496 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 1.7 ttp180 -96.34 126.13 41.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 108.965 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.017 ' CD2' HG12 ' A' ' 104' ' ' VAL . 17.8 mt -118.89 133.18 56.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.01 -1.056 . . . . 0.0 110.582 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 5.4 ttt85 -114.85 150.63 35.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -0.847 . . . . 0.0 110.13 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.523 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -70.32 123.45 21.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.83 . . . . 0.0 110.752 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -81.8 -38.67 25.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.947 . . . . 0.0 108.931 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.636 ' CG ' ' CD2' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -136.35 143.25 43.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.535 -0.728 . . . . 0.0 109.239 179.099 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 74' ' ' CYS . 0.0 OUTLIER -55.46 -161.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.983 . . . . 0.0 110.58 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 7.3 m 78.88 -40.97 0.27 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.587 -0.696 . . . . 0.0 110.54 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.603 ' CD1' ' HB2' ' A' ' 35' ' ' TRP . 20.6 t90 -73.38 104.36 4.36 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.769 -1.207 . . . . 0.0 110.099 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.452 ' OD1' ' HA ' ' A' ' 81' ' ' GLU . 65.1 m-20 -84.1 113.72 21.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.853 . . . . 0.0 110.136 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.459 ' HB2' ' CH2' ' A' ' 75' ' ' TRP . 21.8 tpt180 -87.45 -8.55 56.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.316 -0.865 . . . . 0.0 110.489 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.02 3.04 9.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 110.199 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.69 -2.9 64.98 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.85 144.27 48.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -1.114 . . . . 0.0 110.047 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.65 ' CB ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -46.16 110.67 0.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -0.929 . . . . 0.0 110.408 -179.762 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.35 179.44 3.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.212 -0.93 . . . . 0.0 109.947 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.654 HG13 ' H ' ' A' ' 85' ' ' GLY . 12.5 p -116.85 172.87 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.995 -1.066 . . . . 0.0 110.503 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.597 ' N ' HG22 ' A' ' 83' ' ' VAL . 7.5 t -57.55 -16.35 9.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.303 -0.873 . . . . 0.0 109.96 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.654 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -71.38 -14.25 74.34 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.437 ' HB3' ' O ' ' A' ' 83' ' ' VAL . 5.1 tp10 -75.63 147.75 39.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.406 -1.055 . . . . 0.0 109.67 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 68' ' ' LEU . 4.8 tt0 -157.38 162.44 39.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.212 -0.93 . . . . 0.0 109.981 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.576 ' CZ2' ' HB ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -153.34 142.04 20.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.17 -0.956 . . . . 0.0 110.232 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.859 HD13 ' O ' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -100.25 119.42 38.35 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.497 -0.752 . . . . 0.0 109.98 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.599 ' N ' HD22 ' A' ' 89' ' ' LEU . 5.3 p -97.99 150.72 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 110.749 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.1 t -148.98 51.06 0.97 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.453 -0.779 . . . . 0.0 109.903 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.649 HG22 ' OD1' ' A' ' 10' ' ' ASN . 9.2 m -82.95 139.82 33.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -0.917 . . . . 0.0 110.459 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.798 HG13 ' CA ' ' A' ' 62' ' ' GLN . 8.1 t -75.4 128.75 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.168 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.705 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 48.69 84.32 0.02 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.588 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . . . -177.61 151.46 0.74 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.111 -1.229 . . . . 0.0 110.953 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.621 ' CG ' HG21 ' A' ' 59' ' ' ILE . 1.2 t80 -116.88 112.57 21.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.021 -1.049 . . . . 0.0 110.419 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -124.94 76.71 66.62 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.183 -0.948 . . . . 0.0 110.249 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.414 ' HD3' ' CD1' ' A' ' 96' ' ' TYR . 52.8 Cg_endo -77.18 6.67 4.15 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.009 1.531 . . . . 0.0 110.967 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.589 ' CB ' ' CG ' ' A' ' 102' ' ' GLU . . . 52.41 -161.47 0.1 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.002 -1.062 . . . . 0.0 110.084 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.752 HG22 ' CD2' ' A' ' 14' ' ' HIS . 3.4 t -115.0 -62.01 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.07 -1.019 . . . . 0.0 111.19 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.636 ' CD2' ' CG ' ' A' ' 72' ' ' LYS . 4.5 m-30 -93.71 -29.65 15.3 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.767 -1.208 . . . . 0.0 111.214 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.589 ' CG ' ' CB ' ' A' ' 99' ' ' ALA . 8.6 pt-20 -80.37 161.15 25.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.965 -1.084 . . . . 0.0 110.899 -178.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.478 ' OE2' ' CD2' ' A' ' 105' ' ' LEU . 0.8 OUTLIER -136.05 164.18 28.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.364 -0.835 . . . . 0.0 110.018 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 1.017 HG12 ' CD2' ' A' ' 68' ' ' LEU . 3.9 m -76.25 139.85 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.909 . . . . 0.0 110.43 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.735 ' N ' HD23 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -94.0 -10.34 33.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.329 -0.857 . . . . 0.0 109.145 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER 166.35 -174.66 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.548 -0.72 . . . . 0.0 109.871 179.677 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 107' ' ' LEU . 4.4 mp -133.54 127.47 33.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.3 -0.875 . . . . 0.0 109.762 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.106 HG13 ' HB3' ' A' ' 65' ' ' ALA . 9.4 p -124.51 113.72 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.951 -1.093 . . . . 0.0 111.004 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -70.01 134.95 48.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.184 -0.947 . . . . 0.0 109.941 179.405 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.423 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.454 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 7.1 tt0 . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 121.091 0.472 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.551 ' C ' ' HA3' ' A' ' 41' ' ' GLY . 7.1 p -118.4 139.51 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.157 -0.964 . . . . 0.0 109.991 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.708 HG23 ' CA ' ' A' ' 39' ' ' GLY . 2.2 p -38.85 120.45 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.31 -0.869 . . . . 0.0 111.118 -178.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.659 HD23 ' OG1' ' A' ' 11' ' ' THR . 0.0 OUTLIER -67.99 171.54 5.41 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.817 -0.552 . . . . 0.0 109.766 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 38.1 Cg_endo -64.67 73.8 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.593 1.312 . . . . 0.0 109.969 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.944 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 9.2 m-20 64.1 33.29 12.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.873 -0.517 . . . . 0.0 111.558 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.659 ' OG1' HD23 ' A' ' 8' ' ' LEU . 1.2 p -106.16 169.07 8.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.76 -1.213 . . . . 0.0 109.369 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.572 ' HB2' ' HA ' ' A' ' 38' ' ' GLU . . . -148.75 158.67 44.32 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.008 -1.057 . . . . 0.0 110.496 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.049 HD13 HD11 ' A' ' 15' ' ' LEU . 1.4 pp -127.57 156.94 41.44 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.294 -0.879 . . . . 0.0 110.896 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.512 ' C ' HD13 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -93.39 127.17 38.89 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.526 -0.734 . . . . 0.0 110.622 -179.694 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.049 HD11 HD13 ' A' ' 13' ' ' LEU . 1.1 mm? -114.21 144.66 42.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.487 -0.758 . . . . 0.0 110.151 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.553 ' HB2' HG22 ' A' ' 52' ' ' VAL . 4.2 tttp -107.75 116.54 32.13 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.241 -0.983 . . . . 0.0 109.339 178.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.024 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -79.39 120.85 24.39 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 110.074 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.752 HD12 ' OE1' ' A' ' 50' ' ' GLU . 70.6 mt -105.98 101.21 10.72 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.883 -0.511 . . . . 0.0 109.638 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.841 HD13 ' N ' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -164.04 144.1 8.14 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.074 -1.016 . . . . 0.0 110.608 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.841 ' N ' HD13 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -84.9 103.4 13.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.343 -0.848 . . . . 0.0 109.146 178.94 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.8 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 110.542 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.8 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 30' ' ' VAL . 23.1 m -131.53 90.31 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.997 -1.064 . . . . 0.0 110.686 -179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.576 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 39.98 58.34 2.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.468 -0.77 . . . . 0.0 110.74 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.91 28.05 0.22 Allowed Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.58 -1.295 . . . . 0.0 110.04 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 1.024 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 7.4 m-20 -91.98 148.35 22.27 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.08 -1.247 . . . . 0.0 110.075 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.746 ' OE1' HG11 ' A' ' 52' ' ' VAL . 5.3 tt0 -147.63 131.7 17.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.016 -1.053 . . . . 0.0 110.603 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.589 ' HH2' HG21 ' A' ' 49' ' ' VAL . 10.3 p90 -140.64 172.92 12.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.188 -0.945 . . . . 0.0 110.3 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.763 HD21 ' HB2' ' A' ' 97' ' ' LEU . 17.1 tp -106.16 156.78 18.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.488 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.499 ' N ' ' HG ' ' A' ' 36' ' ' LEU . 1.5 t80 -142.89 115.52 8.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -0.913 . . . . 0.0 110.913 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.572 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 4.3 tm-20 -84.53 141.58 30.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.532 -0.73 . . . . 0.0 109.273 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.708 ' CA ' HG23 ' A' ' 7' ' ' VAL . . . 63.43 47.73 84.76 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.771 ' HB2' HD21 ' A' ' 13' ' ' LEU . 47.1 Cg_endo -68.99 7.06 0.85 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 124.187 1.625 . . . . 0.0 112.071 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.551 ' HA3' ' C ' ' A' ' 6' ' ' VAL . . . -49.67 -57.03 10.05 Favored Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.321 -1.418 . . . . 0.0 109.56 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 61.4 p -71.93 -4.45 28.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.479 -1.012 . . . . 0.0 110.789 -179.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.778 ' OH ' HD12 ' A' ' 15' ' ' LEU . 4.3 t80 -82.67 111.5 18.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.042 -1.036 . . . . 0.0 109.732 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.538 HG23 ' HD2' ' A' ' 45' ' ' PRO . 18.2 mm -102.48 144.56 28.86 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.255 -0.903 . . . . 0.0 109.787 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.538 ' HD2' HG23 ' A' ' 44' ' ' ILE . 42.2 Cg_endo -67.8 96.3 0.43 Allowed 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.033 1.543 . . . . 0.0 111.474 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.1 147.71 23.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 109.482 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.471 ' HG3' ' N ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -50.72 -30.95 15.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.161 -0.962 . . . . 0.0 110.474 -179.572 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.471 ' N ' ' HG3' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -52.25 -25.49 9.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.129 -0.982 . . . . 0.0 110.668 -179.796 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.613 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.5 m -149.18 173.29 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.885 . . . . 0.0 109.615 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.752 ' OE1' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -132.74 134.79 45.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.052 -1.03 . . . . 0.0 110.595 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.434 HG23 ' H ' ' A' ' 51' ' ' VAL . 9.0 t -54.79 130.78 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 109.128 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.879 HG12 ' OE2' ' A' ' 53' ' ' GLU . 5.3 t -104.54 -62.24 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.366 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.967 ' O ' HD13 ' A' ' 54' ' ' ILE . 2.4 mm-40 -146.29 173.72 12.0 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.547 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.967 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.3 mm -133.68 145.88 32.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.503 HD13 ' N ' ' A' ' 56' ' ' GLN . 0.4 OUTLIER -136.71 139.05 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.914 -1.116 . . . . 0.0 110.923 -178.824 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.515 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 2.8 mp0 -88.75 159.63 17.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.574 -0.704 . . . . 0.0 109.939 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.944 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -94.84 138.06 33.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.286 -0.884 . . . . 0.0 110.222 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 1.7 t 178.48 58.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.988 -1.07 . . . . 0.0 111.903 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.58 HG22 ' O ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER -166.04 -52.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.605 -1.31 . . . . 0.0 111.201 178.81 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.574 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 10.5 mt -62.45 161.23 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.655 -1.278 . . . . 0.0 109.552 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.469 ' HB2' ' HB2' ' A' ' 64' ' ' GLN . 1.0 OUTLIER -96.38 -168.43 1.73 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.1 -1.0 . . . . 0.0 110.818 -179.37 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.81 ' HA ' HG13 ' A' ' 93' ' ' VAL . 7.5 tt0 -89.03 -17.5 29.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.323 -0.861 . . . . 0.0 111.116 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.93 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 2.4 p-10 -115.96 -36.34 4.17 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 110.266 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.469 ' HB2' ' HB2' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -55.54 132.05 47.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 111.175 -179.596 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.007 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -109.9 149.71 29.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.384 -0.823 . . . . 0.0 109.381 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.715 ' O ' HG12 ' A' ' 90' ' ' VAL . 0.7 OUTLIER -119.01 123.9 45.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.831 -1.168 . . . . 0.0 110.948 -179.469 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.603 ' HG2' HD22 ' A' ' 105' ' ' LEU . 7.9 ttt180 -91.5 120.91 32.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 109.255 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.626 HD13 ' C ' ' A' ' 103' ' ' GLU . 2.5 mm? -112.66 137.49 50.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.186 -0.946 . . . . 0.0 111.256 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.58 ' CB ' HD11 ' A' ' 105' ' ' LEU . 7.5 ttt180 -128.12 150.53 49.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.539 -0.725 . . . . 0.0 109.466 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.769 ' HB2' ' HG2' ' A' ' 86' ' ' GLU . . . -62.84 136.76 58.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.053 -1.029 . . . . 0.0 110.603 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.504 ' HG3' ' HD2' ' A' ' 72' ' ' LYS . 34.8 tpt85 -107.52 -26.3 10.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.252 -0.905 . . . . 0.0 110.022 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.646 ' HG3' ' CD2' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -143.83 34.7 1.26 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.22 -0.925 . . . . 0.0 110.332 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.57 ' O ' ' CB ' ' A' ' 74' ' ' CYS . 1.1 pt-20 38.76 -162.13 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.585 -0.697 . . . . 0.0 110.447 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.57 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER 77.43 -35.21 0.21 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.382 -0.824 . . . . 0.0 111.156 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.578 ' CB ' ' HB2' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -73.87 113.13 10.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.91 -1.119 . . . . 0.0 109.665 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 79' ' ' GLY . 11.0 t0 -78.17 109.96 12.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.345 -0.847 . . . . 0.0 110.839 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.56 ' HB2' ' CZ2' ' A' ' 75' ' ' TRP . 1.4 tpm_? -88.68 -41.8 12.37 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.281 -0.887 . . . . 0.0 109.79 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -102.95 -9.07 20.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.356 -0.84 . . . . 0.0 110.128 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.498 ' N ' ' OD1' ' A' ' 76' ' ' ASP . . . 103.56 -4.6 47.21 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 81' ' ' GLU . 2.1 mttt -103.63 2.13 32.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -1.167 . . . . 0.0 110.132 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.466 ' OE2' ' OD2' ' A' ' 33' ' ' ASP . 43.5 mm-40 57.32 110.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 110.083 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.44 ' HB2' ' CD ' ' A' ' 86' ' ' GLU . 1.5 mmm-85 -113.8 179.87 3.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.465 -0.772 . . . . 0.0 110.641 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.929 HG13 ' H ' ' A' ' 85' ' ' GLY . 5.8 p -87.56 169.91 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.415 -0.803 . . . . 0.0 110.653 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.679 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -48.55 -23.03 0.86 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.304 -0.873 . . . . 0.0 110.138 179.754 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.929 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -64.66 -34.58 90.29 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.769 ' HG2' ' HB2' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -50.19 162.51 0.21 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.171 -1.193 . . . . 0.0 109.727 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.459 ' HB3' ' HG3' ' A' ' 69' ' ' ARG . 7.8 pt-20 -159.13 151.22 21.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.145 -0.972 . . . . 0.0 110.655 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.521 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -133.0 148.44 52.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.431 -0.793 . . . . 0.0 109.106 179.579 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.928 HD23 ' H ' ' A' ' 90' ' ' VAL . 1.1 tt -109.3 162.23 14.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.176 -0.952 . . . . 0.0 110.15 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.928 ' H ' HD23 ' A' ' 89' ' ' LEU . 14.3 p -137.0 117.78 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.156 -0.965 . . . . 0.0 110.556 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.66 38.27 3.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.396 -0.815 . . . . 0.0 109.789 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.52 ' CG2' ' OD1' ' A' ' 10' ' ' ASN . 2.2 m -88.62 133.78 34.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.848 . . . . 0.0 110.568 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.81 HG13 ' HA ' ' A' ' 62' ' ' GLN . 76.5 t -76.8 147.46 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.317 -0.865 . . . . 0.0 109.871 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.653 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 44.97 82.35 0.03 OUTLIER Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.703 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . . . -165.31 145.84 7.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.33 -1.1 . . . . 0.0 110.393 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.573 ' O ' ' CD1' ' A' ' 96' ' ' TYR . 3.2 t80 -124.81 -13.59 6.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.598 -0.689 . . . . 0.0 110.859 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.763 ' HB2' HD21 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -40.87 98.93 0.19 Allowed Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.151 -0.968 . . . . 0.0 110.185 -179.708 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.712 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 50.2 Cg_endo -86.88 11.63 3.21 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.169 1.615 . . . . 0.0 111.018 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 98' ' ' PRO . . . 67.99 -158.97 0.21 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.027 -1.046 . . . . 0.0 110.111 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.478 HG21 ' HG2' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -123.93 -55.45 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.061 -1.025 . . . . 0.0 110.897 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.646 ' CD2' ' HG3' ' A' ' 72' ' ' LYS . 7.5 m-85 -98.68 -4.54 33.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.869 -1.145 . . . . 0.0 110.159 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.563 ' HG2' ' CH2' ' A' ' 75' ' ' TRP . 6.9 mt-10 -91.05 121.93 33.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.293 -0.88 . . . . 0.0 110.733 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.626 ' C ' HD13 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -102.19 143.32 32.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.411 -0.806 . . . . 0.0 109.975 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 104' ' ' VAL . 3.6 m -71.39 134.08 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.062 -1.024 . . . . 0.0 110.426 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.603 HD22 ' HG2' ' A' ' 67' ' ' ARG . 3.0 mp -84.83 -16.02 42.78 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.447 -0.783 . . . . 0.0 109.168 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 3.2 p30 160.85 -165.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.456 ' HB3' ' NE2' ' A' ' 64' ' ' GLN . 3.4 mp -123.1 109.76 14.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.35 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.007 HG13 ' HB3' ' A' ' 65' ' ' ALA . 10.0 p -97.19 161.55 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.474 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 110' ' ' ALA . 8.8 p-10 -104.65 131.78 51.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.852 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.93 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.496 1.833 0 O-C-N 121.476 -0.765 . . . . 0.0 110.942 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.461 ' O ' ' O ' ' A' ' 41' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.428 0.632 . . . . 0.0 110.757 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.509 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 55.6 t -97.82 157.5 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.381 -0.825 . . . . 0.0 109.524 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.527 ' HA ' ' CA ' ' A' ' 41' ' ' GLY . 48.7 t -38.06 102.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.51 -0.744 . . . . 0.0 110.766 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.903 HD22 ' CG ' ' A' ' 40' ' ' PRO . 1.6 mp -47.73 137.49 9.91 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 110.288 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.672 ' O ' HG23 ' A' ' 11' ' ' THR . 48.4 Cg_endo -73.87 85.05 1.38 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.986 1.519 . . . . 0.0 110.618 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.888 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 9.4 m-20 56.64 48.36 16.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.214 -0.929 . . . . 0.0 110.578 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 9' ' ' PRO . 61.3 p -143.56 170.89 14.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.079 -1.013 . . . . 0.0 110.696 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.866 ' HB2' HD21 ' A' ' 97' ' ' LEU . . . -146.31 159.79 42.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.495 -0.753 . . . . 0.0 110.107 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.877 HD23 ' HG3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -133.3 152.71 51.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 109.983 179.493 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 1.02 ' C ' HD13 ' A' ' 15' ' ' LEU . 32.2 m80 -92.71 133.85 35.61 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.157 -0.964 . . . . 0.0 111.521 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.092 HD21 ' HB2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -124.21 153.85 41.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.419 -0.801 . . . . 0.0 109.274 178.781 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.547 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 8.5 ttmt -107.65 117.1 33.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.984 -1.073 . . . . 0.0 109.277 178.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.006 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -78.6 110.84 14.09 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.318 -0.864 . . . . 0.0 110.123 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 48' ' ' GLU . 82.6 mt -98.53 101.13 12.46 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.365 0.602 . . . . 0.0 109.72 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.544 HD13 ' N ' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -163.87 136.54 5.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.202 -0.936 . . . . 0.0 110.081 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.544 ' N ' HD13 ' A' ' 19' ' ' LEU . 80.3 m-20 -78.43 104.36 8.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 0.0 109.702 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.676 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.147 -0.97 . . . . 0.0 110.587 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.845 HG12 ' HG2' ' A' ' 81' ' ' GLU . 2.0 m . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 121.231 0.539 . . . . 0.0 109.653 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.67 ' O ' HG23 ' A' ' 30' ' ' VAL . 35.7 m -142.0 84.93 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 110.482 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.55 67.37 0.82 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.482 -0.761 . . . . 0.0 110.481 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -179.26 26.44 0.05 OUTLIER Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.592 -1.289 . . . . 0.0 110.587 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 1.006 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 15.7 m-20 -87.99 150.42 23.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.821 -1.4 . . . . 0.0 110.217 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 80.4 tt0 -145.3 130.8 18.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.134 -0.979 . . . . 0.0 110.052 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.873 ' CE2' HD23 ' A' ' 15' ' ' LEU . 8.0 p90 -143.03 166.01 25.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.042 -1.036 . . . . 0.0 110.715 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.584 HD13 ' NE2' ' A' ' 14' ' ' HIS . 56.2 tp -90.17 153.72 20.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.454 -0.779 . . . . 0.0 109.942 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 1.092 ' HB2' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -119.98 109.62 15.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.763 -1.211 . . . . 0.0 110.38 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.527 ' HB2' ' CD2' ' A' ' 97' ' ' LEU . 0.4 OUTLIER -90.71 127.0 36.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.422 -0.799 . . . . 0.0 110.186 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.57 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 57.98 46.86 92.03 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.903 ' CG ' HD22 ' A' ' 8' ' ' LEU . 37.8 Cg_endo -62.85 -21.65 73.26 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.87 1.458 . . . . 0.0 110.095 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.527 ' CA ' ' HA ' ' A' ' 7' ' ' VAL . . . 30.97 -92.09 0.01 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.712 ' O ' HD12 ' A' ' 44' ' ' ILE . 30.2 p -86.21 34.78 0.63 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.38 -1.07 . . . . 0.0 111.666 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.485 ' CE2' HD11 ' A' ' 13' ' ' LEU . 14.4 t80 -69.45 111.36 5.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.772 -1.205 . . . . 0.0 109.592 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.712 HD12 ' O ' ' A' ' 42' ' ' THR . 2.5 mp -103.57 142.58 24.88 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 109.839 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.578 ' HD2' HG23 ' A' ' 44' ' ' ILE . 44.4 Cg_endo -70.96 109.6 2.59 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.007 1.53 . . . . 0.0 110.801 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 49' ' ' VAL . 80.4 mtt180 -111.85 143.81 42.2 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.364 -0.835 . . . . 0.0 110.015 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 46' ' ' ARG . 14.4 pttp -43.55 -38.28 2.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.099 -1.0 . . . . 0.0 110.094 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 8.8 mt-10 -44.89 -43.83 9.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.171 -0.956 . . . . 0.0 110.231 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.748 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.6 m -136.49 173.33 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.326 -0.859 . . . . 0.0 109.99 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -136.06 139.82 43.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.098 -1.001 . . . . 0.0 110.526 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 51' ' ' VAL . 17.1 t -54.74 130.58 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.186 -0.946 . . . . 0.0 109.587 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 15' ' ' LEU . 16.9 t -109.73 -62.39 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.267 -0.896 . . . . 0.0 110.396 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.858 ' O ' HD13 ' A' ' 54' ' ' ILE . 3.2 mt-10 -139.03 173.08 11.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.035 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.858 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.4 mm -131.72 150.55 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 12' ' ' ALA . 0.4 OUTLIER -143.55 144.95 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.84 -1.163 . . . . 0.0 110.883 -179.025 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.459 ' HA ' HG22 ' A' ' 11' ' ' THR . 3.8 mp0 -115.88 169.77 8.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.524 -0.735 . . . . 0.0 109.767 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.888 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -89.11 139.09 30.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 110.078 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.452 ' O ' HG12 ' A' ' 59' ' ' ILE . 2.6 t -169.97 51.4 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 110.261 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.735 HG22 HG13 ' A' ' 60' ' ' ILE . 7.1 mm -146.83 -82.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.085 -1.009 . . . . 0.0 110.631 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.886 HD13 ' HG2' ' A' ' 64' ' ' GLN . 13.3 mt -111.88 -102.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.803 -1.186 . . . . 0.0 110.704 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.535 ' N ' ' HA ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER -175.99 -144.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.848 -1.158 . . . . 0.0 110.822 -179.633 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.963 ' HB2' HG13 ' A' ' 93' ' ' VAL . 6.1 tt0 -87.98 -66.41 0.92 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.511 -0.743 . . . . 0.0 110.884 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.506 ' HA ' ' HB3' ' A' ' 110' ' ' ALA . 3.3 m-20 -31.25 -58.7 0.24 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.299 0.571 . . . . 0.0 110.786 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.886 ' HG2' HD13 ' A' ' 60' ' ' ILE . 2.8 tp-100 -59.87 129.22 40.79 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.224 -0.923 . . . . 0.0 109.66 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.674 ' C ' HD22 ' A' ' 66' ' ' LEU . . . -108.15 146.73 32.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.969 -1.082 . . . . 0.0 110.264 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.708 HD12 HG21 ' A' ' 104' ' ' VAL . 4.0 mm? -121.27 116.34 24.67 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.134 -0.979 . . . . 0.0 109.89 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.687 ' O ' HD23 ' A' ' 68' ' ' LEU . 16.3 ttp180 -90.14 132.47 35.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.064 -1.022 . . . . 0.0 110.01 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 67' ' ' ARG . 12.6 mt -124.14 143.27 50.58 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.522 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.513 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 2.5 ttt180 -117.62 138.88 51.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.714 -0.616 . . . . 0.0 109.577 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -58.33 152.67 17.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.223 -0.923 . . . . 0.0 110.359 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.81 ' C ' HG22 ' A' ' 84' ' ' THR . 8.8 ttt180 -143.48 -11.79 0.7 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.158 -0.964 . . . . 0.0 111.778 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.597 ' HG2' ' CE1' ' A' ' 101' ' ' PHE . 5.4 tppt? -114.57 -4.92 12.78 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.635 -1.29 . . . . 0.0 111.021 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.523 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 7.8 tt0 54.55 69.64 0.7 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.892 -1.13 . . . . 0.0 109.689 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 2.6 t -172.81 -31.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.308 -0.87 . . . . 0.0 110.261 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.594 ' CB ' ' HB2' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -74.16 126.76 31.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.146 -0.972 . . . . 0.0 110.118 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.538 ' HB3' ' N ' ' A' ' 81' ' ' GLU . 39.3 p-10 -101.08 110.34 22.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.156 -0.965 . . . . 0.0 109.905 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.568 ' HB2' ' CZ2' ' A' ' 75' ' ' TRP . 2.3 tpm_? -80.05 -38.08 32.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.391 -0.818 . . . . 0.0 110.032 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.35 24.05 13.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.878 . . . . 0.0 110.108 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.92 9.71 80.23 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 81' ' ' GLU . 30.4 mtpt -130.12 87.97 2.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -1.076 . . . . 0.0 110.038 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.845 ' HG2' HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -43.2 118.48 1.32 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.918 . . . . 0.0 109.58 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.551 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 1.4 ttm180 -117.23 179.67 3.97 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 0.0 110.779 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.608 HG22 ' N ' ' A' ' 84' ' ' THR . 7.4 p -82.51 172.36 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.507 -0.745 . . . . 0.0 110.628 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.81 HG22 ' C ' ' A' ' 71' ' ' ARG . 45.7 p -52.65 -26.39 13.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.353 -0.842 . . . . 0.0 109.99 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -55.96 -43.71 87.83 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.551 ' CB ' ' HB3' ' A' ' 82' ' ' ARG . 12.4 tp10 -55.96 153.52 8.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.403 -1.057 . . . . 0.0 109.527 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.513 ' HB3' ' HG3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -159.47 156.18 27.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.064 -1.022 . . . . 0.0 110.602 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.49 ' CZ2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -142.58 151.12 41.22 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.283 -0.886 . . . . 0.0 109.604 179.679 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.894 HD23 ' H ' ' A' ' 90' ' ' VAL . 1.8 tt -102.21 154.01 19.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.325 -0.86 . . . . 0.0 109.901 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.894 ' H ' HD23 ' A' ' 89' ' ' LEU . 49.4 t -114.2 107.95 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.385 -0.822 . . . . 0.0 110.396 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 91' ' ' THR . 28.9 m -121.47 25.85 9.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.923 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.511 HG21 ' HG3' ' A' ' 38' ' ' GLU . 12.2 t -76.85 171.36 14.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.381 -0.824 . . . . 0.0 110.403 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.963 HG13 ' HB2' ' A' ' 62' ' ' GLN . 3.9 t -92.22 75.81 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 0.0 110.027 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.472 ' HA2' ' HB3' ' A' ' 10' ' ' ASN . . . -128.01 -85.82 0.5 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.712 ' HB1' ' H ' ' A' ' 59' ' ' ILE . . . -177.18 -38.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.362 -1.081 . . . . 0.0 109.707 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.608 ' CD1' ' HB ' ' A' ' 59' ' ' ILE . 3.4 p90 179.92 40.81 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.697 -0.627 . . . . 0.0 109.94 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.866 HD21 ' HB2' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -41.68 103.97 0.33 Allowed Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.281 -0.887 . . . . 0.0 110.155 -179.73 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.718 ' O ' ' HB2' ' A' ' 99' ' ' ALA . 46.7 Cg_endo -72.09 -98.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.08 1.569 . . . . 0.0 110.277 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.718 ' HB2' ' O ' ' A' ' 98' ' ' PRO . . . 169.11 -156.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.769 -1.207 . . . . 0.0 110.156 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.514 HG23 ' CD2' ' A' ' 14' ' ' HIS . 0.3 OUTLIER -128.31 -32.03 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 110.806 -179.563 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.597 ' CE1' ' HG2' ' A' ' 72' ' ' LYS . 1.7 m-85 -130.48 -6.86 4.19 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.75 -1.219 . . . . 0.0 110.897 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.58 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 1.2 pt-20 -110.86 157.73 19.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.013 -1.055 . . . . 0.0 110.675 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.57 166.06 13.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.355 -0.841 . . . . 0.0 109.846 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.708 HG21 HD12 ' A' ' 66' ' ' LEU . 11.5 p -95.63 152.61 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.142 -0.974 . . . . 0.0 110.469 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.834 ' N ' HD22 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -102.55 -34.71 9.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.367 -0.833 . . . . 0.0 109.508 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -164.97 -163.88 0.74 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.557 -0.715 . . . . 0.0 109.63 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.897 ' N ' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -136.93 163.71 30.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 110.578 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 64' ' ' GLN . 33.7 t -138.95 150.48 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.843 . . . . 0.0 110.169 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.455 ' CG ' ' O ' ' A' ' 109' ' ' ASP . 1.7 p-10 -111.67 115.13 28.61 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.882 -1.136 . . . . 0.0 109.81 178.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.506 ' HB3' ' HA ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.493 1.687 0 O-C-N 120.981 -1.074 . . . . 0.0 110.595 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.337 0.589 . . . . 0.0 110.384 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.51 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 41.5 t -113.47 160.04 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 0.0 109.718 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.495 ' CA ' ' HA3' ' A' ' 41' ' ' GLY . 21.5 t -35.56 99.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.65 -0.656 . . . . 0.0 110.855 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.79 HD23 ' OG1' ' A' ' 11' ' ' THR . 2.5 mp -47.45 147.23 2.96 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.458 -0.776 . . . . 0.0 110.865 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 10' ' ' ASN . 50.4 Cg_endo -76.98 69.0 7.17 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.134 1.597 . . . . 0.0 110.462 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.661 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 0.9 OUTLIER 67.68 49.0 1.0 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.21 -0.931 . . . . 0.0 110.741 179.792 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.79 ' OG1' HD23 ' A' ' 8' ' ' LEU . 33.1 p -137.13 171.35 14.62 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.278 -0.889 . . . . 0.0 109.792 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.741 ' HB2' HD21 ' A' ' 97' ' ' LEU . . . -144.3 161.97 37.59 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.954 -1.091 . . . . 0.0 110.785 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.749 HD11 HD11 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -134.04 152.2 51.74 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.244 -0.91 . . . . 0.0 110.419 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.747 ' CE1' HD13 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -88.03 128.19 35.4 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.143 -0.973 . . . . 0.0 110.727 -179.672 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.749 HD11 HD11 ' A' ' 13' ' ' LEU . 2.7 mm? -115.99 148.0 40.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.497 -0.752 . . . . 0.0 110.579 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.708 ' HB2' HG22 ' A' ' 52' ' ' VAL . 1.7 ttmt -114.16 116.85 29.75 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.239 -0.984 . . . . 0.0 108.889 177.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.082 ' HB3' ' HB3' ' A' ' 33' ' ' ASP . . . -80.43 121.95 26.37 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.954 -1.091 . . . . 0.0 109.936 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 69.3 mt -98.66 99.89 11.05 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.493 0.663 . . . . 0.0 109.711 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.501 HD13 ' N ' ' A' ' 20' ' ' ASP . 0.4 OUTLIER -166.73 130.06 1.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.503 -0.748 . . . . 0.0 109.669 -179.797 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.501 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -71.62 101.34 2.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.083 -1.011 . . . . 0.0 110.019 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.749 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.903 . . . . 0.0 109.969 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.749 HG22 ' CB ' ' A' ' 21' ' ' PHE . 1.7 m . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.667 ' O ' HG23 ' A' ' 30' ' ' VAL . 29.6 m -138.85 90.18 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.135 -0.978 . . . . 0.0 110.545 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 46.75 51.61 12.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.864 . . . . 0.0 110.436 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -176.7 25.37 0.06 OUTLIER Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.152 -1.499 . . . . 0.0 111.061 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 1.082 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -66.66 149.84 49.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.508 -1.584 . . . . 0.0 109.011 179.091 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.635 ' CG ' ' CZ ' ' A' ' 101' ' ' PHE . 1.2 pm0 -148.47 138.66 22.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.557 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.418 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 10.1 p90 -158.86 164.68 35.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.335 -0.853 . . . . 0.0 109.816 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.747 HD13 ' CE1' ' A' ' 14' ' ' HIS . 60.6 tp -90.82 156.14 18.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.004 -1.06 . . . . 0.0 109.66 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.731 ' HB2' HD23 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -126.1 114.13 17.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.055 -1.028 . . . . 0.0 110.183 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -84.77 129.38 34.83 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.275 0.559 . . . . 0.0 109.983 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.61 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 64.77 44.33 94.95 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.731 ' HG2' HD22 ' A' ' 8' ' ' LEU . 55.8 Cg_endo -77.48 17.74 0.89 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.604 1.318 . . . . 0.0 110.875 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.578 ' HA2' HD13 ' A' ' 8' ' ' LEU . . . -49.21 -41.99 31.59 Favored Glycine 0 N--CA 1.488 2.114 0 O-C-N 120.755 -1.216 . . . . 0.0 110.367 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.8 p -93.73 19.74 8.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.038 -1.272 . . . . 0.0 110.974 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.61 ' C ' HD12 ' A' ' 44' ' ' ILE . 21.8 t80 -85.45 133.36 34.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.124 -0.985 . . . . 0.0 110.019 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.61 HD12 ' C ' ' A' ' 43' ' ' TYR . 1.5 mp -119.73 145.31 39.02 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.359 -0.838 . . . . 0.0 109.006 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.52 ' HD2' HG23 ' A' ' 44' ' ' ILE . 40.9 Cg_endo -66.89 109.53 1.71 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.869 1.457 . . . . 0.0 110.713 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -111.59 149.58 31.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.462 -0.774 . . . . 0.0 110.246 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -53.07 -29.1 28.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.859 . . . . 0.0 110.312 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.486 ' C ' ' CG1' ' A' ' 49' ' ' VAL . 20.4 tt0 -59.81 -21.69 61.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.173 -0.954 . . . . 0.0 110.512 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.553 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.9 m -150.92 170.8 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.292 -0.88 . . . . 0.0 110.33 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -131.54 138.0 48.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.198 -0.939 . . . . 0.0 110.099 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.434 HG23 ' H ' ' A' ' 51' ' ' VAL . 6.6 t -58.63 125.55 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.716 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.708 HG22 ' HB2' ' A' ' 16' ' ' LYS . 2.8 t -102.27 -63.32 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.276 -0.89 . . . . 0.0 110.291 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.591 ' O ' HD13 ' A' ' 54' ' ' ILE . 3.4 mt-10 -144.01 166.49 24.82 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.18 -0.95 . . . . 0.0 110.252 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.591 HD13 ' O ' ' A' ' 53' ' ' GLU . 2.6 mm -128.71 148.65 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.725 HD11 ' OH ' ' A' ' 96' ' ' TYR . 0.5 OUTLIER -141.6 130.39 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.591 -1.318 . . . . 0.0 111.59 -178.859 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.45 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 23.1 mp0 -94.8 176.0 6.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.589 -0.694 . . . . 0.0 109.708 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.818 ' HB1' ' HB2' ' A' ' 95' ' ' ALA . . . -102.02 144.61 30.4 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.159 -0.963 . . . . 0.0 110.63 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER 170.61 59.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.156 -0.965 . . . . 0.0 111.984 179.53 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.662 HG23 ' H ' ' A' ' 60' ' ' ILE . 1.2 tt -172.71 -60.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.277 -1.515 . . . . 0.0 112.649 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.662 ' H ' HG23 ' A' ' 59' ' ' ILE . 18.8 mm -80.81 169.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.36 -1.463 . . . . 0.0 110.835 -178.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.449 ' N ' HG22 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -109.33 -159.7 0.69 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.474 -0.766 . . . . 0.0 110.326 -179.773 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.987 ' HB2' HG13 ' A' ' 93' ' ' VAL . 14.1 tt0 -91.14 -68.64 0.78 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.327 -0.858 . . . . 0.0 110.295 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.651 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 2.1 m-20 -38.23 -50.97 1.46 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.75 -0.594 . . . . 0.0 110.97 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.486 ' NE2' ' O ' ' A' ' 108' ' ' VAL . 7.9 tp60 -59.69 137.4 58.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.082 -1.011 . . . . 0.0 110.852 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.969 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -127.41 148.95 50.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.412 -0.805 . . . . 0.0 110.069 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.656 HD11 HG21 ' A' ' 60' ' ' ILE . 2.6 mp -127.05 118.13 23.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.318 -0.864 . . . . 0.0 110.152 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.599 ' O ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -91.66 128.26 37.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.002 -1.061 . . . . 0.0 110.029 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.752 HD11 HG21 ' A' ' 90' ' ' VAL . 15.6 mt -120.33 139.85 52.15 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.05 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -120.02 157.54 28.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.483 -0.761 . . . . 0.0 109.754 179.329 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.877 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -68.95 124.58 24.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 111.353 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -84.33 -23.09 30.37 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.503 ' HG2' ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -156.73 146.56 20.89 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.552 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 74' ' ' CYS . 1.9 pt-20 -56.96 -156.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.036 -1.04 . . . . 0.0 110.341 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 6.6 m 77.34 -43.45 0.42 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.525 -0.734 . . . . 0.0 110.889 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.718 ' HZ3' ' HB2' ' A' ' 70' ' ' ALA . 8.3 t90 -74.15 110.94 8.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.793 -1.192 . . . . 0.0 110.353 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 76' ' ' ASP . 2.4 p30 -91.2 127.05 36.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.205 -0.934 . . . . 0.0 110.003 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -86.08 -40.5 15.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 110.039 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.01 -28.79 25.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.166 -0.959 . . . . 0.0 110.275 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 80' ' ' LYS . . . 139.86 -52.29 0.71 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -61.05 -131.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -1.179 . . . . 0.0 109.741 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.535 ' CD ' HG11 ' A' ' 29' ' ' VAL . 15.0 mm-40 -136.97 121.78 18.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.826 -1.171 . . . . 0.0 110.464 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.36 173.26 8.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.535 -0.728 . . . . 0.0 109.888 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.62 HG13 ' H ' ' A' ' 85' ' ' GLY . 13.5 p -88.87 173.03 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 0.0 110.568 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.877 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 10.1 t -67.45 -12.53 60.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.863 . . . . 0.0 110.006 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.62 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -63.49 -14.65 55.2 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.635 ' HG3' ' CZ3' ' A' ' 75' ' ' TRP . 8.4 pt-20 -79.25 166.42 22.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.417 -1.049 . . . . 0.0 109.526 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.496 ' HA ' ' OE2' ' A' ' 102' ' ' GLU . 5.8 pt-20 -157.9 153.55 26.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.808 -1.183 . . . . 0.0 110.774 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.509 ' CE2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -128.38 144.24 51.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.392 -0.817 . . . . 0.0 109.716 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.897 HD23 ' H ' ' A' ' 90' ' ' VAL . 1.4 tt -106.2 158.42 16.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.211 -0.931 . . . . 0.0 110.123 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.897 ' H ' HD23 ' A' ' 89' ' ' LEU . 16.6 t -122.23 136.65 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 0.0 110.571 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.587 HG23 ' C ' ' A' ' 90' ' ' VAL . 61.0 p -155.72 60.26 0.61 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 109.641 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.686 HG21 ' HB3' ' A' ' 95' ' ' ALA . 14.6 t -85.29 167.93 15.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.399 -0.813 . . . . 0.0 110.627 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.987 HG13 ' HB2' ' A' ' 62' ' ' GLN . 3.3 t -108.18 67.17 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.385 -0.822 . . . . 0.0 109.768 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 60' ' ' ILE . . . 110.04 62.85 0.52 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.818 ' HB2' ' HB1' ' A' ' 57' ' ' ALA . . . -174.72 -153.14 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.332 -1.099 . . . . 0.0 110.426 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.725 ' OH ' HD11 ' A' ' 55' ' ' ILE . 2.3 p90 176.46 119.11 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.741 HD21 ' HB2' ' A' ' 12' ' ' ALA . 2.6 mp -106.19 95.65 11.7 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 111.457 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.488 ' O ' ' O ' ' A' ' 99' ' ' ALA . 47.0 Cg_endo -74.94 87.19 1.34 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.9 1.474 . . . . 0.0 108.887 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.597 ' HB3' ' HB2' ' A' ' 102' ' ' GLU . . . -50.05 -172.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.404 -0.81 . . . . 0.0 111.261 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 t -99.47 -66.33 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.433 -0.792 . . . . 0.0 110.496 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.635 ' CZ ' ' CG ' ' A' ' 34' ' ' GLU . 21.5 m-30 -100.15 22.23 11.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.936 -1.102 . . . . 0.0 110.57 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.597 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 2.4 mm-40 -111.56 120.29 41.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.964 -1.085 . . . . 0.0 110.397 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -100.13 156.26 17.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.352 -0.843 . . . . 0.0 110.188 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.649 HG12 HD22 ' A' ' 68' ' ' LEU . 3.5 m -81.87 138.39 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 110.26 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.592 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 3.0 mp -97.14 -9.58 27.62 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.318 -0.864 . . . . 0.0 109.197 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.57 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 0.4 OUTLIER 159.94 -160.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.791 -0.568 . . . . 0.0 109.622 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.875 ' C ' HD22 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -138.42 150.13 46.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.941 . . . . 0.0 110.341 178.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.969 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 14.7 p -134.07 140.66 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.128 -0.982 . . . . 0.0 110.167 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.17 117.84 35.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.881 -1.137 . . . . 0.0 110.003 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 110.014 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.242 0.544 . . . . 0.0 110.151 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.507 ' O ' HD12 ' A' ' 8' ' ' LEU . 9.8 p -126.61 147.24 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.163 -0.961 . . . . 0.0 110.089 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.47 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 83.4 t -41.18 107.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 110.337 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.975 HD23 ' OG1' ' A' ' 11' ' ' THR . 5.4 mp -63.24 163.94 16.21 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.391 -0.818 . . . . 0.0 110.079 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.411 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 47.3 Cg_endo -73.19 -56.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.913 1.48 . . . . 0.0 110.451 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.825 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 63.2 m-80 -158.42 31.77 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 110.174 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.975 ' OG1' HD23 ' A' ' 8' ' ' LEU . 43.9 p -106.41 171.56 7.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.342 -0.849 . . . . 0.0 110.2 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.496 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -147.24 162.46 38.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.193 -0.942 . . . . 0.0 109.93 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.776 HD11 ' HE2' ' A' ' 43' ' ' TYR . 0.6 OUTLIER -130.25 155.79 45.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.021 . . . . 0.0 110.642 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.696 ' C ' HD23 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -96.93 129.16 44.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.341 -0.849 . . . . 0.0 109.08 179.514 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.838 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -126.2 162.28 25.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.703 -1.248 . . . . 0.0 109.48 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.537 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 1.2 ttpt -113.44 118.58 34.91 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.576 -0.85 . . . . 0.0 111.029 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.118 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -73.9 113.18 10.77 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.922 0.868 . . . . 0.0 108.782 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.875 HD23 ' O ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -106.95 106.73 17.4 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.486 0.66 . . . . 0.0 110.655 -178.677 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.86 HD13 ' HG3' ' A' ' 48' ' ' GLU . 5.1 tp -166.72 146.2 5.6 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.564 -0.71 . . . . 0.0 109.903 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.3 105.0 15.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 109.827 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.882 ' HB2' HG22 ' A' ' 29' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.212 -0.93 . . . . 0.0 110.318 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.882 HG22 ' HB2' ' A' ' 21' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 121.226 0.536 . . . . 0.0 109.65 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 30' ' ' VAL . 27.0 m -132.41 81.37 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.07 -1.019 . . . . 0.0 109.764 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 41.31 67.47 0.54 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.617 -0.677 . . . . 0.0 110.295 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -168.47 20.26 0.08 OUTLIER Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.114 -1.517 . . . . 0.0 111.263 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 1.118 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 1.3 m-20 -88.34 150.6 23.13 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.437 -1.625 . . . . 0.0 109.406 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.506 ' HG3' HG21 ' A' ' 52' ' ' VAL . 16.5 tt0 -151.46 139.07 19.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.089 -1.007 . . . . 0.0 110.461 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.662 ' CZ2' HD12 ' A' ' 15' ' ' LEU . 8.7 p90 -154.44 177.63 10.96 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.147 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.523 HD11 ' CE1' ' A' ' 14' ' ' HIS . 0.5 OUTLIER -90.33 158.69 17.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 0.0 110.969 -179.062 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.761 ' HB2' HD21 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -141.99 110.77 6.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.386 -0.821 . . . . 0.0 109.565 179.252 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.472 ' HG2' ' HB2' ' A' ' 12' ' ' ALA . 4.1 tm-20 -93.94 149.44 21.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.205 -0.934 . . . . 0.0 111.001 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.588 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 55.91 45.52 86.2 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.615 ' HG2' HD22 ' A' ' 8' ' ' LEU . 41.8 Cg_endo -70.68 -60.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.757 1.398 . . . . 0.0 109.844 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.492 ' HA3' ' C ' ' A' ' 6' ' ' VAL . . . 41.87 -89.92 0.01 OUTLIER Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 40' ' ' PRO . 19.8 p -66.9 1.32 1.95 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.33 -1.1 . . . . 0.0 111.559 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.776 ' HE2' HD11 ' A' ' 13' ' ' LEU . 6.8 t80 -68.78 124.15 22.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.643 -1.286 . . . . 0.0 110.408 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.65 HG23 ' HD2' ' A' ' 45' ' ' PRO . 6.2 mt -115.52 145.59 34.78 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 109.064 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.65 ' HD2' HG23 ' A' ' 44' ' ' ILE . 42.6 Cg_endo -67.57 109.19 1.78 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.764 1.402 . . . . 0.0 110.751 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -102.37 144.64 30.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.4 -0.812 . . . . 0.0 109.999 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.786 ' O ' HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -37.34 -45.66 0.7 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.572 -0.705 . . . . 0.0 111.062 -179.582 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.86 ' HG3' HD13 ' A' ' 19' ' ' LEU . 11.4 tt0 -49.07 -49.07 43.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -0.964 . . . . 0.0 110.98 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.535 HG12 ' HA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -133.44 142.58 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.915 -1.115 . . . . 0.0 110.741 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -108.62 137.51 46.45 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.323 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.431 HG13 ' HB3' ' A' ' 45' ' ' PRO . 31.3 m -54.01 145.29 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.168 -0.957 . . . . 0.0 109.252 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.734 HG23 ' HA ' ' A' ' 15' ' ' LEU . 31.7 t -117.48 -58.65 3.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.048 -1.033 . . . . 0.0 110.407 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.936 ' O ' HD13 ' A' ' 54' ' ' ILE . 1.9 mt-10 -136.09 172.85 12.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.144 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.936 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.2 mm -136.18 130.73 48.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.322 -0.861 . . . . 0.0 108.828 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.638 HD13 ' H ' ' A' ' 56' ' ' GLN . 0.4 OUTLIER -125.85 144.93 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.214 -0.929 . . . . 0.0 111.162 -178.591 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.638 ' H ' HD13 ' A' ' 55' ' ' ILE . 40.7 mm-40 -100.4 174.28 6.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.468 -0.77 . . . . 0.0 109.779 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.825 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -102.25 125.68 49.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.132 -0.98 . . . . 0.0 109.96 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 3.2 t 179.29 63.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.012 -1.055 . . . . 0.0 111.872 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.533 HG21 ' CD1' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -169.68 -37.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.549 -1.344 . . . . 0.0 111.323 179.107 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 95' ' ' ALA . 9.4 mm -78.1 158.41 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.785 -1.197 . . . . 0.0 110.44 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.513 ' HB2' ' HB3' ' A' ' 64' ' ' GLN . 9.1 mtt180 -62.8 -168.84 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.283 -0.886 . . . . 0.0 110.413 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.842 ' HA ' HG13 ' A' ' 93' ' ' VAL . 9.5 tt0 -91.63 -19.92 22.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.0 110.701 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 2.7 p-10 -127.97 -19.2 4.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.905 -1.122 . . . . 0.0 110.907 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.513 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 6.4 tp-100 -51.34 126.88 18.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.031 -1.043 . . . . 0.0 111.646 -179.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.016 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -108.54 142.37 39.06 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.492 HD23 HD12 ' A' ' 107' ' ' LEU . 1.8 mp -127.59 115.04 18.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.837 -1.165 . . . . 0.0 111.882 -178.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . 4.3 ttm180 -91.36 119.6 31.51 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.71 ' CD2' HG23 ' A' ' 104' ' ' VAL . 21.6 mt -113.74 161.25 17.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 111.396 -178.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.591 ' HB2' HD21 ' A' ' 105' ' ' LEU . 15.7 mtp180 -126.57 161.88 26.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.371 -0.83 . . . . 0.0 110.179 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.888 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -82.63 152.37 25.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.202 -0.936 . . . . 0.0 111.415 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.518 ' HG3' ' N ' ' A' ' 72' ' ' LYS . 9.4 ptt180 -125.31 -27.7 3.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.453 -0.779 . . . . 0.0 109.819 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.518 ' N ' ' HG3' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -124.49 118.46 26.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.283 -0.885 . . . . 0.0 109.762 179.575 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.524 ' N ' ' HB ' ' A' ' 84' ' ' THR . 4.3 pt-20 -54.51 106.82 0.23 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.202 -0.937 . . . . 0.0 110.723 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.507 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER 168.5 -43.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.285 -0.884 . . . . 0.0 110.151 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.779 ' CZ3' ' HB2' ' A' ' 70' ' ' ALA . 2.7 t90 -74.98 104.43 5.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.284 -0.885 . . . . 0.0 110.182 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.482 ' OD2' ' N ' ' A' ' 80' ' ' LYS . 3.4 t70 -96.82 122.04 39.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -0.978 . . . . 0.0 110.226 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.452 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -85.03 -0.38 54.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.886 . . . . 0.0 110.365 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.55 -4.99 8.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.954 . . . . 0.0 110.365 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 101.21 -47.25 1.21 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.482 ' N ' ' OD2' ' A' ' 76' ' ' ASP . 9.1 mmtp -69.54 98.63 1.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -1.14 . . . . 0.0 110.012 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.748 ' OE2' HG21 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -34.17 135.15 0.16 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.718 -0.614 . . . . 0.0 110.913 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.16 179.77 7.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 110.533 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.599 HG22 ' N ' ' A' ' 84' ' ' THR . 10.8 p -77.84 174.02 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.4 -0.813 . . . . 0.0 110.553 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.888 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 2.3 t -73.95 -3.52 29.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.815 . . . . 0.0 110.099 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.572 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -72.88 -13.35 78.84 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.451 ' HG3' ' CZ3' ' A' ' 75' ' ' TRP . 8.3 pt-20 -70.79 172.24 9.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -1.083 . . . . 0.0 110.058 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.452 ' HB3' ' HG2' ' A' ' 69' ' ' ARG . 5.4 pm0 -159.06 172.59 17.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 110.444 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.549 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -155.96 153.66 29.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.342 -0.849 . . . . 0.0 109.795 -179.825 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.974 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -122.25 124.97 45.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.117 -0.99 . . . . 0.0 109.954 179.558 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.974 ' N ' HD22 ' A' ' 89' ' ' LEU . 4.5 p -105.6 138.92 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.429 -0.795 . . . . 0.0 110.263 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.7 t -141.93 49.78 1.56 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.272 -0.892 . . . . 0.0 110.415 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.524 ' CG2' ' HB3' ' A' ' 10' ' ' ASN . 51.6 m -91.28 138.66 31.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -0.937 . . . . 0.0 110.281 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.842 HG13 ' HA ' ' A' ' 62' ' ' GLN . 17.5 t -71.13 140.39 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.147 -0.971 . . . . 0.0 110.15 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.563 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 43.27 80.75 0.04 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.587 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . . . -156.38 154.01 29.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -1.149 . . . . 0.0 110.861 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.539 ' O ' ' CG ' ' A' ' 96' ' ' TYR . 4.9 t80 -117.69 25.69 10.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.502 -0.749 . . . . 0.0 109.961 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 96' ' ' TYR . 2.0 mm? -34.34 91.87 0.05 OUTLIER Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.827 -0.546 . . . . 0.0 111.408 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.518 ' N ' ' O ' ' A' ' 96' ' ' TYR . 48.5 Cg_endo -91.32 115.8 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.827 1.435 . . . . 0.0 110.395 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.747 ' HB1' ' HB3' ' A' ' 102' ' ' GLU . . . -69.76 171.92 8.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.213 -0.929 . . . . 0.0 110.32 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.615 HG21 ' HA ' ' A' ' 35' ' ' TRP . 1.7 t -99.33 -58.5 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.352 -0.843 . . . . 0.0 109.447 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.655 ' HB2' ' HB3' ' A' ' 75' ' ' TRP . 22.8 m-30 -117.6 38.9 3.46 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.156 -0.965 . . . . 0.0 109.257 178.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.747 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 13.6 tt0 -132.11 133.23 44.07 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.124 -0.985 . . . . 0.0 110.879 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -105.08 171.22 7.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.389 -0.819 . . . . 0.0 110.193 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.71 HG23 ' CD2' ' A' ' 68' ' ' LEU . 7.7 p -101.31 144.56 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.172 -0.955 . . . . 0.0 110.306 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.844 ' N ' HD22 ' A' ' 105' ' ' LEU . 1.6 mm? -103.14 -40.07 6.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -0.968 . . . . 0.0 110.118 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.901 ' C ' HD13 ' A' ' 107' ' ' LEU . 1.8 p30 -161.29 171.58 18.11 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.868 . . . . 0.0 109.963 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.901 HD13 ' C ' ' A' ' 106' ' ' ASP . 0.3 OUTLIER -121.96 142.55 50.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.175 -0.953 . . . . 0.0 110.367 -179.855 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.016 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 12.6 p -125.49 157.84 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.398 -0.814 . . . . 0.0 109.499 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.405 ' O ' ' CG ' ' A' ' 109' ' ' ASP . 8.6 p-10 -110.91 121.27 44.93 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.92 -1.113 . . . . 0.0 110.704 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 109.951 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.605 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.505 ' O ' ' O ' ' A' ' 5' ' ' GLN . 12.0 p -38.0 165.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.349 -0.844 . . . . 0.0 111.927 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.571 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 43.7 t -30.83 150.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 CA-C-O 121.586 0.708 . . . . 0.0 111.973 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.659 HD23 ' OG1' ' A' ' 11' ' ' THR . 6.0 mp -106.29 171.23 4.96 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.569 -0.707 . . . . 0.0 109.634 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 44.5 Cg_endo -71.35 -39.44 3.8 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.72 1.379 . . . . 0.0 110.401 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.471 ' ND2' HG21 ' A' ' 93' ' ' VAL . 3.1 m-20 172.19 37.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.338 -0.851 . . . . 0.0 109.681 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.659 ' OG1' HD23 ' A' ' 8' ' ' LEU . 69.9 p -114.58 162.72 16.38 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.329 -0.857 . . . . 0.0 110.957 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.714 ' HB3' ' HG ' ' A' ' 97' ' ' LEU . . . -135.57 161.13 36.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.378 -0.826 . . . . 0.0 109.96 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.982 HD23 ' CG ' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -133.28 153.65 51.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.167 -0.958 . . . . 0.0 110.553 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.802 ' C ' HD13 ' A' ' 15' ' ' LEU . 30.7 m80 -96.58 136.35 37.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.0 109.642 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.913 HD13 ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -135.67 167.18 21.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.126 -0.984 . . . . 0.0 110.561 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 3.2 ttmt -119.04 117.58 29.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.17 -0.956 . . . . 0.0 110.049 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.044 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -75.76 117.54 17.61 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.311 -0.868 . . . . 0.0 109.864 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 61.4 mt -108.62 100.94 10.13 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.188 0.518 . . . . 0.0 109.963 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.729 HD13 ' HG2' ' A' ' 48' ' ' GLU . 9.3 tp -163.79 144.74 8.83 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.157 -0.964 . . . . 0.0 110.294 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -85.2 110.78 19.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.379 -0.826 . . . . 0.0 109.061 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.757 ' CB ' HG22 ' A' ' 29' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 O-C-N 121.103 -0.998 . . . . 0.0 111.103 -178.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.757 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.193 0.521 . . . . 0.0 109.794 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.561 ' O ' HG23 ' A' ' 30' ' ' VAL . 25.2 m -133.39 81.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 0.0 110.336 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 42.36 66.87 0.67 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 110.189 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.52 20.18 0.09 OUTLIER Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.373 -1.394 . . . . 0.0 110.895 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 1.044 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -89.09 152.39 21.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.478 -1.601 . . . . 0.0 108.984 179.191 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 15' ' ' LEU . 23.0 tt0 -155.23 140.12 17.25 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.907 -1.12 . . . . 0.0 110.498 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.729 ' CZ3' ' HB2' ' A' ' 17' ' ' ALA . 5.2 p90 -162.94 172.78 14.56 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.661 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.745 HD13 ' NE2' ' A' ' 14' ' ' HIS . 16.9 tp -90.53 159.93 16.23 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.394 0.616 . . . . 0.0 110.733 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.655 ' HB2' HD11 ' A' ' 15' ' ' LEU . 0.6 OUTLIER -135.38 114.77 12.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.321 -0.862 . . . . 0.0 109.952 179.629 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.476 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -86.96 135.47 33.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.515 -0.741 . . . . 0.0 110.369 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.596 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 54.02 44.31 72.77 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.982 ' CG ' HD23 ' A' ' 13' ' ' LEU . 52.9 Cg_endo -77.03 42.76 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.492 1.259 . . . . 0.0 110.959 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 5' ' ' GLN . . . -65.1 -25.12 70.77 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.525 ' O ' HD12 ' A' ' 44' ' ' ILE . 9.6 p -101.63 12.95 36.32 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.831 -1.394 . . . . 0.0 109.77 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.464 ' HB3' ' HB2' ' A' ' 40' ' ' PRO . 16.6 t80 -86.88 122.53 30.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.393 -0.817 . . . . 0.0 109.556 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.657 HG23 ' HD2' ' A' ' 45' ' ' PRO . 3.7 mp -116.98 145.25 35.17 Favored Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.224 -0.922 . . . . 0.0 109.508 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.657 ' HD2' HG23 ' A' ' 44' ' ' ILE . 43.0 Cg_endo -69.56 83.44 0.66 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.874 1.46 . . . . 0.0 110.172 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -95.72 152.93 18.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.414 -0.804 . . . . 0.0 110.697 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -41.55 -42.97 2.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.352 -0.843 . . . . 0.0 110.69 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.729 ' HG2' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -42.55 -47.94 5.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.856 . . . . 0.0 110.434 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.6 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.2 m -136.15 173.85 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.313 -0.867 . . . . 0.0 110.332 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -133.16 142.02 48.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.388 -0.82 . . . . 0.0 110.206 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' A' ' 45' ' ' PRO . 47.7 t -62.56 130.36 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.229 -0.919 . . . . 0.0 109.833 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.735 HG23 ' HA ' ' A' ' 15' ' ' LEU . 28.2 t -107.82 -61.32 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 110.588 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.775 ' O ' HD13 ' A' ' 54' ' ' ILE . 7.8 mm-40 -139.89 168.08 20.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.168 -0.958 . . . . 0.0 110.293 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.775 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.4 mm -128.89 152.48 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.319 -0.863 . . . . 0.0 109.191 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -149.65 152.25 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.952 -1.092 . . . . 0.0 110.697 -179.698 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.536 ' HA ' ' CB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -123.94 177.89 5.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.432 -0.792 . . . . 0.0 110.078 179.542 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.532 ' CA ' ' HA ' ' A' ' 95' ' ' ALA . . . -87.25 130.02 34.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.186 -0.946 . . . . 0.0 110.727 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 1.5 t 177.41 52.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 111.018 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.86 HG22 HG13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -157.09 -59.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.608 -1.308 . . . . 0.0 111.591 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.86 HG13 HG22 ' A' ' 59' ' ' ILE . 2.3 mt -92.51 -174.46 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 120.14 -1.6 . . . . 0.0 110.8 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.699 ' H ' HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -101.25 169.43 8.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.4 -0.812 . . . . 0.0 110.114 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.634 ' CG ' HG13 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -67.3 -72.69 0.16 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.203 -0.935 . . . . 0.0 111.974 -179.006 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.565 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 5.7 p30 -39.62 -24.1 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.297 -0.877 . . . . 0.0 112.07 -178.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.507 ' NE2' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -57.22 167.98 0.81 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.609 -1.307 . . . . 0.0 112.206 -178.775 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.01 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -150.35 131.25 14.22 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.552 ' HG ' ' CG1' ' A' ' 90' ' ' VAL . 2.5 pp -129.3 127.42 41.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.513 -1.367 . . . . 0.0 112.395 -178.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . 12.5 ttt180 -103.64 130.01 51.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.784 -0.572 . . . . 0.0 109.553 178.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.49 HD23 ' O ' ' A' ' 67' ' ' ARG . 35.2 mt -117.76 149.53 40.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.18 -0.95 . . . . 0.0 111.007 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.443 ' C ' ' HG2' ' A' ' 102' ' ' GLU . 22.7 ttp180 -114.53 139.89 49.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.537 -0.727 . . . . 0.0 109.883 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.567 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -60.45 147.6 40.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.144 -0.973 . . . . 0.0 110.376 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -107.05 -44.1 4.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 109.874 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.592 ' HD2' ' CE2' ' A' ' 101' ' ' PHE . 15.2 ptpt -122.41 134.79 54.6 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.269 -0.894 . . . . 0.0 109.809 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.511 ' N ' ' HB ' ' A' ' 84' ' ' THR . 2.4 pt-20 -57.16 96.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.205 -0.935 . . . . 0.0 110.644 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.52 -42.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 110.443 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.596 ' CB ' ' HB2' ' A' ' 101' ' ' PHE . 2.5 t90 -74.64 120.34 20.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.214 -0.929 . . . . 0.0 110.701 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -117.19 110.21 17.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -0.923 . . . . 0.0 109.401 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.559 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -59.38 -23.06 62.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 110.219 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.462 ' OD2' ' HE2' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -88.57 -21.44 24.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 110.14 179.87 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.26 16.37 27.69 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.462 ' HE2' ' OD2' ' A' ' 78' ' ' ASP . 25.1 mttm -110.39 -137.89 0.37 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.218 -1.166 . . . . 0.0 110.147 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.729 ' CG ' HG11 ' A' ' 29' ' ' VAL . 7.9 mp0 -134.98 105.42 6.36 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.03 -1.043 . . . . 0.0 110.327 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.75 179.54 5.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.224 -0.922 . . . . 0.0 110.68 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.594 HG13 ' H ' ' A' ' 85' ' ' GLY . 13.3 p -91.67 174.45 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.422 -0.799 . . . . 0.0 110.79 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.58 ' N ' HG22 ' A' ' 83' ' ' VAL . 4.6 t -72.01 -6.53 42.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.318 -0.864 . . . . 0.0 110.361 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.594 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -80.03 -19.27 70.29 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.44 ' OE2' ' NH1' ' A' ' 77' ' ' ARG . 8.0 tp10 -66.94 160.61 25.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.462 -1.022 . . . . 0.0 110.053 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.416 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 6.1 pt-20 -154.87 168.12 27.98 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.38 -0.825 . . . . 0.0 110.05 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.592 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -147.5 143.94 28.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.127 -0.983 . . . . 0.0 109.979 179.587 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.851 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.6 OUTLIER -115.46 124.46 51.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.108 -0.995 . . . . 0.0 110.208 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.851 ' N ' HD22 ' A' ' 89' ' ' LEU . 8.5 p -107.05 132.37 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.313 -0.867 . . . . 0.0 110.518 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.836 HG23 HD11 ' A' ' 89' ' ' LEU . 3.5 p -115.4 29.37 8.05 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.488 0.661 . . . . 0.0 109.25 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.585 HG22 ' N ' ' A' ' 93' ' ' VAL . 20.1 m -74.65 171.81 13.21 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.417 -0.802 . . . . 0.0 109.55 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.634 HG13 ' CG ' ' A' ' 62' ' ' GLN . 1.5 t -47.37 172.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.99 -1.069 . . . . 0.0 109.006 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.563 ' O ' ' HB3' ' A' ' 95' ' ' ALA . . . -45.24 -88.87 0.01 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 94' ' ' GLY . . . 60.84 -167.79 0.18 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.569 -0.959 . . . . 0.0 110.213 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.516 ' CD2' ' CD1' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -120.76 -65.46 1.14 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.711 -0.618 . . . . 0.0 109.827 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.714 ' HG ' ' HB3' ' A' ' 12' ' ' ALA . 0.3 OUTLIER 46.23 71.37 1.59 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.559 -0.713 . . . . 0.0 110.695 179.584 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.404 ' HD2' HG21 ' A' ' 55' ' ' ILE . 49.5 Cg_endo -78.15 120.53 5.0 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.939 1.494 . . . . 0.0 110.092 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.844 ' HB1' ' HB2' ' A' ' 102' ' ' GLU . . . -73.55 138.82 45.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.21 -0.931 . . . . 0.0 110.275 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.568 HG23 ' N ' ' A' ' 101' ' ' PHE . 30.5 m -69.65 -51.72 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.157 -0.965 . . . . 0.0 110.754 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.596 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 19.5 m-30 -112.78 26.4 10.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.732 -1.23 . . . . 0.0 110.464 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.844 ' HB2' ' HB1' ' A' ' 99' ' ' ALA . 1.1 tt0 -121.63 141.95 50.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.011 -1.056 . . . . 0.0 110.464 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.03 152.26 36.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.418 -0.801 . . . . 0.0 110.333 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.772 ' C ' HD13 ' A' ' 105' ' ' LEU . 12.4 p -94.45 133.06 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.259 -0.9 . . . . 0.0 110.075 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.772 HD13 ' C ' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -102.76 -21.98 13.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.308 -0.87 . . . . 0.0 110.209 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -174.44 136.31 0.46 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.937 . . . . 0.0 110.396 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.4 pp -99.1 153.25 19.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.89 . . . . 0.0 109.965 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.01 HG13 ' HB3' ' A' ' 65' ' ' ALA . 2.5 p -130.93 147.25 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.083 -1.01 . . . . 0.0 110.605 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -107.19 126.29 52.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.857 . . . . 0.0 110.004 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.927 . . . . 0.0 110.526 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.68 -5.5 28.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -1.157 . . . . 0.0 110.196 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 52.91 178.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.232 -0.918 . . . . 0.0 110.376 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.511 ' HB3' HG13 ' A' ' 44' ' ' ILE . 4.9 ptp -49.79 140.06 12.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.853 . . . . 0.0 110.059 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 41' ' ' GLY . 4.8 mt-30 -112.6 -155.72 0.57 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -0.909 . . . . 0.0 110.239 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.492 ' C ' ' HA3' ' A' ' 41' ' ' GLY . 36.0 m -125.02 158.97 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.307 -0.871 . . . . 0.0 109.519 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.46 ' C ' ' O ' ' A' ' 6' ' ' VAL . 40.5 t -38.78 106.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.267 -0.896 . . . . 0.0 110.54 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.618 HD23 ' OG1' ' A' ' 11' ' ' THR . 3.2 mp -61.09 169.11 2.26 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.549 -0.719 . . . . 0.0 110.694 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 10' ' ' ASN . 48.4 Cg_endo -79.52 63.37 8.72 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.136 1.598 . . . . 0.0 109.85 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.732 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER 64.86 41.95 4.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.504 -0.748 . . . . 0.0 110.824 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.618 ' OG1' HD23 ' A' ' 8' ' ' LEU . 14.9 p -118.98 171.34 8.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.121 -0.987 . . . . 0.0 109.759 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.662 ' CB ' HD22 ' A' ' 97' ' ' LEU . . . -145.0 161.9 38.24 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.887 -1.133 . . . . 0.0 110.814 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.012 HD11 HD11 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -133.53 156.15 48.31 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.33 -0.856 . . . . 0.0 110.441 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.584 ' CD2' HD13 ' A' ' 36' ' ' LEU . 44.7 m80 -91.93 124.04 35.74 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.131 -0.98 . . . . 0.0 110.631 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.012 HD11 HD11 ' A' ' 13' ' ' LEU . 2.4 mm? -111.42 151.31 28.68 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.341 -0.85 . . . . 0.0 110.303 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.641 ' HB2' HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -113.53 117.49 31.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.078 -1.014 . . . . 0.0 109.743 178.756 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.039 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -79.43 112.02 16.27 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.208 -0.933 . . . . 0.0 110.338 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.728 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -104.95 101.7 11.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.842 -0.536 . . . . 0.0 109.594 179.743 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.414 HD13 ' HG3' ' A' ' 48' ' ' GLU . 7.7 tp -161.91 147.0 13.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.09 -1.006 . . . . 0.0 110.584 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -89.46 101.76 14.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.365 -0.835 . . . . 0.0 109.613 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.92 ' HB2' HG22 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -112.9 100.13 8.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 110.216 -179.721 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.575 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 0.7 OUTLIER -101.8 114.59 28.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.721 -0.612 . . . . 0.0 109.983 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER -122.26 136.08 54.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 110.459 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 2.8 ttmm -81.05 -9.44 59.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.887 . . . . 0.0 109.961 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -62.28 -27.45 69.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 110.365 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.83 -2.14 6.38 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -130.49 122.99 28.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.161 -1.199 . . . . 0.0 110.019 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.575 ' HB2' ' HA ' ' A' ' 22' ' ' GLU . 12.6 ptpt -151.35 144.32 24.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -0.884 . . . . 0.0 110.43 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.92 HG22 ' HB2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -113.22 155.85 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.137 -0.977 . . . . 0.0 110.157 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 30' ' ' VAL . 24.0 m -134.8 82.37 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.156 -0.965 . . . . 0.0 110.074 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.728 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 40.79 75.27 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.528 -0.732 . . . . 0.0 110.305 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.16 26.93 0.06 OUTLIER Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.692 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 1.039 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 35.1 m-20 -98.71 149.58 22.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.635 -1.509 . . . . 0.0 110.006 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.822 ' OE2' HG11 ' A' ' 52' ' ' VAL . 3.3 tt0 -151.76 147.03 26.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.02 -1.05 . . . . 0.0 110.436 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.563 ' HA ' ' CG2' ' A' ' 100' ' ' VAL . 7.3 p90 -160.94 171.64 18.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.122 -0.986 . . . . 0.0 111.299 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.614 HD22 ' O ' ' A' ' 98' ' ' PRO . 15.3 tp -92.0 155.82 17.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.571 -0.706 . . . . 0.0 110.021 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.666 ' HB2' HD23 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -134.53 110.56 9.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.126 -0.984 . . . . 0.0 110.219 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.628 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 11.5 tm-20 -84.41 131.85 34.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.863 . . . . 0.0 110.445 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.615 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 66.57 43.56 91.9 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.641 ' HG3' HD23 ' A' ' 13' ' ' LEU . 55.6 Cg_endo -77.27 23.54 0.53 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.553 1.291 . . . . 0.0 111.218 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.492 ' HA3' ' C ' ' A' ' 6' ' ' VAL . . . -49.99 -44.62 41.52 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.422 ' O ' HD12 ' A' ' 44' ' ' ILE . 35.7 p -91.28 29.64 1.4 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -1.183 . . . . 0.0 110.677 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.506 ' HB3' ' O ' ' A' ' 40' ' ' PRO . 15.3 t80 -88.34 132.57 34.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.131 -0.981 . . . . 0.0 110.108 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.727 HG23 ' HD2' ' A' ' 45' ' ' PRO . 4.0 mp -123.31 146.86 50.62 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.34 -0.85 . . . . 0.0 109.534 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.727 ' HD2' HG23 ' A' ' 44' ' ' ILE . 44.3 Cg_endo -71.23 103.81 1.45 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.838 1.441 . . . . 0.0 110.669 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 49' ' ' VAL . 5.9 mtm180 -113.56 140.85 47.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.411 -0.806 . . . . 0.0 110.089 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 46' ' ' ARG . 1.1 tttm -41.71 -34.79 0.67 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.147 -0.97 . . . . 0.0 110.538 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.448 ' HB3' HG13 ' A' ' 49' ' ' VAL . 1.7 tt0 -53.01 -39.27 63.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.955 . . . . 0.0 110.522 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.4 m -144.98 173.3 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.262 -0.899 . . . . 0.0 109.62 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -142.14 139.83 32.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.849 -1.157 . . . . 0.0 110.671 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.846 HG23 ' CD1' ' A' ' 13' ' ' LEU . 6.5 p -55.52 127.69 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.253 -0.904 . . . . 0.0 110.027 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.822 HG11 ' OE2' ' A' ' 34' ' ' GLU . 2.9 t -106.58 -58.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 110.179 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.767 ' O ' HD13 ' A' ' 54' ' ' ILE . 13.1 mm-40 -140.43 170.57 15.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.404 -0.81 . . . . 0.0 110.199 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.767 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -132.76 150.49 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.305 -0.872 . . . . 0.0 109.312 179.612 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.517 HG21 ' HD2' ' A' ' 98' ' ' PRO . 0.5 OUTLIER -141.15 132.67 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.973 -1.08 . . . . 0.0 110.456 -179.529 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.48 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 15.2 mm-40 -89.92 178.62 6.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.402 -0.811 . . . . 0.0 110.449 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -102.54 133.53 47.37 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.194 -0.942 . . . . 0.0 110.811 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 1.3 t 173.61 63.16 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.297 -0.877 . . . . 0.0 111.015 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.912 HG22 ' O ' ' A' ' 95' ' ' ALA . 0.8 OUTLIER -171.18 -31.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.726 -1.234 . . . . 0.0 111.781 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.655 HG22 ' H ' ' A' ' 61' ' ' ARG . 10.1 mt -85.31 179.43 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.619 -1.301 . . . . 0.0 110.432 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.655 ' H ' HG22 ' A' ' 60' ' ' ILE . 1.2 mmt180 -112.17 -153.23 0.52 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.223 -0.923 . . . . 0.0 110.587 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 1.029 ' HA ' HG13 ' A' ' 93' ' ' VAL . 12.9 tt0 -90.86 -12.75 35.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.669 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 4.0 p30 -137.7 -24.89 1.02 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 0.0 111.071 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.454 ' OE1' ' O ' ' A' ' 65' ' ' ALA . 6.1 tp-100 -54.41 133.58 45.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.841 -1.162 . . . . 0.0 110.51 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.015 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -120.95 157.23 30.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.384 -0.822 . . . . 0.0 109.355 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 65' ' ' ALA . 2.8 mt -125.77 113.05 16.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.107 -0.995 . . . . 0.0 110.78 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.469 ' C ' HD23 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -91.68 121.59 33.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.26 -0.9 . . . . 0.0 109.269 178.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.869 ' CD2' HG23 ' A' ' 104' ' ' VAL . 6.0 mt -118.46 151.68 37.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.089 -1.007 . . . . 0.0 110.841 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 2.0 ttm-85 -121.82 155.28 35.69 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.416 -0.802 . . . . 0.0 109.778 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -65.44 152.64 43.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.173 -0.955 . . . . 0.0 110.855 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.516 ' CB ' ' O ' ' A' ' 101' ' ' PHE . 8.2 tpt180 -114.71 -27.37 7.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.375 -0.828 . . . . 0.0 109.837 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.661 ' O ' HG23 ' A' ' 84' ' ' THR . 29.8 mmmt -108.32 -94.66 0.4 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 0.0 109.684 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.54 ' CB ' ' O ' ' A' ' 72' ' ' LYS . 0.5 OUTLIER 164.39 29.72 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.464 -0.773 . . . . 0.0 110.465 179.597 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.2 m -138.64 -6.96 1.48 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.997 -1.064 . . . . 0.0 110.874 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.572 ' CB ' ' HB2' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -76.91 110.17 11.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.066 -1.021 . . . . 0.0 110.299 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.512 ' HB2' ' N ' ' A' ' 80' ' ' LYS . 3.1 p30 -93.16 132.13 37.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.271 -0.893 . . . . 0.0 110.055 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.569 ' HD2' ' CG ' ' A' ' 86' ' ' GLU . 1.7 mtp180 -80.1 -59.04 2.87 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.063 -1.023 . . . . 0.0 110.409 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -98.5 16.78 20.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.267 -0.896 . . . . 0.0 110.516 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.15 16.03 24.28 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.512 ' N ' ' HB2' ' A' ' 76' ' ' ASP . 40.9 mmtt -115.71 91.66 3.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -1.164 . . . . 0.0 110.248 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.438 ' HG3' ' CG1' ' A' ' 29' ' ' VAL . 1.7 tm-20 -43.56 101.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.233 -0.917 . . . . 0.0 110.281 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.548 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -100.67 179.24 4.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 0.0 110.223 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.739 HG23 ' H ' ' A' ' 85' ' ' GLY . 11.0 m -98.72 -178.59 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.227 -0.921 . . . . 0.0 110.589 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 72' ' ' LYS . 0.1 OUTLIER -58.18 -26.0 62.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.488 -0.757 . . . . 0.0 110.627 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.739 ' H ' HG23 ' A' ' 83' ' ' VAL . . . -69.03 -19.0 73.37 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.569 ' CG ' ' HD2' ' A' ' 77' ' ' ARG . 10.0 tp10 -73.7 143.46 46.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.183 -1.187 . . . . 0.0 110.312 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.461 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 3.9 pt-20 -149.31 155.44 40.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.296 -0.878 . . . . 0.0 110.2 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.87 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -136.88 154.77 50.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.088 -1.008 . . . . 0.0 110.129 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.024 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -114.87 134.68 54.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.278 -0.889 . . . . 0.0 110.573 -179.482 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 1.024 ' N ' HD22 ' A' ' 89' ' ' LEU . 3.6 m -99.8 130.14 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.254 -0.904 . . . . 0.0 110.16 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.565 HG23 HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -120.78 53.9 1.1 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.332 -0.855 . . . . 0.0 110.051 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.498 HG22 ' OD1' ' A' ' 10' ' ' ASN . 0.2 OUTLIER -85.36 160.23 19.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 110.456 -179.702 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.029 HG13 ' HA ' ' A' ' 62' ' ' GLN . 90.7 t -109.64 83.89 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.346 -0.846 . . . . 0.0 109.781 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 60' ' ' ILE . . . 87.4 79.53 1.24 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.912 ' O ' HG22 ' A' ' 59' ' ' ILE . . . -162.46 -143.32 0.08 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.28 -1.13 . . . . 0.0 110.599 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.533 ' O ' HD23 ' A' ' 97' ' ' LEU . 9.3 t80 177.17 104.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.662 HD22 ' CB ' ' A' ' 12' ' ' ALA . 15.6 mt -116.78 88.72 26.37 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.046 -1.034 . . . . 0.0 111.052 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.614 ' O ' HD22 ' A' ' 36' ' ' LEU . 49.9 Cg_endo -78.24 108.38 2.48 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.892 1.47 . . . . 0.0 109.825 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.49 ' HA ' ' HB2' ' A' ' 36' ' ' LEU . . . -65.2 -171.56 0.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.164 -0.96 . . . . 0.0 110.692 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.563 ' CG2' ' HA ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -110.49 -55.95 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.389 -0.819 . . . . 0.0 109.581 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.572 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 11.8 m-85 -101.5 -14.64 17.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.948 -1.095 . . . . 0.0 109.656 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.573 ' OE1' ' CD1' ' A' ' 88' ' ' TRP . 23.4 tt0 -93.83 123.94 37.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.363 -0.836 . . . . 0.0 110.906 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.33 164.12 11.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.308 -0.87 . . . . 0.0 109.77 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.869 HG23 ' CD2' ' A' ' 68' ' ' LEU . 8.4 p -86.65 146.76 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.123 -0.985 . . . . 0.0 110.539 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 104' ' ' VAL . 9.4 mp -104.0 -33.29 8.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.366 -0.834 . . . . 0.0 110.142 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.923 ' C ' HD22 ' A' ' 107' ' ' LEU . 0.3 OUTLIER -173.3 -166.55 0.34 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.254 -0.904 . . . . 0.0 110.401 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.923 HD22 ' C ' ' A' ' 106' ' ' ASP . 3.3 mm? -121.54 153.44 37.98 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.25 -0.907 . . . . 0.0 110.032 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.015 HG13 ' HB3' ' A' ' 65' ' ' ALA . 2.8 p -139.05 107.79 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.08 -1.012 . . . . 0.0 110.987 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -70.17 118.28 12.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.882 . . . . 0.0 110.222 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . -75.8 166.4 23.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.219 -0.925 . . . . 0.0 110.42 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 113' ' ' LEU . 11.7 p -86.86 131.21 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 0.0 110.292 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.2 mp -97.34 -28.97 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.214 -0.929 . . . . 0.0 110.216 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.522 ' O ' HG22 ' A' ' 111' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.137 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.37 172.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.184 -1.186 . . . . 0.0 110.102 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -96.79 12.09 33.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.145 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.529 ' HB3' HG13 ' A' ' 44' ' ' ILE . 0.6 OUTLIER -125.9 -164.91 1.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.95 . . . . 0.0 110.701 -179.555 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.467 ' O ' ' O ' ' A' ' 41' ' ' GLY . 0.8 OUTLIER -147.57 -163.97 1.89 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.341 -0.85 . . . . 0.0 109.86 179.56 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.502 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 9.0 m -114.14 176.9 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.09 -1.006 . . . . 0.0 110.21 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.506 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 78.0 t -54.81 143.35 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.426 -0.796 . . . . 0.0 110.769 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.58 HD13 ' N ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -96.5 167.2 12.67 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.433 -0.792 . . . . 0.0 110.052 179.644 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.496 ' O ' ' HB2' ' A' ' 10' ' ' ASN . 46.3 Cg_endo -73.94 69.59 4.6 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.989 1.521 . . . . 0.0 109.52 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 1.043 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 14.6 m-80 60.71 64.48 1.16 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.455 -0.778 . . . . 0.0 110.74 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.55 ' HB ' ' HA ' ' A' ' 56' ' ' GLN . 30.7 p -140.55 172.11 13.17 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.216 -0.927 . . . . 0.0 110.184 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.565 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -144.42 169.33 18.13 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.941 . . . . 0.0 110.017 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.948 HD23 ' CB ' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -134.21 147.62 50.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.084 -1.01 . . . . 0.0 110.148 179.521 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.82 ' CE1' HD13 ' A' ' 36' ' ' LEU . 11.7 m80 -90.26 126.66 35.91 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.039 -1.038 . . . . 0.0 110.395 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.952 HD21 ' HB2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -136.75 155.72 49.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.11 -0.994 . . . . 0.0 110.351 179.37 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.476 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -104.82 122.86 46.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.455 -0.778 . . . . 0.0 110.064 -179.712 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.066 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -82.89 117.82 23.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.934 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.876 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 1.4 mm? -106.72 101.06 10.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.742 -0.599 . . . . 0.0 110.635 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.817 ' C ' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -166.96 165.14 16.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.247 -0.908 . . . . 0.0 110.093 179.409 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.505 ' N ' HD22 ' A' ' 19' ' ' LEU . 80.7 m-20 -96.25 110.73 22.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 0.0 110.612 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.914 ' CB ' HG22 ' A' ' 29' ' ' VAL . 1.1 t80 -121.21 123.88 43.33 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.317 -0.864 . . . . 0.0 110.087 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.462 ' OE2' ' HD2' ' A' ' 28' ' ' LYS . 26.2 tt0 -130.9 114.83 15.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.932 . . . . 0.0 110.209 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -102.69 135.88 43.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.343 -0.848 . . . . 0.0 110.035 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.82 -23.94 66.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -0.926 . . . . 0.0 110.392 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -66.07 -9.85 34.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 110.162 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.7 -45.57 1.17 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.462 ' O ' ' CB ' ' A' ' 28' ' ' LYS . 31.9 t70 -50.61 159.9 0.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -1.138 . . . . 0.0 110.277 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 1.0 OUTLIER 172.59 120.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 109.972 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.914 HG22 ' CB ' ' A' ' 21' ' ' PHE . 2.0 m -110.2 148.74 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.25 -0.906 . . . . 0.0 110.041 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 30' ' ' VAL . 18.6 m -129.77 84.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.083 -1.011 . . . . 0.0 110.312 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.876 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 45.4 69.27 0.46 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.34 -0.85 . . . . 0.0 110.117 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -174.91 27.01 0.08 OUTLIER Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.41 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 1.066 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 1.5 m-20 -89.47 144.97 25.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.877 -1.366 . . . . 0.0 109.966 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.071 ' HG2' HG11 ' A' ' 100' ' ' VAL . 5.7 tt0 -142.57 131.09 22.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -0.99 . . . . 0.0 110.086 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.617 ' CH2' HD12 ' A' ' 15' ' ' LEU . 1.8 p90 -161.37 174.15 13.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.986 -1.071 . . . . 0.0 110.776 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.82 HD13 ' CE1' ' A' ' 14' ' ' HIS . 55.9 tp -94.05 162.09 14.02 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.519 -0.738 . . . . 0.0 110.045 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.952 ' HB2' HD21 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -131.84 110.36 10.77 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.986 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.639 ' HG2' HD11 ' A' ' 97' ' ' LEU . 0.6 OUTLIER -82.48 142.85 31.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.409 -0.807 . . . . 0.0 110.397 -179.715 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.596 ' N ' ' HD3' ' A' ' 40' ' ' PRO . . . 55.66 44.42 86.3 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.948 ' CB ' HD23 ' A' ' 13' ' ' LEU . 54.6 Cg_endo -77.82 15.16 1.33 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.663 1.349 . . . . 0.0 111.086 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 7' ' ' VAL . . . -53.27 -29.72 38.12 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.429 ' O ' ' CD1' ' A' ' 44' ' ' ILE . 48.9 p -103.45 17.19 24.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -1.17 . . . . 0.0 110.518 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.588 ' C ' HD12 ' A' ' 44' ' ' ILE . 12.1 t80 -87.44 125.89 34.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.875 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.803 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.2 mp -107.47 141.8 23.77 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 109.786 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.531 ' HD2' HG23 ' A' ' 44' ' ' ILE . 43.9 Cg_endo -70.57 97.3 0.7 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.957 1.504 . . . . 0.0 110.802 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.88 159.54 22.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.212 -0.93 . . . . 0.0 110.403 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.529 ' HG3' ' N ' ' A' ' 48' ' ' GLU . 16.0 pttm -48.93 -32.25 8.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.326 -0.859 . . . . 0.0 110.782 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.529 ' N ' ' HG3' ' A' ' 47' ' ' LYS . 2.6 tp10 -43.27 -40.52 3.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.085 -1.009 . . . . 0.0 110.206 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -150.13 167.92 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 0.0 110.159 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -122.44 124.47 43.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 0.0 109.949 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.518 HG13 HD13 ' A' ' 13' ' ' LEU . 21.7 t -54.58 133.03 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 109.653 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.934 HG23 ' HA ' ' A' ' 15' ' ' LEU . 4.7 t -111.36 -48.89 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.035 -1.041 . . . . 0.0 110.579 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.908 ' C ' HD13 ' A' ' 54' ' ' ILE . 0.5 OUTLIER -149.6 168.57 23.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.146 -0.971 . . . . 0.0 109.936 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.908 HD13 ' C ' ' A' ' 53' ' ' GLU . 1.2 mm -129.94 131.15 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.378 -0.826 . . . . 0.0 108.974 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.665 HD13 ' N ' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -120.84 136.45 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.028 -1.045 . . . . 0.0 111.334 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.665 ' N ' HD13 ' A' ' 55' ' ' ILE . 56.8 mm-40 -97.69 176.55 5.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.601 -0.687 . . . . 0.0 109.929 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.043 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -90.84 140.23 30.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.202 -0.936 . . . . 0.0 109.825 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 3.4 t -179.49 38.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.017 -1.052 . . . . 0.0 111.536 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.731 HG21 ' CG ' ' A' ' 96' ' ' TYR . 0.6 OUTLIER -159.9 -74.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.536 -1.353 . . . . 0.0 111.827 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.718 ' H ' HG23 ' A' ' 59' ' ' ILE . 77.0 mt -63.31 159.72 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.56 -1.338 . . . . 0.0 110.393 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.36 -166.37 1.08 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.296 -0.878 . . . . 0.0 110.575 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.929 ' HB2' HG13 ' A' ' 93' ' ' VAL . 1.7 tt0 -75.61 -70.82 0.41 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.444 -0.785 . . . . 0.0 110.568 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.843 ' HB3' ' HB2' ' A' ' 110' ' ' ALA . 31.1 m-20 -60.55 -33.82 73.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.362 -0.836 . . . . 0.0 110.42 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -59.46 141.18 55.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.188 -0.945 . . . . 0.0 110.84 -179.774 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.962 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -123.03 140.53 52.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.827 . . . . 0.0 109.773 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.716 HD12 HD21 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -126.19 108.33 11.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.104 -0.997 . . . . 0.0 110.534 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 1.022 ' O ' HD23 ' A' ' 68' ' ' LEU . 4.8 ttm105 -91.2 135.9 33.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.129 -0.982 . . . . 0.0 109.585 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.022 HD23 ' O ' ' A' ' 67' ' ' ARG . 5.4 mt -133.99 150.18 51.24 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.209 -0.932 . . . . 0.0 110.935 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 13.9 ttm180 -107.02 163.81 12.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.461 -0.775 . . . . 0.0 109.641 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -80.57 118.5 22.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.177 -0.952 . . . . 0.0 110.478 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.53 -30.37 52.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.144 -0.972 . . . . 0.0 109.133 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -133.75 157.54 45.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.601 -0.687 . . . . 0.0 109.204 179.45 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.518 ' O ' ' HB3' ' A' ' 74' ' ' CYS . 1.0 OUTLIER -84.65 -179.2 7.07 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.023 -1.048 . . . . 0.0 110.802 -179.367 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER 75.05 -16.01 0.61 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.647 -0.658 . . . . 0.0 111.32 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.612 ' CZ2' ' CG ' ' A' ' 77' ' ' ARG . 5.0 t90 -74.37 104.64 5.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.631 -1.293 . . . . 0.0 110.232 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.513 ' O ' ' CD1' ' A' ' 35' ' ' TRP . 7.4 p-10 -84.8 124.48 31.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.085 -1.009 . . . . 0.0 109.68 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.612 ' CG ' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -80.99 -59.9 2.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.205 -0.935 . . . . 0.0 110.507 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -103.92 11.1 35.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 110.232 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.83 10.95 9.6 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -116.17 111.84 20.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -1.162 . . . . 0.0 110.401 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.496 ' OE2' ' CG ' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -71.47 102.77 2.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.194 -0.941 . . . . 0.0 109.711 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -109.35 178.79 4.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.153 -0.967 . . . . 0.0 110.307 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.633 HG13 ' H ' ' A' ' 85' ' ' GLY . 8.8 p -77.37 174.37 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 0.0 110.29 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.715 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 14.6 t -69.57 -16.39 63.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.203 -0.935 . . . . 0.0 109.984 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.633 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -72.18 -23.01 78.62 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' A' ' 87' ' ' GLU . 6.5 tp10 -63.09 160.05 16.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -1.134 . . . . 0.0 110.212 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.457 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 10.5 pt-20 -149.9 156.54 41.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 110.169 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.568 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -136.21 148.6 48.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.196 -0.94 . . . . 0.0 109.693 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.963 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -102.06 128.31 48.57 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.315 -0.866 . . . . 0.0 110.45 -179.428 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.963 ' N ' HD22 ' A' ' 89' ' ' LEU . 2.7 t -89.15 124.48 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.589 -0.694 . . . . 0.0 110.073 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.477 ' OG1' ' CD1' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -129.74 33.29 4.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -0.904 . . . . 0.0 109.857 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.63 152.6 37.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.856 . . . . 0.0 109.905 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.929 HG13 ' HB2' ' A' ' 62' ' ' GLN . 44.7 t -93.41 109.6 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.181 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.899 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 69.78 76.92 0.47 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -176.42 -175.23 0.65 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -1.124 . . . . 0.0 110.738 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.731 ' CG ' HG21 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -117.13 -61.86 1.65 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.403 -0.81 . . . . 0.0 110.608 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.639 HD11 ' HG2' ' A' ' 38' ' ' GLU . 2.9 mm? 58.45 51.87 4.34 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.063 -1.023 . . . . 0.0 109.733 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 97' ' ' LEU . 50.2 Cg_endo -75.47 -2.31 12.41 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.111 1.585 . . . . 0.0 111.329 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.559 ' HA ' ' CB ' ' A' ' 36' ' ' LEU . . . 51.87 -178.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.059 -1.026 . . . . 0.0 110.093 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 1.071 HG11 ' HG2' ' A' ' 34' ' ' GLU . 2.4 t -97.21 -63.93 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.664 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.556 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 7.5 m-30 -94.09 67.66 3.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.966 -1.083 . . . . 0.0 109.385 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -139.85 144.75 37.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 111.282 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -132.38 121.35 23.33 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.793 ' HB ' HD22 ' A' ' 68' ' ' LEU . 9.0 p -76.89 144.52 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.15 -0.969 . . . . 0.0 111.091 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.761 ' N ' HD22 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -99.17 -26.23 14.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.664 -0.648 . . . . 0.0 109.409 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -177.95 -178.8 0.71 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 110.039 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.35 149.25 44.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.201 -0.937 . . . . 0.0 110.287 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.962 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 11.0 p -131.81 156.3 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.243 -0.911 . . . . 0.0 110.255 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.511 ' O ' ' C ' ' A' ' 110' ' ' ALA . 7.6 p30 -111.18 113.49 26.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.072 -1.017 . . . . 0.0 110.461 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.843 ' HB2' ' HB3' ' A' ' 63' ' ' ASN . . . 26.06 45.29 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 120.956 0.408 . . . . 0.0 111.942 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.64 ' O ' HG21 ' A' ' 108' ' ' VAL . 51.5 t -157.08 154.22 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.949 -1.094 . . . . 0.0 110.528 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.4 mm -129.41 114.19 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.407 -0.808 . . . . 0.0 110.036 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.476 HD13 ' HA ' ' A' ' 113' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.245 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 3' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 0.1 OUTLIER 65.23 -69.95 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -1.097 . . . . 0.0 110.311 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.469 ' N ' ' O ' ' A' ' 1' ' ' GLY . 0.1 OUTLIER -76.67 -172.01 2.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.234 -0.916 . . . . 0.0 110.179 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.702 ' HG3' HD11 ' A' ' 44' ' ' ILE . 20.3 ttm -68.27 161.6 26.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.27 -0.894 . . . . 0.0 109.901 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.531 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 0.4 OUTLIER -112.21 135.01 53.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.133 -0.979 . . . . 0.0 110.735 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.537 HG23 ' N ' ' A' ' 7' ' ' VAL . 33.1 m -74.8 -133.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.214 -0.929 . . . . 0.0 109.257 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.537 ' N ' HG23 ' A' ' 6' ' ' VAL . 21.0 t -105.78 151.76 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.986 -1.071 . . . . 0.0 109.607 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.883 HD23 ' OG1' ' A' ' 11' ' ' THR . 5.4 mp -103.64 157.69 33.37 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 110.256 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -74.18 -49.28 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.061 1.558 . . . . 0.0 110.495 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 1.082 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 5.4 p30 -163.46 27.29 0.09 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.873 . . . . 0.0 110.471 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.883 ' OG1' HD23 ' A' ' 8' ' ' LEU . 19.0 p -104.81 151.7 23.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.965 -1.084 . . . . 0.0 111.125 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.779 ' HB3' HD22 ' A' ' 97' ' ' LEU . . . -132.18 165.45 24.06 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.929 ' CD2' HD12 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -133.88 153.17 51.94 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.788 -1.195 . . . . 0.0 110.485 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.819 ' C ' HD13 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -92.15 136.29 33.3 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.504 -0.748 . . . . 0.0 109.105 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.953 HD13 ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -139.39 153.37 47.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.013 -1.054 . . . . 0.0 110.6 179.763 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 0.3 OUTLIER -113.52 117.53 31.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.267 -0.896 . . . . 0.0 109.91 -179.615 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.095 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -77.59 119.37 21.05 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.24 -0.913 . . . . 0.0 110.195 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.594 HD13 ' HB1' ' A' ' 31' ' ' ALA . 2.4 mm? -103.04 101.01 10.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.772 -0.58 . . . . 0.0 109.517 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.027 HD13 ' N ' ' A' ' 20' ' ' ASP . 2.1 tm? -164.98 144.21 6.79 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.011 -1.055 . . . . 0.0 110.262 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 1.027 ' N ' HD13 ' A' ' 19' ' ' LEU . 2.7 m-20 -85.05 118.72 24.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.667 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.679 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -140.59 144.65 35.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.168 -0.957 . . . . 0.0 110.766 -179.431 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.526 ' CB ' ' HE2' ' A' ' 28' ' ' LYS . 12.6 pt-20 -108.78 131.35 55.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 109.782 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -82.58 167.46 18.31 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.216 -0.928 . . . . 0.0 110.429 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.01 -17.9 24.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.342 -0.849 . . . . 0.0 110.25 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -79.46 -17.11 54.9 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.202 -0.936 . . . . 0.0 110.233 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 129.52 -30.15 3.67 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -64.27 -156.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.186 -1.185 . . . . 0.0 110.088 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.526 ' HE2' ' CB ' ' A' ' 22' ' ' GLU . 1.8 ttmm 174.92 131.14 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.142 -0.974 . . . . 0.0 110.153 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.679 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -92.56 141.72 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.082 -1.011 . . . . 0.0 109.209 179.557 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.654 ' O ' HG23 ' A' ' 30' ' ' VAL . 31.4 m -141.04 89.16 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.074 -1.016 . . . . 0.0 110.451 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.594 ' HB1' HD13 ' A' ' 18' ' ' LEU . . . 44.24 63.66 1.57 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.384 -0.822 . . . . 0.0 110.163 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.93 21.62 0.1 OUTLIER Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.624 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 1.095 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 5.3 m-20 -87.1 149.49 24.65 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.676 -1.485 . . . . 0.0 109.557 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.598 ' OE2' HG11 ' A' ' 52' ' ' VAL . 31.6 tt0 -152.68 145.72 24.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.019 -1.051 . . . . 0.0 110.525 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.703 ' CZ3' ' HB2' ' A' ' 17' ' ' ALA . 6.7 p90 -167.99 168.93 11.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.211 -0.93 . . . . 0.0 110.616 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.682 HD11 ' ND1' ' A' ' 14' ' ' HIS . 0.5 OUTLIER -91.87 156.28 17.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.205 -0.934 . . . . 0.0 110.959 -178.843 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -132.2 111.04 11.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.486 -0.759 . . . . 0.0 109.894 179.604 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.584 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 4.7 tm-20 -79.17 140.19 37.81 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.568 -0.708 . . . . 0.0 109.64 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.612 ' N ' ' HD3' ' A' ' 40' ' ' PRO . . . 54.33 44.56 76.12 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 39' ' ' GLY . 54.5 Cg_endo -76.15 13.15 1.35 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.69 1.363 . . . . 0.0 111.262 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.599 ' HA3' HD13 ' A' ' 8' ' ' LEU . . . -49.95 -41.35 36.8 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.8 p -83.16 18.54 1.68 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.173 -1.192 . . . . 0.0 111.231 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.566 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 3.1 t80 -98.72 130.64 45.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.933 -1.105 . . . . 0.0 110.166 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.702 HD11 ' HG3' ' A' ' 4' ' ' MET . 35.1 mm -114.49 146.01 35.01 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.45 -0.781 . . . . 0.0 109.045 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 44' ' ' ILE . 40.3 Cg_endo -66.22 74.58 0.36 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.733 1.386 . . . . 0.0 110.883 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -73.99 139.08 44.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.376 -0.827 . . . . 0.0 109.819 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.493 ' HG3' ' N ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -45.98 -24.2 0.39 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.917 . . . . 0.0 110.387 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.493 ' N ' ' HG3' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -56.64 -36.16 69.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.159 -0.963 . . . . 0.0 110.211 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.2 m -141.35 170.36 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.36 -0.838 . . . . 0.0 110.027 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -127.98 132.69 49.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.992 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.1 m -56.37 127.64 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.875 . . . . 0.0 110.321 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.827 HG23 ' HA ' ' A' ' 15' ' ' LEU . 21.8 t -96.54 -60.78 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.363 -0.836 . . . . 0.0 109.975 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.855 ' O ' HD13 ' A' ' 54' ' ' ILE . 12.1 mm-40 -143.97 175.88 9.69 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.202 -0.936 . . . . 0.0 110.408 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.855 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -136.74 134.52 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.296 -0.878 . . . . 0.0 108.971 179.349 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.649 HD13 ' N ' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -128.61 130.98 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.008 -1.058 . . . . 0.0 111.003 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.649 ' N ' HD13 ' A' ' 55' ' ' ILE . 6.1 mm100 -94.91 134.28 37.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.499 -0.751 . . . . 0.0 109.412 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.082 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -49.27 137.26 14.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.081 -1.012 . . . . 0.0 110.804 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 8.7 t -179.51 45.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.309 -0.869 . . . . 0.0 111.587 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.648 HG21 ' CD1' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -162.48 -53.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.454 -1.404 . . . . 0.0 111.803 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.568 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 21.8 mt -57.37 165.16 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.552 -1.343 . . . . 0.0 109.947 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.451 ' N ' ' CG2' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -93.34 -161.97 0.89 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.339 -0.851 . . . . 0.0 111.057 -179.431 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.877 ' HA ' HG13 ' A' ' 93' ' ' VAL . 0.7 OUTLIER -58.85 -70.25 0.16 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.461 -0.774 . . . . 0.0 110.72 -179.621 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 15.2 p30 -113.95 26.33 10.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.137 -0.977 . . . . 0.0 110.181 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.442 ' OE1' ' O ' ' A' ' 65' ' ' ALA . 1.8 tp-100 -59.84 138.99 57.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 110.4 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.977 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -113.91 130.32 56.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.383 -0.823 . . . . 0.0 109.706 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.618 HD21 HD12 ' A' ' 107' ' ' LEU . 42.1 mt -125.04 121.33 34.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 110.275 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.599 ' O ' HD12 ' A' ' 105' ' ' LEU . 21.1 ttm-85 -96.83 128.25 43.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.347 -0.845 . . . . 0.0 110.177 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.593 HD23 ' HA ' ' A' ' 104' ' ' VAL . 31.6 mt -118.16 147.2 43.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 109.992 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 11.7 ttt180 -117.39 146.9 43.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 110.243 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.505 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -67.88 136.49 54.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.345 -0.847 . . . . 0.0 110.807 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -116.12 -8.63 11.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.345 -0.847 . . . . 0.0 109.656 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -141.21 108.68 5.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.338 -0.851 . . . . 0.0 109.727 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.716 ' HG3' HG12 ' A' ' 83' ' ' VAL . 28.2 tt0 -56.59 103.49 0.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.066 -1.021 . . . . 0.0 110.045 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 2.1 t 179.27 -33.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.46 -0.775 . . . . 0.0 109.938 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.524 ' CD1' ' C ' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -75.47 137.2 40.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.418 -0.801 . . . . 0.0 110.11 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 13.6 p-10 -102.18 110.2 22.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.864 . . . . 0.0 110.259 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.521 ' NE ' ' O ' ' A' ' 77' ' ' ARG . 5.4 tpm_? -88.5 -19.93 25.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.177 -0.952 . . . . 0.0 109.309 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.55 -12.67 23.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.465 -0.772 . . . . 0.0 109.638 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 115.16 -5.82 21.72 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.434 ' O ' ' CB ' ' A' ' 81' ' ' GLU . 12.4 mmmt -114.89 -70.35 0.8 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.189 -1.183 . . . . 0.0 110.221 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER 171.36 119.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.364 -0.835 . . . . 0.0 109.789 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.49 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 17.1 mmm180 -111.38 178.5 4.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 110.394 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.716 HG12 ' HG3' ' A' ' 73' ' ' GLU . 29.8 m -110.91 179.24 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 110.345 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.446 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 3.3 t -56.2 -27.0 53.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 110.093 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.458 ' O ' ' OE2' ' A' ' 87' ' ' GLU . . . -65.23 -23.77 70.1 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.49 ' CB ' ' HB3' ' A' ' 82' ' ' ARG . 22.1 tp10 -74.63 158.72 33.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.368 -1.078 . . . . 0.0 110.226 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.477 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -157.4 164.83 37.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.338 -0.851 . . . . 0.0 109.962 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.523 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -140.93 149.34 41.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.215 -0.928 . . . . 0.0 110.24 -179.749 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.791 HD13 ' C ' ' A' ' 89' ' ' LEU . 1.3 tm? -112.79 124.36 52.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.345 -0.847 . . . . 0.0 109.633 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.597 ' N ' HD22 ' A' ' 89' ' ' LEU . 8.0 p -105.44 132.36 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.173 -0.954 . . . . 0.0 110.847 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.48 ' OG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -135.88 56.1 1.84 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.301 -0.875 . . . . 0.0 110.006 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 54.5 m -97.51 119.52 36.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.954 . . . . 0.0 110.332 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.877 HG13 ' HA ' ' A' ' 62' ' ' GLN . 18.2 t -50.76 134.2 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.195 -0.941 . . . . 0.0 109.947 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.749 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 48.35 94.97 0.01 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.581 ' O ' HG22 ' A' ' 59' ' ' ILE . . . 178.67 154.79 0.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.088 -1.242 . . . . 0.0 110.949 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.648 ' CD1' HG21 ' A' ' 59' ' ' ILE . 2.5 t80 -134.67 87.18 2.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.488 -0.757 . . . . 0.0 110.15 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.779 HD22 ' HB3' ' A' ' 12' ' ' ALA . 16.9 mt -108.1 87.66 4.07 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.104 -0.998 . . . . 0.0 110.55 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.709 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 47.1 Cg_endo -72.54 -6.19 18.58 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.989 1.52 . . . . 0.0 110.438 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 98' ' ' PRO . . . 68.29 174.91 0.27 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.238 -0.914 . . . . 0.0 110.5 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.459 HG21 ' CA ' ' A' ' 35' ' ' TRP . 4.7 t -94.48 -58.31 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.856 . . . . 0.0 110.052 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 26.7 m-85 -109.45 53.43 0.69 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.1 -1.0 . . . . 0.0 110.318 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 3.2 tt0 -141.13 157.68 44.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.97 -1.081 . . . . 0.0 110.989 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 3.5 pt-20 -132.76 140.45 48.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.0 109.663 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.593 ' HA ' HD23 ' A' ' 68' ' ' LEU . 15.0 p -76.07 137.43 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.158 -0.964 . . . . 0.0 110.525 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.736 ' H ' HD12 ' A' ' 105' ' ' LEU . 1.7 mp -106.51 -19.3 13.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.443 -0.786 . . . . 0.0 110.145 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 37.6 p30 -176.43 162.7 2.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.338 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.618 HD12 HD21 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -120.42 141.99 49.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.361 -0.837 . . . . 0.0 109.778 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.977 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 12.7 p -139.31 160.59 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.064 -1.023 . . . . 0.0 110.859 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.799 ' O ' HG23 ' A' ' 111' ' ' VAL . 2.9 t70 -110.73 116.94 32.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 109.549 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . -62.36 -21.29 65.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.98 -1.075 . . . . 0.0 110.687 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 109' ' ' ASP . 5.0 t 44.16 -122.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.153 -0.967 . . . . 0.0 109.912 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 21.2 mt -107.13 -70.86 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.775 -1.203 . . . . 0.0 110.174 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.492 HD22 ' HA ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.257 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 3' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 4' ' ' MET . 1.7 t 49.55 -91.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -1.161 . . . . 0.0 110.169 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.488 ' HB3' HG12 ' A' ' 44' ' ' ILE . 35.0 m170 49.57 -93.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -0.95 . . . . 0.0 110.187 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.531 ' HG3' ' HG2' ' A' ' 5' ' ' GLN . 6.2 tpt -133.64 -102.68 0.25 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.104 -0.998 . . . . 0.0 110.217 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.531 ' HG2' ' HG3' ' A' ' 4' ' ' MET . 11.2 pt20 -167.18 -170.62 1.54 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.012 -1.055 . . . . 0.0 110.485 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.471 ' O ' HD13 ' A' ' 8' ' ' LEU . 15.1 m -100.02 170.14 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 110.643 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.923 ' C ' HD13 ' A' ' 8' ' ' LEU . 23.2 t -46.87 153.0 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.431 -0.793 . . . . 0.0 110.45 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.923 HD13 ' C ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -106.5 171.41 4.78 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.283 -0.886 . . . . 0.0 108.863 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 45.8 Cg_endo -72.85 77.96 2.21 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.761 1.4 . . . . 0.0 110.156 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.549 ' HB3' ' CA ' ' A' ' 94' ' ' GLY . 78.2 m-20 58.28 74.21 0.44 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.44 -0.787 . . . . 0.0 110.513 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.496 ' HB ' ' HA ' ' A' ' 56' ' ' GLN . 2.9 p -148.39 169.78 19.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.253 -0.904 . . . . 0.0 110.426 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.665 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -147.28 162.95 37.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.455 -0.778 . . . . 0.0 109.768 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.931 HD23 ' HG3' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -133.25 155.78 48.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.006 -1.059 . . . . 0.0 110.833 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.82 ' CD2' HD21 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -93.15 123.92 36.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.445 -0.784 . . . . 0.0 109.636 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.835 HD21 ' HB2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -126.91 155.31 43.24 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.593 -1.317 . . . . 0.0 110.814 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -110.1 117.89 34.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.635 -0.666 . . . . 0.0 109.994 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.031 ' HB3' ' HB3' ' A' ' 33' ' ' ASP . . . -77.04 119.04 20.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 111.006 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 2.7 mm? -109.73 101.22 10.13 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.498 HD13 ' HG3' ' A' ' 48' ' ' GLU . 5.3 tp -164.42 155.5 15.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.017 -1.052 . . . . 0.0 110.482 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.414 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 12.5 p-10 -97.01 101.84 13.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.146 -0.971 . . . . 0.0 110.261 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.942 ' HB2' HG22 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -123.67 126.4 46.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 109.716 179.569 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.521 ' HA ' ' CB ' ' A' ' 28' ' ' LYS . 8.2 tm-20 -149.72 112.59 4.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.045 -1.034 . . . . 0.0 110.833 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.98 165.98 16.51 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.518 -0.739 . . . . 0.0 109.423 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.11 1.41 55.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.97 -1.081 . . . . 0.0 109.92 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.68 -32.47 14.73 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.243 -0.911 . . . . 0.0 110.202 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.85 -50.66 0.52 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -56.98 99.31 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.303 -1.116 . . . . 0.0 110.221 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.521 ' CB ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -153.44 104.72 2.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 110.101 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.942 HG22 ' HB2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -112.5 161.38 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.032 -1.043 . . . . 0.0 109.744 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.564 ' O ' HG23 ' A' ' 30' ' ' VAL . 30.8 m -137.26 77.9 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.95 -1.094 . . . . 0.0 110.5 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 38.74 70.57 0.2 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.768 -0.583 . . . . 0.0 110.523 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.28 28.94 0.05 OUTLIER Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.849 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 1.031 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 18.2 t70 -96.69 149.04 22.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.813 -1.404 . . . . 0.0 109.883 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 36.3 tt0 -146.72 130.35 16.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.326 -0.859 . . . . 0.0 109.819 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.735 ' CZ2' HD12 ' A' ' 15' ' ' LEU . 7.6 p90 -154.81 171.28 19.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.126 -0.983 . . . . 0.0 110.955 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.82 HD21 ' CD2' ' A' ' 14' ' ' HIS . 0.6 OUTLIER -90.61 155.8 18.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.419 -0.801 . . . . 0.0 110.684 -179.587 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.835 ' HB2' HD21 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -132.51 110.49 10.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.365 -0.834 . . . . 0.0 110.008 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.506 ' HB2' HD11 ' A' ' 97' ' ' LEU . 2.1 tm-20 -95.98 135.51 37.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.38 -0.825 . . . . 0.0 110.065 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.604 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 69.71 45.15 59.93 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.931 ' HG3' HD23 ' A' ' 13' ' ' LEU . 44.1 Cg_endo -72.25 -57.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.854 1.45 . . . . 0.0 110.968 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.522 ' CA ' ' HA ' ' A' ' 7' ' ' VAL . . . 46.03 -89.9 0.01 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 40' ' ' PRO . 1.3 p -73.15 6.05 3.04 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.354 -1.086 . . . . 0.0 111.607 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.65 ' CE1' HD13 ' A' ' 15' ' ' LEU . 9.4 t80 -69.31 110.97 4.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.694 -1.254 . . . . 0.0 109.962 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.488 HG12 ' HB3' ' A' ' 3' ' ' HIS . 3.2 mt -105.97 139.92 20.73 Favored Pre-proline 0 C--N 1.297 -1.677 0 O-C-N 121.194 -0.941 . . . . 0.0 108.891 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.517 ' HD3' ' SD ' ' A' ' 4' ' ' MET . 39.5 Cg_endo -66.4 76.37 0.36 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.762 1.401 . . . . 0.0 110.129 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 49' ' ' VAL . 4.6 mtt180 -73.3 153.08 40.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.516 -0.74 . . . . 0.0 110.185 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -43.13 -33.73 0.94 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.308 -0.87 . . . . 0.0 109.963 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.498 ' HG3' HD13 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -47.48 -51.44 20.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 109.821 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -136.06 174.02 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.456 -0.778 . . . . 0.0 109.38 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -134.16 126.63 30.37 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.108 -0.995 . . . . 0.0 110.126 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.822 HG23 HD13 ' A' ' 13' ' ' LEU . 12.4 p -53.84 132.33 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.175 -0.953 . . . . 0.0 108.847 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.545 HG23 ' HA ' ' A' ' 15' ' ' LEU . 44.6 t -109.65 -48.96 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.005 . . . . 0.0 111.195 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 1.043 ' O ' HD13 ' A' ' 54' ' ' ILE . 12.1 mt-10 -138.62 171.92 13.64 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.072 -1.017 . . . . 0.0 110.35 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 1.043 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -139.44 146.41 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.349 -0.844 . . . . 0.0 109.18 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.808 HD13 ' N ' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -141.84 141.89 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.111 -0.993 . . . . 0.0 110.385 -179.413 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.808 ' N ' HD13 ' A' ' 55' ' ' ILE . 8.4 mp0 -112.29 179.8 3.89 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.359 -0.838 . . . . 0.0 110.336 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.58 ' HB1' ' O ' ' A' ' 94' ' ' GLY . . . -80.34 139.5 36.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.264 -0.898 . . . . 0.0 110.3 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 58' ' ' THR . 11.8 t -179.93 56.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.362 -0.837 . . . . 0.0 110.054 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.805 HG22 ' N ' ' A' ' 60' ' ' ILE . 6.3 mm -155.69 -91.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.213 -0.929 . . . . 0.0 111.059 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.805 ' N ' HG22 ' A' ' 59' ' ' ILE . 17.5 mm -108.47 -104.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.836 -1.165 . . . . 0.0 110.839 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.644 ' N ' HG22 ' A' ' 60' ' ' ILE . 2.0 ttp180 -167.6 -170.24 1.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.777 -1.202 . . . . 0.0 110.496 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 1.009 ' HB2' HG13 ' A' ' 93' ' ' VAL . 50.1 tt0 -68.2 -57.14 6.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.842 . . . . 0.0 110.646 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.548 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 68.9 m-80 -34.52 -60.54 0.42 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.321 0.581 . . . . 0.0 111.112 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.434 ' OE1' HD23 ' A' ' 107' ' ' LEU . 4.0 tp-100 -53.6 129.11 31.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.048 -1.033 . . . . 0.0 110.785 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.022 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -108.18 142.39 38.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 109.727 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 65' ' ' ALA . 5.8 mp -124.34 115.03 20.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.604 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.837 ' O ' HD12 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -90.67 125.98 35.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 0.0 109.56 179.479 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 104' ' ' VAL . 13.6 mt -116.58 152.67 33.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.133 -0.98 . . . . 0.0 110.629 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.832 ' HB2' HD21 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -128.51 144.33 51.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 109.854 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.52 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -59.16 140.33 56.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.169 -0.957 . . . . 0.0 110.356 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.468 ' C ' ' CG2' ' A' ' 84' ' ' THR . 7.6 tpt180 -107.53 -18.07 13.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.894 . . . . 0.0 110.121 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.708 ' O ' HG23 ' A' ' 84' ' ' THR . 2.0 mmmp? -112.51 -98.74 0.42 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.952 . . . . 0.0 110.149 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 0.2 OUTLIER 168.09 45.85 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.318 -0.864 . . . . 0.0 109.986 179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 73' ' ' GLU . 17.2 m -154.89 -19.49 0.12 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.209 -0.932 . . . . 0.0 111.676 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.571 ' CB ' ' HB2' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -73.98 121.37 20.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.686 -1.258 . . . . 0.0 110.851 -179.291 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.516 ' HB2' ' CA ' ' A' ' 81' ' ' GLU . 12.5 t70 -108.87 122.47 47.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 0.0 109.665 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.56 ' CG ' ' CZ2' ' A' ' 75' ' ' TRP . 9.4 mtm180 -55.61 -28.24 54.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -0.874 . . . . 0.0 110.607 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.444 ' HB3' ' OD1' ' A' ' 76' ' ' ASP . 11.4 t70 -89.29 -35.11 16.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.168 -0.957 . . . . 0.0 110.218 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 80' ' ' LYS . . . 148.59 -38.87 0.99 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.561 ' HE2' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -59.31 -133.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.384 -1.068 . . . . 0.0 110.077 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.81 ' CG ' HG12 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -141.43 141.81 33.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.898 -1.126 . . . . 0.0 110.067 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.476 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 27.4 mmt-85 -136.22 163.8 29.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.066 -1.021 . . . . 0.0 110.254 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 19.9 m -86.45 -179.12 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.339 -0.85 . . . . 0.0 110.803 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 72' ' ' LYS . 0.1 OUTLIER -62.89 -26.62 68.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.45 -0.781 . . . . 0.0 110.418 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.493 ' H ' HG23 ' A' ' 83' ' ' VAL . . . -64.46 -30.87 79.07 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.476 ' CB ' ' HB3' ' A' ' 82' ' ' ARG . 7.9 tp10 -61.43 151.57 32.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.568 ' CG ' ' HG2' ' A' ' 69' ' ' ARG . 5.4 mt-10 -148.52 169.58 19.96 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.184 -0.948 . . . . 0.0 110.151 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.466 ' HB2' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -156.0 130.24 8.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.229 -0.919 . . . . 0.0 109.927 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.008 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -102.51 136.45 42.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.351 -0.843 . . . . 0.0 109.839 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 1.008 ' N ' HD22 ' A' ' 89' ' ' LEU . 9.7 p -111.39 135.37 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.901 . . . . 0.0 110.581 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.7 t -141.82 16.44 2.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.437 -0.789 . . . . 0.0 109.53 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.4 m -75.47 170.01 16.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.398 -0.814 . . . . 0.0 109.865 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.009 HG13 ' HB2' ' A' ' 62' ' ' GLN . 0.8 OUTLIER -79.14 147.68 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.099 -1.001 . . . . 0.0 109.1 179.524 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.797 ' O ' ' HB3' ' A' ' 95' ' ' ALA . . . 150.96 -13.3 0.85 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.133 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.797 ' HB3' ' O ' ' A' ' 94' ' ' GLY . . . 77.74 -35.04 0.2 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.361 -1.082 . . . . 0.0 111.674 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.655 ' CG ' HG13 ' A' ' 59' ' ' ILE . 1.0 OUTLIER -146.86 147.61 31.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.08 -1.013 . . . . 0.0 110.385 179.685 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.63 ' HB3' HG21 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -160.76 59.86 1.23 Allowed Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.401 -0.812 . . . . 0.0 109.883 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.586 ' HG3' ' CE2' ' A' ' 96' ' ' TYR . 53.0 Cg_endo -76.99 143.25 22.8 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.976 1.514 . . . . 0.0 110.787 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -95.04 -151.42 0.33 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.325 -0.859 . . . . 0.0 110.346 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.15 -66.26 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.219 -0.926 . . . . 0.0 110.485 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.571 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 9.1 m-30 -80.57 -22.18 40.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.937 -1.102 . . . . 0.0 110.013 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.571 ' OE1' ' CH2' ' A' ' 75' ' ' TRP . 0.7 OUTLIER -98.34 131.6 44.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.348 -0.845 . . . . 0.0 110.3 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -115.02 161.1 18.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.165 -0.959 . . . . 0.0 110.174 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.648 ' HA ' HD23 ' A' ' 68' ' ' LEU . 10.1 p -76.98 146.1 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.114 -0.992 . . . . 0.0 110.685 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.837 HD12 ' O ' ' A' ' 67' ' ' ARG . 1.5 mp -105.11 -24.67 12.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.413 -0.804 . . . . 0.0 109.709 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -166.04 174.35 9.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.266 -0.896 . . . . 0.0 110.037 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.434 HD23 ' OE1' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -121.95 131.19 53.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.23 -0.919 . . . . 0.0 110.064 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.022 HG13 ' HB3' ' A' ' 65' ' ' ALA . 14.6 p -125.16 157.14 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.17 -0.956 . . . . 0.0 110.414 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 0.6 OUTLIER -111.12 115.54 29.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.161 -0.962 . . . . 0.0 109.739 179.39 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . -53.09 -177.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.048 -1.033 . . . . 0.0 110.457 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.632 HG23 ' N ' ' A' ' 112' ' ' ILE . 5.7 m -65.07 -143.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.322 -0.861 . . . . 0.0 110.244 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.632 ' N ' HG23 ' A' ' 111' ' ' VAL . 57.1 mt -127.83 122.58 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 110.479 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 112' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.164 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 0.4 OUTLIER -145.43 -178.32 6.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -1.117 . . . . 0.0 110.14 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.507 ' O ' ' HG2' ' A' ' 4' ' ' MET . 65.2 m80 54.59 -160.02 0.17 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.132 -0.98 . . . . 0.0 110.214 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.547 ' HB2' HG13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER 51.76 171.81 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.461 -0.774 . . . . 0.0 110.735 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.51 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 1.3 mt-30 -80.3 -156.72 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.497 -0.752 . . . . 0.0 109.385 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 7' ' ' VAL . 11.4 m -144.26 83.54 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.743 -1.223 . . . . 0.0 110.885 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.616 HG22 HG23 ' A' ' 42' ' ' THR . 2.0 t 27.04 99.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 CA-C-O 121.265 0.555 . . . . 0.0 111.682 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.011 HD23 ' OG1' ' A' ' 11' ' ' THR . 2.3 mp -61.52 168.76 2.91 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.076 -1.015 . . . . 0.0 110.098 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.456 ' O ' ' OD1' ' A' ' 10' ' ' ASN . 45.0 Cg_endo -72.67 -58.4 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.921 1.485 . . . . 0.0 110.406 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 9.6 m120 -162.04 30.87 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.805 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 1.011 ' OG1' HD23 ' A' ' 8' ' ' LEU . 1.1 p -109.9 172.09 7.06 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.312 -0.867 . . . . 0.0 110.22 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.743 ' HB2' HD21 ' A' ' 97' ' ' LEU . . . -144.5 161.32 39.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.213 -0.929 . . . . 0.0 110.659 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.11 ' CD2' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -133.64 155.49 49.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 109.896 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.697 ' C ' HD22 ' A' ' 15' ' ' LEU . 17.8 m80 -97.66 133.45 42.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 109.812 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.11 HD21 ' CD2' ' A' ' 13' ' ' LEU . 2.5 mm? -120.18 151.9 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.343 -0.848 . . . . 0.0 110.535 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -116.09 117.35 29.84 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.349 178.063 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.08 ' HB3' ' HB3' ' A' ' 33' ' ' ASP . . . -82.62 118.53 23.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.089 -1.007 . . . . 0.0 109.724 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.873 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 1.4 mm? -108.15 101.68 10.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.783 -0.573 . . . . 0.0 110.264 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.855 HD13 ' C ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -164.95 174.91 10.0 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 0.0 110.331 179.614 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.4 117.22 33.51 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.097 -1.002 . . . . 0.0 109.862 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.931 ' HB2' HG22 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -125.48 94.02 4.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.143 -0.973 . . . . 0.0 110.583 -179.713 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.569 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 0.6 OUTLIER -103.93 119.88 39.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.576 -0.703 . . . . 0.0 110.135 179.396 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.16 161.66 19.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.295 -0.878 . . . . 0.0 110.275 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.486 ' CG ' ' O ' ' A' ' 24' ' ' LYS . 22.9 tttm -82.71 4.5 24.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 0.0 110.286 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -89.64 5.76 44.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.167 -0.958 . . . . 0.0 110.326 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.62 9.51 86.32 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -122.51 110.56 15.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -1.125 . . . . 0.0 110.019 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.569 ' HB2' ' HA ' ' A' ' 22' ' ' GLU . 6.9 ptpt -138.83 149.23 44.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.23 -0.919 . . . . 0.0 110.741 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.931 HG22 ' HB2' ' A' ' 21' ' ' PHE . 1.4 m -112.71 147.01 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -0.942 . . . . 0.0 109.123 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 30' ' ' VAL . 15.4 m -131.17 82.92 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.886 -1.134 . . . . 0.0 111.03 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.873 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 47.32 69.65 0.49 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.413 -0.805 . . . . 0.0 110.516 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -175.47 24.72 0.06 OUTLIER Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.694 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 1.08 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 11.5 t70 -86.99 143.41 27.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.783 -1.422 . . . . 0.0 110.242 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.76 ' HG2' HG11 ' A' ' 100' ' ' VAL . 8.9 tt0 -143.52 134.6 25.64 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.403 -0.811 . . . . 0.0 109.845 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.631 ' CZ2' ' HB2' ' A' ' 15' ' ' LEU . 13.5 p90 -150.26 163.97 36.93 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.994 -1.066 . . . . 0.0 111.237 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.533 HD13 ' CD2' ' A' ' 14' ' ' HIS . 42.0 tp -94.49 152.38 18.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.553 -0.717 . . . . 0.0 109.95 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.671 ' HB3' HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -133.0 110.66 10.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.064 -1.023 . . . . 0.0 110.367 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.95 ' OE1' HD11 ' A' ' 97' ' ' LEU . 16.5 tp10 -85.83 138.48 32.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.622 -0.674 . . . . 0.0 109.469 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.619 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 54.36 45.02 76.44 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 51.3 Cg_endo -72.13 4.27 3.4 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.827 1.435 . . . . 0.0 111.057 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.542 ' HA3' ' N ' ' A' ' 7' ' ' VAL . . . -42.0 -27.92 0.43 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.616 HG23 HG22 ' A' ' 7' ' ' VAL . 10.8 p -103.19 37.28 2.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.132 -1.217 . . . . 0.0 109.59 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.5 ' N ' ' O ' ' A' ' 40' ' ' PRO . 6.0 t80 -104.25 117.68 34.8 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.527 -0.733 . . . . 0.0 110.021 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.547 HG13 ' HB2' ' A' ' 4' ' ' MET . 3.1 mp -96.47 124.11 52.09 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.235 -0.916 . . . . 0.0 110.318 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.93 127.05 11.11 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.827 1.435 . . . . 0.0 110.335 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -136.82 165.23 26.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.323 -0.86 . . . . 0.0 110.108 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -56.38 -18.83 12.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.732 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.5 ' C ' ' CG1' ' A' ' 49' ' ' VAL . 5.7 tt0 -67.55 -21.62 65.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.419 -0.801 . . . . 0.0 110.444 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.5 ' CG1' ' C ' ' A' ' 48' ' ' GLU . 1.4 m -151.65 173.95 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.026 -1.046 . . . . 0.0 110.38 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.4 137.24 37.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.322 -0.861 . . . . 0.0 110.215 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -57.55 114.55 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 109.526 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.567 HG11 ' OE2' ' A' ' 34' ' ' GLU . 14.4 t -90.96 -60.12 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.946 . . . . 0.0 111.068 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.931 ' C ' HD13 ' A' ' 54' ' ' ILE . 5.6 mt-10 -144.82 169.33 18.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.91 -1.119 . . . . 0.0 110.963 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.931 HD13 ' C ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -134.44 143.24 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.049 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.581 HD13 ' N ' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -137.25 130.14 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.963 -1.085 . . . . 0.0 110.605 -179.535 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.581 ' N ' HD13 ' A' ' 55' ' ' ILE . 2.4 mp0 -83.9 171.64 12.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.587 -0.696 . . . . 0.0 109.958 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.595 ' CA ' ' HA ' ' A' ' 95' ' ' ALA . . . -92.53 128.15 38.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.055 -1.028 . . . . 0.0 110.578 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER 172.71 60.98 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.24 -0.913 . . . . 0.0 111.424 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.566 ' CG2' ' N ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -166.43 -51.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.6 -1.313 . . . . 0.0 111.637 179.331 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.636 HD12 ' O ' ' A' ' 95' ' ' ALA . 3.5 mt -81.6 142.1 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.815 -1.178 . . . . 0.0 110.56 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.46 -170.39 0.28 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.315 -0.866 . . . . 0.0 110.745 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.795 ' HB2' HG13 ' A' ' 93' ' ' VAL . 1.1 tm0? -91.55 -35.89 14.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 0.0 110.445 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.589 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 13.0 m-20 -87.72 -29.65 20.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.521 -0.737 . . . . 0.0 110.965 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 109' ' ' ASP . 7.9 tp-100 -58.63 140.59 54.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.085 -1.009 . . . . 0.0 111.476 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.072 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -118.45 141.44 48.55 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 90' ' ' VAL . 0.5 OUTLIER -126.08 117.5 23.31 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.431 -0.793 . . . . 0.0 110.97 -178.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.544 ' HB3' HD22 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -92.37 125.81 37.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 0.0 109.81 179.328 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.749 HD12 ' OE1' ' A' ' 102' ' ' GLU . 3.5 mm? -112.15 134.09 53.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.984 . . . . 0.0 110.576 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.542 ' CB ' HD11 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -125.66 150.95 47.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -0.881 . . . . 0.0 110.057 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.585 ' CB ' ' HA ' ' A' ' 84' ' ' THR . . . -70.33 142.0 52.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.39 -0.819 . . . . 0.0 110.519 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.452 ' C ' HG23 ' A' ' 84' ' ' THR . 7.8 tpp180 -118.49 -24.45 6.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.429 -0.795 . . . . 0.0 109.615 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 74' ' ' CYS . 2.6 ttpt -127.69 109.35 11.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.493 -0.754 . . . . 0.0 109.847 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -47.17 90.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.436 -0.79 . . . . 0.0 110.346 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 72' ' ' LYS . 0.5 OUTLIER -177.46 -32.89 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 110.094 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.619 ' CZ3' ' HB3' ' A' ' 102' ' ' GLU . 2.8 t90 -75.16 114.75 14.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.327 -0.858 . . . . 0.0 110.011 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.481 ' OD1' ' HA ' ' A' ' 81' ' ' GLU . 67.5 m-20 -91.48 113.55 25.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.924 . . . . 0.0 110.357 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.436 ' HD2' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -57.08 -48.9 77.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.329 -0.857 . . . . 0.0 109.851 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -93.49 -16.3 24.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 109.892 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.77 32.96 5.46 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -129.34 47.99 2.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -1.107 . . . . 0.0 109.989 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.551 ' OE1' ' CE2' ' A' ' 21' ' ' PHE . 7.9 mp0 49.04 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.38 -0.825 . . . . 0.0 110.422 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.476 ' HB2' ' HA ' ' A' ' 76' ' ' ASP . 12.8 mmt180 -113.69 -179.96 3.79 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.393 -0.817 . . . . 0.0 110.121 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.498 HG22 ' N ' ' A' ' 84' ' ' THR . 10.9 p -120.87 165.74 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.223 -0.923 . . . . 0.0 110.651 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.585 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -51.2 -20.99 1.78 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.388 -0.82 . . . . 0.0 110.377 179.726 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.441 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -69.53 -11.58 65.41 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.462 ' HA ' ' OE1' ' A' ' 86' ' ' GLU . 2.1 tp10 -84.48 142.22 30.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.393 -1.063 . . . . 0.0 110.026 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -148.08 158.89 44.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.186 -0.946 . . . . 0.0 110.288 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.584 ' CZ2' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -144.6 134.77 24.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 109.909 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.016 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -95.56 128.7 42.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.14 -0.975 . . . . 0.0 110.055 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 1.016 ' N ' HD22 ' A' ' 89' ' ' LEU . 5.4 p -108.44 128.61 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 109.995 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.538 HG23 HD11 ' A' ' 89' ' ' LEU . 1.1 p -129.51 48.42 2.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -0.88 . . . . 0.0 110.197 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 m -75.83 169.68 17.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.132 -0.98 . . . . 0.0 109.993 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.795 HG13 ' HB2' ' A' ' 62' ' ' GLN . 89.7 t -115.14 131.76 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.216 -0.927 . . . . 0.0 110.495 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 60' ' ' ILE . . . 50.01 44.57 41.64 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.636 ' O ' HD12 ' A' ' 60' ' ' ILE . . . -134.33 157.8 45.43 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.222 -1.163 . . . . 0.0 111.036 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.544 ' CD2' HD11 ' A' ' 55' ' ' ILE . 1.3 t80 -121.78 113.85 20.26 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.95 HD11 ' OE1' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -126.37 84.9 61.14 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.049 -1.032 . . . . 0.0 111.029 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.525 ' O ' ' NE2' ' A' ' 14' ' ' HIS . 50.0 Cg_endo -77.48 117.44 4.32 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.142 1.601 . . . . 0.0 110.02 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.66 ' HB1' ' HG3' ' A' ' 102' ' ' GLU . . . -74.74 -168.95 0.79 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.026 -1.046 . . . . 0.0 110.431 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.76 HG11 ' HG2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -113.93 -57.21 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.205 -0.934 . . . . 0.0 110.45 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.509 ' CE2' ' HB3' ' A' ' 74' ' ' CYS . 21.9 m-30 -103.23 -32.14 9.75 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.75 -1.218 . . . . 0.0 110.672 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.749 ' OE1' HD12 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -80.07 154.83 27.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.199 -0.938 . . . . 0.0 110.641 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.582 ' C ' HD13 ' A' ' 68' ' ' LEU . 6.9 tp10 -128.94 167.73 17.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.458 -0.776 . . . . 0.0 110.2 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.454 ' C ' HD12 ' A' ' 105' ' ' LEU . 10.7 m -72.02 152.31 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.0 110.245 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.562 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 4.7 mp -100.06 -14.57 18.56 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.295 -0.878 . . . . 0.0 109.605 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.599 ' O ' HD22 ' A' ' 107' ' ' LEU . 1.8 p30 165.25 -168.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.61 -0.681 . . . . 0.0 110.151 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.599 HD22 ' O ' ' A' ' 106' ' ' ASP . 1.0 OUTLIER -127.01 116.08 20.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.464 -0.772 . . . . 0.0 109.416 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.072 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 2.0 p -115.87 103.71 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.832 -1.168 . . . . 0.0 111.037 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 3.8 t70 -75.61 115.66 15.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.279 -0.888 . . . . 0.0 110.125 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . -49.86 132.05 22.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.886 . . . . 0.0 110.586 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 110' ' ' ALA . 21.2 t 59.35 98.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.382 -0.824 . . . . 0.0 110.513 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 2.5 mp -46.37 119.69 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.159 -0.963 . . . . 0.0 110.038 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.715 ' O ' HD13 ' A' ' 113' ' ' LEU . 3.4 tm? . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.954 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' A' ' 3' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 50.09 -90.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.298 -1.119 . . . . 0.0 110.302 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.498 ' N ' ' O ' ' A' ' 1' ' ' GLY . 51.5 m-70 -108.64 -151.74 0.48 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.135 -0.978 . . . . 0.0 110.579 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.771 ' HG2' HD11 ' A' ' 44' ' ' ILE . 0.0 OUTLIER 64.09 -175.26 0.16 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.309 -0.87 . . . . 0.0 110.391 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.47 -164.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.192 -0.943 . . . . 0.0 110.261 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.462 ' C ' ' HA2' ' A' ' 41' ' ' GLY . 95.7 t -136.01 135.59 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.166 -0.959 . . . . 0.0 110.131 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.517 ' CG2' ' HA3' ' A' ' 41' ' ' GLY . 79.2 t -60.88 118.7 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 110.829 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.509 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 0.4 OUTLIER -79.16 167.24 36.18 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 109.717 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 42.9 Cg_endo -69.9 -37.12 9.26 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.612 1.322 . . . . 0.0 110.383 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.434 ' CG ' ' HA3' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -170.69 41.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.104 -0.998 . . . . 0.0 110.246 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.444 ' OG1' ' CB ' ' A' ' 8' ' ' LEU . 12.6 p -112.98 160.86 17.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.817 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.746 ' CB ' HD11 ' A' ' 36' ' ' LEU . . . -146.82 155.35 42.28 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.988 -1.07 . . . . 0.0 110.177 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.776 ' CD1' HD22 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -123.39 154.6 38.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.166 -0.959 . . . . 0.0 110.639 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.773 ' NE2' HD12 ' A' ' 55' ' ' ILE . 7.9 m170 -94.96 127.54 41.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 109.966 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.868 HD21 ' HB2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -136.1 148.35 48.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.931 -1.105 . . . . 0.0 110.661 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.492 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -100.78 121.15 41.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.547 -0.721 . . . . 0.0 110.359 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.069 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -82.46 113.57 20.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 110.028 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.456 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -105.12 99.6 9.21 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.547 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.456 ' CD2' ' O ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -167.5 133.33 2.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.356 -0.84 . . . . 0.0 110.079 179.565 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -78.26 101.84 7.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.014 -1.054 . . . . 0.0 108.693 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.788 ' HB2' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -123.51 135.9 54.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.12 -0.988 . . . . 0.0 111.542 -178.516 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -130.18 128.58 42.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.604 -0.685 . . . . 0.0 109.186 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 4.7 t0 -85.31 170.24 12.97 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.148 -0.97 . . . . 0.0 110.89 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -61.79 -31.0 71.18 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.451 -0.78 . . . . 0.0 110.098 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -61.34 -17.11 52.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.311 -0.868 . . . . 0.0 110.138 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.64 -70.7 0.41 Allowed Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.632 -1.271 . . . . 0.0 109.942 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -132.01 156.55 46.03 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.152 -1.205 . . . . 0.0 111.251 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.724 ' HG2' HG13 ' A' ' 29' ' ' VAL . 2.7 tptt -134.47 -95.5 0.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.533 -0.729 . . . . 0.0 109.321 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.886 HG12 ' CB ' ' A' ' 81' ' ' GLU . 0.6 OUTLIER -112.68 151.79 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.917 -1.114 . . . . 0.0 109.225 179.132 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.523 ' O ' HG23 ' A' ' 30' ' ' VAL . 27.0 m -132.64 78.54 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.978 -1.077 . . . . 0.0 111.056 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 30' ' ' VAL . . . 35.68 72.29 0.11 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.741 -0.599 . . . . 0.0 111.23 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.56 34.2 0.02 OUTLIER Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.365 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 1.069 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 3.8 m-20 -93.31 145.62 24.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.893 -1.357 . . . . 0.0 110.36 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 101' ' ' PHE . 14.1 tt0 -140.86 130.18 23.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 0.0 109.396 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.658 ' CH2' HD12 ' A' ' 15' ' ' LEU . 3.7 p90 -157.62 166.95 31.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.97 -1.081 . . . . 0.0 111.286 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.746 HD11 ' CB ' ' A' ' 12' ' ' ALA . 16.2 tp -90.36 155.69 18.77 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.531 -0.731 . . . . 0.0 109.183 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.868 ' HB2' HD21 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -126.42 108.61 11.36 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.099 -1.001 . . . . 0.0 109.841 -179.563 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.617 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -88.44 142.22 27.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.413 -0.804 . . . . 0.0 109.384 179.63 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.611 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 54.52 46.17 74.46 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.617 ' HG3' HD23 ' A' ' 13' ' ' LEU . 47.8 Cg_endo -71.33 18.32 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.861 1.453 . . . . 0.0 112.344 -178.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.517 ' HA3' ' CG2' ' A' ' 7' ' ' VAL . . . -44.81 156.75 0.25 Allowed Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.482 ' HA ' ' HB2' ' A' ' 4' ' ' MET . 20.3 p 53.45 12.13 0.33 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.662 -0.905 . . . . 0.0 111.583 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.543 ' HE2' HG12 ' A' ' 51' ' ' VAL . 7.0 t80 -75.62 132.37 40.58 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.702 -1.249 . . . . 0.0 109.548 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.771 HD11 ' HG2' ' A' ' 4' ' ' MET . 50.3 mt -120.52 134.48 24.19 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.054 -1.028 . . . . 0.0 110.492 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.3 78.46 2.29 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.968 1.509 . . . . 0.0 110.303 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 47' ' ' LYS . 22.8 mtm180 -91.58 151.02 20.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 110.364 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 48' ' ' GLU . 13.7 mttt -42.16 -31.78 0.41 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.238 -0.914 . . . . 0.0 110.287 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -42.9 -51.02 5.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.39 -0.819 . . . . 0.0 109.772 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -134.81 173.76 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.381 -0.825 . . . . 0.0 109.389 179.382 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.41 122.74 28.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.19 -0.944 . . . . 0.0 110.407 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.543 HG12 ' HE2' ' A' ' 43' ' ' TYR . 33.7 m -54.27 123.36 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.113 -0.992 . . . . 0.0 108.678 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.781 HG12 ' HG2' ' A' ' 53' ' ' GLU . 57.1 t -99.36 -54.51 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.148 -0.97 . . . . 0.0 110.472 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.934 ' O ' HD13 ' A' ' 54' ' ' ILE . 27.6 mm-40 -138.72 174.65 10.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 110.205 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.934 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -134.09 144.26 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.405 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.773 HD12 ' NE2' ' A' ' 14' ' ' HIS . 0.2 OUTLIER -134.26 144.67 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.961 -1.087 . . . . 0.0 111.138 -178.73 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.433 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 70.9 mm-40 -119.36 168.51 10.87 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.684 -0.635 . . . . 0.0 109.347 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.617 ' HB1' ' HB3' ' A' ' 95' ' ' ALA . . . -89.51 132.51 35.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.154 -0.966 . . . . 0.0 110.43 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.61 ' N ' ' CB ' ' A' ' 95' ' ' ALA . 1.5 t -176.24 71.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.13 -0.981 . . . . 0.0 111.293 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.771 HD13 ' C ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -176.66 -51.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.825 -1.172 . . . . 0.0 111.732 178.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.768 HG23 ' N ' ' A' ' 61' ' ' ARG . 1.0 OUTLIER -108.3 -167.36 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.157 -1.59 . . . . 0.0 110.791 -179.719 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.768 ' N ' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -123.43 -147.71 0.38 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.461 -0.774 . . . . 0.0 110.115 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.947 ' HB2' HG13 ' A' ' 93' ' ' VAL . 11.4 tt0 -89.67 -71.31 0.61 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.206 -0.934 . . . . 0.0 110.919 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 7.5 p-10 -34.16 -47.66 0.29 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.832 -0.543 . . . . 0.0 111.72 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.491 ' HG2' ' CG1' ' A' ' 60' ' ' ILE . 8.3 tp-100 -56.23 128.18 34.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.958 -1.089 . . . . 0.0 110.931 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.99 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -108.19 149.17 28.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.342 -0.849 . . . . 0.0 109.303 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.451 ' O ' HD22 ' A' ' 89' ' ' LEU . 1.4 mt -126.27 113.71 17.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.068 -1.02 . . . . 0.0 111.333 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.72 ' O ' HD12 ' A' ' 105' ' ' LEU . 1.5 ttm-85 -100.03 122.05 42.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.213 -0.929 . . . . 0.0 109.04 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.553 HD23 ' HA ' ' A' ' 104' ' ' VAL . 20.1 mt -119.21 145.69 45.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.106 -0.996 . . . . 0.0 111.277 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.886 ' CB ' HD21 ' A' ' 105' ' ' LEU . 2.0 ttp85 -121.03 152.6 38.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.541 -0.725 . . . . 0.0 110.059 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.559 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -71.7 159.9 33.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -0.929 . . . . 0.0 110.867 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 101' ' ' PHE . 4.4 tpm_? -132.0 -34.15 1.3 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.457 -0.777 . . . . 0.0 109.813 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -117.98 107.69 14.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 110.036 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.481 ' O ' ' CB ' ' A' ' 74' ' ' CYS . 0.8 OUTLIER -47.89 99.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.619 179.576 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER 169.71 -24.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.329 -0.857 . . . . 0.0 110.294 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.608 ' CZ3' ' HB2' ' A' ' 102' ' ' GLU . 1.3 t90 -74.72 126.73 31.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -0.923 . . . . 0.0 110.058 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 1.5 m-20 -90.82 110.85 22.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 110.001 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.574 ' HG3' ' CZ2' ' A' ' 75' ' ' TRP . 10.1 mtp180 -59.03 -57.65 12.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.158 -0.964 . . . . 0.0 110.169 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.43 0.23 14.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.33 -0.856 . . . . 0.0 110.274 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.72 9.47 16.57 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.497 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -98.51 -11.7 22.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -1.15 . . . . 0.0 109.983 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.886 ' CB ' HG12 ' A' ' 29' ' ' VAL . 2.0 tm-20 61.88 104.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -0.849 . . . . 0.0 110.306 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.492 ' HB3' ' HB3' ' A' ' 86' ' ' GLU . 46.7 mtt180 -123.28 175.04 6.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.333 -0.854 . . . . 0.0 109.918 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.679 HG13 ' H ' ' A' ' 85' ' ' GLY . 10.8 p -76.83 174.74 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.219 -0.925 . . . . 0.0 110.461 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.599 ' N ' HG22 ' A' ' 83' ' ' VAL . 1.9 t -60.61 -10.84 5.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.368 -0.832 . . . . 0.0 110.366 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.679 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -76.91 -10.32 86.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.502 ' HG2' ' CB ' ' A' ' 70' ' ' ALA . 9.0 pt-20 -73.22 153.47 40.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.185 -1.185 . . . . 0.0 109.864 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -160.33 161.15 33.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 110.227 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.887 ' CZ2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -149.56 145.87 27.05 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.161 -0.962 . . . . 0.0 110.215 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.887 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -106.02 125.19 50.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 0.0 110.321 -179.14 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.887 HG22 ' CZ2' ' A' ' 88' ' ' TRP . 22.8 t -93.49 128.07 45.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.467 -0.771 . . . . 0.0 110.765 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.517 ' OG1' ' CD1' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -134.48 30.04 3.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.53 -0.732 . . . . 0.0 109.246 179.383 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.46 130.83 35.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.478 -0.764 . . . . 0.0 110.725 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.947 HG13 ' HB2' ' A' ' 62' ' ' GLN . 6.4 t -65.51 113.82 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.374 -0.829 . . . . 0.0 110.033 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.434 ' HA3' ' CG ' ' A' ' 10' ' ' ASN . . . -179.85 -95.37 0.1 OUTLIER Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.293 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.661 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -150.13 -50.28 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.072 -1.252 . . . . 0.0 111.227 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.603 ' HB3' ' CG2' ' A' ' 59' ' ' ILE . 1.8 p90 176.51 161.37 0.37 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.48 -0.763 . . . . 0.0 110.606 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.614 ' HB2' HG11 ' A' ' 90' ' ' VAL . 12.9 mt -155.41 72.73 5.53 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.363 -0.836 . . . . 0.0 110.172 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.563 ' HD3' ' CD2' ' A' ' 96' ' ' TYR . 45.8 Cg_endo -72.35 128.5 13.76 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.883 1.464 . . . . 0.0 110.541 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.444 ' HB2' ' OE1' ' A' ' 102' ' ' GLU . . . -66.69 -163.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.354 -0.841 . . . . 0.0 110.333 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.86 -68.12 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.361 -0.837 . . . . 0.0 109.807 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 34' ' ' GLU . 16.2 m-30 -80.79 -21.2 41.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.258 -0.901 . . . . 0.0 109.935 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.608 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . 3.5 tt0 -87.8 146.11 25.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.378 -0.826 . . . . 0.0 110.411 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.32 170.73 9.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.464 -0.773 . . . . 0.0 110.066 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.553 ' HA ' HD23 ' A' ' 68' ' ' LEU . 7.6 p -84.52 136.39 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.114 -0.992 . . . . 0.0 110.461 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.886 HD21 ' CB ' ' A' ' 69' ' ' ARG . 1.1 mp -93.95 -29.4 15.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 0.0 109.957 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 105' ' ' LEU . 15.0 p-10 -178.66 123.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.438 -0.788 . . . . 0.0 110.359 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -77.19 144.98 37.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -0.858 . . . . 0.0 109.73 179.73 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.99 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 12.9 p -130.87 154.49 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.062 -1.024 . . . . 0.0 110.307 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 47.4 t0 -110.5 123.37 49.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.148 -0.97 . . . . 0.0 110.144 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . -69.33 -177.63 1.18 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.18 -0.95 . . . . 0.0 110.407 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.696 ' O ' HG23 ' A' ' 112' ' ' ILE . 26.1 t 50.81 75.51 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.92 . . . . 0.0 110.126 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.696 HG23 ' O ' ' A' ' 111' ' ' VAL . 3.2 pt -158.91 154.6 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.235 -0.916 . . . . 0.0 110.264 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 113' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.218 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 51.54 -178.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -1.131 . . . . 0.0 109.943 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.421 ' O ' ' O ' ' A' ' 4' ' ' MET . 25.2 m170 -95.68 134.43 38.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.258 -0.901 . . . . 0.0 109.906 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.57 ' CA ' HD11 ' A' ' 44' ' ' ILE . 4.9 ttt 62.42 139.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.958 . . . . 0.0 109.842 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.55 ' OE1' HD11 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -145.52 161.27 40.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.169 -0.957 . . . . 0.0 110.385 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.479 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 22.0 t -92.36 152.21 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.384 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.466 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 54.4 t -41.44 122.54 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.241 -0.912 . . . . 0.0 110.128 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.898 HD22 ' HG2' ' A' ' 40' ' ' PRO . 1.7 mp -78.85 159.76 73.08 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 110.366 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -75.48 -82.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.949 1.499 . . . . 0.0 110.164 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.727 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 11.4 p30 -129.56 54.7 1.81 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.309 -0.87 . . . . 0.0 109.843 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.874 ' OG1' HD23 ' A' ' 8' ' ' LEU . 1.1 p -132.5 157.47 44.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.145 -0.972 . . . . 0.0 110.111 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.755 ' CB ' HD11 ' A' ' 36' ' ' LEU . . . -141.3 162.08 36.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -0.959 . . . . 0.0 109.574 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.789 HD23 ' HG3' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -133.54 156.36 47.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.937 -1.102 . . . . 0.0 111.164 -179.492 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.667 ' NE2' HD12 ' A' ' 55' ' ' ILE . 8.9 m170 -96.24 123.32 39.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.438 -0.789 . . . . 0.0 109.882 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.854 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -125.76 148.86 48.95 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.081 -1.012 . . . . 0.0 109.55 179.278 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.499 ' HG3' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -96.98 119.22 35.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 110.714 -178.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.992 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -76.92 115.12 16.42 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.622 0.725 . . . . 0.0 110.258 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 86.8 mt -97.84 100.85 12.23 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.672 HD13 ' N ' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -158.64 144.9 17.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.146 -0.971 . . . . 0.0 110.653 -178.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.672 ' N ' HD13 ' A' ' 19' ' ' LEU . 20.1 p-10 -86.4 102.42 14.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 0.0 109.08 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.805 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -122.55 143.01 50.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 110.818 -178.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -100.05 134.51 42.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.418 -0.801 . . . . 0.0 110.092 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.419 ' OD1' ' OE2' ' A' ' 81' ' ' GLU . 2.9 t70 -98.62 147.06 25.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.252 -0.905 . . . . 0.0 110.312 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.497 ' HG3' ' N ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -60.84 -18.65 57.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.921 . . . . 0.0 110.201 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.497 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 4.6 t0 -83.29 -29.08 28.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.148 -0.97 . . . . 0.0 110.15 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.02 -17.49 9.93 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 28' ' ' LYS . 30.2 t70 -58.47 -46.15 87.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.254 -1.145 . . . . 0.0 110.116 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 21' ' ' PHE . 2.1 ttpt 57.88 120.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.456 -0.778 . . . . 0.0 110.434 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.805 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -80.77 134.74 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.202 -0.936 . . . . 0.0 108.804 179.509 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.579 ' O ' HG23 ' A' ' 30' ' ' VAL . 22.8 m -125.96 90.97 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.971 -1.08 . . . . 0.0 110.467 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 42.96 61.57 2.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.0 110.222 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.68 24.14 0.2 Allowed Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.489 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.992 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 1.6 m-20 -88.9 161.15 16.83 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.875 -1.368 . . . . 0.0 110.03 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.499 ' HB3' ' HG3' ' A' ' 16' ' ' LYS . 9.9 pt-20 -159.81 130.97 5.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.251 -0.906 . . . . 0.0 110.575 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.689 ' CZ2' HD12 ' A' ' 15' ' ' LEU . 6.0 p90 -145.64 170.79 15.77 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.376 -0.827 . . . . 0.0 110.228 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.755 HD11 ' CB ' ' A' ' 12' ' ' ALA . 13.6 tp -90.44 156.07 18.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 110.033 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.782 ' HB2' HD21 ' A' ' 15' ' ' LEU . 3.7 t80 -132.76 110.47 10.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -0.872 . . . . 0.0 109.436 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.573 ' HB2' HD13 ' A' ' 97' ' ' LEU . 3.1 tm-20 -91.5 136.5 33.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.298 -0.877 . . . . 0.0 110.094 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.6 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 65.86 46.22 83.59 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.898 ' HG2' HD22 ' A' ' 8' ' ' LEU . 38.7 Cg_endo -66.09 -61.07 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.925 1.487 . . . . 0.0 110.461 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 6' ' ' VAL . . . 43.62 -88.62 0.01 OUTLIER Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.577 ' N ' ' O ' ' A' ' 40' ' ' PRO . 1.4 p -70.39 4.35 2.36 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.31 -1.112 . . . . 0.0 111.658 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.697 ' CE2' HD11 ' A' ' 13' ' ' LEU . 11.1 t80 -68.5 112.26 5.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.609 -1.307 . . . . 0.0 109.976 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.57 HD11 ' CA ' ' A' ' 4' ' ' MET . 4.1 mm -104.13 141.8 23.27 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.345 -0.847 . . . . 0.0 109.737 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.422 ' HD2' HG23 ' A' ' 44' ' ' ILE . 43.0 Cg_endo -70.18 93.35 0.56 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.93 1.49 . . . . 0.0 110.101 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.404 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -102.78 158.9 15.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.272 -0.892 . . . . 0.0 110.604 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -44.56 -35.61 2.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.431 -0.793 . . . . 0.0 110.104 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -45.28 -48.09 12.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.301 -0.874 . . . . 0.0 110.105 179.796 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.554 HG21 ' HH2' ' A' ' 35' ' ' TRP . 0.9 OUTLIER -147.15 173.3 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.267 -0.895 . . . . 0.0 110.077 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.409 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.2 mt-10 -130.66 127.15 38.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.243 -0.911 . . . . 0.0 110.652 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.662 HG23 ' CD1' ' A' ' 13' ' ' LEU . 8.7 p -55.06 128.5 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.185 -0.947 . . . . 0.0 109.456 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.638 HG12 ' HG2' ' A' ' 53' ' ' GLU . 60.2 t -109.84 -61.04 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -0.95 . . . . 0.0 110.907 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 1.007 ' O ' HD13 ' A' ' 54' ' ' ILE . 2.6 mt-10 -124.46 173.96 8.1 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.192 -0.943 . . . . 0.0 110.774 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 1.007 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.1 mm -137.01 155.54 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.667 HD12 ' NE2' ' A' ' 14' ' ' HIS . 1.1 mt -146.82 151.12 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.909 -1.12 . . . . 0.0 111.132 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.479 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 87.5 mm-40 -124.21 170.12 11.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.774 -0.579 . . . . 0.0 110.337 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -86.51 153.85 21.54 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.229 -0.92 . . . . 0.0 110.845 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.523 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER 172.65 29.42 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.073 -1.017 . . . . 0.0 112.621 179.004 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.836 HG22 ' HB3' ' A' ' 96' ' ' TYR . 2.3 tt -161.88 -35.11 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 119.707 -1.871 . . . . 0.0 113.913 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.545 HG23 ' CG ' ' A' ' 64' ' ' GLN . 48.6 mt -75.7 152.49 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.078 -1.639 . . . . 0.0 111.188 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.0 -154.73 0.25 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.556 -0.715 . . . . 0.0 110.18 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.996 ' HA ' HG13 ' A' ' 93' ' ' VAL . 0.7 OUTLIER -82.27 -69.35 0.63 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 110.93 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.561 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 2.2 m-20 -78.49 -8.17 58.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.105 -0.997 . . . . 0.0 110.665 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.545 ' CG ' HG23 ' A' ' 60' ' ' ILE . 5.2 tp-100 -55.32 124.5 17.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.986 -1.071 . . . . 0.0 110.663 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.976 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -108.32 151.04 26.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.308 -0.87 . . . . 0.0 110.232 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.531 HD13 ' HA ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -125.69 121.83 34.58 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.196 -0.94 . . . . 0.0 110.418 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.73 ' HA ' HD22 ' A' ' 89' ' ' LEU . 8.4 mmm180 -93.34 123.91 36.96 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.249 -0.907 . . . . 0.0 110.283 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.629 HD13 ' C ' ' A' ' 103' ' ' GLU . 1.1 mm? -124.99 127.73 47.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.16 -0.963 . . . . 0.0 110.385 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -110.64 165.69 11.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.18 -0.95 . . . . 0.0 110.061 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -76.36 157.82 32.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.084 -1.01 . . . . 0.0 110.649 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.516 ' CB ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -114.59 -38.44 4.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 0.0 109.553 179.53 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -138.82 131.9 29.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.445 -0.784 . . . . 0.0 109.647 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.46 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 1.1 pt-20 -56.55 84.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.113 -0.992 . . . . 0.0 110.13 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' A' ' 72' ' ' LYS . 1.7 m -162.63 -35.33 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.401 -0.812 . . . . 0.0 110.058 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.603 ' CZ2' ' HG2' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -74.1 118.48 17.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.854 . . . . 0.0 110.073 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.406 ' HB3' ' C ' ' A' ' 79' ' ' GLY . 35.7 m-20 -86.86 115.27 24.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.992 . . . . 0.0 110.273 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.603 ' HG2' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -55.48 -55.7 28.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.169 -0.957 . . . . 0.0 110.116 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -105.55 24.22 12.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.245 -0.909 . . . . 0.0 110.066 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.406 ' C ' ' HB3' ' A' ' 76' ' ' ASP . . . 86.73 -10.25 68.4 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 23.9 pttt -87.45 136.97 32.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.391 -1.064 . . . . 0.0 110.161 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.445 ' CB ' ' CD1' ' A' ' 21' ' ' PHE . 3.6 tm-20 -47.14 118.94 2.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -0.913 . . . . 0.0 110.013 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.515 ' CB ' ' OE1' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -131.35 156.96 44.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.102 -0.999 . . . . 0.0 110.66 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.751 HG23 ' H ' ' A' ' 85' ' ' GLY . 23.4 m -86.4 -178.65 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.328 -0.857 . . . . 0.0 110.444 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.824 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 12.5 t -73.61 -6.78 48.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.362 -0.837 . . . . 0.0 109.972 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.751 ' H ' HG23 ' A' ' 83' ' ' VAL . . . -77.03 -24.84 65.56 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.515 ' OE1' ' CB ' ' A' ' 82' ' ' ARG . 4.6 pt-20 -57.11 162.0 2.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.045 -1.268 . . . . 0.0 110.058 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.484 ' CG ' ' O ' ' A' ' 68' ' ' LEU . 6.0 tt0 -159.62 142.49 13.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.185 -0.947 . . . . 0.0 109.877 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.63 ' CZ2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -119.89 148.36 43.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.048 -1.032 . . . . 0.0 110.096 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.031 HD12 HG23 ' A' ' 91' ' ' THR . 1.2 tm? -113.25 128.61 56.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.533 -0.73 . . . . 0.0 110.07 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.847 ' N ' HD13 ' A' ' 89' ' ' LEU . 81.4 t -90.77 102.32 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.854 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 1.031 HG23 HD12 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -109.36 28.5 8.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.404 -0.81 . . . . 0.0 110.348 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.461 HG21 ' HB3' ' A' ' 95' ' ' ALA . 13.9 t -76.22 169.1 18.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 0.0 109.986 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.996 HG13 ' HA ' ' A' ' 62' ' ' GLN . 48.5 t -114.7 107.02 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.187 -0.946 . . . . 0.0 109.985 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.661 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 87.79 78.61 1.26 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 94' ' ' GLY . . . 174.37 -158.53 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.58 -0.953 . . . . 0.0 110.611 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.836 ' HB3' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER 176.21 25.32 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.055 -1.028 . . . . 0.0 111.115 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.697 ' HB2' HD21 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -61.45 110.2 2.88 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.709 -1.244 . . . . 0.0 110.067 179.41 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.665 ' O ' ' HB2' ' A' ' 99' ' ' ALA . 50.5 Cg_endo -79.32 -92.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.921 1.485 . . . . 0.0 110.796 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' A' ' 98' ' ' PRO . . . 171.54 -158.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 0.0 110.146 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.548 ' CG2' ' HA ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -113.36 -59.19 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.18 -0.95 . . . . 0.0 110.043 179.768 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.545 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 17.5 m-30 -99.96 11.8 38.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.069 -1.019 . . . . 0.0 109.457 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 99' ' ' ALA . 6.0 tt0 -96.05 157.59 15.83 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.301 -0.874 . . . . 0.0 110.968 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.629 ' C ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -140.06 128.63 22.92 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.552 -0.718 . . . . 0.0 109.355 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.686 ' C ' HD13 ' A' ' 105' ' ' LEU . 6.9 p -75.58 151.64 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.077 -1.015 . . . . 0.0 110.466 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.749 ' N ' HD22 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -104.14 -24.16 13.2 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.434 -0.792 . . . . 0.0 109.611 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 105' ' ' LEU . 1.0 OUTLIER 172.67 160.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.449 -0.782 . . . . 0.0 109.861 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.6 mp -96.82 134.94 39.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.095 -1.003 . . . . 0.0 109.649 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.976 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 7.0 p -122.01 157.02 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.061 -1.025 . . . . 0.0 110.755 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.52 ' HB3' HG23 ' A' ' 111' ' ' VAL . 1.0 OUTLIER -110.65 131.42 55.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.453 -0.779 . . . . 0.0 109.664 179.447 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . -90.37 34.56 0.87 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.141 -0.974 . . . . 0.0 110.667 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 112' ' ' ILE . 14.3 t -73.44 177.84 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 109.749 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.588 ' H ' HG12 ' A' ' 111' ' ' VAL . 49.7 mt 50.31 32.41 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.097 -1.002 . . . . 0.0 110.021 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.455 ' OXT' ' HG ' ' A' ' 113' ' ' LEU . 31.3 tp . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 118.091 -0.957 . . . . 0.0 110.347 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.65 -164.89 1.92 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.291 -1.123 . . . . 0.0 109.944 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -141.17 32.2 1.74 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.104 -0.997 . . . . 0.0 110.36 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.789 ' HB3' HD12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -91.04 -103.84 0.1 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.333 -0.854 . . . . 0.0 109.955 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 6' ' ' VAL . 48.8 tt0 -105.03 66.85 0.77 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.034 -1.041 . . . . 0.0 109.895 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.509 ' C ' ' HA2' ' A' ' 41' ' ' GLY . 80.6 t -41.57 164.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.362 -0.836 . . . . 0.0 110.467 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.535 ' HA ' ' CA ' ' A' ' 41' ' ' GLY . 33.7 t -37.74 140.89 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.585 -0.697 . . . . 0.0 111.272 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.628 HD23 ' OG1' ' A' ' 11' ' ' THR . 2.7 mp -86.76 168.74 17.07 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.436 -0.79 . . . . 0.0 110.057 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.432 ' O ' ' CB ' ' A' ' 10' ' ' ASN . 47.6 Cg_endo -76.1 59.36 5.89 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.1 1.579 . . . . 0.0 109.944 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.763 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 3.7 m120 65.13 46.24 2.79 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.363 -0.835 . . . . 0.0 109.558 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.628 ' OG1' HD23 ' A' ' 8' ' ' LEU . 17.4 p -134.98 162.13 33.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 110.258 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.776 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -133.68 159.84 39.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.104 -0.997 . . . . 0.0 109.766 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.932 ' CD1' HD22 ' A' ' 15' ' ' LEU . 1.3 pp -133.04 144.96 50.38 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.97 -1.081 . . . . 0.0 110.52 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.678 ' HD2' HG22 ' A' ' 100' ' ' VAL . 29.8 m80 -89.88 131.25 35.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.411 -0.806 . . . . 0.0 109.245 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.031 ' HA ' HG23 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -133.77 158.4 43.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.956 -1.09 . . . . 0.0 110.502 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -106.72 117.78 34.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.422 -0.798 . . . . 0.0 110.571 -179.158 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.04 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -80.49 111.86 17.29 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.366 -0.834 . . . . 0.0 109.693 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.725 HD13 ' HB1' ' A' ' 31' ' ' ALA . 2.4 mm? -103.03 101.47 11.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.673 -0.642 . . . . 0.0 110.359 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.582 HD13 ' H ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -160.88 144.66 13.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.138 -0.976 . . . . 0.0 110.544 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.582 ' H ' HD13 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -82.61 101.62 10.91 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.424 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.88 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -111.01 137.75 48.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.212 -0.93 . . . . 0.0 111.248 -178.355 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.539 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 8.2 tt0 -120.61 118.89 31.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.639 -0.663 . . . . 0.0 110.079 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 27' ' ' ASP . 8.0 t0 -113.09 127.74 56.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.209 -0.932 . . . . 0.0 110.379 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -59.71 -33.19 71.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 110.563 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -121.07 -30.51 4.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.149 -0.969 . . . . 0.0 110.468 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.46 ' C ' ' HB3' ' A' ' 23' ' ' ASP . . . -87.44 39.15 3.11 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 23' ' ' ASP . 4.1 m-20 50.34 -139.83 0.86 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -1.163 . . . . 0.0 110.054 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.539 ' HB2' ' HA ' ' A' ' 22' ' ' GLU . 10.2 ptpt -156.01 150.8 26.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -0.999 . . . . 0.0 110.146 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.9 HG11 ' HB2' ' A' ' 81' ' ' GLU . 1.2 m -110.62 148.07 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.065 -1.022 . . . . 0.0 109.105 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 30' ' ' VAL . 16.5 m -127.9 84.59 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.094 -1.004 . . . . 0.0 110.615 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.725 ' HB1' HD13 ' A' ' 18' ' ' LEU . . . 41.12 70.16 0.28 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.404 -0.81 . . . . 0.0 110.66 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -170.72 22.7 0.08 OUTLIER Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.813 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 1.04 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 3.2 m-20 -88.43 149.33 23.75 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.811 -1.405 . . . . 0.0 109.829 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 68.1 tt0 -148.34 131.09 16.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.784 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.75 ' CZ3' ' HB2' ' A' ' 17' ' ' ALA . 6.3 p90 -151.97 167.22 29.07 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.448 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.658 HD13 ' NE2' ' A' ' 14' ' ' HIS . 16.8 tp -90.84 154.24 19.65 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.549 -0.72 . . . . 0.0 109.846 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.832 ' HB2' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -128.46 109.41 11.38 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.144 -0.972 . . . . 0.0 109.555 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.62 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 5.6 tm-20 -91.92 125.27 36.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.462 -0.774 . . . . 0.0 110.349 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.605 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 62.13 44.83 97.19 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.66 ' HG3' HD23 ' A' ' 13' ' ' LEU . 43.2 Cg_endo -71.08 57.63 2.11 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.681 1.358 . . . . 0.0 109.291 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.535 ' CA ' ' HA ' ' A' ' 7' ' ' VAL . . . -54.21 -14.17 4.29 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.583 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.4 p -136.79 29.24 2.88 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.693 -1.475 . . . . 0.0 111.109 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.791 ' HE2' HG22 ' A' ' 51' ' ' VAL . 15.8 t80 -84.24 111.25 19.22 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.944 -1.102 . . . . 0.0 109.709 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.789 HD12 ' HB3' ' A' ' 4' ' ' MET . 1.7 mm -103.28 138.87 19.66 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 108.963 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.44 ' HD2' HG22 ' A' ' 44' ' ' ILE . 43.6 Cg_endo -69.8 77.26 1.1 Allowed 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 123.847 1.446 . . . . 0.0 110.782 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.435 ' HD2' ' HB ' ' A' ' 44' ' ' ILE . 1.8 mtt180 -93.7 148.83 21.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 110.118 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 48' ' ' GLU . 0.1 OUTLIER -44.77 -34.33 2.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.915 . . . . 0.0 110.301 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.453 ' HG3' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -41.87 -48.38 4.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.603 -0.686 . . . . 0.0 109.585 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.599 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -136.34 173.82 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.388 -0.82 . . . . 0.0 109.09 178.903 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -135.38 129.84 33.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.02 -1.05 . . . . 0.0 110.261 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.791 HG22 ' HE2' ' A' ' 43' ' ' TYR . 19.9 t -54.54 131.17 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.106 -0.996 . . . . 0.0 109.088 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.031 HG23 ' HA ' ' A' ' 15' ' ' LEU . 17.3 t -105.85 -55.55 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.104 -0.997 . . . . 0.0 110.621 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.886 ' C ' HD13 ' A' ' 54' ' ' ILE . 12.8 mm-40 -141.04 166.83 23.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.103 -0.998 . . . . 0.0 110.568 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.886 HD13 ' C ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -133.17 143.26 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.247 -0.908 . . . . 0.0 108.849 179.232 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.776 HG22 ' O ' ' A' ' 12' ' ' ALA . 3.1 tt -140.71 152.11 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.996 -1.065 . . . . 0.0 111.179 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -103.61 179.69 4.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.457 -0.777 . . . . 0.0 110.041 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.763 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -101.97 143.1 32.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.188 -0.945 . . . . 0.0 110.536 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.552 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.8 OUTLIER 174.58 57.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.097 -1.002 . . . . 0.0 111.363 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.728 HG22 HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -161.64 -60.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.503 -1.373 . . . . 0.0 111.776 179.305 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.728 HG13 HG22 ' A' ' 59' ' ' ILE . 1.8 mt -88.82 -144.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 120.169 -1.582 . . . . 0.0 110.377 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.579 ' HA ' ' N ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -165.22 176.66 8.23 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.071 -1.018 . . . . 0.0 110.295 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.805 ' HB2' HG13 ' A' ' 93' ' ' VAL . 17.1 tp60 -68.54 -30.62 69.45 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.139 -0.976 . . . . 0.0 110.217 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 2.5 m120 -69.51 -56.24 7.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.223 -0.923 . . . . 0.0 110.833 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.613 ' HB3' HG22 ' A' ' 60' ' ' ILE . 63.8 tp60 -59.61 140.87 56.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.211 -0.931 . . . . 0.0 110.802 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.072 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -125.27 134.33 52.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.524 -0.735 . . . . 0.0 109.215 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.751 ' O ' HG12 ' A' ' 90' ' ' VAL . 7.9 mp -125.81 118.76 26.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.905 . . . . 0.0 111.028 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.562 ' O ' HD12 ' A' ' 105' ' ' LEU . 8.0 mtt85 -91.7 128.92 37.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.347 -0.846 . . . . 0.0 109.11 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 104' ' ' VAL . 10.7 mt -126.36 153.5 44.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.027 -1.046 . . . . 0.0 110.922 -178.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.481 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 14.4 ttp180 -127.24 157.56 39.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.522 -0.736 . . . . 0.0 110.204 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.51 ' HB2' ' HZ3' ' A' ' 75' ' ' TRP . . . -73.51 141.16 46.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.344 -0.847 . . . . 0.0 111.12 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -107.14 -38.25 6.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.303 -0.873 . . . . 0.0 109.589 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.531 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 9.1 mmtt -98.02 -88.07 0.32 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.356 -0.84 . . . . 0.0 109.922 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' A' ' 72' ' ' LYS . 4.1 pt-20 164.24 -37.25 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.727 0.775 . . . . 0.0 108.948 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' ' 33' ' ' ASP . 1.3 m -56.42 -29.75 61.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.498 -0.751 . . . . 0.0 110.336 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.602 ' HA ' ' HB3' ' A' ' 35' ' ' TRP . 16.8 t90 -76.98 103.81 7.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.167 -0.958 . . . . 0.0 110.087 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 76' ' ' ASP . 1.8 p30 -101.92 114.24 28.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 110.123 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.529 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . 4.9 ppt_? -77.22 -22.15 52.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.29 -0.881 . . . . 0.0 110.33 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.412 ' N ' ' HG3' ' A' ' 77' ' ' ARG . 1.9 t0 -95.25 -19.21 20.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 110.236 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.25 24.66 11.11 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.514 ' O ' ' C ' ' A' ' 81' ' ' GLU . 1.4 mttt -137.14 52.63 1.91 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.243 -1.151 . . . . 0.0 110.155 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.9 ' HB2' HG11 ' A' ' 29' ' ' VAL . 2.2 pm0 26.46 94.84 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.259 0.552 . . . . 0.0 111.336 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.523 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 4.4 mpt_? -103.94 179.68 4.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 110.222 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.534 HG23 ' H ' ' A' ' 85' ' ' GLY . 27.5 m -103.37 178.47 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -0.916 . . . . 0.0 110.144 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 70' ' ' ALA . 2.8 t -59.19 -15.66 16.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 110.203 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.534 ' H ' HG23 ' A' ' 83' ' ' VAL . . . -74.2 -39.17 45.15 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.523 ' CB ' ' HB3' ' A' ' 82' ' ' ARG . 19.4 tp10 -54.09 151.74 6.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -1.127 . . . . 0.0 109.957 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 19.5 pt-20 -159.36 173.85 15.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.173 -0.954 . . . . 0.0 110.436 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.575 ' CD1' ' OE1' ' A' ' 102' ' ' GLU . 0.6 OUTLIER -161.08 160.82 30.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.898 . . . . 0.0 110.103 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.012 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -108.34 138.04 45.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.324 -0.86 . . . . 0.0 110.195 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 1.012 ' N ' HD22 ' A' ' 89' ' ' LEU . 7.3 p -108.61 140.76 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -0.929 . . . . 0.0 110.451 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.4 t -157.55 50.39 0.44 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.393 -0.817 . . . . 0.0 110.261 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 m -75.27 157.9 33.71 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.198 -0.938 . . . . 0.0 110.071 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.805 HG13 ' HB2' ' A' ' 62' ' ' GLN . 2.6 t -77.69 72.89 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.244 -0.91 . . . . 0.0 110.122 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.597 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 87.86 107.04 0.95 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.604 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . . . 179.88 169.33 1.2 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -1.1 . . . . 0.0 110.385 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.489 ' HB2' ' HB ' ' A' ' 59' ' ' ILE . 2.0 t80 -129.57 88.33 2.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.769 -0.582 . . . . 0.0 110.054 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.651 HD22 ' CB ' ' A' ' 12' ' ' ALA . 17.0 mt -119.12 86.23 31.67 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.157 -0.964 . . . . 0.0 110.479 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.473 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 50.0 Cg_endo -79.69 9.26 3.57 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.884 1.465 . . . . 0.0 110.648 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.558 ' CB ' ' HB3' ' A' ' 102' ' ' GLU . . . 58.07 -175.27 0.08 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.15 -0.969 . . . . 0.0 110.063 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.678 HG22 ' HD2' ' A' ' 14' ' ' HIS . 2.8 t -109.44 -55.69 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.078 -1.014 . . . . 0.0 110.532 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.588 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 23.0 m-85 -107.6 9.76 29.29 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.076 -1.015 . . . . 0.0 110.152 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.579 ' OE1' ' CZ2' ' A' ' 75' ' ' TRP . 12.6 tt0 -105.05 153.49 21.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 111.575 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -131.05 167.3 19.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.475 -0.766 . . . . 0.0 110.083 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.726 ' HA ' HD23 ' A' ' 68' ' ' LEU . 7.3 p -92.55 143.36 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.107 -0.996 . . . . 0.0 110.692 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.562 HD12 ' O ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -105.02 -19.39 13.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.406 -0.809 . . . . 0.0 110.114 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -169.6 179.71 3.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.221 -0.925 . . . . 0.0 110.324 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.875 HD22 ' O ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -138.99 141.25 38.35 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.125 -0.984 . . . . 0.0 110.612 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.072 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 8.8 p -139.51 116.7 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.94 -1.1 . . . . 0.0 110.771 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 31.1 t0 -86.81 117.4 25.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.048 -1.033 . . . . 0.0 110.119 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . -67.42 158.87 30.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 110.266 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.2 m -67.42 -152.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 110.415 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.6 pt -101.78 153.76 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.268 -0.895 . . . . 0.0 110.394 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.5 tt . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.189 -179.951 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 1' ' ' GLY . 0.1 OUTLIER 43.26 -166.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -1.133 . . . . 0.0 110.164 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -151.06 -164.1 1.93 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.316 -0.865 . . . . 0.0 110.019 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.9 ttt -67.81 160.47 28.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.147 -0.971 . . . . 0.0 109.947 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -123.39 155.54 37.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.327 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.75 -162.78 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.497 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.458 ' HA ' ' HA2' ' A' ' 41' ' ' GLY . 60.5 t -87.9 84.1 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 110.482 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.808 HD23 ' OG1' ' A' ' 11' ' ' THR . 0.1 OUTLIER -47.07 160.54 0.34 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.399 -0.813 . . . . 0.0 109.988 179.588 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.02 -47.81 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.861 1.453 . . . . 0.0 110.402 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.759 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 5.4 m120 -162.67 31.95 0.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.195 -0.94 . . . . 0.0 110.142 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.808 ' OG1' HD23 ' A' ' 8' ' ' LEU . 14.1 p -104.8 166.62 10.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.31 -0.869 . . . . 0.0 110.171 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.783 ' HB2' HD21 ' A' ' 97' ' ' LEU . . . -144.74 160.07 41.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.026 -1.046 . . . . 0.0 110.471 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.846 HD11 HD11 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -133.16 151.11 51.98 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.09 -1.006 . . . . 0.0 109.646 179.509 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.724 ' CE1' HD13 ' A' ' 36' ' ' LEU . 65.7 m80 -95.36 127.21 41.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 0.0 110.582 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.847 ' N ' HD22 ' A' ' 15' ' ' LEU . 1.7 mm? -113.95 152.17 31.24 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.517 -0.739 . . . . 0.0 110.277 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.54 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -108.09 115.89 30.95 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.19 -0.944 . . . . 0.0 108.707 178.049 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.769 ' HA ' HG12 ' A' ' 49' ' ' VAL . . . -78.6 111.26 14.49 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.941 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 48' ' ' GLU . 51.1 mt -98.11 100.95 12.3 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.251 0.548 . . . . 0.0 109.982 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.68 HD13 ' N ' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -159.47 134.0 7.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 110.129 -179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.68 ' N ' HD13 ' A' ' 19' ' ' LEU . 9.5 m-20 -75.68 101.63 5.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.034 -1.042 . . . . 0.0 109.715 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.817 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -125.67 80.74 1.92 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.844 . . . . 0.0 110.435 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.49 ' OE2' ' CG1' ' A' ' 30' ' ' VAL . 0.7 OUTLIER -100.88 114.53 28.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.0 109.691 179.558 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.51 177.31 8.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 110.515 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -54.91 -16.4 2.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.425 -0.797 . . . . 0.0 110.462 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -61.9 -36.0 80.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.135 -0.978 . . . . 0.0 110.092 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.13 -20.78 46.0 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.98 73.59 1.47 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.144 -1.21 . . . . 0.0 110.643 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 21' ' ' PHE . 20.5 tptp -107.67 -119.06 0.25 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.313 -0.867 . . . . 0.0 109.72 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.817 HG22 ' CB ' ' A' ' 21' ' ' PHE . 1.5 m -109.1 140.03 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 120.724 -1.235 . . . . 0.0 109.55 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.614 ' O ' HG23 ' A' ' 30' ' ' VAL . 27.2 m -140.57 83.55 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.165 -0.96 . . . . 0.0 110.188 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.52 70.97 0.37 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.507 -0.745 . . . . 0.0 110.565 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.54 27.92 0.03 OUTLIER Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.34 -1.41 . . . . 0.0 110.892 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.552 ' O ' ' N ' ' A' ' 17' ' ' ALA . 2.2 m-20 -94.13 156.45 16.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.664 -1.492 . . . . 0.0 110.002 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 16.5 tt0 -148.61 145.34 27.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.011 -1.055 . . . . 0.0 110.525 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.572 ' CZ2' ' HB2' ' A' ' 15' ' ' LEU . 12.5 p90 -149.95 166.89 28.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.362 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.724 HD13 ' CE1' ' A' ' 14' ' ' HIS . 53.6 tp -96.47 151.81 19.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.188 -0.945 . . . . 0.0 109.953 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.805 ' HB3' HD23 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -130.77 115.53 16.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.034 -1.041 . . . . 0.0 110.493 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.508 ' HB2' ' CD2' ' A' ' 97' ' ' LEU . 2.6 tm-20 -96.95 120.99 38.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.536 -0.728 . . . . 0.0 110.326 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.579 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 72.82 46.39 30.15 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 41.6 Cg_endo -66.44 61.29 0.52 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.884 1.465 . . . . 0.0 110.54 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.547 ' C ' ' O ' ' A' ' 40' ' ' PRO . . . -19.0 -92.1 0.01 OUTLIER Glycine 0 N--CA 1.501 2.977 0 N-CA-C 111.491 -0.643 . . . . 0.0 111.491 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.9 p -109.96 49.01 0.86 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.041 -1.27 . . . . 0.0 110.365 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.664 ' OH ' HD12 ' A' ' 15' ' ' LEU . 30.9 t80 -69.83 130.22 41.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.041 -1.037 . . . . 0.0 110.358 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.66 HG23 ' HD2' ' A' ' 45' ' ' PRO . 5.5 mt -124.94 145.29 49.61 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.356 -0.84 . . . . 0.0 109.591 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.66 ' HD2' HG23 ' A' ' 44' ' ' ILE . 45.8 Cg_endo -71.43 90.8 0.68 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.987 1.519 . . . . 0.0 110.584 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 49' ' ' VAL . 3.9 mtp180 -98.21 152.64 19.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.294 -0.879 . . . . 0.0 110.03 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 46' ' ' ARG . 32.0 tttm -41.49 -31.55 0.27 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.288 -0.883 . . . . 0.0 110.479 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 18' ' ' LEU . 16.7 tt0 -53.82 -41.41 67.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.128 -0.983 . . . . 0.0 109.923 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.769 HG12 ' HA ' ' A' ' 17' ' ' ALA . 2.1 m -145.7 171.27 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.636 -0.665 . . . . 0.0 109.386 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.21 140.58 47.61 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.684 -1.26 . . . . 0.0 111.125 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.554 HG23 ' HB3' ' A' ' 45' ' ' PRO . 24.9 t -56.53 123.23 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 109.067 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.54 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 7.2 t -105.1 -60.32 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.118 -0.989 . . . . 0.0 110.729 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.888 ' O ' HD13 ' A' ' 54' ' ' ILE . 27.1 mm-40 -138.06 162.61 33.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 110.394 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.888 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -134.49 137.96 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.318 -0.864 . . . . 0.0 109.325 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.804 HD13 ' O ' ' A' ' 96' ' ' TYR . 1.0 OUTLIER -137.37 142.19 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.92 -1.113 . . . . 0.0 111.573 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.526 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 4.0 mm100 -90.67 -179.65 5.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.382 -0.823 . . . . 0.0 109.299 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.84 ' HB1' ' O ' ' A' ' 94' ' ' GLY . . . -98.41 124.07 42.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.788 -1.195 . . . . 0.0 110.667 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.458 ' O ' HG12 ' A' ' 59' ' ' ILE . 10.1 t -172.12 49.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.443 -0.786 . . . . 0.0 109.818 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.813 HG22 ' N ' ' A' ' 60' ' ' ILE . 0.7 OUTLIER -150.5 -75.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.083 -1.01 . . . . 0.0 111.533 -179.077 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.813 ' N ' HG22 ' A' ' 59' ' ' ILE . 10.0 mt -92.47 125.28 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.905 -1.122 . . . . 0.0 111.534 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.569 ' HA ' ' N ' ' A' ' 94' ' ' GLY . 0.1 OUTLIER -68.66 -165.73 0.07 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.45 -0.781 . . . . 0.0 110.351 179.564 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.788 ' HB3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -91.62 -12.97 32.71 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.142 -0.974 . . . . 0.0 111.023 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.626 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 0.9 OUTLIER -87.66 -54.28 4.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.024 -1.047 . . . . 0.0 109.522 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.447 ' HB3' ' HG2' ' A' ' 61' ' ' ARG . 4.1 tp-100 -57.49 128.39 36.8 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.229 -0.919 . . . . 0.0 110.199 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.978 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -107.8 139.72 41.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.293 -0.879 . . . . 0.0 108.888 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.616 ' O ' HG12 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -120.84 124.72 45.73 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.198 -0.939 . . . . 0.0 110.876 -179.015 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.759 ' O ' HD23 ' A' ' 68' ' ' LEU . 1.4 mtm180 -90.3 126.53 35.88 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.395 -0.816 . . . . 0.0 109.055 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.759 HD23 ' O ' ' A' ' 67' ' ' ARG . 14.2 mt -120.01 147.34 44.91 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.216 -0.994 . . . . 0.0 111.702 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.662 ' HB2' HD21 ' A' ' 105' ' ' LEU . 12.4 ttm180 -126.44 162.74 24.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.552 -0.717 . . . . 0.0 110.241 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . -78.67 153.28 31.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.22 -0.925 . . . . 0.0 110.619 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.503 ' CZ ' ' HG3' ' A' ' 103' ' ' GLU . 19.8 tpp85 -126.84 -31.14 2.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.886 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 20.9 tptm -121.34 128.85 52.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.759 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.486 ' HA ' ' N ' ' A' ' 84' ' ' THR . 6.5 pt-20 -67.06 58.38 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.195 -0.941 . . . . 0.0 110.401 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -149.62 -24.37 0.27 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.367 -0.833 . . . . 0.0 110.977 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.604 ' CZ2' ' HG2' ' A' ' 77' ' ' ARG . 1.2 t90 -73.87 117.34 15.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.972 -1.08 . . . . 0.0 109.72 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.437 ' HA ' ' HB2' ' A' ' 82' ' ' ARG . 6.1 m-20 -81.53 117.33 21.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.325 -0.859 . . . . 0.0 110.893 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.604 ' HG2' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -81.74 -45.94 14.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.343 -0.848 . . . . 0.0 109.606 179.25 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.68 -1.85 36.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.364 -0.835 . . . . 0.0 110.331 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.3 -35.11 5.02 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -78.94 -103.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.295 -1.121 . . . . 0.0 110.12 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.451 ' CD ' HG21 ' A' ' 29' ' ' VAL . 71.8 mm-40 -137.93 127.26 24.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.929 -1.107 . . . . 0.0 109.837 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.437 ' HB2' ' HA ' ' A' ' 76' ' ' ASP . 18.5 mmt180 -131.42 171.97 12.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.235 -0.916 . . . . 0.0 110.4 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.612 HG22 ' N ' ' A' ' 84' ' ' THR . 2.3 p -116.01 171.61 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -0.819 . . . . 0.0 110.062 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.612 ' N ' HG22 ' A' ' 83' ' ' VAL . 13.6 t -57.13 -164.23 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.25 -0.98 . . . . 0.0 108.563 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 86' ' ' GLU . . . 68.65 -58.89 0.48 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.52 ' O ' ' CB ' ' A' ' 70' ' ' ALA . 1.9 tp10 -43.89 151.38 0.21 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -1.141 . . . . 0.0 109.103 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.545 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 5.8 pt-20 -145.16 160.04 42.06 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.205 -0.934 . . . . 0.0 110.741 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.565 ' CE2' ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -135.43 156.72 48.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.472 -0.768 . . . . 0.0 109.286 179.43 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.882 HD23 ' H ' ' A' ' 90' ' ' VAL . 1.1 tt -113.43 160.42 18.45 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.808 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.882 ' H ' HD23 ' A' ' 89' ' ' LEU . 2.4 p -135.7 123.86 37.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.148 -0.97 . . . . 0.0 110.588 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.19 32.27 4.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.453 -0.779 . . . . 0.0 109.474 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.462 ' O ' ' O ' ' A' ' 61' ' ' ARG . 11.8 t -76.02 171.66 14.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.41 -0.806 . . . . 0.0 110.467 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.788 HG22 ' HB3' ' A' ' 62' ' ' GLN . 2.3 t -80.49 -172.48 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.393 -0.817 . . . . 0.0 110.207 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.84 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . -33.61 96.92 0.01 OUTLIER Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . . . -163.7 148.96 10.9 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.17 -1.194 . . . . 0.0 111.731 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.804 ' O ' HD13 ' A' ' 55' ' ' ILE . 8.4 t80 -109.03 110.37 21.63 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.783 HD21 ' HB2' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -127.78 66.11 69.79 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.027 -1.045 . . . . 0.0 111.236 -178.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.522 ' HG3' ' CZ ' ' A' ' 96' ' ' TYR . 45.2 Cg_endo -74.03 89.66 1.02 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.005 1.529 . . . . 0.0 109.651 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 1.026 ' HB3' ' HB3' ' A' ' 102' ' ' GLU . . . -45.63 149.57 0.58 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.286 -0.884 . . . . 0.0 111.232 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.752 HG23 ' H ' ' A' ' 101' ' ' PHE . 2.3 m -52.16 -69.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.61 -0.681 . . . . 0.0 110.66 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.752 ' H ' HG23 ' A' ' 100' ' ' VAL . 7.0 m-85 -99.73 62.03 1.17 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.821 -1.175 . . . . 0.0 109.674 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 1.026 ' HB3' ' HB3' ' A' ' 99' ' ' ALA . 4.0 tt0 -140.5 147.99 40.4 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.047 -1.033 . . . . 0.0 110.98 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.503 ' HG3' ' CZ ' ' A' ' 71' ' ' ARG . 1.3 mm-40 -132.15 150.89 52.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.501 -0.749 . . . . 0.0 109.679 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.686 ' C ' HD23 ' A' ' 105' ' ' LEU . 4.8 m -83.66 149.04 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.113 -0.992 . . . . 0.0 110.349 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.703 ' N ' HD23 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -103.19 -10.96 18.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.425 -0.797 . . . . 0.0 109.287 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER 163.58 172.05 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.662 -0.649 . . . . 0.0 109.767 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.2 mp -116.43 123.23 47.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.169 -0.957 . . . . 0.0 109.766 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.978 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 13.6 p -116.56 155.48 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.029 -1.044 . . . . 0.0 110.681 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -110.05 120.85 43.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.385 -0.822 . . . . 0.0 109.571 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . -59.11 131.06 49.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.296 -0.878 . . . . 0.0 110.937 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.64 ' C ' HD12 ' A' ' 112' ' ' ILE . 40.7 t 56.02 160.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.855 . . . . 0.0 110.782 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.64 HD12 ' C ' ' A' ' 111' ' ' VAL . 3.5 mp -149.41 -69.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.499 -0.751 . . . . 0.0 109.908 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.614 HD12 ' O ' ' A' ' 112' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.113 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 t -114.41 -25.45 8.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.188 -1.184 . . . . 0.0 110.167 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -99.83 -80.9 0.47 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.874 . . . . 0.0 110.143 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 44.5 ttm -45.99 160.53 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.451 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.435 ' O ' ' O ' ' A' ' 41' ' ' GLY . 1.2 tt0 -118.06 -174.15 2.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.886 . . . . 0.0 109.905 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.512 ' O ' ' CD1' ' A' ' 8' ' ' LEU . 67.4 t -128.54 147.61 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 109.741 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.513 ' HA ' ' CA ' ' A' ' 41' ' ' GLY . 10.6 t -43.44 120.58 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.074 -1.016 . . . . 0.0 110.098 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.536 HD23 ' OG1' ' A' ' 11' ' ' THR . 4.0 mp -76.53 164.84 57.11 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.441 -0.787 . . . . 0.0 110.361 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 10' ' ' ASN . 46.2 Cg_endo -75.57 70.31 5.72 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 124.121 1.59 . . . . 0.0 109.914 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 1.045 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 11.6 m-20 58.42 55.84 4.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.382 -0.824 . . . . 0.0 110.397 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.536 ' OG1' HD23 ' A' ' 8' ' ' LEU . 6.2 p -136.38 171.48 14.43 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.066 -1.022 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.581 ' HB2' HD22 ' A' ' 97' ' ' LEU . . . -145.37 158.06 43.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.203 -0.936 . . . . 0.0 110.719 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.822 ' CD2' HD21 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -130.49 154.85 47.34 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.391 -0.818 . . . . 0.0 109.268 179.119 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.635 ' O ' HD13 ' A' ' 15' ' ' LEU . 40.7 m80 -94.79 131.63 40.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.975 . . . . 0.0 110.209 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.828 ' N ' HD22 ' A' ' 15' ' ' LEU . 1.7 mm? -120.02 140.34 51.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.634 -0.666 . . . . 0.0 109.962 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.563 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 4.8 ttmt -95.82 117.09 29.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.965 -1.084 . . . . 0.0 109.174 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.84 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -81.78 105.73 13.15 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 110.591 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.664 HD13 ' CA ' ' A' ' 31' ' ' ALA . 1.9 mm? -99.08 101.53 12.92 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.48 HD13 ' CG ' ' A' ' 48' ' ' GLU . 5.0 tp -161.77 148.6 14.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.089 -1.007 . . . . 0.0 110.696 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.64 115.68 22.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.369 -0.832 . . . . 0.0 109.037 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.943 ' HB2' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -134.34 70.04 1.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.982 -1.074 . . . . 0.0 110.988 -179.055 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 1.5 tt0 -92.94 111.61 23.28 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.878 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 27' ' ' ASP . 0.7 OUTLIER -125.61 152.08 45.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.503 -0.748 . . . . 0.0 110.413 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.01 4.32 54.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.137 -0.977 . . . . 0.0 109.894 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.467 ' OD1' ' HB3' ' A' ' 23' ' ' ASP . 3.6 p-10 -100.92 -36.47 9.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 0.0 110.618 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.78 -40.51 0.08 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 23' ' ' ASP . 2.1 m-20 -68.79 131.6 45.42 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.21 -1.17 . . . . 0.0 109.857 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -166.49 63.18 0.1 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.237 -0.915 . . . . 0.0 110.86 -179.199 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.943 HG22 ' HB2' ' A' ' 21' ' ' PHE . 1.0 OUTLIER -108.07 160.88 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.18 -0.95 . . . . 0.0 109.74 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.617 ' O ' HG23 ' A' ' 30' ' ' VAL . 26.9 m -139.06 85.11 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.017 -1.052 . . . . 0.0 110.549 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.664 ' CA ' HD13 ' A' ' 18' ' ' LEU . . . 40.22 76.35 0.07 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.544 -0.722 . . . . 0.0 110.667 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.99 31.8 0.03 OUTLIER Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.359 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.84 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 13.0 m-20 -99.55 155.56 17.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.934 -1.333 . . . . 0.0 110.377 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.652 ' OE2' HG11 ' A' ' 52' ' ' VAL . 9.8 tt0 -151.51 134.76 15.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.376 -0.827 . . . . 0.0 109.9 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.538 ' CZ3' ' HB2' ' A' ' 17' ' ' ALA . 7.8 p90 -148.29 167.67 24.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.172 -0.955 . . . . 0.0 110.679 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.554 HD21 ' HA ' ' A' ' 97' ' ' LEU . 44.5 tp -97.5 153.32 18.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.329 -0.857 . . . . 0.0 109.772 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.529 ' HB3' HD23 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -138.14 110.5 7.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.143 -0.973 . . . . 0.0 109.919 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.557 ' HB3' HD22 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -97.2 138.17 35.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.334 -0.854 . . . . 0.0 110.44 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.619 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 72.25 40.8 54.85 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 54.0 Cg_endo -78.12 47.9 2.51 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.23 1.121 . . . . 0.0 109.828 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.513 ' CA ' ' HA ' ' A' ' 7' ' ' VAL . . . -42.78 -31.86 1.24 Allowed Glycine 0 N--CA 1.49 2.278 0 O-C-N 121.53 -0.731 . . . . 0.0 111.277 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.621 ' O ' HD12 ' A' ' 44' ' ' ILE . 6.7 p -136.46 42.92 2.5 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.82 -1.4 . . . . 0.0 111.02 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.558 ' CZ ' ' HG ' ' A' ' 15' ' ' LEU . 14.7 t80 -79.75 111.99 16.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.106 -0.996 . . . . 0.0 109.654 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.621 HD12 ' O ' ' A' ' 42' ' ' THR . 3.6 mp -96.04 133.37 25.31 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 0.0 109.992 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.17 96.82 0.89 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.907 1.477 . . . . 0.0 110.442 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 -104.12 159.41 15.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 110.282 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.86 -28.52 6.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.146 -0.971 . . . . 0.0 110.419 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.48 ' CG ' HD13 ' A' ' 19' ' ' LEU . 7.2 tt0 -50.36 -39.85 47.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.17 -0.956 . . . . 0.0 110.077 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.77 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.6 m -141.79 173.65 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.426 -0.796 . . . . 0.0 109.998 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.52 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.7 mt-10 -132.61 137.09 46.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.107 -0.996 . . . . 0.0 110.349 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 51' ' ' VAL . 21.3 t -54.52 132.53 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.971 . . . . 0.0 109.335 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.939 HG12 ' HG2' ' A' ' 53' ' ' GLU . 97.2 t -118.57 -59.54 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.96 -1.088 . . . . 0.0 110.932 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.939 ' HG2' HG12 ' A' ' 52' ' ' VAL . 43.2 mm-40 -137.21 164.53 28.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.058 -1.026 . . . . 0.0 111.273 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.774 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -136.46 137.97 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.832 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.569 HD13 ' N ' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -138.41 137.15 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.806 -1.184 . . . . 0.0 111.466 -178.671 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.569 ' N ' HD13 ' A' ' 55' ' ' ILE . 1.3 mp0 -93.03 167.09 12.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.621 -0.674 . . . . 0.0 110.065 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.045 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -82.72 140.1 33.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 0.0 110.265 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 4.4 t 179.87 39.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.01 -1.056 . . . . 0.0 111.719 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.835 HG23 ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER -161.05 -70.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.468 -1.395 . . . . 0.0 111.838 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.711 ' H ' HG23 ' A' ' 59' ' ' ILE . 4.2 mm -41.86 164.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.903 -1.123 . . . . 0.0 110.297 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.43 ' N ' ' CG2' ' A' ' 60' ' ' ILE . 2.6 mpt_? -94.3 -164.12 1.13 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.101 -0.999 . . . . 0.0 110.989 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.983 ' HA ' HG13 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -67.05 -68.01 0.41 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 111.352 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.647 ' CB ' ' HB3' ' A' ' 110' ' ' ALA . 52.3 m-20 -113.22 24.6 12.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.924 -1.11 . . . . 0.0 111.23 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -61.95 133.6 55.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.867 -1.146 . . . . 0.0 109.282 178.744 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.5 ' O ' ' HB ' ' A' ' 108' ' ' VAL . . . -109.51 128.44 55.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.852 -1.155 . . . . 0.0 110.181 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.659 ' O ' HD22 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -126.28 127.3 45.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.93 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.796 ' C ' HD22 ' A' ' 68' ' ' LEU . 10.8 mtt180 -90.85 130.89 36.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.601 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.963 HD12 ' OE1' ' A' ' 102' ' ' GLU . 4.2 mm? -116.78 130.43 56.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 111.035 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 1.9 ttt180 -107.16 156.68 18.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.578 -0.701 . . . . 0.0 109.633 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -88.66 142.14 27.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.201 -0.937 . . . . 0.0 110.543 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -115.05 -17.33 11.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.347 -0.846 . . . . 0.0 109.697 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -132.96 116.4 16.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.49 -0.756 . . . . 0.0 109.988 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.67 ' HG3' HG12 ' A' ' 83' ' ' VAL . 1.2 tm-20 -62.16 103.32 0.37 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 110.318 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER 167.1 -25.04 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.294 -0.879 . . . . 0.0 110.028 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.579 ' CZ2' ' HB3' ' A' ' 77' ' ' ARG . 1.3 t90 -75.14 105.26 6.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.363 -0.836 . . . . 0.0 110.375 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.412 ' OD1' ' HB3' ' A' ' 35' ' ' TRP . 16.0 p-10 -87.36 109.55 19.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.181 -0.949 . . . . 0.0 109.767 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.579 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -89.77 -13.65 36.24 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.215 -0.928 . . . . 0.0 110.587 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.437 ' OD2' ' NH1' ' A' ' 77' ' ' ARG . 0.2 OUTLIER -124.88 13.33 8.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.986 -1.071 . . . . 0.0 110.267 179.675 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.78 21.23 78.91 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 15.5 mmmt -119.79 -7.31 10.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.174 -1.192 . . . . 0.0 110.012 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.487 ' HB3' HG11 ' A' ' 29' ' ' VAL . 25.3 mm-40 60.66 124.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.358 -0.839 . . . . 0.0 110.234 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -141.66 179.52 6.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.303 -0.873 . . . . 0.0 110.356 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.856 HG23 ' H ' ' A' ' 85' ' ' GLY . 6.3 m -96.16 -178.59 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.223 -0.923 . . . . 0.0 111.245 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.555 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 25.7 p -57.2 -23.07 45.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.467 -0.77 . . . . 0.0 110.545 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.856 ' H ' HG23 ' A' ' 83' ' ' VAL . . . -65.18 -25.7 71.18 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 82' ' ' ARG . 6.1 pt-20 -65.58 153.11 42.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.357 -1.084 . . . . 0.0 110.632 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.12 147.8 18.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.483 -0.76 . . . . 0.0 109.635 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.898 ' CE2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -134.59 144.76 48.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.997 -1.064 . . . . 0.0 110.381 -179.8 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.796 HD13 ' C ' ' A' ' 89' ' ' LEU . 1.3 tm? -94.65 139.03 31.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.427 -0.796 . . . . 0.0 110.254 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.898 HG22 ' CE2' ' A' ' 88' ' ' TRP . 12.1 t -112.98 131.81 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.199 -0.938 . . . . 0.0 110.722 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.757 ' OG1' HD11 ' A' ' 89' ' ' LEU . 16.6 m -135.55 45.57 2.44 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.578 -0.701 . . . . 0.0 109.679 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.543 ' OG1' HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -82.2 128.67 34.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.899 . . . . 0.0 110.736 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.983 HG13 ' HA ' ' A' ' 62' ' ' GLN . 47.2 t -70.31 114.3 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.568 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.623 ' O ' ' HB2' ' A' ' 95' ' ' ALA . . . 56.96 97.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.835 ' O ' HG23 ' A' ' 59' ' ' ILE . . . 174.88 -176.88 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.108 -1.23 . . . . 0.0 110.606 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.77 ' CD2' HG21 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -147.35 101.99 3.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.3 -0.875 . . . . 0.0 110.499 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.581 HD22 ' HB2' ' A' ' 12' ' ' ALA . 18.7 mt -126.33 71.22 70.91 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.116 -0.99 . . . . 0.0 110.025 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.482 ' HD3' ' CD1' ' A' ' 96' ' ' TYR . 50.5 Cg_endo -81.84 17.29 1.56 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.996 1.524 . . . . 0.0 110.965 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.92 ' HB3' ' CG ' ' A' ' 102' ' ' GLU . . . 43.48 -164.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.12 -0.987 . . . . 0.0 110.674 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.53 ' CG2' ' HA ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -115.92 -44.85 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.191 -0.943 . . . . 0.0 111.656 -178.816 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.567 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 23.1 m-85 -110.59 40.94 1.88 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.617 -1.302 . . . . 0.0 111.977 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.963 ' OE1' HD12 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -141.9 165.33 27.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.722 -1.236 . . . . 0.0 110.62 179.18 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.538 ' C ' HD13 ' A' ' 68' ' ' LEU . 1.9 tt0 -131.26 158.83 39.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.418 -0.801 . . . . 0.0 109.905 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.734 HG12 HD11 ' A' ' 68' ' ' LEU . 6.3 m -82.05 142.17 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.058 -1.027 . . . . 0.0 110.451 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.601 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 4.4 mp -90.58 -14.49 32.39 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.371 -0.831 . . . . 0.0 109.271 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 1.0 OUTLIER 163.85 -172.75 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.633 -0.667 . . . . 0.0 109.918 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 0.7 OUTLIER -125.8 130.98 52.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.12 -0.987 . . . . 0.0 110.073 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.739 HG21 ' NH1' ' A' ' 67' ' ' ARG . 24.2 t -123.81 148.89 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.133 -0.979 . . . . 0.0 110.877 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -112.16 113.23 25.37 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.27 -0.894 . . . . 0.0 108.882 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.647 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . . . -63.4 105.68 0.79 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.745 -1.222 . . . . 0.0 109.829 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.1 p -114.22 4.36 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 110.186 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 112' ' ' ILE . 38.6 mm -52.49 89.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.408 -0.807 . . . . 0.0 110.369 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 111' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.175 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.54 87.96 2.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -1.178 . . . . 0.0 110.106 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -174.16 131.52 0.39 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.329 -0.857 . . . . 0.0 110.185 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.5 mtp -78.63 158.79 28.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.344 -0.847 . . . . 0.0 109.996 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.623 ' OE1' HD11 ' A' ' 8' ' ' LEU . 1.9 mt-30 -142.43 104.06 4.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.131 -0.981 . . . . 0.0 110.625 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 5' ' ' GLN . 8.2 p -45.05 165.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 0.0 109.718 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.482 HG13 ' HA2' ' A' ' 41' ' ' GLY . 13.8 t -54.08 125.27 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.076 -1.015 . . . . 0.0 110.169 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.623 HD11 ' OE1' ' A' ' 5' ' ' GLN . 6.5 mp -71.65 162.95 70.27 Favored Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 109.919 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.69 -89.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.926 1.488 . . . . 0.0 110.17 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.795 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 72.9 m-80 -128.64 25.02 5.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.962 . . . . 0.0 110.015 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.842 HG22 ' H ' ' A' ' 57' ' ' ALA . 27.4 p -104.48 170.6 7.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.316 -0.865 . . . . 0.0 110.077 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.585 ' HB2' ' HA ' ' A' ' 38' ' ' GLU . . . -139.75 161.86 36.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.217 -0.927 . . . . 0.0 110.117 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.056 ' CD2' HD21 ' A' ' 15' ' ' LEU . 0.6 OUTLIER -132.77 155.58 48.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.942 . . . . 0.0 110.021 179.781 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.689 ' C ' HD22 ' A' ' 15' ' ' LEU . 42.9 m80 -90.96 129.16 37.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.165 -0.959 . . . . 0.0 110.555 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.056 HD21 ' CD2' ' A' ' 13' ' ' LEU . 2.2 mm? -120.11 146.74 45.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.665 -0.647 . . . . 0.0 110.231 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.541 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -110.78 116.28 31.01 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.187 -0.945 . . . . 0.0 108.592 178.044 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.057 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -75.3 115.47 14.97 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.157 -0.964 . . . . 0.0 110.135 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.624 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.6 mt -103.26 99.84 9.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.701 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.809 ' C ' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -167.57 165.99 14.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.026 -1.046 . . . . 0.0 110.559 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.523 ' N ' HD22 ' A' ' 19' ' ' LEU . 11.6 t70 -98.27 103.12 15.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.734 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.989 ' CB ' HG22 ' A' ' 29' ' ' VAL . 1.9 t80 -101.01 101.78 12.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 109.923 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -85.48 118.98 25.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.395 -0.816 . . . . 0.0 110.146 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.467 ' OD2' ' HB2' ' A' ' 25' ' ' ASP . 2.4 t70 -118.62 132.73 56.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.917 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 tttp -71.98 -23.54 61.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 110.161 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.467 ' HB2' ' OD2' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -68.83 -31.08 69.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 109.885 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 127.41 -6.43 7.12 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.48 44.39 0.96 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.149 -1.206 . . . . 0.0 110.28 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -68.82 123.55 21.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 110.111 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.989 HG22 ' CB ' ' A' ' 21' ' ' PHE . 1.3 m -109.83 150.0 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.211 -0.931 . . . . 0.0 109.474 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.47 ' O ' HG23 ' A' ' 30' ' ' VAL . 15.4 m -134.91 93.69 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.145 -0.972 . . . . 0.0 110.905 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.624 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 42.05 68.35 0.48 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.285 -0.885 . . . . 0.0 110.471 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -166.75 19.35 0.09 OUTLIER Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.294 -1.431 . . . . 0.0 111.043 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 1.057 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 1.9 m-20 -88.9 148.6 23.75 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.414 -1.639 . . . . 0.0 109.931 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.464 ' HG3' ' HG3' ' A' ' 16' ' ' LYS . 27.7 tt0 -149.79 132.14 15.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.017 -1.052 . . . . 0.0 110.575 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -148.96 177.16 9.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.37 -0.831 . . . . 0.0 109.877 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.568 ' CD1' ' CD2' ' A' ' 14' ' ' HIS . 8.4 tp -102.94 153.99 19.67 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.157 -0.965 . . . . 0.0 110.227 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.622 ' CZ ' ' HA ' ' A' ' 40' ' ' PRO . 1.0 OUTLIER -130.88 110.46 11.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.433 -0.792 . . . . 0.0 109.68 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.591 ' HG3' HD11 ' A' ' 97' ' ' LEU . 8.9 tm-20 -92.01 132.71 36.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.574 -0.704 . . . . 0.0 109.356 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.585 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 60.24 47.05 93.02 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.622 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 37.6 Cg_endo -61.47 75.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.984 1.518 . . . . 0.0 110.467 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.482 ' HA2' HG13 ' A' ' 7' ' ' VAL . . . -42.86 110.83 0.3 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 5' ' ' GLN . 3.0 p 38.33 44.21 0.69 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.598 -0.942 . . . . 0.0 111.622 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.616 ' OH ' HD12 ' A' ' 15' ' ' LEU . 13.6 t80 -68.74 122.28 18.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.732 -1.23 . . . . 0.0 109.309 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.446 HG23 ' HD2' ' A' ' 45' ' ' PRO . 31.4 mt -111.7 142.16 26.08 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 110.18 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.821 ' HB3' HG23 ' A' ' 51' ' ' VAL . 45.0 Cg_endo -73.19 96.09 0.87 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.09 1.574 . . . . 0.0 110.353 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.403 ' O ' ' C ' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -106.13 161.8 14.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 110.242 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 46' ' ' ARG . 35.7 mttt -43.26 -31.24 0.59 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.341 -0.85 . . . . 0.0 110.299 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.474 ' HB3' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -55.19 -45.66 75.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.266 -0.896 . . . . 0.0 110.605 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.601 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.4 m -144.4 165.86 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.232 -0.917 . . . . 0.0 110.031 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -125.76 141.88 51.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.296 -0.877 . . . . 0.0 110.234 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.821 HG23 ' HB3' ' A' ' 45' ' ' PRO . 46.6 t -60.18 119.86 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.858 . . . . 0.0 109.832 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.833 HG12 ' HG2' ' A' ' 53' ' ' GLU . 16.7 t -95.1 -64.02 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 0.0 110.474 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.833 ' HG2' HG12 ' A' ' 52' ' ' VAL . 44.8 mm-40 -141.96 175.62 9.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.56 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.816 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -134.95 146.06 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.36 -0.838 . . . . 0.0 109.111 179.439 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -140.08 131.74 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.971 -1.081 . . . . 0.0 110.739 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.499 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 2.5 mp0 -86.5 156.01 20.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.49 -0.756 . . . . 0.0 109.835 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.037 ' HB1' ' HA ' ' A' ' 95' ' ' ALA . . . -95.3 142.85 27.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 0.0 110.818 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.62 HG22 ' C ' ' A' ' 57' ' ' ALA . 0.1 OUTLIER 168.81 51.69 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.424 -0.797 . . . . 0.0 110.777 179.758 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.9 HD13 ' CD1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -153.48 -28.75 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.728 -1.232 . . . . 0.0 111.419 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.731 HD12 ' O ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER -87.58 168.58 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.644 -1.285 . . . . 0.0 110.844 -179.098 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.522 ' CB ' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -107.23 -177.29 3.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.521 -0.737 . . . . 0.0 110.323 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.956 ' HA ' HG12 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -66.46 -72.26 0.17 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.273 -0.892 . . . . 0.0 110.671 -179.747 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.536 ' CB ' ' HB3' ' A' ' 110' ' ' ALA . 1.1 m-80 -77.55 -6.84 55.08 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.314 -0.866 . . . . 0.0 110.207 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.522 ' HB2' ' CB ' ' A' ' 61' ' ' ARG . 5.3 tp-100 -61.1 129.26 40.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.144 -0.973 . . . . 0.0 110.657 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.632 ' O ' HD22 ' A' ' 66' ' ' LEU . . . -108.67 144.99 35.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.074 -1.016 . . . . 0.0 109.752 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.672 ' HB2' HG13 ' A' ' 90' ' ' VAL . 1.7 mm? -123.13 114.6 20.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.182 -0.948 . . . . 0.0 110.522 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.819 ' HG2' HD23 ' A' ' 89' ' ' LEU . 18.5 mtm180 -97.99 122.04 40.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.297 -0.877 . . . . 0.0 109.881 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.777 HD23 ' HA ' ' A' ' 104' ' ' VAL . 13.2 mt -118.88 135.82 54.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.961 . . . . 0.0 110.61 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.852 ' HB2' HD11 ' A' ' 105' ' ' LEU . 29.2 ttt180 -98.22 160.74 14.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.55 -0.719 . . . . 0.0 109.865 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.514 ' HB2' ' HZ3' ' A' ' 75' ' ' TRP . . . -75.99 164.16 26.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.261 -0.899 . . . . 0.0 111.193 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 101' ' ' PHE . 1.0 OUTLIER -124.51 -42.6 2.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.66 -0.65 . . . . 0.0 109.493 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.501 ' HB2' ' CD2' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -122.03 138.67 54.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.41 -0.806 . . . . 0.0 109.998 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.528 ' HG3' HG23 ' A' ' 83' ' ' VAL . 0.6 OUTLIER -69.52 60.55 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.151 -0.968 . . . . 0.0 109.481 179.336 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 72' ' ' LYS . 2.2 t -151.18 -25.63 0.21 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.219 -0.926 . . . . 0.0 111.309 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.595 ' CZ2' ' HB3' ' A' ' 77' ' ' ARG . 1.7 t90 -73.6 116.23 13.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.754 -1.216 . . . . 0.0 110.519 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.488 ' HB3' ' HA ' ' A' ' 81' ' ' GLU . 2.5 p-10 -107.07 109.61 21.51 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.251 -0.905 . . . . 0.0 110.07 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.595 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -88.82 -4.09 58.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.243 -0.911 . . . . 0.0 110.242 179.671 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -117.66 -12.48 10.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.883 . . . . 0.0 110.089 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.18 -46.23 1.13 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.403 ' O ' ' HD2' ' A' ' 82' ' ' ARG . 11.4 mtmt -82.55 127.13 33.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -1.161 . . . . 0.0 110.26 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.591 ' CG ' HG11 ' A' ' 29' ' ' VAL . 6.1 tp10 -46.28 119.55 2.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 0.0 110.109 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.403 ' HD2' ' O ' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -101.43 175.04 5.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 110.317 -179.858 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.584 HG22 ' N ' ' A' ' 84' ' ' THR . 13.8 p -106.69 172.84 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 110.306 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.584 ' N ' HG22 ' A' ' 83' ' ' VAL . 40.6 p -60.75 -174.08 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.323 -0.861 . . . . 0.0 109.022 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 87' ' ' GLU . . . 70.8 -56.37 0.99 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 4.4 tp10 -44.32 153.78 0.14 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.032 -1.275 . . . . 0.0 109.545 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.54 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 13.4 mp0 -145.23 149.8 35.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.741 -1.224 . . . . 0.0 111.385 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.572 ' CZ2' ' HB ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -111.74 163.27 14.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.395 -0.815 . . . . 0.0 108.903 178.606 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.819 HD23 ' HG2' ' A' ' 67' ' ' ARG . 1.5 tm? -129.32 141.67 51.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.989 -1.069 . . . . 0.0 110.309 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.824 HG21 HD12 ' A' ' 97' ' ' LEU . 7.1 p -126.15 139.49 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.61 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 91' ' ' THR . 22.3 m -137.46 40.55 2.42 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.174 -0.954 . . . . 0.0 110.132 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.7 m -82.44 126.71 32.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.169 -0.957 . . . . 0.0 110.376 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.956 HG12 ' HA ' ' A' ' 62' ' ' GLN . 3.8 m -58.19 112.56 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.134 -0.979 . . . . 0.0 110.265 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 60' ' ' ILE . . . 71.44 96.6 0.06 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 1.037 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . . . -169.41 176.03 5.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.324 -1.103 . . . . 0.0 110.826 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.9 ' CD1' HD13 ' A' ' 59' ' ' ILE . 1.0 OUTLIER -129.0 -70.57 0.66 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.495 -0.753 . . . . 0.0 109.514 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.824 HD12 HG21 ' A' ' 90' ' ' VAL . 4.8 mt 48.92 78.27 0.41 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.484 -0.76 . . . . 0.0 111.247 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.739 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 48.9 Cg_endo -74.65 -14.79 21.96 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.806 1.424 . . . . 0.0 109.548 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.739 ' HB3' ' O ' ' A' ' 98' ' ' PRO . . . 72.14 173.46 0.3 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.537 -0.727 . . . . 0.0 111.161 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.531 HG12 ' CD1' ' A' ' 101' ' ' PHE . 94.2 t -99.81 -61.09 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.538 -0.727 . . . . 0.0 109.603 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.586 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 18.0 m-30 -111.43 45.44 1.2 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.335 -0.853 . . . . 0.0 109.992 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 11.4 mt-10 -134.05 144.88 48.93 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.676 -1.265 . . . . 0.0 111.887 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.45 ' O ' HD12 ' A' ' 105' ' ' LEU . 1.3 tt0 -119.37 123.27 43.74 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.777 ' HA ' HD23 ' A' ' 68' ' ' LEU . 7.2 p -54.05 149.02 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.218 -0.926 . . . . 0.0 110.779 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.852 HD11 ' HB2' ' A' ' 69' ' ' ARG . 8.4 mp -103.46 -32.92 9.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.574 -0.704 . . . . 0.0 110.387 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -179.84 148.38 0.31 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.026 -1.046 . . . . 0.0 110.722 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 mp -88.33 125.52 34.73 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.331 -0.856 . . . . 0.0 109.555 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 64' ' ' GLN . 74.2 t -116.85 140.53 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.067 -1.021 . . . . 0.0 111.434 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 14.4 t0 -111.29 114.15 27.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 109.496 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.536 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . . . -84.22 177.31 8.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.862 -1.149 . . . . 0.0 110.282 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.431 ' O ' ' CG ' ' A' ' 63' ' ' ASN . 19.6 m -61.81 -145.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.255 -0.903 . . . . 0.0 110.599 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.406 ' N ' HG23 ' A' ' 111' ' ' VAL . 15.7 mm -109.08 146.53 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.9 . . . . 0.0 110.279 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.179 179.991 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.427 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.3 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 0.3 OUTLIER 65.31 146.25 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.25 -1.147 . . . . 0.0 110.048 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -58.32 101.27 0.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.16 -0.962 . . . . 0.0 110.28 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.846 ' HG3' HD11 ' A' ' 44' ' ' ILE . 14.9 ttt -131.28 150.1 52.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.177 -0.952 . . . . 0.0 110.154 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 4' ' ' MET . 14.2 pt20 -176.76 142.5 0.41 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.179 -0.951 . . . . 0.0 110.392 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.497 HG23 ' N ' ' A' ' 7' ' ' VAL . 6.7 m -66.75 -150.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -0.885 . . . . 0.0 110.079 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.738 ' C ' HD13 ' A' ' 8' ' ' LEU . 4.0 t -83.32 144.48 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 110.178 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.749 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -100.25 168.74 8.93 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.207 -0.933 . . . . 0.0 109.519 179.667 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 42.8 Cg_endo -70.15 68.94 1.89 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.641 1.337 . . . . 0.0 110.732 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.837 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 4.9 m120 68.67 69.86 0.29 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.555 -0.715 . . . . 0.0 111.227 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.482 ' OG1' ' HB2' ' A' ' 8' ' ' LEU . 7.8 p -138.87 159.71 41.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.942 . . . . 0.0 109.921 178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.573 ' CB ' HD22 ' A' ' 97' ' ' LEU . . . -139.04 155.68 47.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.157 -0.964 . . . . 0.0 110.333 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.977 HD13 HD11 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -130.48 156.74 44.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -0.932 . . . . 0.0 110.609 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.994 ' C ' HD13 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -93.98 128.2 40.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.597 -0.689 . . . . 0.0 109.424 179.625 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.994 HD13 ' C ' ' A' ' 14' ' ' HIS . 0.1 OUTLIER -121.58 153.15 38.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.065 -1.022 . . . . 0.0 110.098 -179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -110.09 116.52 31.7 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.21 -0.931 . . . . 0.0 109.385 178.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.986 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -76.61 115.93 16.82 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.285 -0.885 . . . . 0.0 110.434 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.741 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -102.83 99.77 9.73 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.475 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.627 HD13 ' H ' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -167.59 147.31 5.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 110.745 -179.443 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.627 ' H ' HD13 ' A' ' 19' ' ' LEU . 32.4 t70 -85.39 110.82 19.41 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.727 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -129.17 144.41 51.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.081 -1.012 . . . . 0.0 112.054 -177.893 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.06 123.13 46.05 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.95 144.7 29.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.977 -1.077 . . . . 0.0 110.88 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -74.04 -33.05 63.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.413 -0.805 . . . . 0.0 109.507 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.94 -25.06 4.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.439 -0.788 . . . . 0.0 110.226 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.477 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -88.76 27.51 7.18 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.4 OUTLIER 61.63 -84.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -1.175 . . . . 0.0 110.4 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.508 ' CG ' ' O ' ' A' ' 21' ' ' PHE . 1.9 ttmm 178.13 142.44 0.1 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.373 -0.829 . . . . 0.0 110.344 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.727 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -100.66 139.97 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.203 -0.935 . . . . 0.0 109.333 179.658 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 30' ' ' VAL . 20.1 m -127.63 85.67 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.065 -1.022 . . . . 0.0 110.575 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.741 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 41.62 71.18 0.22 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.315 -0.866 . . . . 0.0 110.381 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -179.68 28.83 0.05 OUTLIER Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.536 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.986 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 42.5 m-20 -93.44 147.94 22.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.769 -1.43 . . . . 0.0 110.0 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.473 ' HG2' HG11 ' A' ' 100' ' ' VAL . 15.3 tt0 -143.07 143.56 31.91 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.032 -1.042 . . . . 0.0 110.176 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.563 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 7.1 p90 -159.95 168.83 24.78 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.014 -1.054 . . . . 0.0 111.105 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.869 HD22 ' O ' ' A' ' 98' ' ' PRO . 14.2 tp -97.32 153.29 18.15 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.353 -0.842 . . . . 0.0 109.774 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.602 ' CZ ' ' HA ' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -140.96 109.6 5.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.98 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.816 ' HG2' HD22 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -97.77 137.77 36.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.355 -0.84 . . . . 0.0 109.402 179.614 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.595 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 78.73 46.68 8.41 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.602 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 38.1 Cg_endo -63.47 71.32 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.052 1.554 . . . . 0.0 111.041 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.552 ' HA2' HG22 ' A' ' 7' ' ' VAL . . . -46.43 95.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER 46.13 40.44 7.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -1.137 . . . . 0.0 110.413 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.561 ' HB3' ' HB2' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -68.64 131.87 45.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.105 -0.997 . . . . 0.0 109.929 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.846 HD11 ' HG3' ' A' ' 4' ' ' MET . 23.3 mm -121.08 148.22 48.5 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.388 -0.82 . . . . 0.0 109.124 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.714 ' HD2' HG23 ' A' ' 44' ' ' ILE . 41.2 Cg_endo -67.85 75.03 0.64 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.689 1.363 . . . . 0.0 110.863 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 49' ' ' VAL . 13.0 ttt85 -66.84 143.47 56.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.424 -0.798 . . . . 0.0 109.895 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -41.25 -33.62 0.4 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.344 -0.848 . . . . 0.0 110.523 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -49.46 -50.89 39.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.157 -0.964 . . . . 0.0 109.95 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.675 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.4 m -133.0 173.51 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.353 -0.842 . . . . 0.0 109.408 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.48 132.77 44.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.088 -1.008 . . . . 0.0 110.56 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.732 ' HA ' HD12 ' A' ' 15' ' ' LEU . 9.4 p -54.41 143.53 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.041 -1.037 . . . . 0.0 108.232 178.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.714 HG23 ' HA ' ' A' ' 15' ' ' LEU . 13.0 t -123.33 -57.5 2.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.666 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.959 ' O ' HD13 ' A' ' 54' ' ' ILE . 31.1 mm-40 -135.35 167.36 21.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.393 -0.817 . . . . 0.0 110.092 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.959 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -136.77 147.94 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.436 -0.79 . . . . 0.0 109.067 179.359 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.556 HD13 ' H ' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -142.12 136.08 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.072 -1.017 . . . . 0.0 110.791 -179.21 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.556 ' H ' HD13 ' A' ' 55' ' ' ILE . 90.2 mm-40 -91.91 174.13 7.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.403 -0.811 . . . . 0.0 109.887 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.837 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -97.97 127.45 43.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.95 . . . . 0.0 110.348 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER 172.18 91.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.325 -0.86 . . . . 0.0 110.535 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.804 HD13 ' CE1' ' A' ' 96' ' ' TYR . 0.0 OUTLIER 177.76 -50.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.03 -1.044 . . . . 0.0 110.569 179.605 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.622 HG22 ' N ' ' A' ' 61' ' ' ARG . 15.7 mm -117.97 -93.34 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.788 -1.195 . . . . 0.0 110.33 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.622 ' N ' HG22 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -178.8 -163.34 0.06 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.129 -0.982 . . . . 0.0 111.042 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.829 ' HB3' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -92.51 -72.27 0.6 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.307 -0.871 . . . . 0.0 110.671 -179.353 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.783 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 3.1 m-20 -41.84 -24.59 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.675 -0.641 . . . . 0.0 111.636 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.967 ' OE1' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -58.47 134.01 56.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.846 -1.159 . . . . 0.0 110.294 -179.51 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.078 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -109.21 138.95 44.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.949 . . . . 0.0 109.285 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.967 HD13 ' OE1' ' A' ' 64' ' ' GLN . 2.0 tp -126.25 111.7 14.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -0.991 . . . . 0.0 110.848 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.614 ' O ' HD12 ' A' ' 105' ' ' LEU . 1.1 tpp180 -89.42 123.31 33.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.242 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.603 HD23 ' HA ' ' A' ' 104' ' ' VAL . 13.2 mt -122.57 146.99 46.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.877 . . . . 0.0 111.264 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 13.5 ttp85 -114.41 165.01 13.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.577 -0.702 . . . . 0.0 109.365 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.879 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -83.59 161.21 21.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.956 -1.09 . . . . 0.0 111.278 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.486 ' HB3' ' O ' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -123.83 -35.91 2.8 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.791 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.479 ' HG3' ' CD1' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -125.44 151.25 46.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.511 -0.743 . . . . 0.0 109.463 179.091 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.514 ' OE1' HG23 ' A' ' 83' ' ' VAL . 20.3 tt0 -83.08 95.99 8.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.123 -0.985 . . . . 0.0 109.556 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.77 -27.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.18 -0.95 . . . . 0.0 110.719 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.577 ' HZ3' ' HB2' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -74.46 125.8 29.34 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.036 -1.04 . . . . 0.0 110.16 -179.671 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 77' ' ' ARG . 34.9 m-20 -94.73 119.53 33.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 109.536 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 76' ' ' ASP . 5.0 mtm180 -39.6 -55.91 1.77 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.456 -0.778 . . . . 0.0 110.821 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -118.42 -8.1 10.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.1 -1.0 . . . . 0.0 110.396 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.41 -20.52 2.96 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.431 ' O ' ' CG ' ' A' ' 76' ' ' ASP . 4.4 mttp -63.88 -132.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -1.083 . . . . 0.0 109.866 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.536 ' HB3' ' CG1' ' A' ' 29' ' ' VAL . 5.9 mp0 -142.65 120.85 12.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.942 -1.098 . . . . 0.0 110.077 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.468 ' HD3' ' HG2' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -132.51 178.14 7.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.93 . . . . 0.0 110.186 179.823 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.917 HG13 ' H ' ' A' ' 85' ' ' GLY . 7.7 p -107.86 179.95 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.378 -0.826 . . . . 0.0 110.267 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.879 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 8.8 t -70.24 -15.53 62.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 110.343 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.917 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -86.75 8.37 75.89 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.468 ' HG2' ' HD3' ' A' ' 82' ' ' ARG . 13.6 tp10 -91.14 162.96 14.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.24 -1.153 . . . . 0.0 109.888 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.468 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 12.5 pt-20 -153.5 156.95 39.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.949 -1.094 . . . . 0.0 110.359 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.577 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -139.51 147.53 41.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.762 179.894 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.951 HD13 ' N ' ' A' ' 90' ' ' VAL . 2.7 tm? -103.41 146.97 27.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -0.852 . . . . 0.0 109.493 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.951 ' N ' HD13 ' A' ' 89' ' ' LEU . 20.5 t -104.47 117.42 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.146 -0.971 . . . . 0.0 110.224 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.69 -0.18 8.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.576 -0.702 . . . . 0.0 109.909 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.52 171.41 15.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.425 -0.797 . . . . 0.0 110.112 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.829 HG13 ' HB3' ' A' ' 62' ' ' GLN . 11.1 t -86.43 166.6 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.131 -0.98 . . . . 0.0 110.019 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.781 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 144.02 -28.18 2.0 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 59' ' ' ILE . . . 58.34 14.25 2.8 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.337 -1.096 . . . . 0.0 110.921 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.804 ' CE1' HD13 ' A' ' 59' ' ' ILE . 6.7 t80 179.99 85.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.088 -1.008 . . . . 0.0 110.674 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.816 HD22 ' HG2' ' A' ' 38' ' ' GLU . 69.3 mt -129.45 81.63 69.54 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 109.54 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.869 ' O ' HD22 ' A' ' 36' ' ' LEU . 44.3 Cg_endo -71.8 141.48 37.42 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.076 1.566 . . . . 0.0 110.774 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -85.19 -164.85 1.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.41 -0.806 . . . . 0.0 109.941 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.473 HG11 ' HG2' ' A' ' 34' ' ' GLU . 18.7 t -109.47 -62.75 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.215 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.515 ' HB2' ' HB2' ' A' ' 75' ' ' TRP . 14.8 m-85 -97.6 -33.06 11.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.278 -0.889 . . . . 0.0 110.189 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.565 ' OE1' ' CH2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -80.95 154.03 27.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 110.243 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -128.79 172.18 11.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.91 . . . . 0.0 110.45 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.603 ' HA ' HD23 ' A' ' 68' ' ' LEU . 7.5 p -93.28 142.69 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.903 . . . . 0.0 110.644 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.711 ' H ' HD12 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -106.34 -19.81 13.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.477 -0.764 . . . . 0.0 109.608 179.755 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -174.63 156.24 2.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.497 -0.752 . . . . 0.0 109.944 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.437 HD23 HD11 ' A' ' 66' ' ' LEU . 3.3 mp -107.54 146.09 32.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.899 . . . . 0.0 110.356 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.078 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 8.9 p -134.41 159.52 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.139 -0.976 . . . . 0.0 109.848 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 110' ' ' ALA . 8.2 p-10 -110.36 125.71 53.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.122 -0.986 . . . . 0.0 110.114 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.783 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . -43.03 148.01 0.29 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.216 -0.928 . . . . 0.0 110.408 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.558 ' O ' HG22 ' A' ' 111' ' ' VAL . 13.9 p -157.41 44.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.258 -0.901 . . . . 0.0 110.377 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.421 ' O ' ' C ' ' A' ' 113' ' ' LEU . 1.9 tt -121.17 150.73 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.298 -0.876 . . . . 0.0 110.257 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 112' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.21 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 50.31 42.38 25.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.344 -1.092 . . . . 0.0 110.328 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.472 ' O ' ' HB3' ' A' ' 4' ' ' MET . 0.3 OUTLIER -171.92 110.77 0.28 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.177 -0.952 . . . . 0.0 110.194 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.707 ' SD ' HD11 ' A' ' 44' ' ' ILE . 15.3 ttt 62.32 153.37 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.361 -0.837 . . . . 0.0 110.333 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.462 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 1.8 mt-30 -130.83 176.05 8.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.357 -0.839 . . . . 0.0 109.867 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 8' ' ' LEU . 14.2 t -90.63 143.35 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.22 -0.925 . . . . 0.0 109.471 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.455 ' C ' ' O ' ' A' ' 6' ' ' VAL . 40.7 t -39.4 95.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.436 -0.79 . . . . 0.0 110.102 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 6' ' ' VAL . 0.9 OUTLIER -45.55 165.84 0.16 Allowed Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.451 -0.781 . . . . 0.0 110.167 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.69 -56.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 124.165 1.613 . . . . 0.0 110.648 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.775 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 2.0 m-20 -166.75 26.01 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.084 -1.01 . . . . 0.0 110.588 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 7.2 p -103.58 171.76 7.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.171 -0.956 . . . . 0.0 109.655 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.834 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -141.42 160.4 40.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.858 -1.151 . . . . 0.0 110.689 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.097 ' CD2' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -129.59 155.18 46.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.103 -0.998 . . . . 0.0 109.927 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.62 ' CE1' HD21 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -92.74 126.51 37.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 110.321 -179.278 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.097 HD21 ' CD2' ' A' ' 13' ' ' LEU . 2.6 mm? -112.19 151.51 29.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.671 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.607 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 9.0 ttmt -119.58 117.0 27.2 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.953 -1.092 . . . . 0.0 109.362 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.962 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -77.93 120.33 22.64 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.271 -0.893 . . . . 0.0 110.335 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.499 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 0.5 OUTLIER -99.29 101.76 13.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.629 -0.669 . . . . 0.0 109.731 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.63 HD13 ' H ' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -159.04 141.04 13.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.327 -0.858 . . . . 0.0 110.04 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.63 ' H ' HD13 ' A' ' 19' ' ' LEU . 4.1 m-20 -90.07 103.6 16.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.856 . . . . 0.0 110.258 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.636 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -128.96 104.48 7.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.393 -0.817 . . . . 0.0 110.042 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -122.92 116.42 23.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.269 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -86.63 177.28 7.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -0.882 . . . . 0.0 110.345 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.5 tttp -79.96 -2.35 43.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.145 -0.972 . . . . 0.0 110.149 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -62.75 -30.54 71.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.195 -0.941 . . . . 0.0 110.188 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 27' ' ' ASP . . . 145.01 -30.09 1.8 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 26' ' ' GLY . 0.2 OUTLIER 170.91 141.84 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.297 -1.119 . . . . 0.0 109.939 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 1.0 OUTLIER -137.9 -99.73 0.19 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.098 -1.001 . . . . 0.0 110.427 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.636 HG22 ' CB ' ' A' ' 21' ' ' PHE . 1.5 m -112.08 137.41 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.035 -1.041 . . . . 0.0 109.752 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 30' ' ' VAL . 29.6 m -137.37 80.88 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.9 . . . . 0.0 110.026 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.499 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 47.91 68.62 0.64 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.891 . . . . 0.0 110.18 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.14 29.54 0.04 OUTLIER Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.362 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.962 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 38.1 m-20 -83.99 146.72 27.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.789 -1.418 . . . . 0.0 109.473 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.619 ' OE1' HG11 ' A' ' 100' ' ' VAL . 4.8 tt0 -144.22 147.34 33.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.099 -1.001 . . . . 0.0 111.056 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.619 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 11.5 p90 -156.7 164.41 38.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.465 -0.772 . . . . 0.0 110.188 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.62 HD21 ' CE1' ' A' ' 14' ' ' HIS . 0.2 OUTLIER -96.74 149.46 21.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.244 -0.91 . . . . 0.0 110.394 -179.796 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.57 ' HB3' HD23 ' A' ' 13' ' ' LEU . 2.9 t80 -131.55 110.74 11.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.233 -0.917 . . . . 0.0 110.502 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.594 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 2.3 tm-20 -85.75 125.12 32.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.652 -0.655 . . . . 0.0 110.001 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.594 ' N ' ' HD3' ' A' ' 40' ' ' PRO . . . 74.63 44.85 24.81 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.594 ' HD3' ' N ' ' A' ' 39' ' ' GLY . 55.9 Cg_endo -77.88 32.96 0.44 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.494 1.26 . . . . 0.0 111.222 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 5' ' ' GLN . . . -54.39 -59.53 9.95 Favored Glycine 0 N--CA 1.487 2.096 0 O-C-N 120.53 -1.356 . . . . 0.0 109.976 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 75.5 p -78.87 12.35 2.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -1.174 . . . . 0.0 111.501 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.615 ' OH ' HD12 ' A' ' 15' ' ' LEU . 3.2 t80 -72.99 130.6 40.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.851 -1.156 . . . . 0.0 110.078 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.707 HD11 ' SD ' ' A' ' 4' ' ' MET . 1.9 mt -118.66 143.11 32.81 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.982 . . . . 0.0 109.798 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.518 ' HD2' HG23 ' A' ' 44' ' ' ILE . 46.0 Cg_endo -72.58 107.17 2.24 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.971 1.511 . . . . 0.0 110.458 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 49' ' ' VAL . 1.2 mtt-85 -114.91 148.73 38.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.306 -0.871 . . . . 0.0 110.229 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 46' ' ' ARG . 0.3 OUTLIER -40.44 -45.95 2.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.353 -0.842 . . . . 0.0 110.847 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.426 ' C ' ' CG1' ' A' ' 49' ' ' VAL . 3.0 mt-10 -42.53 -39.06 2.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.407 -0.808 . . . . 0.0 110.875 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.63 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.6 m -145.96 174.09 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.15 -0.969 . . . . 0.0 110.549 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 49' ' ' VAL . 1.6 mm-40 -139.39 139.61 37.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.255 -0.903 . . . . 0.0 110.395 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.446 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . 5.0 m -55.23 130.98 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.147 -0.971 . . . . 0.0 110.223 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.607 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 3.7 t -104.12 -58.7 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.312 -0.867 . . . . 0.0 110.351 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.888 ' C ' HD13 ' A' ' 54' ' ' ILE . 3.7 mt-10 -143.36 171.06 14.64 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.097 -1.002 . . . . 0.0 110.4 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.888 HD13 ' C ' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -132.23 135.96 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.781 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.834 HG22 ' O ' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -129.91 143.86 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.913 -1.117 . . . . 0.0 111.694 -178.588 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.468 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 93.1 mm-40 -91.84 158.78 16.13 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.644 -0.66 . . . . 0.0 109.383 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.775 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -102.35 132.85 48.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.175 -0.953 . . . . 0.0 110.193 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 3.7 t 178.5 55.02 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.132 -0.98 . . . . 0.0 111.584 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.591 HG22 ' O ' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -157.42 -51.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.462 -1.398 . . . . 0.0 111.599 179.341 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.554 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 13.9 mm -70.05 157.42 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.616 -1.302 . . . . 0.0 110.644 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.438 ' O ' HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -90.43 179.58 5.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.35 -0.844 . . . . 0.0 110.004 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.981 ' HA ' HG12 ' A' ' 93' ' ' VAL . 4.4 mt-30 -83.42 -27.07 29.81 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.151 -0.968 . . . . 0.0 110.714 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.711 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 3.1 m120 -94.4 -34.94 12.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.129 -0.982 . . . . 0.0 110.526 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -58.69 129.3 41.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.115 -0.991 . . . . 0.0 111.146 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.103 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -108.3 143.5 37.09 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.557 ' O ' HD13 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -126.72 120.47 29.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.081 -1.012 . . . . 0.0 110.578 -179.194 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.705 ' O ' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -89.69 141.87 28.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.489 -0.757 . . . . 0.0 109.462 179.591 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.705 HD22 ' O ' ' A' ' 67' ' ' ARG . 1.8 mm? -125.41 125.74 43.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.15 -0.969 . . . . 0.0 111.081 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.9 ' HB2' HD11 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -105.41 159.31 16.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.461 -0.774 . . . . 0.0 109.615 179.433 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.3 151.33 46.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.212 -0.93 . . . . 0.0 110.878 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -116.01 -30.16 6.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.434 -0.791 . . . . 0.0 109.589 179.322 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -149.43 130.21 14.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.304 -0.873 . . . . 0.0 109.802 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.46 ' N ' ' HD3' ' A' ' 72' ' ' LYS . 0.3 OUTLIER -56.57 90.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.176 -0.953 . . . . 0.0 109.903 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 72' ' ' LYS . 37.5 t -176.0 -29.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.384 -0.822 . . . . 0.0 110.442 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.584 ' CE3' ' HG2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -73.89 120.88 20.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.147 -0.971 . . . . 0.0 110.005 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.423 ' OD2' ' O ' ' A' ' 79' ' ' GLY . 3.5 m-20 -80.02 113.85 18.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.354 -0.841 . . . . 0.0 110.051 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.477 ' HB2' ' OE2' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -55.65 -54.7 40.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 110.355 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.68 -13.94 12.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.363 -0.836 . . . . 0.0 110.411 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.423 ' O ' ' OD2' ' A' ' 76' ' ' ASP . . . 143.42 -22.03 2.22 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.8 mmtt -85.77 157.51 20.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.524 -0.986 . . . . 0.0 109.741 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.521 ' HB3' HG11 ' A' ' 29' ' ' VAL . 37.8 mm-40 -69.37 126.5 29.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 110.161 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.473 ' HD2' ' OE1' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -122.2 175.23 6.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.493 -0.754 . . . . 0.0 110.702 -179.541 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.633 HG22 ' N ' ' A' ' 84' ' ' THR . 4.8 p -119.35 171.8 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.417 -0.802 . . . . 0.0 110.423 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.633 ' N ' HG22 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -54.78 -170.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.105 -0.997 . . . . 0.0 108.789 178.746 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 86' ' ' GLU . . . 70.77 -55.88 0.98 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.626 ' HG3' ' N ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -44.76 156.37 0.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.171 -1.193 . . . . 0.0 109.11 179.335 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.626 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 12.9 pt-20 -155.61 145.06 21.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.656 -1.278 . . . . 0.0 111.148 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -112.3 160.39 17.71 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 90' ' ' VAL . 0.1 OUTLIER -115.33 127.72 55.61 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.966 -1.084 . . . . 0.0 111.221 -178.88 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.64 ' N ' HD12 ' A' ' 89' ' ' LEU . 25.0 t -92.64 108.3 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.394 -0.816 . . . . 0.0 109.705 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.0 m -128.19 46.12 2.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.967 . . . . 0.0 110.829 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 53.2 m -107.8 131.3 54.61 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.15 -0.969 . . . . 0.0 110.149 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.981 HG12 ' HA ' ' A' ' 62' ' ' GLN . 27.5 m -66.9 150.29 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.253 -0.904 . . . . 0.0 110.477 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.618 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 41.08 82.03 0.02 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.712 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . . . -159.63 147.08 16.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -1.151 . . . . 0.0 110.207 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.567 ' O ' ' CG ' ' A' ' 96' ' ' TYR . 14.9 t80 -133.49 59.27 1.74 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.379 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.685 HD21 ' HB1' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -117.55 99.91 52.51 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 120.911 -1.118 . . . . 0.0 109.783 178.888 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.727 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 47.3 Cg_endo -77.56 18.08 0.87 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 124.111 1.585 . . . . 0.0 111.854 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 98' ' ' PRO . . . 70.1 -178.59 0.22 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.81 -1.181 . . . . 0.0 110.426 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.619 HG11 ' OE1' ' A' ' 34' ' ' GLU . 2.6 t -102.57 -61.72 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 109.793 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.537 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 22.0 m-85 -107.73 47.92 0.87 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.27 -0.894 . . . . 0.0 109.925 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.646 ' HB2' HD12 ' A' ' 68' ' ' LEU . 17.8 mt-10 -138.85 158.67 43.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.904 -1.122 . . . . 0.0 111.611 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.63 ' O ' HD13 ' A' ' 68' ' ' LEU . 9.9 mt-10 -132.49 167.53 19.81 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.606 -0.684 . . . . 0.0 109.395 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.521 ' C ' HD13 ' A' ' 105' ' ' LEU . 3.8 m -90.75 146.89 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.937 -1.102 . . . . 0.0 110.263 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.9 HD11 ' HB2' ' A' ' 69' ' ' ARG . 0.8 OUTLIER -102.28 -11.24 18.86 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.405 -0.809 . . . . 0.0 109.351 179.315 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 0.5 OUTLIER 162.46 127.71 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.61 -0.682 . . . . 0.0 110.098 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.1 mp -76.45 121.86 23.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 109.598 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.103 HG13 ' HB3' ' A' ' 65' ' ' ALA . 9.1 p -111.31 153.98 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.094 -1.004 . . . . 0.0 110.467 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.778 ' OD2' HD11 ' A' ' 112' ' ' ILE . 1.5 t0 -110.91 120.17 41.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -0.874 . . . . 0.0 109.821 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . -50.16 -82.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.007 -1.058 . . . . 0.0 110.216 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 111' ' ' VAL . 9.6 p -162.72 135.33 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.379 -0.826 . . . . 0.0 110.019 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.778 HD11 ' OD2' ' A' ' 109' ' ' ASP . 3.8 mt -130.44 -140.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.216 -0.928 . . . . 0.0 109.712 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.512 ' H ' HG22 ' A' ' 112' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.004 -1.06 . . . . 0.0 110.303 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.68 -41.0 39.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.283 -1.128 . . . . 0.0 110.116 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.453 ' O ' ' O ' ' A' ' 4' ' ' MET . 0.3 OUTLIER -151.5 164.59 36.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.203 -0.936 . . . . 0.0 109.999 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.697 ' HG3' HD11 ' A' ' 44' ' ' ILE . 0.5 OUTLIER 57.22 111.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.261 -0.9 . . . . 0.0 110.187 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 2.4 mt-30 -95.33 146.44 24.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.251 -0.906 . . . . 0.0 110.188 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.0 t -77.26 155.89 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.932 . . . . 0.0 110.37 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 74.9 t -45.21 106.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.321 -0.862 . . . . 0.0 110.217 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.761 HD23 ' OG1' ' A' ' 11' ' ' THR . 3.5 mp -49.83 164.72 0.34 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.7 -57.13 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.992 1.522 . . . . 0.0 110.498 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.68 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 3.2 m120 -163.41 31.11 0.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -0.904 . . . . 0.0 110.011 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.761 ' OG1' HD23 ' A' ' 8' ' ' LEU . 55.2 p -112.62 171.82 7.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.316 -0.865 . . . . 0.0 110.37 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -137.74 165.96 25.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.177 -0.952 . . . . 0.0 110.029 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.855 HD23 ' CG ' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -133.95 155.63 49.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.149 -0.969 . . . . 0.0 111.032 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.628 ' C ' HD23 ' A' ' 15' ' ' LEU . 52.8 m80 -99.06 132.74 44.14 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.288 -0.883 . . . . 0.0 110.474 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.856 HD21 ' HB2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -137.06 156.76 48.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.997 -1.064 . . . . 0.0 109.984 178.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 3.4 mtpt -107.94 123.56 48.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.358 -0.839 . . . . 0.0 110.742 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.087 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -82.1 119.68 24.33 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.314 -0.866 . . . . 0.0 110.157 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.861 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 2.8 mm? -101.06 101.18 11.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.581 -0.699 . . . . 0.0 109.865 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.487 HD13 ' HA ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -160.99 147.15 14.74 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.102 -0.999 . . . . 0.0 110.502 -179.679 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -88.75 113.26 24.12 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.672 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -130.6 142.89 50.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.081 -1.012 . . . . 0.0 111.733 -178.27 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -102.16 123.69 46.45 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.442 -0.786 . . . . 0.0 109.548 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -89.33 164.36 14.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.077 -1.014 . . . . 0.0 110.669 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -32.57 59.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.384 -0.822 . . . . 0.0 110.065 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -65.77 -27.85 68.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 110.215 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.85 26.41 5.02 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 28' ' ' LYS . 0.4 OUTLIER -103.27 -43.04 5.55 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.204 -1.174 . . . . 0.0 110.126 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 21' ' ' PHE . 37.5 tttt 58.08 133.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.635 -0.666 . . . . 0.0 110.888 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.672 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -95.35 147.4 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.223 -0.923 . . . . 0.0 109.027 179.207 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 30' ' ' VAL . 16.7 m -130.99 85.61 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.961 -1.087 . . . . 0.0 110.98 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.861 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 42.16 68.76 0.43 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.409 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.88 23.51 0.09 OUTLIER Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.445 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 1.087 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 10.5 m-20 -85.72 154.22 21.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.818 -1.401 . . . . 0.0 109.734 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 78.7 tt0 -155.93 138.71 15.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 110.312 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.667 ' CH2' HD12 ' A' ' 15' ' ' LEU . 3.8 p90 -157.77 177.14 11.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.164 -0.96 . . . . 0.0 110.523 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.654 HD22 ' O ' ' A' ' 98' ' ' PRO . 39.7 tp -90.43 165.56 13.76 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.433 -0.792 . . . . 0.0 110.824 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.856 ' HB2' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -135.73 110.84 8.91 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.58 -0.7 . . . . 0.0 109.467 179.554 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -86.22 131.31 34.26 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.193 -0.942 . . . . 0.0 110.441 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.597 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 54.98 45.99 79.15 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.855 ' CG ' HD23 ' A' ' 13' ' ' LEU . 39.5 Cg_endo -67.03 -60.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.918 1.483 . . . . 0.0 110.338 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 5' ' ' GLN . . . 37.83 -86.81 0.01 OUTLIER Glycine 0 N--CA 1.497 2.72 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.617 ' N ' ' O ' ' A' ' 40' ' ' PRO . 1.2 p -54.4 -7.65 0.17 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.337 -1.096 . . . . 0.0 112.008 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.599 ' CD2' HD21 ' A' ' 13' ' ' LEU . 6.6 t80 -67.37 130.09 41.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.61 -1.307 . . . . 0.0 110.096 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.697 HD11 ' HG3' ' A' ' 4' ' ' MET . 34.1 mt -119.56 147.78 44.4 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.51 -0.744 . . . . 0.0 109.639 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.695 ' HD2' HG23 ' A' ' 44' ' ' ILE . 40.4 Cg_endo -68.48 87.62 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.841 1.442 . . . . 0.0 110.462 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 49' ' ' VAL . 18.3 mmt85 -95.91 157.73 15.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.402 -0.811 . . . . 0.0 110.112 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -53.66 -19.84 4.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.177 -0.952 . . . . 0.0 110.107 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.489 ' C ' ' CG1' ' A' ' 49' ' ' VAL . 1.8 tp10 -62.65 -36.51 83.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.283 -0.885 . . . . 0.0 109.752 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.489 ' CG1' ' C ' ' A' ' 48' ' ' GLU . 0.9 OUTLIER -150.05 173.92 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.393 -0.817 . . . . 0.0 109.521 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 52' ' ' VAL . 6.3 mt-10 -130.88 125.59 33.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.043 -1.036 . . . . 0.0 110.507 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 51' ' ' VAL . 2.6 p -54.21 124.84 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.098 -1.001 . . . . 0.0 109.139 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.877 HG12 ' HG2' ' A' ' 53' ' ' GLU . 47.1 t -104.37 -61.79 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.106 -0.996 . . . . 0.0 111.1 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.95 ' O ' HD13 ' A' ' 54' ' ' ILE . 4.5 mm-40 -134.84 174.09 10.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.071 -1.018 . . . . 0.0 110.612 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.95 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.1 mm -135.24 131.76 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.486 HG13 ' HG2' ' A' ' 98' ' ' PRO . 0.3 OUTLIER -121.13 137.31 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.106 -0.996 . . . . 0.0 111.269 -178.583 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.495 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 6.8 mp0 -95.37 169.24 10.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.505 -0.747 . . . . 0.0 110.543 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.888 ' HB1' ' HB3' ' A' ' 95' ' ' ALA . . . -96.85 118.99 34.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.821 . . . . 0.0 110.282 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 58' ' ' THR . 8.1 t -176.91 78.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.053 -1.03 . . . . 0.0 110.726 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.79 HG21 ' CD1' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -179.12 -59.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.944 -1.098 . . . . 0.0 111.104 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.697 HG13 HG22 ' A' ' 59' ' ' ILE . 1.7 mt -92.75 -139.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 120.295 -1.503 . . . . 0.0 109.695 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.503 ' H ' HG22 ' A' ' 60' ' ' ILE . 14.7 mtt85 -155.53 -162.02 1.26 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.077 -1.014 . . . . 0.0 110.092 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.834 ' CB ' HG12 ' A' ' 93' ' ' VAL . 2.2 mt-30 -83.06 -72.28 0.46 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.944 . . . . 0.0 111.109 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.563 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 9.6 p30 -45.41 -41.1 8.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -0.918 . . . . 0.0 111.304 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.85 136.87 51.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.877 -1.139 . . . . 0.0 111.14 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.989 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -121.96 142.65 50.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.515 -0.741 . . . . 0.0 109.296 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.936 HD22 ' C ' ' A' ' 65' ' ' ALA . 4.4 mm? -125.85 112.8 16.43 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.962 -1.086 . . . . 0.0 110.668 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.494 ' O ' ' HG3' ' A' ' 67' ' ' ARG . 3.5 ptp180 -90.91 126.98 36.21 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.031 -1.043 . . . . 0.0 110.362 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.789 HD23 ' HA ' ' A' ' 104' ' ' VAL . 17.2 mt -123.02 137.82 54.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.363 -0.836 . . . . 0.0 110.678 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -98.79 154.09 18.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.313 -0.867 . . . . 0.0 109.953 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.905 ' HB2' ' HG3' ' A' ' 86' ' ' GLU . . . -67.92 140.35 56.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.378 -0.826 . . . . 0.0 111.6 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 101' ' ' PHE . 15.1 tpp85 -104.38 -38.46 6.82 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.5 ' HB2' ' HB3' ' A' ' 101' ' ' PHE . 2.0 mmtt -113.81 155.96 24.75 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.453 ' OE2' ' OD1' ' A' ' 27' ' ' ASP . 12.5 pt-20 -86.82 27.76 0.96 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.988 -1.07 . . . . 0.0 110.275 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.6 -20.97 4.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.211 -0.93 . . . . 0.0 110.689 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.6 ' HB2' ' CD2' ' A' ' 101' ' ' PHE . 13.7 t90 -73.99 107.27 6.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.155 -0.965 . . . . 0.0 110.426 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 82' ' ' ARG . 8.3 m-20 -112.75 122.96 49.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.353 -0.842 . . . . 0.0 110.157 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.5 ' NH2' ' OD2' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -88.01 -20.41 25.85 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.265 -0.897 . . . . 0.0 110.256 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.5 ' OD2' ' NH2' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -96.16 6.98 47.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.208 -0.933 . . . . 0.0 110.032 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.07 9.33 86.83 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 76' ' ' ASP . 2.0 mmmt -117.88 135.61 53.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -1.189 . . . . 0.0 110.406 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.75 125.77 7.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -0.865 . . . . 0.0 110.159 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.504 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 1.5 mtt-85 -137.36 142.88 41.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.89 . . . . 0.0 110.115 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.556 HG13 ' H ' ' A' ' 85' ' ' GLY . 11.4 p -78.62 170.72 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.912 . . . . 0.0 110.215 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.754 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -55.44 -17.51 5.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.513 -0.742 . . . . 0.0 110.384 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.556 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -72.74 -12.2 78.1 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.905 ' HG3' ' HB2' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -67.3 170.97 6.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.969 -1.312 . . . . 0.0 109.848 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -159.59 145.61 16.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.15 -0.969 . . . . 0.0 110.277 179.66 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.596 ' CZ2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -132.08 133.69 44.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.22 -0.925 . . . . 0.0 110.016 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.073 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -107.06 138.72 42.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 110.018 179.737 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 1.073 ' N ' HD22 ' A' ' 89' ' ' LEU . 63.5 t -93.91 101.35 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.343 -0.848 . . . . 0.0 110.137 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.868 ' HB ' HD11 ' A' ' 89' ' ' LEU . 1.5 t -119.64 0.2 10.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.596 -0.69 . . . . 0.0 109.717 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 93' ' ' VAL . 98.9 m -88.06 114.44 24.68 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.429 -0.794 . . . . 0.0 110.259 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.834 HG12 ' CB ' ' A' ' 62' ' ' GLN . 16.6 m -41.31 124.7 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.453 -0.78 . . . . 0.0 109.753 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' A' ' 96' ' ' TYR . . . -174.93 34.78 0.1 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.888 ' HB3' ' HB1' ' A' ' 57' ' ' ALA . . . 45.58 -80.83 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.758 -0.848 . . . . 0.0 111.627 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.79 ' CD1' HG21 ' A' ' 59' ' ' ILE . 3.8 t80 -125.12 159.76 30.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.625 -1.297 . . . . 0.0 110.06 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -173.28 69.07 0.36 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.131 -0.98 . . . . 0.0 110.555 -179.441 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.654 ' O ' HD22 ' A' ' 36' ' ' LEU . 45.1 Cg_endo -74.89 145.27 31.68 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.839 1.441 . . . . 0.0 109.938 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.786 ' HB3' ' CG ' ' A' ' 102' ' ' GLU . . . -104.95 -141.67 0.37 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.038 -1.039 . . . . 0.0 111.15 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.512 ' CG2' ' HA ' ' A' ' 35' ' ' TRP . 0.9 OUTLIER -121.29 -58.42 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.136 -0.978 . . . . 0.0 111.819 -178.826 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.6 ' CD2' ' HB2' ' A' ' 75' ' ' TRP . 9.7 m-30 -111.35 55.6 0.66 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.161 -1.587 . . . . 0.0 111.492 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.786 ' CG ' ' HB3' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -141.2 143.83 34.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.592 -1.317 . . . . 0.0 110.815 179.218 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.407 ' O ' ' CD1' ' A' ' 105' ' ' LEU . 12.5 tp10 -118.56 128.31 54.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.586 -0.696 . . . . 0.0 110.171 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.789 ' HA ' HD23 ' A' ' 68' ' ' LEU . 4.9 p -65.28 148.53 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.389 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 1.6 mp -105.19 -45.56 4.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.354 -0.841 . . . . 0.0 109.944 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.11 133.14 2.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.878 . . . . 0.0 109.963 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.855 ' C ' HD22 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -76.06 142.65 41.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.939 . . . . 0.0 111.119 -179.499 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.989 HG13 ' HB3' ' A' ' 65' ' ' ALA . 3.4 p -128.03 149.88 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.993 -1.067 . . . . 0.0 109.709 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.2 119.58 39.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.058 -1.026 . . . . 0.0 110.544 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 63' ' ' ASN . . . -81.82 -173.59 4.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.028 -1.045 . . . . 0.0 109.862 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.73 HG12 HG23 ' A' ' 112' ' ' ILE . 86.8 t -74.78 -89.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.169 -0.957 . . . . 0.0 110.439 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.73 HG23 HG12 ' A' ' 111' ' ' VAL . 3.0 pt -119.86 -24.81 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.083 -1.011 . . . . 0.0 110.039 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.557 ' OXT' HD23 ' A' ' 113' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.142 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.543 ' O ' ' CG ' ' A' ' 3' ' ' HIS . 79.8 p -63.27 -49.24 74.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -1.112 . . . . 0.0 110.086 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 2' ' ' SER . 0.2 OUTLIER 174.49 -33.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.168 -0.958 . . . . 0.0 110.41 179.913 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.42 ' HA ' HD11 ' A' ' 44' ' ' ILE . 1.5 mtt -98.31 137.63 36.75 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.179 -0.951 . . . . 0.0 110.462 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.513 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -97.4 -173.94 2.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.311 -0.868 . . . . 0.0 110.071 179.714 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.522 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 3.5 t -123.29 160.09 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.243 -0.91 . . . . 0.0 109.954 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.471 ' O ' ' O ' ' A' ' 8' ' ' LEU . 10.6 t -57.06 81.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.374 -0.828 . . . . 0.0 110.837 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.798 ' C ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -45.62 171.38 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.43 -0.794 . . . . 0.0 110.113 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.632 ' N ' HD22 ' A' ' 8' ' ' LEU . 51.3 Cg_endo -75.44 -99.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.524 1.276 . . . . 0.0 111.955 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.963 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 0.8 OUTLIER -112.38 83.94 1.89 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.761 -1.212 . . . . 0.0 110.934 -178.711 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.744 HG23 HD23 ' A' ' 8' ' ' LEU . 1.7 p -156.16 169.6 24.13 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.204 -0.935 . . . . 0.0 110.17 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.909 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -145.9 167.37 23.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 108.883 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.813 HD23 ' HG3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -134.55 153.75 51.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.826 -1.171 . . . . 0.0 111.137 179.859 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.897 ' CE1' HD13 ' A' ' 36' ' ' LEU . 7.8 m80 -98.5 135.63 39.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -0.858 . . . . 0.0 109.261 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.951 HD13 ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -139.11 165.53 26.91 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.128 -0.983 . . . . 0.0 110.172 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 1.6 tttt -114.51 120.91 41.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 111.108 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.0 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -81.56 112.53 18.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.416 -0.802 . . . . 0.0 109.696 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.809 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -100.47 101.6 12.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.395 -0.816 . . . . 0.0 110.124 -179.871 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.581 HD23 ' HG3' ' A' ' 48' ' ' GLU . 0.1 OUTLIER -162.27 139.18 8.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 110.208 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.577 ' H ' HD13 ' A' ' 19' ' ' LEU . 33.9 p-10 -78.83 101.53 7.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.687 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.883 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -121.62 104.91 9.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.27 -0.894 . . . . 0.0 110.53 -179.46 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 2.3 pt-20 -119.79 115.89 24.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.401 -0.812 . . . . 0.0 109.819 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.75 175.17 6.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.176 -0.952 . . . . 0.0 110.44 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -65.24 -13.44 58.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.426 -0.796 . . . . 0.0 110.176 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.4 -25.87 68.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 110.057 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.78 -66.44 0.48 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -148.13 134.22 19.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.304 -1.115 . . . . 0.0 110.168 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.3 tptt -125.15 -90.47 0.55 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.126 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.883 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -106.63 143.32 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.681 -1.262 . . . . 0.0 109.416 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.613 ' O ' HG23 ' A' ' 30' ' ' VAL . 29.1 m -138.59 88.58 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.024 -1.047 . . . . 0.0 110.676 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.809 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 41.55 65.32 0.86 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.372 -0.83 . . . . 0.0 110.55 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -175.17 26.02 0.07 OUTLIER Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.501 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 1.0 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 10.0 m-20 -86.7 154.53 20.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.893 -1.357 . . . . 0.0 109.833 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.724 ' OE2' HG21 ' A' ' 52' ' ' VAL . 3.8 tt0 -153.59 131.27 11.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.251 -0.906 . . . . 0.0 110.176 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.776 ' CZ3' ' HB2' ' A' ' 17' ' ' ALA . 6.8 p90 -151.94 165.17 35.43 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.062 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.897 HD13 ' CE1' ' A' ' 14' ' ' HIS . 51.6 tp -91.44 161.86 14.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -0.834 . . . . 0.0 110.173 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.612 ' CE2' ' HB2' ' A' ' 43' ' ' TYR . 0.9 OUTLIER -136.78 111.99 9.09 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.366 -0.834 . . . . 0.0 109.89 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.648 ' HB2' HD21 ' A' ' 97' ' ' LEU . 2.4 tm-20 -84.31 140.68 31.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.683 -0.635 . . . . 0.0 109.803 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.609 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 59.05 40.77 95.97 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.813 ' HG3' HD23 ' A' ' 13' ' ' LEU . 49.2 Cg_endo -75.2 -51.14 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.375 1.197 . . . . 0.0 109.535 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.588 ' N ' HD12 ' A' ' 8' ' ' LEU . . . 41.63 -94.08 0.01 OUTLIER Glycine 0 N--CA 1.486 1.967 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 40' ' ' PRO . 1.8 t -78.23 19.9 0.42 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.425 -1.044 . . . . 0.0 112.05 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.612 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 1.6 t80 -67.61 111.05 3.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.675 -1.266 . . . . 0.0 109.006 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.457 HG23 ' HD2' ' A' ' 45' ' ' PRO . 51.1 mm -90.11 142.14 28.42 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.295 -0.878 . . . . 0.0 110.609 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.653 ' HB3' HG23 ' A' ' 51' ' ' VAL . 48.3 Cg_endo -74.74 106.5 2.27 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.184 1.623 . . . . 0.0 110.467 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.428 ' O ' ' N ' ' A' ' 48' ' ' GLU . 0.7 OUTLIER -84.95 147.85 26.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 109.789 179.699 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -43.71 -25.82 0.2 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.163 -0.96 . . . . 0.0 109.933 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.581 ' HG3' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -62.15 -46.45 88.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -0.863 . . . . 0.0 110.51 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.641 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -124.03 173.17 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.183 -0.948 . . . . 0.0 110.418 -179.656 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.416 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.0 mm-40 -135.1 137.12 42.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 110.22 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.653 HG23 ' HB3' ' A' ' 45' ' ' PRO . 12.2 t -56.98 138.79 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 109.234 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.724 HG21 ' OE2' ' A' ' 34' ' ' GLU . 39.4 t -121.86 -51.27 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.031 -1.043 . . . . 0.0 110.799 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.822 ' O ' HD13 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -145.6 166.89 24.45 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.977 -1.077 . . . . 0.0 110.147 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.822 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -134.29 131.24 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.335 -0.853 . . . . 0.0 109.245 179.185 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.909 HG22 ' O ' ' A' ' 12' ' ' ALA . 8.0 tt -117.03 145.93 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.061 -1.024 . . . . 0.0 111.44 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.452 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 3.9 mp0 -105.79 -179.51 3.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.618 -0.676 . . . . 0.0 109.837 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.963 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -97.16 136.06 38.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.159 -0.963 . . . . 0.0 111.17 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 4.7 t 176.23 57.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.443 -0.786 . . . . 0.0 111.134 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.621 HG21 ' CG ' ' A' ' 96' ' ' TYR . 0.5 OUTLIER -173.77 -48.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.507 -1.371 . . . . 0.0 112.33 179.389 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.602 HG22 ' N ' ' A' ' 61' ' ' ARG . 70.7 mt -75.69 172.63 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.577 -1.327 . . . . 0.0 110.333 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.602 ' N ' HG22 ' A' ' 60' ' ' ILE . 29.7 mtt-85 -117.81 -174.31 2.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.035 -1.04 . . . . 0.0 110.256 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.798 ' CA ' HG13 ' A' ' 93' ' ' VAL . 41.7 tt0 -79.16 -30.22 43.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.17 -0.956 . . . . 0.0 110.96 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 7.2 p30 -105.94 -21.87 13.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.009 -1.057 . . . . 0.0 110.625 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 109' ' ' ASP . 5.5 tp-100 -58.39 135.0 57.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.873 -1.142 . . . . 0.0 110.699 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.106 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -112.96 135.47 53.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.487 -0.758 . . . . 0.0 109.324 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.592 ' O ' HD22 ' A' ' 89' ' ' LEU . 1.3 mp -124.82 117.23 23.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.192 -0.942 . . . . 0.0 111.173 -179.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.496 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 1.7 ttp180 -96.34 126.13 41.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 108.965 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.017 ' CD2' HG12 ' A' ' 104' ' ' VAL . 17.8 mt -118.89 133.18 56.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.01 -1.056 . . . . 0.0 110.582 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 5.4 ttt85 -114.85 150.63 35.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -0.847 . . . . 0.0 110.13 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.523 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -70.32 123.45 21.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.83 . . . . 0.0 110.752 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -81.8 -38.67 25.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.947 . . . . 0.0 108.931 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.636 ' CG ' ' CD2' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -136.35 143.25 43.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.535 -0.728 . . . . 0.0 109.239 179.099 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 74' ' ' CYS . 0.0 OUTLIER -55.46 -161.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.983 . . . . 0.0 110.58 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 7.3 m 78.88 -40.97 0.27 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.587 -0.696 . . . . 0.0 110.54 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.603 ' CD1' ' HB2' ' A' ' 35' ' ' TRP . 20.6 t90 -73.38 104.36 4.36 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.769 -1.207 . . . . 0.0 110.099 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.452 ' OD1' ' HA ' ' A' ' 81' ' ' GLU . 65.1 m-20 -84.1 113.72 21.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.853 . . . . 0.0 110.136 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.459 ' HB2' ' CH2' ' A' ' 75' ' ' TRP . 21.8 tpt180 -87.45 -8.55 56.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.316 -0.865 . . . . 0.0 110.489 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.02 3.04 9.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 110.199 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.69 -2.9 64.98 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.85 144.27 48.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -1.114 . . . . 0.0 110.047 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.65 ' CB ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -46.16 110.67 0.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -0.929 . . . . 0.0 110.408 -179.762 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.35 179.44 3.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.212 -0.93 . . . . 0.0 109.947 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.654 HG13 ' H ' ' A' ' 85' ' ' GLY . 12.5 p -116.85 172.87 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.995 -1.066 . . . . 0.0 110.503 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.597 ' N ' HG22 ' A' ' 83' ' ' VAL . 7.5 t -57.55 -16.35 9.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.303 -0.873 . . . . 0.0 109.96 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.654 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -71.38 -14.25 74.34 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.437 ' HB3' ' O ' ' A' ' 83' ' ' VAL . 5.1 tp10 -75.63 147.75 39.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.406 -1.055 . . . . 0.0 109.67 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 68' ' ' LEU . 4.8 tt0 -157.38 162.44 39.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.212 -0.93 . . . . 0.0 109.981 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.576 ' CZ2' ' HB ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -153.34 142.04 20.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.17 -0.956 . . . . 0.0 110.232 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.859 HD13 ' O ' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -100.25 119.42 38.35 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.497 -0.752 . . . . 0.0 109.98 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.599 ' N ' HD22 ' A' ' 89' ' ' LEU . 5.3 p -97.99 150.72 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 110.749 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.1 t -148.98 51.06 0.97 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.453 -0.779 . . . . 0.0 109.903 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.649 HG22 ' OD1' ' A' ' 10' ' ' ASN . 9.2 m -82.95 139.82 33.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -0.917 . . . . 0.0 110.459 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.798 HG13 ' CA ' ' A' ' 62' ' ' GLN . 8.1 t -75.4 128.75 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.168 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.705 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 48.69 84.32 0.02 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.588 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . . . -177.61 151.46 0.74 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.111 -1.229 . . . . 0.0 110.953 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.621 ' CG ' HG21 ' A' ' 59' ' ' ILE . 1.2 t80 -116.88 112.57 21.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.021 -1.049 . . . . 0.0 110.419 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -124.94 76.71 66.62 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.183 -0.948 . . . . 0.0 110.249 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.414 ' HD3' ' CD1' ' A' ' 96' ' ' TYR . 52.8 Cg_endo -77.18 6.67 4.15 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.009 1.531 . . . . 0.0 110.967 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.589 ' CB ' ' CG ' ' A' ' 102' ' ' GLU . . . 52.41 -161.47 0.1 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.002 -1.062 . . . . 0.0 110.084 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.752 HG22 ' CD2' ' A' ' 14' ' ' HIS . 3.4 t -115.0 -62.01 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.07 -1.019 . . . . 0.0 111.19 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.636 ' CD2' ' CG ' ' A' ' 72' ' ' LYS . 4.5 m-30 -93.71 -29.65 15.3 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.767 -1.208 . . . . 0.0 111.214 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.589 ' CG ' ' CB ' ' A' ' 99' ' ' ALA . 8.6 pt-20 -80.37 161.15 25.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.965 -1.084 . . . . 0.0 110.899 -178.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.478 ' OE2' ' CD2' ' A' ' 105' ' ' LEU . 0.8 OUTLIER -136.05 164.18 28.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.364 -0.835 . . . . 0.0 110.018 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 1.017 HG12 ' CD2' ' A' ' 68' ' ' LEU . 3.9 m -76.25 139.85 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.909 . . . . 0.0 110.43 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.735 ' N ' HD23 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -94.0 -10.34 33.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.329 -0.857 . . . . 0.0 109.145 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER 166.35 -174.66 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.548 -0.72 . . . . 0.0 109.871 179.677 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 107' ' ' LEU . 4.4 mp -133.54 127.47 33.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.3 -0.875 . . . . 0.0 109.762 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.106 HG13 ' HB3' ' A' ' 65' ' ' ALA . 9.4 p -124.51 113.72 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.951 -1.093 . . . . 0.0 111.004 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -70.01 134.95 48.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.184 -0.947 . . . . 0.0 109.941 179.405 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . -88.68 53.59 2.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.423 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 110' ' ' ALA . 55.3 t -153.43 120.47 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 110.178 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.2 tt -118.49 141.56 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.227 -0.921 . . . . 0.0 110.146 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.144 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.3 m -87.63 139.54 30.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.208 -1.172 . . . . 0.0 110.19 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.474 ' O ' ' O ' ' A' ' 4' ' ' MET . 0.5 OUTLIER -44.38 131.67 6.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.344 -0.848 . . . . 0.0 110.367 -179.828 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.474 ' O ' ' O ' ' A' ' 3' ' ' HIS . 0.0 OUTLIER 58.48 120.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.186 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.454 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 7.1 tt0 -117.84 168.17 10.72 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.211 -0.931 . . . . 0.0 110.205 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.551 ' C ' ' HA3' ' A' ' 41' ' ' GLY . 7.1 p -118.4 139.51 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.157 -0.964 . . . . 0.0 109.991 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.708 HG23 ' CA ' ' A' ' 39' ' ' GLY . 2.2 p -38.85 120.45 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.31 -0.869 . . . . 0.0 111.118 -178.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.659 HD23 ' OG1' ' A' ' 11' ' ' THR . 0.0 OUTLIER -67.99 171.54 5.41 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.817 -0.552 . . . . 0.0 109.766 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 38.1 Cg_endo -64.67 73.8 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.593 1.312 . . . . 0.0 109.969 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.944 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 9.2 m-20 64.1 33.29 12.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.873 -0.517 . . . . 0.0 111.558 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.659 ' OG1' HD23 ' A' ' 8' ' ' LEU . 1.2 p -106.16 169.07 8.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.76 -1.213 . . . . 0.0 109.369 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.572 ' HB2' ' HA ' ' A' ' 38' ' ' GLU . . . -148.75 158.67 44.32 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.008 -1.057 . . . . 0.0 110.496 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.049 HD13 HD11 ' A' ' 15' ' ' LEU . 1.4 pp -127.57 156.94 41.44 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.294 -0.879 . . . . 0.0 110.896 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.512 ' C ' HD13 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -93.39 127.17 38.89 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.526 -0.734 . . . . 0.0 110.622 -179.694 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.049 HD11 HD13 ' A' ' 13' ' ' LEU . 1.1 mm? -114.21 144.66 42.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.487 -0.758 . . . . 0.0 110.151 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.553 ' HB2' HG22 ' A' ' 52' ' ' VAL . 4.2 tttp -107.75 116.54 32.13 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.241 -0.983 . . . . 0.0 109.339 178.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.024 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -79.39 120.85 24.39 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 110.074 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.752 HD12 ' OE1' ' A' ' 50' ' ' GLU . 70.6 mt -105.98 101.21 10.72 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.883 -0.511 . . . . 0.0 109.638 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.841 HD13 ' N ' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -164.04 144.1 8.14 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.074 -1.016 . . . . 0.0 110.608 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.841 ' N ' HD13 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -84.9 103.4 13.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.343 -0.848 . . . . 0.0 109.146 178.94 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.8 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -115.39 111.66 21.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 110.542 -179.067 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.554 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 7.8 tt0 -91.98 126.71 37.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.349 -0.844 . . . . 0.0 110.272 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -108.88 146.59 33.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.143 -0.973 . . . . 0.0 110.109 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.08 3.48 20.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.286 -0.884 . . . . 0.0 110.435 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.61 1.65 46.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.221 -0.925 . . . . 0.0 110.356 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.34 -17.76 54.65 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -101.0 90.41 4.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.334 -1.098 . . . . 0.0 109.72 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -107.31 164.46 12.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.24 -0.913 . . . . 0.0 110.463 -179.547 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.8 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -110.73 141.87 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.215 -0.928 . . . . 0.0 109.032 179.422 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 30' ' ' VAL . 23.1 m -131.53 90.31 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.997 -1.064 . . . . 0.0 110.686 -179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.576 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 39.98 58.34 2.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.468 -0.77 . . . . 0.0 110.74 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.91 28.05 0.22 Allowed Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.58 -1.295 . . . . 0.0 110.04 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 1.024 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 7.4 m-20 -91.98 148.35 22.27 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.08 -1.247 . . . . 0.0 110.075 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.746 ' OE1' HG11 ' A' ' 52' ' ' VAL . 5.3 tt0 -147.63 131.7 17.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.016 -1.053 . . . . 0.0 110.603 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.589 ' HH2' HG21 ' A' ' 49' ' ' VAL . 10.3 p90 -140.64 172.92 12.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.188 -0.945 . . . . 0.0 110.3 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.763 HD21 ' HB2' ' A' ' 97' ' ' LEU . 17.1 tp -106.16 156.78 18.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.488 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.499 ' N ' ' HG ' ' A' ' 36' ' ' LEU . 1.5 t80 -142.89 115.52 8.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -0.913 . . . . 0.0 110.913 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.572 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 4.3 tm-20 -84.53 141.58 30.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.532 -0.73 . . . . 0.0 109.273 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.708 ' CA ' HG23 ' A' ' 7' ' ' VAL . . . 63.43 47.73 84.76 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.771 ' HB2' HD21 ' A' ' 13' ' ' LEU . 47.1 Cg_endo -68.99 7.06 0.85 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 124.187 1.625 . . . . 0.0 112.071 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.551 ' HA3' ' C ' ' A' ' 6' ' ' VAL . . . -49.67 -57.03 10.05 Favored Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.321 -1.418 . . . . 0.0 109.56 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 61.4 p -71.93 -4.45 28.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.479 -1.012 . . . . 0.0 110.789 -179.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.778 ' OH ' HD12 ' A' ' 15' ' ' LEU . 4.3 t80 -82.67 111.5 18.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.042 -1.036 . . . . 0.0 109.732 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.538 HG23 ' HD2' ' A' ' 45' ' ' PRO . 18.2 mm -102.48 144.56 28.86 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.255 -0.903 . . . . 0.0 109.787 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.538 ' HD2' HG23 ' A' ' 44' ' ' ILE . 42.2 Cg_endo -67.8 96.3 0.43 Allowed 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.033 1.543 . . . . 0.0 111.474 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.1 147.71 23.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 109.482 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.471 ' HG3' ' N ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -50.72 -30.95 15.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.161 -0.962 . . . . 0.0 110.474 -179.572 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.471 ' N ' ' HG3' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -52.25 -25.49 9.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.129 -0.982 . . . . 0.0 110.668 -179.796 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.613 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.5 m -149.18 173.29 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.885 . . . . 0.0 109.615 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.752 ' OE1' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -132.74 134.79 45.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.052 -1.03 . . . . 0.0 110.595 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.434 HG23 ' H ' ' A' ' 51' ' ' VAL . 9.0 t -54.79 130.78 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 109.128 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.879 HG12 ' OE2' ' A' ' 53' ' ' GLU . 5.3 t -104.54 -62.24 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.366 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.967 ' O ' HD13 ' A' ' 54' ' ' ILE . 2.4 mm-40 -146.29 173.72 12.0 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.547 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.967 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.3 mm -133.68 145.88 32.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.503 HD13 ' N ' ' A' ' 56' ' ' GLN . 0.4 OUTLIER -136.71 139.05 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.914 -1.116 . . . . 0.0 110.923 -178.824 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.515 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 2.8 mp0 -88.75 159.63 17.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.574 -0.704 . . . . 0.0 109.939 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.944 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -94.84 138.06 33.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.286 -0.884 . . . . 0.0 110.222 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 1.7 t 178.48 58.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.988 -1.07 . . . . 0.0 111.903 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.58 HG22 ' O ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER -166.04 -52.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.605 -1.31 . . . . 0.0 111.201 178.81 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.574 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 10.5 mt -62.45 161.23 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.655 -1.278 . . . . 0.0 109.552 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.469 ' HB2' ' HB2' ' A' ' 64' ' ' GLN . 1.0 OUTLIER -96.38 -168.43 1.73 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.1 -1.0 . . . . 0.0 110.818 -179.37 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.81 ' HA ' HG13 ' A' ' 93' ' ' VAL . 7.5 tt0 -89.03 -17.5 29.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.323 -0.861 . . . . 0.0 111.116 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.93 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 2.4 p-10 -115.96 -36.34 4.17 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 110.266 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.469 ' HB2' ' HB2' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -55.54 132.05 47.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 111.175 -179.596 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.007 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -109.9 149.71 29.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.384 -0.823 . . . . 0.0 109.381 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.715 ' O ' HG12 ' A' ' 90' ' ' VAL . 0.7 OUTLIER -119.01 123.9 45.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.831 -1.168 . . . . 0.0 110.948 -179.469 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.603 ' HG2' HD22 ' A' ' 105' ' ' LEU . 7.9 ttt180 -91.5 120.91 32.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 109.255 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.626 HD13 ' C ' ' A' ' 103' ' ' GLU . 2.5 mm? -112.66 137.49 50.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.186 -0.946 . . . . 0.0 111.256 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.58 ' CB ' HD11 ' A' ' 105' ' ' LEU . 7.5 ttt180 -128.12 150.53 49.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.539 -0.725 . . . . 0.0 109.466 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.769 ' HB2' ' HG2' ' A' ' 86' ' ' GLU . . . -62.84 136.76 58.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.053 -1.029 . . . . 0.0 110.603 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.504 ' HG3' ' HD2' ' A' ' 72' ' ' LYS . 34.8 tpt85 -107.52 -26.3 10.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.252 -0.905 . . . . 0.0 110.022 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.646 ' HG3' ' CD2' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -143.83 34.7 1.26 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.22 -0.925 . . . . 0.0 110.332 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.57 ' O ' ' CB ' ' A' ' 74' ' ' CYS . 1.1 pt-20 38.76 -162.13 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.585 -0.697 . . . . 0.0 110.447 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.57 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER 77.43 -35.21 0.21 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.382 -0.824 . . . . 0.0 111.156 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.578 ' CB ' ' HB2' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -73.87 113.13 10.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.91 -1.119 . . . . 0.0 109.665 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 79' ' ' GLY . 11.0 t0 -78.17 109.96 12.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.345 -0.847 . . . . 0.0 110.839 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.56 ' HB2' ' CZ2' ' A' ' 75' ' ' TRP . 1.4 tpm_? -88.68 -41.8 12.37 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.281 -0.887 . . . . 0.0 109.79 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -102.95 -9.07 20.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.356 -0.84 . . . . 0.0 110.128 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.498 ' N ' ' OD1' ' A' ' 76' ' ' ASP . . . 103.56 -4.6 47.21 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 81' ' ' GLU . 2.1 mttt -103.63 2.13 32.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -1.167 . . . . 0.0 110.132 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.466 ' OE2' ' OD2' ' A' ' 33' ' ' ASP . 43.5 mm-40 57.32 110.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 110.083 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.44 ' HB2' ' CD ' ' A' ' 86' ' ' GLU . 1.5 mmm-85 -113.8 179.87 3.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.465 -0.772 . . . . 0.0 110.641 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.929 HG13 ' H ' ' A' ' 85' ' ' GLY . 5.8 p -87.56 169.91 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.415 -0.803 . . . . 0.0 110.653 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.679 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -48.55 -23.03 0.86 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.304 -0.873 . . . . 0.0 110.138 179.754 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.929 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -64.66 -34.58 90.29 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.769 ' HG2' ' HB2' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -50.19 162.51 0.21 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.171 -1.193 . . . . 0.0 109.727 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.459 ' HB3' ' HG3' ' A' ' 69' ' ' ARG . 7.8 pt-20 -159.13 151.22 21.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.145 -0.972 . . . . 0.0 110.655 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.521 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -133.0 148.44 52.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.431 -0.793 . . . . 0.0 109.106 179.579 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.928 HD23 ' H ' ' A' ' 90' ' ' VAL . 1.1 tt -109.3 162.23 14.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.176 -0.952 . . . . 0.0 110.15 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.928 ' H ' HD23 ' A' ' 89' ' ' LEU . 14.3 p -137.0 117.78 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.156 -0.965 . . . . 0.0 110.556 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.66 38.27 3.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.396 -0.815 . . . . 0.0 109.789 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.52 ' CG2' ' OD1' ' A' ' 10' ' ' ASN . 2.2 m -88.62 133.78 34.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.848 . . . . 0.0 110.568 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.81 HG13 ' HA ' ' A' ' 62' ' ' GLN . 76.5 t -76.8 147.46 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.317 -0.865 . . . . 0.0 109.871 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.653 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 44.97 82.35 0.03 OUTLIER Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.703 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . . . -165.31 145.84 7.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.33 -1.1 . . . . 0.0 110.393 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.573 ' O ' ' CD1' ' A' ' 96' ' ' TYR . 3.2 t80 -124.81 -13.59 6.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.598 -0.689 . . . . 0.0 110.859 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.763 ' HB2' HD21 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -40.87 98.93 0.19 Allowed Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.151 -0.968 . . . . 0.0 110.185 -179.708 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.712 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 50.2 Cg_endo -86.88 11.63 3.21 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.169 1.615 . . . . 0.0 111.018 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 98' ' ' PRO . . . 67.99 -158.97 0.21 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.027 -1.046 . . . . 0.0 110.111 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.478 HG21 ' HG2' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -123.93 -55.45 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.061 -1.025 . . . . 0.0 110.897 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.646 ' CD2' ' HG3' ' A' ' 72' ' ' LYS . 7.5 m-85 -98.68 -4.54 33.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.869 -1.145 . . . . 0.0 110.159 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.563 ' HG2' ' CH2' ' A' ' 75' ' ' TRP . 6.9 mt-10 -91.05 121.93 33.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.293 -0.88 . . . . 0.0 110.733 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.626 ' C ' HD13 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -102.19 143.32 32.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.411 -0.806 . . . . 0.0 109.975 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 104' ' ' VAL . 3.6 m -71.39 134.08 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.062 -1.024 . . . . 0.0 110.426 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.603 HD22 ' HG2' ' A' ' 67' ' ' ARG . 3.0 mp -84.83 -16.02 42.78 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.447 -0.783 . . . . 0.0 109.168 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 3.2 p30 160.85 -165.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.456 ' HB3' ' NE2' ' A' ' 64' ' ' GLN . 3.4 mp -123.1 109.76 14.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.35 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.007 HG13 ' HB3' ' A' ' 65' ' ' ALA . 10.0 p -97.19 161.55 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.474 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 110' ' ' ALA . 8.8 p-10 -104.65 131.78 51.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.852 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.93 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . -38.4 148.73 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.476 -0.765 . . . . 0.0 110.942 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.629 ' O ' HG22 ' A' ' 111' ' ' VAL . 2.4 p -131.12 79.73 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -0.866 . . . . 0.0 109.951 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.409 ' H ' HG23 ' A' ' 112' ' ' ILE . 0.9 OUTLIER -60.04 163.49 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.9 . . . . 0.0 110.09 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.697 HD13 ' C ' ' A' ' 113' ' ' LEU . 3.1 tm? . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.048 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 0.7 OUTLIER -137.95 -163.3 1.42 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.269 -1.136 . . . . 0.0 110.18 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' A' ' 2' ' ' SER . 2.6 m170 58.93 149.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 110.144 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.469 ' O ' ' O ' ' A' ' 3' ' ' HIS . 1.1 mtp 54.12 107.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.302 -0.874 . . . . 0.0 110.058 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.461 ' O ' ' O ' ' A' ' 41' ' ' GLY . 0.2 OUTLIER -99.29 164.76 11.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.143 -0.973 . . . . 0.0 110.757 -179.571 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.509 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 55.6 t -97.82 157.5 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.381 -0.825 . . . . 0.0 109.524 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.527 ' HA ' ' CA ' ' A' ' 41' ' ' GLY . 48.7 t -38.06 102.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.51 -0.744 . . . . 0.0 110.766 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.903 HD22 ' CG ' ' A' ' 40' ' ' PRO . 1.6 mp -47.73 137.49 9.91 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 110.288 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.672 ' O ' HG23 ' A' ' 11' ' ' THR . 48.4 Cg_endo -73.87 85.05 1.38 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.986 1.519 . . . . 0.0 110.618 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.888 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 9.4 m-20 56.64 48.36 16.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.214 -0.929 . . . . 0.0 110.578 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 9' ' ' PRO . 61.3 p -143.56 170.89 14.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.079 -1.013 . . . . 0.0 110.696 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.866 ' HB2' HD21 ' A' ' 97' ' ' LEU . . . -146.31 159.79 42.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.495 -0.753 . . . . 0.0 110.107 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.877 HD23 ' HG3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -133.3 152.71 51.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 109.983 179.493 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 1.02 ' C ' HD13 ' A' ' 15' ' ' LEU . 32.2 m80 -92.71 133.85 35.61 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.157 -0.964 . . . . 0.0 111.521 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.092 HD21 ' HB2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -124.21 153.85 41.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.419 -0.801 . . . . 0.0 109.274 178.781 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.547 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 8.5 ttmt -107.65 117.1 33.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.984 -1.073 . . . . 0.0 109.277 178.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.006 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -78.6 110.84 14.09 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.318 -0.864 . . . . 0.0 110.123 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 48' ' ' GLU . 82.6 mt -98.53 101.13 12.46 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.365 0.602 . . . . 0.0 109.72 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.544 HD13 ' N ' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -163.87 136.54 5.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.202 -0.936 . . . . 0.0 110.081 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.544 ' N ' HD13 ' A' ' 19' ' ' LEU . 80.3 m-20 -78.43 104.36 8.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 0.0 109.702 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.676 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -127.36 126.3 42.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.147 -0.97 . . . . 0.0 110.587 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -120.32 126.05 49.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.385 -0.822 . . . . 0.0 110.02 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.517 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -67.05 167.39 11.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.188 -0.945 . . . . 0.0 110.439 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.68 -24.85 23.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.328 -0.857 . . . . 0.0 110.229 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.76 -27.07 68.47 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.396 -0.815 . . . . 0.0 110.197 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 22' ' ' GLU . . . 146.01 -54.29 0.55 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.418 ' HA ' ' CB ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -155.7 148.58 24.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.223 -1.163 . . . . 0.0 110.238 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . 5.3 tptp -147.14 -73.66 0.21 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 110.459 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.845 HG12 ' HG2' ' A' ' 81' ' ' GLU . 2.0 m -103.54 139.79 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.206 -0.934 . . . . 0.0 109.653 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.67 ' O ' HG23 ' A' ' 30' ' ' VAL . 35.7 m -142.0 84.93 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 110.482 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.55 67.37 0.82 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.482 -0.761 . . . . 0.0 110.481 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -179.26 26.44 0.05 OUTLIER Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.592 -1.289 . . . . 0.0 110.587 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 1.006 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 15.7 m-20 -87.99 150.42 23.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.821 -1.4 . . . . 0.0 110.217 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 80.4 tt0 -145.3 130.8 18.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.134 -0.979 . . . . 0.0 110.052 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.873 ' CE2' HD23 ' A' ' 15' ' ' LEU . 8.0 p90 -143.03 166.01 25.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.042 -1.036 . . . . 0.0 110.715 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.584 HD13 ' NE2' ' A' ' 14' ' ' HIS . 56.2 tp -90.17 153.72 20.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.454 -0.779 . . . . 0.0 109.942 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 1.092 ' HB2' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -119.98 109.62 15.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.763 -1.211 . . . . 0.0 110.38 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.527 ' HB2' ' CD2' ' A' ' 97' ' ' LEU . 0.4 OUTLIER -90.71 127.0 36.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.422 -0.799 . . . . 0.0 110.186 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.57 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 57.98 46.86 92.03 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.903 ' CG ' HD22 ' A' ' 8' ' ' LEU . 37.8 Cg_endo -62.85 -21.65 73.26 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.87 1.458 . . . . 0.0 110.095 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.527 ' CA ' ' HA ' ' A' ' 7' ' ' VAL . . . 30.97 -92.09 0.01 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.712 ' O ' HD12 ' A' ' 44' ' ' ILE . 30.2 p -86.21 34.78 0.63 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.38 -1.07 . . . . 0.0 111.666 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.485 ' CE2' HD11 ' A' ' 13' ' ' LEU . 14.4 t80 -69.45 111.36 5.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.772 -1.205 . . . . 0.0 109.592 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.712 HD12 ' O ' ' A' ' 42' ' ' THR . 2.5 mp -103.57 142.58 24.88 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 109.839 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.578 ' HD2' HG23 ' A' ' 44' ' ' ILE . 44.4 Cg_endo -70.96 109.6 2.59 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.007 1.53 . . . . 0.0 110.801 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 49' ' ' VAL . 80.4 mtt180 -111.85 143.81 42.2 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.364 -0.835 . . . . 0.0 110.015 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 46' ' ' ARG . 14.4 pttp -43.55 -38.28 2.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.099 -1.0 . . . . 0.0 110.094 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 8.8 mt-10 -44.89 -43.83 9.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.171 -0.956 . . . . 0.0 110.231 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.748 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.6 m -136.49 173.33 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.326 -0.859 . . . . 0.0 109.99 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -136.06 139.82 43.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.098 -1.001 . . . . 0.0 110.526 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 51' ' ' VAL . 17.1 t -54.74 130.58 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.186 -0.946 . . . . 0.0 109.587 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 15' ' ' LEU . 16.9 t -109.73 -62.39 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.267 -0.896 . . . . 0.0 110.396 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.858 ' O ' HD13 ' A' ' 54' ' ' ILE . 3.2 mt-10 -139.03 173.08 11.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.035 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.858 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.4 mm -131.72 150.55 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 12' ' ' ALA . 0.4 OUTLIER -143.55 144.95 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.84 -1.163 . . . . 0.0 110.883 -179.025 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.459 ' HA ' HG22 ' A' ' 11' ' ' THR . 3.8 mp0 -115.88 169.77 8.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.524 -0.735 . . . . 0.0 109.767 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.888 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -89.11 139.09 30.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 110.078 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.452 ' O ' HG12 ' A' ' 59' ' ' ILE . 2.6 t -169.97 51.4 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 110.261 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.735 HG22 HG13 ' A' ' 60' ' ' ILE . 7.1 mm -146.83 -82.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.085 -1.009 . . . . 0.0 110.631 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.886 HD13 ' HG2' ' A' ' 64' ' ' GLN . 13.3 mt -111.88 -102.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.803 -1.186 . . . . 0.0 110.704 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.535 ' N ' ' HA ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER -175.99 -144.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.848 -1.158 . . . . 0.0 110.822 -179.633 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.963 ' HB2' HG13 ' A' ' 93' ' ' VAL . 6.1 tt0 -87.98 -66.41 0.92 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.511 -0.743 . . . . 0.0 110.884 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.506 ' HA ' ' HB3' ' A' ' 110' ' ' ALA . 3.3 m-20 -31.25 -58.7 0.24 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.299 0.571 . . . . 0.0 110.786 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.886 ' HG2' HD13 ' A' ' 60' ' ' ILE . 2.8 tp-100 -59.87 129.22 40.79 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.224 -0.923 . . . . 0.0 109.66 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.674 ' C ' HD22 ' A' ' 66' ' ' LEU . . . -108.15 146.73 32.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.969 -1.082 . . . . 0.0 110.264 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.708 HD12 HG21 ' A' ' 104' ' ' VAL . 4.0 mm? -121.27 116.34 24.67 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.134 -0.979 . . . . 0.0 109.89 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.687 ' O ' HD23 ' A' ' 68' ' ' LEU . 16.3 ttp180 -90.14 132.47 35.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.064 -1.022 . . . . 0.0 110.01 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 67' ' ' ARG . 12.6 mt -124.14 143.27 50.58 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.522 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.513 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 2.5 ttt180 -117.62 138.88 51.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.714 -0.616 . . . . 0.0 109.577 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -58.33 152.67 17.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.223 -0.923 . . . . 0.0 110.359 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.81 ' C ' HG22 ' A' ' 84' ' ' THR . 8.8 ttt180 -143.48 -11.79 0.7 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.158 -0.964 . . . . 0.0 111.778 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.597 ' HG2' ' CE1' ' A' ' 101' ' ' PHE . 5.4 tppt? -114.57 -4.92 12.78 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.635 -1.29 . . . . 0.0 111.021 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.523 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 7.8 tt0 54.55 69.64 0.7 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.892 -1.13 . . . . 0.0 109.689 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 2.6 t -172.81 -31.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.308 -0.87 . . . . 0.0 110.261 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.594 ' CB ' ' HB2' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -74.16 126.76 31.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.146 -0.972 . . . . 0.0 110.118 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.538 ' HB3' ' N ' ' A' ' 81' ' ' GLU . 39.3 p-10 -101.08 110.34 22.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.156 -0.965 . . . . 0.0 109.905 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.568 ' HB2' ' CZ2' ' A' ' 75' ' ' TRP . 2.3 tpm_? -80.05 -38.08 32.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.391 -0.818 . . . . 0.0 110.032 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.35 24.05 13.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.878 . . . . 0.0 110.108 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.92 9.71 80.23 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 81' ' ' GLU . 30.4 mtpt -130.12 87.97 2.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -1.076 . . . . 0.0 110.038 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.845 ' HG2' HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -43.2 118.48 1.32 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.918 . . . . 0.0 109.58 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.551 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 1.4 ttm180 -117.23 179.67 3.97 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 0.0 110.779 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.608 HG22 ' N ' ' A' ' 84' ' ' THR . 7.4 p -82.51 172.36 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.507 -0.745 . . . . 0.0 110.628 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.81 HG22 ' C ' ' A' ' 71' ' ' ARG . 45.7 p -52.65 -26.39 13.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.353 -0.842 . . . . 0.0 109.99 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -55.96 -43.71 87.83 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.551 ' CB ' ' HB3' ' A' ' 82' ' ' ARG . 12.4 tp10 -55.96 153.52 8.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.403 -1.057 . . . . 0.0 109.527 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.513 ' HB3' ' HG3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -159.47 156.18 27.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.064 -1.022 . . . . 0.0 110.602 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.49 ' CZ2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -142.58 151.12 41.22 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.283 -0.886 . . . . 0.0 109.604 179.679 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.894 HD23 ' H ' ' A' ' 90' ' ' VAL . 1.8 tt -102.21 154.01 19.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.325 -0.86 . . . . 0.0 109.901 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.894 ' H ' HD23 ' A' ' 89' ' ' LEU . 49.4 t -114.2 107.95 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.385 -0.822 . . . . 0.0 110.396 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 91' ' ' THR . 28.9 m -121.47 25.85 9.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.923 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.511 HG21 ' HG3' ' A' ' 38' ' ' GLU . 12.2 t -76.85 171.36 14.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.381 -0.824 . . . . 0.0 110.403 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.963 HG13 ' HB2' ' A' ' 62' ' ' GLN . 3.9 t -92.22 75.81 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 0.0 110.027 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.472 ' HA2' ' HB3' ' A' ' 10' ' ' ASN . . . -128.01 -85.82 0.5 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.712 ' HB1' ' H ' ' A' ' 59' ' ' ILE . . . -177.18 -38.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.362 -1.081 . . . . 0.0 109.707 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.608 ' CD1' ' HB ' ' A' ' 59' ' ' ILE . 3.4 p90 179.92 40.81 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.697 -0.627 . . . . 0.0 109.94 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.866 HD21 ' HB2' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -41.68 103.97 0.33 Allowed Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.281 -0.887 . . . . 0.0 110.155 -179.73 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.718 ' O ' ' HB2' ' A' ' 99' ' ' ALA . 46.7 Cg_endo -72.09 -98.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.08 1.569 . . . . 0.0 110.277 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.718 ' HB2' ' O ' ' A' ' 98' ' ' PRO . . . 169.11 -156.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.769 -1.207 . . . . 0.0 110.156 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.514 HG23 ' CD2' ' A' ' 14' ' ' HIS . 0.3 OUTLIER -128.31 -32.03 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 110.806 -179.563 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.597 ' CE1' ' HG2' ' A' ' 72' ' ' LYS . 1.7 m-85 -130.48 -6.86 4.19 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.75 -1.219 . . . . 0.0 110.897 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.58 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 1.2 pt-20 -110.86 157.73 19.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.013 -1.055 . . . . 0.0 110.675 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.57 166.06 13.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.355 -0.841 . . . . 0.0 109.846 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.708 HG21 HD12 ' A' ' 66' ' ' LEU . 11.5 p -95.63 152.61 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.142 -0.974 . . . . 0.0 110.469 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.834 ' N ' HD22 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -102.55 -34.71 9.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.367 -0.833 . . . . 0.0 109.508 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -164.97 -163.88 0.74 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.557 -0.715 . . . . 0.0 109.63 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.897 ' N ' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -136.93 163.71 30.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 110.578 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 64' ' ' GLN . 33.7 t -138.95 150.48 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.843 . . . . 0.0 110.169 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.455 ' CG ' ' O ' ' A' ' 109' ' ' ASP . 1.7 p-10 -111.67 115.13 28.61 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.882 -1.136 . . . . 0.0 109.81 178.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.506 ' HB3' ' HA ' ' A' ' 63' ' ' ASN . . . -78.02 177.2 8.48 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.981 -1.074 . . . . 0.0 110.595 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.44 160.49 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.335 -0.853 . . . . 0.0 109.843 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.5 mm -72.11 137.4 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.292 -0.88 . . . . 0.0 110.271 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.265 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.436 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.11 -69.04 0.34 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -1.193 . . . . 0.0 110.227 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.453 ' O ' ' HB3' ' A' ' 4' ' ' MET . 77.5 m80 -92.47 125.42 37.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.176 -0.952 . . . . 0.0 110.262 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.504 ' CG ' ' N ' ' A' ' 5' ' ' GLN . 5.6 ttp 57.33 168.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.933 . . . . 0.0 110.074 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.504 ' N ' ' CG ' ' A' ' 4' ' ' MET . 0.0 OUTLIER 176.49 -173.91 0.1 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.148 -0.97 . . . . 0.0 110.384 179.807 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.51 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 41.5 t -113.47 160.04 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 0.0 109.718 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.495 ' CA ' ' HA3' ' A' ' 41' ' ' GLY . 21.5 t -35.56 99.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.65 -0.656 . . . . 0.0 110.855 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.79 HD23 ' OG1' ' A' ' 11' ' ' THR . 2.5 mp -47.45 147.23 2.96 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.458 -0.776 . . . . 0.0 110.865 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 10' ' ' ASN . 50.4 Cg_endo -76.98 69.0 7.17 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.134 1.597 . . . . 0.0 110.462 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.661 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 0.9 OUTLIER 67.68 49.0 1.0 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.21 -0.931 . . . . 0.0 110.741 179.792 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.79 ' OG1' HD23 ' A' ' 8' ' ' LEU . 33.1 p -137.13 171.35 14.62 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.278 -0.889 . . . . 0.0 109.792 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.741 ' HB2' HD21 ' A' ' 97' ' ' LEU . . . -144.3 161.97 37.59 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.954 -1.091 . . . . 0.0 110.785 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.749 HD11 HD11 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -134.04 152.2 51.74 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.244 -0.91 . . . . 0.0 110.419 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.747 ' CE1' HD13 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -88.03 128.19 35.4 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.143 -0.973 . . . . 0.0 110.727 -179.672 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.749 HD11 HD11 ' A' ' 13' ' ' LEU . 2.7 mm? -115.99 148.0 40.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.497 -0.752 . . . . 0.0 110.579 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.708 ' HB2' HG22 ' A' ' 52' ' ' VAL . 1.7 ttmt -114.16 116.85 29.75 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.239 -0.984 . . . . 0.0 108.889 177.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.082 ' HB3' ' HB3' ' A' ' 33' ' ' ASP . . . -80.43 121.95 26.37 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.954 -1.091 . . . . 0.0 109.936 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 69.3 mt -98.66 99.89 11.05 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.493 0.663 . . . . 0.0 109.711 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.501 HD13 ' N ' ' A' ' 20' ' ' ASP . 0.4 OUTLIER -166.73 130.06 1.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.503 -0.748 . . . . 0.0 109.669 -179.797 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.501 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -71.62 101.34 2.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.083 -1.011 . . . . 0.0 110.019 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.749 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -129.51 71.38 1.44 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.903 . . . . 0.0 109.969 -179.88 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.496 ' HA ' ' HB3' ' A' ' 28' ' ' LYS . 4.7 tt0 -102.39 114.92 29.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.273 -0.892 . . . . 0.0 110.381 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -81.36 177.39 9.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 110.064 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.7 4.01 12.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 110.35 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.95 -25.44 68.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.317 -0.865 . . . . 0.0 110.166 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.16 -37.75 1.89 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.57 96.56 0.05 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.297 -1.119 . . . . 0.0 110.472 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.565 ' HG2' HG13 ' A' ' 29' ' ' VAL . 3.1 tptt -99.67 -107.71 0.21 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.166 -0.959 . . . . 0.0 109.892 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.749 HG22 ' CB ' ' A' ' 21' ' ' PHE . 1.7 m -112.03 137.04 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.767 -1.208 . . . . 0.0 109.189 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.667 ' O ' HG23 ' A' ' 30' ' ' VAL . 29.6 m -138.85 90.18 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.135 -0.978 . . . . 0.0 110.545 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 46.75 51.61 12.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.864 . . . . 0.0 110.436 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -176.7 25.37 0.06 OUTLIER Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.152 -1.499 . . . . 0.0 111.061 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 1.082 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -66.66 149.84 49.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.508 -1.584 . . . . 0.0 109.011 179.091 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.635 ' CG ' ' CZ ' ' A' ' 101' ' ' PHE . 1.2 pm0 -148.47 138.66 22.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.557 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.418 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 10.1 p90 -158.86 164.68 35.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.335 -0.853 . . . . 0.0 109.816 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.747 HD13 ' CE1' ' A' ' 14' ' ' HIS . 60.6 tp -90.82 156.14 18.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.004 -1.06 . . . . 0.0 109.66 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.731 ' HB2' HD23 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -126.1 114.13 17.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.055 -1.028 . . . . 0.0 110.183 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -84.77 129.38 34.83 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.275 0.559 . . . . 0.0 109.983 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.61 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 64.77 44.33 94.95 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.731 ' HG2' HD22 ' A' ' 8' ' ' LEU . 55.8 Cg_endo -77.48 17.74 0.89 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.604 1.318 . . . . 0.0 110.875 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.578 ' HA2' HD13 ' A' ' 8' ' ' LEU . . . -49.21 -41.99 31.59 Favored Glycine 0 N--CA 1.488 2.114 0 O-C-N 120.755 -1.216 . . . . 0.0 110.367 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.8 p -93.73 19.74 8.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.038 -1.272 . . . . 0.0 110.974 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.61 ' C ' HD12 ' A' ' 44' ' ' ILE . 21.8 t80 -85.45 133.36 34.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.124 -0.985 . . . . 0.0 110.019 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.61 HD12 ' C ' ' A' ' 43' ' ' TYR . 1.5 mp -119.73 145.31 39.02 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.359 -0.838 . . . . 0.0 109.006 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.52 ' HD2' HG23 ' A' ' 44' ' ' ILE . 40.9 Cg_endo -66.89 109.53 1.71 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.869 1.457 . . . . 0.0 110.713 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -111.59 149.58 31.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.462 -0.774 . . . . 0.0 110.246 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -53.07 -29.1 28.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.859 . . . . 0.0 110.312 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.486 ' C ' ' CG1' ' A' ' 49' ' ' VAL . 20.4 tt0 -59.81 -21.69 61.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.173 -0.954 . . . . 0.0 110.512 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.553 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.9 m -150.92 170.8 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.292 -0.88 . . . . 0.0 110.33 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -131.54 138.0 48.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.198 -0.939 . . . . 0.0 110.099 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.434 HG23 ' H ' ' A' ' 51' ' ' VAL . 6.6 t -58.63 125.55 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.716 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.708 HG22 ' HB2' ' A' ' 16' ' ' LYS . 2.8 t -102.27 -63.32 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.276 -0.89 . . . . 0.0 110.291 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.591 ' O ' HD13 ' A' ' 54' ' ' ILE . 3.4 mt-10 -144.01 166.49 24.82 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.18 -0.95 . . . . 0.0 110.252 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.591 HD13 ' O ' ' A' ' 53' ' ' GLU . 2.6 mm -128.71 148.65 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.725 HD11 ' OH ' ' A' ' 96' ' ' TYR . 0.5 OUTLIER -141.6 130.39 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.591 -1.318 . . . . 0.0 111.59 -178.859 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.45 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 23.1 mp0 -94.8 176.0 6.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.589 -0.694 . . . . 0.0 109.708 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.818 ' HB1' ' HB2' ' A' ' 95' ' ' ALA . . . -102.02 144.61 30.4 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.159 -0.963 . . . . 0.0 110.63 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER 170.61 59.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.156 -0.965 . . . . 0.0 111.984 179.53 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.662 HG23 ' H ' ' A' ' 60' ' ' ILE . 1.2 tt -172.71 -60.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.277 -1.515 . . . . 0.0 112.649 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.662 ' H ' HG23 ' A' ' 59' ' ' ILE . 18.8 mm -80.81 169.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.36 -1.463 . . . . 0.0 110.835 -178.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.449 ' N ' HG22 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -109.33 -159.7 0.69 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.474 -0.766 . . . . 0.0 110.326 -179.773 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.987 ' HB2' HG13 ' A' ' 93' ' ' VAL . 14.1 tt0 -91.14 -68.64 0.78 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.327 -0.858 . . . . 0.0 110.295 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.651 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 2.1 m-20 -38.23 -50.97 1.46 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.75 -0.594 . . . . 0.0 110.97 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.486 ' NE2' ' O ' ' A' ' 108' ' ' VAL . 7.9 tp60 -59.69 137.4 58.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.082 -1.011 . . . . 0.0 110.852 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.969 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -127.41 148.95 50.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.412 -0.805 . . . . 0.0 110.069 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.656 HD11 HG21 ' A' ' 60' ' ' ILE . 2.6 mp -127.05 118.13 23.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.318 -0.864 . . . . 0.0 110.152 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.599 ' O ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -91.66 128.26 37.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.002 -1.061 . . . . 0.0 110.029 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.752 HD11 HG21 ' A' ' 90' ' ' VAL . 15.6 mt -120.33 139.85 52.15 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.05 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -120.02 157.54 28.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.483 -0.761 . . . . 0.0 109.754 179.329 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.877 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -68.95 124.58 24.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 111.353 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -84.33 -23.09 30.37 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.503 ' HG2' ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -156.73 146.56 20.89 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.552 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 74' ' ' CYS . 1.9 pt-20 -56.96 -156.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.036 -1.04 . . . . 0.0 110.341 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 6.6 m 77.34 -43.45 0.42 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.525 -0.734 . . . . 0.0 110.889 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.718 ' HZ3' ' HB2' ' A' ' 70' ' ' ALA . 8.3 t90 -74.15 110.94 8.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.793 -1.192 . . . . 0.0 110.353 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 76' ' ' ASP . 2.4 p30 -91.2 127.05 36.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.205 -0.934 . . . . 0.0 110.003 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -86.08 -40.5 15.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 110.039 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.01 -28.79 25.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.166 -0.959 . . . . 0.0 110.275 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 80' ' ' LYS . . . 139.86 -52.29 0.71 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -61.05 -131.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -1.179 . . . . 0.0 109.741 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.535 ' CD ' HG11 ' A' ' 29' ' ' VAL . 15.0 mm-40 -136.97 121.78 18.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.826 -1.171 . . . . 0.0 110.464 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.36 173.26 8.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.535 -0.728 . . . . 0.0 109.888 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.62 HG13 ' H ' ' A' ' 85' ' ' GLY . 13.5 p -88.87 173.03 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 0.0 110.568 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.877 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 10.1 t -67.45 -12.53 60.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.863 . . . . 0.0 110.006 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.62 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -63.49 -14.65 55.2 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.635 ' HG3' ' CZ3' ' A' ' 75' ' ' TRP . 8.4 pt-20 -79.25 166.42 22.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.417 -1.049 . . . . 0.0 109.526 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.496 ' HA ' ' OE2' ' A' ' 102' ' ' GLU . 5.8 pt-20 -157.9 153.55 26.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.808 -1.183 . . . . 0.0 110.774 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.509 ' CE2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -128.38 144.24 51.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.392 -0.817 . . . . 0.0 109.716 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.897 HD23 ' H ' ' A' ' 90' ' ' VAL . 1.4 tt -106.2 158.42 16.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.211 -0.931 . . . . 0.0 110.123 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.897 ' H ' HD23 ' A' ' 89' ' ' LEU . 16.6 t -122.23 136.65 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 0.0 110.571 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.587 HG23 ' C ' ' A' ' 90' ' ' VAL . 61.0 p -155.72 60.26 0.61 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 109.641 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.686 HG21 ' HB3' ' A' ' 95' ' ' ALA . 14.6 t -85.29 167.93 15.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.399 -0.813 . . . . 0.0 110.627 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.987 HG13 ' HB2' ' A' ' 62' ' ' GLN . 3.3 t -108.18 67.17 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.385 -0.822 . . . . 0.0 109.768 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 60' ' ' ILE . . . 110.04 62.85 0.52 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.818 ' HB2' ' HB1' ' A' ' 57' ' ' ALA . . . -174.72 -153.14 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.332 -1.099 . . . . 0.0 110.426 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.725 ' OH ' HD11 ' A' ' 55' ' ' ILE . 2.3 p90 176.46 119.11 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.741 HD21 ' HB2' ' A' ' 12' ' ' ALA . 2.6 mp -106.19 95.65 11.7 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 111.457 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.488 ' O ' ' O ' ' A' ' 99' ' ' ALA . 47.0 Cg_endo -74.94 87.19 1.34 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.9 1.474 . . . . 0.0 108.887 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.597 ' HB3' ' HB2' ' A' ' 102' ' ' GLU . . . -50.05 -172.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.404 -0.81 . . . . 0.0 111.261 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 t -99.47 -66.33 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.433 -0.792 . . . . 0.0 110.496 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.635 ' CZ ' ' CG ' ' A' ' 34' ' ' GLU . 21.5 m-30 -100.15 22.23 11.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.936 -1.102 . . . . 0.0 110.57 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.597 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 2.4 mm-40 -111.56 120.29 41.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.964 -1.085 . . . . 0.0 110.397 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -100.13 156.26 17.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.352 -0.843 . . . . 0.0 110.188 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.649 HG12 HD22 ' A' ' 68' ' ' LEU . 3.5 m -81.87 138.39 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 110.26 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.592 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 3.0 mp -97.14 -9.58 27.62 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.318 -0.864 . . . . 0.0 109.197 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.57 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 0.4 OUTLIER 159.94 -160.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.791 -0.568 . . . . 0.0 109.622 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.875 ' C ' HD22 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -138.42 150.13 46.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.941 . . . . 0.0 110.341 178.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.969 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 14.7 p -134.07 140.66 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.128 -0.982 . . . . 0.0 110.167 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.17 117.84 35.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.881 -1.137 . . . . 0.0 110.003 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . -54.21 -78.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 110.014 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.3 t -142.35 147.1 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.357 -0.839 . . . . 0.0 110.273 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.518 HG22 ' N ' ' A' ' 113' ' ' LEU . 3.0 mt -112.83 170.93 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.346 -0.846 . . . . 0.0 109.679 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.518 ' N ' HG22 ' A' ' 112' ' ' ILE . 11.8 mt . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.093 -1.004 . . . . 0.0 110.126 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 84.8 p -115.22 83.67 1.96 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.331 -1.099 . . . . 0.0 110.206 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -164.38 128.4 2.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.907 . . . . 0.0 110.335 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.453 ' HG2' ' N ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -112.49 152.83 28.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 110.213 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.453 ' N ' ' HG2' ' A' ' 4' ' ' MET . 0.5 OUTLIER -122.22 -170.71 2.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.151 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.507 ' O ' HD12 ' A' ' 8' ' ' LEU . 9.8 p -126.61 147.24 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.163 -0.961 . . . . 0.0 110.089 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.47 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 83.4 t -41.18 107.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 110.337 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.975 HD23 ' OG1' ' A' ' 11' ' ' THR . 5.4 mp -63.24 163.94 16.21 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.391 -0.818 . . . . 0.0 110.079 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.411 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 47.3 Cg_endo -73.19 -56.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.913 1.48 . . . . 0.0 110.451 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.825 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 63.2 m-80 -158.42 31.77 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 110.174 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.975 ' OG1' HD23 ' A' ' 8' ' ' LEU . 43.9 p -106.41 171.56 7.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.342 -0.849 . . . . 0.0 110.2 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.496 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -147.24 162.46 38.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.193 -0.942 . . . . 0.0 109.93 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.776 HD11 ' HE2' ' A' ' 43' ' ' TYR . 0.6 OUTLIER -130.25 155.79 45.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.021 . . . . 0.0 110.642 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.696 ' C ' HD23 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -96.93 129.16 44.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.341 -0.849 . . . . 0.0 109.08 179.514 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.838 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -126.2 162.28 25.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.703 -1.248 . . . . 0.0 109.48 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.537 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 1.2 ttpt -113.44 118.58 34.91 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.576 -0.85 . . . . 0.0 111.029 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.118 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -73.9 113.18 10.77 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.922 0.868 . . . . 0.0 108.782 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.875 HD23 ' O ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -106.95 106.73 17.4 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.486 0.66 . . . . 0.0 110.655 -178.677 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.86 HD13 ' HG3' ' A' ' 48' ' ' GLU . 5.1 tp -166.72 146.2 5.6 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.564 -0.71 . . . . 0.0 109.903 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.3 105.0 15.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 109.827 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.882 ' HB2' HG22 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -125.14 118.52 26.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.212 -0.93 . . . . 0.0 110.318 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.54 114.98 27.25 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.141 -0.975 . . . . 0.0 110.149 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.35 145.41 48.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.158 -0.964 . . . . 0.0 110.224 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -80.57 -9.04 59.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.909 . . . . 0.0 110.207 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.2 -14.08 59.6 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.266 -0.896 . . . . 0.0 110.169 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.27 -5.42 30.12 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.18 29.09 1.11 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.117 -1.225 . . . . 0.0 110.027 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.6 ttpp -66.78 116.0 7.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.356 -0.84 . . . . 0.0 110.37 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.882 HG22 ' HB2' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -109.0 146.76 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.262 -0.899 . . . . 0.0 109.65 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 30' ' ' VAL . 27.0 m -132.41 81.37 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.07 -1.019 . . . . 0.0 109.764 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 41.31 67.47 0.54 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.617 -0.677 . . . . 0.0 110.295 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -168.47 20.26 0.08 OUTLIER Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.114 -1.517 . . . . 0.0 111.263 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 1.118 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 1.3 m-20 -88.34 150.6 23.13 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.437 -1.625 . . . . 0.0 109.406 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.506 ' HG3' HG21 ' A' ' 52' ' ' VAL . 16.5 tt0 -151.46 139.07 19.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.089 -1.007 . . . . 0.0 110.461 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.662 ' CZ2' HD12 ' A' ' 15' ' ' LEU . 8.7 p90 -154.44 177.63 10.96 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.147 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.523 HD11 ' CE1' ' A' ' 14' ' ' HIS . 0.5 OUTLIER -90.33 158.69 17.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 0.0 110.969 -179.062 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.761 ' HB2' HD21 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -141.99 110.77 6.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.386 -0.821 . . . . 0.0 109.565 179.252 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.472 ' HG2' ' HB2' ' A' ' 12' ' ' ALA . 4.1 tm-20 -93.94 149.44 21.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.205 -0.934 . . . . 0.0 111.001 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.588 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 55.91 45.52 86.2 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.615 ' HG2' HD22 ' A' ' 8' ' ' LEU . 41.8 Cg_endo -70.68 -60.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.757 1.398 . . . . 0.0 109.844 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.492 ' HA3' ' C ' ' A' ' 6' ' ' VAL . . . 41.87 -89.92 0.01 OUTLIER Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 40' ' ' PRO . 19.8 p -66.9 1.32 1.95 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.33 -1.1 . . . . 0.0 111.559 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.776 ' HE2' HD11 ' A' ' 13' ' ' LEU . 6.8 t80 -68.78 124.15 22.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.643 -1.286 . . . . 0.0 110.408 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.65 HG23 ' HD2' ' A' ' 45' ' ' PRO . 6.2 mt -115.52 145.59 34.78 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 109.064 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.65 ' HD2' HG23 ' A' ' 44' ' ' ILE . 42.6 Cg_endo -67.57 109.19 1.78 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.764 1.402 . . . . 0.0 110.751 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -102.37 144.64 30.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.4 -0.812 . . . . 0.0 109.999 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.786 ' O ' HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -37.34 -45.66 0.7 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.572 -0.705 . . . . 0.0 111.062 -179.582 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.86 ' HG3' HD13 ' A' ' 19' ' ' LEU . 11.4 tt0 -49.07 -49.07 43.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -0.964 . . . . 0.0 110.98 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.535 HG12 ' HA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -133.44 142.58 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.915 -1.115 . . . . 0.0 110.741 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -108.62 137.51 46.45 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.323 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.431 HG13 ' HB3' ' A' ' 45' ' ' PRO . 31.3 m -54.01 145.29 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.168 -0.957 . . . . 0.0 109.252 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.734 HG23 ' HA ' ' A' ' 15' ' ' LEU . 31.7 t -117.48 -58.65 3.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.048 -1.033 . . . . 0.0 110.407 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.936 ' O ' HD13 ' A' ' 54' ' ' ILE . 1.9 mt-10 -136.09 172.85 12.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.144 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.936 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.2 mm -136.18 130.73 48.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.322 -0.861 . . . . 0.0 108.828 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.638 HD13 ' H ' ' A' ' 56' ' ' GLN . 0.4 OUTLIER -125.85 144.93 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.214 -0.929 . . . . 0.0 111.162 -178.591 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.638 ' H ' HD13 ' A' ' 55' ' ' ILE . 40.7 mm-40 -100.4 174.28 6.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.468 -0.77 . . . . 0.0 109.779 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.825 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -102.25 125.68 49.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.132 -0.98 . . . . 0.0 109.96 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 3.2 t 179.29 63.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.012 -1.055 . . . . 0.0 111.872 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.533 HG21 ' CD1' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -169.68 -37.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.549 -1.344 . . . . 0.0 111.323 179.107 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 95' ' ' ALA . 9.4 mm -78.1 158.41 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.785 -1.197 . . . . 0.0 110.44 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.513 ' HB2' ' HB3' ' A' ' 64' ' ' GLN . 9.1 mtt180 -62.8 -168.84 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.283 -0.886 . . . . 0.0 110.413 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.842 ' HA ' HG13 ' A' ' 93' ' ' VAL . 9.5 tt0 -91.63 -19.92 22.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.0 110.701 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 2.7 p-10 -127.97 -19.2 4.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.905 -1.122 . . . . 0.0 110.907 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.513 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 6.4 tp-100 -51.34 126.88 18.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.031 -1.043 . . . . 0.0 111.646 -179.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.016 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -108.54 142.37 39.06 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.492 HD23 HD12 ' A' ' 107' ' ' LEU . 1.8 mp -127.59 115.04 18.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.837 -1.165 . . . . 0.0 111.882 -178.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . 4.3 ttm180 -91.36 119.6 31.51 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.71 ' CD2' HG23 ' A' ' 104' ' ' VAL . 21.6 mt -113.74 161.25 17.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 111.396 -178.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.591 ' HB2' HD21 ' A' ' 105' ' ' LEU . 15.7 mtp180 -126.57 161.88 26.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.371 -0.83 . . . . 0.0 110.179 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.888 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -82.63 152.37 25.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.202 -0.936 . . . . 0.0 111.415 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.518 ' HG3' ' N ' ' A' ' 72' ' ' LYS . 9.4 ptt180 -125.31 -27.7 3.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.453 -0.779 . . . . 0.0 109.819 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.518 ' N ' ' HG3' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -124.49 118.46 26.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.283 -0.885 . . . . 0.0 109.762 179.575 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.524 ' N ' ' HB ' ' A' ' 84' ' ' THR . 4.3 pt-20 -54.51 106.82 0.23 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.202 -0.937 . . . . 0.0 110.723 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.507 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER 168.5 -43.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.285 -0.884 . . . . 0.0 110.151 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.779 ' CZ3' ' HB2' ' A' ' 70' ' ' ALA . 2.7 t90 -74.98 104.43 5.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.284 -0.885 . . . . 0.0 110.182 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.482 ' OD2' ' N ' ' A' ' 80' ' ' LYS . 3.4 t70 -96.82 122.04 39.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -0.978 . . . . 0.0 110.226 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.452 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -85.03 -0.38 54.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.886 . . . . 0.0 110.365 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.55 -4.99 8.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.954 . . . . 0.0 110.365 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 101.21 -47.25 1.21 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.482 ' N ' ' OD2' ' A' ' 76' ' ' ASP . 9.1 mmtp -69.54 98.63 1.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -1.14 . . . . 0.0 110.012 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.748 ' OE2' HG21 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -34.17 135.15 0.16 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.718 -0.614 . . . . 0.0 110.913 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.16 179.77 7.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 110.533 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.599 HG22 ' N ' ' A' ' 84' ' ' THR . 10.8 p -77.84 174.02 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.4 -0.813 . . . . 0.0 110.553 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.888 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 2.3 t -73.95 -3.52 29.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.815 . . . . 0.0 110.099 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.572 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -72.88 -13.35 78.84 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.451 ' HG3' ' CZ3' ' A' ' 75' ' ' TRP . 8.3 pt-20 -70.79 172.24 9.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -1.083 . . . . 0.0 110.058 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.452 ' HB3' ' HG2' ' A' ' 69' ' ' ARG . 5.4 pm0 -159.06 172.59 17.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 110.444 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.549 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -155.96 153.66 29.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.342 -0.849 . . . . 0.0 109.795 -179.825 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.974 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -122.25 124.97 45.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.117 -0.99 . . . . 0.0 109.954 179.558 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.974 ' N ' HD22 ' A' ' 89' ' ' LEU . 4.5 p -105.6 138.92 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.429 -0.795 . . . . 0.0 110.263 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.7 t -141.93 49.78 1.56 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.272 -0.892 . . . . 0.0 110.415 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.524 ' CG2' ' HB3' ' A' ' 10' ' ' ASN . 51.6 m -91.28 138.66 31.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -0.937 . . . . 0.0 110.281 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.842 HG13 ' HA ' ' A' ' 62' ' ' GLN . 17.5 t -71.13 140.39 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.147 -0.971 . . . . 0.0 110.15 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.563 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 43.27 80.75 0.04 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.587 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . . . -156.38 154.01 29.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -1.149 . . . . 0.0 110.861 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.539 ' O ' ' CG ' ' A' ' 96' ' ' TYR . 4.9 t80 -117.69 25.69 10.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.502 -0.749 . . . . 0.0 109.961 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 96' ' ' TYR . 2.0 mm? -34.34 91.87 0.05 OUTLIER Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.827 -0.546 . . . . 0.0 111.408 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.518 ' N ' ' O ' ' A' ' 96' ' ' TYR . 48.5 Cg_endo -91.32 115.8 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.827 1.435 . . . . 0.0 110.395 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.747 ' HB1' ' HB3' ' A' ' 102' ' ' GLU . . . -69.76 171.92 8.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.213 -0.929 . . . . 0.0 110.32 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.615 HG21 ' HA ' ' A' ' 35' ' ' TRP . 1.7 t -99.33 -58.5 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.352 -0.843 . . . . 0.0 109.447 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.655 ' HB2' ' HB3' ' A' ' 75' ' ' TRP . 22.8 m-30 -117.6 38.9 3.46 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.156 -0.965 . . . . 0.0 109.257 178.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.747 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 13.6 tt0 -132.11 133.23 44.07 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.124 -0.985 . . . . 0.0 110.879 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -105.08 171.22 7.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.389 -0.819 . . . . 0.0 110.193 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.71 HG23 ' CD2' ' A' ' 68' ' ' LEU . 7.7 p -101.31 144.56 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.172 -0.955 . . . . 0.0 110.306 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.844 ' N ' HD22 ' A' ' 105' ' ' LEU . 1.6 mm? -103.14 -40.07 6.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -0.968 . . . . 0.0 110.118 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.901 ' C ' HD13 ' A' ' 107' ' ' LEU . 1.8 p30 -161.29 171.58 18.11 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.868 . . . . 0.0 109.963 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.901 HD13 ' C ' ' A' ' 106' ' ' ASP . 0.3 OUTLIER -121.96 142.55 50.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.175 -0.953 . . . . 0.0 110.367 -179.855 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.016 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 12.6 p -125.49 157.84 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.398 -0.814 . . . . 0.0 109.499 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.405 ' O ' ' CG ' ' A' ' 109' ' ' ASP . 8.6 p-10 -110.91 121.27 44.93 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.92 -1.113 . . . . 0.0 110.704 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . -75.93 172.2 13.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 109.951 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.6 m -129.4 -29.54 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.951 -1.093 . . . . 0.0 110.876 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.417 ' O ' HG23 ' A' ' 112' ' ' ILE . 0.6 OUTLIER -144.94 27.89 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.928 -1.108 . . . . 0.0 110.69 -179.7 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.34 -179.978 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.3 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.445 ' OG ' ' HG3' ' A' ' 45' ' ' PRO . 74.6 m 45.47 -165.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.259 -1.142 . . . . 0.0 110.424 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.472 ' O ' ' CB ' ' A' ' 4' ' ' MET . 0.4 OUTLIER 60.28 13.55 4.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 0.0 110.161 -179.798 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.472 ' CB ' ' O ' ' A' ' 3' ' ' HIS . 0.2 OUTLIER 67.46 128.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.902 . . . . 0.0 110.368 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.605 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 0.6 OUTLIER -133.38 86.01 2.26 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.282 -0.886 . . . . 0.0 109.836 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.505 ' O ' ' O ' ' A' ' 5' ' ' GLN . 12.0 p -38.0 165.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.349 -0.844 . . . . 0.0 111.927 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.571 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 43.7 t -30.83 150.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 CA-C-O 121.586 0.708 . . . . 0.0 111.973 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.659 HD23 ' OG1' ' A' ' 11' ' ' THR . 6.0 mp -106.29 171.23 4.96 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.569 -0.707 . . . . 0.0 109.634 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 44.5 Cg_endo -71.35 -39.44 3.8 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.72 1.379 . . . . 0.0 110.401 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.471 ' ND2' HG21 ' A' ' 93' ' ' VAL . 3.1 m-20 172.19 37.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.338 -0.851 . . . . 0.0 109.681 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.659 ' OG1' HD23 ' A' ' 8' ' ' LEU . 69.9 p -114.58 162.72 16.38 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.329 -0.857 . . . . 0.0 110.957 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.714 ' HB3' ' HG ' ' A' ' 97' ' ' LEU . . . -135.57 161.13 36.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.378 -0.826 . . . . 0.0 109.96 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.982 HD23 ' CG ' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -133.28 153.65 51.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.167 -0.958 . . . . 0.0 110.553 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.802 ' C ' HD13 ' A' ' 15' ' ' LEU . 30.7 m80 -96.58 136.35 37.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.0 109.642 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.913 HD13 ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -135.67 167.18 21.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.126 -0.984 . . . . 0.0 110.561 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 3.2 ttmt -119.04 117.58 29.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.17 -0.956 . . . . 0.0 110.049 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.044 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -75.76 117.54 17.61 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.311 -0.868 . . . . 0.0 109.864 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 61.4 mt -108.62 100.94 10.13 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.188 0.518 . . . . 0.0 109.963 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.729 HD13 ' HG2' ' A' ' 48' ' ' GLU . 9.3 tp -163.79 144.74 8.83 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.157 -0.964 . . . . 0.0 110.294 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -85.2 110.78 19.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.379 -0.826 . . . . 0.0 109.061 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.757 ' CB ' HG22 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -128.23 112.55 14.63 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.103 -0.998 . . . . 0.0 111.103 -178.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -94.26 113.84 25.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.348 -0.845 . . . . 0.0 109.265 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.87 163.82 19.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.363 -0.836 . . . . 0.0 110.503 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.78 -31.45 18.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.297 -0.877 . . . . 0.0 110.234 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.35 -11.5 10.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.347 -0.846 . . . . 0.0 110.33 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.457 ' O ' ' CB ' ' A' ' 27' ' ' ASP . . . -87.1 5.06 85.85 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER 66.17 10.73 7.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.329 -1.101 . . . . 0.0 110.372 179.796 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 29.6 ttpt 55.94 112.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.275 -0.891 . . . . 0.0 110.391 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.757 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -90.15 150.08 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.154 -0.967 . . . . 0.0 109.794 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.561 ' O ' HG23 ' A' ' 30' ' ' VAL . 25.2 m -133.39 81.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 0.0 110.336 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 42.36 66.87 0.67 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 110.189 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.52 20.18 0.09 OUTLIER Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.373 -1.394 . . . . 0.0 110.895 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 1.044 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -89.09 152.39 21.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.478 -1.601 . . . . 0.0 108.984 179.191 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 15' ' ' LEU . 23.0 tt0 -155.23 140.12 17.25 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.907 -1.12 . . . . 0.0 110.498 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.729 ' CZ3' ' HB2' ' A' ' 17' ' ' ALA . 5.2 p90 -162.94 172.78 14.56 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.661 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.745 HD13 ' NE2' ' A' ' 14' ' ' HIS . 16.9 tp -90.53 159.93 16.23 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.394 0.616 . . . . 0.0 110.733 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.655 ' HB2' HD11 ' A' ' 15' ' ' LEU . 0.6 OUTLIER -135.38 114.77 12.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.321 -0.862 . . . . 0.0 109.952 179.629 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.476 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -86.96 135.47 33.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.515 -0.741 . . . . 0.0 110.369 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.596 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 54.02 44.31 72.77 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.982 ' CG ' HD23 ' A' ' 13' ' ' LEU . 52.9 Cg_endo -77.03 42.76 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.492 1.259 . . . . 0.0 110.959 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 5' ' ' GLN . . . -65.1 -25.12 70.77 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.525 ' O ' HD12 ' A' ' 44' ' ' ILE . 9.6 p -101.63 12.95 36.32 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.831 -1.394 . . . . 0.0 109.77 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.464 ' HB3' ' HB2' ' A' ' 40' ' ' PRO . 16.6 t80 -86.88 122.53 30.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.393 -0.817 . . . . 0.0 109.556 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.657 HG23 ' HD2' ' A' ' 45' ' ' PRO . 3.7 mp -116.98 145.25 35.17 Favored Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.224 -0.922 . . . . 0.0 109.508 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.657 ' HD2' HG23 ' A' ' 44' ' ' ILE . 43.0 Cg_endo -69.56 83.44 0.66 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.874 1.46 . . . . 0.0 110.172 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -95.72 152.93 18.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.414 -0.804 . . . . 0.0 110.697 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -41.55 -42.97 2.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.352 -0.843 . . . . 0.0 110.69 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.729 ' HG2' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -42.55 -47.94 5.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.856 . . . . 0.0 110.434 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.6 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.2 m -136.15 173.85 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.313 -0.867 . . . . 0.0 110.332 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -133.16 142.02 48.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.388 -0.82 . . . . 0.0 110.206 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' A' ' 45' ' ' PRO . 47.7 t -62.56 130.36 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.229 -0.919 . . . . 0.0 109.833 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.735 HG23 ' HA ' ' A' ' 15' ' ' LEU . 28.2 t -107.82 -61.32 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 110.588 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.775 ' O ' HD13 ' A' ' 54' ' ' ILE . 7.8 mm-40 -139.89 168.08 20.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.168 -0.958 . . . . 0.0 110.293 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.775 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.4 mm -128.89 152.48 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.319 -0.863 . . . . 0.0 109.191 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -149.65 152.25 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.952 -1.092 . . . . 0.0 110.697 -179.698 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.536 ' HA ' ' CB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -123.94 177.89 5.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.432 -0.792 . . . . 0.0 110.078 179.542 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.532 ' CA ' ' HA ' ' A' ' 95' ' ' ALA . . . -87.25 130.02 34.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.186 -0.946 . . . . 0.0 110.727 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 1.5 t 177.41 52.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 111.018 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.86 HG22 HG13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -157.09 -59.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.608 -1.308 . . . . 0.0 111.591 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.86 HG13 HG22 ' A' ' 59' ' ' ILE . 2.3 mt -92.51 -174.46 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 120.14 -1.6 . . . . 0.0 110.8 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.699 ' H ' HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -101.25 169.43 8.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.4 -0.812 . . . . 0.0 110.114 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.634 ' CG ' HG13 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -67.3 -72.69 0.16 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.203 -0.935 . . . . 0.0 111.974 -179.006 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.565 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 5.7 p30 -39.62 -24.1 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.297 -0.877 . . . . 0.0 112.07 -178.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.507 ' NE2' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -57.22 167.98 0.81 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.609 -1.307 . . . . 0.0 112.206 -178.775 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.01 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -150.35 131.25 14.22 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.552 ' HG ' ' CG1' ' A' ' 90' ' ' VAL . 2.5 pp -129.3 127.42 41.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.513 -1.367 . . . . 0.0 112.395 -178.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . 12.5 ttt180 -103.64 130.01 51.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.784 -0.572 . . . . 0.0 109.553 178.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.49 HD23 ' O ' ' A' ' 67' ' ' ARG . 35.2 mt -117.76 149.53 40.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.18 -0.95 . . . . 0.0 111.007 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.443 ' C ' ' HG2' ' A' ' 102' ' ' GLU . 22.7 ttp180 -114.53 139.89 49.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.537 -0.727 . . . . 0.0 109.883 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.567 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -60.45 147.6 40.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.144 -0.973 . . . . 0.0 110.376 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -107.05 -44.1 4.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 109.874 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.592 ' HD2' ' CE2' ' A' ' 101' ' ' PHE . 15.2 ptpt -122.41 134.79 54.6 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.269 -0.894 . . . . 0.0 109.809 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.511 ' N ' ' HB ' ' A' ' 84' ' ' THR . 2.4 pt-20 -57.16 96.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.205 -0.935 . . . . 0.0 110.644 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.52 -42.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 110.443 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.596 ' CB ' ' HB2' ' A' ' 101' ' ' PHE . 2.5 t90 -74.64 120.34 20.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.214 -0.929 . . . . 0.0 110.701 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -117.19 110.21 17.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -0.923 . . . . 0.0 109.401 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.559 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -59.38 -23.06 62.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 110.219 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.462 ' OD2' ' HE2' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -88.57 -21.44 24.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 110.14 179.87 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.26 16.37 27.69 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.462 ' HE2' ' OD2' ' A' ' 78' ' ' ASP . 25.1 mttm -110.39 -137.89 0.37 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.218 -1.166 . . . . 0.0 110.147 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.729 ' CG ' HG11 ' A' ' 29' ' ' VAL . 7.9 mp0 -134.98 105.42 6.36 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.03 -1.043 . . . . 0.0 110.327 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.75 179.54 5.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.224 -0.922 . . . . 0.0 110.68 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.594 HG13 ' H ' ' A' ' 85' ' ' GLY . 13.3 p -91.67 174.45 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.422 -0.799 . . . . 0.0 110.79 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.58 ' N ' HG22 ' A' ' 83' ' ' VAL . 4.6 t -72.01 -6.53 42.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.318 -0.864 . . . . 0.0 110.361 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.594 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -80.03 -19.27 70.29 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.44 ' OE2' ' NH1' ' A' ' 77' ' ' ARG . 8.0 tp10 -66.94 160.61 25.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.462 -1.022 . . . . 0.0 110.053 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.416 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 6.1 pt-20 -154.87 168.12 27.98 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.38 -0.825 . . . . 0.0 110.05 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.592 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -147.5 143.94 28.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.127 -0.983 . . . . 0.0 109.979 179.587 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.851 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.6 OUTLIER -115.46 124.46 51.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.108 -0.995 . . . . 0.0 110.208 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.851 ' N ' HD22 ' A' ' 89' ' ' LEU . 8.5 p -107.05 132.37 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.313 -0.867 . . . . 0.0 110.518 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.836 HG23 HD11 ' A' ' 89' ' ' LEU . 3.5 p -115.4 29.37 8.05 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.488 0.661 . . . . 0.0 109.25 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.585 HG22 ' N ' ' A' ' 93' ' ' VAL . 20.1 m -74.65 171.81 13.21 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.417 -0.802 . . . . 0.0 109.55 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.634 HG13 ' CG ' ' A' ' 62' ' ' GLN . 1.5 t -47.37 172.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.99 -1.069 . . . . 0.0 109.006 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.563 ' O ' ' HB3' ' A' ' 95' ' ' ALA . . . -45.24 -88.87 0.01 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 94' ' ' GLY . . . 60.84 -167.79 0.18 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.569 -0.959 . . . . 0.0 110.213 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.516 ' CD2' ' CD1' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -120.76 -65.46 1.14 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.711 -0.618 . . . . 0.0 109.827 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.714 ' HG ' ' HB3' ' A' ' 12' ' ' ALA . 0.3 OUTLIER 46.23 71.37 1.59 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.559 -0.713 . . . . 0.0 110.695 179.584 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.404 ' HD2' HG21 ' A' ' 55' ' ' ILE . 49.5 Cg_endo -78.15 120.53 5.0 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.939 1.494 . . . . 0.0 110.092 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.844 ' HB1' ' HB2' ' A' ' 102' ' ' GLU . . . -73.55 138.82 45.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.21 -0.931 . . . . 0.0 110.275 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.568 HG23 ' N ' ' A' ' 101' ' ' PHE . 30.5 m -69.65 -51.72 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.157 -0.965 . . . . 0.0 110.754 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.596 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 19.5 m-30 -112.78 26.4 10.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.732 -1.23 . . . . 0.0 110.464 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.844 ' HB2' ' HB1' ' A' ' 99' ' ' ALA . 1.1 tt0 -121.63 141.95 50.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.011 -1.056 . . . . 0.0 110.464 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.03 152.26 36.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.418 -0.801 . . . . 0.0 110.333 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.772 ' C ' HD13 ' A' ' 105' ' ' LEU . 12.4 p -94.45 133.06 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.259 -0.9 . . . . 0.0 110.075 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.772 HD13 ' C ' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -102.76 -21.98 13.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.308 -0.87 . . . . 0.0 110.209 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -174.44 136.31 0.46 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.937 . . . . 0.0 110.396 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.4 pp -99.1 153.25 19.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.89 . . . . 0.0 109.965 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.01 HG13 ' HB3' ' A' ' 65' ' ' ALA . 2.5 p -130.93 147.25 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.083 -1.01 . . . . 0.0 110.605 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -107.19 126.29 52.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.857 . . . . 0.0 110.004 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . -66.96 139.13 57.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.927 . . . . 0.0 110.526 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 111' ' ' VAL . 47.7 t -141.89 91.45 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.414 -0.804 . . . . 0.0 109.811 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 71.8 mt -125.81 142.69 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.197 -0.939 . . . . 0.0 110.33 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.675 ' OXT' HD13 ' A' ' 113' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.168 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 41' ' ' GLY . 4.8 mt-30 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.332 0.587 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.492 ' C ' ' HA3' ' A' ' 41' ' ' GLY . 36.0 m -125.02 158.97 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.307 -0.871 . . . . 0.0 109.519 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.46 ' C ' ' O ' ' A' ' 6' ' ' VAL . 40.5 t -38.78 106.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.267 -0.896 . . . . 0.0 110.54 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.618 HD23 ' OG1' ' A' ' 11' ' ' THR . 3.2 mp -61.09 169.11 2.26 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.549 -0.719 . . . . 0.0 110.694 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 10' ' ' ASN . 48.4 Cg_endo -79.52 63.37 8.72 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.136 1.598 . . . . 0.0 109.85 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.732 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER 64.86 41.95 4.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.504 -0.748 . . . . 0.0 110.824 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.618 ' OG1' HD23 ' A' ' 8' ' ' LEU . 14.9 p -118.98 171.34 8.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.121 -0.987 . . . . 0.0 109.759 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.662 ' CB ' HD22 ' A' ' 97' ' ' LEU . . . -145.0 161.9 38.24 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.887 -1.133 . . . . 0.0 110.814 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.012 HD11 HD11 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -133.53 156.15 48.31 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.33 -0.856 . . . . 0.0 110.441 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.584 ' CD2' HD13 ' A' ' 36' ' ' LEU . 44.7 m80 -91.93 124.04 35.74 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.131 -0.98 . . . . 0.0 110.631 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.012 HD11 HD11 ' A' ' 13' ' ' LEU . 2.4 mm? -111.42 151.31 28.68 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.341 -0.85 . . . . 0.0 110.303 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.641 ' HB2' HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -113.53 117.49 31.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.078 -1.014 . . . . 0.0 109.743 178.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.039 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -79.43 112.02 16.27 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.208 -0.933 . . . . 0.0 110.338 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.728 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -104.95 101.7 11.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.842 -0.536 . . . . 0.0 109.594 179.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.414 HD13 ' HG3' ' A' ' 48' ' ' GLU . 7.7 tp -161.91 147.0 13.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.09 -1.006 . . . . 0.0 110.584 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -89.46 101.76 14.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.365 -0.835 . . . . 0.0 109.613 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.92 ' HB2' HG22 ' A' ' 29' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 110.216 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.92 HG22 ' HB2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.232 0.539 . . . . 0.0 110.157 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 30' ' ' VAL . 24.0 m -134.8 82.37 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.156 -0.965 . . . . 0.0 110.074 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.728 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 40.79 75.27 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.528 -0.732 . . . . 0.0 110.305 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.16 26.93 0.06 OUTLIER Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.692 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 1.039 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 35.1 m-20 -98.71 149.58 22.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.635 -1.509 . . . . 0.0 110.006 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.822 ' OE2' HG11 ' A' ' 52' ' ' VAL . 3.3 tt0 -151.76 147.03 26.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.02 -1.05 . . . . 0.0 110.436 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.563 ' HA ' ' CG2' ' A' ' 100' ' ' VAL . 7.3 p90 -160.94 171.64 18.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.122 -0.986 . . . . 0.0 111.299 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.614 HD22 ' O ' ' A' ' 98' ' ' PRO . 15.3 tp -92.0 155.82 17.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.571 -0.706 . . . . 0.0 110.021 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.666 ' HB2' HD23 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -134.53 110.56 9.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.126 -0.984 . . . . 0.0 110.219 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.628 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 11.5 tm-20 -84.41 131.85 34.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.863 . . . . 0.0 110.445 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.615 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 66.57 43.56 91.9 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.641 ' HG3' HD23 ' A' ' 13' ' ' LEU . 55.6 Cg_endo -77.27 23.54 0.53 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.553 1.291 . . . . 0.0 111.218 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.492 ' HA3' ' C ' ' A' ' 6' ' ' VAL . . . -49.99 -44.62 41.52 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.422 ' O ' HD12 ' A' ' 44' ' ' ILE . 35.7 p -91.28 29.64 1.4 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -1.183 . . . . 0.0 110.677 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.506 ' HB3' ' O ' ' A' ' 40' ' ' PRO . 15.3 t80 -88.34 132.57 34.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.131 -0.981 . . . . 0.0 110.108 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.727 HG23 ' HD2' ' A' ' 45' ' ' PRO . 4.0 mp -123.31 146.86 50.62 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.34 -0.85 . . . . 0.0 109.534 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.727 ' HD2' HG23 ' A' ' 44' ' ' ILE . 44.3 Cg_endo -71.23 103.81 1.45 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.838 1.441 . . . . 0.0 110.669 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 49' ' ' VAL . 5.9 mtm180 -113.56 140.85 47.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.411 -0.806 . . . . 0.0 110.089 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 46' ' ' ARG . 1.1 tttm -41.71 -34.79 0.67 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.147 -0.97 . . . . 0.0 110.538 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.448 ' HB3' HG13 ' A' ' 49' ' ' VAL . 1.7 tt0 -53.01 -39.27 63.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.955 . . . . 0.0 110.522 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.4 m -144.98 173.3 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.262 -0.899 . . . . 0.0 109.62 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -142.14 139.83 32.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.849 -1.157 . . . . 0.0 110.671 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.846 HG23 ' CD1' ' A' ' 13' ' ' LEU . 6.5 p -55.52 127.69 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.253 -0.904 . . . . 0.0 110.027 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.822 HG11 ' OE2' ' A' ' 34' ' ' GLU . 2.9 t -106.58 -58.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 110.179 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.767 ' O ' HD13 ' A' ' 54' ' ' ILE . 13.1 mm-40 -140.43 170.57 15.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.404 -0.81 . . . . 0.0 110.199 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.767 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -132.76 150.49 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.305 -0.872 . . . . 0.0 109.312 179.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.517 HG21 ' HD2' ' A' ' 98' ' ' PRO . 0.5 OUTLIER -141.15 132.67 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.973 -1.08 . . . . 0.0 110.456 -179.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.48 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 15.2 mm-40 -89.92 178.62 6.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.402 -0.811 . . . . 0.0 110.449 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -102.54 133.53 47.37 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.194 -0.942 . . . . 0.0 110.811 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 1.3 t 173.61 63.16 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.297 -0.877 . . . . 0.0 111.015 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.912 HG22 ' O ' ' A' ' 95' ' ' ALA . 0.8 OUTLIER -171.18 -31.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.726 -1.234 . . . . 0.0 111.781 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.655 HG22 ' H ' ' A' ' 61' ' ' ARG . 10.1 mt -85.31 179.43 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.619 -1.301 . . . . 0.0 110.432 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.655 ' H ' HG22 ' A' ' 60' ' ' ILE . 1.2 mmt180 -112.17 -153.23 0.52 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.223 -0.923 . . . . 0.0 110.587 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 1.029 ' HA ' HG13 ' A' ' 93' ' ' VAL . 12.9 tt0 -90.86 -12.75 35.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.669 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 4.0 p30 -137.7 -24.89 1.02 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 0.0 111.071 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.454 ' OE1' ' O ' ' A' ' 65' ' ' ALA . 6.1 tp-100 -54.41 133.58 45.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.841 -1.162 . . . . 0.0 110.51 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.015 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -120.95 157.23 30.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.384 -0.822 . . . . 0.0 109.355 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 65' ' ' ALA . 2.8 mt -125.77 113.05 16.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.107 -0.995 . . . . 0.0 110.78 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.469 ' C ' HD23 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -91.68 121.59 33.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.26 -0.9 . . . . 0.0 109.269 178.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.869 ' CD2' HG23 ' A' ' 104' ' ' VAL . 6.0 mt -118.46 151.68 37.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.089 -1.007 . . . . 0.0 110.841 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 2.0 ttm-85 -121.82 155.28 35.69 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.416 -0.802 . . . . 0.0 109.778 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -65.44 152.64 43.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.173 -0.955 . . . . 0.0 110.855 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.516 ' CB ' ' O ' ' A' ' 101' ' ' PHE . 8.2 tpt180 -114.71 -27.37 7.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.375 -0.828 . . . . 0.0 109.837 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.661 ' O ' HG23 ' A' ' 84' ' ' THR . 29.8 mmmt -108.32 -94.66 0.4 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 0.0 109.684 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.54 ' CB ' ' O ' ' A' ' 72' ' ' LYS . 0.5 OUTLIER 164.39 29.72 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.464 -0.773 . . . . 0.0 110.465 179.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.2 m -138.64 -6.96 1.48 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.997 -1.064 . . . . 0.0 110.874 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.572 ' CB ' ' HB2' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -76.91 110.17 11.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.066 -1.021 . . . . 0.0 110.299 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.512 ' HB2' ' N ' ' A' ' 80' ' ' LYS . 3.1 p30 -93.16 132.13 37.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.271 -0.893 . . . . 0.0 110.055 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.569 ' HD2' ' CG ' ' A' ' 86' ' ' GLU . 1.7 mtp180 -80.1 -59.04 2.87 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.063 -1.023 . . . . 0.0 110.409 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -98.5 16.78 20.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.267 -0.896 . . . . 0.0 110.516 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.15 16.03 24.28 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.512 ' N ' ' HB2' ' A' ' 76' ' ' ASP . 40.9 mmtt -115.71 91.66 3.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -1.164 . . . . 0.0 110.248 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.438 ' HG3' ' CG1' ' A' ' 29' ' ' VAL . 1.7 tm-20 -43.56 101.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.233 -0.917 . . . . 0.0 110.281 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.548 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -100.67 179.24 4.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 0.0 110.223 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.739 HG23 ' H ' ' A' ' 85' ' ' GLY . 11.0 m -98.72 -178.59 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.227 -0.921 . . . . 0.0 110.589 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 72' ' ' LYS . 0.1 OUTLIER -58.18 -26.0 62.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.488 -0.757 . . . . 0.0 110.627 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.739 ' H ' HG23 ' A' ' 83' ' ' VAL . . . -69.03 -19.0 73.37 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.569 ' CG ' ' HD2' ' A' ' 77' ' ' ARG . 10.0 tp10 -73.7 143.46 46.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.183 -1.187 . . . . 0.0 110.312 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.461 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 3.9 pt-20 -149.31 155.44 40.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.296 -0.878 . . . . 0.0 110.2 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.87 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -136.88 154.77 50.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.088 -1.008 . . . . 0.0 110.129 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.024 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -114.87 134.68 54.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.278 -0.889 . . . . 0.0 110.573 -179.482 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 1.024 ' N ' HD22 ' A' ' 89' ' ' LEU . 3.6 m -99.8 130.14 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.254 -0.904 . . . . 0.0 110.16 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.565 HG23 HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -120.78 53.9 1.1 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.332 -0.855 . . . . 0.0 110.051 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.498 HG22 ' OD1' ' A' ' 10' ' ' ASN . 0.2 OUTLIER -85.36 160.23 19.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 110.456 -179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.029 HG13 ' HA ' ' A' ' 62' ' ' GLN . 90.7 t -109.64 83.89 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.346 -0.846 . . . . 0.0 109.781 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 60' ' ' ILE . . . 87.4 79.53 1.24 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.912 ' O ' HG22 ' A' ' 59' ' ' ILE . . . -162.46 -143.32 0.08 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.28 -1.13 . . . . 0.0 110.599 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.533 ' O ' HD23 ' A' ' 97' ' ' LEU . 9.3 t80 177.17 104.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.662 HD22 ' CB ' ' A' ' 12' ' ' ALA . 15.6 mt -116.78 88.72 26.37 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.046 -1.034 . . . . 0.0 111.052 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.614 ' O ' HD22 ' A' ' 36' ' ' LEU . 49.9 Cg_endo -78.24 108.38 2.48 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.892 1.47 . . . . 0.0 109.825 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.49 ' HA ' ' HB2' ' A' ' 36' ' ' LEU . . . -65.2 -171.56 0.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.164 -0.96 . . . . 0.0 110.692 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.563 ' CG2' ' HA ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -110.49 -55.95 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.389 -0.819 . . . . 0.0 109.581 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.572 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 11.8 m-85 -101.5 -14.64 17.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.948 -1.095 . . . . 0.0 109.656 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.573 ' OE1' ' CD1' ' A' ' 88' ' ' TRP . 23.4 tt0 -93.83 123.94 37.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.363 -0.836 . . . . 0.0 110.906 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.33 164.12 11.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.308 -0.87 . . . . 0.0 109.77 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.869 HG23 ' CD2' ' A' ' 68' ' ' LEU . 8.4 p -86.65 146.76 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.123 -0.985 . . . . 0.0 110.539 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 104' ' ' VAL . 9.4 mp -104.0 -33.29 8.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.366 -0.834 . . . . 0.0 110.142 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.923 ' C ' HD22 ' A' ' 107' ' ' LEU . 0.3 OUTLIER -173.3 -166.55 0.34 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.254 -0.904 . . . . 0.0 110.401 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.923 HD22 ' C ' ' A' ' 106' ' ' ASP . 3.3 mm? -121.54 153.44 37.98 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.25 -0.907 . . . . 0.0 110.032 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.015 HG13 ' HB3' ' A' ' 65' ' ' ALA . 2.8 p -139.05 107.79 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.08 -1.012 . . . . 0.0 110.987 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -70.17 118.28 12.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.882 . . . . 0.0 110.222 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.219 -0.925 . . . . 0.0 110.42 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.467 ' O ' ' O ' ' A' ' 41' ' ' GLY . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.111 0.481 . . . . 0.0 109.86 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.502 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 9.0 m -114.14 176.9 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.09 -1.006 . . . . 0.0 110.21 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.506 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 78.0 t -54.81 143.35 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.426 -0.796 . . . . 0.0 110.769 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.58 HD13 ' N ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -96.5 167.2 12.67 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.433 -0.792 . . . . 0.0 110.052 179.644 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.496 ' O ' ' HB2' ' A' ' 10' ' ' ASN . 46.3 Cg_endo -73.94 69.59 4.6 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.989 1.521 . . . . 0.0 109.52 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 1.043 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 14.6 m-80 60.71 64.48 1.16 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.455 -0.778 . . . . 0.0 110.74 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.55 ' HB ' ' HA ' ' A' ' 56' ' ' GLN . 30.7 p -140.55 172.11 13.17 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.216 -0.927 . . . . 0.0 110.184 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.565 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -144.42 169.33 18.13 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.941 . . . . 0.0 110.017 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.948 HD23 ' CB ' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -134.21 147.62 50.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.084 -1.01 . . . . 0.0 110.148 179.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 1.002 ' CD2' HD13 ' A' ' 36' ' ' LEU . 15.0 m-70 -90.26 126.66 35.91 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.039 -1.038 . . . . 0.0 110.395 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.952 HD21 ' HB2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -136.75 155.72 49.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.11 -0.994 . . . . 0.0 110.351 179.37 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.476 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -104.82 122.86 46.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.455 -0.778 . . . . 0.0 110.064 -179.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.066 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -82.89 117.82 23.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.934 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.876 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 1.4 mm? -106.72 101.06 10.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.742 -0.599 . . . . 0.0 110.635 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.817 ' C ' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -166.96 165.14 16.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.247 -0.908 . . . . 0.0 110.093 179.409 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.505 ' N ' HD22 ' A' ' 19' ' ' LEU . 80.7 m-20 -96.25 110.73 22.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 0.0 110.612 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.914 ' CB ' HG22 ' A' ' 29' ' ' VAL . 1.1 t80 . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.317 -0.864 . . . . 0.0 110.087 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.914 HG22 ' CB ' ' A' ' 21' ' ' PHE . 2.0 m . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.233 0.54 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 30' ' ' VAL . 18.6 m -129.77 84.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.083 -1.011 . . . . 0.0 110.312 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.876 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 45.4 69.27 0.46 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.34 -0.85 . . . . 0.0 110.117 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -174.91 27.01 0.08 OUTLIER Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.41 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 1.066 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 1.5 m-20 -89.47 144.97 25.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.877 -1.366 . . . . 0.0 109.966 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.071 ' HG2' HG11 ' A' ' 100' ' ' VAL . 5.7 tt0 -142.57 131.09 22.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -0.99 . . . . 0.0 110.086 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.617 ' CH2' HD12 ' A' ' 15' ' ' LEU . 1.8 p90 -161.37 174.15 13.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.986 -1.071 . . . . 0.0 110.776 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 1.002 HD13 ' CD2' ' A' ' 14' ' ' HIS . 55.9 tp -94.05 162.09 14.02 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.519 -0.738 . . . . 0.0 110.045 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.952 ' HB2' HD21 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -131.84 110.36 10.77 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.986 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.639 ' HG2' HD11 ' A' ' 97' ' ' LEU . 0.6 OUTLIER -82.48 142.85 31.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.409 -0.807 . . . . 0.0 110.397 -179.715 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.596 ' N ' ' HD3' ' A' ' 40' ' ' PRO . . . 55.66 44.42 86.3 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.948 ' CB ' HD23 ' A' ' 13' ' ' LEU . 54.6 Cg_endo -77.82 15.16 1.33 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.663 1.349 . . . . 0.0 111.086 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 7' ' ' VAL . . . -53.27 -29.72 38.12 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.429 ' O ' ' CD1' ' A' ' 44' ' ' ILE . 48.9 p -103.45 17.19 24.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -1.17 . . . . 0.0 110.518 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.588 ' C ' HD12 ' A' ' 44' ' ' ILE . 12.1 t80 -87.44 125.89 34.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.875 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.803 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.2 mp -107.47 141.8 23.77 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 109.786 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.531 ' HD2' HG23 ' A' ' 44' ' ' ILE . 43.9 Cg_endo -70.57 97.3 0.7 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.957 1.504 . . . . 0.0 110.802 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.88 159.54 22.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.212 -0.93 . . . . 0.0 110.403 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.529 ' HG3' ' N ' ' A' ' 48' ' ' GLU . 16.0 pttm -48.93 -32.25 8.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.326 -0.859 . . . . 0.0 110.782 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.529 ' N ' ' HG3' ' A' ' 47' ' ' LYS . 2.6 tp10 -43.27 -40.52 3.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.085 -1.009 . . . . 0.0 110.206 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -150.13 167.92 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 0.0 110.159 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -122.44 124.47 43.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 0.0 109.949 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.518 HG13 HD13 ' A' ' 13' ' ' LEU . 21.7 t -54.58 133.03 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 109.653 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.934 HG23 ' HA ' ' A' ' 15' ' ' LEU . 4.7 t -111.36 -48.89 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.035 -1.041 . . . . 0.0 110.579 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.908 ' C ' HD13 ' A' ' 54' ' ' ILE . 0.5 OUTLIER -149.6 168.57 23.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.146 -0.971 . . . . 0.0 109.936 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.908 HD13 ' C ' ' A' ' 53' ' ' GLU . 1.2 mm -129.94 131.15 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.378 -0.826 . . . . 0.0 108.974 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.665 HD13 ' N ' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -120.84 136.45 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.028 -1.045 . . . . 0.0 111.334 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.665 ' N ' HD13 ' A' ' 55' ' ' ILE . 56.8 mm-40 -97.69 176.55 5.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.601 -0.687 . . . . 0.0 109.929 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.043 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -90.84 140.23 30.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.202 -0.936 . . . . 0.0 109.825 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 3.4 t -179.49 38.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.017 -1.052 . . . . 0.0 111.536 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.731 HG21 ' CG ' ' A' ' 96' ' ' TYR . 0.6 OUTLIER -159.9 -74.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.536 -1.353 . . . . 0.0 111.827 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.718 ' H ' HG23 ' A' ' 59' ' ' ILE . 77.0 mt -63.31 159.72 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.56 -1.338 . . . . 0.0 110.393 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.36 -166.37 1.08 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.296 -0.878 . . . . 0.0 110.575 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.929 ' HB2' HG13 ' A' ' 93' ' ' VAL . 1.7 tt0 -75.61 -70.82 0.41 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.444 -0.785 . . . . 0.0 110.568 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.843 ' HB3' ' HB2' ' A' ' 110' ' ' ALA . 8.5 m120 -60.55 -33.82 73.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.362 -0.836 . . . . 0.0 110.42 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -59.46 141.18 55.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.188 -0.945 . . . . 0.0 110.84 -179.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.962 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -123.03 140.53 52.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.827 . . . . 0.0 109.773 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.716 HD12 HD21 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -126.19 108.33 11.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.104 -0.997 . . . . 0.0 110.534 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 1.022 ' O ' HD23 ' A' ' 68' ' ' LEU . 4.8 ttm105 -91.2 135.9 33.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.129 -0.982 . . . . 0.0 109.585 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.022 HD23 ' O ' ' A' ' 67' ' ' ARG . 5.4 mt -133.99 150.18 51.24 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.209 -0.932 . . . . 0.0 110.935 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 13.9 ttm180 -107.02 163.81 12.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.461 -0.775 . . . . 0.0 109.641 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -80.57 118.5 22.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.177 -0.952 . . . . 0.0 110.478 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.53 -30.37 52.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.144 -0.972 . . . . 0.0 109.133 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -133.75 157.54 45.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.601 -0.687 . . . . 0.0 109.204 179.45 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.518 ' O ' ' HB3' ' A' ' 74' ' ' CYS . 1.0 OUTLIER -84.65 -179.2 7.07 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.023 -1.048 . . . . 0.0 110.802 -179.367 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER 75.05 -16.01 0.61 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.647 -0.658 . . . . 0.0 111.32 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.612 ' CZ2' ' CG ' ' A' ' 77' ' ' ARG . 5.0 t90 -74.37 104.64 5.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.631 -1.293 . . . . 0.0 110.232 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.513 ' O ' ' CD1' ' A' ' 35' ' ' TRP . 7.4 p-10 -84.8 124.48 31.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.085 -1.009 . . . . 0.0 109.68 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.612 ' CG ' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -80.99 -59.9 2.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.205 -0.935 . . . . 0.0 110.507 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -103.92 11.1 35.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 110.232 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.83 10.95 9.6 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -116.17 111.84 20.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -1.162 . . . . 0.0 110.401 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.496 ' OE2' ' CG ' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -71.47 102.77 2.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.194 -0.941 . . . . 0.0 109.711 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -109.35 178.79 4.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.153 -0.967 . . . . 0.0 110.307 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.633 HG13 ' H ' ' A' ' 85' ' ' GLY . 8.8 p -77.37 174.37 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 0.0 110.29 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.715 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 14.6 t -69.57 -16.39 63.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.203 -0.935 . . . . 0.0 109.984 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.633 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -72.18 -23.01 78.62 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' A' ' 87' ' ' GLU . 6.5 tp10 -63.09 160.05 16.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -1.134 . . . . 0.0 110.212 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.457 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 10.5 pt-20 -149.9 156.54 41.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 110.169 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.568 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -136.21 148.6 48.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.196 -0.94 . . . . 0.0 109.693 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.963 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -102.06 128.31 48.57 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.315 -0.866 . . . . 0.0 110.45 -179.428 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.963 ' N ' HD22 ' A' ' 89' ' ' LEU . 2.7 t -89.15 124.48 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.589 -0.694 . . . . 0.0 110.073 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.477 ' OG1' ' CD1' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -129.74 33.29 4.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -0.904 . . . . 0.0 109.857 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.63 152.6 37.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.856 . . . . 0.0 109.905 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.929 HG13 ' HB2' ' A' ' 62' ' ' GLN . 44.7 t -93.41 109.6 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.181 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.899 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 69.78 76.92 0.47 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -176.42 -175.23 0.65 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -1.124 . . . . 0.0 110.738 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.731 ' CG ' HG21 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -117.13 -61.86 1.65 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.403 -0.81 . . . . 0.0 110.608 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.639 HD11 ' HG2' ' A' ' 38' ' ' GLU . 2.9 mm? 58.45 51.87 4.34 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.063 -1.023 . . . . 0.0 109.733 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 97' ' ' LEU . 50.2 Cg_endo -75.47 -2.31 12.41 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.111 1.585 . . . . 0.0 111.329 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.559 ' HA ' ' CB ' ' A' ' 36' ' ' LEU . . . 51.87 -178.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.059 -1.026 . . . . 0.0 110.093 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 1.071 HG11 ' HG2' ' A' ' 34' ' ' GLU . 2.4 t -97.21 -63.93 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.664 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.556 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 7.5 m-30 -94.09 67.66 3.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.966 -1.083 . . . . 0.0 109.385 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -139.85 144.75 37.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 111.282 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -132.38 121.35 23.33 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.793 ' HB ' HD22 ' A' ' 68' ' ' LEU . 9.0 p -76.89 144.52 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.15 -0.969 . . . . 0.0 111.091 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.761 ' N ' HD22 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -99.17 -26.23 14.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.664 -0.648 . . . . 0.0 109.409 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -177.95 -178.8 0.71 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 110.039 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.35 149.25 44.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.201 -0.937 . . . . 0.0 110.287 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.962 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 11.0 p -131.81 156.3 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.243 -0.911 . . . . 0.0 110.255 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.511 ' O ' ' C ' ' A' ' 110' ' ' ALA . 7.6 p30 -111.18 113.49 26.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.072 -1.017 . . . . 0.0 110.461 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.843 ' HB2' ' HB3' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.5 2.067 0 CA-C-O 120.956 0.408 . . . . 0.0 111.942 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.531 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.432 0.634 . . . . 0.0 110.735 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.537 HG23 ' N ' ' A' ' 7' ' ' VAL . 33.1 m -74.8 -133.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.214 -0.929 . . . . 0.0 109.257 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.537 ' N ' HG23 ' A' ' 6' ' ' VAL . 21.0 t -105.78 151.76 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.986 -1.071 . . . . 0.0 109.607 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.883 HD23 ' OG1' ' A' ' 11' ' ' THR . 5.4 mp -103.64 157.69 33.37 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 110.256 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -74.18 -49.28 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.061 1.558 . . . . 0.0 110.495 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 1.082 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 5.4 p30 -163.46 27.29 0.09 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.873 . . . . 0.0 110.471 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.883 ' OG1' HD23 ' A' ' 8' ' ' LEU . 19.0 p -104.81 151.7 23.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.965 -1.084 . . . . 0.0 111.125 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.779 ' HB3' HD22 ' A' ' 97' ' ' LEU . . . -132.18 165.45 24.06 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.929 ' CD2' HD12 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -133.88 153.17 51.94 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.788 -1.195 . . . . 0.0 110.485 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.882 ' CD2' HD11 ' A' ' 36' ' ' LEU . 4.6 m170 -92.15 136.29 33.3 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.504 -0.748 . . . . 0.0 109.105 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.953 HD13 ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -139.39 153.37 47.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.013 -1.054 . . . . 0.0 110.6 179.763 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 0.3 OUTLIER -113.52 117.53 31.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.267 -0.896 . . . . 0.0 109.91 -179.615 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.095 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -77.59 119.37 21.05 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.24 -0.913 . . . . 0.0 110.195 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.594 HD13 ' HB1' ' A' ' 31' ' ' ALA . 2.4 mm? -103.04 101.01 10.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.772 -0.58 . . . . 0.0 109.517 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.027 HD13 ' N ' ' A' ' 20' ' ' ASP . 2.1 tm? -164.98 144.21 6.79 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.011 -1.055 . . . . 0.0 110.262 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 1.027 ' N ' HD13 ' A' ' 19' ' ' LEU . 2.7 m-20 -85.05 118.72 24.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.667 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.679 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.168 -0.957 . . . . 0.0 110.766 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.679 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.654 ' O ' HG23 ' A' ' 30' ' ' VAL . 31.4 m -141.04 89.16 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.074 -1.016 . . . . 0.0 110.451 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.594 ' HB1' HD13 ' A' ' 18' ' ' LEU . . . 44.24 63.66 1.57 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.384 -0.822 . . . . 0.0 110.163 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.93 21.62 0.1 OUTLIER Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.624 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 1.095 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 5.3 m-20 -87.1 149.49 24.65 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.676 -1.485 . . . . 0.0 109.557 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.598 ' OE2' HG11 ' A' ' 52' ' ' VAL . 31.6 tt0 -152.68 145.72 24.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.019 -1.051 . . . . 0.0 110.525 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.703 ' CZ3' ' HB2' ' A' ' 17' ' ' ALA . 6.7 p90 -167.99 168.93 11.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.211 -0.93 . . . . 0.0 110.616 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.882 HD11 ' CD2' ' A' ' 14' ' ' HIS . 0.5 OUTLIER -91.87 156.28 17.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.205 -0.934 . . . . 0.0 110.959 -178.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -132.2 111.04 11.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.486 -0.759 . . . . 0.0 109.894 179.604 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.584 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 4.7 tm-20 -79.17 140.19 37.81 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.568 -0.708 . . . . 0.0 109.64 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.612 ' N ' ' HD3' ' A' ' 40' ' ' PRO . . . 54.33 44.56 76.12 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 39' ' ' GLY . 54.5 Cg_endo -76.15 13.15 1.35 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.69 1.363 . . . . 0.0 111.262 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.599 ' HA3' HD13 ' A' ' 8' ' ' LEU . . . -49.95 -41.35 36.8 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.8 p -83.16 18.54 1.68 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.173 -1.192 . . . . 0.0 111.231 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.566 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 3.1 t80 -98.72 130.64 45.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.933 -1.105 . . . . 0.0 110.166 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.547 ' CG2' ' HD2' ' A' ' 45' ' ' PRO . 35.1 mm -114.49 146.01 35.01 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.45 -0.781 . . . . 0.0 109.045 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 44' ' ' ILE . 40.3 Cg_endo -66.22 74.58 0.36 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.733 1.386 . . . . 0.0 110.883 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -73.99 139.08 44.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.376 -0.827 . . . . 0.0 109.819 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.493 ' HG3' ' N ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -45.98 -24.2 0.39 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.917 . . . . 0.0 110.387 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.493 ' N ' ' HG3' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -56.64 -36.16 69.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.159 -0.963 . . . . 0.0 110.211 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.2 m -141.35 170.36 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.36 -0.838 . . . . 0.0 110.027 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -127.98 132.69 49.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.992 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.1 m -56.37 127.64 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.875 . . . . 0.0 110.321 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.827 HG23 ' HA ' ' A' ' 15' ' ' LEU . 21.8 t -96.54 -60.78 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.363 -0.836 . . . . 0.0 109.975 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.855 ' O ' HD13 ' A' ' 54' ' ' ILE . 12.1 mm-40 -143.97 175.88 9.69 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.202 -0.936 . . . . 0.0 110.408 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.855 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -136.74 134.52 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.296 -0.878 . . . . 0.0 108.971 179.349 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.649 HD13 ' N ' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -128.61 130.98 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.008 -1.058 . . . . 0.0 111.003 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.649 ' N ' HD13 ' A' ' 55' ' ' ILE . 6.1 mm100 -94.91 134.28 37.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.499 -0.751 . . . . 0.0 109.412 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.082 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -49.27 137.26 14.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.081 -1.012 . . . . 0.0 110.804 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 8.7 t -179.51 45.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.309 -0.869 . . . . 0.0 111.587 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.648 HG21 ' CD1' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -162.48 -53.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.454 -1.404 . . . . 0.0 111.803 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.568 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 21.8 mt -57.37 165.16 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.552 -1.343 . . . . 0.0 109.947 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.451 ' N ' ' CG2' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -93.34 -161.97 0.89 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.339 -0.851 . . . . 0.0 111.057 -179.431 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.877 ' HA ' HG13 ' A' ' 93' ' ' VAL . 0.7 OUTLIER -58.85 -70.25 0.16 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.461 -0.774 . . . . 0.0 110.72 -179.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 15.2 p30 -113.95 26.33 10.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.137 -0.977 . . . . 0.0 110.181 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.442 ' OE1' ' O ' ' A' ' 65' ' ' ALA . 1.8 tp-100 -59.84 138.99 57.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 110.4 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.977 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -113.91 130.32 56.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.383 -0.823 . . . . 0.0 109.706 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.618 HD21 HD12 ' A' ' 107' ' ' LEU . 42.1 mt -125.04 121.33 34.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 110.275 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.599 ' O ' HD12 ' A' ' 105' ' ' LEU . 21.1 ttm-85 -96.83 128.25 43.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.347 -0.845 . . . . 0.0 110.177 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.593 HD23 ' HA ' ' A' ' 104' ' ' VAL . 31.6 mt -118.16 147.2 43.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 109.992 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 11.7 ttt180 -117.39 146.9 43.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 110.243 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.505 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -67.88 136.49 54.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.345 -0.847 . . . . 0.0 110.807 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -116.12 -8.63 11.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.345 -0.847 . . . . 0.0 109.656 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -141.21 108.68 5.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.338 -0.851 . . . . 0.0 109.727 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.716 ' HG3' HG12 ' A' ' 83' ' ' VAL . 28.2 tt0 -56.59 103.49 0.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.066 -1.021 . . . . 0.0 110.045 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 2.1 t 179.27 -33.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.46 -0.775 . . . . 0.0 109.938 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.524 ' CD1' ' C ' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -75.47 137.2 40.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.418 -0.801 . . . . 0.0 110.11 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 13.6 p-10 -102.18 110.2 22.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.864 . . . . 0.0 110.259 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.521 ' NE ' ' O ' ' A' ' 77' ' ' ARG . 5.4 tpm_? -88.5 -19.93 25.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.177 -0.952 . . . . 0.0 109.309 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.55 -12.67 23.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.465 -0.772 . . . . 0.0 109.638 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 115.16 -5.82 21.72 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.434 ' O ' ' CB ' ' A' ' 81' ' ' GLU . 12.4 mmmt -114.89 -70.35 0.8 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.189 -1.183 . . . . 0.0 110.221 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER 171.36 119.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.364 -0.835 . . . . 0.0 109.789 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.49 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 17.1 mmm180 -111.38 178.5 4.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 110.394 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.716 HG12 ' HG3' ' A' ' 73' ' ' GLU . 29.8 m -110.91 179.24 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 110.345 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.446 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 3.3 t -56.2 -27.0 53.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 110.093 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.458 ' O ' ' OE2' ' A' ' 87' ' ' GLU . . . -65.23 -23.77 70.1 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.49 ' CB ' ' HB3' ' A' ' 82' ' ' ARG . 22.1 tp10 -74.63 158.72 33.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.368 -1.078 . . . . 0.0 110.226 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.477 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -157.4 164.83 37.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.338 -0.851 . . . . 0.0 109.962 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.523 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -140.93 149.34 41.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.215 -0.928 . . . . 0.0 110.24 -179.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.791 HD13 ' C ' ' A' ' 89' ' ' LEU . 1.3 tm? -112.79 124.36 52.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.345 -0.847 . . . . 0.0 109.633 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.597 ' N ' HD22 ' A' ' 89' ' ' LEU . 8.0 p -105.44 132.36 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.173 -0.954 . . . . 0.0 110.847 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.48 ' OG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -135.88 56.1 1.84 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.301 -0.875 . . . . 0.0 110.006 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 54.5 m -97.51 119.52 36.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.954 . . . . 0.0 110.332 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.877 HG13 ' HA ' ' A' ' 62' ' ' GLN . 18.2 t -50.76 134.2 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.195 -0.941 . . . . 0.0 109.947 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.749 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 48.35 94.97 0.01 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.581 ' O ' HG22 ' A' ' 59' ' ' ILE . . . 178.67 154.79 0.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.088 -1.242 . . . . 0.0 110.949 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.648 ' CD1' HG21 ' A' ' 59' ' ' ILE . 2.5 t80 -134.67 87.18 2.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.488 -0.757 . . . . 0.0 110.15 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.779 HD22 ' HB3' ' A' ' 12' ' ' ALA . 16.9 mt -108.1 87.66 4.07 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.104 -0.998 . . . . 0.0 110.55 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.709 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 47.1 Cg_endo -72.54 -6.19 18.58 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.989 1.52 . . . . 0.0 110.438 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 98' ' ' PRO . . . 68.29 174.91 0.27 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.238 -0.914 . . . . 0.0 110.5 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.459 HG21 ' CA ' ' A' ' 35' ' ' TRP . 4.7 t -94.48 -58.31 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.856 . . . . 0.0 110.052 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 26.7 m-85 -109.45 53.43 0.69 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.1 -1.0 . . . . 0.0 110.318 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 3.2 tt0 -141.13 157.68 44.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.97 -1.081 . . . . 0.0 110.989 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 3.5 pt-20 -132.76 140.45 48.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.0 109.663 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.593 ' HA ' HD23 ' A' ' 68' ' ' LEU . 15.0 p -76.07 137.43 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.158 -0.964 . . . . 0.0 110.525 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.736 ' H ' HD12 ' A' ' 105' ' ' LEU . 1.7 mp -106.51 -19.3 13.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.443 -0.786 . . . . 0.0 110.145 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 37.6 p30 -176.43 162.7 2.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.338 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.618 HD12 HD21 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -120.42 141.99 49.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.361 -0.837 . . . . 0.0 109.778 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.977 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 12.7 p -139.31 160.59 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.064 -1.023 . . . . 0.0 110.859 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -110.73 116.94 32.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 109.549 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.492 1.656 0 O-C-N 120.98 -1.075 . . . . 0.0 110.687 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.246 0.546 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.471 ' O ' HD13 ' A' ' 8' ' ' LEU . 15.1 m -100.02 170.14 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 110.643 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.923 ' C ' HD13 ' A' ' 8' ' ' LEU . 23.2 t -46.87 153.0 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.431 -0.793 . . . . 0.0 110.45 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.923 HD13 ' C ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -106.5 171.41 4.78 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.283 -0.886 . . . . 0.0 108.863 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 45.8 Cg_endo -72.85 77.96 2.21 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.761 1.4 . . . . 0.0 110.156 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.549 ' HB3' ' CA ' ' A' ' 94' ' ' GLY . 78.2 m-20 58.28 74.21 0.44 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.44 -0.787 . . . . 0.0 110.513 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.496 ' HB ' ' HA ' ' A' ' 56' ' ' GLN . 2.9 p -148.39 169.78 19.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.253 -0.904 . . . . 0.0 110.426 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.665 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -147.28 162.95 37.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.455 -0.778 . . . . 0.0 109.768 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.931 HD23 ' HG3' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -133.25 155.78 48.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.006 -1.059 . . . . 0.0 110.833 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.917 ' CD2' HD11 ' A' ' 36' ' ' LEU . 4.6 m170 -93.15 123.92 36.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.445 -0.784 . . . . 0.0 109.636 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.835 HD21 ' HB2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -126.91 155.31 43.24 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.593 -1.317 . . . . 0.0 110.814 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -110.1 117.89 34.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.635 -0.666 . . . . 0.0 109.994 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.031 ' HB3' ' HB3' ' A' ' 33' ' ' ASP . . . -77.04 119.04 20.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 111.006 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 2.7 mm? -109.73 101.22 10.13 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.498 HD13 ' HG3' ' A' ' 48' ' ' GLU . 5.3 tp -164.42 155.5 15.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.017 -1.052 . . . . 0.0 110.482 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.414 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 12.5 p-10 -97.01 101.84 13.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.146 -0.971 . . . . 0.0 110.261 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.942 ' HB2' HG22 ' A' ' 29' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 109.716 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.942 HG22 ' HB2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.162 0.505 . . . . 0.0 109.744 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.564 ' O ' HG23 ' A' ' 30' ' ' VAL . 30.8 m -137.26 77.9 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.95 -1.094 . . . . 0.0 110.5 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 38.74 70.57 0.2 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.768 -0.583 . . . . 0.0 110.523 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.28 28.94 0.05 OUTLIER Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.849 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 1.031 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 18.2 t70 -96.69 149.04 22.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.813 -1.404 . . . . 0.0 109.883 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 36.3 tt0 -146.72 130.35 16.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.326 -0.859 . . . . 0.0 109.819 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.735 ' CZ2' HD12 ' A' ' 15' ' ' LEU . 7.6 p90 -154.81 171.28 19.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.126 -0.983 . . . . 0.0 110.955 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.917 HD11 ' CD2' ' A' ' 14' ' ' HIS . 0.6 OUTLIER -90.61 155.8 18.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.419 -0.801 . . . . 0.0 110.684 -179.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.835 ' HB2' HD21 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -132.51 110.49 10.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.365 -0.834 . . . . 0.0 110.008 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.506 ' HB2' HD11 ' A' ' 97' ' ' LEU . 2.1 tm-20 -95.98 135.51 37.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.38 -0.825 . . . . 0.0 110.065 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.604 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 69.71 45.15 59.93 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.931 ' HG3' HD23 ' A' ' 13' ' ' LEU . 44.1 Cg_endo -72.25 -57.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.854 1.45 . . . . 0.0 110.968 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.522 ' CA ' ' HA ' ' A' ' 7' ' ' VAL . . . 46.03 -89.9 0.01 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 40' ' ' PRO . 1.3 p -73.15 6.05 3.04 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.354 -1.086 . . . . 0.0 111.607 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.65 ' CE1' HD13 ' A' ' 15' ' ' LEU . 9.4 t80 -69.31 110.97 4.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.694 -1.254 . . . . 0.0 109.962 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.437 HG23 ' HD2' ' A' ' 45' ' ' PRO . 3.2 mt -105.97 139.92 20.73 Favored Pre-proline 0 C--N 1.297 -1.677 0 O-C-N 121.194 -0.941 . . . . 0.0 108.891 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.437 ' HD2' HG23 ' A' ' 44' ' ' ILE . 39.5 Cg_endo -66.4 76.37 0.36 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.762 1.401 . . . . 0.0 110.129 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 49' ' ' VAL . 4.6 mtt180 -73.3 153.08 40.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.516 -0.74 . . . . 0.0 110.185 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -43.13 -33.73 0.94 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.308 -0.87 . . . . 0.0 109.963 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.498 ' HG3' HD13 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -47.48 -51.44 20.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 109.821 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -136.06 174.02 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.456 -0.778 . . . . 0.0 109.38 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -134.16 126.63 30.37 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.108 -0.995 . . . . 0.0 110.126 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.822 HG23 HD13 ' A' ' 13' ' ' LEU . 12.4 p -53.84 132.33 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.175 -0.953 . . . . 0.0 108.847 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.545 HG23 ' HA ' ' A' ' 15' ' ' LEU . 44.6 t -109.65 -48.96 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.005 . . . . 0.0 111.195 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 1.043 ' O ' HD13 ' A' ' 54' ' ' ILE . 12.1 mt-10 -138.62 171.92 13.64 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.072 -1.017 . . . . 0.0 110.35 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 1.043 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -139.44 146.41 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.349 -0.844 . . . . 0.0 109.18 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.808 HD13 ' N ' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -141.84 141.89 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.111 -0.993 . . . . 0.0 110.385 -179.413 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.808 ' N ' HD13 ' A' ' 55' ' ' ILE . 1.3 mp0 -112.29 179.8 3.89 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.359 -0.838 . . . . 0.0 110.336 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.58 ' HB1' ' O ' ' A' ' 94' ' ' GLY . . . -80.34 139.5 36.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.264 -0.898 . . . . 0.0 110.3 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 58' ' ' THR . 11.8 t -179.93 56.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.362 -0.837 . . . . 0.0 110.054 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.805 HG22 ' N ' ' A' ' 60' ' ' ILE . 6.3 mm -155.69 -91.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.213 -0.929 . . . . 0.0 111.059 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.805 ' N ' HG22 ' A' ' 59' ' ' ILE . 17.5 mm -108.47 -104.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.836 -1.165 . . . . 0.0 110.839 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.644 ' N ' HG22 ' A' ' 60' ' ' ILE . 2.0 ttp180 -167.6 -170.24 1.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.777 -1.202 . . . . 0.0 110.496 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 1.009 ' HB2' HG13 ' A' ' 93' ' ' VAL . 6.5 tt0 -68.2 -57.14 6.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.842 . . . . 0.0 110.646 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.548 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 68.9 m-80 -34.52 -60.54 0.42 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.321 0.581 . . . . 0.0 111.112 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.586 ' NE2' HD23 ' A' ' 107' ' ' LEU . 35.6 tp60 -53.6 129.11 31.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.048 -1.033 . . . . 0.0 110.785 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.022 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -108.18 142.39 38.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 109.727 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 65' ' ' ALA . 5.8 mp -124.34 115.03 20.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.604 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.837 ' O ' HD12 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -90.67 125.98 35.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 0.0 109.56 179.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 104' ' ' VAL . 13.6 mt -116.58 152.67 33.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.133 -0.98 . . . . 0.0 110.629 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.832 ' HB2' HD21 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -128.51 144.33 51.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 109.854 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.52 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -59.16 140.33 56.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.169 -0.957 . . . . 0.0 110.356 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.468 ' C ' ' CG2' ' A' ' 84' ' ' THR . 7.6 tpt180 -107.53 -18.07 13.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.894 . . . . 0.0 110.121 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.708 ' O ' HG23 ' A' ' 84' ' ' THR . 2.0 mmmp? -112.51 -98.74 0.42 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.952 . . . . 0.0 110.149 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 0.2 OUTLIER 168.09 45.85 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.318 -0.864 . . . . 0.0 109.986 179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 73' ' ' GLU . 17.2 m -154.89 -19.49 0.12 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.209 -0.932 . . . . 0.0 111.676 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.571 ' CB ' ' HB2' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -73.98 121.37 20.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.686 -1.258 . . . . 0.0 110.851 -179.291 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.516 ' HB2' ' CA ' ' A' ' 81' ' ' GLU . 12.5 t70 -108.87 122.47 47.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 0.0 109.665 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.56 ' CG ' ' CZ2' ' A' ' 75' ' ' TRP . 9.4 mtm180 -55.61 -28.24 54.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -0.874 . . . . 0.0 110.607 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.444 ' HB3' ' OD1' ' A' ' 76' ' ' ASP . 11.4 t70 -89.29 -35.11 16.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.168 -0.957 . . . . 0.0 110.218 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 80' ' ' LYS . . . 148.59 -38.87 0.99 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.561 ' HE2' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -59.31 -133.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.384 -1.068 . . . . 0.0 110.077 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.81 ' CG ' HG12 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -141.43 141.81 33.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.898 -1.126 . . . . 0.0 110.067 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.476 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 27.4 mmt-85 -136.22 163.8 29.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.066 -1.021 . . . . 0.0 110.254 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 19.9 m -86.45 -179.12 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.339 -0.85 . . . . 0.0 110.803 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 72' ' ' LYS . 0.1 OUTLIER -62.89 -26.62 68.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.45 -0.781 . . . . 0.0 110.418 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.493 ' H ' HG23 ' A' ' 83' ' ' VAL . . . -64.46 -30.87 79.07 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.476 ' CB ' ' HB3' ' A' ' 82' ' ' ARG . 7.9 tp10 -61.43 151.57 32.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.568 ' CG ' ' HG2' ' A' ' 69' ' ' ARG . 5.4 mt-10 -148.52 169.58 19.96 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.184 -0.948 . . . . 0.0 110.151 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.466 ' HB2' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -156.0 130.24 8.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.229 -0.919 . . . . 0.0 109.927 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.008 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -102.51 136.45 42.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.351 -0.843 . . . . 0.0 109.839 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 1.008 ' N ' HD22 ' A' ' 89' ' ' LEU . 9.7 p -111.39 135.37 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.901 . . . . 0.0 110.581 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.7 t -141.82 16.44 2.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.437 -0.789 . . . . 0.0 109.53 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.4 m -75.47 170.01 16.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.398 -0.814 . . . . 0.0 109.865 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.009 HG13 ' HB2' ' A' ' 62' ' ' GLN . 0.8 OUTLIER -79.14 147.68 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.099 -1.001 . . . . 0.0 109.1 179.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.797 ' O ' ' HB3' ' A' ' 95' ' ' ALA . . . 150.96 -13.3 0.85 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.133 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.797 ' HB3' ' O ' ' A' ' 94' ' ' GLY . . . 77.74 -35.04 0.2 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.361 -1.082 . . . . 0.0 111.674 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.655 ' CG ' HG13 ' A' ' 59' ' ' ILE . 1.0 OUTLIER -146.86 147.61 31.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.08 -1.013 . . . . 0.0 110.385 179.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.63 ' HB3' HG21 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -160.76 59.86 1.23 Allowed Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.401 -0.812 . . . . 0.0 109.883 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.586 ' HG3' ' CE2' ' A' ' 96' ' ' TYR . 53.0 Cg_endo -76.99 143.25 22.8 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.976 1.514 . . . . 0.0 110.787 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -95.04 -151.42 0.33 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.325 -0.859 . . . . 0.0 110.346 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.15 -66.26 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.219 -0.926 . . . . 0.0 110.485 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.571 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 9.1 m-30 -80.57 -22.18 40.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.937 -1.102 . . . . 0.0 110.013 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.571 ' OE1' ' CH2' ' A' ' 75' ' ' TRP . 0.7 OUTLIER -98.34 131.6 44.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.348 -0.845 . . . . 0.0 110.3 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -115.02 161.1 18.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.165 -0.959 . . . . 0.0 110.174 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.648 ' HA ' HD23 ' A' ' 68' ' ' LEU . 10.1 p -76.98 146.1 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.114 -0.992 . . . . 0.0 110.685 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.837 HD12 ' O ' ' A' ' 67' ' ' ARG . 1.5 mp -105.11 -24.67 12.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.413 -0.804 . . . . 0.0 109.709 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -166.04 174.35 9.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.266 -0.896 . . . . 0.0 110.037 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.586 HD23 ' NE2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -121.95 131.19 53.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.23 -0.919 . . . . 0.0 110.064 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.022 HG13 ' HB3' ' A' ' 65' ' ' ALA . 14.6 p -125.16 157.14 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.17 -0.956 . . . . 0.0 110.414 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 0.6 OUTLIER -111.12 115.54 29.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.161 -0.962 . . . . 0.0 109.739 179.39 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.048 -1.033 . . . . 0.0 110.457 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.51 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 1.3 mt-30 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 7' ' ' VAL . 11.4 m -144.26 83.54 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.743 -1.223 . . . . 0.0 110.885 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.616 HG22 HG23 ' A' ' 42' ' ' THR . 2.0 t 27.04 99.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 CA-C-O 121.265 0.555 . . . . 0.0 111.682 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.011 HD23 ' OG1' ' A' ' 11' ' ' THR . 2.3 mp -61.52 168.76 2.91 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.076 -1.015 . . . . 0.0 110.098 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.456 ' O ' ' OD1' ' A' ' 10' ' ' ASN . 45.0 Cg_endo -72.67 -58.4 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.921 1.485 . . . . 0.0 110.406 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 9.6 m120 -162.04 30.87 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.805 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 1.011 ' OG1' HD23 ' A' ' 8' ' ' LEU . 1.1 p -109.9 172.09 7.06 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.312 -0.867 . . . . 0.0 110.22 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.743 ' HB2' HD21 ' A' ' 97' ' ' LEU . . . -144.5 161.32 39.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.213 -0.929 . . . . 0.0 110.659 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.11 ' CD2' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -133.64 155.49 49.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 109.896 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.697 ' C ' HD22 ' A' ' 15' ' ' LEU . 17.8 m80 -97.66 133.45 42.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 109.812 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.11 HD21 ' CD2' ' A' ' 13' ' ' LEU . 2.5 mm? -120.18 151.9 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.343 -0.848 . . . . 0.0 110.535 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -116.09 117.35 29.84 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.349 178.063 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.08 ' HB3' ' HB3' ' A' ' 33' ' ' ASP . . . -82.62 118.53 23.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.089 -1.007 . . . . 0.0 109.724 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.873 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 1.4 mm? -108.15 101.68 10.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.783 -0.573 . . . . 0.0 110.264 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.855 HD13 ' C ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -164.95 174.91 10.0 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 0.0 110.331 179.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.4 117.22 33.51 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.097 -1.002 . . . . 0.0 109.862 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.931 ' HB2' HG22 ' A' ' 29' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.143 -0.973 . . . . 0.0 110.583 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.931 HG22 ' HB2' ' A' ' 21' ' ' PHE . 1.4 m . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 30' ' ' VAL . 15.4 m -131.17 82.92 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.886 -1.134 . . . . 0.0 111.03 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.873 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 47.32 69.65 0.49 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.413 -0.805 . . . . 0.0 110.516 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -175.47 24.72 0.06 OUTLIER Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.694 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 1.08 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 11.5 t70 -86.99 143.41 27.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.783 -1.422 . . . . 0.0 110.242 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.76 ' HG2' HG11 ' A' ' 100' ' ' VAL . 8.9 tt0 -143.52 134.6 25.64 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.403 -0.811 . . . . 0.0 109.845 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.631 ' CZ2' ' HB2' ' A' ' 15' ' ' LEU . 13.5 p90 -150.26 163.97 36.93 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.994 -1.066 . . . . 0.0 111.237 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.533 HD13 ' CD2' ' A' ' 14' ' ' HIS . 42.0 tp -94.49 152.38 18.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.553 -0.717 . . . . 0.0 109.95 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.671 ' HB3' HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -133.0 110.66 10.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.064 -1.023 . . . . 0.0 110.367 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.95 ' OE1' HD11 ' A' ' 97' ' ' LEU . 16.5 tp10 -85.83 138.48 32.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.622 -0.674 . . . . 0.0 109.469 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.619 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 54.36 45.02 76.44 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 51.3 Cg_endo -72.13 4.27 3.4 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.827 1.435 . . . . 0.0 111.057 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.542 ' HA3' ' N ' ' A' ' 7' ' ' VAL . . . -42.0 -27.92 0.43 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.616 HG23 HG22 ' A' ' 7' ' ' VAL . 10.8 p -103.19 37.28 2.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.132 -1.217 . . . . 0.0 109.59 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.5 ' N ' ' O ' ' A' ' 40' ' ' PRO . 6.0 t80 -104.25 117.68 34.8 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.527 -0.733 . . . . 0.0 110.021 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.468 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.1 mp -96.47 124.11 52.09 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.235 -0.916 . . . . 0.0 110.318 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.93 127.05 11.11 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.827 1.435 . . . . 0.0 110.335 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -136.82 165.23 26.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.323 -0.86 . . . . 0.0 110.108 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -56.38 -18.83 12.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.732 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.5 ' C ' ' CG1' ' A' ' 49' ' ' VAL . 5.7 tt0 -67.55 -21.62 65.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.419 -0.801 . . . . 0.0 110.444 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.5 ' CG1' ' C ' ' A' ' 48' ' ' GLU . 1.4 m -151.65 173.95 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.026 -1.046 . . . . 0.0 110.38 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.4 137.24 37.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.322 -0.861 . . . . 0.0 110.215 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -57.55 114.55 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 109.526 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.567 HG11 ' OE2' ' A' ' 34' ' ' GLU . 14.4 t -90.96 -60.12 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.946 . . . . 0.0 111.068 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.931 ' C ' HD13 ' A' ' 54' ' ' ILE . 5.6 mt-10 -144.82 169.33 18.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.91 -1.119 . . . . 0.0 110.963 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.931 HD13 ' C ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -134.44 143.24 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.049 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.581 HD13 ' N ' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -137.25 130.14 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.963 -1.085 . . . . 0.0 110.605 -179.535 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.581 ' N ' HD13 ' A' ' 55' ' ' ILE . 2.4 mp0 -83.9 171.64 12.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.587 -0.696 . . . . 0.0 109.958 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.595 ' CA ' ' HA ' ' A' ' 95' ' ' ALA . . . -92.53 128.15 38.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.055 -1.028 . . . . 0.0 110.578 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER 172.71 60.98 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.24 -0.913 . . . . 0.0 111.424 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.566 ' CG2' ' N ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -166.43 -51.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.6 -1.313 . . . . 0.0 111.637 179.331 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.636 HD12 ' O ' ' A' ' 95' ' ' ALA . 3.5 mt -81.6 142.1 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.815 -1.178 . . . . 0.0 110.56 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.46 -170.39 0.28 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.315 -0.866 . . . . 0.0 110.745 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.795 ' HB2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -91.55 -35.89 14.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 0.0 110.445 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.589 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 2.0 m120 -87.72 -29.65 20.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.521 -0.737 . . . . 0.0 110.965 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 109' ' ' ASP . 7.9 tp-100 -58.63 140.59 54.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.085 -1.009 . . . . 0.0 111.476 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.072 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -118.45 141.44 48.55 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 90' ' ' VAL . 0.5 OUTLIER -126.08 117.5 23.31 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.431 -0.793 . . . . 0.0 110.97 -178.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.544 ' HB3' HD22 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -92.37 125.81 37.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 0.0 109.81 179.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.749 HD12 ' OE1' ' A' ' 102' ' ' GLU . 3.5 mm? -112.15 134.09 53.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.984 . . . . 0.0 110.576 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.542 ' CB ' HD11 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -125.66 150.95 47.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -0.881 . . . . 0.0 110.057 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.585 ' CB ' ' HA ' ' A' ' 84' ' ' THR . . . -70.33 142.0 52.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.39 -0.819 . . . . 0.0 110.519 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.452 ' C ' HG23 ' A' ' 84' ' ' THR . 7.8 tpp180 -118.49 -24.45 6.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.429 -0.795 . . . . 0.0 109.615 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 74' ' ' CYS . 2.6 ttpt -127.69 109.35 11.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.493 -0.754 . . . . 0.0 109.847 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -47.17 90.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.436 -0.79 . . . . 0.0 110.346 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 72' ' ' LYS . 0.5 OUTLIER -177.46 -32.89 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 110.094 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.619 ' CZ3' ' HB3' ' A' ' 102' ' ' GLU . 2.8 t90 -75.16 114.75 14.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.327 -0.858 . . . . 0.0 110.011 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.481 ' OD1' ' HA ' ' A' ' 81' ' ' GLU . 67.5 m-20 -91.48 113.55 25.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.924 . . . . 0.0 110.357 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.436 ' HD2' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -57.08 -48.9 77.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.329 -0.857 . . . . 0.0 109.851 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -93.49 -16.3 24.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 109.892 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.77 32.96 5.46 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -129.34 47.99 2.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -1.107 . . . . 0.0 109.989 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.551 ' OE1' ' CE2' ' A' ' 21' ' ' PHE . 7.9 mp0 49.04 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.38 -0.825 . . . . 0.0 110.422 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.476 ' HB2' ' HA ' ' A' ' 76' ' ' ASP . 12.8 mmt180 -113.69 -179.96 3.79 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.393 -0.817 . . . . 0.0 110.121 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.498 HG22 ' N ' ' A' ' 84' ' ' THR . 10.9 p -120.87 165.74 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.223 -0.923 . . . . 0.0 110.651 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.585 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -51.2 -20.99 1.78 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.388 -0.82 . . . . 0.0 110.377 179.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.441 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -69.53 -11.58 65.41 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.462 ' HA ' ' OE1' ' A' ' 86' ' ' GLU . 2.1 tp10 -84.48 142.22 30.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.393 -1.063 . . . . 0.0 110.026 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -148.08 158.89 44.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.186 -0.946 . . . . 0.0 110.288 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.584 ' CZ2' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -144.6 134.77 24.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 109.909 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.016 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -95.56 128.7 42.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.14 -0.975 . . . . 0.0 110.055 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 1.016 ' N ' HD22 ' A' ' 89' ' ' LEU . 5.4 p -108.44 128.61 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 109.995 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.538 HG23 HD11 ' A' ' 89' ' ' LEU . 1.1 p -129.51 48.42 2.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -0.88 . . . . 0.0 110.197 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 m -75.83 169.68 17.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.132 -0.98 . . . . 0.0 109.993 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.795 HG13 ' HB2' ' A' ' 62' ' ' GLN . 89.7 t -115.14 131.76 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.216 -0.927 . . . . 0.0 110.495 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 60' ' ' ILE . . . 50.01 44.57 41.64 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.636 ' O ' HD12 ' A' ' 60' ' ' ILE . . . -134.33 157.8 45.43 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.222 -1.163 . . . . 0.0 111.036 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.544 ' CD2' HD11 ' A' ' 55' ' ' ILE . 1.3 t80 -121.78 113.85 20.26 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.95 HD11 ' OE1' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -126.37 84.9 61.14 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.049 -1.032 . . . . 0.0 111.029 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.525 ' O ' ' NE2' ' A' ' 14' ' ' HIS . 50.0 Cg_endo -77.48 117.44 4.32 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.142 1.601 . . . . 0.0 110.02 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.66 ' HB1' ' HG3' ' A' ' 102' ' ' GLU . . . -74.74 -168.95 0.79 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.026 -1.046 . . . . 0.0 110.431 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.76 HG11 ' HG2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -113.93 -57.21 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.205 -0.934 . . . . 0.0 110.45 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.509 ' CE2' ' HB3' ' A' ' 74' ' ' CYS . 21.9 m-30 -103.23 -32.14 9.75 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.75 -1.218 . . . . 0.0 110.672 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.749 ' OE1' HD12 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -80.07 154.83 27.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.199 -0.938 . . . . 0.0 110.641 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.582 ' C ' HD13 ' A' ' 68' ' ' LEU . 6.9 tp10 -128.94 167.73 17.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.458 -0.776 . . . . 0.0 110.2 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.454 ' C ' HD12 ' A' ' 105' ' ' LEU . 10.7 m -72.02 152.31 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.0 110.245 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.562 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 4.7 mp -100.06 -14.57 18.56 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.295 -0.878 . . . . 0.0 109.605 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.599 ' O ' HD22 ' A' ' 107' ' ' LEU . 1.8 p30 165.25 -168.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.61 -0.681 . . . . 0.0 110.151 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.599 HD22 ' O ' ' A' ' 106' ' ' ASP . 1.0 OUTLIER -127.01 116.08 20.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.464 -0.772 . . . . 0.0 109.416 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.072 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 2.0 p -115.87 103.71 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.832 -1.168 . . . . 0.0 111.037 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 3.8 t70 -75.61 115.66 15.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.279 -0.888 . . . . 0.0 110.125 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.886 . . . . 0.0 110.586 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.169 0.509 . . . . 0.0 110.261 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.462 ' C ' ' HA2' ' A' ' 41' ' ' GLY . 95.7 t -136.01 135.59 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.166 -0.959 . . . . 0.0 110.131 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.517 ' CG2' ' HA3' ' A' ' 41' ' ' GLY . 79.2 t -60.88 118.7 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 110.829 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.509 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 0.4 OUTLIER -79.16 167.24 36.18 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 109.717 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 42.9 Cg_endo -69.9 -37.12 9.26 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.612 1.322 . . . . 0.0 110.383 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.434 ' CG ' ' HA3' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -170.69 41.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.104 -0.998 . . . . 0.0 110.246 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.444 ' OG1' ' CB ' ' A' ' 8' ' ' LEU . 12.6 p -112.98 160.86 17.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.817 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.746 ' CB ' HD11 ' A' ' 36' ' ' LEU . . . -146.82 155.35 42.28 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.988 -1.07 . . . . 0.0 110.177 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.776 ' CD1' HD22 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -123.39 154.6 38.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.166 -0.959 . . . . 0.0 110.639 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.773 ' NE2' HD12 ' A' ' 55' ' ' ILE . 7.9 m170 -94.96 127.54 41.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 109.966 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.868 HD21 ' HB2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -136.1 148.35 48.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.931 -1.105 . . . . 0.0 110.661 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.492 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -100.78 121.15 41.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.547 -0.721 . . . . 0.0 110.359 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.069 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -82.46 113.57 20.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 110.028 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.456 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -105.12 99.6 9.21 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.547 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.456 ' CD2' ' O ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -167.5 133.33 2.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.356 -0.84 . . . . 0.0 110.079 179.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -78.26 101.84 7.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.014 -1.054 . . . . 0.0 108.693 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.788 ' HB2' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.12 -0.988 . . . . 0.0 111.542 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.886 HG12 ' CB ' ' A' ' 81' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.523 ' O ' HG23 ' A' ' 30' ' ' VAL . 27.0 m -132.64 78.54 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.978 -1.077 . . . . 0.0 111.056 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 30' ' ' VAL . . . 35.68 72.29 0.11 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.741 -0.599 . . . . 0.0 111.23 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.56 34.2 0.02 OUTLIER Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.365 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 1.069 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 3.8 m-20 -93.31 145.62 24.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.893 -1.357 . . . . 0.0 110.36 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 101' ' ' PHE . 14.1 tt0 -140.86 130.18 23.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 0.0 109.396 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.658 ' CH2' HD12 ' A' ' 15' ' ' LEU . 3.7 p90 -157.62 166.95 31.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.97 -1.081 . . . . 0.0 111.286 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.746 HD11 ' CB ' ' A' ' 12' ' ' ALA . 16.2 tp -90.36 155.69 18.77 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.531 -0.731 . . . . 0.0 109.183 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.868 ' HB2' HD21 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -126.42 108.61 11.36 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.099 -1.001 . . . . 0.0 109.841 -179.563 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.617 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -88.44 142.22 27.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.413 -0.804 . . . . 0.0 109.384 179.63 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.611 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 54.52 46.17 74.46 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.617 ' HG3' HD23 ' A' ' 13' ' ' LEU . 47.8 Cg_endo -71.33 18.32 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.861 1.453 . . . . 0.0 112.344 -178.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.517 ' HA3' ' CG2' ' A' ' 7' ' ' VAL . . . -44.81 156.75 0.25 Allowed Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 41' ' ' GLY . 20.3 p 53.45 12.13 0.33 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.662 -0.905 . . . . 0.0 111.583 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.543 ' HE2' HG12 ' A' ' 51' ' ' VAL . 7.0 t80 -75.62 132.37 40.58 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.702 -1.249 . . . . 0.0 109.548 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.422 ' HB ' ' CZ ' ' A' ' 46' ' ' ARG . 50.3 mt -120.52 134.48 24.19 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.054 -1.028 . . . . 0.0 110.492 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.3 78.46 2.29 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.968 1.509 . . . . 0.0 110.303 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 47' ' ' LYS . 22.8 mtm180 -91.58 151.02 20.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 110.364 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 48' ' ' GLU . 13.7 mttt -42.16 -31.78 0.41 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.238 -0.914 . . . . 0.0 110.287 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -42.9 -51.02 5.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.39 -0.819 . . . . 0.0 109.772 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -134.81 173.76 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.381 -0.825 . . . . 0.0 109.389 179.382 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.41 122.74 28.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.19 -0.944 . . . . 0.0 110.407 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.543 HG12 ' HE2' ' A' ' 43' ' ' TYR . 33.7 m -54.27 123.36 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.113 -0.992 . . . . 0.0 108.678 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.781 HG12 ' HG2' ' A' ' 53' ' ' GLU . 57.1 t -99.36 -54.51 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.148 -0.97 . . . . 0.0 110.472 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.934 ' O ' HD13 ' A' ' 54' ' ' ILE . 27.6 mm-40 -138.72 174.65 10.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 110.205 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.934 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -134.09 144.26 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.405 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.773 HD12 ' NE2' ' A' ' 14' ' ' HIS . 0.2 OUTLIER -134.26 144.67 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.961 -1.087 . . . . 0.0 111.138 -178.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.433 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 70.9 mm-40 -119.36 168.51 10.87 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.684 -0.635 . . . . 0.0 109.347 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.617 ' HB1' ' HB3' ' A' ' 95' ' ' ALA . . . -89.51 132.51 35.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.154 -0.966 . . . . 0.0 110.43 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.61 ' N ' ' CB ' ' A' ' 95' ' ' ALA . 1.5 t -176.24 71.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.13 -0.981 . . . . 0.0 111.293 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.771 HD13 ' C ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -176.66 -51.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.825 -1.172 . . . . 0.0 111.732 178.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.768 HG23 ' N ' ' A' ' 61' ' ' ARG . 1.0 OUTLIER -108.3 -167.36 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.157 -1.59 . . . . 0.0 110.791 -179.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.768 ' N ' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -123.43 -147.71 0.38 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.461 -0.774 . . . . 0.0 110.115 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.947 ' HB2' HG13 ' A' ' 93' ' ' VAL . 11.4 tt0 -89.67 -71.31 0.61 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.206 -0.934 . . . . 0.0 110.919 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 7.5 p-10 -34.16 -47.66 0.29 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.832 -0.543 . . . . 0.0 111.72 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' A' ' 108' ' ' VAL . 54.0 tp60 -56.23 128.18 34.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.958 -1.089 . . . . 0.0 110.931 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.99 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -108.19 149.17 28.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.342 -0.849 . . . . 0.0 109.303 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.451 ' O ' HD22 ' A' ' 89' ' ' LEU . 1.4 mt -126.27 113.71 17.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.068 -1.02 . . . . 0.0 111.333 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.72 ' O ' HD12 ' A' ' 105' ' ' LEU . 1.5 ttm-85 -100.03 122.05 42.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.213 -0.929 . . . . 0.0 109.04 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.553 HD23 ' HA ' ' A' ' 104' ' ' VAL . 20.1 mt -119.21 145.69 45.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.106 -0.996 . . . . 0.0 111.277 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.886 ' CB ' HD21 ' A' ' 105' ' ' LEU . 2.0 ttp85 -121.03 152.6 38.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.541 -0.725 . . . . 0.0 110.059 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.559 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -71.7 159.9 33.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -0.929 . . . . 0.0 110.867 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 101' ' ' PHE . 4.4 tpm_? -132.0 -34.15 1.3 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.457 -0.777 . . . . 0.0 109.813 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -117.98 107.69 14.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 110.036 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.481 ' O ' ' CB ' ' A' ' 74' ' ' CYS . 0.8 OUTLIER -47.89 99.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.619 179.576 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER 169.71 -24.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.329 -0.857 . . . . 0.0 110.294 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.608 ' CZ3' ' HB2' ' A' ' 102' ' ' GLU . 1.3 t90 -74.72 126.73 31.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -0.923 . . . . 0.0 110.058 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 1.5 m-20 -90.82 110.85 22.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 110.001 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.574 ' HG3' ' CZ2' ' A' ' 75' ' ' TRP . 10.1 mtp180 -59.03 -57.65 12.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.158 -0.964 . . . . 0.0 110.169 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.43 0.23 14.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.33 -0.856 . . . . 0.0 110.274 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.72 9.47 16.57 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -98.51 -11.7 22.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -1.15 . . . . 0.0 109.983 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.886 ' CB ' HG12 ' A' ' 29' ' ' VAL . 2.0 tm-20 61.88 104.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -0.849 . . . . 0.0 110.306 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.492 ' HB3' ' HB3' ' A' ' 86' ' ' GLU . 46.7 mtt180 -123.28 175.04 6.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.333 -0.854 . . . . 0.0 109.918 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.679 HG13 ' H ' ' A' ' 85' ' ' GLY . 10.8 p -76.83 174.74 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.219 -0.925 . . . . 0.0 110.461 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.599 ' N ' HG22 ' A' ' 83' ' ' VAL . 1.9 t -60.61 -10.84 5.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.368 -0.832 . . . . 0.0 110.366 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.679 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -76.91 -10.32 86.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.502 ' HG2' ' CB ' ' A' ' 70' ' ' ALA . 9.0 pt-20 -73.22 153.47 40.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.185 -1.185 . . . . 0.0 109.864 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -160.33 161.15 33.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 110.227 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.887 ' CZ2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -149.56 145.87 27.05 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.161 -0.962 . . . . 0.0 110.215 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.887 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -106.02 125.19 50.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 0.0 110.321 -179.14 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.887 HG22 ' CZ2' ' A' ' 88' ' ' TRP . 22.8 t -93.49 128.07 45.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.467 -0.771 . . . . 0.0 110.765 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.517 ' OG1' ' CD1' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -134.48 30.04 3.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.53 -0.732 . . . . 0.0 109.246 179.383 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.46 130.83 35.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.478 -0.764 . . . . 0.0 110.725 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.947 HG13 ' HB2' ' A' ' 62' ' ' GLN . 6.4 t -65.51 113.82 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.374 -0.829 . . . . 0.0 110.033 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.434 ' HA3' ' CG ' ' A' ' 10' ' ' ASN . . . -179.85 -95.37 0.1 OUTLIER Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.293 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.661 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -150.13 -50.28 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.072 -1.252 . . . . 0.0 111.227 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.603 ' HB3' ' CG2' ' A' ' 59' ' ' ILE . 1.8 p90 176.51 161.37 0.37 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.48 -0.763 . . . . 0.0 110.606 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.614 ' HB2' HG11 ' A' ' 90' ' ' VAL . 12.9 mt -155.41 72.73 5.53 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.363 -0.836 . . . . 0.0 110.172 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.563 ' HD3' ' CD2' ' A' ' 96' ' ' TYR . 45.8 Cg_endo -72.35 128.5 13.76 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.883 1.464 . . . . 0.0 110.541 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.444 ' HB2' ' OE1' ' A' ' 102' ' ' GLU . . . -66.69 -163.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.354 -0.841 . . . . 0.0 110.333 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.86 -68.12 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.361 -0.837 . . . . 0.0 109.807 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 34' ' ' GLU . 16.2 m-30 -80.79 -21.2 41.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.258 -0.901 . . . . 0.0 109.935 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.608 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . 3.5 tt0 -87.8 146.11 25.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.378 -0.826 . . . . 0.0 110.411 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.32 170.73 9.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.464 -0.773 . . . . 0.0 110.066 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.553 ' HA ' HD23 ' A' ' 68' ' ' LEU . 7.6 p -84.52 136.39 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.114 -0.992 . . . . 0.0 110.461 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.886 HD21 ' CB ' ' A' ' 69' ' ' ARG . 1.1 mp -93.95 -29.4 15.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 0.0 109.957 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 105' ' ' LEU . 15.0 p-10 -178.66 123.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.438 -0.788 . . . . 0.0 110.359 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.469 HD12 ' NE2' ' A' ' 64' ' ' GLN . 0.9 OUTLIER -77.19 144.98 37.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -0.858 . . . . 0.0 109.73 179.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.99 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 12.9 p -130.87 154.49 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.062 -1.024 . . . . 0.0 110.307 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 47.4 t0 -110.5 123.37 49.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.148 -0.97 . . . . 0.0 110.144 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.18 -0.95 . . . . 0.0 110.407 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.55 ' OE1' HD11 ' A' ' 8' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.291 0.567 . . . . 0.0 110.385 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.479 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 22.0 t -92.36 152.21 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.384 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.466 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 54.4 t -41.44 122.54 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.241 -0.912 . . . . 0.0 110.128 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.898 HD22 ' HG2' ' A' ' 40' ' ' PRO . 1.7 mp -78.85 159.76 73.08 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 110.366 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -75.48 -82.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.949 1.499 . . . . 0.0 110.164 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.727 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 11.4 p30 -129.56 54.7 1.81 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.309 -0.87 . . . . 0.0 109.843 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.874 ' OG1' HD23 ' A' ' 8' ' ' LEU . 1.1 p -132.5 157.47 44.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.145 -0.972 . . . . 0.0 110.111 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.755 ' CB ' HD11 ' A' ' 36' ' ' LEU . . . -141.3 162.08 36.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -0.959 . . . . 0.0 109.574 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.789 HD23 ' HG3' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -133.54 156.36 47.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.937 -1.102 . . . . 0.0 111.164 -179.492 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.667 ' NE2' HD12 ' A' ' 55' ' ' ILE . 8.9 m170 -96.24 123.32 39.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.438 -0.789 . . . . 0.0 109.882 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.854 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -125.76 148.86 48.95 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.081 -1.012 . . . . 0.0 109.55 179.278 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.499 ' HG3' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -96.98 119.22 35.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 110.714 -178.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.992 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -76.92 115.12 16.42 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.622 0.725 . . . . 0.0 110.258 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 86.8 mt -97.84 100.85 12.23 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.672 HD13 ' N ' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -158.64 144.9 17.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.146 -0.971 . . . . 0.0 110.653 -178.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.672 ' N ' HD13 ' A' ' 19' ' ' LEU . 20.1 p-10 -86.4 102.42 14.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 0.0 109.08 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.805 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 110.818 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.805 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.579 ' O ' HG23 ' A' ' 30' ' ' VAL . 22.8 m -125.96 90.97 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.971 -1.08 . . . . 0.0 110.467 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 42.96 61.57 2.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.0 110.222 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.68 24.14 0.2 Allowed Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.489 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.992 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 1.6 m-20 -88.9 161.15 16.83 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.875 -1.368 . . . . 0.0 110.03 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.499 ' HB3' ' HG3' ' A' ' 16' ' ' LYS . 9.9 pt-20 -159.81 130.97 5.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.251 -0.906 . . . . 0.0 110.575 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.689 ' CZ2' HD12 ' A' ' 15' ' ' LEU . 6.0 p90 -145.64 170.79 15.77 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.376 -0.827 . . . . 0.0 110.228 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.755 HD11 ' CB ' ' A' ' 12' ' ' ALA . 13.6 tp -90.44 156.07 18.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 110.033 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.782 ' HB2' HD21 ' A' ' 15' ' ' LEU . 3.7 t80 -132.76 110.47 10.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -0.872 . . . . 0.0 109.436 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.573 ' HB2' HD13 ' A' ' 97' ' ' LEU . 3.1 tm-20 -91.5 136.5 33.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.298 -0.877 . . . . 0.0 110.094 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.6 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 65.86 46.22 83.59 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.898 ' HG2' HD22 ' A' ' 8' ' ' LEU . 38.7 Cg_endo -66.09 -61.07 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.925 1.487 . . . . 0.0 110.461 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 6' ' ' VAL . . . 43.62 -88.62 0.01 OUTLIER Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.577 ' N ' ' O ' ' A' ' 40' ' ' PRO . 1.4 p -70.39 4.35 2.36 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.31 -1.112 . . . . 0.0 111.658 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.697 ' CE2' HD11 ' A' ' 13' ' ' LEU . 11.1 t80 -68.5 112.26 5.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.609 -1.307 . . . . 0.0 109.976 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.422 HG23 ' HD2' ' A' ' 45' ' ' PRO . 4.1 mm -104.13 141.8 23.27 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.345 -0.847 . . . . 0.0 109.737 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.422 ' HD2' HG23 ' A' ' 44' ' ' ILE . 43.0 Cg_endo -70.18 93.35 0.56 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.93 1.49 . . . . 0.0 110.101 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.404 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -102.78 158.9 15.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.272 -0.892 . . . . 0.0 110.604 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -44.56 -35.61 2.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.431 -0.793 . . . . 0.0 110.104 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -45.28 -48.09 12.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.301 -0.874 . . . . 0.0 110.105 179.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.554 HG21 ' HH2' ' A' ' 35' ' ' TRP . 0.9 OUTLIER -147.15 173.3 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.267 -0.895 . . . . 0.0 110.077 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.409 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.2 mt-10 -130.66 127.15 38.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.243 -0.911 . . . . 0.0 110.652 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.662 HG23 ' CD1' ' A' ' 13' ' ' LEU . 8.7 p -55.06 128.5 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.185 -0.947 . . . . 0.0 109.456 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.638 HG12 ' HG2' ' A' ' 53' ' ' GLU . 60.2 t -109.84 -61.04 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -0.95 . . . . 0.0 110.907 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 1.007 ' O ' HD13 ' A' ' 54' ' ' ILE . 2.6 mt-10 -124.46 173.96 8.1 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.192 -0.943 . . . . 0.0 110.774 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 1.007 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.1 mm -137.01 155.54 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.667 HD12 ' NE2' ' A' ' 14' ' ' HIS . 1.1 mt -146.82 151.12 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.909 -1.12 . . . . 0.0 111.132 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.479 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 87.5 mm-40 -124.21 170.12 11.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.774 -0.579 . . . . 0.0 110.337 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -86.51 153.85 21.54 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.229 -0.92 . . . . 0.0 110.845 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.523 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER 172.65 29.42 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.073 -1.017 . . . . 0.0 112.621 179.004 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.836 HG22 ' HB3' ' A' ' 96' ' ' TYR . 2.3 tt -161.88 -35.11 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 119.707 -1.871 . . . . 0.0 113.913 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.545 HG23 ' CG ' ' A' ' 64' ' ' GLN . 48.6 mt -75.7 152.49 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.078 -1.639 . . . . 0.0 111.188 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.0 -154.73 0.25 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.556 -0.715 . . . . 0.0 110.18 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.996 ' HA ' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -82.27 -69.35 0.63 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 110.93 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.561 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 2.2 m-20 -78.49 -8.17 58.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.105 -0.997 . . . . 0.0 110.665 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.545 ' CG ' HG23 ' A' ' 60' ' ' ILE . 5.2 tp-100 -55.32 124.5 17.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.986 -1.071 . . . . 0.0 110.663 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.976 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -108.32 151.04 26.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.308 -0.87 . . . . 0.0 110.232 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.531 HD13 ' HA ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -125.69 121.83 34.58 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.196 -0.94 . . . . 0.0 110.418 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.73 ' HA ' HD22 ' A' ' 89' ' ' LEU . 8.4 mmm180 -93.34 123.91 36.96 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.249 -0.907 . . . . 0.0 110.283 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.629 HD13 ' C ' ' A' ' 103' ' ' GLU . 1.1 mm? -124.99 127.73 47.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.16 -0.963 . . . . 0.0 110.385 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -110.64 165.69 11.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.18 -0.95 . . . . 0.0 110.061 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -76.36 157.82 32.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.084 -1.01 . . . . 0.0 110.649 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.516 ' CB ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -114.59 -38.44 4.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 0.0 109.553 179.53 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -138.82 131.9 29.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.445 -0.784 . . . . 0.0 109.647 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.46 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 1.1 pt-20 -56.55 84.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.113 -0.992 . . . . 0.0 110.13 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' A' ' 72' ' ' LYS . 1.7 m -162.63 -35.33 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.401 -0.812 . . . . 0.0 110.058 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.603 ' CZ2' ' HG2' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -74.1 118.48 17.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.854 . . . . 0.0 110.073 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.406 ' HB3' ' C ' ' A' ' 79' ' ' GLY . 35.7 m-20 -86.86 115.27 24.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.992 . . . . 0.0 110.273 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.603 ' HG2' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -55.48 -55.7 28.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.169 -0.957 . . . . 0.0 110.116 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -105.55 24.22 12.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.245 -0.909 . . . . 0.0 110.066 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.406 ' C ' ' HB3' ' A' ' 76' ' ' ASP . . . 86.73 -10.25 68.4 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 23.9 pttt -87.45 136.97 32.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.391 -1.064 . . . . 0.0 110.161 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.445 ' CB ' ' CD1' ' A' ' 21' ' ' PHE . 3.6 tm-20 -47.14 118.94 2.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -0.913 . . . . 0.0 110.013 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.515 ' CB ' ' OE1' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -131.35 156.96 44.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.102 -0.999 . . . . 0.0 110.66 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.751 HG23 ' H ' ' A' ' 85' ' ' GLY . 23.4 m -86.4 -178.65 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.328 -0.857 . . . . 0.0 110.444 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.824 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 12.5 t -73.61 -6.78 48.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.362 -0.837 . . . . 0.0 109.972 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.751 ' H ' HG23 ' A' ' 83' ' ' VAL . . . -77.03 -24.84 65.56 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.515 ' OE1' ' CB ' ' A' ' 82' ' ' ARG . 4.6 pt-20 -57.11 162.0 2.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.045 -1.268 . . . . 0.0 110.058 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.484 ' CG ' ' O ' ' A' ' 68' ' ' LEU . 6.0 tt0 -159.62 142.49 13.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.185 -0.947 . . . . 0.0 109.877 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.63 ' CZ2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -119.89 148.36 43.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.048 -1.032 . . . . 0.0 110.096 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.031 HD12 HG23 ' A' ' 91' ' ' THR . 1.2 tm? -113.25 128.61 56.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.533 -0.73 . . . . 0.0 110.07 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.847 ' N ' HD13 ' A' ' 89' ' ' LEU . 81.4 t -90.77 102.32 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.854 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 1.031 HG23 HD12 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -109.36 28.5 8.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.404 -0.81 . . . . 0.0 110.348 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.461 HG21 ' HB3' ' A' ' 95' ' ' ALA . 13.9 t -76.22 169.1 18.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 0.0 109.986 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.996 HG13 ' HA ' ' A' ' 62' ' ' GLN . 48.5 t -114.7 107.02 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.187 -0.946 . . . . 0.0 109.985 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.661 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 87.79 78.61 1.26 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 94' ' ' GLY . . . 174.37 -158.53 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.58 -0.953 . . . . 0.0 110.611 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.836 ' HB3' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER 176.21 25.32 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.055 -1.028 . . . . 0.0 111.115 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.697 ' HB2' HD21 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -61.45 110.2 2.88 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.709 -1.244 . . . . 0.0 110.067 179.41 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.665 ' O ' ' HB2' ' A' ' 99' ' ' ALA . 50.5 Cg_endo -79.32 -92.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.921 1.485 . . . . 0.0 110.796 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' A' ' 98' ' ' PRO . . . 171.54 -158.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 0.0 110.146 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.548 ' CG2' ' HA ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -113.36 -59.19 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.18 -0.95 . . . . 0.0 110.043 179.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.545 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 17.5 m-30 -99.96 11.8 38.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.069 -1.019 . . . . 0.0 109.457 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 99' ' ' ALA . 6.0 tt0 -96.05 157.59 15.83 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.301 -0.874 . . . . 0.0 110.968 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.629 ' C ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -140.06 128.63 22.92 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.552 -0.718 . . . . 0.0 109.355 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.686 ' C ' HD13 ' A' ' 105' ' ' LEU . 6.9 p -75.58 151.64 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.077 -1.015 . . . . 0.0 110.466 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.749 ' N ' HD22 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -104.14 -24.16 13.2 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.434 -0.792 . . . . 0.0 109.611 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 105' ' ' LEU . 1.0 OUTLIER 172.67 160.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.449 -0.782 . . . . 0.0 109.861 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.6 mp -96.82 134.94 39.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.095 -1.003 . . . . 0.0 109.649 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.976 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 7.0 p -122.01 157.02 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.061 -1.025 . . . . 0.0 110.755 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.65 131.42 55.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.453 -0.779 . . . . 0.0 109.664 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.141 -0.974 . . . . 0.0 110.667 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 6' ' ' VAL . 48.8 tt0 . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.2 0.524 . . . . 0.0 109.895 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.509 ' C ' ' HA2' ' A' ' 41' ' ' GLY . 80.6 t -41.57 164.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.362 -0.836 . . . . 0.0 110.467 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.535 ' HA ' ' CA ' ' A' ' 41' ' ' GLY . 33.7 t -37.74 140.89 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.585 -0.697 . . . . 0.0 111.272 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.628 HD23 ' OG1' ' A' ' 11' ' ' THR . 2.7 mp -86.76 168.74 17.07 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.436 -0.79 . . . . 0.0 110.057 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.432 ' O ' ' CB ' ' A' ' 10' ' ' ASN . 47.6 Cg_endo -76.1 59.36 5.89 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.1 1.579 . . . . 0.0 109.944 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.763 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 3.5 m-80 65.13 46.24 2.79 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.363 -0.835 . . . . 0.0 109.558 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.628 ' OG1' HD23 ' A' ' 8' ' ' LEU . 17.4 p -134.98 162.13 33.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 110.258 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.776 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -133.68 159.84 39.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.104 -0.997 . . . . 0.0 109.766 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.932 ' CD1' HD22 ' A' ' 15' ' ' LEU . 1.3 pp -133.04 144.96 50.38 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.97 -1.081 . . . . 0.0 110.52 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.678 ' HD2' HG22 ' A' ' 100' ' ' VAL . 29.8 m80 -89.88 131.25 35.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.411 -0.806 . . . . 0.0 109.245 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.031 ' HA ' HG23 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -133.77 158.4 43.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.956 -1.09 . . . . 0.0 110.502 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -106.72 117.78 34.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.422 -0.798 . . . . 0.0 110.571 -179.158 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.04 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -80.49 111.86 17.29 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.366 -0.834 . . . . 0.0 109.693 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.725 HD13 ' HB1' ' A' ' 31' ' ' ALA . 2.4 mm? -103.03 101.47 11.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.673 -0.642 . . . . 0.0 110.359 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.582 HD13 ' H ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -160.88 144.66 13.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.138 -0.976 . . . . 0.0 110.544 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.582 ' H ' HD13 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -82.61 101.62 10.91 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.424 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.88 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.212 -0.93 . . . . 0.0 111.248 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.9 HG11 ' HB2' ' A' ' 81' ' ' GLU . 1.2 m . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 30' ' ' VAL . 16.5 m -127.9 84.59 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.094 -1.004 . . . . 0.0 110.615 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.725 ' HB1' HD13 ' A' ' 18' ' ' LEU . . . 41.12 70.16 0.28 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.404 -0.81 . . . . 0.0 110.66 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -170.72 22.7 0.08 OUTLIER Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.813 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 1.04 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 3.2 m-20 -88.43 149.33 23.75 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.811 -1.405 . . . . 0.0 109.829 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 68.1 tt0 -148.34 131.09 16.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.784 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.75 ' CZ3' ' HB2' ' A' ' 17' ' ' ALA . 6.3 p90 -151.97 167.22 29.07 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.448 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.658 HD13 ' NE2' ' A' ' 14' ' ' HIS . 16.8 tp -90.84 154.24 19.65 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.549 -0.72 . . . . 0.0 109.846 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.832 ' HB2' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -128.46 109.41 11.38 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.144 -0.972 . . . . 0.0 109.555 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.62 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 5.6 tm-20 -91.92 125.27 36.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.462 -0.774 . . . . 0.0 110.349 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.605 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 62.13 44.83 97.19 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.66 ' HG3' HD23 ' A' ' 13' ' ' LEU . 43.2 Cg_endo -71.08 57.63 2.11 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.681 1.358 . . . . 0.0 109.291 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.535 ' CA ' ' HA ' ' A' ' 7' ' ' VAL . . . -54.21 -14.17 4.29 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.583 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.4 p -136.79 29.24 2.88 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.693 -1.475 . . . . 0.0 111.109 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.791 ' HE2' HG22 ' A' ' 51' ' ' VAL . 15.8 t80 -84.24 111.25 19.22 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.944 -1.102 . . . . 0.0 109.709 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.701 HD13 ' C ' ' A' ' 43' ' ' TYR . 1.7 mm -103.28 138.87 19.66 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 108.963 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.44 ' HD2' HG22 ' A' ' 44' ' ' ILE . 43.6 Cg_endo -69.8 77.26 1.1 Allowed 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 123.847 1.446 . . . . 0.0 110.782 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.435 ' HD2' ' HB ' ' A' ' 44' ' ' ILE . 1.8 mtt180 -93.7 148.83 21.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 110.118 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 48' ' ' GLU . 0.1 OUTLIER -44.77 -34.33 2.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.915 . . . . 0.0 110.301 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.453 ' HG3' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -41.87 -48.38 4.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.603 -0.686 . . . . 0.0 109.585 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.599 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -136.34 173.82 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.388 -0.82 . . . . 0.0 109.09 178.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -135.38 129.84 33.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.02 -1.05 . . . . 0.0 110.261 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.791 HG22 ' HE2' ' A' ' 43' ' ' TYR . 19.9 t -54.54 131.17 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.106 -0.996 . . . . 0.0 109.088 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 1.031 HG23 ' HA ' ' A' ' 15' ' ' LEU . 17.3 t -105.85 -55.55 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.104 -0.997 . . . . 0.0 110.621 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.886 ' C ' HD13 ' A' ' 54' ' ' ILE . 12.8 mm-40 -141.04 166.83 23.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.103 -0.998 . . . . 0.0 110.568 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.886 HD13 ' C ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -133.17 143.26 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.247 -0.908 . . . . 0.0 108.849 179.232 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.776 HG22 ' O ' ' A' ' 12' ' ' ALA . 3.1 tt -140.71 152.11 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.996 -1.065 . . . . 0.0 111.179 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -103.61 179.69 4.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.457 -0.777 . . . . 0.0 110.041 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.763 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -101.97 143.1 32.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.188 -0.945 . . . . 0.0 110.536 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.552 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.8 OUTLIER 174.58 57.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.097 -1.002 . . . . 0.0 111.363 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.728 HG22 HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -161.64 -60.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.503 -1.373 . . . . 0.0 111.776 179.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.728 HG13 HG22 ' A' ' 59' ' ' ILE . 1.8 mt -88.82 -144.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 120.169 -1.582 . . . . 0.0 110.377 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.579 ' HA ' ' N ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -165.22 176.66 8.23 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.071 -1.018 . . . . 0.0 110.295 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.805 ' HB2' HG13 ' A' ' 93' ' ' VAL . 1.3 tp-100 -68.54 -30.62 69.45 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.139 -0.976 . . . . 0.0 110.217 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 2.5 m120 -69.51 -56.24 7.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.223 -0.923 . . . . 0.0 110.833 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.613 ' HB3' HG22 ' A' ' 60' ' ' ILE . 63.8 tp60 -59.61 140.87 56.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.211 -0.931 . . . . 0.0 110.802 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.072 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -125.27 134.33 52.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.524 -0.735 . . . . 0.0 109.215 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.751 ' O ' HG12 ' A' ' 90' ' ' VAL . 7.9 mp -125.81 118.76 26.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.905 . . . . 0.0 111.028 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.562 ' O ' HD12 ' A' ' 105' ' ' LEU . 8.0 mtt85 -91.7 128.92 37.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.347 -0.846 . . . . 0.0 109.11 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 104' ' ' VAL . 10.7 mt -126.36 153.5 44.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.027 -1.046 . . . . 0.0 110.922 -178.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.481 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 14.4 ttp180 -127.24 157.56 39.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.522 -0.736 . . . . 0.0 110.204 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.51 ' HB2' ' HZ3' ' A' ' 75' ' ' TRP . . . -73.51 141.16 46.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.344 -0.847 . . . . 0.0 111.12 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -107.14 -38.25 6.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.303 -0.873 . . . . 0.0 109.589 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.531 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 9.1 mmtt -98.02 -88.07 0.32 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.356 -0.84 . . . . 0.0 109.922 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' A' ' 72' ' ' LYS . 4.1 pt-20 164.24 -37.25 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.727 0.775 . . . . 0.0 108.948 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' ' 33' ' ' ASP . 1.3 m -56.42 -29.75 61.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.498 -0.751 . . . . 0.0 110.336 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.602 ' HA ' ' HB3' ' A' ' 35' ' ' TRP . 16.8 t90 -76.98 103.81 7.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.167 -0.958 . . . . 0.0 110.087 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 76' ' ' ASP . 1.8 p30 -101.92 114.24 28.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 110.123 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.529 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . 4.9 ppt_? -77.22 -22.15 52.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.29 -0.881 . . . . 0.0 110.33 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.412 ' N ' ' HG3' ' A' ' 77' ' ' ARG . 1.9 t0 -95.25 -19.21 20.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 110.236 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.25 24.66 11.11 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.514 ' O ' ' C ' ' A' ' 81' ' ' GLU . 1.4 mttt -137.14 52.63 1.91 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.243 -1.151 . . . . 0.0 110.155 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.9 ' HB2' HG11 ' A' ' 29' ' ' VAL . 2.2 pm0 26.46 94.84 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.259 0.552 . . . . 0.0 111.336 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.523 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 4.4 mpt_? -103.94 179.68 4.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 110.222 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.534 HG23 ' H ' ' A' ' 85' ' ' GLY . 27.5 m -103.37 178.47 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -0.916 . . . . 0.0 110.144 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 70' ' ' ALA . 2.8 t -59.19 -15.66 16.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 110.203 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.534 ' H ' HG23 ' A' ' 83' ' ' VAL . . . -74.2 -39.17 45.15 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.523 ' CB ' ' HB3' ' A' ' 82' ' ' ARG . 19.4 tp10 -54.09 151.74 6.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -1.127 . . . . 0.0 109.957 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 19.5 pt-20 -159.36 173.85 15.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.173 -0.954 . . . . 0.0 110.436 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.575 ' CD1' ' OE1' ' A' ' 102' ' ' GLU . 0.6 OUTLIER -161.08 160.82 30.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.898 . . . . 0.0 110.103 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.012 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -108.34 138.04 45.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.324 -0.86 . . . . 0.0 110.195 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 1.012 ' N ' HD22 ' A' ' 89' ' ' LEU . 7.3 p -108.61 140.76 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -0.929 . . . . 0.0 110.451 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.4 t -157.55 50.39 0.44 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.393 -0.817 . . . . 0.0 110.261 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 m -75.27 157.9 33.71 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.198 -0.938 . . . . 0.0 110.071 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.805 HG13 ' HB2' ' A' ' 62' ' ' GLN . 2.6 t -77.69 72.89 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.244 -0.91 . . . . 0.0 110.122 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.597 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 87.86 107.04 0.95 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.604 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . . . 179.88 169.33 1.2 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -1.1 . . . . 0.0 110.385 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.489 ' HB2' ' HB ' ' A' ' 59' ' ' ILE . 2.0 t80 -129.57 88.33 2.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.769 -0.582 . . . . 0.0 110.054 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.651 HD22 ' CB ' ' A' ' 12' ' ' ALA . 17.0 mt -119.12 86.23 31.67 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.157 -0.964 . . . . 0.0 110.479 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.473 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 50.0 Cg_endo -79.69 9.26 3.57 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.884 1.465 . . . . 0.0 110.648 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.558 ' CB ' ' HB3' ' A' ' 102' ' ' GLU . . . 58.07 -175.27 0.08 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.15 -0.969 . . . . 0.0 110.063 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.678 HG22 ' HD2' ' A' ' 14' ' ' HIS . 2.8 t -109.44 -55.69 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.078 -1.014 . . . . 0.0 110.532 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.588 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 23.0 m-85 -107.6 9.76 29.29 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.076 -1.015 . . . . 0.0 110.152 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.579 ' OE1' ' CZ2' ' A' ' 75' ' ' TRP . 12.6 tt0 -105.05 153.49 21.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 111.575 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -131.05 167.3 19.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.475 -0.766 . . . . 0.0 110.083 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.726 ' HA ' HD23 ' A' ' 68' ' ' LEU . 7.3 p -92.55 143.36 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.107 -0.996 . . . . 0.0 110.692 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.562 HD12 ' O ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -105.02 -19.39 13.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.406 -0.809 . . . . 0.0 110.114 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -169.6 179.71 3.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.221 -0.925 . . . . 0.0 110.324 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.875 HD22 ' O ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -138.99 141.25 38.35 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.125 -0.984 . . . . 0.0 110.612 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.072 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 8.8 p -139.51 116.7 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.94 -1.1 . . . . 0.0 110.771 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 31.1 t0 -86.81 117.4 25.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.048 -1.033 . . . . 0.0 110.119 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 110.266 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.333 0.587 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.75 -162.78 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.497 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.458 ' HA ' ' HA2' ' A' ' 41' ' ' GLY . 60.5 t -87.9 84.1 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 110.482 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.808 HD23 ' OG1' ' A' ' 11' ' ' THR . 0.1 OUTLIER -47.07 160.54 0.34 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.399 -0.813 . . . . 0.0 109.988 179.588 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.02 -47.81 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.861 1.453 . . . . 0.0 110.402 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.759 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 5.4 m120 -162.67 31.95 0.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.195 -0.94 . . . . 0.0 110.142 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.808 ' OG1' HD23 ' A' ' 8' ' ' LEU . 14.1 p -104.8 166.62 10.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.31 -0.869 . . . . 0.0 110.171 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.783 ' HB2' HD21 ' A' ' 97' ' ' LEU . . . -144.74 160.07 41.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.026 -1.046 . . . . 0.0 110.471 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.846 HD11 HD11 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -133.16 151.11 51.98 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.09 -1.006 . . . . 0.0 109.646 179.509 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.724 ' CE1' HD13 ' A' ' 36' ' ' LEU . 65.7 m80 -95.36 127.21 41.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 0.0 110.582 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.847 ' N ' HD22 ' A' ' 15' ' ' LEU . 1.7 mm? -113.95 152.17 31.24 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.517 -0.739 . . . . 0.0 110.277 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.54 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -108.09 115.89 30.95 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.19 -0.944 . . . . 0.0 108.707 178.049 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.769 ' HA ' HG12 ' A' ' 49' ' ' VAL . . . -78.6 111.26 14.49 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.941 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 48' ' ' GLU . 51.1 mt -98.11 100.95 12.3 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.251 0.548 . . . . 0.0 109.982 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.68 HD13 ' N ' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -159.47 134.0 7.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 110.129 -179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.68 ' N ' HD13 ' A' ' 19' ' ' LEU . 9.5 m-20 -75.68 101.63 5.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.034 -1.042 . . . . 0.0 109.715 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.817 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.844 . . . . 0.0 110.435 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.817 HG22 ' CB ' ' A' ' 21' ' ' PHE . 1.5 m . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 121.271 0.558 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 30' ' ' VAL . 27.2 m -140.57 83.55 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.165 -0.96 . . . . 0.0 110.188 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.52 70.97 0.37 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.507 -0.745 . . . . 0.0 110.565 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.54 27.92 0.03 OUTLIER Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.34 -1.41 . . . . 0.0 110.892 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.552 ' O ' ' N ' ' A' ' 17' ' ' ALA . 2.2 m-20 -94.13 156.45 16.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.664 -1.492 . . . . 0.0 110.002 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 16.5 tt0 -148.61 145.34 27.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.011 -1.055 . . . . 0.0 110.525 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.572 ' CZ2' ' HB2' ' A' ' 15' ' ' LEU . 12.5 p90 -149.95 166.89 28.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.362 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.724 HD13 ' CE1' ' A' ' 14' ' ' HIS . 53.6 tp -96.47 151.81 19.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.188 -0.945 . . . . 0.0 109.953 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.805 ' HB3' HD23 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -130.77 115.53 16.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.034 -1.041 . . . . 0.0 110.493 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.508 ' HB2' ' CD2' ' A' ' 97' ' ' LEU . 2.6 tm-20 -96.95 120.99 38.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.536 -0.728 . . . . 0.0 110.326 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.579 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 72.82 46.39 30.15 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 41.6 Cg_endo -66.44 61.29 0.52 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.884 1.465 . . . . 0.0 110.54 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.547 ' C ' ' O ' ' A' ' 40' ' ' PRO . . . -19.0 -92.1 0.01 OUTLIER Glycine 0 N--CA 1.501 2.977 0 N-CA-C 111.491 -0.643 . . . . 0.0 111.491 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.9 p -109.96 49.01 0.86 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.041 -1.27 . . . . 0.0 110.365 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.664 ' OH ' HD12 ' A' ' 15' ' ' LEU . 30.9 t80 -69.83 130.22 41.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.041 -1.037 . . . . 0.0 110.358 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.66 HG23 ' HD2' ' A' ' 45' ' ' PRO . 5.5 mt -124.94 145.29 49.61 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.356 -0.84 . . . . 0.0 109.591 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.66 ' HD2' HG23 ' A' ' 44' ' ' ILE . 45.8 Cg_endo -71.43 90.8 0.68 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.987 1.519 . . . . 0.0 110.584 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 49' ' ' VAL . 3.9 mtp180 -98.21 152.64 19.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.294 -0.879 . . . . 0.0 110.03 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 46' ' ' ARG . 32.0 tttm -41.49 -31.55 0.27 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.288 -0.883 . . . . 0.0 110.479 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 18' ' ' LEU . 16.7 tt0 -53.82 -41.41 67.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.128 -0.983 . . . . 0.0 109.923 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.769 HG12 ' HA ' ' A' ' 17' ' ' ALA . 2.1 m -145.7 171.27 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.636 -0.665 . . . . 0.0 109.386 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.21 140.58 47.61 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.684 -1.26 . . . . 0.0 111.125 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.554 HG23 ' HB3' ' A' ' 45' ' ' PRO . 24.9 t -56.53 123.23 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 109.067 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.54 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 7.2 t -105.1 -60.32 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.118 -0.989 . . . . 0.0 110.729 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.888 ' O ' HD13 ' A' ' 54' ' ' ILE . 27.1 mm-40 -138.06 162.61 33.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 110.394 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.888 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -134.49 137.96 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.318 -0.864 . . . . 0.0 109.325 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.804 HD13 ' O ' ' A' ' 96' ' ' TYR . 1.0 OUTLIER -137.37 142.19 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.92 -1.113 . . . . 0.0 111.573 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.526 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 4.0 mm100 -90.67 -179.65 5.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.382 -0.823 . . . . 0.0 109.299 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.84 ' HB1' ' O ' ' A' ' 94' ' ' GLY . . . -98.41 124.07 42.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.788 -1.195 . . . . 0.0 110.667 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.458 ' O ' HG12 ' A' ' 59' ' ' ILE . 10.1 t -172.12 49.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.443 -0.786 . . . . 0.0 109.818 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.813 HG22 ' N ' ' A' ' 60' ' ' ILE . 0.7 OUTLIER -150.5 -75.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.083 -1.01 . . . . 0.0 111.533 -179.077 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.813 ' N ' HG22 ' A' ' 59' ' ' ILE . 10.0 mt -92.47 125.28 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.905 -1.122 . . . . 0.0 111.534 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.569 ' HA ' ' N ' ' A' ' 94' ' ' GLY . 0.1 OUTLIER -68.66 -165.73 0.07 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.45 -0.781 . . . . 0.0 110.351 179.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.788 ' HB3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -91.62 -12.97 32.71 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.142 -0.974 . . . . 0.0 111.023 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.626 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 0.9 OUTLIER -87.66 -54.28 4.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.024 -1.047 . . . . 0.0 109.522 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.447 ' HB3' ' HG2' ' A' ' 61' ' ' ARG . 4.1 tp-100 -57.49 128.39 36.8 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.229 -0.919 . . . . 0.0 110.199 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.978 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -107.8 139.72 41.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.293 -0.879 . . . . 0.0 108.888 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.616 ' O ' HG12 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -120.84 124.72 45.73 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.198 -0.939 . . . . 0.0 110.876 -179.015 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.759 ' O ' HD23 ' A' ' 68' ' ' LEU . 1.4 mtm180 -90.3 126.53 35.88 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.395 -0.816 . . . . 0.0 109.055 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.759 HD23 ' O ' ' A' ' 67' ' ' ARG . 14.2 mt -120.01 147.34 44.91 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.216 -0.994 . . . . 0.0 111.702 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.662 ' HB2' HD21 ' A' ' 105' ' ' LEU . 12.4 ttm180 -126.44 162.74 24.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.552 -0.717 . . . . 0.0 110.241 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . -78.67 153.28 31.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.22 -0.925 . . . . 0.0 110.619 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.503 ' CZ ' ' HG3' ' A' ' 103' ' ' GLU . 19.8 tpp85 -126.84 -31.14 2.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.886 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 20.9 tptm -121.34 128.85 52.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.759 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.486 ' HA ' ' N ' ' A' ' 84' ' ' THR . 6.5 pt-20 -67.06 58.38 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.195 -0.941 . . . . 0.0 110.401 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -149.62 -24.37 0.27 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.367 -0.833 . . . . 0.0 110.977 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.604 ' CZ2' ' HG2' ' A' ' 77' ' ' ARG . 1.2 t90 -73.87 117.34 15.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.972 -1.08 . . . . 0.0 109.72 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.437 ' HA ' ' HB2' ' A' ' 82' ' ' ARG . 6.1 m-20 -81.53 117.33 21.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.325 -0.859 . . . . 0.0 110.893 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.604 ' HG2' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -81.74 -45.94 14.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.343 -0.848 . . . . 0.0 109.606 179.25 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.68 -1.85 36.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.364 -0.835 . . . . 0.0 110.331 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.3 -35.11 5.02 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -78.94 -103.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.295 -1.121 . . . . 0.0 110.12 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.451 ' CD ' HG21 ' A' ' 29' ' ' VAL . 71.8 mm-40 -137.93 127.26 24.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.929 -1.107 . . . . 0.0 109.837 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.437 ' HB2' ' HA ' ' A' ' 76' ' ' ASP . 18.5 mmt180 -131.42 171.97 12.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.235 -0.916 . . . . 0.0 110.4 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.612 HG22 ' N ' ' A' ' 84' ' ' THR . 2.3 p -116.01 171.61 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -0.819 . . . . 0.0 110.062 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.612 ' N ' HG22 ' A' ' 83' ' ' VAL . 13.6 t -57.13 -164.23 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.25 -0.98 . . . . 0.0 108.563 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 86' ' ' GLU . . . 68.65 -58.89 0.48 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.52 ' O ' ' CB ' ' A' ' 70' ' ' ALA . 1.9 tp10 -43.89 151.38 0.21 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -1.141 . . . . 0.0 109.103 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.545 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 5.8 pt-20 -145.16 160.04 42.06 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.205 -0.934 . . . . 0.0 110.741 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.565 ' CE2' ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -135.43 156.72 48.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.472 -0.768 . . . . 0.0 109.286 179.43 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.882 HD23 ' H ' ' A' ' 90' ' ' VAL . 1.1 tt -113.43 160.42 18.45 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.808 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.882 ' H ' HD23 ' A' ' 89' ' ' LEU . 2.4 p -135.7 123.86 37.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.148 -0.97 . . . . 0.0 110.588 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.19 32.27 4.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.453 -0.779 . . . . 0.0 109.474 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.462 ' O ' ' O ' ' A' ' 61' ' ' ARG . 11.8 t -76.02 171.66 14.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.41 -0.806 . . . . 0.0 110.467 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.788 HG22 ' HB3' ' A' ' 62' ' ' GLN . 2.3 t -80.49 -172.48 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.393 -0.817 . . . . 0.0 110.207 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.84 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . -33.61 96.92 0.01 OUTLIER Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . . . -163.7 148.96 10.9 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.17 -1.194 . . . . 0.0 111.731 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.804 ' O ' HD13 ' A' ' 55' ' ' ILE . 8.4 t80 -109.03 110.37 21.63 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.783 HD21 ' HB2' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -127.78 66.11 69.79 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.027 -1.045 . . . . 0.0 111.236 -178.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.522 ' HG3' ' CZ ' ' A' ' 96' ' ' TYR . 45.2 Cg_endo -74.03 89.66 1.02 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.005 1.529 . . . . 0.0 109.651 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 1.026 ' HB3' ' HB3' ' A' ' 102' ' ' GLU . . . -45.63 149.57 0.58 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.286 -0.884 . . . . 0.0 111.232 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.752 HG23 ' H ' ' A' ' 101' ' ' PHE . 2.3 m -52.16 -69.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.61 -0.681 . . . . 0.0 110.66 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.752 ' H ' HG23 ' A' ' 100' ' ' VAL . 7.0 m-85 -99.73 62.03 1.17 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.821 -1.175 . . . . 0.0 109.674 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 1.026 ' HB3' ' HB3' ' A' ' 99' ' ' ALA . 4.0 tt0 -140.5 147.99 40.4 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.047 -1.033 . . . . 0.0 110.98 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.503 ' HG3' ' CZ ' ' A' ' 71' ' ' ARG . 1.3 mm-40 -132.15 150.89 52.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.501 -0.749 . . . . 0.0 109.679 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.686 ' C ' HD23 ' A' ' 105' ' ' LEU . 4.8 m -83.66 149.04 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.113 -0.992 . . . . 0.0 110.349 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.703 ' N ' HD23 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -103.19 -10.96 18.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.425 -0.797 . . . . 0.0 109.287 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER 163.58 172.05 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.662 -0.649 . . . . 0.0 109.767 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.2 mp -116.43 123.23 47.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.169 -0.957 . . . . 0.0 109.766 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.978 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 13.6 p -116.56 155.48 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.029 -1.044 . . . . 0.0 110.681 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -110.05 120.85 43.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.385 -0.822 . . . . 0.0 109.571 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.296 -0.878 . . . . 0.0 110.937 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.435 ' O ' ' O ' ' A' ' 41' ' ' GLY . 1.2 tt0 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.215 0.531 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.512 ' O ' ' CD1' ' A' ' 8' ' ' LEU . 67.4 t -128.54 147.61 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 109.741 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.513 ' HA ' ' CA ' ' A' ' 41' ' ' GLY . 10.6 t -43.44 120.58 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.074 -1.016 . . . . 0.0 110.098 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.536 HD23 ' OG1' ' A' ' 11' ' ' THR . 4.0 mp -76.53 164.84 57.11 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.441 -0.787 . . . . 0.0 110.361 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 10' ' ' ASN . 46.2 Cg_endo -75.57 70.31 5.72 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 124.121 1.59 . . . . 0.0 109.914 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 1.045 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 11.6 m-20 58.42 55.84 4.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.382 -0.824 . . . . 0.0 110.397 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.536 ' OG1' HD23 ' A' ' 8' ' ' LEU . 6.2 p -136.38 171.48 14.43 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.066 -1.022 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.581 ' HB2' HD22 ' A' ' 97' ' ' LEU . . . -145.37 158.06 43.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.203 -0.936 . . . . 0.0 110.719 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.822 ' CD2' HD21 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -130.49 154.85 47.34 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.391 -0.818 . . . . 0.0 109.268 179.119 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.635 ' O ' HD13 ' A' ' 15' ' ' LEU . 40.7 m80 -94.79 131.63 40.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.975 . . . . 0.0 110.209 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.828 ' N ' HD22 ' A' ' 15' ' ' LEU . 1.7 mm? -120.02 140.34 51.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.634 -0.666 . . . . 0.0 109.962 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.563 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 4.8 ttmt -95.82 117.09 29.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.965 -1.084 . . . . 0.0 109.174 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.84 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -81.78 105.73 13.15 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 110.591 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.664 HD13 ' CA ' ' A' ' 31' ' ' ALA . 1.9 mm? -99.08 101.53 12.92 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.48 HD13 ' CG ' ' A' ' 48' ' ' GLU . 5.0 tp -161.77 148.6 14.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.089 -1.007 . . . . 0.0 110.696 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.64 115.68 22.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.369 -0.832 . . . . 0.0 109.037 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.943 ' HB2' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 120.982 -1.074 . . . . 0.0 110.988 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.943 HG22 ' HB2' ' A' ' 21' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 121.184 0.516 . . . . 0.0 109.74 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.617 ' O ' HG23 ' A' ' 30' ' ' VAL . 26.9 m -139.06 85.11 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.017 -1.052 . . . . 0.0 110.549 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.664 ' CA ' HD13 ' A' ' 18' ' ' LEU . . . 40.22 76.35 0.07 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.544 -0.722 . . . . 0.0 110.667 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.99 31.8 0.03 OUTLIER Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.359 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.84 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 13.0 m-20 -99.55 155.56 17.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.934 -1.333 . . . . 0.0 110.377 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.652 ' OE2' HG11 ' A' ' 52' ' ' VAL . 9.8 tt0 -151.51 134.76 15.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.376 -0.827 . . . . 0.0 109.9 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.538 ' CZ3' ' HB2' ' A' ' 17' ' ' ALA . 7.8 p90 -148.29 167.67 24.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.172 -0.955 . . . . 0.0 110.679 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.554 HD21 ' HA ' ' A' ' 97' ' ' LEU . 44.5 tp -97.5 153.32 18.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.329 -0.857 . . . . 0.0 109.772 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.529 ' HB3' HD23 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -138.14 110.5 7.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.143 -0.973 . . . . 0.0 109.919 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.557 ' HB3' HD22 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -97.2 138.17 35.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.334 -0.854 . . . . 0.0 110.44 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.619 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 72.25 40.8 54.85 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 54.0 Cg_endo -78.12 47.9 2.51 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.23 1.121 . . . . 0.0 109.828 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.513 ' CA ' ' HA ' ' A' ' 7' ' ' VAL . . . -42.78 -31.86 1.24 Allowed Glycine 0 N--CA 1.49 2.278 0 O-C-N 121.53 -0.731 . . . . 0.0 111.277 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.621 ' O ' HD12 ' A' ' 44' ' ' ILE . 6.7 p -136.46 42.92 2.5 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.82 -1.4 . . . . 0.0 111.02 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.558 ' CZ ' ' HG ' ' A' ' 15' ' ' LEU . 14.7 t80 -79.75 111.99 16.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.106 -0.996 . . . . 0.0 109.654 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.621 HD12 ' O ' ' A' ' 42' ' ' THR . 3.6 mp -96.04 133.37 25.31 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 0.0 109.992 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.17 96.82 0.89 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.907 1.477 . . . . 0.0 110.442 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 -104.12 159.41 15.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 110.282 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.86 -28.52 6.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.146 -0.971 . . . . 0.0 110.419 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.48 ' CG ' HD13 ' A' ' 19' ' ' LEU . 7.2 tt0 -50.36 -39.85 47.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.17 -0.956 . . . . 0.0 110.077 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.77 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.6 m -141.79 173.65 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.426 -0.796 . . . . 0.0 109.998 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.52 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.7 mt-10 -132.61 137.09 46.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.107 -0.996 . . . . 0.0 110.349 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 51' ' ' VAL . 21.3 t -54.52 132.53 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.971 . . . . 0.0 109.335 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.939 HG12 ' HG2' ' A' ' 53' ' ' GLU . 97.2 t -118.57 -59.54 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.96 -1.088 . . . . 0.0 110.932 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.939 ' HG2' HG12 ' A' ' 52' ' ' VAL . 43.2 mm-40 -137.21 164.53 28.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.058 -1.026 . . . . 0.0 111.273 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.774 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -136.46 137.97 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.569 HD13 ' N ' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -138.41 137.15 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.806 -1.184 . . . . 0.0 111.466 -178.671 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.569 ' N ' HD13 ' A' ' 55' ' ' ILE . 1.3 mp0 -93.03 167.09 12.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.621 -0.674 . . . . 0.0 110.065 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.045 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -82.72 140.1 33.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 0.0 110.265 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 4.4 t 179.87 39.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.01 -1.056 . . . . 0.0 111.719 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.835 HG23 ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER -161.05 -70.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.468 -1.395 . . . . 0.0 111.838 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.711 ' H ' HG23 ' A' ' 59' ' ' ILE . 4.2 mm -41.86 164.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.903 -1.123 . . . . 0.0 110.297 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.43 ' N ' ' CG2' ' A' ' 60' ' ' ILE . 2.6 mpt_? -94.3 -164.12 1.13 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.101 -0.999 . . . . 0.0 110.989 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.983 ' HA ' HG13 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -67.05 -68.01 0.41 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 111.352 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.647 ' CB ' ' HB3' ' A' ' 110' ' ' ALA . 52.3 m-20 -113.22 24.6 12.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.924 -1.11 . . . . 0.0 111.23 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -61.95 133.6 55.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.867 -1.146 . . . . 0.0 109.282 178.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.5 ' O ' ' HB ' ' A' ' 108' ' ' VAL . . . -109.51 128.44 55.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.852 -1.155 . . . . 0.0 110.181 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.659 ' O ' HD22 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -126.28 127.3 45.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.93 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.796 ' C ' HD22 ' A' ' 68' ' ' LEU . 10.8 mtt180 -90.85 130.89 36.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.601 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.963 HD12 ' OE1' ' A' ' 102' ' ' GLU . 4.2 mm? -116.78 130.43 56.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 111.035 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 1.9 ttt180 -107.16 156.68 18.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.578 -0.701 . . . . 0.0 109.633 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -88.66 142.14 27.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.201 -0.937 . . . . 0.0 110.543 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -115.05 -17.33 11.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.347 -0.846 . . . . 0.0 109.697 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -132.96 116.4 16.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.49 -0.756 . . . . 0.0 109.988 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.67 ' HG3' HG12 ' A' ' 83' ' ' VAL . 1.2 tm-20 -62.16 103.32 0.37 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 110.318 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER 167.1 -25.04 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.294 -0.879 . . . . 0.0 110.028 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.579 ' CZ2' ' HB3' ' A' ' 77' ' ' ARG . 1.3 t90 -75.14 105.26 6.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.363 -0.836 . . . . 0.0 110.375 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.412 ' OD1' ' HB3' ' A' ' 35' ' ' TRP . 16.0 p-10 -87.36 109.55 19.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.181 -0.949 . . . . 0.0 109.767 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.579 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -89.77 -13.65 36.24 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.215 -0.928 . . . . 0.0 110.587 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.437 ' OD2' ' NH1' ' A' ' 77' ' ' ARG . 0.2 OUTLIER -124.88 13.33 8.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.986 -1.071 . . . . 0.0 110.267 179.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.78 21.23 78.91 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 15.5 mmmt -119.79 -7.31 10.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.174 -1.192 . . . . 0.0 110.012 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.487 ' HB3' HG11 ' A' ' 29' ' ' VAL . 25.3 mm-40 60.66 124.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.358 -0.839 . . . . 0.0 110.234 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -141.66 179.52 6.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.303 -0.873 . . . . 0.0 110.356 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.856 HG23 ' H ' ' A' ' 85' ' ' GLY . 6.3 m -96.16 -178.59 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.223 -0.923 . . . . 0.0 111.245 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.555 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 25.7 p -57.2 -23.07 45.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.467 -0.77 . . . . 0.0 110.545 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.856 ' H ' HG23 ' A' ' 83' ' ' VAL . . . -65.18 -25.7 71.18 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 82' ' ' ARG . 6.1 pt-20 -65.58 153.11 42.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.357 -1.084 . . . . 0.0 110.632 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.12 147.8 18.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.483 -0.76 . . . . 0.0 109.635 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.898 ' CE2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -134.59 144.76 48.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.997 -1.064 . . . . 0.0 110.381 -179.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.796 HD13 ' C ' ' A' ' 89' ' ' LEU . 1.3 tm? -94.65 139.03 31.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.427 -0.796 . . . . 0.0 110.254 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.898 HG22 ' CE2' ' A' ' 88' ' ' TRP . 12.1 t -112.98 131.81 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.199 -0.938 . . . . 0.0 110.722 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.757 ' OG1' HD11 ' A' ' 89' ' ' LEU . 16.6 m -135.55 45.57 2.44 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.578 -0.701 . . . . 0.0 109.679 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.543 ' OG1' HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -82.2 128.67 34.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.899 . . . . 0.0 110.736 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.983 HG13 ' HA ' ' A' ' 62' ' ' GLN . 47.2 t -70.31 114.3 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.568 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.623 ' O ' ' HB2' ' A' ' 95' ' ' ALA . . . 56.96 97.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.835 ' O ' HG23 ' A' ' 59' ' ' ILE . . . 174.88 -176.88 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.108 -1.23 . . . . 0.0 110.606 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.77 ' CD2' HG21 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -147.35 101.99 3.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.3 -0.875 . . . . 0.0 110.499 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.581 HD22 ' HB2' ' A' ' 12' ' ' ALA . 18.7 mt -126.33 71.22 70.91 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.116 -0.99 . . . . 0.0 110.025 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.482 ' HD3' ' CD1' ' A' ' 96' ' ' TYR . 50.5 Cg_endo -81.84 17.29 1.56 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.996 1.524 . . . . 0.0 110.965 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.92 ' HB3' ' CG ' ' A' ' 102' ' ' GLU . . . 43.48 -164.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.12 -0.987 . . . . 0.0 110.674 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.53 ' CG2' ' HA ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -115.92 -44.85 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.191 -0.943 . . . . 0.0 111.656 -178.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.567 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 23.1 m-85 -110.59 40.94 1.88 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.617 -1.302 . . . . 0.0 111.977 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.963 ' OE1' HD12 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -141.9 165.33 27.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.722 -1.236 . . . . 0.0 110.62 179.18 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.538 ' C ' HD13 ' A' ' 68' ' ' LEU . 1.9 tt0 -131.26 158.83 39.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.418 -0.801 . . . . 0.0 109.905 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.734 HG12 HD11 ' A' ' 68' ' ' LEU . 6.3 m -82.05 142.17 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.058 -1.027 . . . . 0.0 110.451 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.601 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 4.4 mp -90.58 -14.49 32.39 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.371 -0.831 . . . . 0.0 109.271 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 1.0 OUTLIER 163.85 -172.75 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.633 -0.667 . . . . 0.0 109.918 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 0.7 OUTLIER -125.8 130.98 52.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.12 -0.987 . . . . 0.0 110.073 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.739 HG21 ' NH1' ' A' ' 67' ' ' ARG . 24.2 t -123.81 148.89 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.133 -0.979 . . . . 0.0 110.877 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -112.16 113.23 25.37 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.27 -0.894 . . . . 0.0 108.882 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.647 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.491 1.604 0 O-C-N 120.745 -1.222 . . . . 0.0 109.829 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.623 ' OE1' HD11 ' A' ' 8' ' ' LEU . 1.9 mt-30 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.267 0.556 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 5' ' ' GLN . 8.2 p -45.05 165.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 0.0 109.718 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.482 HG13 ' HA2' ' A' ' 41' ' ' GLY . 13.8 t -54.08 125.27 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.076 -1.015 . . . . 0.0 110.169 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.623 HD11 ' OE1' ' A' ' 5' ' ' GLN . 6.5 mp -71.65 162.95 70.27 Favored Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 109.919 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.69 -89.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.926 1.488 . . . . 0.0 110.17 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.795 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 72.9 m-80 -128.64 25.02 5.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.962 . . . . 0.0 110.015 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.842 HG22 ' H ' ' A' ' 57' ' ' ALA . 27.4 p -104.48 170.6 7.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.316 -0.865 . . . . 0.0 110.077 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.585 ' HB2' ' HA ' ' A' ' 38' ' ' GLU . . . -139.75 161.86 36.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.217 -0.927 . . . . 0.0 110.117 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.056 ' CD2' HD21 ' A' ' 15' ' ' LEU . 0.6 OUTLIER -132.77 155.58 48.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.942 . . . . 0.0 110.021 179.781 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.689 ' C ' HD22 ' A' ' 15' ' ' LEU . 42.9 m80 -90.96 129.16 37.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.165 -0.959 . . . . 0.0 110.555 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.056 HD21 ' CD2' ' A' ' 13' ' ' LEU . 2.2 mm? -120.11 146.74 45.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.665 -0.647 . . . . 0.0 110.231 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.541 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -110.78 116.28 31.01 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.187 -0.945 . . . . 0.0 108.592 178.044 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.057 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -75.3 115.47 14.97 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.157 -0.964 . . . . 0.0 110.135 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.624 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.6 mt -103.26 99.84 9.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.701 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.809 ' C ' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -167.57 165.99 14.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.026 -1.046 . . . . 0.0 110.559 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.523 ' N ' HD22 ' A' ' 19' ' ' LEU . 11.6 t70 -98.27 103.12 15.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.734 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.989 ' CB ' HG22 ' A' ' 29' ' ' VAL . 1.9 t80 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 109.923 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.989 HG22 ' CB ' ' A' ' 21' ' ' PHE . 1.3 m . . . . . 0 N--CA 1.495 1.777 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.47 ' O ' HG23 ' A' ' 30' ' ' VAL . 15.4 m -134.91 93.69 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.145 -0.972 . . . . 0.0 110.905 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.624 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 42.05 68.35 0.48 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.285 -0.885 . . . . 0.0 110.471 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -166.75 19.35 0.09 OUTLIER Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.294 -1.431 . . . . 0.0 111.043 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 1.057 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 1.9 m-20 -88.9 148.6 23.75 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.414 -1.639 . . . . 0.0 109.931 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.464 ' HG3' ' HG3' ' A' ' 16' ' ' LYS . 27.7 tt0 -149.79 132.14 15.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.017 -1.052 . . . . 0.0 110.575 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -148.96 177.16 9.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.37 -0.831 . . . . 0.0 109.877 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.568 ' CD1' ' CD2' ' A' ' 14' ' ' HIS . 8.4 tp -102.94 153.99 19.67 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.157 -0.965 . . . . 0.0 110.227 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.622 ' CZ ' ' HA ' ' A' ' 40' ' ' PRO . 1.0 OUTLIER -130.88 110.46 11.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.433 -0.792 . . . . 0.0 109.68 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.591 ' HG3' HD11 ' A' ' 97' ' ' LEU . 8.9 tm-20 -92.01 132.71 36.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.574 -0.704 . . . . 0.0 109.356 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.585 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 60.24 47.05 93.02 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.622 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 37.6 Cg_endo -61.47 75.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.984 1.518 . . . . 0.0 110.467 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.482 ' HA2' HG13 ' A' ' 7' ' ' VAL . . . -42.86 110.83 0.3 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 5' ' ' GLN . 3.0 p 38.33 44.21 0.69 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.598 -0.942 . . . . 0.0 111.622 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.616 ' OH ' HD12 ' A' ' 15' ' ' LEU . 13.6 t80 -68.74 122.28 18.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.732 -1.23 . . . . 0.0 109.309 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.446 HG23 ' HD2' ' A' ' 45' ' ' PRO . 31.4 mt -111.7 142.16 26.08 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 110.18 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.821 ' HB3' HG23 ' A' ' 51' ' ' VAL . 45.0 Cg_endo -73.19 96.09 0.87 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.09 1.574 . . . . 0.0 110.353 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.403 ' O ' ' C ' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -106.13 161.8 14.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 110.242 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 46' ' ' ARG . 35.7 mttt -43.26 -31.24 0.59 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.341 -0.85 . . . . 0.0 110.299 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.474 ' HB3' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -55.19 -45.66 75.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.266 -0.896 . . . . 0.0 110.605 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.601 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.4 m -144.4 165.86 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.232 -0.917 . . . . 0.0 110.031 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -125.76 141.88 51.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.296 -0.877 . . . . 0.0 110.234 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.821 HG23 ' HB3' ' A' ' 45' ' ' PRO . 46.6 t -60.18 119.86 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.858 . . . . 0.0 109.832 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.833 HG12 ' HG2' ' A' ' 53' ' ' GLU . 16.7 t -95.1 -64.02 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 0.0 110.474 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.833 ' HG2' HG12 ' A' ' 52' ' ' VAL . 44.8 mm-40 -141.96 175.62 9.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.56 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.816 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -134.95 146.06 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.36 -0.838 . . . . 0.0 109.111 179.439 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -140.08 131.74 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.971 -1.081 . . . . 0.0 110.739 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.499 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 2.5 mp0 -86.5 156.01 20.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.49 -0.756 . . . . 0.0 109.835 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.037 ' HB1' ' HA ' ' A' ' 95' ' ' ALA . . . -95.3 142.85 27.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 0.0 110.818 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.62 HG22 ' C ' ' A' ' 57' ' ' ALA . 0.1 OUTLIER 168.81 51.69 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.424 -0.797 . . . . 0.0 110.777 179.758 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.9 HD13 ' CD1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -153.48 -28.75 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.728 -1.232 . . . . 0.0 111.419 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.731 HD12 ' O ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER -87.58 168.58 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.644 -1.285 . . . . 0.0 110.844 -179.098 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.522 ' CB ' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -107.23 -177.29 3.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.521 -0.737 . . . . 0.0 110.323 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.956 ' HA ' HG12 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -66.46 -72.26 0.17 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.273 -0.892 . . . . 0.0 110.671 -179.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.536 ' CB ' ' HB3' ' A' ' 110' ' ' ALA . 1.1 m-80 -77.55 -6.84 55.08 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.314 -0.866 . . . . 0.0 110.207 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.549 ' NE2' ' N ' ' A' ' 108' ' ' VAL . 44.7 tp60 -61.1 129.26 40.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.144 -0.973 . . . . 0.0 110.657 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.632 ' O ' HD22 ' A' ' 66' ' ' LEU . . . -108.67 144.99 35.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.074 -1.016 . . . . 0.0 109.752 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.672 ' HB2' HG13 ' A' ' 90' ' ' VAL . 1.7 mm? -123.13 114.6 20.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.182 -0.948 . . . . 0.0 110.522 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.819 ' HG2' HD23 ' A' ' 89' ' ' LEU . 18.5 mtm180 -97.99 122.04 40.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.297 -0.877 . . . . 0.0 109.881 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.777 HD23 ' HA ' ' A' ' 104' ' ' VAL . 13.2 mt -118.88 135.82 54.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.961 . . . . 0.0 110.61 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.852 ' HB2' HD11 ' A' ' 105' ' ' LEU . 29.2 ttt180 -98.22 160.74 14.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.55 -0.719 . . . . 0.0 109.865 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.514 ' HB2' ' HZ3' ' A' ' 75' ' ' TRP . . . -75.99 164.16 26.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.261 -0.899 . . . . 0.0 111.193 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 101' ' ' PHE . 1.0 OUTLIER -124.51 -42.6 2.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.66 -0.65 . . . . 0.0 109.493 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.501 ' HB2' ' CD2' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -122.03 138.67 54.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.41 -0.806 . . . . 0.0 109.998 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.528 ' HG3' HG23 ' A' ' 83' ' ' VAL . 0.6 OUTLIER -69.52 60.55 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.151 -0.968 . . . . 0.0 109.481 179.336 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 72' ' ' LYS . 2.2 t -151.18 -25.63 0.21 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.219 -0.926 . . . . 0.0 111.309 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.595 ' CZ2' ' HB3' ' A' ' 77' ' ' ARG . 1.7 t90 -73.6 116.23 13.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.754 -1.216 . . . . 0.0 110.519 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.488 ' HB3' ' HA ' ' A' ' 81' ' ' GLU . 2.5 p-10 -107.07 109.61 21.51 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.251 -0.905 . . . . 0.0 110.07 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.595 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -88.82 -4.09 58.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.243 -0.911 . . . . 0.0 110.242 179.671 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -117.66 -12.48 10.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.883 . . . . 0.0 110.089 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.18 -46.23 1.13 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.403 ' O ' ' HD2' ' A' ' 82' ' ' ARG . 11.4 mtmt -82.55 127.13 33.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -1.161 . . . . 0.0 110.26 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.591 ' CG ' HG11 ' A' ' 29' ' ' VAL . 6.1 tp10 -46.28 119.55 2.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 0.0 110.109 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.403 ' HD2' ' O ' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -101.43 175.04 5.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 110.317 -179.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.584 HG22 ' N ' ' A' ' 84' ' ' THR . 13.8 p -106.69 172.84 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 110.306 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.584 ' N ' HG22 ' A' ' 83' ' ' VAL . 40.6 p -60.75 -174.08 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.323 -0.861 . . . . 0.0 109.022 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 87' ' ' GLU . . . 70.8 -56.37 0.99 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 4.4 tp10 -44.32 153.78 0.14 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.032 -1.275 . . . . 0.0 109.545 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.54 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 13.4 mp0 -145.23 149.8 35.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.741 -1.224 . . . . 0.0 111.385 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.572 ' CZ2' ' HB ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -111.74 163.27 14.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.395 -0.815 . . . . 0.0 108.903 178.606 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.819 HD23 ' HG2' ' A' ' 67' ' ' ARG . 1.5 tm? -129.32 141.67 51.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.989 -1.069 . . . . 0.0 110.309 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.824 HG21 HD12 ' A' ' 97' ' ' LEU . 7.1 p -126.15 139.49 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.61 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 91' ' ' THR . 22.3 m -137.46 40.55 2.42 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.174 -0.954 . . . . 0.0 110.132 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.7 m -82.44 126.71 32.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.169 -0.957 . . . . 0.0 110.376 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.956 HG12 ' HA ' ' A' ' 62' ' ' GLN . 3.8 m -58.19 112.56 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.134 -0.979 . . . . 0.0 110.265 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 60' ' ' ILE . . . 71.44 96.6 0.06 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 1.037 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . . . -169.41 176.03 5.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.324 -1.103 . . . . 0.0 110.826 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.9 ' CD1' HD13 ' A' ' 59' ' ' ILE . 1.0 OUTLIER -129.0 -70.57 0.66 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.495 -0.753 . . . . 0.0 109.514 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.824 HD12 HG21 ' A' ' 90' ' ' VAL . 4.8 mt 48.92 78.27 0.41 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.484 -0.76 . . . . 0.0 111.247 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.739 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 48.9 Cg_endo -74.65 -14.79 21.96 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.806 1.424 . . . . 0.0 109.548 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.739 ' HB3' ' O ' ' A' ' 98' ' ' PRO . . . 72.14 173.46 0.3 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.537 -0.727 . . . . 0.0 111.161 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.531 HG12 ' CD1' ' A' ' 101' ' ' PHE . 94.2 t -99.81 -61.09 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.538 -0.727 . . . . 0.0 109.603 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.586 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 18.0 m-30 -111.43 45.44 1.2 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.335 -0.853 . . . . 0.0 109.992 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 11.4 mt-10 -134.05 144.88 48.93 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.676 -1.265 . . . . 0.0 111.887 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.45 ' O ' HD12 ' A' ' 105' ' ' LEU . 1.3 tt0 -119.37 123.27 43.74 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.777 ' HA ' HD23 ' A' ' 68' ' ' LEU . 7.2 p -54.05 149.02 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.218 -0.926 . . . . 0.0 110.779 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.852 HD11 ' HB2' ' A' ' 69' ' ' ARG . 8.4 mp -103.46 -32.92 9.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.574 -0.704 . . . . 0.0 110.387 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -179.84 148.38 0.31 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.026 -1.046 . . . . 0.0 110.722 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 mp -88.33 125.52 34.73 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.331 -0.856 . . . . 0.0 109.555 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.549 ' N ' ' NE2' ' A' ' 64' ' ' GLN . 74.2 t -116.85 140.53 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.067 -1.021 . . . . 0.0 111.434 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 14.4 t0 -111.29 114.15 27.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 109.496 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.536 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.494 1.736 0 O-C-N 120.862 -1.149 . . . . 0.0 110.282 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.2 0.524 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.497 HG23 ' N ' ' A' ' 7' ' ' VAL . 6.7 m -66.75 -150.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -0.885 . . . . 0.0 110.079 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.738 ' C ' HD13 ' A' ' 8' ' ' LEU . 4.0 t -83.32 144.48 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 110.178 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.749 HD22 ' H ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -100.25 168.74 8.93 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.207 -0.933 . . . . 0.0 109.519 179.667 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 42.8 Cg_endo -70.15 68.94 1.89 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.641 1.337 . . . . 0.0 110.732 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.837 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 4.9 m120 68.67 69.86 0.29 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.555 -0.715 . . . . 0.0 111.227 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.482 ' OG1' ' HB2' ' A' ' 8' ' ' LEU . 7.8 p -138.87 159.71 41.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.942 . . . . 0.0 109.921 178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.573 ' CB ' HD22 ' A' ' 97' ' ' LEU . . . -139.04 155.68 47.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.157 -0.964 . . . . 0.0 110.333 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.977 HD13 HD11 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -130.48 156.74 44.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -0.932 . . . . 0.0 110.609 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.994 ' C ' HD13 ' A' ' 15' ' ' LEU . 10.5 m170 -93.98 128.2 40.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.597 -0.689 . . . . 0.0 109.424 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.994 HD13 ' C ' ' A' ' 14' ' ' HIS . 0.1 OUTLIER -121.58 153.15 38.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.065 -1.022 . . . . 0.0 110.098 -179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -110.09 116.52 31.7 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.21 -0.931 . . . . 0.0 109.385 178.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.986 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -76.61 115.93 16.82 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.285 -0.885 . . . . 0.0 110.434 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.741 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -102.83 99.77 9.73 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.475 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.627 HD13 ' H ' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -167.59 147.31 5.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 110.745 -179.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.627 ' H ' HD13 ' A' ' 19' ' ' LEU . 32.4 t70 -85.39 110.82 19.41 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.727 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.081 -1.012 . . . . 0.0 112.054 -177.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.727 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 30' ' ' VAL . 20.1 m -127.63 85.67 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.065 -1.022 . . . . 0.0 110.575 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.741 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 41.62 71.18 0.22 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.315 -0.866 . . . . 0.0 110.381 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -179.68 28.83 0.05 OUTLIER Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.536 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.986 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 42.5 m-20 -93.44 147.94 22.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.769 -1.43 . . . . 0.0 110.0 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.473 ' HG2' HG11 ' A' ' 100' ' ' VAL . 15.3 tt0 -143.07 143.56 31.91 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.032 -1.042 . . . . 0.0 110.176 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.563 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 7.1 p90 -159.95 168.83 24.78 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.014 -1.054 . . . . 0.0 111.105 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.869 HD22 ' O ' ' A' ' 98' ' ' PRO . 14.2 tp -97.32 153.29 18.15 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.353 -0.842 . . . . 0.0 109.774 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.602 ' CZ ' ' HA ' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -140.96 109.6 5.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.98 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.816 ' HG2' HD22 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -97.77 137.77 36.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.355 -0.84 . . . . 0.0 109.402 179.614 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.595 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 78.73 46.68 8.41 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.602 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 38.1 Cg_endo -63.47 71.32 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.052 1.554 . . . . 0.0 111.041 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.552 ' HA2' HG22 ' A' ' 7' ' ' VAL . . . -46.43 95.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER 46.13 40.44 7.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -1.137 . . . . 0.0 110.413 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.561 ' HB3' ' HB2' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -68.64 131.87 45.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.105 -0.997 . . . . 0.0 109.929 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.714 HG23 ' HD2' ' A' ' 45' ' ' PRO . 23.3 mm -121.08 148.22 48.5 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.388 -0.82 . . . . 0.0 109.124 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.714 ' HD2' HG23 ' A' ' 44' ' ' ILE . 41.2 Cg_endo -67.85 75.03 0.64 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.689 1.363 . . . . 0.0 110.863 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 49' ' ' VAL . 13.0 ttt85 -66.84 143.47 56.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.424 -0.798 . . . . 0.0 109.895 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -41.25 -33.62 0.4 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.344 -0.848 . . . . 0.0 110.523 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -49.46 -50.89 39.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.157 -0.964 . . . . 0.0 109.95 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.675 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.4 m -133.0 173.51 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.353 -0.842 . . . . 0.0 109.408 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.48 132.77 44.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.088 -1.008 . . . . 0.0 110.56 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.732 ' HA ' HD12 ' A' ' 15' ' ' LEU . 9.4 p -54.41 143.53 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.041 -1.037 . . . . 0.0 108.232 178.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.714 HG23 ' HA ' ' A' ' 15' ' ' LEU . 13.0 t -123.33 -57.5 2.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.666 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.959 ' O ' HD13 ' A' ' 54' ' ' ILE . 31.1 mm-40 -135.35 167.36 21.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.393 -0.817 . . . . 0.0 110.092 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.959 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -136.77 147.94 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.436 -0.79 . . . . 0.0 109.067 179.359 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.556 HD13 ' H ' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -142.12 136.08 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.072 -1.017 . . . . 0.0 110.791 -179.21 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.556 ' H ' HD13 ' A' ' 55' ' ' ILE . 90.2 mm-40 -91.91 174.13 7.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.403 -0.811 . . . . 0.0 109.887 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.837 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -97.97 127.45 43.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.95 . . . . 0.0 110.348 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER 172.18 91.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.325 -0.86 . . . . 0.0 110.535 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.804 HD13 ' CE1' ' A' ' 96' ' ' TYR . 0.0 OUTLIER 177.76 -50.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.03 -1.044 . . . . 0.0 110.569 179.605 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.622 HG22 ' N ' ' A' ' 61' ' ' ARG . 15.7 mm -117.97 -93.34 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.788 -1.195 . . . . 0.0 110.33 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.622 ' N ' HG22 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -178.8 -163.34 0.06 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.129 -0.982 . . . . 0.0 111.042 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.829 ' HB3' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -92.51 -72.27 0.6 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.307 -0.871 . . . . 0.0 110.671 -179.353 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.783 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 3.1 m-20 -41.84 -24.59 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.675 -0.641 . . . . 0.0 111.636 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.967 ' OE1' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -58.47 134.01 56.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.846 -1.159 . . . . 0.0 110.294 -179.51 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.078 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -109.21 138.95 44.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.949 . . . . 0.0 109.285 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.967 HD13 ' OE1' ' A' ' 64' ' ' GLN . 2.0 tp -126.25 111.7 14.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -0.991 . . . . 0.0 110.848 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.614 ' O ' HD12 ' A' ' 105' ' ' LEU . 1.1 tpp180 -89.42 123.31 33.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.242 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.603 HD23 ' HA ' ' A' ' 104' ' ' VAL . 13.2 mt -122.57 146.99 46.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.877 . . . . 0.0 111.264 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 13.5 ttp85 -114.41 165.01 13.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.577 -0.702 . . . . 0.0 109.365 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.879 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -83.59 161.21 21.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.956 -1.09 . . . . 0.0 111.278 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.486 ' HB3' ' O ' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -123.83 -35.91 2.8 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.479 ' HG3' ' CD1' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -125.44 151.25 46.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.511 -0.743 . . . . 0.0 109.463 179.091 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.514 ' OE1' HG23 ' A' ' 83' ' ' VAL . 20.3 tt0 -83.08 95.99 8.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.123 -0.985 . . . . 0.0 109.556 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.77 -27.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.18 -0.95 . . . . 0.0 110.719 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.577 ' HZ3' ' HB2' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -74.46 125.8 29.34 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.036 -1.04 . . . . 0.0 110.16 -179.671 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 77' ' ' ARG . 34.9 m-20 -94.73 119.53 33.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 109.536 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 76' ' ' ASP . 5.0 mtm180 -39.6 -55.91 1.77 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.456 -0.778 . . . . 0.0 110.821 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -118.42 -8.1 10.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.1 -1.0 . . . . 0.0 110.396 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.41 -20.52 2.96 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.431 ' O ' ' CG ' ' A' ' 76' ' ' ASP . 4.4 mttp -63.88 -132.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -1.083 . . . . 0.0 109.866 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.536 ' HB3' ' CG1' ' A' ' 29' ' ' VAL . 5.9 mp0 -142.65 120.85 12.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.942 -1.098 . . . . 0.0 110.077 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.468 ' HD3' ' HG2' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -132.51 178.14 7.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.93 . . . . 0.0 110.186 179.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.917 HG13 ' H ' ' A' ' 85' ' ' GLY . 7.7 p -107.86 179.95 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.378 -0.826 . . . . 0.0 110.267 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.879 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 8.8 t -70.24 -15.53 62.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 110.343 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.917 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -86.75 8.37 75.89 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.468 ' HG2' ' HD3' ' A' ' 82' ' ' ARG . 13.6 tp10 -91.14 162.96 14.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.24 -1.153 . . . . 0.0 109.888 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.468 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 12.5 pt-20 -153.5 156.95 39.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.949 -1.094 . . . . 0.0 110.359 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.577 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -139.51 147.53 41.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.762 179.894 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.951 HD13 ' N ' ' A' ' 90' ' ' VAL . 2.7 tm? -103.41 146.97 27.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -0.852 . . . . 0.0 109.493 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.951 ' N ' HD13 ' A' ' 89' ' ' LEU . 20.5 t -104.47 117.42 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.146 -0.971 . . . . 0.0 110.224 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.69 -0.18 8.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.576 -0.702 . . . . 0.0 109.909 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.52 171.41 15.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.425 -0.797 . . . . 0.0 110.112 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.829 HG13 ' HB3' ' A' ' 62' ' ' GLN . 11.1 t -86.43 166.6 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.131 -0.98 . . . . 0.0 110.019 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.781 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 144.02 -28.18 2.0 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 59' ' ' ILE . . . 58.34 14.25 2.8 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.337 -1.096 . . . . 0.0 110.921 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.804 ' CE1' HD13 ' A' ' 59' ' ' ILE . 6.7 t80 179.99 85.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.088 -1.008 . . . . 0.0 110.674 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.816 HD22 ' HG2' ' A' ' 38' ' ' GLU . 69.3 mt -129.45 81.63 69.54 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 109.54 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.869 ' O ' HD22 ' A' ' 36' ' ' LEU . 44.3 Cg_endo -71.8 141.48 37.42 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.076 1.566 . . . . 0.0 110.774 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -85.19 -164.85 1.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.41 -0.806 . . . . 0.0 109.941 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.473 HG11 ' HG2' ' A' ' 34' ' ' GLU . 18.7 t -109.47 -62.75 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.215 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.515 ' HB2' ' HB2' ' A' ' 75' ' ' TRP . 14.8 m-85 -97.6 -33.06 11.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.278 -0.889 . . . . 0.0 110.189 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.565 ' OE1' ' CH2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -80.95 154.03 27.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 110.243 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -128.79 172.18 11.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.91 . . . . 0.0 110.45 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.603 ' HA ' HD23 ' A' ' 68' ' ' LEU . 7.5 p -93.28 142.69 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.903 . . . . 0.0 110.644 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.711 ' H ' HD12 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -106.34 -19.81 13.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.477 -0.764 . . . . 0.0 109.608 179.755 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -174.63 156.24 2.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.497 -0.752 . . . . 0.0 109.944 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.437 HD23 HD11 ' A' ' 66' ' ' LEU . 3.3 mp -107.54 146.09 32.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.899 . . . . 0.0 110.356 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.078 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 8.9 p -134.41 159.52 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.139 -0.976 . . . . 0.0 109.848 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 110' ' ' ALA . 8.2 p-10 -110.36 125.71 53.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.122 -0.986 . . . . 0.0 110.114 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.783 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.216 -0.928 . . . . 0.0 110.408 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.462 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 1.8 mt-30 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.269 0.557 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 8' ' ' LEU . 14.2 t -90.63 143.35 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.22 -0.925 . . . . 0.0 109.471 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.455 ' C ' ' O ' ' A' ' 6' ' ' VAL . 40.7 t -39.4 95.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.436 -0.79 . . . . 0.0 110.102 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 6' ' ' VAL . 0.9 OUTLIER -45.55 165.84 0.16 Allowed Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.451 -0.781 . . . . 0.0 110.167 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.69 -56.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 124.165 1.613 . . . . 0.0 110.648 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.775 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -166.75 26.01 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.084 -1.01 . . . . 0.0 110.588 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 7.2 p -103.58 171.76 7.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.171 -0.956 . . . . 0.0 109.655 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.834 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -141.42 160.4 40.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.858 -1.151 . . . . 0.0 110.689 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.097 ' CD2' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -129.59 155.18 46.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.103 -0.998 . . . . 0.0 109.927 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.613 ' CD2' ' N ' ' A' ' 14' ' ' HIS . 5.2 m170 -92.74 126.51 37.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 110.321 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.097 HD21 ' CD2' ' A' ' 13' ' ' LEU . 2.6 mm? -112.19 151.51 29.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.671 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.607 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 9.0 ttmt -119.58 117.0 27.2 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.953 -1.092 . . . . 0.0 109.362 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.962 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -77.93 120.33 22.64 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.271 -0.893 . . . . 0.0 110.335 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.499 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 0.5 OUTLIER -99.29 101.76 13.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.629 -0.669 . . . . 0.0 109.731 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.63 HD13 ' H ' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -159.04 141.04 13.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.327 -0.858 . . . . 0.0 110.04 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.63 ' H ' HD13 ' A' ' 19' ' ' LEU . 4.1 m-20 -90.07 103.6 16.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.856 . . . . 0.0 110.258 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.636 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.393 -0.817 . . . . 0.0 110.042 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.636 HG22 ' CB ' ' A' ' 21' ' ' PHE . 1.5 m . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.187 0.517 . . . . 0.0 109.752 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 30' ' ' VAL . 29.6 m -137.37 80.88 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.9 . . . . 0.0 110.026 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.499 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 47.91 68.62 0.64 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.891 . . . . 0.0 110.18 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.14 29.54 0.04 OUTLIER Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.362 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.962 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 38.1 m-20 -83.99 146.72 27.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.789 -1.418 . . . . 0.0 109.473 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.619 ' OE1' HG11 ' A' ' 100' ' ' VAL . 4.8 tt0 -144.22 147.34 33.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.099 -1.001 . . . . 0.0 111.056 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.619 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 11.5 p90 -156.7 164.41 38.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.465 -0.772 . . . . 0.0 110.188 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.527 ' HB2' ' HA ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -96.74 149.46 21.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.244 -0.91 . . . . 0.0 110.394 -179.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.57 ' HB3' HD23 ' A' ' 13' ' ' LEU . 2.9 t80 -131.55 110.74 11.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.233 -0.917 . . . . 0.0 110.502 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.594 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 2.3 tm-20 -85.75 125.12 32.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.652 -0.655 . . . . 0.0 110.001 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.594 ' N ' ' HD3' ' A' ' 40' ' ' PRO . . . 74.63 44.85 24.81 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.594 ' HD3' ' N ' ' A' ' 39' ' ' GLY . 55.9 Cg_endo -77.88 32.96 0.44 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.494 1.26 . . . . 0.0 111.222 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 5' ' ' GLN . . . -54.39 -59.53 9.95 Favored Glycine 0 N--CA 1.487 2.096 0 O-C-N 120.53 -1.356 . . . . 0.0 109.976 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 75.5 p -78.87 12.35 2.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -1.174 . . . . 0.0 111.501 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.615 ' OH ' HD12 ' A' ' 15' ' ' LEU . 3.2 t80 -72.99 130.6 40.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.851 -1.156 . . . . 0.0 110.078 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.518 HG23 ' HD2' ' A' ' 45' ' ' PRO . 1.9 mt -118.66 143.11 32.81 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.982 . . . . 0.0 109.798 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.518 ' HD2' HG23 ' A' ' 44' ' ' ILE . 46.0 Cg_endo -72.58 107.17 2.24 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.971 1.511 . . . . 0.0 110.458 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 49' ' ' VAL . 1.2 mtt-85 -114.91 148.73 38.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.306 -0.871 . . . . 0.0 110.229 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 46' ' ' ARG . 0.3 OUTLIER -40.44 -45.95 2.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.353 -0.842 . . . . 0.0 110.847 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.426 ' C ' ' CG1' ' A' ' 49' ' ' VAL . 3.0 mt-10 -42.53 -39.06 2.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.407 -0.808 . . . . 0.0 110.875 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.63 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.6 m -145.96 174.09 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.15 -0.969 . . . . 0.0 110.549 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 49' ' ' VAL . 1.6 mm-40 -139.39 139.61 37.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.255 -0.903 . . . . 0.0 110.395 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.446 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . 5.0 m -55.23 130.98 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.147 -0.971 . . . . 0.0 110.223 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.607 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 3.7 t -104.12 -58.7 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.312 -0.867 . . . . 0.0 110.351 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.888 ' C ' HD13 ' A' ' 54' ' ' ILE . 3.7 mt-10 -143.36 171.06 14.64 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.097 -1.002 . . . . 0.0 110.4 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.888 HD13 ' C ' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -132.23 135.96 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.834 HG22 ' O ' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -129.91 143.86 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.913 -1.117 . . . . 0.0 111.694 -178.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.468 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 93.1 mm-40 -91.84 158.78 16.13 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.644 -0.66 . . . . 0.0 109.383 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.775 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -102.35 132.85 48.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.175 -0.953 . . . . 0.0 110.193 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 3.7 t 178.5 55.02 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.132 -0.98 . . . . 0.0 111.584 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.591 HG22 ' O ' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -157.42 -51.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.462 -1.398 . . . . 0.0 111.599 179.341 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.554 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 13.9 mm -70.05 157.42 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.616 -1.302 . . . . 0.0 110.644 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.438 ' O ' HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -90.43 179.58 5.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.35 -0.844 . . . . 0.0 110.004 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.981 ' HA ' HG12 ' A' ' 93' ' ' VAL . 4.4 mt-30 -83.42 -27.07 29.81 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.151 -0.968 . . . . 0.0 110.714 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.711 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 3.1 m120 -94.4 -34.94 12.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.129 -0.982 . . . . 0.0 110.526 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.429 ' NE2' ' O ' ' A' ' 108' ' ' VAL . 40.6 tp60 -58.69 129.3 41.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.115 -0.991 . . . . 0.0 111.146 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.103 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -108.3 143.5 37.09 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.557 ' O ' HD13 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -126.72 120.47 29.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.081 -1.012 . . . . 0.0 110.578 -179.194 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.705 ' O ' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -89.69 141.87 28.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.489 -0.757 . . . . 0.0 109.462 179.591 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.705 HD22 ' O ' ' A' ' 67' ' ' ARG . 1.8 mm? -125.41 125.74 43.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.15 -0.969 . . . . 0.0 111.081 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.9 ' HB2' HD11 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -105.41 159.31 16.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.461 -0.774 . . . . 0.0 109.615 179.433 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.3 151.33 46.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.212 -0.93 . . . . 0.0 110.878 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -116.01 -30.16 6.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.434 -0.791 . . . . 0.0 109.589 179.322 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -149.43 130.21 14.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.304 -0.873 . . . . 0.0 109.802 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.46 ' N ' ' HD3' ' A' ' 72' ' ' LYS . 0.3 OUTLIER -56.57 90.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.176 -0.953 . . . . 0.0 109.903 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 72' ' ' LYS . 37.5 t -176.0 -29.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.384 -0.822 . . . . 0.0 110.442 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.584 ' CE3' ' HG2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -73.89 120.88 20.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.147 -0.971 . . . . 0.0 110.005 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.423 ' OD2' ' O ' ' A' ' 79' ' ' GLY . 3.5 m-20 -80.02 113.85 18.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.354 -0.841 . . . . 0.0 110.051 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.477 ' HB2' ' OE2' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -55.65 -54.7 40.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 110.355 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.68 -13.94 12.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.363 -0.836 . . . . 0.0 110.411 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.423 ' O ' ' OD2' ' A' ' 76' ' ' ASP . . . 143.42 -22.03 2.22 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.8 mmtt -85.77 157.51 20.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.524 -0.986 . . . . 0.0 109.741 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.521 ' HB3' HG11 ' A' ' 29' ' ' VAL . 37.8 mm-40 -69.37 126.5 29.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 110.161 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.473 ' HD2' ' OE1' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -122.2 175.23 6.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.493 -0.754 . . . . 0.0 110.702 -179.541 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.633 HG22 ' N ' ' A' ' 84' ' ' THR . 4.8 p -119.35 171.8 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.417 -0.802 . . . . 0.0 110.423 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.633 ' N ' HG22 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -54.78 -170.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.105 -0.997 . . . . 0.0 108.789 178.746 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 86' ' ' GLU . . . 70.77 -55.88 0.98 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.626 ' HG3' ' N ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -44.76 156.37 0.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.171 -1.193 . . . . 0.0 109.11 179.335 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.626 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 12.9 pt-20 -155.61 145.06 21.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.656 -1.278 . . . . 0.0 111.148 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -112.3 160.39 17.71 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 90' ' ' VAL . 0.1 OUTLIER -115.33 127.72 55.61 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.966 -1.084 . . . . 0.0 111.221 -178.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.64 ' N ' HD12 ' A' ' 89' ' ' LEU . 25.0 t -92.64 108.3 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.394 -0.816 . . . . 0.0 109.705 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.0 m -128.19 46.12 2.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.967 . . . . 0.0 110.829 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.453 ' CG2' ' ND2' ' A' ' 10' ' ' ASN . 53.2 m -107.8 131.3 54.61 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.15 -0.969 . . . . 0.0 110.149 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.981 HG12 ' HA ' ' A' ' 62' ' ' GLN . 27.5 m -66.9 150.29 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.253 -0.904 . . . . 0.0 110.477 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.618 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 41.08 82.03 0.02 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.712 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . . . -159.63 147.08 16.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -1.151 . . . . 0.0 110.207 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.567 ' O ' ' CG ' ' A' ' 96' ' ' TYR . 14.9 t80 -133.49 59.27 1.74 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.379 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.685 HD21 ' HB1' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -117.55 99.91 52.51 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 120.911 -1.118 . . . . 0.0 109.783 178.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.727 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 47.3 Cg_endo -77.56 18.08 0.87 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 124.111 1.585 . . . . 0.0 111.854 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 98' ' ' PRO . . . 70.1 -178.59 0.22 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.81 -1.181 . . . . 0.0 110.426 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.619 HG11 ' OE1' ' A' ' 34' ' ' GLU . 2.6 t -102.57 -61.72 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 109.793 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.537 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 22.0 m-85 -107.73 47.92 0.87 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.27 -0.894 . . . . 0.0 109.925 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.646 ' HB2' HD12 ' A' ' 68' ' ' LEU . 17.8 mt-10 -138.85 158.67 43.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.904 -1.122 . . . . 0.0 111.611 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.63 ' O ' HD13 ' A' ' 68' ' ' LEU . 9.9 mt-10 -132.49 167.53 19.81 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.606 -0.684 . . . . 0.0 109.395 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.521 ' C ' HD13 ' A' ' 105' ' ' LEU . 3.8 m -90.75 146.89 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.937 -1.102 . . . . 0.0 110.263 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.9 HD11 ' HB2' ' A' ' 69' ' ' ARG . 0.8 OUTLIER -102.28 -11.24 18.86 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.405 -0.809 . . . . 0.0 109.351 179.315 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 0.5 OUTLIER 162.46 127.71 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.61 -0.682 . . . . 0.0 110.098 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.1 mp -76.45 121.86 23.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 109.598 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.103 HG13 ' HB3' ' A' ' 65' ' ' ALA . 9.1 p -111.31 153.98 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.094 -1.004 . . . . 0.0 110.467 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -110.91 120.17 41.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -0.874 . . . . 0.0 109.821 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.007 -1.058 . . . . 0.0 110.216 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 2.4 mt-30 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.332 0.587 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.0 t -77.26 155.89 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.932 . . . . 0.0 110.37 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 74.9 t -45.21 106.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.321 -0.862 . . . . 0.0 110.217 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.761 HD23 ' OG1' ' A' ' 11' ' ' THR . 3.5 mp -49.83 164.72 0.34 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.7 -57.13 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.992 1.522 . . . . 0.0 110.498 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.68 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 3.2 m120 -163.41 31.11 0.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -0.904 . . . . 0.0 110.011 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.761 ' OG1' HD23 ' A' ' 8' ' ' LEU . 55.2 p -112.62 171.82 7.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.316 -0.865 . . . . 0.0 110.37 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -137.74 165.96 25.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.177 -0.952 . . . . 0.0 110.029 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.855 HD23 ' CG ' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -133.95 155.63 49.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.149 -0.969 . . . . 0.0 111.032 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.628 ' C ' HD23 ' A' ' 15' ' ' LEU . 52.8 m80 -99.06 132.74 44.14 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.288 -0.883 . . . . 0.0 110.474 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.856 HD21 ' HB2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -137.06 156.76 48.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.997 -1.064 . . . . 0.0 109.984 178.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 3.4 mtpt -107.94 123.56 48.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.358 -0.839 . . . . 0.0 110.742 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.087 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -82.1 119.68 24.33 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.314 -0.866 . . . . 0.0 110.157 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.861 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 2.8 mm? -101.06 101.18 11.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.581 -0.699 . . . . 0.0 109.865 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.487 HD13 ' HA ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -160.99 147.15 14.74 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.102 -0.999 . . . . 0.0 110.502 -179.679 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -88.75 113.26 24.12 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.672 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.081 -1.012 . . . . 0.0 111.733 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.672 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 30' ' ' VAL . 16.7 m -130.99 85.61 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.961 -1.087 . . . . 0.0 110.98 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.861 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 42.16 68.76 0.43 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.409 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.88 23.51 0.09 OUTLIER Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.445 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 1.087 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 10.5 m-20 -85.72 154.22 21.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.818 -1.401 . . . . 0.0 109.734 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 78.7 tt0 -155.93 138.71 15.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 110.312 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.667 ' CH2' HD12 ' A' ' 15' ' ' LEU . 3.8 p90 -157.77 177.14 11.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.164 -0.96 . . . . 0.0 110.523 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.654 HD22 ' O ' ' A' ' 98' ' ' PRO . 39.7 tp -90.43 165.56 13.76 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.433 -0.792 . . . . 0.0 110.824 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.856 ' HB2' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -135.73 110.84 8.91 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.58 -0.7 . . . . 0.0 109.467 179.554 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -86.22 131.31 34.26 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.193 -0.942 . . . . 0.0 110.441 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.597 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 54.98 45.99 79.15 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.855 ' CG ' HD23 ' A' ' 13' ' ' LEU . 39.5 Cg_endo -67.03 -60.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.918 1.483 . . . . 0.0 110.338 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 5' ' ' GLN . . . 37.83 -86.81 0.01 OUTLIER Glycine 0 N--CA 1.497 2.72 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.617 ' N ' ' O ' ' A' ' 40' ' ' PRO . 1.2 p -54.4 -7.65 0.17 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.337 -1.096 . . . . 0.0 112.008 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.599 ' CD2' HD21 ' A' ' 13' ' ' LEU . 6.6 t80 -67.37 130.09 41.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.61 -1.307 . . . . 0.0 110.096 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.695 HG23 ' HD2' ' A' ' 45' ' ' PRO . 34.1 mt -119.56 147.78 44.4 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.51 -0.744 . . . . 0.0 109.639 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.695 ' HD2' HG23 ' A' ' 44' ' ' ILE . 40.4 Cg_endo -68.48 87.62 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.841 1.442 . . . . 0.0 110.462 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 49' ' ' VAL . 18.3 mmt85 -95.91 157.73 15.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.402 -0.811 . . . . 0.0 110.112 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -53.66 -19.84 4.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.177 -0.952 . . . . 0.0 110.107 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.489 ' C ' ' CG1' ' A' ' 49' ' ' VAL . 1.8 tp10 -62.65 -36.51 83.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.283 -0.885 . . . . 0.0 109.752 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.489 ' CG1' ' C ' ' A' ' 48' ' ' GLU . 0.9 OUTLIER -150.05 173.92 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.393 -0.817 . . . . 0.0 109.521 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 52' ' ' VAL . 6.3 mt-10 -130.88 125.59 33.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.043 -1.036 . . . . 0.0 110.507 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 51' ' ' VAL . 2.6 p -54.21 124.84 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.098 -1.001 . . . . 0.0 109.139 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.877 HG12 ' HG2' ' A' ' 53' ' ' GLU . 47.1 t -104.37 -61.79 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.106 -0.996 . . . . 0.0 111.1 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.95 ' O ' HD13 ' A' ' 54' ' ' ILE . 4.5 mm-40 -134.84 174.09 10.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.071 -1.018 . . . . 0.0 110.612 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.95 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.1 mm -135.24 131.76 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.486 HG13 ' HG2' ' A' ' 98' ' ' PRO . 0.3 OUTLIER -121.13 137.31 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.106 -0.996 . . . . 0.0 111.269 -178.583 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.495 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 6.8 mp0 -95.37 169.24 10.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.505 -0.747 . . . . 0.0 110.543 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.888 ' HB1' ' HB3' ' A' ' 95' ' ' ALA . . . -96.85 118.99 34.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.821 . . . . 0.0 110.282 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 58' ' ' THR . 8.1 t -176.91 78.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.053 -1.03 . . . . 0.0 110.726 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.79 HG21 ' CD1' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -179.12 -59.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.944 -1.098 . . . . 0.0 111.104 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.697 HG13 HG22 ' A' ' 59' ' ' ILE . 1.7 mt -92.75 -139.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 120.295 -1.503 . . . . 0.0 109.695 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.503 ' H ' HG22 ' A' ' 60' ' ' ILE . 14.7 mtt85 -155.53 -162.02 1.26 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.077 -1.014 . . . . 0.0 110.092 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.834 ' CB ' HG12 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -83.06 -72.28 0.46 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.944 . . . . 0.0 111.109 -179.171 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.563 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 9.6 p30 -45.41 -41.1 8.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -0.918 . . . . 0.0 111.304 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.85 136.87 51.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.877 -1.139 . . . . 0.0 111.14 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.989 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -121.96 142.65 50.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.515 -0.741 . . . . 0.0 109.296 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.936 HD22 ' C ' ' A' ' 65' ' ' ALA . 4.4 mm? -125.85 112.8 16.43 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.962 -1.086 . . . . 0.0 110.668 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.494 ' O ' ' HG3' ' A' ' 67' ' ' ARG . 3.5 ptp180 -90.91 126.98 36.21 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.031 -1.043 . . . . 0.0 110.362 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.789 HD23 ' HA ' ' A' ' 104' ' ' VAL . 17.2 mt -123.02 137.82 54.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.363 -0.836 . . . . 0.0 110.678 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -98.79 154.09 18.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.313 -0.867 . . . . 0.0 109.953 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.905 ' HB2' ' HG3' ' A' ' 86' ' ' GLU . . . -67.92 140.35 56.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.378 -0.826 . . . . 0.0 111.6 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 101' ' ' PHE . 15.1 tpp85 -104.38 -38.46 6.82 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.5 ' HB2' ' HB3' ' A' ' 101' ' ' PHE . 2.0 mmtt -113.81 155.96 24.75 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -86.82 27.76 0.96 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.988 -1.07 . . . . 0.0 110.275 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.6 -20.97 4.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.211 -0.93 . . . . 0.0 110.689 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.6 ' HB2' ' CD2' ' A' ' 101' ' ' PHE . 13.7 t90 -73.99 107.27 6.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.155 -0.965 . . . . 0.0 110.426 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 82' ' ' ARG . 8.3 m-20 -112.75 122.96 49.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.353 -0.842 . . . . 0.0 110.157 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.5 ' NH2' ' OD2' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -88.01 -20.41 25.85 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.265 -0.897 . . . . 0.0 110.256 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.5 ' OD2' ' NH2' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -96.16 6.98 47.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.208 -0.933 . . . . 0.0 110.032 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.07 9.33 86.83 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 76' ' ' ASP . 2.0 mmmt -117.88 135.61 53.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -1.189 . . . . 0.0 110.406 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.75 125.77 7.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -0.865 . . . . 0.0 110.159 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.504 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 1.5 mtt-85 -137.36 142.88 41.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.89 . . . . 0.0 110.115 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.556 HG13 ' H ' ' A' ' 85' ' ' GLY . 11.4 p -78.62 170.72 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.912 . . . . 0.0 110.215 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.754 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -55.44 -17.51 5.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.513 -0.742 . . . . 0.0 110.384 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.556 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -72.74 -12.2 78.1 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.905 ' HG3' ' HB2' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -67.3 170.97 6.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.969 -1.312 . . . . 0.0 109.848 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -159.59 145.61 16.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.15 -0.969 . . . . 0.0 110.277 179.66 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.596 ' CZ2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -132.08 133.69 44.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.22 -0.925 . . . . 0.0 110.016 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.073 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -107.06 138.72 42.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 110.018 179.737 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 1.073 ' N ' HD22 ' A' ' 89' ' ' LEU . 63.5 t -93.91 101.35 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.343 -0.848 . . . . 0.0 110.137 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.868 ' HB ' HD11 ' A' ' 89' ' ' LEU . 1.5 t -119.64 0.2 10.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.596 -0.69 . . . . 0.0 109.717 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 93' ' ' VAL . 98.9 m -88.06 114.44 24.68 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.429 -0.794 . . . . 0.0 110.259 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.834 HG12 ' CB ' ' A' ' 62' ' ' GLN . 16.6 m -41.31 124.7 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.453 -0.78 . . . . 0.0 109.753 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' A' ' 96' ' ' TYR . . . -174.93 34.78 0.1 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.888 ' HB3' ' HB1' ' A' ' 57' ' ' ALA . . . 45.58 -80.83 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.758 -0.848 . . . . 0.0 111.627 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.79 ' CD1' HG21 ' A' ' 59' ' ' ILE . 3.8 t80 -125.12 159.76 30.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.625 -1.297 . . . . 0.0 110.06 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -173.28 69.07 0.36 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.131 -0.98 . . . . 0.0 110.555 -179.441 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.654 ' O ' HD22 ' A' ' 36' ' ' LEU . 45.1 Cg_endo -74.89 145.27 31.68 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.839 1.441 . . . . 0.0 109.938 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.786 ' HB3' ' CG ' ' A' ' 102' ' ' GLU . . . -104.95 -141.67 0.37 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.038 -1.039 . . . . 0.0 111.15 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.512 ' CG2' ' HA ' ' A' ' 35' ' ' TRP . 0.9 OUTLIER -121.29 -58.42 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.136 -0.978 . . . . 0.0 111.819 -178.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.6 ' CD2' ' HB2' ' A' ' 75' ' ' TRP . 9.7 m-30 -111.35 55.6 0.66 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.161 -1.587 . . . . 0.0 111.492 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.786 ' CG ' ' HB3' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -141.2 143.83 34.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.592 -1.317 . . . . 0.0 110.815 179.218 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.407 ' O ' ' CD1' ' A' ' 105' ' ' LEU . 12.5 tp10 -118.56 128.31 54.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.586 -0.696 . . . . 0.0 110.171 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.789 ' HA ' HD23 ' A' ' 68' ' ' LEU . 4.9 p -65.28 148.53 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.389 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 1.6 mp -105.19 -45.56 4.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.354 -0.841 . . . . 0.0 109.944 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.11 133.14 2.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.878 . . . . 0.0 109.963 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.855 ' C ' HD22 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -76.06 142.65 41.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.939 . . . . 0.0 111.119 -179.499 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.989 HG13 ' HB3' ' A' ' 65' ' ' ALA . 3.4 p -128.03 149.88 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.993 -1.067 . . . . 0.0 109.709 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.2 119.58 39.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.058 -1.026 . . . . 0.0 110.544 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.028 -1.045 . . . . 0.0 109.862 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.513 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.35 0.595 . . . . 0.0 110.071 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.522 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 3.5 t -123.29 160.09 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.243 -0.91 . . . . 0.0 109.954 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.471 ' O ' ' O ' ' A' ' 8' ' ' LEU . 10.6 t -57.06 81.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.374 -0.828 . . . . 0.0 110.837 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.798 ' C ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -45.62 171.38 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.43 -0.794 . . . . 0.0 110.113 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.632 ' N ' HD22 ' A' ' 8' ' ' LEU . 51.3 Cg_endo -75.44 -99.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.524 1.276 . . . . 0.0 111.955 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.963 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 0.8 OUTLIER -112.38 83.94 1.89 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.761 -1.212 . . . . 0.0 110.934 -178.711 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.744 HG23 HD23 ' A' ' 8' ' ' LEU . 1.7 p -156.16 169.6 24.13 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.204 -0.935 . . . . 0.0 110.17 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.909 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -145.9 167.37 23.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 108.883 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.813 HD23 ' HG3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -134.55 153.75 51.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.826 -1.171 . . . . 0.0 111.137 179.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 1.04 ' CD2' HD13 ' A' ' 36' ' ' LEU . 14.3 m-70 -98.5 135.63 39.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -0.858 . . . . 0.0 109.261 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.951 HD13 ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -139.11 165.53 26.91 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.128 -0.983 . . . . 0.0 110.172 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 1.6 tttt -114.51 120.91 41.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 111.108 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.0 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -81.56 112.53 18.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.416 -0.802 . . . . 0.0 109.696 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.809 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -100.47 101.6 12.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.395 -0.816 . . . . 0.0 110.124 -179.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.581 HD23 ' HG3' ' A' ' 48' ' ' GLU . 0.1 OUTLIER -162.27 139.18 8.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 110.208 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.577 ' H ' HD13 ' A' ' 19' ' ' LEU . 33.9 p-10 -78.83 101.53 7.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.687 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.883 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.27 -0.894 . . . . 0.0 110.53 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.883 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.613 ' O ' HG23 ' A' ' 30' ' ' VAL . 29.1 m -138.59 88.58 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.024 -1.047 . . . . 0.0 110.676 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.809 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 41.55 65.32 0.86 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.372 -0.83 . . . . 0.0 110.55 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -175.17 26.02 0.07 OUTLIER Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.501 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 1.0 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 10.0 m-20 -86.7 154.53 20.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.893 -1.357 . . . . 0.0 109.833 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.724 ' OE2' HG21 ' A' ' 52' ' ' VAL . 3.8 tt0 -153.59 131.27 11.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.251 -0.906 . . . . 0.0 110.176 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.776 ' CZ3' ' HB2' ' A' ' 17' ' ' ALA . 6.8 p90 -151.94 165.17 35.43 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.062 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 1.04 HD13 ' CD2' ' A' ' 14' ' ' HIS . 51.6 tp -91.44 161.86 14.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -0.834 . . . . 0.0 110.173 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.612 ' CE2' ' HB2' ' A' ' 43' ' ' TYR . 0.9 OUTLIER -136.78 111.99 9.09 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.366 -0.834 . . . . 0.0 109.89 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.648 ' HB2' HD21 ' A' ' 97' ' ' LEU . 2.4 tm-20 -84.31 140.68 31.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.683 -0.635 . . . . 0.0 109.803 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.609 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 59.05 40.77 95.97 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.813 ' HG3' HD23 ' A' ' 13' ' ' LEU . 49.2 Cg_endo -75.2 -51.14 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.375 1.197 . . . . 0.0 109.535 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.588 ' N ' HD12 ' A' ' 8' ' ' LEU . . . 41.63 -94.08 0.01 OUTLIER Glycine 0 N--CA 1.486 1.967 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 40' ' ' PRO . 1.8 t -78.23 19.9 0.42 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.425 -1.044 . . . . 0.0 112.05 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.612 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 1.6 t80 -67.61 111.05 3.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.675 -1.266 . . . . 0.0 109.006 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.457 HG23 ' HD2' ' A' ' 45' ' ' PRO . 51.1 mm -90.11 142.14 28.42 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.295 -0.878 . . . . 0.0 110.609 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.653 ' HB3' HG23 ' A' ' 51' ' ' VAL . 48.3 Cg_endo -74.74 106.5 2.27 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.184 1.623 . . . . 0.0 110.467 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.428 ' O ' ' N ' ' A' ' 48' ' ' GLU . 0.7 OUTLIER -84.95 147.85 26.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 109.789 179.699 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -43.71 -25.82 0.2 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.163 -0.96 . . . . 0.0 109.933 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.581 ' HG3' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -62.15 -46.45 88.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -0.863 . . . . 0.0 110.51 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.641 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -124.03 173.17 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.183 -0.948 . . . . 0.0 110.418 -179.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.416 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.0 mm-40 -135.1 137.12 42.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 110.22 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.653 HG23 ' HB3' ' A' ' 45' ' ' PRO . 12.2 t -56.98 138.79 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 109.234 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.724 HG21 ' OE2' ' A' ' 34' ' ' GLU . 39.4 t -121.86 -51.27 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.031 -1.043 . . . . 0.0 110.799 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.822 ' O ' HD13 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -145.6 166.89 24.45 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.977 -1.077 . . . . 0.0 110.147 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.822 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -134.29 131.24 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.335 -0.853 . . . . 0.0 109.245 179.185 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.909 HG22 ' O ' ' A' ' 12' ' ' ALA . 8.0 tt -117.03 145.93 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.061 -1.024 . . . . 0.0 111.44 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.452 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 14.4 mp0 -105.79 -179.51 3.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.618 -0.676 . . . . 0.0 109.837 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.963 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -97.16 136.06 38.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.159 -0.963 . . . . 0.0 111.17 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 4.7 t 176.23 57.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.443 -0.786 . . . . 0.0 111.134 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.621 HG21 ' CG ' ' A' ' 96' ' ' TYR . 0.5 OUTLIER -173.77 -48.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.507 -1.371 . . . . 0.0 112.33 179.389 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.602 HG22 ' N ' ' A' ' 61' ' ' ARG . 70.7 mt -75.69 172.63 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.577 -1.327 . . . . 0.0 110.333 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.602 ' N ' HG22 ' A' ' 60' ' ' ILE . 29.7 mtt-85 -117.81 -174.31 2.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.035 -1.04 . . . . 0.0 110.256 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.798 ' CA ' HG13 ' A' ' 93' ' ' VAL . 5.6 tt0 -79.16 -30.22 43.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.17 -0.956 . . . . 0.0 110.96 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 7.2 p30 -105.94 -21.87 13.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.009 -1.057 . . . . 0.0 110.625 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 109' ' ' ASP . 5.5 tp-100 -58.39 135.0 57.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.873 -1.142 . . . . 0.0 110.699 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.106 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -112.96 135.47 53.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.487 -0.758 . . . . 0.0 109.324 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.592 ' O ' HD22 ' A' ' 89' ' ' LEU . 1.3 mp -124.82 117.23 23.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.192 -0.942 . . . . 0.0 111.173 -179.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.496 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 1.7 ttp180 -96.34 126.13 41.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 108.965 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.017 ' CD2' HG12 ' A' ' 104' ' ' VAL . 17.8 mt -118.89 133.18 56.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.01 -1.056 . . . . 0.0 110.582 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 5.4 ttt85 -114.85 150.63 35.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -0.847 . . . . 0.0 110.13 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.523 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -70.32 123.45 21.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.83 . . . . 0.0 110.752 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -81.8 -38.67 25.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.947 . . . . 0.0 108.931 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.636 ' CG ' ' CD2' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -136.35 143.25 43.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.535 -0.728 . . . . 0.0 109.239 179.099 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 74' ' ' CYS . 0.0 OUTLIER -55.46 -161.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.983 . . . . 0.0 110.58 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 7.3 m 78.88 -40.97 0.27 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.587 -0.696 . . . . 0.0 110.54 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.603 ' CD1' ' HB2' ' A' ' 35' ' ' TRP . 20.6 t90 -73.38 104.36 4.36 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.769 -1.207 . . . . 0.0 110.099 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.452 ' OD1' ' HA ' ' A' ' 81' ' ' GLU . 65.1 m-20 -84.1 113.72 21.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.853 . . . . 0.0 110.136 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.459 ' HB2' ' CH2' ' A' ' 75' ' ' TRP . 21.8 tpt180 -87.45 -8.55 56.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.316 -0.865 . . . . 0.0 110.489 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.02 3.04 9.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 110.199 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.69 -2.9 64.98 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.85 144.27 48.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -1.114 . . . . 0.0 110.047 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.65 ' CB ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -46.16 110.67 0.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -0.929 . . . . 0.0 110.408 -179.762 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.35 179.44 3.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.212 -0.93 . . . . 0.0 109.947 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.654 HG13 ' H ' ' A' ' 85' ' ' GLY . 12.5 p -116.85 172.87 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.995 -1.066 . . . . 0.0 110.503 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.597 ' N ' HG22 ' A' ' 83' ' ' VAL . 7.5 t -57.55 -16.35 9.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.303 -0.873 . . . . 0.0 109.96 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.654 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -71.38 -14.25 74.34 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.437 ' HB3' ' O ' ' A' ' 83' ' ' VAL . 5.1 tp10 -75.63 147.75 39.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.406 -1.055 . . . . 0.0 109.67 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 68' ' ' LEU . 4.8 tt0 -157.38 162.44 39.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.212 -0.93 . . . . 0.0 109.981 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.576 ' CZ2' ' HB ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -153.34 142.04 20.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.17 -0.956 . . . . 0.0 110.232 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.859 HD13 ' O ' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -100.25 119.42 38.35 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.497 -0.752 . . . . 0.0 109.98 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.599 ' N ' HD22 ' A' ' 89' ' ' LEU . 5.3 p -97.99 150.72 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 110.749 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.1 t -148.98 51.06 0.97 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.453 -0.779 . . . . 0.0 109.903 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.649 HG22 ' OD1' ' A' ' 10' ' ' ASN . 9.2 m -82.95 139.82 33.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -0.917 . . . . 0.0 110.459 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.798 HG13 ' CA ' ' A' ' 62' ' ' GLN . 8.1 t -75.4 128.75 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.168 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.705 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 48.69 84.32 0.02 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.588 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . . . -177.61 151.46 0.74 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.111 -1.229 . . . . 0.0 110.953 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.621 ' CG ' HG21 ' A' ' 59' ' ' ILE . 1.2 t80 -116.88 112.57 21.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.021 -1.049 . . . . 0.0 110.419 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -124.94 76.71 66.62 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.183 -0.948 . . . . 0.0 110.249 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.414 ' HD3' ' CD1' ' A' ' 96' ' ' TYR . 52.8 Cg_endo -77.18 6.67 4.15 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.009 1.531 . . . . 0.0 110.967 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.589 ' CB ' ' CG ' ' A' ' 102' ' ' GLU . . . 52.41 -161.47 0.1 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.002 -1.062 . . . . 0.0 110.084 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.67 HG11 ' HG2' ' A' ' 34' ' ' GLU . 3.4 t -115.0 -62.01 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.07 -1.019 . . . . 0.0 111.19 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.636 ' CD2' ' CG ' ' A' ' 72' ' ' LYS . 4.5 m-30 -93.71 -29.65 15.3 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.767 -1.208 . . . . 0.0 111.214 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.589 ' CG ' ' CB ' ' A' ' 99' ' ' ALA . 8.6 pt-20 -80.37 161.15 25.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.965 -1.084 . . . . 0.0 110.899 -178.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.478 ' OE2' ' CD2' ' A' ' 105' ' ' LEU . 0.8 OUTLIER -136.05 164.18 28.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.364 -0.835 . . . . 0.0 110.018 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 1.017 HG12 ' CD2' ' A' ' 68' ' ' LEU . 3.9 m -76.25 139.85 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.909 . . . . 0.0 110.43 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.735 ' N ' HD23 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -94.0 -10.34 33.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.329 -0.857 . . . . 0.0 109.145 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER 166.35 -174.66 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.548 -0.72 . . . . 0.0 109.871 179.677 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 107' ' ' LEU . 4.4 mp -133.54 127.47 33.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.3 -0.875 . . . . 0.0 109.762 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.106 HG13 ' HB3' ' A' ' 65' ' ' ALA . 9.4 p -124.51 113.72 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.951 -1.093 . . . . 0.0 111.004 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -70.01 134.95 48.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.184 -0.947 . . . . 0.0 109.941 179.405 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.423 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.454 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 7.1 tt0 . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 121.091 0.472 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.551 ' C ' ' HA3' ' A' ' 41' ' ' GLY . 7.1 p -118.4 139.51 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.157 -0.964 . . . . 0.0 109.991 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.708 HG23 ' CA ' ' A' ' 39' ' ' GLY . 2.2 p -38.85 120.45 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.31 -0.869 . . . . 0.0 111.118 -178.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.659 HD23 ' OG1' ' A' ' 11' ' ' THR . 0.0 OUTLIER -67.99 171.54 5.41 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.817 -0.552 . . . . 0.0 109.766 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 38.1 Cg_endo -64.67 73.8 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.593 1.312 . . . . 0.0 109.969 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.944 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 9.2 m-20 64.1 33.29 12.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.873 -0.517 . . . . 0.0 111.558 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.659 ' OG1' HD23 ' A' ' 8' ' ' LEU . 1.2 p -106.16 169.07 8.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.76 -1.213 . . . . 0.0 109.369 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.572 ' HB2' ' HA ' ' A' ' 38' ' ' GLU . . . -148.75 158.67 44.32 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.008 -1.057 . . . . 0.0 110.496 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.049 HD13 HD11 ' A' ' 15' ' ' LEU . 1.4 pp -127.57 156.94 41.44 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.294 -0.879 . . . . 0.0 110.896 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.621 ' CD2' ' N ' ' A' ' 14' ' ' HIS . 6.6 m170 -93.39 127.17 38.89 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.526 -0.734 . . . . 0.0 110.622 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.049 HD11 HD13 ' A' ' 13' ' ' LEU . 1.1 mm? -114.21 144.66 42.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.487 -0.758 . . . . 0.0 110.151 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.553 ' HB2' HG22 ' A' ' 52' ' ' VAL . 4.2 tttp -107.75 116.54 32.13 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.241 -0.983 . . . . 0.0 109.339 178.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.024 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -79.39 120.85 24.39 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 110.074 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.752 HD12 ' OE1' ' A' ' 50' ' ' GLU . 70.6 mt -105.98 101.21 10.72 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.883 -0.511 . . . . 0.0 109.638 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.841 HD13 ' N ' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -164.04 144.1 8.14 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.074 -1.016 . . . . 0.0 110.608 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.841 ' N ' HD13 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -84.9 103.4 13.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.343 -0.848 . . . . 0.0 109.146 178.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.8 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 110.542 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.8 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 30' ' ' VAL . 23.1 m -131.53 90.31 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.997 -1.064 . . . . 0.0 110.686 -179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.576 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 39.98 58.34 2.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.468 -0.77 . . . . 0.0 110.74 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.91 28.05 0.22 Allowed Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.58 -1.295 . . . . 0.0 110.04 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 1.024 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 7.4 m-20 -91.98 148.35 22.27 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.08 -1.247 . . . . 0.0 110.075 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.746 ' OE1' HG11 ' A' ' 52' ' ' VAL . 5.3 tt0 -147.63 131.7 17.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.016 -1.053 . . . . 0.0 110.603 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.589 ' HH2' HG21 ' A' ' 49' ' ' VAL . 10.3 p90 -140.64 172.92 12.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.188 -0.945 . . . . 0.0 110.3 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.763 HD21 ' HB2' ' A' ' 97' ' ' LEU . 17.1 tp -106.16 156.78 18.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.488 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.499 ' N ' ' HG ' ' A' ' 36' ' ' LEU . 1.5 t80 -142.89 115.52 8.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -0.913 . . . . 0.0 110.913 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.572 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 4.3 tm-20 -84.53 141.58 30.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.532 -0.73 . . . . 0.0 109.273 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.708 ' CA ' HG23 ' A' ' 7' ' ' VAL . . . 63.43 47.73 84.76 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.771 ' HB2' HD21 ' A' ' 13' ' ' LEU . 47.1 Cg_endo -68.99 7.06 0.85 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 124.187 1.625 . . . . 0.0 112.071 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.551 ' HA3' ' C ' ' A' ' 6' ' ' VAL . . . -49.67 -57.03 10.05 Favored Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.321 -1.418 . . . . 0.0 109.56 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 61.4 p -71.93 -4.45 28.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.479 -1.012 . . . . 0.0 110.789 -179.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.778 ' OH ' HD12 ' A' ' 15' ' ' LEU . 4.3 t80 -82.67 111.5 18.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.042 -1.036 . . . . 0.0 109.732 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.538 HG23 ' HD2' ' A' ' 45' ' ' PRO . 18.2 mm -102.48 144.56 28.86 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.255 -0.903 . . . . 0.0 109.787 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.538 ' HD2' HG23 ' A' ' 44' ' ' ILE . 42.2 Cg_endo -67.8 96.3 0.43 Allowed 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.033 1.543 . . . . 0.0 111.474 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.1 147.71 23.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 109.482 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.471 ' HG3' ' N ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -50.72 -30.95 15.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.161 -0.962 . . . . 0.0 110.474 -179.572 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.471 ' N ' ' HG3' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -52.25 -25.49 9.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.129 -0.982 . . . . 0.0 110.668 -179.796 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.613 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.5 m -149.18 173.29 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.885 . . . . 0.0 109.615 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.752 ' OE1' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -132.74 134.79 45.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.052 -1.03 . . . . 0.0 110.595 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.434 HG23 ' H ' ' A' ' 51' ' ' VAL . 9.0 t -54.79 130.78 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 109.128 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.879 HG12 ' OE2' ' A' ' 53' ' ' GLU . 5.3 t -104.54 -62.24 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.366 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.967 ' O ' HD13 ' A' ' 54' ' ' ILE . 2.4 mm-40 -146.29 173.72 12.0 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.547 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.967 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.3 mm -133.68 145.88 32.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.503 HD13 ' N ' ' A' ' 56' ' ' GLN . 0.4 OUTLIER -136.71 139.05 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.914 -1.116 . . . . 0.0 110.923 -178.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.515 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 2.8 mp0 -88.75 159.63 17.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.574 -0.704 . . . . 0.0 109.939 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.944 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -94.84 138.06 33.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.286 -0.884 . . . . 0.0 110.222 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 1.7 t 178.48 58.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.988 -1.07 . . . . 0.0 111.903 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.58 HG22 ' O ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER -166.04 -52.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.605 -1.31 . . . . 0.0 111.201 178.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.574 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 10.5 mt -62.45 161.23 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.655 -1.278 . . . . 0.0 109.552 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.469 ' HB2' ' HB2' ' A' ' 64' ' ' GLN . 1.0 OUTLIER -96.38 -168.43 1.73 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.1 -1.0 . . . . 0.0 110.818 -179.37 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.81 ' HA ' HG13 ' A' ' 93' ' ' VAL . 7.5 tt0 -89.03 -17.5 29.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.323 -0.861 . . . . 0.0 111.116 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.93 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 2.4 p-10 -115.96 -36.34 4.17 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 110.266 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.469 ' HB2' ' HB2' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -55.54 132.05 47.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 111.175 -179.596 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.007 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -109.9 149.71 29.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.384 -0.823 . . . . 0.0 109.381 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.715 ' O ' HG12 ' A' ' 90' ' ' VAL . 0.7 OUTLIER -119.01 123.9 45.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.831 -1.168 . . . . 0.0 110.948 -179.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.603 ' HG2' HD22 ' A' ' 105' ' ' LEU . 7.9 ttt180 -91.5 120.91 32.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 109.255 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.626 HD13 ' C ' ' A' ' 103' ' ' GLU . 2.5 mm? -112.66 137.49 50.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.186 -0.946 . . . . 0.0 111.256 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.58 ' CB ' HD11 ' A' ' 105' ' ' LEU . 7.5 ttt180 -128.12 150.53 49.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.539 -0.725 . . . . 0.0 109.466 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.769 ' HB2' ' HG2' ' A' ' 86' ' ' GLU . . . -62.84 136.76 58.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.053 -1.029 . . . . 0.0 110.603 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.504 ' HG3' ' HD2' ' A' ' 72' ' ' LYS . 34.8 tpt85 -107.52 -26.3 10.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.252 -0.905 . . . . 0.0 110.022 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.646 ' HG3' ' CD2' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -143.83 34.7 1.26 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.22 -0.925 . . . . 0.0 110.332 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.57 ' O ' ' CB ' ' A' ' 74' ' ' CYS . 1.1 pt-20 38.76 -162.13 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.585 -0.697 . . . . 0.0 110.447 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.57 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER 77.43 -35.21 0.21 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.382 -0.824 . . . . 0.0 111.156 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.578 ' CB ' ' HB2' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -73.87 113.13 10.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.91 -1.119 . . . . 0.0 109.665 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 79' ' ' GLY . 11.0 t0 -78.17 109.96 12.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.345 -0.847 . . . . 0.0 110.839 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.56 ' HB2' ' CZ2' ' A' ' 75' ' ' TRP . 1.4 tpm_? -88.68 -41.8 12.37 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.281 -0.887 . . . . 0.0 109.79 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -102.95 -9.07 20.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.356 -0.84 . . . . 0.0 110.128 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.498 ' N ' ' OD1' ' A' ' 76' ' ' ASP . . . 103.56 -4.6 47.21 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 81' ' ' GLU . 2.1 mttt -103.63 2.13 32.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -1.167 . . . . 0.0 110.132 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.466 ' OE2' ' OD2' ' A' ' 33' ' ' ASP . 43.5 mm-40 57.32 110.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 110.083 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.44 ' HB2' ' CD ' ' A' ' 86' ' ' GLU . 1.5 mmm-85 -113.8 179.87 3.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.465 -0.772 . . . . 0.0 110.641 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.929 HG13 ' H ' ' A' ' 85' ' ' GLY . 5.8 p -87.56 169.91 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.415 -0.803 . . . . 0.0 110.653 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.679 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -48.55 -23.03 0.86 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.304 -0.873 . . . . 0.0 110.138 179.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.929 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -64.66 -34.58 90.29 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.769 ' HG2' ' HB2' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -50.19 162.51 0.21 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.171 -1.193 . . . . 0.0 109.727 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.459 ' HB3' ' HG3' ' A' ' 69' ' ' ARG . 7.8 pt-20 -159.13 151.22 21.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.145 -0.972 . . . . 0.0 110.655 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.521 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -133.0 148.44 52.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.431 -0.793 . . . . 0.0 109.106 179.579 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.928 HD23 ' H ' ' A' ' 90' ' ' VAL . 1.1 tt -109.3 162.23 14.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.176 -0.952 . . . . 0.0 110.15 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.928 ' H ' HD23 ' A' ' 89' ' ' LEU . 14.3 p -137.0 117.78 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.156 -0.965 . . . . 0.0 110.556 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.66 38.27 3.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.396 -0.815 . . . . 0.0 109.789 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.52 ' CG2' ' OD1' ' A' ' 10' ' ' ASN . 2.2 m -88.62 133.78 34.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.848 . . . . 0.0 110.568 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.81 HG13 ' HA ' ' A' ' 62' ' ' GLN . 76.5 t -76.8 147.46 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.317 -0.865 . . . . 0.0 109.871 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.653 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 44.97 82.35 0.03 OUTLIER Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.703 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . . . -165.31 145.84 7.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.33 -1.1 . . . . 0.0 110.393 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.573 ' O ' ' CD1' ' A' ' 96' ' ' TYR . 3.2 t80 -124.81 -13.59 6.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.598 -0.689 . . . . 0.0 110.859 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.763 ' HB2' HD21 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -40.87 98.93 0.19 Allowed Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.151 -0.968 . . . . 0.0 110.185 -179.708 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.712 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 50.2 Cg_endo -86.88 11.63 3.21 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.169 1.615 . . . . 0.0 111.018 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 98' ' ' PRO . . . 67.99 -158.97 0.21 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.027 -1.046 . . . . 0.0 110.111 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.478 HG21 ' HG2' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -123.93 -55.45 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.061 -1.025 . . . . 0.0 110.897 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.646 ' CD2' ' HG3' ' A' ' 72' ' ' LYS . 7.5 m-85 -98.68 -4.54 33.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.869 -1.145 . . . . 0.0 110.159 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.563 ' HG2' ' CH2' ' A' ' 75' ' ' TRP . 6.9 mt-10 -91.05 121.93 33.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.293 -0.88 . . . . 0.0 110.733 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.626 ' C ' HD13 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -102.19 143.32 32.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.411 -0.806 . . . . 0.0 109.975 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 104' ' ' VAL . 3.6 m -71.39 134.08 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.062 -1.024 . . . . 0.0 110.426 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.603 HD22 ' HG2' ' A' ' 67' ' ' ARG . 3.0 mp -84.83 -16.02 42.78 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.447 -0.783 . . . . 0.0 109.168 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 3.2 p30 160.85 -165.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.456 ' HB3' ' NE2' ' A' ' 64' ' ' GLN . 3.4 mp -123.1 109.76 14.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.35 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.007 HG13 ' HB3' ' A' ' 65' ' ' ALA . 10.0 p -97.19 161.55 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.474 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 110' ' ' ALA . 8.8 p-10 -104.65 131.78 51.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.852 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.93 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.496 1.833 0 O-C-N 121.476 -0.765 . . . . 0.0 110.942 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.492 ' NE2' HD11 ' A' ' 8' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.428 0.632 . . . . 0.0 110.757 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.509 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 55.6 t -97.82 157.5 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.381 -0.825 . . . . 0.0 109.524 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.527 ' HA ' ' CA ' ' A' ' 41' ' ' GLY . 48.7 t -38.06 102.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.51 -0.744 . . . . 0.0 110.766 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.903 HD22 ' CG ' ' A' ' 40' ' ' PRO . 1.6 mp -47.73 137.49 9.91 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 110.288 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.672 ' O ' HG23 ' A' ' 11' ' ' THR . 48.4 Cg_endo -73.87 85.05 1.38 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.986 1.519 . . . . 0.0 110.618 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.888 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 9.4 m-20 56.64 48.36 16.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.214 -0.929 . . . . 0.0 110.578 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 9' ' ' PRO . 61.3 p -143.56 170.89 14.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.079 -1.013 . . . . 0.0 110.696 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.866 ' HB2' HD21 ' A' ' 97' ' ' LEU . . . -146.31 159.79 42.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.495 -0.753 . . . . 0.0 110.107 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.877 HD23 ' HG3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -133.3 152.71 51.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 109.983 179.493 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 1.02 ' C ' HD13 ' A' ' 15' ' ' LEU . 32.2 m80 -92.71 133.85 35.61 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.157 -0.964 . . . . 0.0 111.521 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.092 HD21 ' HB2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -124.21 153.85 41.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.419 -0.801 . . . . 0.0 109.274 178.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.547 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 8.5 ttmt -107.65 117.1 33.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.984 -1.073 . . . . 0.0 109.277 178.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.006 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -78.6 110.84 14.09 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.318 -0.864 . . . . 0.0 110.123 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 48' ' ' GLU . 82.6 mt -98.53 101.13 12.46 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.365 0.602 . . . . 0.0 109.72 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.544 HD13 ' N ' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -163.87 136.54 5.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.202 -0.936 . . . . 0.0 110.081 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.544 ' N ' HD13 ' A' ' 19' ' ' LEU . 80.3 m-20 -78.43 104.36 8.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 0.0 109.702 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.676 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.147 -0.97 . . . . 0.0 110.587 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.845 HG12 ' HG2' ' A' ' 81' ' ' GLU . 2.0 m . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 121.231 0.539 . . . . 0.0 109.653 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.67 ' O ' HG23 ' A' ' 30' ' ' VAL . 35.7 m -142.0 84.93 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 110.482 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.55 67.37 0.82 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.482 -0.761 . . . . 0.0 110.481 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -179.26 26.44 0.05 OUTLIER Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.592 -1.289 . . . . 0.0 110.587 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 1.006 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 15.7 m-20 -87.99 150.42 23.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.821 -1.4 . . . . 0.0 110.217 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 80.4 tt0 -145.3 130.8 18.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.134 -0.979 . . . . 0.0 110.052 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.873 ' CE2' HD23 ' A' ' 15' ' ' LEU . 8.0 p90 -143.03 166.01 25.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.042 -1.036 . . . . 0.0 110.715 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.584 HD13 ' NE2' ' A' ' 14' ' ' HIS . 56.2 tp -90.17 153.72 20.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.454 -0.779 . . . . 0.0 109.942 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 1.092 ' HB2' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -119.98 109.62 15.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.763 -1.211 . . . . 0.0 110.38 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.527 ' HB2' ' CD2' ' A' ' 97' ' ' LEU . 0.4 OUTLIER -90.71 127.0 36.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.422 -0.799 . . . . 0.0 110.186 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.57 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 57.98 46.86 92.03 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.903 ' CG ' HD22 ' A' ' 8' ' ' LEU . 37.8 Cg_endo -62.85 -21.65 73.26 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.87 1.458 . . . . 0.0 110.095 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.527 ' CA ' ' HA ' ' A' ' 7' ' ' VAL . . . 30.97 -92.09 0.01 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.712 ' O ' HD12 ' A' ' 44' ' ' ILE . 30.2 p -86.21 34.78 0.63 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.38 -1.07 . . . . 0.0 111.666 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.485 ' CE2' HD11 ' A' ' 13' ' ' LEU . 14.4 t80 -69.45 111.36 5.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.772 -1.205 . . . . 0.0 109.592 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.712 HD12 ' O ' ' A' ' 42' ' ' THR . 2.5 mp -103.57 142.58 24.88 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 109.839 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.578 ' HD2' HG23 ' A' ' 44' ' ' ILE . 44.4 Cg_endo -70.96 109.6 2.59 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.007 1.53 . . . . 0.0 110.801 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 49' ' ' VAL . 80.4 mtt180 -111.85 143.81 42.2 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.364 -0.835 . . . . 0.0 110.015 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 46' ' ' ARG . 14.4 pttp -43.55 -38.28 2.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.099 -1.0 . . . . 0.0 110.094 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 8.8 mt-10 -44.89 -43.83 9.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.171 -0.956 . . . . 0.0 110.231 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.748 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.6 m -136.49 173.33 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.326 -0.859 . . . . 0.0 109.99 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -136.06 139.82 43.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.098 -1.001 . . . . 0.0 110.526 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 51' ' ' VAL . 17.1 t -54.74 130.58 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.186 -0.946 . . . . 0.0 109.587 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 15' ' ' LEU . 16.9 t -109.73 -62.39 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.267 -0.896 . . . . 0.0 110.396 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.858 ' O ' HD13 ' A' ' 54' ' ' ILE . 3.2 mt-10 -139.03 173.08 11.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.035 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.858 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.4 mm -131.72 150.55 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 12' ' ' ALA . 0.4 OUTLIER -143.55 144.95 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.84 -1.163 . . . . 0.0 110.883 -179.025 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.459 ' HA ' HG22 ' A' ' 11' ' ' THR . 13.6 mp0 -115.88 169.77 8.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.524 -0.735 . . . . 0.0 109.767 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.888 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -89.11 139.09 30.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 110.078 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.452 ' O ' HG12 ' A' ' 59' ' ' ILE . 2.6 t -169.97 51.4 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 110.261 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.735 HG22 HG13 ' A' ' 60' ' ' ILE . 7.1 mm -146.83 -82.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.085 -1.009 . . . . 0.0 110.631 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.886 HD13 ' HG2' ' A' ' 64' ' ' GLN . 13.3 mt -111.88 -102.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.803 -1.186 . . . . 0.0 110.704 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.535 ' N ' ' HA ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER -175.99 -144.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.848 -1.158 . . . . 0.0 110.822 -179.633 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.963 ' HB2' HG13 ' A' ' 93' ' ' VAL . 6.1 tt0 -87.98 -66.41 0.92 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.511 -0.743 . . . . 0.0 110.884 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.506 ' HA ' ' HB3' ' A' ' 110' ' ' ALA . 3.3 m-20 -31.25 -58.7 0.24 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.299 0.571 . . . . 0.0 110.786 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.886 ' HG2' HD13 ' A' ' 60' ' ' ILE . 2.8 tp-100 -59.87 129.22 40.79 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.224 -0.923 . . . . 0.0 109.66 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.674 ' C ' HD22 ' A' ' 66' ' ' LEU . . . -108.15 146.73 32.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.969 -1.082 . . . . 0.0 110.264 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.708 HD12 HG21 ' A' ' 104' ' ' VAL . 4.0 mm? -121.27 116.34 24.67 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.134 -0.979 . . . . 0.0 109.89 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.687 ' O ' HD23 ' A' ' 68' ' ' LEU . 16.3 ttp180 -90.14 132.47 35.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.064 -1.022 . . . . 0.0 110.01 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 67' ' ' ARG . 12.6 mt -124.14 143.27 50.58 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.522 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.513 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 2.5 ttt180 -117.62 138.88 51.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.714 -0.616 . . . . 0.0 109.577 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -58.33 152.67 17.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.223 -0.923 . . . . 0.0 110.359 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.81 ' C ' HG22 ' A' ' 84' ' ' THR . 8.8 ttt180 -143.48 -11.79 0.7 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.158 -0.964 . . . . 0.0 111.778 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.597 ' HG2' ' CE1' ' A' ' 101' ' ' PHE . 5.4 tppt? -114.57 -4.92 12.78 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.635 -1.29 . . . . 0.0 111.021 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.523 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 7.8 tt0 54.55 69.64 0.7 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.892 -1.13 . . . . 0.0 109.689 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 2.6 t -172.81 -31.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.308 -0.87 . . . . 0.0 110.261 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.594 ' CB ' ' HB2' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -74.16 126.76 31.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.146 -0.972 . . . . 0.0 110.118 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.538 ' HB3' ' N ' ' A' ' 81' ' ' GLU . 39.3 p-10 -101.08 110.34 22.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.156 -0.965 . . . . 0.0 109.905 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.568 ' HB2' ' CZ2' ' A' ' 75' ' ' TRP . 2.3 tpm_? -80.05 -38.08 32.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.391 -0.818 . . . . 0.0 110.032 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.35 24.05 13.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.878 . . . . 0.0 110.108 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.92 9.71 80.23 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 81' ' ' GLU . 30.4 mtpt -130.12 87.97 2.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -1.076 . . . . 0.0 110.038 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.845 ' HG2' HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -43.2 118.48 1.32 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.918 . . . . 0.0 109.58 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.551 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 1.4 ttm180 -117.23 179.67 3.97 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 0.0 110.779 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.608 HG22 ' N ' ' A' ' 84' ' ' THR . 7.4 p -82.51 172.36 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.507 -0.745 . . . . 0.0 110.628 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.81 HG22 ' C ' ' A' ' 71' ' ' ARG . 45.7 p -52.65 -26.39 13.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.353 -0.842 . . . . 0.0 109.99 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -55.96 -43.71 87.83 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.551 ' CB ' ' HB3' ' A' ' 82' ' ' ARG . 12.4 tp10 -55.96 153.52 8.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.403 -1.057 . . . . 0.0 109.527 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.513 ' HB3' ' HG3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -159.47 156.18 27.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.064 -1.022 . . . . 0.0 110.602 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.49 ' CZ2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -142.58 151.12 41.22 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.283 -0.886 . . . . 0.0 109.604 179.679 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.894 HD23 ' H ' ' A' ' 90' ' ' VAL . 1.8 tt -102.21 154.01 19.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.325 -0.86 . . . . 0.0 109.901 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.894 ' H ' HD23 ' A' ' 89' ' ' LEU . 49.4 t -114.2 107.95 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.385 -0.822 . . . . 0.0 110.396 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 91' ' ' THR . 28.9 m -121.47 25.85 9.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.923 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.511 HG21 ' HG3' ' A' ' 38' ' ' GLU . 12.2 t -76.85 171.36 14.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.381 -0.824 . . . . 0.0 110.403 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.963 HG13 ' HB2' ' A' ' 62' ' ' GLN . 3.9 t -92.22 75.81 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 0.0 110.027 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.472 ' HA2' ' HB3' ' A' ' 10' ' ' ASN . . . -128.01 -85.82 0.5 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.712 ' HB1' ' H ' ' A' ' 59' ' ' ILE . . . -177.18 -38.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.362 -1.081 . . . . 0.0 109.707 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.608 ' CD1' ' HB ' ' A' ' 59' ' ' ILE . 3.4 p90 179.92 40.81 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.697 -0.627 . . . . 0.0 109.94 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.866 HD21 ' HB2' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -41.68 103.97 0.33 Allowed Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.281 -0.887 . . . . 0.0 110.155 -179.73 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.718 ' O ' ' HB2' ' A' ' 99' ' ' ALA . 46.7 Cg_endo -72.09 -98.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.08 1.569 . . . . 0.0 110.277 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.718 ' HB2' ' O ' ' A' ' 98' ' ' PRO . . . 169.11 -156.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.769 -1.207 . . . . 0.0 110.156 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.514 HG23 ' CD2' ' A' ' 14' ' ' HIS . 0.3 OUTLIER -128.31 -32.03 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 110.806 -179.563 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.597 ' CE1' ' HG2' ' A' ' 72' ' ' LYS . 1.7 m-85 -130.48 -6.86 4.19 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.75 -1.219 . . . . 0.0 110.897 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.58 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 1.2 pt-20 -110.86 157.73 19.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.013 -1.055 . . . . 0.0 110.675 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.57 166.06 13.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.355 -0.841 . . . . 0.0 109.846 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.708 HG21 HD12 ' A' ' 66' ' ' LEU . 11.5 p -95.63 152.61 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.142 -0.974 . . . . 0.0 110.469 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.834 ' N ' HD22 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -102.55 -34.71 9.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.367 -0.833 . . . . 0.0 109.508 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -164.97 -163.88 0.74 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.557 -0.715 . . . . 0.0 109.63 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.897 ' N ' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -136.93 163.71 30.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 110.578 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 64' ' ' GLN . 33.7 t -138.95 150.48 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.843 . . . . 0.0 110.169 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.455 ' CG ' ' O ' ' A' ' 109' ' ' ASP . 1.7 p-10 -111.67 115.13 28.61 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.882 -1.136 . . . . 0.0 109.81 178.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.506 ' HB3' ' HA ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.493 1.687 0 O-C-N 120.981 -1.074 . . . . 0.0 110.595 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.337 0.589 . . . . 0.0 110.384 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.51 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 41.5 t -113.47 160.04 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 0.0 109.718 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.495 ' CA ' ' HA3' ' A' ' 41' ' ' GLY . 21.5 t -35.56 99.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.65 -0.656 . . . . 0.0 110.855 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.79 HD23 ' OG1' ' A' ' 11' ' ' THR . 2.5 mp -47.45 147.23 2.96 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.458 -0.776 . . . . 0.0 110.865 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 10' ' ' ASN . 50.4 Cg_endo -76.98 69.0 7.17 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.134 1.597 . . . . 0.0 110.462 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.661 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 0.9 OUTLIER 67.68 49.0 1.0 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.21 -0.931 . . . . 0.0 110.741 179.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.79 ' OG1' HD23 ' A' ' 8' ' ' LEU . 33.1 p -137.13 171.35 14.62 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.278 -0.889 . . . . 0.0 109.792 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.741 ' HB2' HD21 ' A' ' 97' ' ' LEU . . . -144.3 161.97 37.59 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.954 -1.091 . . . . 0.0 110.785 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.749 HD11 HD11 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -134.04 152.2 51.74 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.244 -0.91 . . . . 0.0 110.419 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.826 ' CD2' HD13 ' A' ' 36' ' ' LEU . 9.1 m170 -88.03 128.19 35.4 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.143 -0.973 . . . . 0.0 110.727 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.749 HD11 HD11 ' A' ' 13' ' ' LEU . 2.7 mm? -115.99 148.0 40.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.497 -0.752 . . . . 0.0 110.579 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.708 ' HB2' HG22 ' A' ' 52' ' ' VAL . 1.7 ttmt -114.16 116.85 29.75 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.239 -0.984 . . . . 0.0 108.889 177.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.082 ' HB3' ' HB3' ' A' ' 33' ' ' ASP . . . -80.43 121.95 26.37 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.954 -1.091 . . . . 0.0 109.936 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 69.3 mt -98.66 99.89 11.05 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.493 0.663 . . . . 0.0 109.711 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.501 HD13 ' N ' ' A' ' 20' ' ' ASP . 0.4 OUTLIER -166.73 130.06 1.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.503 -0.748 . . . . 0.0 109.669 -179.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.501 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -71.62 101.34 2.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.083 -1.011 . . . . 0.0 110.019 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.749 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.903 . . . . 0.0 109.969 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.749 HG22 ' CB ' ' A' ' 21' ' ' PHE . 1.7 m . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.667 ' O ' HG23 ' A' ' 30' ' ' VAL . 29.6 m -138.85 90.18 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.135 -0.978 . . . . 0.0 110.545 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 46.75 51.61 12.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.864 . . . . 0.0 110.436 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -176.7 25.37 0.06 OUTLIER Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.152 -1.499 . . . . 0.0 111.061 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 1.082 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -66.66 149.84 49.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.508 -1.584 . . . . 0.0 109.011 179.091 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.635 ' CG ' ' CZ ' ' A' ' 101' ' ' PHE . 1.2 pm0 -148.47 138.66 22.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.557 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.418 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 10.1 p90 -158.86 164.68 35.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.335 -0.853 . . . . 0.0 109.816 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.826 HD13 ' CD2' ' A' ' 14' ' ' HIS . 60.6 tp -90.82 156.14 18.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.004 -1.06 . . . . 0.0 109.66 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.731 ' HB2' HD23 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -126.1 114.13 17.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.055 -1.028 . . . . 0.0 110.183 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -84.77 129.38 34.83 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.275 0.559 . . . . 0.0 109.983 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.61 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 64.77 44.33 94.95 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.731 ' HG2' HD22 ' A' ' 8' ' ' LEU . 55.8 Cg_endo -77.48 17.74 0.89 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.604 1.318 . . . . 0.0 110.875 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.578 ' HA2' HD13 ' A' ' 8' ' ' LEU . . . -49.21 -41.99 31.59 Favored Glycine 0 N--CA 1.488 2.114 0 O-C-N 120.755 -1.216 . . . . 0.0 110.367 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.8 p -93.73 19.74 8.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.038 -1.272 . . . . 0.0 110.974 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.61 ' C ' HD12 ' A' ' 44' ' ' ILE . 21.8 t80 -85.45 133.36 34.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.124 -0.985 . . . . 0.0 110.019 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.61 HD12 ' C ' ' A' ' 43' ' ' TYR . 1.5 mp -119.73 145.31 39.02 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.359 -0.838 . . . . 0.0 109.006 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.52 ' HD2' HG23 ' A' ' 44' ' ' ILE . 40.9 Cg_endo -66.89 109.53 1.71 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.869 1.457 . . . . 0.0 110.713 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -111.59 149.58 31.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.462 -0.774 . . . . 0.0 110.246 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -53.07 -29.1 28.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.859 . . . . 0.0 110.312 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.486 ' C ' ' CG1' ' A' ' 49' ' ' VAL . 20.4 tt0 -59.81 -21.69 61.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.173 -0.954 . . . . 0.0 110.512 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.553 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.9 m -150.92 170.8 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.292 -0.88 . . . . 0.0 110.33 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -131.54 138.0 48.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.198 -0.939 . . . . 0.0 110.099 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.434 HG23 ' H ' ' A' ' 51' ' ' VAL . 6.6 t -58.63 125.55 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.716 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.708 HG22 ' HB2' ' A' ' 16' ' ' LYS . 2.8 t -102.27 -63.32 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.276 -0.89 . . . . 0.0 110.291 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.591 ' O ' HD13 ' A' ' 54' ' ' ILE . 3.4 mt-10 -144.01 166.49 24.82 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.18 -0.95 . . . . 0.0 110.252 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.591 HD13 ' O ' ' A' ' 53' ' ' GLU . 2.6 mm -128.71 148.65 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.725 HD11 ' OH ' ' A' ' 96' ' ' TYR . 0.5 OUTLIER -141.6 130.39 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.591 -1.318 . . . . 0.0 111.59 -178.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.45 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 23.1 mp0 -94.8 176.0 6.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.589 -0.694 . . . . 0.0 109.708 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.818 ' HB1' ' HB2' ' A' ' 95' ' ' ALA . . . -102.02 144.61 30.4 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.159 -0.963 . . . . 0.0 110.63 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER 170.61 59.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.156 -0.965 . . . . 0.0 111.984 179.53 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.662 HG23 ' H ' ' A' ' 60' ' ' ILE . 1.2 tt -172.71 -60.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.277 -1.515 . . . . 0.0 112.649 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.662 ' H ' HG23 ' A' ' 59' ' ' ILE . 18.8 mm -80.81 169.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.36 -1.463 . . . . 0.0 110.835 -178.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.449 ' N ' HG22 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -109.33 -159.7 0.69 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.474 -0.766 . . . . 0.0 110.326 -179.773 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.987 ' HB2' HG13 ' A' ' 93' ' ' VAL . 2.9 tt0 -91.14 -68.64 0.78 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.327 -0.858 . . . . 0.0 110.295 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.651 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 2.1 m-20 -38.23 -50.97 1.46 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.75 -0.594 . . . . 0.0 110.97 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.486 ' NE2' ' O ' ' A' ' 108' ' ' VAL . 7.9 tp60 -59.69 137.4 58.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.082 -1.011 . . . . 0.0 110.852 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.969 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -127.41 148.95 50.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.412 -0.805 . . . . 0.0 110.069 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.656 HD11 HG21 ' A' ' 60' ' ' ILE . 2.6 mp -127.05 118.13 23.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.318 -0.864 . . . . 0.0 110.152 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.599 ' O ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -91.66 128.26 37.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.002 -1.061 . . . . 0.0 110.029 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.752 HD11 HG21 ' A' ' 90' ' ' VAL . 15.6 mt -120.33 139.85 52.15 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.05 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -120.02 157.54 28.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.483 -0.761 . . . . 0.0 109.754 179.329 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.877 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -68.95 124.58 24.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 111.353 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -84.33 -23.09 30.37 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.503 ' HG2' ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -156.73 146.56 20.89 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.552 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 74' ' ' CYS . 1.9 pt-20 -56.96 -156.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.036 -1.04 . . . . 0.0 110.341 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 6.6 m 77.34 -43.45 0.42 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.525 -0.734 . . . . 0.0 110.889 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.718 ' HZ3' ' HB2' ' A' ' 70' ' ' ALA . 8.3 t90 -74.15 110.94 8.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.793 -1.192 . . . . 0.0 110.353 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 76' ' ' ASP . 2.4 p30 -91.2 127.05 36.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.205 -0.934 . . . . 0.0 110.003 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -86.08 -40.5 15.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 110.039 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.01 -28.79 25.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.166 -0.959 . . . . 0.0 110.275 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 80' ' ' LYS . . . 139.86 -52.29 0.71 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -61.05 -131.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -1.179 . . . . 0.0 109.741 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.535 ' CD ' HG11 ' A' ' 29' ' ' VAL . 15.0 mm-40 -136.97 121.78 18.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.826 -1.171 . . . . 0.0 110.464 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.36 173.26 8.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.535 -0.728 . . . . 0.0 109.888 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.62 HG13 ' H ' ' A' ' 85' ' ' GLY . 13.5 p -88.87 173.03 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 0.0 110.568 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.877 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 10.1 t -67.45 -12.53 60.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.863 . . . . 0.0 110.006 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.62 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -63.49 -14.65 55.2 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.635 ' HG3' ' CZ3' ' A' ' 75' ' ' TRP . 8.4 pt-20 -79.25 166.42 22.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.417 -1.049 . . . . 0.0 109.526 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.496 ' HA ' ' OE2' ' A' ' 102' ' ' GLU . 5.8 pt-20 -157.9 153.55 26.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.808 -1.183 . . . . 0.0 110.774 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.509 ' CE2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -128.38 144.24 51.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.392 -0.817 . . . . 0.0 109.716 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.897 HD23 ' H ' ' A' ' 90' ' ' VAL . 1.4 tt -106.2 158.42 16.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.211 -0.931 . . . . 0.0 110.123 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.897 ' H ' HD23 ' A' ' 89' ' ' LEU . 16.6 t -122.23 136.65 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 0.0 110.571 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.587 HG23 ' C ' ' A' ' 90' ' ' VAL . 61.0 p -155.72 60.26 0.61 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 109.641 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.686 HG21 ' HB3' ' A' ' 95' ' ' ALA . 14.6 t -85.29 167.93 15.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.399 -0.813 . . . . 0.0 110.627 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.987 HG13 ' HB2' ' A' ' 62' ' ' GLN . 3.3 t -108.18 67.17 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.385 -0.822 . . . . 0.0 109.768 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 60' ' ' ILE . . . 110.04 62.85 0.52 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.818 ' HB2' ' HB1' ' A' ' 57' ' ' ALA . . . -174.72 -153.14 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.332 -1.099 . . . . 0.0 110.426 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.725 ' OH ' HD11 ' A' ' 55' ' ' ILE . 2.3 p90 176.46 119.11 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.741 HD21 ' HB2' ' A' ' 12' ' ' ALA . 2.6 mp -106.19 95.65 11.7 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 111.457 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.488 ' O ' ' O ' ' A' ' 99' ' ' ALA . 47.0 Cg_endo -74.94 87.19 1.34 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.9 1.474 . . . . 0.0 108.887 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.597 ' HB3' ' HB2' ' A' ' 102' ' ' GLU . . . -50.05 -172.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.404 -0.81 . . . . 0.0 111.261 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 t -99.47 -66.33 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.433 -0.792 . . . . 0.0 110.496 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.635 ' CZ ' ' CG ' ' A' ' 34' ' ' GLU . 21.5 m-30 -100.15 22.23 11.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.936 -1.102 . . . . 0.0 110.57 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.597 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 2.4 mm-40 -111.56 120.29 41.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.964 -1.085 . . . . 0.0 110.397 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -100.13 156.26 17.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.352 -0.843 . . . . 0.0 110.188 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.649 HG12 HD22 ' A' ' 68' ' ' LEU . 3.5 m -81.87 138.39 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 110.26 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.592 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 3.0 mp -97.14 -9.58 27.62 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.318 -0.864 . . . . 0.0 109.197 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.57 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 0.4 OUTLIER 159.94 -160.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.791 -0.568 . . . . 0.0 109.622 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.875 ' C ' HD22 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -138.42 150.13 46.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.941 . . . . 0.0 110.341 178.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.969 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 14.7 p -134.07 140.66 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.128 -0.982 . . . . 0.0 110.167 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.17 117.84 35.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.881 -1.137 . . . . 0.0 110.003 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 110.014 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.242 0.544 . . . . 0.0 110.151 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.507 ' O ' HD12 ' A' ' 8' ' ' LEU . 9.8 p -126.61 147.24 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.163 -0.961 . . . . 0.0 110.089 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.47 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 83.4 t -41.18 107.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 110.337 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.975 HD23 ' OG1' ' A' ' 11' ' ' THR . 5.4 mp -63.24 163.94 16.21 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.391 -0.818 . . . . 0.0 110.079 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.411 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 47.3 Cg_endo -73.19 -56.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.913 1.48 . . . . 0.0 110.451 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.825 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 63.2 m-80 -158.42 31.77 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 110.174 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.975 ' OG1' HD23 ' A' ' 8' ' ' LEU . 43.9 p -106.41 171.56 7.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.342 -0.849 . . . . 0.0 110.2 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.496 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -147.24 162.46 38.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.193 -0.942 . . . . 0.0 109.93 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.776 HD11 ' HE2' ' A' ' 43' ' ' TYR . 0.6 OUTLIER -130.25 155.79 45.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.021 . . . . 0.0 110.642 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.696 ' C ' HD23 ' A' ' 15' ' ' LEU . 2.4 m170 -96.93 129.16 44.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.341 -0.849 . . . . 0.0 109.08 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.838 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -126.2 162.28 25.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.703 -1.248 . . . . 0.0 109.48 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.537 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 1.2 ttpt -113.44 118.58 34.91 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.576 -0.85 . . . . 0.0 111.029 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.118 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -73.9 113.18 10.77 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.922 0.868 . . . . 0.0 108.782 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.875 HD23 ' O ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -106.95 106.73 17.4 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.486 0.66 . . . . 0.0 110.655 -178.677 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.86 HD13 ' HG3' ' A' ' 48' ' ' GLU . 5.1 tp -166.72 146.2 5.6 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.564 -0.71 . . . . 0.0 109.903 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.3 105.0 15.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 109.827 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.882 ' HB2' HG22 ' A' ' 29' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.212 -0.93 . . . . 0.0 110.318 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.882 HG22 ' HB2' ' A' ' 21' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 121.226 0.536 . . . . 0.0 109.65 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 30' ' ' VAL . 27.0 m -132.41 81.37 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.07 -1.019 . . . . 0.0 109.764 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 41.31 67.47 0.54 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.617 -0.677 . . . . 0.0 110.295 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -168.47 20.26 0.08 OUTLIER Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.114 -1.517 . . . . 0.0 111.263 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 1.118 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 1.3 m-20 -88.34 150.6 23.13 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.437 -1.625 . . . . 0.0 109.406 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.506 ' HG3' HG21 ' A' ' 52' ' ' VAL . 16.5 tt0 -151.46 139.07 19.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.089 -1.007 . . . . 0.0 110.461 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.662 ' CZ2' HD12 ' A' ' 15' ' ' LEU . 8.7 p90 -154.44 177.63 10.96 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.147 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.553 HD21 ' CE1' ' A' ' 14' ' ' HIS . 0.5 OUTLIER -90.33 158.69 17.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 0.0 110.969 -179.062 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.761 ' HB2' HD21 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -141.99 110.77 6.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.386 -0.821 . . . . 0.0 109.565 179.252 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.472 ' HG2' ' HB2' ' A' ' 12' ' ' ALA . 4.1 tm-20 -93.94 149.44 21.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.205 -0.934 . . . . 0.0 111.001 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.588 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 55.91 45.52 86.2 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.615 ' HG2' HD22 ' A' ' 8' ' ' LEU . 41.8 Cg_endo -70.68 -60.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.757 1.398 . . . . 0.0 109.844 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.492 ' HA3' ' C ' ' A' ' 6' ' ' VAL . . . 41.87 -89.92 0.01 OUTLIER Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 40' ' ' PRO . 19.8 p -66.9 1.32 1.95 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.33 -1.1 . . . . 0.0 111.559 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.776 ' HE2' HD11 ' A' ' 13' ' ' LEU . 6.8 t80 -68.78 124.15 22.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.643 -1.286 . . . . 0.0 110.408 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.65 HG23 ' HD2' ' A' ' 45' ' ' PRO . 6.2 mt -115.52 145.59 34.78 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 109.064 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.65 ' HD2' HG23 ' A' ' 44' ' ' ILE . 42.6 Cg_endo -67.57 109.19 1.78 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.764 1.402 . . . . 0.0 110.751 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -102.37 144.64 30.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.4 -0.812 . . . . 0.0 109.999 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.786 ' O ' HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -37.34 -45.66 0.7 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.572 -0.705 . . . . 0.0 111.062 -179.582 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.86 ' HG3' HD13 ' A' ' 19' ' ' LEU . 11.4 tt0 -49.07 -49.07 43.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -0.964 . . . . 0.0 110.98 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.535 HG12 ' HA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -133.44 142.58 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.915 -1.115 . . . . 0.0 110.741 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -108.62 137.51 46.45 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.323 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.431 HG13 ' HB3' ' A' ' 45' ' ' PRO . 31.3 m -54.01 145.29 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.168 -0.957 . . . . 0.0 109.252 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.734 HG23 ' HA ' ' A' ' 15' ' ' LEU . 31.7 t -117.48 -58.65 3.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.048 -1.033 . . . . 0.0 110.407 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.936 ' O ' HD13 ' A' ' 54' ' ' ILE . 1.9 mt-10 -136.09 172.85 12.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.144 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.936 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.2 mm -136.18 130.73 48.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.322 -0.861 . . . . 0.0 108.828 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.638 HD13 ' H ' ' A' ' 56' ' ' GLN . 0.4 OUTLIER -125.85 144.93 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.214 -0.929 . . . . 0.0 111.162 -178.591 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.638 ' H ' HD13 ' A' ' 55' ' ' ILE . 40.7 mm-40 -100.4 174.28 6.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.468 -0.77 . . . . 0.0 109.779 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.825 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -102.25 125.68 49.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.132 -0.98 . . . . 0.0 109.96 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 3.2 t 179.29 63.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.012 -1.055 . . . . 0.0 111.872 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.533 HG21 ' CD1' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -169.68 -37.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.549 -1.344 . . . . 0.0 111.323 179.107 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 95' ' ' ALA . 9.4 mm -78.1 158.41 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.785 -1.197 . . . . 0.0 110.44 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.513 ' HB2' ' HB3' ' A' ' 64' ' ' GLN . 9.1 mtt180 -62.8 -168.84 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.283 -0.886 . . . . 0.0 110.413 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.842 ' HA ' HG13 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -91.63 -19.92 22.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.0 110.701 -179.435 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 2.7 p30 -127.97 -19.2 4.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.905 -1.122 . . . . 0.0 110.907 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.513 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 6.4 tp-100 -51.34 126.88 18.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.031 -1.043 . . . . 0.0 111.646 -179.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.016 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -108.54 142.37 39.06 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.492 HD23 HD12 ' A' ' 107' ' ' LEU . 1.8 mp -127.59 115.04 18.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.837 -1.165 . . . . 0.0 111.882 -178.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . 4.3 ttm180 -91.36 119.6 31.51 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.71 ' CD2' HG23 ' A' ' 104' ' ' VAL . 21.6 mt -113.74 161.25 17.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 111.396 -178.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.591 ' HB2' HD21 ' A' ' 105' ' ' LEU . 15.7 mtp180 -126.57 161.88 26.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.371 -0.83 . . . . 0.0 110.179 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.888 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -82.63 152.37 25.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.202 -0.936 . . . . 0.0 111.415 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.518 ' HG3' ' N ' ' A' ' 72' ' ' LYS . 9.4 ptt180 -125.31 -27.7 3.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.453 -0.779 . . . . 0.0 109.819 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.518 ' N ' ' HG3' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -124.49 118.46 26.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.283 -0.885 . . . . 0.0 109.762 179.575 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.524 ' N ' ' HB ' ' A' ' 84' ' ' THR . 4.3 pt-20 -54.51 106.82 0.23 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.202 -0.937 . . . . 0.0 110.723 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.507 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER 168.5 -43.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.285 -0.884 . . . . 0.0 110.151 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.779 ' CZ3' ' HB2' ' A' ' 70' ' ' ALA . 2.7 t90 -74.98 104.43 5.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.284 -0.885 . . . . 0.0 110.182 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.482 ' OD2' ' N ' ' A' ' 80' ' ' LYS . 3.4 t70 -96.82 122.04 39.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -0.978 . . . . 0.0 110.226 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.452 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -85.03 -0.38 54.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.886 . . . . 0.0 110.365 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.55 -4.99 8.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.954 . . . . 0.0 110.365 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 101.21 -47.25 1.21 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.482 ' N ' ' OD2' ' A' ' 76' ' ' ASP . 9.1 mmtp -69.54 98.63 1.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -1.14 . . . . 0.0 110.012 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.748 ' OE2' HG21 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -34.17 135.15 0.16 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.718 -0.614 . . . . 0.0 110.913 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.16 179.77 7.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 110.533 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.599 HG22 ' N ' ' A' ' 84' ' ' THR . 10.8 p -77.84 174.02 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.4 -0.813 . . . . 0.0 110.553 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.888 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 2.3 t -73.95 -3.52 29.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.815 . . . . 0.0 110.099 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.572 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -72.88 -13.35 78.84 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.451 ' HG3' ' CZ3' ' A' ' 75' ' ' TRP . 8.3 pt-20 -70.79 172.24 9.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -1.083 . . . . 0.0 110.058 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.452 ' HB3' ' HG2' ' A' ' 69' ' ' ARG . 5.4 pm0 -159.06 172.59 17.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 110.444 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.549 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -155.96 153.66 29.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.342 -0.849 . . . . 0.0 109.795 -179.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.974 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -122.25 124.97 45.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.117 -0.99 . . . . 0.0 109.954 179.558 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.974 ' N ' HD22 ' A' ' 89' ' ' LEU . 4.5 p -105.6 138.92 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.429 -0.795 . . . . 0.0 110.263 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.7 t -141.93 49.78 1.56 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.272 -0.892 . . . . 0.0 110.415 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.524 ' CG2' ' HB3' ' A' ' 10' ' ' ASN . 51.6 m -91.28 138.66 31.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -0.937 . . . . 0.0 110.281 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.842 HG13 ' HA ' ' A' ' 62' ' ' GLN . 17.5 t -71.13 140.39 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.147 -0.971 . . . . 0.0 110.15 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.563 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 43.27 80.75 0.04 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.587 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . . . -156.38 154.01 29.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -1.149 . . . . 0.0 110.861 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.539 ' O ' ' CG ' ' A' ' 96' ' ' TYR . 4.9 t80 -117.69 25.69 10.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.502 -0.749 . . . . 0.0 109.961 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 96' ' ' TYR . 2.0 mm? -34.34 91.87 0.05 OUTLIER Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.827 -0.546 . . . . 0.0 111.408 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.518 ' N ' ' O ' ' A' ' 96' ' ' TYR . 48.5 Cg_endo -91.32 115.8 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.827 1.435 . . . . 0.0 110.395 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.747 ' HB1' ' HB3' ' A' ' 102' ' ' GLU . . . -69.76 171.92 8.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.213 -0.929 . . . . 0.0 110.32 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.615 HG21 ' HA ' ' A' ' 35' ' ' TRP . 1.7 t -99.33 -58.5 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.352 -0.843 . . . . 0.0 109.447 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.655 ' HB2' ' HB3' ' A' ' 75' ' ' TRP . 22.8 m-30 -117.6 38.9 3.46 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.156 -0.965 . . . . 0.0 109.257 178.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.747 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 13.6 tt0 -132.11 133.23 44.07 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.124 -0.985 . . . . 0.0 110.879 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -105.08 171.22 7.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.389 -0.819 . . . . 0.0 110.193 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.71 HG23 ' CD2' ' A' ' 68' ' ' LEU . 7.7 p -101.31 144.56 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.172 -0.955 . . . . 0.0 110.306 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.844 ' N ' HD22 ' A' ' 105' ' ' LEU . 1.6 mm? -103.14 -40.07 6.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -0.968 . . . . 0.0 110.118 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.901 ' C ' HD13 ' A' ' 107' ' ' LEU . 1.8 p30 -161.29 171.58 18.11 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.868 . . . . 0.0 109.963 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.901 HD13 ' C ' ' A' ' 106' ' ' ASP . 0.3 OUTLIER -121.96 142.55 50.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.175 -0.953 . . . . 0.0 110.367 -179.855 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.016 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 12.6 p -125.49 157.84 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.398 -0.814 . . . . 0.0 109.499 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.405 ' O ' ' CG ' ' A' ' 109' ' ' ASP . 8.6 p-10 -110.91 121.27 44.93 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.92 -1.113 . . . . 0.0 110.704 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 109.951 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.605 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.505 ' O ' ' O ' ' A' ' 5' ' ' GLN . 12.0 p -38.0 165.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.349 -0.844 . . . . 0.0 111.927 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.571 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 43.7 t -30.83 150.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 CA-C-O 121.586 0.708 . . . . 0.0 111.973 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.659 HD23 ' OG1' ' A' ' 11' ' ' THR . 6.0 mp -106.29 171.23 4.96 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.569 -0.707 . . . . 0.0 109.634 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 44.5 Cg_endo -71.35 -39.44 3.8 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.72 1.379 . . . . 0.0 110.401 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.471 ' ND2' HG21 ' A' ' 93' ' ' VAL . 3.1 m-20 172.19 37.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.338 -0.851 . . . . 0.0 109.681 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.659 ' OG1' HD23 ' A' ' 8' ' ' LEU . 69.9 p -114.58 162.72 16.38 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.329 -0.857 . . . . 0.0 110.957 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.714 ' HB3' ' HG ' ' A' ' 97' ' ' LEU . . . -135.57 161.13 36.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.378 -0.826 . . . . 0.0 109.96 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.982 HD23 ' CG ' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -133.28 153.65 51.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.167 -0.958 . . . . 0.0 110.553 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.802 ' C ' HD13 ' A' ' 15' ' ' LEU . 30.7 m80 -96.58 136.35 37.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.0 109.642 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.913 HD13 ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -135.67 167.18 21.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.126 -0.984 . . . . 0.0 110.561 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 3.2 ttmt -119.04 117.58 29.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.17 -0.956 . . . . 0.0 110.049 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.044 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -75.76 117.54 17.61 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.311 -0.868 . . . . 0.0 109.864 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 61.4 mt -108.62 100.94 10.13 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.188 0.518 . . . . 0.0 109.963 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.729 HD13 ' HG2' ' A' ' 48' ' ' GLU . 9.3 tp -163.79 144.74 8.83 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.157 -0.964 . . . . 0.0 110.294 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -85.2 110.78 19.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.379 -0.826 . . . . 0.0 109.061 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.757 ' CB ' HG22 ' A' ' 29' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 O-C-N 121.103 -0.998 . . . . 0.0 111.103 -178.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.757 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.193 0.521 . . . . 0.0 109.794 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.561 ' O ' HG23 ' A' ' 30' ' ' VAL . 25.2 m -133.39 81.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 0.0 110.336 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 42.36 66.87 0.67 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 110.189 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.52 20.18 0.09 OUTLIER Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.373 -1.394 . . . . 0.0 110.895 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 1.044 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -89.09 152.39 21.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.478 -1.601 . . . . 0.0 108.984 179.191 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 15' ' ' LEU . 23.0 tt0 -155.23 140.12 17.25 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.907 -1.12 . . . . 0.0 110.498 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.729 ' CZ3' ' HB2' ' A' ' 17' ' ' ALA . 5.2 p90 -162.94 172.78 14.56 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.661 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.745 HD13 ' NE2' ' A' ' 14' ' ' HIS . 16.9 tp -90.53 159.93 16.23 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.394 0.616 . . . . 0.0 110.733 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.655 ' HB2' HD11 ' A' ' 15' ' ' LEU . 0.6 OUTLIER -135.38 114.77 12.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.321 -0.862 . . . . 0.0 109.952 179.629 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.476 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -86.96 135.47 33.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.515 -0.741 . . . . 0.0 110.369 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.596 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 54.02 44.31 72.77 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.982 ' CG ' HD23 ' A' ' 13' ' ' LEU . 52.9 Cg_endo -77.03 42.76 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.492 1.259 . . . . 0.0 110.959 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 5' ' ' GLN . . . -65.1 -25.12 70.77 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.525 ' O ' HD12 ' A' ' 44' ' ' ILE . 9.6 p -101.63 12.95 36.32 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.831 -1.394 . . . . 0.0 109.77 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.464 ' HB3' ' HB2' ' A' ' 40' ' ' PRO . 16.6 t80 -86.88 122.53 30.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.393 -0.817 . . . . 0.0 109.556 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.657 HG23 ' HD2' ' A' ' 45' ' ' PRO . 3.7 mp -116.98 145.25 35.17 Favored Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.224 -0.922 . . . . 0.0 109.508 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.657 ' HD2' HG23 ' A' ' 44' ' ' ILE . 43.0 Cg_endo -69.56 83.44 0.66 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.874 1.46 . . . . 0.0 110.172 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -95.72 152.93 18.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.414 -0.804 . . . . 0.0 110.697 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -41.55 -42.97 2.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.352 -0.843 . . . . 0.0 110.69 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.729 ' HG2' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -42.55 -47.94 5.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.856 . . . . 0.0 110.434 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.6 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.2 m -136.15 173.85 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.313 -0.867 . . . . 0.0 110.332 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -133.16 142.02 48.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.388 -0.82 . . . . 0.0 110.206 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' A' ' 45' ' ' PRO . 47.7 t -62.56 130.36 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.229 -0.919 . . . . 0.0 109.833 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.735 HG23 ' HA ' ' A' ' 15' ' ' LEU . 28.2 t -107.82 -61.32 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 110.588 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.775 ' O ' HD13 ' A' ' 54' ' ' ILE . 7.8 mm-40 -139.89 168.08 20.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.168 -0.958 . . . . 0.0 110.293 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.775 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.4 mm -128.89 152.48 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.319 -0.863 . . . . 0.0 109.191 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -149.65 152.25 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.952 -1.092 . . . . 0.0 110.697 -179.698 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.536 ' HA ' ' CB ' ' A' ' 11' ' ' THR . 0.2 OUTLIER -123.94 177.89 5.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.432 -0.792 . . . . 0.0 110.078 179.542 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.532 ' CA ' ' HA ' ' A' ' 95' ' ' ALA . . . -87.25 130.02 34.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.186 -0.946 . . . . 0.0 110.727 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 1.5 t 177.41 52.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 111.018 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.86 HG22 HG13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -157.09 -59.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.608 -1.308 . . . . 0.0 111.591 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.86 HG13 HG22 ' A' ' 59' ' ' ILE . 2.3 mt -92.51 -174.46 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 120.14 -1.6 . . . . 0.0 110.8 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.699 ' H ' HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -101.25 169.43 8.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.4 -0.812 . . . . 0.0 110.114 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.634 ' CG ' HG13 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -67.3 -72.69 0.16 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.203 -0.935 . . . . 0.0 111.974 -179.006 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.565 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 5.7 p30 -39.62 -24.1 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.297 -0.877 . . . . 0.0 112.07 -178.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.507 ' NE2' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -57.22 167.98 0.81 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.609 -1.307 . . . . 0.0 112.206 -178.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.01 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -150.35 131.25 14.22 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.552 ' HG ' ' CG1' ' A' ' 90' ' ' VAL . 2.5 pp -129.3 127.42 41.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.513 -1.367 . . . . 0.0 112.395 -178.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . 12.5 ttt180 -103.64 130.01 51.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.784 -0.572 . . . . 0.0 109.553 178.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.49 HD23 ' O ' ' A' ' 67' ' ' ARG . 35.2 mt -117.76 149.53 40.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.18 -0.95 . . . . 0.0 111.007 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.443 ' C ' ' HG2' ' A' ' 102' ' ' GLU . 22.7 ttp180 -114.53 139.89 49.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.537 -0.727 . . . . 0.0 109.883 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.567 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -60.45 147.6 40.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.144 -0.973 . . . . 0.0 110.376 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -107.05 -44.1 4.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 109.874 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.592 ' HD2' ' CE2' ' A' ' 101' ' ' PHE . 15.2 ptpt -122.41 134.79 54.6 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.269 -0.894 . . . . 0.0 109.809 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.511 ' N ' ' HB ' ' A' ' 84' ' ' THR . 2.4 pt-20 -57.16 96.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.205 -0.935 . . . . 0.0 110.644 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.52 -42.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 110.443 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.596 ' CB ' ' HB2' ' A' ' 101' ' ' PHE . 2.5 t90 -74.64 120.34 20.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.214 -0.929 . . . . 0.0 110.701 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -117.19 110.21 17.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -0.923 . . . . 0.0 109.401 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.559 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -59.38 -23.06 62.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 110.219 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.462 ' OD2' ' HE2' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -88.57 -21.44 24.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 110.14 179.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.26 16.37 27.69 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.462 ' HE2' ' OD2' ' A' ' 78' ' ' ASP . 25.1 mttm -110.39 -137.89 0.37 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.218 -1.166 . . . . 0.0 110.147 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.729 ' CG ' HG11 ' A' ' 29' ' ' VAL . 7.9 mp0 -134.98 105.42 6.36 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.03 -1.043 . . . . 0.0 110.327 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.75 179.54 5.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.224 -0.922 . . . . 0.0 110.68 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.594 HG13 ' H ' ' A' ' 85' ' ' GLY . 13.3 p -91.67 174.45 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.422 -0.799 . . . . 0.0 110.79 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.58 ' N ' HG22 ' A' ' 83' ' ' VAL . 4.6 t -72.01 -6.53 42.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.318 -0.864 . . . . 0.0 110.361 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.594 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -80.03 -19.27 70.29 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.44 ' OE2' ' NH1' ' A' ' 77' ' ' ARG . 8.0 tp10 -66.94 160.61 25.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.462 -1.022 . . . . 0.0 110.053 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.416 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 6.1 pt-20 -154.87 168.12 27.98 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.38 -0.825 . . . . 0.0 110.05 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.592 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -147.5 143.94 28.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.127 -0.983 . . . . 0.0 109.979 179.587 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.851 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.6 OUTLIER -115.46 124.46 51.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.108 -0.995 . . . . 0.0 110.208 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.851 ' N ' HD22 ' A' ' 89' ' ' LEU . 8.5 p -107.05 132.37 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.313 -0.867 . . . . 0.0 110.518 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.836 HG23 HD11 ' A' ' 89' ' ' LEU . 3.5 p -115.4 29.37 8.05 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.488 0.661 . . . . 0.0 109.25 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.585 HG22 ' N ' ' A' ' 93' ' ' VAL . 20.1 m -74.65 171.81 13.21 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.417 -0.802 . . . . 0.0 109.55 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.634 HG13 ' CG ' ' A' ' 62' ' ' GLN . 1.5 t -47.37 172.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.99 -1.069 . . . . 0.0 109.006 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.563 ' O ' ' HB3' ' A' ' 95' ' ' ALA . . . -45.24 -88.87 0.01 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 94' ' ' GLY . . . 60.84 -167.79 0.18 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.569 -0.959 . . . . 0.0 110.213 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.516 ' CD2' ' CD1' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -120.76 -65.46 1.14 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.711 -0.618 . . . . 0.0 109.827 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.714 ' HG ' ' HB3' ' A' ' 12' ' ' ALA . 0.3 OUTLIER 46.23 71.37 1.59 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.559 -0.713 . . . . 0.0 110.695 179.584 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.404 ' HD2' HG21 ' A' ' 55' ' ' ILE . 49.5 Cg_endo -78.15 120.53 5.0 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.939 1.494 . . . . 0.0 110.092 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.844 ' HB1' ' HB2' ' A' ' 102' ' ' GLU . . . -73.55 138.82 45.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.21 -0.931 . . . . 0.0 110.275 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.568 HG23 ' N ' ' A' ' 101' ' ' PHE . 30.5 m -69.65 -51.72 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.157 -0.965 . . . . 0.0 110.754 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.596 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 19.5 m-30 -112.78 26.4 10.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.732 -1.23 . . . . 0.0 110.464 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.844 ' HB2' ' HB1' ' A' ' 99' ' ' ALA . 1.1 tt0 -121.63 141.95 50.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.011 -1.056 . . . . 0.0 110.464 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.03 152.26 36.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.418 -0.801 . . . . 0.0 110.333 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.772 ' C ' HD13 ' A' ' 105' ' ' LEU . 12.4 p -94.45 133.06 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.259 -0.9 . . . . 0.0 110.075 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.772 HD13 ' C ' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -102.76 -21.98 13.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.308 -0.87 . . . . 0.0 110.209 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -174.44 136.31 0.46 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.937 . . . . 0.0 110.396 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.4 pp -99.1 153.25 19.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.89 . . . . 0.0 109.965 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.01 HG13 ' HB3' ' A' ' 65' ' ' ALA . 2.5 p -130.93 147.25 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.083 -1.01 . . . . 0.0 110.605 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -107.19 126.29 52.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.857 . . . . 0.0 110.004 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.927 . . . . 0.0 110.526 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.68 -5.5 28.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -1.157 . . . . 0.0 110.196 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 52.91 178.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.232 -0.918 . . . . 0.0 110.376 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.511 ' HB3' HG13 ' A' ' 44' ' ' ILE . 4.9 ptp -49.79 140.06 12.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.853 . . . . 0.0 110.059 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 41' ' ' GLY . 4.8 mt-30 -112.6 -155.72 0.57 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -0.909 . . . . 0.0 110.239 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.492 ' C ' ' HA3' ' A' ' 41' ' ' GLY . 36.0 m -125.02 158.97 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.307 -0.871 . . . . 0.0 109.519 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.46 ' C ' ' O ' ' A' ' 6' ' ' VAL . 40.5 t -38.78 106.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.267 -0.896 . . . . 0.0 110.54 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.618 HD23 ' OG1' ' A' ' 11' ' ' THR . 3.2 mp -61.09 169.11 2.26 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.549 -0.719 . . . . 0.0 110.694 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 10' ' ' ASN . 48.4 Cg_endo -79.52 63.37 8.72 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.136 1.598 . . . . 0.0 109.85 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.732 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER 64.86 41.95 4.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.504 -0.748 . . . . 0.0 110.824 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.618 ' OG1' HD23 ' A' ' 8' ' ' LEU . 14.9 p -118.98 171.34 8.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.121 -0.987 . . . . 0.0 109.759 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.662 ' CB ' HD22 ' A' ' 97' ' ' LEU . . . -145.0 161.9 38.24 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.887 -1.133 . . . . 0.0 110.814 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.012 HD11 HD11 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -133.53 156.15 48.31 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.33 -0.856 . . . . 0.0 110.441 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.584 ' CD2' HD13 ' A' ' 36' ' ' LEU . 44.7 m80 -91.93 124.04 35.74 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.131 -0.98 . . . . 0.0 110.631 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.012 HD11 HD11 ' A' ' 13' ' ' LEU . 2.4 mm? -111.42 151.31 28.68 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.341 -0.85 . . . . 0.0 110.303 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.641 ' HB2' HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -113.53 117.49 31.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.078 -1.014 . . . . 0.0 109.743 178.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.039 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -79.43 112.02 16.27 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.208 -0.933 . . . . 0.0 110.338 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.728 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -104.95 101.7 11.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.842 -0.536 . . . . 0.0 109.594 179.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.414 HD13 ' HG3' ' A' ' 48' ' ' GLU . 7.7 tp -161.91 147.0 13.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.09 -1.006 . . . . 0.0 110.584 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -89.46 101.76 14.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.365 -0.835 . . . . 0.0 109.613 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.92 ' HB2' HG22 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -112.9 100.13 8.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 110.216 -179.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.575 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 0.7 OUTLIER -101.8 114.59 28.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.721 -0.612 . . . . 0.0 109.983 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER -122.26 136.08 54.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 110.459 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 2.8 ttmm -81.05 -9.44 59.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.887 . . . . 0.0 109.961 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -62.28 -27.45 69.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 110.365 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.83 -2.14 6.38 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -130.49 122.99 28.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.161 -1.199 . . . . 0.0 110.019 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.575 ' HB2' ' HA ' ' A' ' 22' ' ' GLU . 12.6 ptpt -151.35 144.32 24.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -0.884 . . . . 0.0 110.43 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.92 HG22 ' HB2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -113.22 155.85 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.137 -0.977 . . . . 0.0 110.157 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 30' ' ' VAL . 24.0 m -134.8 82.37 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.156 -0.965 . . . . 0.0 110.074 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.728 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 40.79 75.27 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.528 -0.732 . . . . 0.0 110.305 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.16 26.93 0.06 OUTLIER Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.692 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 1.039 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 35.1 m-20 -98.71 149.58 22.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.635 -1.509 . . . . 0.0 110.006 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.822 ' OE2' HG11 ' A' ' 52' ' ' VAL . 3.3 tt0 -151.76 147.03 26.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.02 -1.05 . . . . 0.0 110.436 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.563 ' HA ' ' CG2' ' A' ' 100' ' ' VAL . 7.3 p90 -160.94 171.64 18.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.122 -0.986 . . . . 0.0 111.299 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.614 HD22 ' O ' ' A' ' 98' ' ' PRO . 15.3 tp -92.0 155.82 17.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.571 -0.706 . . . . 0.0 110.021 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.666 ' HB2' HD23 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -134.53 110.56 9.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.126 -0.984 . . . . 0.0 110.219 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.628 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 11.5 tm-20 -84.41 131.85 34.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.863 . . . . 0.0 110.445 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.615 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 66.57 43.56 91.9 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.641 ' HG3' HD23 ' A' ' 13' ' ' LEU . 55.6 Cg_endo -77.27 23.54 0.53 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.553 1.291 . . . . 0.0 111.218 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.492 ' HA3' ' C ' ' A' ' 6' ' ' VAL . . . -49.99 -44.62 41.52 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.422 ' O ' HD12 ' A' ' 44' ' ' ILE . 35.7 p -91.28 29.64 1.4 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -1.183 . . . . 0.0 110.677 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.506 ' HB3' ' O ' ' A' ' 40' ' ' PRO . 15.3 t80 -88.34 132.57 34.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.131 -0.981 . . . . 0.0 110.108 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.727 HG23 ' HD2' ' A' ' 45' ' ' PRO . 4.0 mp -123.31 146.86 50.62 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.34 -0.85 . . . . 0.0 109.534 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.727 ' HD2' HG23 ' A' ' 44' ' ' ILE . 44.3 Cg_endo -71.23 103.81 1.45 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.838 1.441 . . . . 0.0 110.669 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 49' ' ' VAL . 5.9 mtm180 -113.56 140.85 47.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.411 -0.806 . . . . 0.0 110.089 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 46' ' ' ARG . 1.1 tttm -41.71 -34.79 0.67 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.147 -0.97 . . . . 0.0 110.538 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.448 ' HB3' HG13 ' A' ' 49' ' ' VAL . 1.7 tt0 -53.01 -39.27 63.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.955 . . . . 0.0 110.522 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.4 m -144.98 173.3 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.262 -0.899 . . . . 0.0 109.62 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -142.14 139.83 32.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.849 -1.157 . . . . 0.0 110.671 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.846 HG23 ' CD1' ' A' ' 13' ' ' LEU . 6.5 p -55.52 127.69 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.253 -0.904 . . . . 0.0 110.027 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.822 HG11 ' OE2' ' A' ' 34' ' ' GLU . 2.9 t -106.58 -58.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 110.179 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.767 ' O ' HD13 ' A' ' 54' ' ' ILE . 13.1 mm-40 -140.43 170.57 15.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.404 -0.81 . . . . 0.0 110.199 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.767 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -132.76 150.49 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.305 -0.872 . . . . 0.0 109.312 179.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.517 HG21 ' HD2' ' A' ' 98' ' ' PRO . 0.5 OUTLIER -141.15 132.67 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.973 -1.08 . . . . 0.0 110.456 -179.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.48 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 15.2 mm-40 -89.92 178.62 6.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.402 -0.811 . . . . 0.0 110.449 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -102.54 133.53 47.37 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.194 -0.942 . . . . 0.0 110.811 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 1.3 t 173.61 63.16 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.297 -0.877 . . . . 0.0 111.015 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.912 HG22 ' O ' ' A' ' 95' ' ' ALA . 0.8 OUTLIER -171.18 -31.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.726 -1.234 . . . . 0.0 111.781 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.655 HG22 ' H ' ' A' ' 61' ' ' ARG . 10.1 mt -85.31 179.43 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.619 -1.301 . . . . 0.0 110.432 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.655 ' H ' HG22 ' A' ' 60' ' ' ILE . 1.2 mmt180 -112.17 -153.23 0.52 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.223 -0.923 . . . . 0.0 110.587 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 1.029 ' HA ' HG13 ' A' ' 93' ' ' VAL . 12.9 tt0 -90.86 -12.75 35.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.669 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 4.0 p30 -137.7 -24.89 1.02 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 0.0 111.071 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.454 ' OE1' ' O ' ' A' ' 65' ' ' ALA . 6.1 tp-100 -54.41 133.58 45.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.841 -1.162 . . . . 0.0 110.51 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.015 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -120.95 157.23 30.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.384 -0.822 . . . . 0.0 109.355 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 65' ' ' ALA . 2.8 mt -125.77 113.05 16.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.107 -0.995 . . . . 0.0 110.78 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.469 ' C ' HD23 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -91.68 121.59 33.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.26 -0.9 . . . . 0.0 109.269 178.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.869 ' CD2' HG23 ' A' ' 104' ' ' VAL . 6.0 mt -118.46 151.68 37.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.089 -1.007 . . . . 0.0 110.841 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 2.0 ttm-85 -121.82 155.28 35.69 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.416 -0.802 . . . . 0.0 109.778 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -65.44 152.64 43.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.173 -0.955 . . . . 0.0 110.855 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.516 ' CB ' ' O ' ' A' ' 101' ' ' PHE . 8.2 tpt180 -114.71 -27.37 7.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.375 -0.828 . . . . 0.0 109.837 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.661 ' O ' HG23 ' A' ' 84' ' ' THR . 29.8 mmmt -108.32 -94.66 0.4 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 0.0 109.684 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.54 ' CB ' ' O ' ' A' ' 72' ' ' LYS . 0.5 OUTLIER 164.39 29.72 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.464 -0.773 . . . . 0.0 110.465 179.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.2 m -138.64 -6.96 1.48 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.997 -1.064 . . . . 0.0 110.874 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.572 ' CB ' ' HB2' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -76.91 110.17 11.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.066 -1.021 . . . . 0.0 110.299 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.512 ' HB2' ' N ' ' A' ' 80' ' ' LYS . 3.1 p30 -93.16 132.13 37.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.271 -0.893 . . . . 0.0 110.055 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.569 ' HD2' ' CG ' ' A' ' 86' ' ' GLU . 1.7 mtp180 -80.1 -59.04 2.87 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.063 -1.023 . . . . 0.0 110.409 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -98.5 16.78 20.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.267 -0.896 . . . . 0.0 110.516 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.15 16.03 24.28 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.512 ' N ' ' HB2' ' A' ' 76' ' ' ASP . 40.9 mmtt -115.71 91.66 3.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -1.164 . . . . 0.0 110.248 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.438 ' HG3' ' CG1' ' A' ' 29' ' ' VAL . 1.7 tm-20 -43.56 101.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.233 -0.917 . . . . 0.0 110.281 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.548 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -100.67 179.24 4.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -0.87 . . . . 0.0 110.223 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.739 HG23 ' H ' ' A' ' 85' ' ' GLY . 11.0 m -98.72 -178.59 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.227 -0.921 . . . . 0.0 110.589 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 72' ' ' LYS . 0.1 OUTLIER -58.18 -26.0 62.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.488 -0.757 . . . . 0.0 110.627 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.739 ' H ' HG23 ' A' ' 83' ' ' VAL . . . -69.03 -19.0 73.37 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.569 ' CG ' ' HD2' ' A' ' 77' ' ' ARG . 10.0 tp10 -73.7 143.46 46.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.183 -1.187 . . . . 0.0 110.312 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.461 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 3.9 pt-20 -149.31 155.44 40.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.296 -0.878 . . . . 0.0 110.2 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.87 ' CZ2' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -136.88 154.77 50.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.088 -1.008 . . . . 0.0 110.129 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.024 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -114.87 134.68 54.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.278 -0.889 . . . . 0.0 110.573 -179.482 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 1.024 ' N ' HD22 ' A' ' 89' ' ' LEU . 3.6 m -99.8 130.14 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.254 -0.904 . . . . 0.0 110.16 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.565 HG23 HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -120.78 53.9 1.1 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.332 -0.855 . . . . 0.0 110.051 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.498 HG22 ' OD1' ' A' ' 10' ' ' ASN . 0.2 OUTLIER -85.36 160.23 19.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 110.456 -179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.029 HG13 ' HA ' ' A' ' 62' ' ' GLN . 90.7 t -109.64 83.89 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.346 -0.846 . . . . 0.0 109.781 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 60' ' ' ILE . . . 87.4 79.53 1.24 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.912 ' O ' HG22 ' A' ' 59' ' ' ILE . . . -162.46 -143.32 0.08 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.28 -1.13 . . . . 0.0 110.599 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.533 ' O ' HD23 ' A' ' 97' ' ' LEU . 9.3 t80 177.17 104.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.662 HD22 ' CB ' ' A' ' 12' ' ' ALA . 15.6 mt -116.78 88.72 26.37 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.046 -1.034 . . . . 0.0 111.052 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.614 ' O ' HD22 ' A' ' 36' ' ' LEU . 49.9 Cg_endo -78.24 108.38 2.48 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.892 1.47 . . . . 0.0 109.825 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.49 ' HA ' ' HB2' ' A' ' 36' ' ' LEU . . . -65.2 -171.56 0.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.164 -0.96 . . . . 0.0 110.692 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.563 ' CG2' ' HA ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -110.49 -55.95 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.389 -0.819 . . . . 0.0 109.581 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.572 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 11.8 m-85 -101.5 -14.64 17.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.948 -1.095 . . . . 0.0 109.656 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.573 ' OE1' ' CD1' ' A' ' 88' ' ' TRP . 23.4 tt0 -93.83 123.94 37.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.363 -0.836 . . . . 0.0 110.906 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.33 164.12 11.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.308 -0.87 . . . . 0.0 109.77 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.869 HG23 ' CD2' ' A' ' 68' ' ' LEU . 8.4 p -86.65 146.76 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.123 -0.985 . . . . 0.0 110.539 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 104' ' ' VAL . 9.4 mp -104.0 -33.29 8.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.366 -0.834 . . . . 0.0 110.142 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.923 ' C ' HD22 ' A' ' 107' ' ' LEU . 0.3 OUTLIER -173.3 -166.55 0.34 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.254 -0.904 . . . . 0.0 110.401 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.923 HD22 ' C ' ' A' ' 106' ' ' ASP . 3.3 mm? -121.54 153.44 37.98 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.25 -0.907 . . . . 0.0 110.032 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.015 HG13 ' HB3' ' A' ' 65' ' ' ALA . 2.8 p -139.05 107.79 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.08 -1.012 . . . . 0.0 110.987 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -70.17 118.28 12.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.882 . . . . 0.0 110.222 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . -75.8 166.4 23.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.219 -0.925 . . . . 0.0 110.42 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 113' ' ' LEU . 11.7 p -86.86 131.21 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 0.0 110.292 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.2 mp -97.34 -28.97 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.214 -0.929 . . . . 0.0 110.216 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.522 ' O ' HG22 ' A' ' 111' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.137 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.37 172.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.184 -1.186 . . . . 0.0 110.102 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -96.79 12.09 33.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.145 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.529 ' HB3' HG13 ' A' ' 44' ' ' ILE . 0.6 OUTLIER -125.9 -164.91 1.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.95 . . . . 0.0 110.701 -179.555 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.467 ' O ' ' O ' ' A' ' 41' ' ' GLY . 0.8 OUTLIER -147.57 -163.97 1.89 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.341 -0.85 . . . . 0.0 109.86 179.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.502 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 9.0 m -114.14 176.9 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.09 -1.006 . . . . 0.0 110.21 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.506 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 78.0 t -54.81 143.35 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.426 -0.796 . . . . 0.0 110.769 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.58 HD13 ' N ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -96.5 167.2 12.67 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.433 -0.792 . . . . 0.0 110.052 179.644 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.496 ' O ' ' HB2' ' A' ' 10' ' ' ASN . 46.3 Cg_endo -73.94 69.59 4.6 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.989 1.521 . . . . 0.0 109.52 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 1.043 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 14.6 m-80 60.71 64.48 1.16 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.455 -0.778 . . . . 0.0 110.74 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.55 ' HB ' ' HA ' ' A' ' 56' ' ' GLN . 30.7 p -140.55 172.11 13.17 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.216 -0.927 . . . . 0.0 110.184 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.565 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -144.42 169.33 18.13 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.941 . . . . 0.0 110.017 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.948 HD23 ' CB ' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -134.21 147.62 50.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.084 -1.01 . . . . 0.0 110.148 179.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 1.002 ' CD2' HD13 ' A' ' 36' ' ' LEU . 15.0 m-70 -90.26 126.66 35.91 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.039 -1.038 . . . . 0.0 110.395 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.952 HD21 ' HB2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -136.75 155.72 49.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.11 -0.994 . . . . 0.0 110.351 179.37 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.476 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -104.82 122.86 46.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.455 -0.778 . . . . 0.0 110.064 -179.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.066 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -82.89 117.82 23.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.934 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.876 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 1.4 mm? -106.72 101.06 10.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.742 -0.599 . . . . 0.0 110.635 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.817 ' C ' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -166.96 165.14 16.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.247 -0.908 . . . . 0.0 110.093 179.409 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.505 ' N ' HD22 ' A' ' 19' ' ' LEU . 80.7 m-20 -96.25 110.73 22.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 0.0 110.612 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.914 ' CB ' HG22 ' A' ' 29' ' ' VAL . 1.1 t80 -121.21 123.88 43.33 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.317 -0.864 . . . . 0.0 110.087 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.462 ' OE2' ' HD2' ' A' ' 28' ' ' LYS . 26.2 tt0 -130.9 114.83 15.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.932 . . . . 0.0 110.209 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -102.69 135.88 43.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.343 -0.848 . . . . 0.0 110.035 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.82 -23.94 66.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -0.926 . . . . 0.0 110.392 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -66.07 -9.85 34.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 110.162 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.7 -45.57 1.17 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.462 ' O ' ' CB ' ' A' ' 28' ' ' LYS . 31.9 t70 -50.61 159.9 0.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -1.138 . . . . 0.0 110.277 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 1.0 OUTLIER 172.59 120.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 109.972 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.914 HG22 ' CB ' ' A' ' 21' ' ' PHE . 2.0 m -110.2 148.74 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.25 -0.906 . . . . 0.0 110.041 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 30' ' ' VAL . 18.6 m -129.77 84.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.083 -1.011 . . . . 0.0 110.312 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.876 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 45.4 69.27 0.46 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.34 -0.85 . . . . 0.0 110.117 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -174.91 27.01 0.08 OUTLIER Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.41 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 1.066 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 1.5 m-20 -89.47 144.97 25.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.877 -1.366 . . . . 0.0 109.966 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.071 ' HG2' HG11 ' A' ' 100' ' ' VAL . 5.7 tt0 -142.57 131.09 22.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -0.99 . . . . 0.0 110.086 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.617 ' CH2' HD12 ' A' ' 15' ' ' LEU . 1.8 p90 -161.37 174.15 13.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.986 -1.071 . . . . 0.0 110.776 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 1.002 HD13 ' CD2' ' A' ' 14' ' ' HIS . 55.9 tp -94.05 162.09 14.02 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.519 -0.738 . . . . 0.0 110.045 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.952 ' HB2' HD21 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -131.84 110.36 10.77 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.986 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.639 ' HG2' HD11 ' A' ' 97' ' ' LEU . 0.6 OUTLIER -82.48 142.85 31.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.409 -0.807 . . . . 0.0 110.397 -179.715 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.596 ' N ' ' HD3' ' A' ' 40' ' ' PRO . . . 55.66 44.42 86.3 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.948 ' CB ' HD23 ' A' ' 13' ' ' LEU . 54.6 Cg_endo -77.82 15.16 1.33 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.663 1.349 . . . . 0.0 111.086 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 7' ' ' VAL . . . -53.27 -29.72 38.12 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.429 ' O ' ' CD1' ' A' ' 44' ' ' ILE . 48.9 p -103.45 17.19 24.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -1.17 . . . . 0.0 110.518 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.588 ' C ' HD12 ' A' ' 44' ' ' ILE . 12.1 t80 -87.44 125.89 34.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.875 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.803 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.2 mp -107.47 141.8 23.77 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 109.786 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.531 ' HD2' HG23 ' A' ' 44' ' ' ILE . 43.9 Cg_endo -70.57 97.3 0.7 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.957 1.504 . . . . 0.0 110.802 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.88 159.54 22.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.212 -0.93 . . . . 0.0 110.403 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.529 ' HG3' ' N ' ' A' ' 48' ' ' GLU . 16.0 pttm -48.93 -32.25 8.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.326 -0.859 . . . . 0.0 110.782 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.529 ' N ' ' HG3' ' A' ' 47' ' ' LYS . 2.6 tp10 -43.27 -40.52 3.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.085 -1.009 . . . . 0.0 110.206 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -150.13 167.92 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -0.902 . . . . 0.0 110.159 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -122.44 124.47 43.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 0.0 109.949 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.518 HG13 HD13 ' A' ' 13' ' ' LEU . 21.7 t -54.58 133.03 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 109.653 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.934 HG23 ' HA ' ' A' ' 15' ' ' LEU . 4.7 t -111.36 -48.89 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.035 -1.041 . . . . 0.0 110.579 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.908 ' C ' HD13 ' A' ' 54' ' ' ILE . 0.5 OUTLIER -149.6 168.57 23.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.146 -0.971 . . . . 0.0 109.936 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.908 HD13 ' C ' ' A' ' 53' ' ' GLU . 1.2 mm -129.94 131.15 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.378 -0.826 . . . . 0.0 108.974 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.665 HD13 ' N ' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -120.84 136.45 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.028 -1.045 . . . . 0.0 111.334 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.665 ' N ' HD13 ' A' ' 55' ' ' ILE . 56.8 mm-40 -97.69 176.55 5.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.601 -0.687 . . . . 0.0 109.929 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.043 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -90.84 140.23 30.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.202 -0.936 . . . . 0.0 109.825 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 3.4 t -179.49 38.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.017 -1.052 . . . . 0.0 111.536 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.731 HG21 ' CG ' ' A' ' 96' ' ' TYR . 0.6 OUTLIER -159.9 -74.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.536 -1.353 . . . . 0.0 111.827 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.718 ' H ' HG23 ' A' ' 59' ' ' ILE . 77.0 mt -63.31 159.72 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.56 -1.338 . . . . 0.0 110.393 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.36 -166.37 1.08 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.296 -0.878 . . . . 0.0 110.575 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.929 ' HB2' HG13 ' A' ' 93' ' ' VAL . 1.7 tt0 -75.61 -70.82 0.41 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.444 -0.785 . . . . 0.0 110.568 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.843 ' HB3' ' HB2' ' A' ' 110' ' ' ALA . 8.5 m120 -60.55 -33.82 73.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.362 -0.836 . . . . 0.0 110.42 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -59.46 141.18 55.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.188 -0.945 . . . . 0.0 110.84 -179.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.962 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -123.03 140.53 52.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.827 . . . . 0.0 109.773 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.716 HD12 HD21 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -126.19 108.33 11.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.104 -0.997 . . . . 0.0 110.534 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 1.022 ' O ' HD23 ' A' ' 68' ' ' LEU . 4.8 ttm105 -91.2 135.9 33.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.129 -0.982 . . . . 0.0 109.585 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.022 HD23 ' O ' ' A' ' 67' ' ' ARG . 5.4 mt -133.99 150.18 51.24 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.209 -0.932 . . . . 0.0 110.935 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 13.9 ttm180 -107.02 163.81 12.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.461 -0.775 . . . . 0.0 109.641 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -80.57 118.5 22.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.177 -0.952 . . . . 0.0 110.478 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.53 -30.37 52.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.144 -0.972 . . . . 0.0 109.133 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -133.75 157.54 45.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.601 -0.687 . . . . 0.0 109.204 179.45 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.518 ' O ' ' HB3' ' A' ' 74' ' ' CYS . 1.0 OUTLIER -84.65 -179.2 7.07 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.023 -1.048 . . . . 0.0 110.802 -179.367 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER 75.05 -16.01 0.61 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.647 -0.658 . . . . 0.0 111.32 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.612 ' CZ2' ' CG ' ' A' ' 77' ' ' ARG . 5.0 t90 -74.37 104.64 5.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.631 -1.293 . . . . 0.0 110.232 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.513 ' O ' ' CD1' ' A' ' 35' ' ' TRP . 7.4 p-10 -84.8 124.48 31.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.085 -1.009 . . . . 0.0 109.68 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.612 ' CG ' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -80.99 -59.9 2.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.205 -0.935 . . . . 0.0 110.507 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -103.92 11.1 35.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 110.232 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.83 10.95 9.6 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -116.17 111.84 20.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -1.162 . . . . 0.0 110.401 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.496 ' OE2' ' CG ' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -71.47 102.77 2.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.194 -0.941 . . . . 0.0 109.711 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -109.35 178.79 4.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.153 -0.967 . . . . 0.0 110.307 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.633 HG13 ' H ' ' A' ' 85' ' ' GLY . 8.8 p -77.37 174.37 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 0.0 110.29 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.715 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 14.6 t -69.57 -16.39 63.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.203 -0.935 . . . . 0.0 109.984 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.633 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -72.18 -23.01 78.62 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' A' ' 87' ' ' GLU . 6.5 tp10 -63.09 160.05 16.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -1.134 . . . . 0.0 110.212 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.457 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 10.5 pt-20 -149.9 156.54 41.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 110.169 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.568 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -136.21 148.6 48.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.196 -0.94 . . . . 0.0 109.693 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.963 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -102.06 128.31 48.57 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.315 -0.866 . . . . 0.0 110.45 -179.428 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.963 ' N ' HD22 ' A' ' 89' ' ' LEU . 2.7 t -89.15 124.48 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.589 -0.694 . . . . 0.0 110.073 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.477 ' OG1' ' CD1' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -129.74 33.29 4.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -0.904 . . . . 0.0 109.857 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.63 152.6 37.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.856 . . . . 0.0 109.905 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.929 HG13 ' HB2' ' A' ' 62' ' ' GLN . 44.7 t -93.41 109.6 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.181 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.899 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 69.78 76.92 0.47 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -176.42 -175.23 0.65 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -1.124 . . . . 0.0 110.738 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.731 ' CG ' HG21 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -117.13 -61.86 1.65 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.403 -0.81 . . . . 0.0 110.608 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.639 HD11 ' HG2' ' A' ' 38' ' ' GLU . 2.9 mm? 58.45 51.87 4.34 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.063 -1.023 . . . . 0.0 109.733 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 97' ' ' LEU . 50.2 Cg_endo -75.47 -2.31 12.41 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.111 1.585 . . . . 0.0 111.329 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.559 ' HA ' ' CB ' ' A' ' 36' ' ' LEU . . . 51.87 -178.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.059 -1.026 . . . . 0.0 110.093 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 1.071 HG11 ' HG2' ' A' ' 34' ' ' GLU . 2.4 t -97.21 -63.93 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.664 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.556 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 7.5 m-30 -94.09 67.66 3.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.966 -1.083 . . . . 0.0 109.385 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -139.85 144.75 37.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 111.282 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -132.38 121.35 23.33 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.793 ' HB ' HD22 ' A' ' 68' ' ' LEU . 9.0 p -76.89 144.52 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.15 -0.969 . . . . 0.0 111.091 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.761 ' N ' HD22 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -99.17 -26.23 14.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.664 -0.648 . . . . 0.0 109.409 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -177.95 -178.8 0.71 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 110.039 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.35 149.25 44.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.201 -0.937 . . . . 0.0 110.287 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.962 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 11.0 p -131.81 156.3 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.243 -0.911 . . . . 0.0 110.255 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.511 ' O ' ' C ' ' A' ' 110' ' ' ALA . 7.6 p30 -111.18 113.49 26.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.072 -1.017 . . . . 0.0 110.461 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.843 ' HB2' ' HB3' ' A' ' 63' ' ' ASN . . . 26.06 45.29 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 120.956 0.408 . . . . 0.0 111.942 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.64 ' O ' HG21 ' A' ' 108' ' ' VAL . 51.5 t -157.08 154.22 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.949 -1.094 . . . . 0.0 110.528 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.4 mm -129.41 114.19 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.407 -0.808 . . . . 0.0 110.036 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.476 HD13 ' HA ' ' A' ' 113' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.245 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 3' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 0.1 OUTLIER 65.23 -69.95 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -1.097 . . . . 0.0 110.311 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.469 ' N ' ' O ' ' A' ' 1' ' ' GLY . 0.1 OUTLIER -76.67 -172.01 2.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.234 -0.916 . . . . 0.0 110.179 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.702 ' HG3' HD11 ' A' ' 44' ' ' ILE . 20.3 ttm -68.27 161.6 26.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.27 -0.894 . . . . 0.0 109.901 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.531 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 0.4 OUTLIER -112.21 135.01 53.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.133 -0.979 . . . . 0.0 110.735 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.537 HG23 ' N ' ' A' ' 7' ' ' VAL . 33.1 m -74.8 -133.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.214 -0.929 . . . . 0.0 109.257 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.537 ' N ' HG23 ' A' ' 6' ' ' VAL . 21.0 t -105.78 151.76 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.986 -1.071 . . . . 0.0 109.607 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.883 HD23 ' OG1' ' A' ' 11' ' ' THR . 5.4 mp -103.64 157.69 33.37 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 110.256 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -74.18 -49.28 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.061 1.558 . . . . 0.0 110.495 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 1.082 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 5.4 p30 -163.46 27.29 0.09 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.302 -0.873 . . . . 0.0 110.471 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.883 ' OG1' HD23 ' A' ' 8' ' ' LEU . 19.0 p -104.81 151.7 23.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.965 -1.084 . . . . 0.0 111.125 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.779 ' HB3' HD22 ' A' ' 97' ' ' LEU . . . -132.18 165.45 24.06 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.929 ' CD2' HD12 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -133.88 153.17 51.94 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.788 -1.195 . . . . 0.0 110.485 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.882 ' CD2' HD11 ' A' ' 36' ' ' LEU . 4.6 m170 -92.15 136.29 33.3 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.504 -0.748 . . . . 0.0 109.105 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.953 HD13 ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -139.39 153.37 47.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.013 -1.054 . . . . 0.0 110.6 179.763 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 0.3 OUTLIER -113.52 117.53 31.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.267 -0.896 . . . . 0.0 109.91 -179.615 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.095 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -77.59 119.37 21.05 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.24 -0.913 . . . . 0.0 110.195 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.594 HD13 ' HB1' ' A' ' 31' ' ' ALA . 2.4 mm? -103.04 101.01 10.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.772 -0.58 . . . . 0.0 109.517 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.027 HD13 ' N ' ' A' ' 20' ' ' ASP . 2.1 tm? -164.98 144.21 6.79 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.011 -1.055 . . . . 0.0 110.262 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 1.027 ' N ' HD13 ' A' ' 19' ' ' LEU . 2.7 m-20 -85.05 118.72 24.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.667 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.679 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -140.59 144.65 35.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.168 -0.957 . . . . 0.0 110.766 -179.431 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.526 ' CB ' ' HE2' ' A' ' 28' ' ' LYS . 12.6 pt-20 -108.78 131.35 55.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 109.782 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -82.58 167.46 18.31 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.216 -0.928 . . . . 0.0 110.429 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.01 -17.9 24.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.342 -0.849 . . . . 0.0 110.25 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -79.46 -17.11 54.9 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.202 -0.936 . . . . 0.0 110.233 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 129.52 -30.15 3.67 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -64.27 -156.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.186 -1.185 . . . . 0.0 110.088 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.526 ' HE2' ' CB ' ' A' ' 22' ' ' GLU . 1.8 ttmm 174.92 131.14 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.142 -0.974 . . . . 0.0 110.153 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.679 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -92.56 141.72 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.082 -1.011 . . . . 0.0 109.209 179.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.654 ' O ' HG23 ' A' ' 30' ' ' VAL . 31.4 m -141.04 89.16 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.074 -1.016 . . . . 0.0 110.451 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.594 ' HB1' HD13 ' A' ' 18' ' ' LEU . . . 44.24 63.66 1.57 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.384 -0.822 . . . . 0.0 110.163 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.93 21.62 0.1 OUTLIER Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.624 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 1.095 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 5.3 m-20 -87.1 149.49 24.65 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.676 -1.485 . . . . 0.0 109.557 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.598 ' OE2' HG11 ' A' ' 52' ' ' VAL . 31.6 tt0 -152.68 145.72 24.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.019 -1.051 . . . . 0.0 110.525 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.703 ' CZ3' ' HB2' ' A' ' 17' ' ' ALA . 6.7 p90 -167.99 168.93 11.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.211 -0.93 . . . . 0.0 110.616 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.882 HD11 ' CD2' ' A' ' 14' ' ' HIS . 0.5 OUTLIER -91.87 156.28 17.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.205 -0.934 . . . . 0.0 110.959 -178.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -132.2 111.04 11.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.486 -0.759 . . . . 0.0 109.894 179.604 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.584 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 4.7 tm-20 -79.17 140.19 37.81 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.568 -0.708 . . . . 0.0 109.64 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.612 ' N ' ' HD3' ' A' ' 40' ' ' PRO . . . 54.33 44.56 76.12 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 39' ' ' GLY . 54.5 Cg_endo -76.15 13.15 1.35 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.69 1.363 . . . . 0.0 111.262 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.599 ' HA3' HD13 ' A' ' 8' ' ' LEU . . . -49.95 -41.35 36.8 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.8 p -83.16 18.54 1.68 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.173 -1.192 . . . . 0.0 111.231 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.566 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 3.1 t80 -98.72 130.64 45.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.933 -1.105 . . . . 0.0 110.166 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.702 HD11 ' HG3' ' A' ' 4' ' ' MET . 35.1 mm -114.49 146.01 35.01 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.45 -0.781 . . . . 0.0 109.045 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 44' ' ' ILE . 40.3 Cg_endo -66.22 74.58 0.36 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.733 1.386 . . . . 0.0 110.883 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -73.99 139.08 44.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.376 -0.827 . . . . 0.0 109.819 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.493 ' HG3' ' N ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -45.98 -24.2 0.39 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.917 . . . . 0.0 110.387 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.493 ' N ' ' HG3' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -56.64 -36.16 69.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.159 -0.963 . . . . 0.0 110.211 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.2 m -141.35 170.36 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.36 -0.838 . . . . 0.0 110.027 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -127.98 132.69 49.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.992 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.1 m -56.37 127.64 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.875 . . . . 0.0 110.321 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.827 HG23 ' HA ' ' A' ' 15' ' ' LEU . 21.8 t -96.54 -60.78 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.363 -0.836 . . . . 0.0 109.975 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.855 ' O ' HD13 ' A' ' 54' ' ' ILE . 12.1 mm-40 -143.97 175.88 9.69 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.202 -0.936 . . . . 0.0 110.408 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.855 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -136.74 134.52 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.296 -0.878 . . . . 0.0 108.971 179.349 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.649 HD13 ' N ' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -128.61 130.98 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.008 -1.058 . . . . 0.0 111.003 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.649 ' N ' HD13 ' A' ' 55' ' ' ILE . 6.1 mm100 -94.91 134.28 37.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.499 -0.751 . . . . 0.0 109.412 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.082 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -49.27 137.26 14.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.081 -1.012 . . . . 0.0 110.804 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 8.7 t -179.51 45.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.309 -0.869 . . . . 0.0 111.587 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.648 HG21 ' CD1' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -162.48 -53.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.454 -1.404 . . . . 0.0 111.803 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.568 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 21.8 mt -57.37 165.16 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.552 -1.343 . . . . 0.0 109.947 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.451 ' N ' ' CG2' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -93.34 -161.97 0.89 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.339 -0.851 . . . . 0.0 111.057 -179.431 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.877 ' HA ' HG13 ' A' ' 93' ' ' VAL . 0.7 OUTLIER -58.85 -70.25 0.16 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.461 -0.774 . . . . 0.0 110.72 -179.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 15.2 p30 -113.95 26.33 10.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.137 -0.977 . . . . 0.0 110.181 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.442 ' OE1' ' O ' ' A' ' 65' ' ' ALA . 1.8 tp-100 -59.84 138.99 57.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 110.4 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.977 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -113.91 130.32 56.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.383 -0.823 . . . . 0.0 109.706 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.618 HD21 HD12 ' A' ' 107' ' ' LEU . 42.1 mt -125.04 121.33 34.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 110.275 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.599 ' O ' HD12 ' A' ' 105' ' ' LEU . 21.1 ttm-85 -96.83 128.25 43.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.347 -0.845 . . . . 0.0 110.177 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.593 HD23 ' HA ' ' A' ' 104' ' ' VAL . 31.6 mt -118.16 147.2 43.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 109.992 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 11.7 ttt180 -117.39 146.9 43.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 110.243 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.505 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -67.88 136.49 54.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.345 -0.847 . . . . 0.0 110.807 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -116.12 -8.63 11.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.345 -0.847 . . . . 0.0 109.656 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -141.21 108.68 5.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.338 -0.851 . . . . 0.0 109.727 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.716 ' HG3' HG12 ' A' ' 83' ' ' VAL . 28.2 tt0 -56.59 103.49 0.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.066 -1.021 . . . . 0.0 110.045 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 2.1 t 179.27 -33.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.46 -0.775 . . . . 0.0 109.938 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.524 ' CD1' ' C ' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -75.47 137.2 40.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.418 -0.801 . . . . 0.0 110.11 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 13.6 p-10 -102.18 110.2 22.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.864 . . . . 0.0 110.259 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.521 ' NE ' ' O ' ' A' ' 77' ' ' ARG . 5.4 tpm_? -88.5 -19.93 25.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.177 -0.952 . . . . 0.0 109.309 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.55 -12.67 23.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.465 -0.772 . . . . 0.0 109.638 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 115.16 -5.82 21.72 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.434 ' O ' ' CB ' ' A' ' 81' ' ' GLU . 12.4 mmmt -114.89 -70.35 0.8 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.189 -1.183 . . . . 0.0 110.221 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER 171.36 119.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.364 -0.835 . . . . 0.0 109.789 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.49 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 17.1 mmm180 -111.38 178.5 4.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 110.394 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.716 HG12 ' HG3' ' A' ' 73' ' ' GLU . 29.8 m -110.91 179.24 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 110.345 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.446 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 3.3 t -56.2 -27.0 53.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 110.093 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.458 ' O ' ' OE2' ' A' ' 87' ' ' GLU . . . -65.23 -23.77 70.1 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.49 ' CB ' ' HB3' ' A' ' 82' ' ' ARG . 22.1 tp10 -74.63 158.72 33.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.368 -1.078 . . . . 0.0 110.226 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.477 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -157.4 164.83 37.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.338 -0.851 . . . . 0.0 109.962 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.523 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -140.93 149.34 41.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.215 -0.928 . . . . 0.0 110.24 -179.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.791 HD13 ' C ' ' A' ' 89' ' ' LEU . 1.3 tm? -112.79 124.36 52.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.345 -0.847 . . . . 0.0 109.633 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.597 ' N ' HD22 ' A' ' 89' ' ' LEU . 8.0 p -105.44 132.36 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.173 -0.954 . . . . 0.0 110.847 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.48 ' OG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -135.88 56.1 1.84 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.301 -0.875 . . . . 0.0 110.006 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 54.5 m -97.51 119.52 36.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.954 . . . . 0.0 110.332 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.877 HG13 ' HA ' ' A' ' 62' ' ' GLN . 18.2 t -50.76 134.2 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.195 -0.941 . . . . 0.0 109.947 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.749 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 48.35 94.97 0.01 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.581 ' O ' HG22 ' A' ' 59' ' ' ILE . . . 178.67 154.79 0.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.088 -1.242 . . . . 0.0 110.949 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.648 ' CD1' HG21 ' A' ' 59' ' ' ILE . 2.5 t80 -134.67 87.18 2.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.488 -0.757 . . . . 0.0 110.15 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.779 HD22 ' HB3' ' A' ' 12' ' ' ALA . 16.9 mt -108.1 87.66 4.07 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.104 -0.998 . . . . 0.0 110.55 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.709 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 47.1 Cg_endo -72.54 -6.19 18.58 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.989 1.52 . . . . 0.0 110.438 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 98' ' ' PRO . . . 68.29 174.91 0.27 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.238 -0.914 . . . . 0.0 110.5 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.459 HG21 ' CA ' ' A' ' 35' ' ' TRP . 4.7 t -94.48 -58.31 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.856 . . . . 0.0 110.052 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 26.7 m-85 -109.45 53.43 0.69 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.1 -1.0 . . . . 0.0 110.318 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 3.2 tt0 -141.13 157.68 44.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.97 -1.081 . . . . 0.0 110.989 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 3.5 pt-20 -132.76 140.45 48.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.0 109.663 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.593 ' HA ' HD23 ' A' ' 68' ' ' LEU . 15.0 p -76.07 137.43 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.158 -0.964 . . . . 0.0 110.525 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.736 ' H ' HD12 ' A' ' 105' ' ' LEU . 1.7 mp -106.51 -19.3 13.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.443 -0.786 . . . . 0.0 110.145 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 37.6 p30 -176.43 162.7 2.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 110.338 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.618 HD12 HD21 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -120.42 141.99 49.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.361 -0.837 . . . . 0.0 109.778 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.977 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 12.7 p -139.31 160.59 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.064 -1.023 . . . . 0.0 110.859 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.799 ' O ' HG23 ' A' ' 111' ' ' VAL . 2.9 t70 -110.73 116.94 32.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 109.549 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . -62.36 -21.29 65.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.98 -1.075 . . . . 0.0 110.687 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 109' ' ' ASP . 5.0 t 44.16 -122.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.153 -0.967 . . . . 0.0 109.912 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 21.2 mt -107.13 -70.86 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.775 -1.203 . . . . 0.0 110.174 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.492 HD22 ' HA ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.257 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 3' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 4' ' ' MET . 1.7 t 49.55 -91.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -1.161 . . . . 0.0 110.169 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.488 ' HB3' HG12 ' A' ' 44' ' ' ILE . 35.0 m170 49.57 -93.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -0.95 . . . . 0.0 110.187 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.531 ' HG3' ' HG2' ' A' ' 5' ' ' GLN . 6.2 tpt -133.64 -102.68 0.25 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.104 -0.998 . . . . 0.0 110.217 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.531 ' HG2' ' HG3' ' A' ' 4' ' ' MET . 11.2 pt20 -167.18 -170.62 1.54 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.012 -1.055 . . . . 0.0 110.485 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.471 ' O ' HD13 ' A' ' 8' ' ' LEU . 15.1 m -100.02 170.14 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 110.643 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.923 ' C ' HD13 ' A' ' 8' ' ' LEU . 23.2 t -46.87 153.0 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.431 -0.793 . . . . 0.0 110.45 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.923 HD13 ' C ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -106.5 171.41 4.78 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.283 -0.886 . . . . 0.0 108.863 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 45.8 Cg_endo -72.85 77.96 2.21 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.761 1.4 . . . . 0.0 110.156 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.549 ' HB3' ' CA ' ' A' ' 94' ' ' GLY . 78.2 m-20 58.28 74.21 0.44 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.44 -0.787 . . . . 0.0 110.513 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.496 ' HB ' ' HA ' ' A' ' 56' ' ' GLN . 2.9 p -148.39 169.78 19.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.253 -0.904 . . . . 0.0 110.426 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.665 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -147.28 162.95 37.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.455 -0.778 . . . . 0.0 109.768 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.931 HD23 ' HG3' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -133.25 155.78 48.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.006 -1.059 . . . . 0.0 110.833 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.917 ' CD2' HD11 ' A' ' 36' ' ' LEU . 4.6 m170 -93.15 123.92 36.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.445 -0.784 . . . . 0.0 109.636 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.835 HD21 ' HB2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -126.91 155.31 43.24 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.593 -1.317 . . . . 0.0 110.814 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -110.1 117.89 34.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.635 -0.666 . . . . 0.0 109.994 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.031 ' HB3' ' HB3' ' A' ' 33' ' ' ASP . . . -77.04 119.04 20.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 111.006 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 2.7 mm? -109.73 101.22 10.13 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.498 HD13 ' HG3' ' A' ' 48' ' ' GLU . 5.3 tp -164.42 155.5 15.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.017 -1.052 . . . . 0.0 110.482 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.414 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 12.5 p-10 -97.01 101.84 13.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.146 -0.971 . . . . 0.0 110.261 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.942 ' HB2' HG22 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -123.67 126.4 46.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 109.716 179.569 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.521 ' HA ' ' CB ' ' A' ' 28' ' ' LYS . 8.2 tm-20 -149.72 112.59 4.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.045 -1.034 . . . . 0.0 110.833 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.98 165.98 16.51 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.518 -0.739 . . . . 0.0 109.423 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.11 1.41 55.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.97 -1.081 . . . . 0.0 109.92 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.68 -32.47 14.73 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.243 -0.911 . . . . 0.0 110.202 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.85 -50.66 0.52 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -56.98 99.31 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.303 -1.116 . . . . 0.0 110.221 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.521 ' CB ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -153.44 104.72 2.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 110.101 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.942 HG22 ' HB2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -112.5 161.38 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.032 -1.043 . . . . 0.0 109.744 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.564 ' O ' HG23 ' A' ' 30' ' ' VAL . 30.8 m -137.26 77.9 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.95 -1.094 . . . . 0.0 110.5 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 38.74 70.57 0.2 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.768 -0.583 . . . . 0.0 110.523 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.28 28.94 0.05 OUTLIER Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.849 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 1.031 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 18.2 t70 -96.69 149.04 22.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.813 -1.404 . . . . 0.0 109.883 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 36.3 tt0 -146.72 130.35 16.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.326 -0.859 . . . . 0.0 109.819 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.735 ' CZ2' HD12 ' A' ' 15' ' ' LEU . 7.6 p90 -154.81 171.28 19.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.126 -0.983 . . . . 0.0 110.955 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.917 HD11 ' CD2' ' A' ' 14' ' ' HIS . 0.6 OUTLIER -90.61 155.8 18.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.419 -0.801 . . . . 0.0 110.684 -179.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.835 ' HB2' HD21 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -132.51 110.49 10.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.365 -0.834 . . . . 0.0 110.008 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.506 ' HB2' HD11 ' A' ' 97' ' ' LEU . 2.1 tm-20 -95.98 135.51 37.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.38 -0.825 . . . . 0.0 110.065 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.604 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 69.71 45.15 59.93 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.931 ' HG3' HD23 ' A' ' 13' ' ' LEU . 44.1 Cg_endo -72.25 -57.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.854 1.45 . . . . 0.0 110.968 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.522 ' CA ' ' HA ' ' A' ' 7' ' ' VAL . . . 46.03 -89.9 0.01 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 40' ' ' PRO . 1.3 p -73.15 6.05 3.04 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.354 -1.086 . . . . 0.0 111.607 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.65 ' CE1' HD13 ' A' ' 15' ' ' LEU . 9.4 t80 -69.31 110.97 4.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.694 -1.254 . . . . 0.0 109.962 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.488 HG12 ' HB3' ' A' ' 3' ' ' HIS . 3.2 mt -105.97 139.92 20.73 Favored Pre-proline 0 C--N 1.297 -1.677 0 O-C-N 121.194 -0.941 . . . . 0.0 108.891 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.517 ' HD3' ' SD ' ' A' ' 4' ' ' MET . 39.5 Cg_endo -66.4 76.37 0.36 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.762 1.401 . . . . 0.0 110.129 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 49' ' ' VAL . 4.6 mtt180 -73.3 153.08 40.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.516 -0.74 . . . . 0.0 110.185 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -43.13 -33.73 0.94 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.308 -0.87 . . . . 0.0 109.963 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.498 ' HG3' HD13 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -47.48 -51.44 20.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 0.0 109.821 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -136.06 174.02 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.456 -0.778 . . . . 0.0 109.38 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -134.16 126.63 30.37 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.108 -0.995 . . . . 0.0 110.126 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.822 HG23 HD13 ' A' ' 13' ' ' LEU . 12.4 p -53.84 132.33 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.175 -0.953 . . . . 0.0 108.847 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.545 HG23 ' HA ' ' A' ' 15' ' ' LEU . 44.6 t -109.65 -48.96 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.005 . . . . 0.0 111.195 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 1.043 ' O ' HD13 ' A' ' 54' ' ' ILE . 12.1 mt-10 -138.62 171.92 13.64 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.072 -1.017 . . . . 0.0 110.35 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 1.043 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -139.44 146.41 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.349 -0.844 . . . . 0.0 109.18 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.808 HD13 ' N ' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -141.84 141.89 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.111 -0.993 . . . . 0.0 110.385 -179.413 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.808 ' N ' HD13 ' A' ' 55' ' ' ILE . 1.3 mp0 -112.29 179.8 3.89 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.359 -0.838 . . . . 0.0 110.336 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.58 ' HB1' ' O ' ' A' ' 94' ' ' GLY . . . -80.34 139.5 36.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.264 -0.898 . . . . 0.0 110.3 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 58' ' ' THR . 11.8 t -179.93 56.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.362 -0.837 . . . . 0.0 110.054 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.805 HG22 ' N ' ' A' ' 60' ' ' ILE . 6.3 mm -155.69 -91.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.213 -0.929 . . . . 0.0 111.059 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.805 ' N ' HG22 ' A' ' 59' ' ' ILE . 17.5 mm -108.47 -104.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.836 -1.165 . . . . 0.0 110.839 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.644 ' N ' HG22 ' A' ' 60' ' ' ILE . 2.0 ttp180 -167.6 -170.24 1.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.777 -1.202 . . . . 0.0 110.496 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 1.009 ' HB2' HG13 ' A' ' 93' ' ' VAL . 6.5 tt0 -68.2 -57.14 6.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.842 . . . . 0.0 110.646 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.548 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 68.9 m-80 -34.52 -60.54 0.42 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.321 0.581 . . . . 0.0 111.112 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.586 ' NE2' HD23 ' A' ' 107' ' ' LEU . 35.6 tp60 -53.6 129.11 31.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.048 -1.033 . . . . 0.0 110.785 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.022 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -108.18 142.39 38.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 109.727 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 65' ' ' ALA . 5.8 mp -124.34 115.03 20.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.604 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.837 ' O ' HD12 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -90.67 125.98 35.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 0.0 109.56 179.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 104' ' ' VAL . 13.6 mt -116.58 152.67 33.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.133 -0.98 . . . . 0.0 110.629 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.832 ' HB2' HD21 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -128.51 144.33 51.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 109.854 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.52 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -59.16 140.33 56.01 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.169 -0.957 . . . . 0.0 110.356 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.468 ' C ' ' CG2' ' A' ' 84' ' ' THR . 7.6 tpt180 -107.53 -18.07 13.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.894 . . . . 0.0 110.121 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.708 ' O ' HG23 ' A' ' 84' ' ' THR . 2.0 mmmp? -112.51 -98.74 0.42 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.952 . . . . 0.0 110.149 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 83' ' ' VAL . 0.2 OUTLIER 168.09 45.85 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.318 -0.864 . . . . 0.0 109.986 179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 73' ' ' GLU . 17.2 m -154.89 -19.49 0.12 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.209 -0.932 . . . . 0.0 111.676 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.571 ' CB ' ' HB2' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -73.98 121.37 20.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.686 -1.258 . . . . 0.0 110.851 -179.291 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.516 ' HB2' ' CA ' ' A' ' 81' ' ' GLU . 12.5 t70 -108.87 122.47 47.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 0.0 109.665 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.56 ' CG ' ' CZ2' ' A' ' 75' ' ' TRP . 9.4 mtm180 -55.61 -28.24 54.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -0.874 . . . . 0.0 110.607 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.444 ' HB3' ' OD1' ' A' ' 76' ' ' ASP . 11.4 t70 -89.29 -35.11 16.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.168 -0.957 . . . . 0.0 110.218 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 80' ' ' LYS . . . 148.59 -38.87 0.99 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.561 ' HE2' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -59.31 -133.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.384 -1.068 . . . . 0.0 110.077 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.81 ' CG ' HG12 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -141.43 141.81 33.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.898 -1.126 . . . . 0.0 110.067 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.476 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 27.4 mmt-85 -136.22 163.8 29.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.066 -1.021 . . . . 0.0 110.254 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 73' ' ' GLU . 19.9 m -86.45 -179.12 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.339 -0.85 . . . . 0.0 110.803 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 72' ' ' LYS . 0.1 OUTLIER -62.89 -26.62 68.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.45 -0.781 . . . . 0.0 110.418 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.493 ' H ' HG23 ' A' ' 83' ' ' VAL . . . -64.46 -30.87 79.07 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.476 ' CB ' ' HB3' ' A' ' 82' ' ' ARG . 7.9 tp10 -61.43 151.57 32.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.568 ' CG ' ' HG2' ' A' ' 69' ' ' ARG . 5.4 mt-10 -148.52 169.58 19.96 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.184 -0.948 . . . . 0.0 110.151 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.466 ' HB2' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -156.0 130.24 8.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.229 -0.919 . . . . 0.0 109.927 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.008 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -102.51 136.45 42.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.351 -0.843 . . . . 0.0 109.839 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 1.008 ' N ' HD22 ' A' ' 89' ' ' LEU . 9.7 p -111.39 135.37 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.901 . . . . 0.0 110.581 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.7 t -141.82 16.44 2.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.437 -0.789 . . . . 0.0 109.53 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.4 m -75.47 170.01 16.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.398 -0.814 . . . . 0.0 109.865 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.009 HG13 ' HB2' ' A' ' 62' ' ' GLN . 0.8 OUTLIER -79.14 147.68 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.099 -1.001 . . . . 0.0 109.1 179.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.797 ' O ' ' HB3' ' A' ' 95' ' ' ALA . . . 150.96 -13.3 0.85 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.133 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.797 ' HB3' ' O ' ' A' ' 94' ' ' GLY . . . 77.74 -35.04 0.2 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.361 -1.082 . . . . 0.0 111.674 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.655 ' CG ' HG13 ' A' ' 59' ' ' ILE . 1.0 OUTLIER -146.86 147.61 31.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.08 -1.013 . . . . 0.0 110.385 179.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.63 ' HB3' HG21 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -160.76 59.86 1.23 Allowed Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.401 -0.812 . . . . 0.0 109.883 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.586 ' HG3' ' CE2' ' A' ' 96' ' ' TYR . 53.0 Cg_endo -76.99 143.25 22.8 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.976 1.514 . . . . 0.0 110.787 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -95.04 -151.42 0.33 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.325 -0.859 . . . . 0.0 110.346 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.15 -66.26 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.219 -0.926 . . . . 0.0 110.485 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.571 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 9.1 m-30 -80.57 -22.18 40.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.937 -1.102 . . . . 0.0 110.013 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.571 ' OE1' ' CH2' ' A' ' 75' ' ' TRP . 0.7 OUTLIER -98.34 131.6 44.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.348 -0.845 . . . . 0.0 110.3 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -115.02 161.1 18.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.165 -0.959 . . . . 0.0 110.174 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.648 ' HA ' HD23 ' A' ' 68' ' ' LEU . 10.1 p -76.98 146.1 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.114 -0.992 . . . . 0.0 110.685 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.837 HD12 ' O ' ' A' ' 67' ' ' ARG . 1.5 mp -105.11 -24.67 12.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.413 -0.804 . . . . 0.0 109.709 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -166.04 174.35 9.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.266 -0.896 . . . . 0.0 110.037 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.586 HD23 ' NE2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -121.95 131.19 53.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.23 -0.919 . . . . 0.0 110.064 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.022 HG13 ' HB3' ' A' ' 65' ' ' ALA . 14.6 p -125.16 157.14 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.17 -0.956 . . . . 0.0 110.414 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 0.6 OUTLIER -111.12 115.54 29.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.161 -0.962 . . . . 0.0 109.739 179.39 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . -53.09 -177.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.048 -1.033 . . . . 0.0 110.457 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.632 HG23 ' N ' ' A' ' 112' ' ' ILE . 5.7 m -65.07 -143.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.322 -0.861 . . . . 0.0 110.244 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.632 ' N ' HG23 ' A' ' 111' ' ' VAL . 57.1 mt -127.83 122.58 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 110.479 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 112' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.164 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 0.4 OUTLIER -145.43 -178.32 6.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -1.117 . . . . 0.0 110.14 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.507 ' O ' ' HG2' ' A' ' 4' ' ' MET . 97.2 m-70 54.59 -160.02 0.17 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.132 -0.98 . . . . 0.0 110.214 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.547 ' HB2' HG13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER 51.76 171.81 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.461 -0.774 . . . . 0.0 110.735 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.51 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 1.3 mt-30 -80.3 -156.72 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.497 -0.752 . . . . 0.0 109.385 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 7' ' ' VAL . 11.4 m -144.26 83.54 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.743 -1.223 . . . . 0.0 110.885 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.616 HG22 HG23 ' A' ' 42' ' ' THR . 2.0 t 27.04 99.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 CA-C-O 121.265 0.555 . . . . 0.0 111.682 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.011 HD23 ' OG1' ' A' ' 11' ' ' THR . 2.3 mp -61.52 168.76 2.91 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.076 -1.015 . . . . 0.0 110.098 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.456 ' O ' ' OD1' ' A' ' 10' ' ' ASN . 45.0 Cg_endo -72.67 -58.4 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.921 1.485 . . . . 0.0 110.406 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 9.6 m120 -162.04 30.87 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.805 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 1.011 ' OG1' HD23 ' A' ' 8' ' ' LEU . 1.1 p -109.9 172.09 7.06 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.312 -0.867 . . . . 0.0 110.22 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.743 ' HB2' HD21 ' A' ' 97' ' ' LEU . . . -144.5 161.32 39.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.213 -0.929 . . . . 0.0 110.659 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.11 ' CD2' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -133.64 155.49 49.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 109.896 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.697 ' C ' HD22 ' A' ' 15' ' ' LEU . 17.8 m80 -97.66 133.45 42.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 109.812 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.11 HD21 ' CD2' ' A' ' 13' ' ' LEU . 2.5 mm? -120.18 151.9 38.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.343 -0.848 . . . . 0.0 110.535 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -116.09 117.35 29.84 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.349 178.063 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.08 ' HB3' ' HB3' ' A' ' 33' ' ' ASP . . . -82.62 118.53 23.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.089 -1.007 . . . . 0.0 109.724 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.873 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 1.4 mm? -108.15 101.68 10.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.783 -0.573 . . . . 0.0 110.264 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.855 HD13 ' C ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -164.95 174.91 10.0 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 0.0 110.331 179.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.4 117.22 33.51 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.097 -1.002 . . . . 0.0 109.862 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.931 ' HB2' HG22 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -125.48 94.02 4.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.143 -0.973 . . . . 0.0 110.583 -179.713 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.569 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 0.6 OUTLIER -103.93 119.88 39.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.576 -0.703 . . . . 0.0 110.135 179.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.16 161.66 19.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.295 -0.878 . . . . 0.0 110.275 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.486 ' CG ' ' O ' ' A' ' 24' ' ' LYS . 22.9 tttm -82.71 4.5 24.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 0.0 110.286 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -89.64 5.76 44.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.167 -0.958 . . . . 0.0 110.326 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.62 9.51 86.32 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -122.51 110.56 15.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -1.125 . . . . 0.0 110.019 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.569 ' HB2' ' HA ' ' A' ' 22' ' ' GLU . 6.9 ptpt -138.83 149.23 44.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.23 -0.919 . . . . 0.0 110.741 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.931 HG22 ' HB2' ' A' ' 21' ' ' PHE . 1.4 m -112.71 147.01 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -0.942 . . . . 0.0 109.123 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 30' ' ' VAL . 15.4 m -131.17 82.92 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.886 -1.134 . . . . 0.0 111.03 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.873 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 47.32 69.65 0.49 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.413 -0.805 . . . . 0.0 110.516 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -175.47 24.72 0.06 OUTLIER Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.694 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 1.08 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 11.5 t70 -86.99 143.41 27.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.783 -1.422 . . . . 0.0 110.242 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.76 ' HG2' HG11 ' A' ' 100' ' ' VAL . 8.9 tt0 -143.52 134.6 25.64 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.403 -0.811 . . . . 0.0 109.845 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.631 ' CZ2' ' HB2' ' A' ' 15' ' ' LEU . 13.5 p90 -150.26 163.97 36.93 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.994 -1.066 . . . . 0.0 111.237 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.533 HD13 ' CD2' ' A' ' 14' ' ' HIS . 42.0 tp -94.49 152.38 18.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.553 -0.717 . . . . 0.0 109.95 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.671 ' HB3' HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -133.0 110.66 10.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.064 -1.023 . . . . 0.0 110.367 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.95 ' OE1' HD11 ' A' ' 97' ' ' LEU . 16.5 tp10 -85.83 138.48 32.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.622 -0.674 . . . . 0.0 109.469 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.619 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 54.36 45.02 76.44 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 51.3 Cg_endo -72.13 4.27 3.4 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.827 1.435 . . . . 0.0 111.057 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.542 ' HA3' ' N ' ' A' ' 7' ' ' VAL . . . -42.0 -27.92 0.43 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.616 HG23 HG22 ' A' ' 7' ' ' VAL . 10.8 p -103.19 37.28 2.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.132 -1.217 . . . . 0.0 109.59 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.5 ' N ' ' O ' ' A' ' 40' ' ' PRO . 6.0 t80 -104.25 117.68 34.8 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.527 -0.733 . . . . 0.0 110.021 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.547 HG13 ' HB2' ' A' ' 4' ' ' MET . 3.1 mp -96.47 124.11 52.09 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.235 -0.916 . . . . 0.0 110.318 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.93 127.05 11.11 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.827 1.435 . . . . 0.0 110.335 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -136.82 165.23 26.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.323 -0.86 . . . . 0.0 110.108 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -56.38 -18.83 12.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.732 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.5 ' C ' ' CG1' ' A' ' 49' ' ' VAL . 5.7 tt0 -67.55 -21.62 65.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.419 -0.801 . . . . 0.0 110.444 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.5 ' CG1' ' C ' ' A' ' 48' ' ' GLU . 1.4 m -151.65 173.95 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.026 -1.046 . . . . 0.0 110.38 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.4 137.24 37.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.322 -0.861 . . . . 0.0 110.215 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.9 t -57.55 114.55 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 109.526 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.567 HG11 ' OE2' ' A' ' 34' ' ' GLU . 14.4 t -90.96 -60.12 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.946 . . . . 0.0 111.068 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.931 ' C ' HD13 ' A' ' 54' ' ' ILE . 5.6 mt-10 -144.82 169.33 18.25 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.91 -1.119 . . . . 0.0 110.963 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.931 HD13 ' C ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -134.44 143.24 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.049 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.581 HD13 ' N ' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -137.25 130.14 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.963 -1.085 . . . . 0.0 110.605 -179.535 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.581 ' N ' HD13 ' A' ' 55' ' ' ILE . 2.4 mp0 -83.9 171.64 12.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.587 -0.696 . . . . 0.0 109.958 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.595 ' CA ' ' HA ' ' A' ' 95' ' ' ALA . . . -92.53 128.15 38.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.055 -1.028 . . . . 0.0 110.578 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER 172.71 60.98 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.24 -0.913 . . . . 0.0 111.424 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.566 ' CG2' ' N ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -166.43 -51.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.6 -1.313 . . . . 0.0 111.637 179.331 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.636 HD12 ' O ' ' A' ' 95' ' ' ALA . 3.5 mt -81.6 142.1 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.815 -1.178 . . . . 0.0 110.56 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.46 -170.39 0.28 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.315 -0.866 . . . . 0.0 110.745 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.795 ' HB2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -91.55 -35.89 14.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 0.0 110.445 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.589 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 2.0 m120 -87.72 -29.65 20.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.521 -0.737 . . . . 0.0 110.965 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 109' ' ' ASP . 7.9 tp-100 -58.63 140.59 54.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.085 -1.009 . . . . 0.0 111.476 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.072 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -118.45 141.44 48.55 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 90' ' ' VAL . 0.5 OUTLIER -126.08 117.5 23.31 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.431 -0.793 . . . . 0.0 110.97 -178.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.544 ' HB3' HD22 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -92.37 125.81 37.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 0.0 109.81 179.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.749 HD12 ' OE1' ' A' ' 102' ' ' GLU . 3.5 mm? -112.15 134.09 53.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.984 . . . . 0.0 110.576 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.542 ' CB ' HD11 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -125.66 150.95 47.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -0.881 . . . . 0.0 110.057 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.585 ' CB ' ' HA ' ' A' ' 84' ' ' THR . . . -70.33 142.0 52.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.39 -0.819 . . . . 0.0 110.519 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.452 ' C ' HG23 ' A' ' 84' ' ' THR . 7.8 tpp180 -118.49 -24.45 6.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.429 -0.795 . . . . 0.0 109.615 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 74' ' ' CYS . 2.6 ttpt -127.69 109.35 11.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.493 -0.754 . . . . 0.0 109.847 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -47.17 90.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.436 -0.79 . . . . 0.0 110.346 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 72' ' ' LYS . 0.5 OUTLIER -177.46 -32.89 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 110.094 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.619 ' CZ3' ' HB3' ' A' ' 102' ' ' GLU . 2.8 t90 -75.16 114.75 14.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.327 -0.858 . . . . 0.0 110.011 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.481 ' OD1' ' HA ' ' A' ' 81' ' ' GLU . 67.5 m-20 -91.48 113.55 25.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.924 . . . . 0.0 110.357 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.436 ' HD2' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -57.08 -48.9 77.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.329 -0.857 . . . . 0.0 109.851 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -93.49 -16.3 24.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 109.892 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.77 32.96 5.46 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -129.34 47.99 2.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -1.107 . . . . 0.0 109.989 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.551 ' OE1' ' CE2' ' A' ' 21' ' ' PHE . 7.9 mp0 49.04 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.38 -0.825 . . . . 0.0 110.422 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.476 ' HB2' ' HA ' ' A' ' 76' ' ' ASP . 12.8 mmt180 -113.69 -179.96 3.79 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.393 -0.817 . . . . 0.0 110.121 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.498 HG22 ' N ' ' A' ' 84' ' ' THR . 10.9 p -120.87 165.74 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.223 -0.923 . . . . 0.0 110.651 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.585 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -51.2 -20.99 1.78 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.388 -0.82 . . . . 0.0 110.377 179.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.441 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -69.53 -11.58 65.41 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.462 ' HA ' ' OE1' ' A' ' 86' ' ' GLU . 2.1 tp10 -84.48 142.22 30.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.393 -1.063 . . . . 0.0 110.026 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -148.08 158.89 44.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.186 -0.946 . . . . 0.0 110.288 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.584 ' CZ2' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -144.6 134.77 24.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 109.909 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.016 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -95.56 128.7 42.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.14 -0.975 . . . . 0.0 110.055 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 1.016 ' N ' HD22 ' A' ' 89' ' ' LEU . 5.4 p -108.44 128.61 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 109.995 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.538 HG23 HD11 ' A' ' 89' ' ' LEU . 1.1 p -129.51 48.42 2.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -0.88 . . . . 0.0 110.197 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 m -75.83 169.68 17.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.132 -0.98 . . . . 0.0 109.993 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.795 HG13 ' HB2' ' A' ' 62' ' ' GLN . 89.7 t -115.14 131.76 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.216 -0.927 . . . . 0.0 110.495 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 60' ' ' ILE . . . 50.01 44.57 41.64 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.636 ' O ' HD12 ' A' ' 60' ' ' ILE . . . -134.33 157.8 45.43 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.222 -1.163 . . . . 0.0 111.036 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.544 ' CD2' HD11 ' A' ' 55' ' ' ILE . 1.3 t80 -121.78 113.85 20.26 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.95 HD11 ' OE1' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -126.37 84.9 61.14 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.049 -1.032 . . . . 0.0 111.029 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.525 ' O ' ' NE2' ' A' ' 14' ' ' HIS . 50.0 Cg_endo -77.48 117.44 4.32 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.142 1.601 . . . . 0.0 110.02 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.66 ' HB1' ' HG3' ' A' ' 102' ' ' GLU . . . -74.74 -168.95 0.79 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.026 -1.046 . . . . 0.0 110.431 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.76 HG11 ' HG2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -113.93 -57.21 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.205 -0.934 . . . . 0.0 110.45 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.509 ' CE2' ' HB3' ' A' ' 74' ' ' CYS . 21.9 m-30 -103.23 -32.14 9.75 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.75 -1.218 . . . . 0.0 110.672 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.749 ' OE1' HD12 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -80.07 154.83 27.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.199 -0.938 . . . . 0.0 110.641 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.582 ' C ' HD13 ' A' ' 68' ' ' LEU . 6.9 tp10 -128.94 167.73 17.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.458 -0.776 . . . . 0.0 110.2 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.454 ' C ' HD12 ' A' ' 105' ' ' LEU . 10.7 m -72.02 152.31 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.0 110.245 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.562 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 4.7 mp -100.06 -14.57 18.56 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.295 -0.878 . . . . 0.0 109.605 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.599 ' O ' HD22 ' A' ' 107' ' ' LEU . 1.8 p30 165.25 -168.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.61 -0.681 . . . . 0.0 110.151 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.599 HD22 ' O ' ' A' ' 106' ' ' ASP . 1.0 OUTLIER -127.01 116.08 20.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.464 -0.772 . . . . 0.0 109.416 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.072 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 2.0 p -115.87 103.71 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.832 -1.168 . . . . 0.0 111.037 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 3.8 t70 -75.61 115.66 15.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.279 -0.888 . . . . 0.0 110.125 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . -49.86 132.05 22.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.282 -0.886 . . . . 0.0 110.586 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 110' ' ' ALA . 21.2 t 59.35 98.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.382 -0.824 . . . . 0.0 110.513 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 2.5 mp -46.37 119.69 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.159 -0.963 . . . . 0.0 110.038 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.715 ' O ' HD13 ' A' ' 113' ' ' LEU . 3.4 tm? . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.954 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' A' ' 3' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 50.09 -90.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.298 -1.119 . . . . 0.0 110.302 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.498 ' N ' ' O ' ' A' ' 1' ' ' GLY . 51.5 m-70 -108.64 -151.74 0.48 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.135 -0.978 . . . . 0.0 110.579 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.771 ' HG2' HD11 ' A' ' 44' ' ' ILE . 0.0 OUTLIER 64.09 -175.26 0.16 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.309 -0.87 . . . . 0.0 110.391 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.47 -164.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.192 -0.943 . . . . 0.0 110.261 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.462 ' C ' ' HA2' ' A' ' 41' ' ' GLY . 95.7 t -136.01 135.59 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.166 -0.959 . . . . 0.0 110.131 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.517 ' CG2' ' HA3' ' A' ' 41' ' ' GLY . 79.2 t -60.88 118.7 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 110.829 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.509 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 0.4 OUTLIER -79.16 167.24 36.18 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 0.0 109.717 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 42.9 Cg_endo -69.9 -37.12 9.26 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.612 1.322 . . . . 0.0 110.383 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.434 ' CG ' ' HA3' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -170.69 41.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.104 -0.998 . . . . 0.0 110.246 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.444 ' OG1' ' CB ' ' A' ' 8' ' ' LEU . 12.6 p -112.98 160.86 17.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.817 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.746 ' CB ' HD11 ' A' ' 36' ' ' LEU . . . -146.82 155.35 42.28 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.988 -1.07 . . . . 0.0 110.177 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.776 ' CD1' HD22 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -123.39 154.6 38.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.166 -0.959 . . . . 0.0 110.639 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.773 ' NE2' HD12 ' A' ' 55' ' ' ILE . 7.9 m170 -94.96 127.54 41.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 109.966 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.868 HD21 ' HB2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -136.1 148.35 48.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.931 -1.105 . . . . 0.0 110.661 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.492 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -100.78 121.15 41.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.547 -0.721 . . . . 0.0 110.359 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.069 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -82.46 113.57 20.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 110.028 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.456 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -105.12 99.6 9.21 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.547 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.456 ' CD2' ' O ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -167.5 133.33 2.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.356 -0.84 . . . . 0.0 110.079 179.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -78.26 101.84 7.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.014 -1.054 . . . . 0.0 108.693 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.788 ' HB2' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -123.51 135.9 54.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.12 -0.988 . . . . 0.0 111.542 -178.516 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -130.18 128.58 42.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.604 -0.685 . . . . 0.0 109.186 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 4.7 t0 -85.31 170.24 12.97 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.148 -0.97 . . . . 0.0 110.89 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -61.79 -31.0 71.18 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.451 -0.78 . . . . 0.0 110.098 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -61.34 -17.11 52.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.311 -0.868 . . . . 0.0 110.138 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.64 -70.7 0.41 Allowed Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.632 -1.271 . . . . 0.0 109.942 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -132.01 156.55 46.03 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.152 -1.205 . . . . 0.0 111.251 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.724 ' HG2' HG13 ' A' ' 29' ' ' VAL . 2.7 tptt -134.47 -95.5 0.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.533 -0.729 . . . . 0.0 109.321 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.886 HG12 ' CB ' ' A' ' 81' ' ' GLU . 0.6 OUTLIER -112.68 151.79 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.917 -1.114 . . . . 0.0 109.225 179.132 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.523 ' O ' HG23 ' A' ' 30' ' ' VAL . 27.0 m -132.64 78.54 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.978 -1.077 . . . . 0.0 111.056 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 30' ' ' VAL . . . 35.68 72.29 0.11 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.741 -0.599 . . . . 0.0 111.23 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.56 34.2 0.02 OUTLIER Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.365 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 1.069 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 3.8 m-20 -93.31 145.62 24.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.893 -1.357 . . . . 0.0 110.36 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 101' ' ' PHE . 14.1 tt0 -140.86 130.18 23.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 0.0 109.396 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.658 ' CH2' HD12 ' A' ' 15' ' ' LEU . 3.7 p90 -157.62 166.95 31.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.97 -1.081 . . . . 0.0 111.286 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.746 HD11 ' CB ' ' A' ' 12' ' ' ALA . 16.2 tp -90.36 155.69 18.77 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.531 -0.731 . . . . 0.0 109.183 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.868 ' HB2' HD21 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -126.42 108.61 11.36 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.099 -1.001 . . . . 0.0 109.841 -179.563 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.617 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -88.44 142.22 27.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.413 -0.804 . . . . 0.0 109.384 179.63 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.611 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 54.52 46.17 74.46 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.617 ' HG3' HD23 ' A' ' 13' ' ' LEU . 47.8 Cg_endo -71.33 18.32 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.861 1.453 . . . . 0.0 112.344 -178.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.517 ' HA3' ' CG2' ' A' ' 7' ' ' VAL . . . -44.81 156.75 0.25 Allowed Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.482 ' HA ' ' HB2' ' A' ' 4' ' ' MET . 20.3 p 53.45 12.13 0.33 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.662 -0.905 . . . . 0.0 111.583 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.543 ' HE2' HG12 ' A' ' 51' ' ' VAL . 7.0 t80 -75.62 132.37 40.58 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.702 -1.249 . . . . 0.0 109.548 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.771 HD11 ' HG2' ' A' ' 4' ' ' MET . 50.3 mt -120.52 134.48 24.19 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.054 -1.028 . . . . 0.0 110.492 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.3 78.46 2.29 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.968 1.509 . . . . 0.0 110.303 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 47' ' ' LYS . 22.8 mtm180 -91.58 151.02 20.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 110.364 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 48' ' ' GLU . 13.7 mttt -42.16 -31.78 0.41 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.238 -0.914 . . . . 0.0 110.287 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -42.9 -51.02 5.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.39 -0.819 . . . . 0.0 109.772 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -134.81 173.76 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.381 -0.825 . . . . 0.0 109.389 179.382 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.41 122.74 28.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.19 -0.944 . . . . 0.0 110.407 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.543 HG12 ' HE2' ' A' ' 43' ' ' TYR . 33.7 m -54.27 123.36 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.113 -0.992 . . . . 0.0 108.678 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.781 HG12 ' HG2' ' A' ' 53' ' ' GLU . 57.1 t -99.36 -54.51 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.148 -0.97 . . . . 0.0 110.472 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.934 ' O ' HD13 ' A' ' 54' ' ' ILE . 27.6 mm-40 -138.72 174.65 10.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 110.205 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.934 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -134.09 144.26 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.405 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.773 HD12 ' NE2' ' A' ' 14' ' ' HIS . 0.2 OUTLIER -134.26 144.67 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.961 -1.087 . . . . 0.0 111.138 -178.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.433 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 70.9 mm-40 -119.36 168.51 10.87 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.684 -0.635 . . . . 0.0 109.347 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.617 ' HB1' ' HB3' ' A' ' 95' ' ' ALA . . . -89.51 132.51 35.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.154 -0.966 . . . . 0.0 110.43 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.61 ' N ' ' CB ' ' A' ' 95' ' ' ALA . 1.5 t -176.24 71.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.13 -0.981 . . . . 0.0 111.293 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.771 HD13 ' C ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -176.66 -51.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.825 -1.172 . . . . 0.0 111.732 178.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.768 HG23 ' N ' ' A' ' 61' ' ' ARG . 1.0 OUTLIER -108.3 -167.36 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.157 -1.59 . . . . 0.0 110.791 -179.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.768 ' N ' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -123.43 -147.71 0.38 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.461 -0.774 . . . . 0.0 110.115 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.947 ' HB2' HG13 ' A' ' 93' ' ' VAL . 11.4 tt0 -89.67 -71.31 0.61 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.206 -0.934 . . . . 0.0 110.919 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 7.5 p-10 -34.16 -47.66 0.29 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.832 -0.543 . . . . 0.0 111.72 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' A' ' 108' ' ' VAL . 54.0 tp60 -56.23 128.18 34.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.958 -1.089 . . . . 0.0 110.931 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.99 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -108.19 149.17 28.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.342 -0.849 . . . . 0.0 109.303 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.451 ' O ' HD22 ' A' ' 89' ' ' LEU . 1.4 mt -126.27 113.71 17.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.068 -1.02 . . . . 0.0 111.333 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.72 ' O ' HD12 ' A' ' 105' ' ' LEU . 1.5 ttm-85 -100.03 122.05 42.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.213 -0.929 . . . . 0.0 109.04 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.553 HD23 ' HA ' ' A' ' 104' ' ' VAL . 20.1 mt -119.21 145.69 45.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.106 -0.996 . . . . 0.0 111.277 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.886 ' CB ' HD21 ' A' ' 105' ' ' LEU . 2.0 ttp85 -121.03 152.6 38.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.541 -0.725 . . . . 0.0 110.059 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.559 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -71.7 159.9 33.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -0.929 . . . . 0.0 110.867 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 101' ' ' PHE . 4.4 tpm_? -132.0 -34.15 1.3 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.457 -0.777 . . . . 0.0 109.813 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -117.98 107.69 14.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 110.036 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.481 ' O ' ' CB ' ' A' ' 74' ' ' CYS . 0.8 OUTLIER -47.89 99.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.619 179.576 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER 169.71 -24.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.329 -0.857 . . . . 0.0 110.294 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.608 ' CZ3' ' HB2' ' A' ' 102' ' ' GLU . 1.3 t90 -74.72 126.73 31.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -0.923 . . . . 0.0 110.058 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 1.5 m-20 -90.82 110.85 22.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 110.001 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.574 ' HG3' ' CZ2' ' A' ' 75' ' ' TRP . 10.1 mtp180 -59.03 -57.65 12.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.158 -0.964 . . . . 0.0 110.169 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.43 0.23 14.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.33 -0.856 . . . . 0.0 110.274 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.72 9.47 16.57 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.497 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -98.51 -11.7 22.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -1.15 . . . . 0.0 109.983 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.886 ' CB ' HG12 ' A' ' 29' ' ' VAL . 2.0 tm-20 61.88 104.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -0.849 . . . . 0.0 110.306 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.492 ' HB3' ' HB3' ' A' ' 86' ' ' GLU . 46.7 mtt180 -123.28 175.04 6.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.333 -0.854 . . . . 0.0 109.918 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.679 HG13 ' H ' ' A' ' 85' ' ' GLY . 10.8 p -76.83 174.74 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.219 -0.925 . . . . 0.0 110.461 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.599 ' N ' HG22 ' A' ' 83' ' ' VAL . 1.9 t -60.61 -10.84 5.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.368 -0.832 . . . . 0.0 110.366 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.679 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -76.91 -10.32 86.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.502 ' HG2' ' CB ' ' A' ' 70' ' ' ALA . 9.0 pt-20 -73.22 153.47 40.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.185 -1.185 . . . . 0.0 109.864 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -160.33 161.15 33.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 110.227 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.887 ' CZ2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -149.56 145.87 27.05 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.161 -0.962 . . . . 0.0 110.215 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.887 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -106.02 125.19 50.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 0.0 110.321 -179.14 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.887 HG22 ' CZ2' ' A' ' 88' ' ' TRP . 22.8 t -93.49 128.07 45.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.467 -0.771 . . . . 0.0 110.765 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.517 ' OG1' ' CD1' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -134.48 30.04 3.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.53 -0.732 . . . . 0.0 109.246 179.383 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.46 130.83 35.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.478 -0.764 . . . . 0.0 110.725 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.947 HG13 ' HB2' ' A' ' 62' ' ' GLN . 6.4 t -65.51 113.82 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.374 -0.829 . . . . 0.0 110.033 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.434 ' HA3' ' CG ' ' A' ' 10' ' ' ASN . . . -179.85 -95.37 0.1 OUTLIER Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.293 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.661 ' O ' HG22 ' A' ' 60' ' ' ILE . . . -150.13 -50.28 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.072 -1.252 . . . . 0.0 111.227 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.603 ' HB3' ' CG2' ' A' ' 59' ' ' ILE . 1.8 p90 176.51 161.37 0.37 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.48 -0.763 . . . . 0.0 110.606 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.614 ' HB2' HG11 ' A' ' 90' ' ' VAL . 12.9 mt -155.41 72.73 5.53 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.363 -0.836 . . . . 0.0 110.172 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.563 ' HD3' ' CD2' ' A' ' 96' ' ' TYR . 45.8 Cg_endo -72.35 128.5 13.76 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.883 1.464 . . . . 0.0 110.541 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.444 ' HB2' ' OE1' ' A' ' 102' ' ' GLU . . . -66.69 -163.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.354 -0.841 . . . . 0.0 110.333 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.86 -68.12 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.361 -0.837 . . . . 0.0 109.807 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 34' ' ' GLU . 16.2 m-30 -80.79 -21.2 41.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.258 -0.901 . . . . 0.0 109.935 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.608 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . 3.5 tt0 -87.8 146.11 25.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.378 -0.826 . . . . 0.0 110.411 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.32 170.73 9.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.464 -0.773 . . . . 0.0 110.066 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.553 ' HA ' HD23 ' A' ' 68' ' ' LEU . 7.6 p -84.52 136.39 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.114 -0.992 . . . . 0.0 110.461 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.886 HD21 ' CB ' ' A' ' 69' ' ' ARG . 1.1 mp -93.95 -29.4 15.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 0.0 109.957 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 105' ' ' LEU . 15.0 p-10 -178.66 123.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.438 -0.788 . . . . 0.0 110.359 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.469 HD12 ' NE2' ' A' ' 64' ' ' GLN . 0.9 OUTLIER -77.19 144.98 37.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -0.858 . . . . 0.0 109.73 179.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.99 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 12.9 p -130.87 154.49 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.062 -1.024 . . . . 0.0 110.307 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 47.4 t0 -110.5 123.37 49.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.148 -0.97 . . . . 0.0 110.144 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . -69.33 -177.63 1.18 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.18 -0.95 . . . . 0.0 110.407 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.696 ' O ' HG23 ' A' ' 112' ' ' ILE . 26.1 t 50.81 75.51 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.92 . . . . 0.0 110.126 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.696 HG23 ' O ' ' A' ' 111' ' ' VAL . 3.2 pt -158.91 154.6 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.235 -0.916 . . . . 0.0 110.264 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 113' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.218 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 51.54 -178.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -1.131 . . . . 0.0 109.943 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.421 ' O ' ' O ' ' A' ' 4' ' ' MET . 25.2 m170 -95.68 134.43 38.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.258 -0.901 . . . . 0.0 109.906 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.57 ' CA ' HD11 ' A' ' 44' ' ' ILE . 4.9 ttt 62.42 139.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.958 . . . . 0.0 109.842 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.55 ' OE1' HD11 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -145.52 161.27 40.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.169 -0.957 . . . . 0.0 110.385 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.479 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 22.0 t -92.36 152.21 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.384 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.466 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 54.4 t -41.44 122.54 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.241 -0.912 . . . . 0.0 110.128 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.898 HD22 ' HG2' ' A' ' 40' ' ' PRO . 1.7 mp -78.85 159.76 73.08 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 110.366 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -75.48 -82.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.949 1.499 . . . . 0.0 110.164 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.727 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 11.4 p30 -129.56 54.7 1.81 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.309 -0.87 . . . . 0.0 109.843 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.874 ' OG1' HD23 ' A' ' 8' ' ' LEU . 1.1 p -132.5 157.47 44.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.145 -0.972 . . . . 0.0 110.111 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.755 ' CB ' HD11 ' A' ' 36' ' ' LEU . . . -141.3 162.08 36.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -0.959 . . . . 0.0 109.574 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.789 HD23 ' HG3' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -133.54 156.36 47.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.937 -1.102 . . . . 0.0 111.164 -179.492 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.667 ' NE2' HD12 ' A' ' 55' ' ' ILE . 8.9 m170 -96.24 123.32 39.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.438 -0.789 . . . . 0.0 109.882 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.854 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -125.76 148.86 48.95 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.081 -1.012 . . . . 0.0 109.55 179.278 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.499 ' HG3' ' HB3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -96.98 119.22 35.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 110.714 -178.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.992 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -76.92 115.12 16.42 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.622 0.725 . . . . 0.0 110.258 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 86.8 mt -97.84 100.85 12.23 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.672 HD13 ' N ' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -158.64 144.9 17.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.146 -0.971 . . . . 0.0 110.653 -178.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.672 ' N ' HD13 ' A' ' 19' ' ' LEU . 20.1 p-10 -86.4 102.42 14.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 0.0 109.08 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.805 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -122.55 143.01 50.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 110.818 -178.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -100.05 134.51 42.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.418 -0.801 . . . . 0.0 110.092 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.419 ' OD1' ' OE2' ' A' ' 81' ' ' GLU . 2.9 t70 -98.62 147.06 25.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.252 -0.905 . . . . 0.0 110.312 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.497 ' HG3' ' N ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -60.84 -18.65 57.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.921 . . . . 0.0 110.201 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.497 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 4.6 t0 -83.29 -29.08 28.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.148 -0.97 . . . . 0.0 110.15 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.02 -17.49 9.93 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 28' ' ' LYS . 30.2 t70 -58.47 -46.15 87.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.254 -1.145 . . . . 0.0 110.116 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 21' ' ' PHE . 2.1 ttpt 57.88 120.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.456 -0.778 . . . . 0.0 110.434 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.805 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -80.77 134.74 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.202 -0.936 . . . . 0.0 108.804 179.509 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.579 ' O ' HG23 ' A' ' 30' ' ' VAL . 22.8 m -125.96 90.97 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.971 -1.08 . . . . 0.0 110.467 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 42.96 61.57 2.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.0 110.222 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.68 24.14 0.2 Allowed Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.489 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.992 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 1.6 m-20 -88.9 161.15 16.83 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.875 -1.368 . . . . 0.0 110.03 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.499 ' HB3' ' HG3' ' A' ' 16' ' ' LYS . 9.9 pt-20 -159.81 130.97 5.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.251 -0.906 . . . . 0.0 110.575 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.689 ' CZ2' HD12 ' A' ' 15' ' ' LEU . 6.0 p90 -145.64 170.79 15.77 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.376 -0.827 . . . . 0.0 110.228 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.755 HD11 ' CB ' ' A' ' 12' ' ' ALA . 13.6 tp -90.44 156.07 18.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 110.033 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.782 ' HB2' HD21 ' A' ' 15' ' ' LEU . 3.7 t80 -132.76 110.47 10.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -0.872 . . . . 0.0 109.436 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.573 ' HB2' HD13 ' A' ' 97' ' ' LEU . 3.1 tm-20 -91.5 136.5 33.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.298 -0.877 . . . . 0.0 110.094 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.6 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 65.86 46.22 83.59 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.898 ' HG2' HD22 ' A' ' 8' ' ' LEU . 38.7 Cg_endo -66.09 -61.07 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.925 1.487 . . . . 0.0 110.461 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 6' ' ' VAL . . . 43.62 -88.62 0.01 OUTLIER Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.577 ' N ' ' O ' ' A' ' 40' ' ' PRO . 1.4 p -70.39 4.35 2.36 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.31 -1.112 . . . . 0.0 111.658 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.697 ' CE2' HD11 ' A' ' 13' ' ' LEU . 11.1 t80 -68.5 112.26 5.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.609 -1.307 . . . . 0.0 109.976 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.57 HD11 ' CA ' ' A' ' 4' ' ' MET . 4.1 mm -104.13 141.8 23.27 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.345 -0.847 . . . . 0.0 109.737 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.422 ' HD2' HG23 ' A' ' 44' ' ' ILE . 43.0 Cg_endo -70.18 93.35 0.56 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.93 1.49 . . . . 0.0 110.101 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.404 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -102.78 158.9 15.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.272 -0.892 . . . . 0.0 110.604 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -44.56 -35.61 2.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.431 -0.793 . . . . 0.0 110.104 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -45.28 -48.09 12.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.301 -0.874 . . . . 0.0 110.105 179.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.554 HG21 ' HH2' ' A' ' 35' ' ' TRP . 0.9 OUTLIER -147.15 173.3 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.267 -0.895 . . . . 0.0 110.077 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.409 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.2 mt-10 -130.66 127.15 38.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.243 -0.911 . . . . 0.0 110.652 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.662 HG23 ' CD1' ' A' ' 13' ' ' LEU . 8.7 p -55.06 128.5 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.185 -0.947 . . . . 0.0 109.456 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.638 HG12 ' HG2' ' A' ' 53' ' ' GLU . 60.2 t -109.84 -61.04 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -0.95 . . . . 0.0 110.907 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 1.007 ' O ' HD13 ' A' ' 54' ' ' ILE . 2.6 mt-10 -124.46 173.96 8.1 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.192 -0.943 . . . . 0.0 110.774 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 1.007 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.1 mm -137.01 155.54 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.667 HD12 ' NE2' ' A' ' 14' ' ' HIS . 1.1 mt -146.82 151.12 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.909 -1.12 . . . . 0.0 111.132 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.479 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 87.5 mm-40 -124.21 170.12 11.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.774 -0.579 . . . . 0.0 110.337 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -86.51 153.85 21.54 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.229 -0.92 . . . . 0.0 110.845 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.523 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER 172.65 29.42 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.073 -1.017 . . . . 0.0 112.621 179.004 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.836 HG22 ' HB3' ' A' ' 96' ' ' TYR . 2.3 tt -161.88 -35.11 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 119.707 -1.871 . . . . 0.0 113.913 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.545 HG23 ' CG ' ' A' ' 64' ' ' GLN . 48.6 mt -75.7 152.49 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.078 -1.639 . . . . 0.0 111.188 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.0 -154.73 0.25 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.556 -0.715 . . . . 0.0 110.18 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.996 ' HA ' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -82.27 -69.35 0.63 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 110.93 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.561 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 2.2 m-20 -78.49 -8.17 58.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.105 -0.997 . . . . 0.0 110.665 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.545 ' CG ' HG23 ' A' ' 60' ' ' ILE . 5.2 tp-100 -55.32 124.5 17.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.986 -1.071 . . . . 0.0 110.663 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.976 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -108.32 151.04 26.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.308 -0.87 . . . . 0.0 110.232 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.531 HD13 ' HA ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -125.69 121.83 34.58 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.196 -0.94 . . . . 0.0 110.418 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.73 ' HA ' HD22 ' A' ' 89' ' ' LEU . 8.4 mmm180 -93.34 123.91 36.96 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.249 -0.907 . . . . 0.0 110.283 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.629 HD13 ' C ' ' A' ' 103' ' ' GLU . 1.1 mm? -124.99 127.73 47.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.16 -0.963 . . . . 0.0 110.385 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -110.64 165.69 11.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.18 -0.95 . . . . 0.0 110.061 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -76.36 157.82 32.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.084 -1.01 . . . . 0.0 110.649 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.516 ' CB ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -114.59 -38.44 4.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 0.0 109.553 179.53 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -138.82 131.9 29.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.445 -0.784 . . . . 0.0 109.647 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.46 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 1.1 pt-20 -56.55 84.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.113 -0.992 . . . . 0.0 110.13 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' A' ' 72' ' ' LYS . 1.7 m -162.63 -35.33 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.401 -0.812 . . . . 0.0 110.058 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.603 ' CZ2' ' HG2' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -74.1 118.48 17.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.854 . . . . 0.0 110.073 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.406 ' HB3' ' C ' ' A' ' 79' ' ' GLY . 35.7 m-20 -86.86 115.27 24.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.992 . . . . 0.0 110.273 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.603 ' HG2' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -55.48 -55.7 28.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.169 -0.957 . . . . 0.0 110.116 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -105.55 24.22 12.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.245 -0.909 . . . . 0.0 110.066 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.406 ' C ' ' HB3' ' A' ' 76' ' ' ASP . . . 86.73 -10.25 68.4 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 23.9 pttt -87.45 136.97 32.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.391 -1.064 . . . . 0.0 110.161 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.445 ' CB ' ' CD1' ' A' ' 21' ' ' PHE . 3.6 tm-20 -47.14 118.94 2.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -0.913 . . . . 0.0 110.013 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.515 ' CB ' ' OE1' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -131.35 156.96 44.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.102 -0.999 . . . . 0.0 110.66 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.751 HG23 ' H ' ' A' ' 85' ' ' GLY . 23.4 m -86.4 -178.65 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.328 -0.857 . . . . 0.0 110.444 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.824 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 12.5 t -73.61 -6.78 48.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.362 -0.837 . . . . 0.0 109.972 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.751 ' H ' HG23 ' A' ' 83' ' ' VAL . . . -77.03 -24.84 65.56 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.515 ' OE1' ' CB ' ' A' ' 82' ' ' ARG . 4.6 pt-20 -57.11 162.0 2.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.045 -1.268 . . . . 0.0 110.058 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.484 ' CG ' ' O ' ' A' ' 68' ' ' LEU . 6.0 tt0 -159.62 142.49 13.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.185 -0.947 . . . . 0.0 109.877 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.63 ' CZ2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -119.89 148.36 43.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.048 -1.032 . . . . 0.0 110.096 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.031 HD12 HG23 ' A' ' 91' ' ' THR . 1.2 tm? -113.25 128.61 56.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.533 -0.73 . . . . 0.0 110.07 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.847 ' N ' HD13 ' A' ' 89' ' ' LEU . 81.4 t -90.77 102.32 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.854 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 1.031 HG23 HD12 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -109.36 28.5 8.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.404 -0.81 . . . . 0.0 110.348 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.461 HG21 ' HB3' ' A' ' 95' ' ' ALA . 13.9 t -76.22 169.1 18.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 0.0 109.986 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.996 HG13 ' HA ' ' A' ' 62' ' ' GLN . 48.5 t -114.7 107.02 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.187 -0.946 . . . . 0.0 109.985 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.661 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 87.79 78.61 1.26 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 94' ' ' GLY . . . 174.37 -158.53 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.58 -0.953 . . . . 0.0 110.611 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.836 ' HB3' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER 176.21 25.32 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.055 -1.028 . . . . 0.0 111.115 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.697 ' HB2' HD21 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -61.45 110.2 2.88 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.709 -1.244 . . . . 0.0 110.067 179.41 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.665 ' O ' ' HB2' ' A' ' 99' ' ' ALA . 50.5 Cg_endo -79.32 -92.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.921 1.485 . . . . 0.0 110.796 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' A' ' 98' ' ' PRO . . . 171.54 -158.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 0.0 110.146 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.548 ' CG2' ' HA ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -113.36 -59.19 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.18 -0.95 . . . . 0.0 110.043 179.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.545 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 17.5 m-30 -99.96 11.8 38.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.069 -1.019 . . . . 0.0 109.457 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 99' ' ' ALA . 6.0 tt0 -96.05 157.59 15.83 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.301 -0.874 . . . . 0.0 110.968 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.629 ' C ' HD13 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -140.06 128.63 22.92 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.552 -0.718 . . . . 0.0 109.355 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.686 ' C ' HD13 ' A' ' 105' ' ' LEU . 6.9 p -75.58 151.64 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.077 -1.015 . . . . 0.0 110.466 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.749 ' N ' HD22 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -104.14 -24.16 13.2 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.434 -0.792 . . . . 0.0 109.611 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 105' ' ' LEU . 1.0 OUTLIER 172.67 160.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.449 -0.782 . . . . 0.0 109.861 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.6 mp -96.82 134.94 39.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.095 -1.003 . . . . 0.0 109.649 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.976 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 7.0 p -122.01 157.02 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.061 -1.025 . . . . 0.0 110.755 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.52 ' HB3' HG23 ' A' ' 111' ' ' VAL . 1.0 OUTLIER -110.65 131.42 55.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.453 -0.779 . . . . 0.0 109.664 179.447 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . -90.37 34.56 0.87 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.141 -0.974 . . . . 0.0 110.667 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 112' ' ' ILE . 14.3 t -73.44 177.84 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 109.749 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.588 ' H ' HG12 ' A' ' 111' ' ' VAL . 49.7 mt 50.31 32.41 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.097 -1.002 . . . . 0.0 110.021 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.455 ' OXT' ' HG ' ' A' ' 113' ' ' LEU . 31.3 tp . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 118.091 -0.957 . . . . 0.0 110.347 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.65 -164.89 1.92 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.291 -1.123 . . . . 0.0 109.944 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -141.17 32.2 1.74 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.104 -0.997 . . . . 0.0 110.36 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.789 ' HB3' HD12 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -91.04 -103.84 0.1 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.333 -0.854 . . . . 0.0 109.955 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 6' ' ' VAL . 48.8 tt0 -105.03 66.85 0.77 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.034 -1.041 . . . . 0.0 109.895 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.509 ' C ' ' HA2' ' A' ' 41' ' ' GLY . 80.6 t -41.57 164.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.362 -0.836 . . . . 0.0 110.467 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.535 ' HA ' ' CA ' ' A' ' 41' ' ' GLY . 33.7 t -37.74 140.89 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.585 -0.697 . . . . 0.0 111.272 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.628 HD23 ' OG1' ' A' ' 11' ' ' THR . 2.7 mp -86.76 168.74 17.07 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.436 -0.79 . . . . 0.0 110.057 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.432 ' O ' ' CB ' ' A' ' 10' ' ' ASN . 47.6 Cg_endo -76.1 59.36 5.89 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.1 1.579 . . . . 0.0 109.944 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.763 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 3.5 m-80 65.13 46.24 2.79 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.363 -0.835 . . . . 0.0 109.558 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.628 ' OG1' HD23 ' A' ' 8' ' ' LEU . 17.4 p -134.98 162.13 33.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.254 -0.904 . . . . 0.0 110.258 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.776 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -133.68 159.84 39.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.104 -0.997 . . . . 0.0 109.766 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.932 ' CD1' HD22 ' A' ' 15' ' ' LEU . 1.3 pp -133.04 144.96 50.38 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.97 -1.081 . . . . 0.0 110.52 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.678 ' HD2' HG22 ' A' ' 100' ' ' VAL . 29.8 m80 -89.88 131.25 35.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.411 -0.806 . . . . 0.0 109.245 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.031 ' HA ' HG23 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -133.77 158.4 43.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.956 -1.09 . . . . 0.0 110.502 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -106.72 117.78 34.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.422 -0.798 . . . . 0.0 110.571 -179.158 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.04 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -80.49 111.86 17.29 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.366 -0.834 . . . . 0.0 109.693 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.725 HD13 ' HB1' ' A' ' 31' ' ' ALA . 2.4 mm? -103.03 101.47 11.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.673 -0.642 . . . . 0.0 110.359 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.582 HD13 ' H ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -160.88 144.66 13.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.138 -0.976 . . . . 0.0 110.544 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.582 ' H ' HD13 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -82.61 101.62 10.91 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.424 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.88 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -111.01 137.75 48.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.212 -0.93 . . . . 0.0 111.248 -178.355 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.539 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 8.2 tt0 -120.61 118.89 31.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.639 -0.663 . . . . 0.0 110.079 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 27' ' ' ASP . 8.0 t0 -113.09 127.74 56.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.209 -0.932 . . . . 0.0 110.379 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -59.71 -33.19 71.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 110.563 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -121.07 -30.51 4.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.149 -0.969 . . . . 0.0 110.468 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.46 ' C ' ' HB3' ' A' ' 23' ' ' ASP . . . -87.44 39.15 3.11 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 23' ' ' ASP . 4.1 m-20 50.34 -139.83 0.86 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -1.163 . . . . 0.0 110.054 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.539 ' HB2' ' HA ' ' A' ' 22' ' ' GLU . 10.2 ptpt -156.01 150.8 26.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -0.999 . . . . 0.0 110.146 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.9 HG11 ' HB2' ' A' ' 81' ' ' GLU . 1.2 m -110.62 148.07 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.065 -1.022 . . . . 0.0 109.105 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 30' ' ' VAL . 16.5 m -127.9 84.59 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.094 -1.004 . . . . 0.0 110.615 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.725 ' HB1' HD13 ' A' ' 18' ' ' LEU . . . 41.12 70.16 0.28 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.404 -0.81 . . . . 0.0 110.66 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -170.72 22.7 0.08 OUTLIER Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.813 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 1.04 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 3.2 m-20 -88.43 149.33 23.75 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.811 -1.405 . . . . 0.0 109.829 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 68.1 tt0 -148.34 131.09 16.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.784 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.75 ' CZ3' ' HB2' ' A' ' 17' ' ' ALA . 6.3 p90 -151.97 167.22 29.07 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.448 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.658 HD13 ' NE2' ' A' ' 14' ' ' HIS . 16.8 tp -90.84 154.24 19.65 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.549 -0.72 . . . . 0.0 109.846 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.832 ' HB2' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -128.46 109.41 11.38 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.144 -0.972 . . . . 0.0 109.555 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.62 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 5.6 tm-20 -91.92 125.27 36.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.462 -0.774 . . . . 0.0 110.349 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.605 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 62.13 44.83 97.19 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.66 ' HG3' HD23 ' A' ' 13' ' ' LEU . 43.2 Cg_endo -71.08 57.63 2.11 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.681 1.358 . . . . 0.0 109.291 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.535 ' CA ' ' HA ' ' A' ' 7' ' ' VAL . . . -54.21 -14.17 4.29 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.583 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.4 p -136.79 29.24 2.88 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.693 -1.475 . . . . 0.0 111.109 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.791 ' HE2' HG22 ' A' ' 51' ' ' VAL . 15.8 t80 -84.24 111.25 19.22 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.944 -1.102 . . . . 0.0 109.709 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.789 HD12 ' HB3' ' A' ' 4' ' ' MET . 1.7 mm -103.28 138.87 19.66 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 108.963 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.44 ' HD2' HG22 ' A' ' 44' ' ' ILE . 43.6 Cg_endo -69.8 77.26 1.1 Allowed 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 123.847 1.446 . . . . 0.0 110.782 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.435 ' HD2' ' HB ' ' A' ' 44' ' ' ILE . 1.8 mtt180 -93.7 148.83 21.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 110.118 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 48' ' ' GLU . 0.1 OUTLIER -44.77 -34.33 2.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.915 . . . . 0.0 110.301 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.453 ' HG3' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -41.87 -48.38 4.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.603 -0.686 . . . . 0.0 109.585 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.599 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -136.34 173.82 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.388 -0.82 . . . . 0.0 109.09 178.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -135.38 129.84 33.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.02 -1.05 . . . . 0.0 110.261 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.791 HG22 ' HE2' ' A' ' 43' ' ' TYR . 19.9 t -54.54 131.17 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.106 -0.996 . . . . 0.0 109.088 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.031 HG23 ' HA ' ' A' ' 15' ' ' LEU . 17.3 t -105.85 -55.55 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.104 -0.997 . . . . 0.0 110.621 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.886 ' C ' HD13 ' A' ' 54' ' ' ILE . 12.8 mm-40 -141.04 166.83 23.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.103 -0.998 . . . . 0.0 110.568 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.886 HD13 ' C ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -133.17 143.26 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.247 -0.908 . . . . 0.0 108.849 179.232 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.776 HG22 ' O ' ' A' ' 12' ' ' ALA . 3.1 tt -140.71 152.11 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.996 -1.065 . . . . 0.0 111.179 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -103.61 179.69 4.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.457 -0.777 . . . . 0.0 110.041 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.763 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -101.97 143.1 32.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.188 -0.945 . . . . 0.0 110.536 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.552 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.8 OUTLIER 174.58 57.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.097 -1.002 . . . . 0.0 111.363 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.728 HG22 HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -161.64 -60.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.503 -1.373 . . . . 0.0 111.776 179.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.728 HG13 HG22 ' A' ' 59' ' ' ILE . 1.8 mt -88.82 -144.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 120.169 -1.582 . . . . 0.0 110.377 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.579 ' HA ' ' N ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -165.22 176.66 8.23 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.071 -1.018 . . . . 0.0 110.295 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.805 ' HB2' HG13 ' A' ' 93' ' ' VAL . 1.3 tp-100 -68.54 -30.62 69.45 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.139 -0.976 . . . . 0.0 110.217 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 2.5 m120 -69.51 -56.24 7.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.223 -0.923 . . . . 0.0 110.833 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.613 ' HB3' HG22 ' A' ' 60' ' ' ILE . 63.8 tp60 -59.61 140.87 56.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.211 -0.931 . . . . 0.0 110.802 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.072 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -125.27 134.33 52.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.524 -0.735 . . . . 0.0 109.215 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.751 ' O ' HG12 ' A' ' 90' ' ' VAL . 7.9 mp -125.81 118.76 26.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.905 . . . . 0.0 111.028 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.562 ' O ' HD12 ' A' ' 105' ' ' LEU . 8.0 mtt85 -91.7 128.92 37.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.347 -0.846 . . . . 0.0 109.11 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 104' ' ' VAL . 10.7 mt -126.36 153.5 44.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.027 -1.046 . . . . 0.0 110.922 -178.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.481 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 14.4 ttp180 -127.24 157.56 39.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.522 -0.736 . . . . 0.0 110.204 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.51 ' HB2' ' HZ3' ' A' ' 75' ' ' TRP . . . -73.51 141.16 46.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.344 -0.847 . . . . 0.0 111.12 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -107.14 -38.25 6.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.303 -0.873 . . . . 0.0 109.589 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.531 ' O ' ' HB3' ' A' ' 73' ' ' GLU . 9.1 mmtt -98.02 -88.07 0.32 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.356 -0.84 . . . . 0.0 109.922 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' A' ' 72' ' ' LYS . 4.1 pt-20 164.24 -37.25 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.727 0.775 . . . . 0.0 108.948 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' ' 33' ' ' ASP . 1.3 m -56.42 -29.75 61.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.498 -0.751 . . . . 0.0 110.336 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.602 ' HA ' ' HB3' ' A' ' 35' ' ' TRP . 16.8 t90 -76.98 103.81 7.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.167 -0.958 . . . . 0.0 110.087 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 76' ' ' ASP . 1.8 p30 -101.92 114.24 28.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 110.123 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.529 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . 4.9 ppt_? -77.22 -22.15 52.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.29 -0.881 . . . . 0.0 110.33 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.412 ' N ' ' HG3' ' A' ' 77' ' ' ARG . 1.9 t0 -95.25 -19.21 20.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 110.236 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 98.25 24.66 11.11 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.514 ' O ' ' C ' ' A' ' 81' ' ' GLU . 1.4 mttt -137.14 52.63 1.91 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.243 -1.151 . . . . 0.0 110.155 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.9 ' HB2' HG11 ' A' ' 29' ' ' VAL . 2.2 pm0 26.46 94.84 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.259 0.552 . . . . 0.0 111.336 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.523 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 4.4 mpt_? -103.94 179.68 4.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 110.222 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.534 HG23 ' H ' ' A' ' 85' ' ' GLY . 27.5 m -103.37 178.47 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -0.916 . . . . 0.0 110.144 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 70' ' ' ALA . 2.8 t -59.19 -15.66 16.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 110.203 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.534 ' H ' HG23 ' A' ' 83' ' ' VAL . . . -74.2 -39.17 45.15 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.523 ' CB ' ' HB3' ' A' ' 82' ' ' ARG . 19.4 tp10 -54.09 151.74 6.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -1.127 . . . . 0.0 109.957 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 19.5 pt-20 -159.36 173.85 15.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.173 -0.954 . . . . 0.0 110.436 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.575 ' CD1' ' OE1' ' A' ' 102' ' ' GLU . 0.6 OUTLIER -161.08 160.82 30.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.898 . . . . 0.0 110.103 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.012 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -108.34 138.04 45.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.324 -0.86 . . . . 0.0 110.195 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 1.012 ' N ' HD22 ' A' ' 89' ' ' LEU . 7.3 p -108.61 140.76 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -0.929 . . . . 0.0 110.451 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.4 t -157.55 50.39 0.44 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.393 -0.817 . . . . 0.0 110.261 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.8 m -75.27 157.9 33.71 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.198 -0.938 . . . . 0.0 110.071 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.805 HG13 ' HB2' ' A' ' 62' ' ' GLN . 2.6 t -77.69 72.89 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.244 -0.91 . . . . 0.0 110.122 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.597 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 87.86 107.04 0.95 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.604 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . . . 179.88 169.33 1.2 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -1.1 . . . . 0.0 110.385 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.489 ' HB2' ' HB ' ' A' ' 59' ' ' ILE . 2.0 t80 -129.57 88.33 2.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.769 -0.582 . . . . 0.0 110.054 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.651 HD22 ' CB ' ' A' ' 12' ' ' ALA . 17.0 mt -119.12 86.23 31.67 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.157 -0.964 . . . . 0.0 110.479 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.473 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 50.0 Cg_endo -79.69 9.26 3.57 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.884 1.465 . . . . 0.0 110.648 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.558 ' CB ' ' HB3' ' A' ' 102' ' ' GLU . . . 58.07 -175.27 0.08 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.15 -0.969 . . . . 0.0 110.063 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.678 HG22 ' HD2' ' A' ' 14' ' ' HIS . 2.8 t -109.44 -55.69 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.078 -1.014 . . . . 0.0 110.532 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.588 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 23.0 m-85 -107.6 9.76 29.29 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.076 -1.015 . . . . 0.0 110.152 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.579 ' OE1' ' CZ2' ' A' ' 75' ' ' TRP . 12.6 tt0 -105.05 153.49 21.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 111.575 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -131.05 167.3 19.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.475 -0.766 . . . . 0.0 110.083 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.726 ' HA ' HD23 ' A' ' 68' ' ' LEU . 7.3 p -92.55 143.36 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.107 -0.996 . . . . 0.0 110.692 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.562 HD12 ' O ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -105.02 -19.39 13.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.406 -0.809 . . . . 0.0 110.114 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -169.6 179.71 3.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.221 -0.925 . . . . 0.0 110.324 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.875 HD22 ' O ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -138.99 141.25 38.35 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.125 -0.984 . . . . 0.0 110.612 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.072 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 8.8 p -139.51 116.7 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.94 -1.1 . . . . 0.0 110.771 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 31.1 t0 -86.81 117.4 25.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.048 -1.033 . . . . 0.0 110.119 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . -67.42 158.87 30.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 110.266 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.2 m -67.42 -152.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 110.415 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.6 pt -101.78 153.76 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.268 -0.895 . . . . 0.0 110.394 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.5 tt . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.189 -179.951 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 1' ' ' GLY . 0.1 OUTLIER 43.26 -166.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -1.133 . . . . 0.0 110.164 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -151.06 -164.1 1.93 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.316 -0.865 . . . . 0.0 110.019 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.9 ttt -67.81 160.47 28.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.147 -0.971 . . . . 0.0 109.947 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -123.39 155.54 37.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.327 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.75 -162.78 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.497 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.458 ' HA ' ' HA2' ' A' ' 41' ' ' GLY . 60.5 t -87.9 84.1 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 110.482 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.808 HD23 ' OG1' ' A' ' 11' ' ' THR . 0.1 OUTLIER -47.07 160.54 0.34 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.399 -0.813 . . . . 0.0 109.988 179.588 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.02 -47.81 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.861 1.453 . . . . 0.0 110.402 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.759 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 5.4 m120 -162.67 31.95 0.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.195 -0.94 . . . . 0.0 110.142 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.808 ' OG1' HD23 ' A' ' 8' ' ' LEU . 14.1 p -104.8 166.62 10.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.31 -0.869 . . . . 0.0 110.171 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.783 ' HB2' HD21 ' A' ' 97' ' ' LEU . . . -144.74 160.07 41.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.026 -1.046 . . . . 0.0 110.471 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.846 HD11 HD11 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -133.16 151.11 51.98 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.09 -1.006 . . . . 0.0 109.646 179.509 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.724 ' CE1' HD13 ' A' ' 36' ' ' LEU . 65.7 m80 -95.36 127.21 41.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 0.0 110.582 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.847 ' N ' HD22 ' A' ' 15' ' ' LEU . 1.7 mm? -113.95 152.17 31.24 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.517 -0.739 . . . . 0.0 110.277 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.54 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -108.09 115.89 30.95 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.19 -0.944 . . . . 0.0 108.707 178.049 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.769 ' HA ' HG12 ' A' ' 49' ' ' VAL . . . -78.6 111.26 14.49 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.941 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 48' ' ' GLU . 51.1 mt -98.11 100.95 12.3 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.251 0.548 . . . . 0.0 109.982 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.68 HD13 ' N ' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -159.47 134.0 7.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 110.129 -179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.68 ' N ' HD13 ' A' ' 19' ' ' LEU . 9.5 m-20 -75.68 101.63 5.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.034 -1.042 . . . . 0.0 109.715 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.817 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -125.67 80.74 1.92 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.844 . . . . 0.0 110.435 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.49 ' OE2' ' CG1' ' A' ' 30' ' ' VAL . 0.7 OUTLIER -100.88 114.53 28.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.0 109.691 179.558 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.51 177.31 8.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 110.515 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -54.91 -16.4 2.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.425 -0.797 . . . . 0.0 110.462 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -61.9 -36.0 80.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.135 -0.978 . . . . 0.0 110.092 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.13 -20.78 46.0 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.98 73.59 1.47 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.144 -1.21 . . . . 0.0 110.643 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 21' ' ' PHE . 20.5 tptp -107.67 -119.06 0.25 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.313 -0.867 . . . . 0.0 109.72 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.817 HG22 ' CB ' ' A' ' 21' ' ' PHE . 1.5 m -109.1 140.03 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 120.724 -1.235 . . . . 0.0 109.55 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.614 ' O ' HG23 ' A' ' 30' ' ' VAL . 27.2 m -140.57 83.55 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.165 -0.96 . . . . 0.0 110.188 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.52 70.97 0.37 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.507 -0.745 . . . . 0.0 110.565 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.54 27.92 0.03 OUTLIER Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.34 -1.41 . . . . 0.0 110.892 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.552 ' O ' ' N ' ' A' ' 17' ' ' ALA . 2.2 m-20 -94.13 156.45 16.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.664 -1.492 . . . . 0.0 110.002 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 16.5 tt0 -148.61 145.34 27.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.011 -1.055 . . . . 0.0 110.525 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.572 ' CZ2' ' HB2' ' A' ' 15' ' ' LEU . 12.5 p90 -149.95 166.89 28.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.362 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.724 HD13 ' CE1' ' A' ' 14' ' ' HIS . 53.6 tp -96.47 151.81 19.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.188 -0.945 . . . . 0.0 109.953 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.805 ' HB3' HD23 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -130.77 115.53 16.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.034 -1.041 . . . . 0.0 110.493 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.508 ' HB2' ' CD2' ' A' ' 97' ' ' LEU . 2.6 tm-20 -96.95 120.99 38.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.536 -0.728 . . . . 0.0 110.326 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.579 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 72.82 46.39 30.15 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 41.6 Cg_endo -66.44 61.29 0.52 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.884 1.465 . . . . 0.0 110.54 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.547 ' C ' ' O ' ' A' ' 40' ' ' PRO . . . -19.0 -92.1 0.01 OUTLIER Glycine 0 N--CA 1.501 2.977 0 N-CA-C 111.491 -0.643 . . . . 0.0 111.491 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.9 p -109.96 49.01 0.86 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.041 -1.27 . . . . 0.0 110.365 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.664 ' OH ' HD12 ' A' ' 15' ' ' LEU . 30.9 t80 -69.83 130.22 41.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.041 -1.037 . . . . 0.0 110.358 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.66 HG23 ' HD2' ' A' ' 45' ' ' PRO . 5.5 mt -124.94 145.29 49.61 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.356 -0.84 . . . . 0.0 109.591 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.66 ' HD2' HG23 ' A' ' 44' ' ' ILE . 45.8 Cg_endo -71.43 90.8 0.68 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.987 1.519 . . . . 0.0 110.584 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 49' ' ' VAL . 3.9 mtp180 -98.21 152.64 19.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.294 -0.879 . . . . 0.0 110.03 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 46' ' ' ARG . 32.0 tttm -41.49 -31.55 0.27 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.288 -0.883 . . . . 0.0 110.479 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 18' ' ' LEU . 16.7 tt0 -53.82 -41.41 67.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.128 -0.983 . . . . 0.0 109.923 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.769 HG12 ' HA ' ' A' ' 17' ' ' ALA . 2.1 m -145.7 171.27 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.636 -0.665 . . . . 0.0 109.386 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.21 140.58 47.61 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.684 -1.26 . . . . 0.0 111.125 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.554 HG23 ' HB3' ' A' ' 45' ' ' PRO . 24.9 t -56.53 123.23 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 109.067 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.54 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 7.2 t -105.1 -60.32 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.118 -0.989 . . . . 0.0 110.729 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.888 ' O ' HD13 ' A' ' 54' ' ' ILE . 27.1 mm-40 -138.06 162.61 33.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 110.394 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.888 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -134.49 137.96 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.318 -0.864 . . . . 0.0 109.325 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.804 HD13 ' O ' ' A' ' 96' ' ' TYR . 1.0 OUTLIER -137.37 142.19 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.92 -1.113 . . . . 0.0 111.573 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.526 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 4.0 mm100 -90.67 -179.65 5.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.382 -0.823 . . . . 0.0 109.299 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.84 ' HB1' ' O ' ' A' ' 94' ' ' GLY . . . -98.41 124.07 42.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.788 -1.195 . . . . 0.0 110.667 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.458 ' O ' HG12 ' A' ' 59' ' ' ILE . 10.1 t -172.12 49.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.443 -0.786 . . . . 0.0 109.818 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.813 HG22 ' N ' ' A' ' 60' ' ' ILE . 0.7 OUTLIER -150.5 -75.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.083 -1.01 . . . . 0.0 111.533 -179.077 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.813 ' N ' HG22 ' A' ' 59' ' ' ILE . 10.0 mt -92.47 125.28 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.905 -1.122 . . . . 0.0 111.534 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.569 ' HA ' ' N ' ' A' ' 94' ' ' GLY . 0.1 OUTLIER -68.66 -165.73 0.07 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.45 -0.781 . . . . 0.0 110.351 179.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.788 ' HB3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -91.62 -12.97 32.71 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.142 -0.974 . . . . 0.0 111.023 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.626 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 0.9 OUTLIER -87.66 -54.28 4.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.024 -1.047 . . . . 0.0 109.522 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.447 ' HB3' ' HG2' ' A' ' 61' ' ' ARG . 4.1 tp-100 -57.49 128.39 36.8 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.229 -0.919 . . . . 0.0 110.199 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.978 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -107.8 139.72 41.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.293 -0.879 . . . . 0.0 108.888 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.616 ' O ' HG12 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -120.84 124.72 45.73 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.198 -0.939 . . . . 0.0 110.876 -179.015 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.759 ' O ' HD23 ' A' ' 68' ' ' LEU . 1.4 mtm180 -90.3 126.53 35.88 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.395 -0.816 . . . . 0.0 109.055 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.759 HD23 ' O ' ' A' ' 67' ' ' ARG . 14.2 mt -120.01 147.34 44.91 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.216 -0.994 . . . . 0.0 111.702 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.662 ' HB2' HD21 ' A' ' 105' ' ' LEU . 12.4 ttm180 -126.44 162.74 24.89 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.552 -0.717 . . . . 0.0 110.241 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . -78.67 153.28 31.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.22 -0.925 . . . . 0.0 110.619 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.503 ' CZ ' ' HG3' ' A' ' 103' ' ' GLU . 19.8 tpp85 -126.84 -31.14 2.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.886 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 20.9 tptm -121.34 128.85 52.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.26 -0.9 . . . . 0.0 109.759 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.486 ' HA ' ' N ' ' A' ' 84' ' ' THR . 6.5 pt-20 -67.06 58.38 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.195 -0.941 . . . . 0.0 110.401 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -149.62 -24.37 0.27 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.367 -0.833 . . . . 0.0 110.977 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.604 ' CZ2' ' HG2' ' A' ' 77' ' ' ARG . 1.2 t90 -73.87 117.34 15.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.972 -1.08 . . . . 0.0 109.72 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.437 ' HA ' ' HB2' ' A' ' 82' ' ' ARG . 6.1 m-20 -81.53 117.33 21.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.325 -0.859 . . . . 0.0 110.893 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.604 ' HG2' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -81.74 -45.94 14.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.343 -0.848 . . . . 0.0 109.606 179.25 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.68 -1.85 36.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.364 -0.835 . . . . 0.0 110.331 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.3 -35.11 5.02 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -78.94 -103.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.295 -1.121 . . . . 0.0 110.12 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.451 ' CD ' HG21 ' A' ' 29' ' ' VAL . 71.8 mm-40 -137.93 127.26 24.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.929 -1.107 . . . . 0.0 109.837 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.437 ' HB2' ' HA ' ' A' ' 76' ' ' ASP . 18.5 mmt180 -131.42 171.97 12.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.235 -0.916 . . . . 0.0 110.4 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.612 HG22 ' N ' ' A' ' 84' ' ' THR . 2.3 p -116.01 171.61 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -0.819 . . . . 0.0 110.062 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.612 ' N ' HG22 ' A' ' 83' ' ' VAL . 13.6 t -57.13 -164.23 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.25 -0.98 . . . . 0.0 108.563 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 86' ' ' GLU . . . 68.65 -58.89 0.48 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.52 ' O ' ' CB ' ' A' ' 70' ' ' ALA . 1.9 tp10 -43.89 151.38 0.21 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -1.141 . . . . 0.0 109.103 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.545 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 5.8 pt-20 -145.16 160.04 42.06 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.205 -0.934 . . . . 0.0 110.741 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.565 ' CE2' ' O ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -135.43 156.72 48.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.472 -0.768 . . . . 0.0 109.286 179.43 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.882 HD23 ' H ' ' A' ' 90' ' ' VAL . 1.1 tt -113.43 160.42 18.45 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.808 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.882 ' H ' HD23 ' A' ' 89' ' ' LEU . 2.4 p -135.7 123.86 37.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.148 -0.97 . . . . 0.0 110.588 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.19 32.27 4.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.453 -0.779 . . . . 0.0 109.474 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.462 ' O ' ' O ' ' A' ' 61' ' ' ARG . 11.8 t -76.02 171.66 14.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.41 -0.806 . . . . 0.0 110.467 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.788 HG22 ' HB3' ' A' ' 62' ' ' GLN . 2.3 t -80.49 -172.48 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.393 -0.817 . . . . 0.0 110.207 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.84 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . -33.61 96.92 0.01 OUTLIER Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . . . -163.7 148.96 10.9 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.17 -1.194 . . . . 0.0 111.731 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.804 ' O ' HD13 ' A' ' 55' ' ' ILE . 8.4 t80 -109.03 110.37 21.63 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.783 HD21 ' HB2' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -127.78 66.11 69.79 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.027 -1.045 . . . . 0.0 111.236 -178.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.522 ' HG3' ' CZ ' ' A' ' 96' ' ' TYR . 45.2 Cg_endo -74.03 89.66 1.02 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.005 1.529 . . . . 0.0 109.651 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 1.026 ' HB3' ' HB3' ' A' ' 102' ' ' GLU . . . -45.63 149.57 0.58 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.286 -0.884 . . . . 0.0 111.232 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.752 HG23 ' H ' ' A' ' 101' ' ' PHE . 2.3 m -52.16 -69.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.61 -0.681 . . . . 0.0 110.66 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.752 ' H ' HG23 ' A' ' 100' ' ' VAL . 7.0 m-85 -99.73 62.03 1.17 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.821 -1.175 . . . . 0.0 109.674 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 1.026 ' HB3' ' HB3' ' A' ' 99' ' ' ALA . 4.0 tt0 -140.5 147.99 40.4 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.047 -1.033 . . . . 0.0 110.98 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.503 ' HG3' ' CZ ' ' A' ' 71' ' ' ARG . 1.3 mm-40 -132.15 150.89 52.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.501 -0.749 . . . . 0.0 109.679 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.686 ' C ' HD23 ' A' ' 105' ' ' LEU . 4.8 m -83.66 149.04 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.113 -0.992 . . . . 0.0 110.349 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.703 ' N ' HD23 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -103.19 -10.96 18.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.425 -0.797 . . . . 0.0 109.287 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER 163.58 172.05 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.662 -0.649 . . . . 0.0 109.767 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.2 mp -116.43 123.23 47.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.169 -0.957 . . . . 0.0 109.766 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.978 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 13.6 p -116.56 155.48 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.029 -1.044 . . . . 0.0 110.681 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -110.05 120.85 43.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.385 -0.822 . . . . 0.0 109.571 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . -59.11 131.06 49.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.296 -0.878 . . . . 0.0 110.937 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.64 ' C ' HD12 ' A' ' 112' ' ' ILE . 40.7 t 56.02 160.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.855 . . . . 0.0 110.782 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.64 HD12 ' C ' ' A' ' 111' ' ' VAL . 3.5 mp -149.41 -69.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.499 -0.751 . . . . 0.0 109.908 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.614 HD12 ' O ' ' A' ' 112' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.113 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 t -114.41 -25.45 8.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.188 -1.184 . . . . 0.0 110.167 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -99.83 -80.9 0.47 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.874 . . . . 0.0 110.143 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 44.5 ttm -45.99 160.53 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.451 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.435 ' O ' ' O ' ' A' ' 41' ' ' GLY . 1.2 tt0 -118.06 -174.15 2.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.886 . . . . 0.0 109.905 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.512 ' O ' ' CD1' ' A' ' 8' ' ' LEU . 67.4 t -128.54 147.61 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 109.741 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.513 ' HA ' ' CA ' ' A' ' 41' ' ' GLY . 10.6 t -43.44 120.58 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.074 -1.016 . . . . 0.0 110.098 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.536 HD23 ' OG1' ' A' ' 11' ' ' THR . 4.0 mp -76.53 164.84 57.11 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.441 -0.787 . . . . 0.0 110.361 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 10' ' ' ASN . 46.2 Cg_endo -75.57 70.31 5.72 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 124.121 1.59 . . . . 0.0 109.914 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 1.045 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 11.6 m-20 58.42 55.84 4.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.382 -0.824 . . . . 0.0 110.397 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.536 ' OG1' HD23 ' A' ' 8' ' ' LEU . 6.2 p -136.38 171.48 14.43 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.066 -1.022 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.581 ' HB2' HD22 ' A' ' 97' ' ' LEU . . . -145.37 158.06 43.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.203 -0.936 . . . . 0.0 110.719 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.822 ' CD2' HD21 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -130.49 154.85 47.34 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.391 -0.818 . . . . 0.0 109.268 179.119 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.635 ' O ' HD13 ' A' ' 15' ' ' LEU . 40.7 m80 -94.79 131.63 40.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.975 . . . . 0.0 110.209 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.828 ' N ' HD22 ' A' ' 15' ' ' LEU . 1.7 mm? -120.02 140.34 51.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.634 -0.666 . . . . 0.0 109.962 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.563 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 4.8 ttmt -95.82 117.09 29.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.965 -1.084 . . . . 0.0 109.174 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.84 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -81.78 105.73 13.15 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 110.591 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.664 HD13 ' CA ' ' A' ' 31' ' ' ALA . 1.9 mm? -99.08 101.53 12.92 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.48 HD13 ' CG ' ' A' ' 48' ' ' GLU . 5.0 tp -161.77 148.6 14.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.089 -1.007 . . . . 0.0 110.696 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.64 115.68 22.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.369 -0.832 . . . . 0.0 109.037 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.943 ' HB2' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -134.34 70.04 1.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.982 -1.074 . . . . 0.0 110.988 -179.055 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 1.5 tt0 -92.94 111.61 23.28 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.878 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 27' ' ' ASP . 0.7 OUTLIER -125.61 152.08 45.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.503 -0.748 . . . . 0.0 110.413 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.01 4.32 54.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.137 -0.977 . . . . 0.0 109.894 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.467 ' OD1' ' HB3' ' A' ' 23' ' ' ASP . 3.6 p-10 -100.92 -36.47 9.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 0.0 110.618 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.78 -40.51 0.08 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 23' ' ' ASP . 2.1 m-20 -68.79 131.6 45.42 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.21 -1.17 . . . . 0.0 109.857 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -166.49 63.18 0.1 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.237 -0.915 . . . . 0.0 110.86 -179.199 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.943 HG22 ' HB2' ' A' ' 21' ' ' PHE . 1.0 OUTLIER -108.07 160.88 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.18 -0.95 . . . . 0.0 109.74 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.617 ' O ' HG23 ' A' ' 30' ' ' VAL . 26.9 m -139.06 85.11 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.017 -1.052 . . . . 0.0 110.549 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.664 ' CA ' HD13 ' A' ' 18' ' ' LEU . . . 40.22 76.35 0.07 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.544 -0.722 . . . . 0.0 110.667 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.99 31.8 0.03 OUTLIER Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.359 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.84 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 13.0 m-20 -99.55 155.56 17.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.934 -1.333 . . . . 0.0 110.377 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.652 ' OE2' HG11 ' A' ' 52' ' ' VAL . 9.8 tt0 -151.51 134.76 15.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.376 -0.827 . . . . 0.0 109.9 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.538 ' CZ3' ' HB2' ' A' ' 17' ' ' ALA . 7.8 p90 -148.29 167.67 24.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.172 -0.955 . . . . 0.0 110.679 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.554 HD21 ' HA ' ' A' ' 97' ' ' LEU . 44.5 tp -97.5 153.32 18.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.329 -0.857 . . . . 0.0 109.772 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.529 ' HB3' HD23 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -138.14 110.5 7.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.143 -0.973 . . . . 0.0 109.919 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.557 ' HB3' HD22 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -97.2 138.17 35.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.334 -0.854 . . . . 0.0 110.44 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.619 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 72.25 40.8 54.85 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 39' ' ' GLY . 54.0 Cg_endo -78.12 47.9 2.51 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.23 1.121 . . . . 0.0 109.828 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.513 ' CA ' ' HA ' ' A' ' 7' ' ' VAL . . . -42.78 -31.86 1.24 Allowed Glycine 0 N--CA 1.49 2.278 0 O-C-N 121.53 -0.731 . . . . 0.0 111.277 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.621 ' O ' HD12 ' A' ' 44' ' ' ILE . 6.7 p -136.46 42.92 2.5 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.82 -1.4 . . . . 0.0 111.02 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.558 ' CZ ' ' HG ' ' A' ' 15' ' ' LEU . 14.7 t80 -79.75 111.99 16.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.106 -0.996 . . . . 0.0 109.654 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.621 HD12 ' O ' ' A' ' 42' ' ' THR . 3.6 mp -96.04 133.37 25.31 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 0.0 109.992 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.17 96.82 0.89 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.907 1.477 . . . . 0.0 110.442 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 -104.12 159.41 15.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 110.282 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.86 -28.52 6.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.146 -0.971 . . . . 0.0 110.419 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.48 ' CG ' HD13 ' A' ' 19' ' ' LEU . 7.2 tt0 -50.36 -39.85 47.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.17 -0.956 . . . . 0.0 110.077 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.77 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.6 m -141.79 173.65 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.426 -0.796 . . . . 0.0 109.998 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.52 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.7 mt-10 -132.61 137.09 46.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.107 -0.996 . . . . 0.0 110.349 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 51' ' ' VAL . 21.3 t -54.52 132.53 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.971 . . . . 0.0 109.335 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.939 HG12 ' HG2' ' A' ' 53' ' ' GLU . 97.2 t -118.57 -59.54 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.96 -1.088 . . . . 0.0 110.932 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.939 ' HG2' HG12 ' A' ' 52' ' ' VAL . 43.2 mm-40 -137.21 164.53 28.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.058 -1.026 . . . . 0.0 111.273 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.774 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -136.46 137.97 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.569 HD13 ' N ' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -138.41 137.15 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.806 -1.184 . . . . 0.0 111.466 -178.671 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.569 ' N ' HD13 ' A' ' 55' ' ' ILE . 1.3 mp0 -93.03 167.09 12.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.621 -0.674 . . . . 0.0 110.065 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.045 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -82.72 140.1 33.26 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 0.0 110.265 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 4.4 t 179.87 39.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.01 -1.056 . . . . 0.0 111.719 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.835 HG23 ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER -161.05 -70.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.468 -1.395 . . . . 0.0 111.838 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.711 ' H ' HG23 ' A' ' 59' ' ' ILE . 4.2 mm -41.86 164.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.903 -1.123 . . . . 0.0 110.297 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.43 ' N ' ' CG2' ' A' ' 60' ' ' ILE . 2.6 mpt_? -94.3 -164.12 1.13 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.101 -0.999 . . . . 0.0 110.989 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.983 ' HA ' HG13 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -67.05 -68.01 0.41 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 111.352 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.647 ' CB ' ' HB3' ' A' ' 110' ' ' ALA . 52.3 m-20 -113.22 24.6 12.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.924 -1.11 . . . . 0.0 111.23 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -61.95 133.6 55.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.867 -1.146 . . . . 0.0 109.282 178.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.5 ' O ' ' HB ' ' A' ' 108' ' ' VAL . . . -109.51 128.44 55.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.852 -1.155 . . . . 0.0 110.181 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.659 ' O ' HD22 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -126.28 127.3 45.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.93 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.796 ' C ' HD22 ' A' ' 68' ' ' LEU . 10.8 mtt180 -90.85 130.89 36.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.601 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.963 HD12 ' OE1' ' A' ' 102' ' ' GLU . 4.2 mm? -116.78 130.43 56.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 111.035 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 1.9 ttt180 -107.16 156.68 18.56 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.578 -0.701 . . . . 0.0 109.633 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -88.66 142.14 27.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.201 -0.937 . . . . 0.0 110.543 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -115.05 -17.33 11.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.347 -0.846 . . . . 0.0 109.697 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -132.96 116.4 16.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.49 -0.756 . . . . 0.0 109.988 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.67 ' HG3' HG12 ' A' ' 83' ' ' VAL . 1.2 tm-20 -62.16 103.32 0.37 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 110.318 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER 167.1 -25.04 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.294 -0.879 . . . . 0.0 110.028 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.579 ' CZ2' ' HB3' ' A' ' 77' ' ' ARG . 1.3 t90 -75.14 105.26 6.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.363 -0.836 . . . . 0.0 110.375 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.412 ' OD1' ' HB3' ' A' ' 35' ' ' TRP . 16.0 p-10 -87.36 109.55 19.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.181 -0.949 . . . . 0.0 109.767 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.579 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -89.77 -13.65 36.24 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.215 -0.928 . . . . 0.0 110.587 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.437 ' OD2' ' NH1' ' A' ' 77' ' ' ARG . 0.2 OUTLIER -124.88 13.33 8.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.986 -1.071 . . . . 0.0 110.267 179.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.78 21.23 78.91 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 15.5 mmmt -119.79 -7.31 10.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.174 -1.192 . . . . 0.0 110.012 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.487 ' HB3' HG11 ' A' ' 29' ' ' VAL . 25.3 mm-40 60.66 124.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.358 -0.839 . . . . 0.0 110.234 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -141.66 179.52 6.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.303 -0.873 . . . . 0.0 110.356 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.856 HG23 ' H ' ' A' ' 85' ' ' GLY . 6.3 m -96.16 -178.59 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.223 -0.923 . . . . 0.0 111.245 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.555 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 25.7 p -57.2 -23.07 45.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.467 -0.77 . . . . 0.0 110.545 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.856 ' H ' HG23 ' A' ' 83' ' ' VAL . . . -65.18 -25.7 71.18 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 82' ' ' ARG . 6.1 pt-20 -65.58 153.11 42.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.357 -1.084 . . . . 0.0 110.632 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.12 147.8 18.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.483 -0.76 . . . . 0.0 109.635 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.898 ' CE2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -134.59 144.76 48.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.997 -1.064 . . . . 0.0 110.381 -179.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.796 HD13 ' C ' ' A' ' 89' ' ' LEU . 1.3 tm? -94.65 139.03 31.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.427 -0.796 . . . . 0.0 110.254 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.898 HG22 ' CE2' ' A' ' 88' ' ' TRP . 12.1 t -112.98 131.81 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.199 -0.938 . . . . 0.0 110.722 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.757 ' OG1' HD11 ' A' ' 89' ' ' LEU . 16.6 m -135.55 45.57 2.44 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.578 -0.701 . . . . 0.0 109.679 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.543 ' OG1' HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -82.2 128.67 34.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.899 . . . . 0.0 110.736 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.983 HG13 ' HA ' ' A' ' 62' ' ' GLN . 47.2 t -70.31 114.3 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.568 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.623 ' O ' ' HB2' ' A' ' 95' ' ' ALA . . . 56.96 97.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.835 ' O ' HG23 ' A' ' 59' ' ' ILE . . . 174.88 -176.88 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.108 -1.23 . . . . 0.0 110.606 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.77 ' CD2' HG21 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -147.35 101.99 3.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.3 -0.875 . . . . 0.0 110.499 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.581 HD22 ' HB2' ' A' ' 12' ' ' ALA . 18.7 mt -126.33 71.22 70.91 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.116 -0.99 . . . . 0.0 110.025 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.482 ' HD3' ' CD1' ' A' ' 96' ' ' TYR . 50.5 Cg_endo -81.84 17.29 1.56 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.996 1.524 . . . . 0.0 110.965 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.92 ' HB3' ' CG ' ' A' ' 102' ' ' GLU . . . 43.48 -164.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.12 -0.987 . . . . 0.0 110.674 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.53 ' CG2' ' HA ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -115.92 -44.85 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.191 -0.943 . . . . 0.0 111.656 -178.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.567 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 23.1 m-85 -110.59 40.94 1.88 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.617 -1.302 . . . . 0.0 111.977 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.963 ' OE1' HD12 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -141.9 165.33 27.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.722 -1.236 . . . . 0.0 110.62 179.18 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.538 ' C ' HD13 ' A' ' 68' ' ' LEU . 1.9 tt0 -131.26 158.83 39.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.418 -0.801 . . . . 0.0 109.905 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.734 HG12 HD11 ' A' ' 68' ' ' LEU . 6.3 m -82.05 142.17 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.058 -1.027 . . . . 0.0 110.451 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.601 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 4.4 mp -90.58 -14.49 32.39 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.371 -0.831 . . . . 0.0 109.271 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 1.0 OUTLIER 163.85 -172.75 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.633 -0.667 . . . . 0.0 109.918 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 107' ' ' LEU . 0.7 OUTLIER -125.8 130.98 52.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.12 -0.987 . . . . 0.0 110.073 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.739 HG21 ' NH1' ' A' ' 67' ' ' ARG . 24.2 t -123.81 148.89 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.133 -0.979 . . . . 0.0 110.877 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -112.16 113.23 25.37 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.27 -0.894 . . . . 0.0 108.882 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.647 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . . . -63.4 105.68 0.79 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.745 -1.222 . . . . 0.0 109.829 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.1 p -114.22 4.36 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 110.186 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 112' ' ' ILE . 38.6 mm -52.49 89.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.408 -0.807 . . . . 0.0 110.369 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 111' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.175 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.54 87.96 2.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -1.178 . . . . 0.0 110.106 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -174.16 131.52 0.39 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.329 -0.857 . . . . 0.0 110.185 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.5 mtp -78.63 158.79 28.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.344 -0.847 . . . . 0.0 109.996 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.623 ' OE1' HD11 ' A' ' 8' ' ' LEU . 1.9 mt-30 -142.43 104.06 4.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.131 -0.981 . . . . 0.0 110.625 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 5' ' ' GLN . 8.2 p -45.05 165.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 0.0 109.718 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.482 HG13 ' HA2' ' A' ' 41' ' ' GLY . 13.8 t -54.08 125.27 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.076 -1.015 . . . . 0.0 110.169 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.623 HD11 ' OE1' ' A' ' 5' ' ' GLN . 6.5 mp -71.65 162.95 70.27 Favored Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 109.919 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.69 -89.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.926 1.488 . . . . 0.0 110.17 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.795 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 72.9 m-80 -128.64 25.02 5.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.962 . . . . 0.0 110.015 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.842 HG22 ' H ' ' A' ' 57' ' ' ALA . 27.4 p -104.48 170.6 7.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.316 -0.865 . . . . 0.0 110.077 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.585 ' HB2' ' HA ' ' A' ' 38' ' ' GLU . . . -139.75 161.86 36.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.217 -0.927 . . . . 0.0 110.117 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.056 ' CD2' HD21 ' A' ' 15' ' ' LEU . 0.6 OUTLIER -132.77 155.58 48.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.942 . . . . 0.0 110.021 179.781 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.689 ' C ' HD22 ' A' ' 15' ' ' LEU . 42.9 m80 -90.96 129.16 37.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.165 -0.959 . . . . 0.0 110.555 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.056 HD21 ' CD2' ' A' ' 13' ' ' LEU . 2.2 mm? -120.11 146.74 45.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.665 -0.647 . . . . 0.0 110.231 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.541 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -110.78 116.28 31.01 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.187 -0.945 . . . . 0.0 108.592 178.044 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.057 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -75.3 115.47 14.97 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.157 -0.964 . . . . 0.0 110.135 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.624 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.6 mt -103.26 99.84 9.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.701 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.809 ' C ' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -167.57 165.99 14.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.026 -1.046 . . . . 0.0 110.559 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.523 ' N ' HD22 ' A' ' 19' ' ' LEU . 11.6 t70 -98.27 103.12 15.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.734 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.989 ' CB ' HG22 ' A' ' 29' ' ' VAL . 1.9 t80 -101.01 101.78 12.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 109.923 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -85.48 118.98 25.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.395 -0.816 . . . . 0.0 110.146 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.467 ' OD2' ' HB2' ' A' ' 25' ' ' ASP . 2.4 t70 -118.62 132.73 56.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.917 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 tttp -71.98 -23.54 61.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 110.161 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.467 ' HB2' ' OD2' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -68.83 -31.08 69.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 109.885 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 127.41 -6.43 7.12 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.48 44.39 0.96 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.149 -1.206 . . . . 0.0 110.28 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -68.82 123.55 21.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 110.111 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.989 HG22 ' CB ' ' A' ' 21' ' ' PHE . 1.3 m -109.83 150.0 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.211 -0.931 . . . . 0.0 109.474 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.47 ' O ' HG23 ' A' ' 30' ' ' VAL . 15.4 m -134.91 93.69 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.145 -0.972 . . . . 0.0 110.905 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.624 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 42.05 68.35 0.48 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.285 -0.885 . . . . 0.0 110.471 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -166.75 19.35 0.09 OUTLIER Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.294 -1.431 . . . . 0.0 111.043 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 1.057 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 1.9 m-20 -88.9 148.6 23.75 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.414 -1.639 . . . . 0.0 109.931 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.464 ' HG3' ' HG3' ' A' ' 16' ' ' LYS . 27.7 tt0 -149.79 132.14 15.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.017 -1.052 . . . . 0.0 110.575 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 8.2 p90 -148.96 177.16 9.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.37 -0.831 . . . . 0.0 109.877 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.568 ' CD1' ' CD2' ' A' ' 14' ' ' HIS . 8.4 tp -102.94 153.99 19.67 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.157 -0.965 . . . . 0.0 110.227 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.622 ' CZ ' ' HA ' ' A' ' 40' ' ' PRO . 1.0 OUTLIER -130.88 110.46 11.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.433 -0.792 . . . . 0.0 109.68 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.591 ' HG3' HD11 ' A' ' 97' ' ' LEU . 8.9 tm-20 -92.01 132.71 36.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.574 -0.704 . . . . 0.0 109.356 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.585 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 60.24 47.05 93.02 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.622 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 37.6 Cg_endo -61.47 75.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.984 1.518 . . . . 0.0 110.467 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.482 ' HA2' HG13 ' A' ' 7' ' ' VAL . . . -42.86 110.83 0.3 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 5' ' ' GLN . 3.0 p 38.33 44.21 0.69 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.598 -0.942 . . . . 0.0 111.622 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.616 ' OH ' HD12 ' A' ' 15' ' ' LEU . 13.6 t80 -68.74 122.28 18.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.732 -1.23 . . . . 0.0 109.309 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.446 HG23 ' HD2' ' A' ' 45' ' ' PRO . 31.4 mt -111.7 142.16 26.08 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 110.18 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.821 ' HB3' HG23 ' A' ' 51' ' ' VAL . 45.0 Cg_endo -73.19 96.09 0.87 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.09 1.574 . . . . 0.0 110.353 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.403 ' O ' ' C ' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -106.13 161.8 14.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 110.242 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 46' ' ' ARG . 35.7 mttt -43.26 -31.24 0.59 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.341 -0.85 . . . . 0.0 110.299 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.474 ' HB3' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -55.19 -45.66 75.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.266 -0.896 . . . . 0.0 110.605 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.601 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.4 m -144.4 165.86 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.232 -0.917 . . . . 0.0 110.031 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -125.76 141.88 51.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.296 -0.877 . . . . 0.0 110.234 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.821 HG23 ' HB3' ' A' ' 45' ' ' PRO . 46.6 t -60.18 119.86 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.858 . . . . 0.0 109.832 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.833 HG12 ' HG2' ' A' ' 53' ' ' GLU . 16.7 t -95.1 -64.02 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 0.0 110.474 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.833 ' HG2' HG12 ' A' ' 52' ' ' VAL . 44.8 mm-40 -141.96 175.62 9.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.56 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.816 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -134.95 146.06 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.36 -0.838 . . . . 0.0 109.111 179.439 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -140.08 131.74 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.971 -1.081 . . . . 0.0 110.739 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.499 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 2.5 mp0 -86.5 156.01 20.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.49 -0.756 . . . . 0.0 109.835 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.037 ' HB1' ' HA ' ' A' ' 95' ' ' ALA . . . -95.3 142.85 27.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 0.0 110.818 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.62 HG22 ' C ' ' A' ' 57' ' ' ALA . 0.1 OUTLIER 168.81 51.69 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.424 -0.797 . . . . 0.0 110.777 179.758 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.9 HD13 ' CD1' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -153.48 -28.75 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.728 -1.232 . . . . 0.0 111.419 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.731 HD12 ' O ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER -87.58 168.58 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.644 -1.285 . . . . 0.0 110.844 -179.098 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.522 ' CB ' ' HB2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -107.23 -177.29 3.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.521 -0.737 . . . . 0.0 110.323 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.956 ' HA ' HG12 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -66.46 -72.26 0.17 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.273 -0.892 . . . . 0.0 110.671 -179.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.536 ' CB ' ' HB3' ' A' ' 110' ' ' ALA . 1.1 m-80 -77.55 -6.84 55.08 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.314 -0.866 . . . . 0.0 110.207 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.549 ' NE2' ' N ' ' A' ' 108' ' ' VAL . 44.7 tp60 -61.1 129.26 40.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.144 -0.973 . . . . 0.0 110.657 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.632 ' O ' HD22 ' A' ' 66' ' ' LEU . . . -108.67 144.99 35.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.074 -1.016 . . . . 0.0 109.752 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.672 ' HB2' HG13 ' A' ' 90' ' ' VAL . 1.7 mm? -123.13 114.6 20.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.182 -0.948 . . . . 0.0 110.522 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.819 ' HG2' HD23 ' A' ' 89' ' ' LEU . 18.5 mtm180 -97.99 122.04 40.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.297 -0.877 . . . . 0.0 109.881 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.777 HD23 ' HA ' ' A' ' 104' ' ' VAL . 13.2 mt -118.88 135.82 54.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.961 . . . . 0.0 110.61 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.852 ' HB2' HD11 ' A' ' 105' ' ' LEU . 29.2 ttt180 -98.22 160.74 14.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.55 -0.719 . . . . 0.0 109.865 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.514 ' HB2' ' HZ3' ' A' ' 75' ' ' TRP . . . -75.99 164.16 26.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.261 -0.899 . . . . 0.0 111.193 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 101' ' ' PHE . 1.0 OUTLIER -124.51 -42.6 2.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.66 -0.65 . . . . 0.0 109.493 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.501 ' HB2' ' CD2' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -122.03 138.67 54.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.41 -0.806 . . . . 0.0 109.998 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.528 ' HG3' HG23 ' A' ' 83' ' ' VAL . 0.6 OUTLIER -69.52 60.55 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.151 -0.968 . . . . 0.0 109.481 179.336 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 72' ' ' LYS . 2.2 t -151.18 -25.63 0.21 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.219 -0.926 . . . . 0.0 111.309 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.595 ' CZ2' ' HB3' ' A' ' 77' ' ' ARG . 1.7 t90 -73.6 116.23 13.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.754 -1.216 . . . . 0.0 110.519 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.488 ' HB3' ' HA ' ' A' ' 81' ' ' GLU . 2.5 p-10 -107.07 109.61 21.51 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.251 -0.905 . . . . 0.0 110.07 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.595 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -88.82 -4.09 58.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.243 -0.911 . . . . 0.0 110.242 179.671 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -117.66 -12.48 10.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.883 . . . . 0.0 110.089 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.18 -46.23 1.13 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.403 ' O ' ' HD2' ' A' ' 82' ' ' ARG . 11.4 mtmt -82.55 127.13 33.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -1.161 . . . . 0.0 110.26 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.591 ' CG ' HG11 ' A' ' 29' ' ' VAL . 6.1 tp10 -46.28 119.55 2.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 0.0 110.109 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.403 ' HD2' ' O ' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -101.43 175.04 5.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 110.317 -179.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.584 HG22 ' N ' ' A' ' 84' ' ' THR . 13.8 p -106.69 172.84 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 110.306 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.584 ' N ' HG22 ' A' ' 83' ' ' VAL . 40.6 p -60.75 -174.08 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.323 -0.861 . . . . 0.0 109.022 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 87' ' ' GLU . . . 70.8 -56.37 0.99 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 4.4 tp10 -44.32 153.78 0.14 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.032 -1.275 . . . . 0.0 109.545 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.54 ' CB ' ' HA ' ' A' ' 69' ' ' ARG . 13.4 mp0 -145.23 149.8 35.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.741 -1.224 . . . . 0.0 111.385 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.572 ' CZ2' ' HB ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -111.74 163.27 14.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.395 -0.815 . . . . 0.0 108.903 178.606 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.819 HD23 ' HG2' ' A' ' 67' ' ' ARG . 1.5 tm? -129.32 141.67 51.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.989 -1.069 . . . . 0.0 110.309 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.824 HG21 HD12 ' A' ' 97' ' ' LEU . 7.1 p -126.15 139.49 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.61 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 91' ' ' THR . 22.3 m -137.46 40.55 2.42 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.174 -0.954 . . . . 0.0 110.132 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.7 m -82.44 126.71 32.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.169 -0.957 . . . . 0.0 110.376 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.956 HG12 ' HA ' ' A' ' 62' ' ' GLN . 3.8 m -58.19 112.56 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.134 -0.979 . . . . 0.0 110.265 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 60' ' ' ILE . . . 71.44 96.6 0.06 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 1.037 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . . . -169.41 176.03 5.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.324 -1.103 . . . . 0.0 110.826 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.9 ' CD1' HD13 ' A' ' 59' ' ' ILE . 1.0 OUTLIER -129.0 -70.57 0.66 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.495 -0.753 . . . . 0.0 109.514 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.824 HD12 HG21 ' A' ' 90' ' ' VAL . 4.8 mt 48.92 78.27 0.41 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.484 -0.76 . . . . 0.0 111.247 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.739 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 48.9 Cg_endo -74.65 -14.79 21.96 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.806 1.424 . . . . 0.0 109.548 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.739 ' HB3' ' O ' ' A' ' 98' ' ' PRO . . . 72.14 173.46 0.3 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.537 -0.727 . . . . 0.0 111.161 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.531 HG12 ' CD1' ' A' ' 101' ' ' PHE . 94.2 t -99.81 -61.09 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.538 -0.727 . . . . 0.0 109.603 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.586 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 18.0 m-30 -111.43 45.44 1.2 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.335 -0.853 . . . . 0.0 109.992 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 11.4 mt-10 -134.05 144.88 48.93 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.676 -1.265 . . . . 0.0 111.887 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.45 ' O ' HD12 ' A' ' 105' ' ' LEU . 1.3 tt0 -119.37 123.27 43.74 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.777 ' HA ' HD23 ' A' ' 68' ' ' LEU . 7.2 p -54.05 149.02 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.218 -0.926 . . . . 0.0 110.779 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.852 HD11 ' HB2' ' A' ' 69' ' ' ARG . 8.4 mp -103.46 -32.92 9.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.574 -0.704 . . . . 0.0 110.387 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -179.84 148.38 0.31 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.026 -1.046 . . . . 0.0 110.722 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 mp -88.33 125.52 34.73 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.331 -0.856 . . . . 0.0 109.555 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.549 ' N ' ' NE2' ' A' ' 64' ' ' GLN . 74.2 t -116.85 140.53 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.067 -1.021 . . . . 0.0 111.434 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 14.4 t0 -111.29 114.15 27.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 109.496 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.536 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . . . -84.22 177.31 8.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.862 -1.149 . . . . 0.0 110.282 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.431 ' O ' ' CG ' ' A' ' 63' ' ' ASN . 19.6 m -61.81 -145.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.255 -0.903 . . . . 0.0 110.599 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.406 ' N ' HG23 ' A' ' 111' ' ' VAL . 15.7 mm -109.08 146.53 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.9 . . . . 0.0 110.279 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.179 179.991 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.427 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.3 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 0.3 OUTLIER 65.31 146.25 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.25 -1.147 . . . . 0.0 110.048 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -58.32 101.27 0.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.16 -0.962 . . . . 0.0 110.28 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.846 ' HG3' HD11 ' A' ' 44' ' ' ILE . 14.9 ttt -131.28 150.1 52.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.177 -0.952 . . . . 0.0 110.154 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 4' ' ' MET . 14.2 pt20 -176.76 142.5 0.41 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.179 -0.951 . . . . 0.0 110.392 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.497 HG23 ' N ' ' A' ' 7' ' ' VAL . 6.7 m -66.75 -150.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -0.885 . . . . 0.0 110.079 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.738 ' C ' HD13 ' A' ' 8' ' ' LEU . 4.0 t -83.32 144.48 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 110.178 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.749 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -100.25 168.74 8.93 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.207 -0.933 . . . . 0.0 109.519 179.667 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 42.8 Cg_endo -70.15 68.94 1.89 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.641 1.337 . . . . 0.0 110.732 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.837 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 4.9 m120 68.67 69.86 0.29 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.555 -0.715 . . . . 0.0 111.227 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.482 ' OG1' ' HB2' ' A' ' 8' ' ' LEU . 7.8 p -138.87 159.71 41.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.942 . . . . 0.0 109.921 178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.573 ' CB ' HD22 ' A' ' 97' ' ' LEU . . . -139.04 155.68 47.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.157 -0.964 . . . . 0.0 110.333 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.977 HD13 HD11 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -130.48 156.74 44.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -0.932 . . . . 0.0 110.609 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.994 ' C ' HD13 ' A' ' 15' ' ' LEU . 10.5 m170 -93.98 128.2 40.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.597 -0.689 . . . . 0.0 109.424 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.994 HD13 ' C ' ' A' ' 14' ' ' HIS . 0.1 OUTLIER -121.58 153.15 38.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.065 -1.022 . . . . 0.0 110.098 -179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -110.09 116.52 31.7 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.21 -0.931 . . . . 0.0 109.385 178.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.986 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -76.61 115.93 16.82 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.285 -0.885 . . . . 0.0 110.434 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.741 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -102.83 99.77 9.73 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.475 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.627 HD13 ' H ' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -167.59 147.31 5.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 110.745 -179.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.627 ' H ' HD13 ' A' ' 19' ' ' LEU . 32.4 t70 -85.39 110.82 19.41 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.727 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -129.17 144.41 51.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.081 -1.012 . . . . 0.0 112.054 -177.893 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.06 123.13 46.05 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.95 144.7 29.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.977 -1.077 . . . . 0.0 110.88 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -74.04 -33.05 63.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.413 -0.805 . . . . 0.0 109.507 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.94 -25.06 4.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.439 -0.788 . . . . 0.0 110.226 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.477 ' HA2' ' HB ' ' A' ' 83' ' ' VAL . . . -88.76 27.51 7.18 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.4 OUTLIER 61.63 -84.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -1.175 . . . . 0.0 110.4 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.508 ' CG ' ' O ' ' A' ' 21' ' ' PHE . 1.9 ttmm 178.13 142.44 0.1 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.373 -0.829 . . . . 0.0 110.344 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.727 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -100.66 139.97 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.203 -0.935 . . . . 0.0 109.333 179.658 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 30' ' ' VAL . 20.1 m -127.63 85.67 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.065 -1.022 . . . . 0.0 110.575 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.741 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 41.62 71.18 0.22 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.315 -0.866 . . . . 0.0 110.381 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -179.68 28.83 0.05 OUTLIER Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.536 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.986 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 42.5 m-20 -93.44 147.94 22.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.769 -1.43 . . . . 0.0 110.0 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.473 ' HG2' HG11 ' A' ' 100' ' ' VAL . 15.3 tt0 -143.07 143.56 31.91 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.032 -1.042 . . . . 0.0 110.176 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.563 ' CH2' ' HB2' ' A' ' 15' ' ' LEU . 7.1 p90 -159.95 168.83 24.78 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.014 -1.054 . . . . 0.0 111.105 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.869 HD22 ' O ' ' A' ' 98' ' ' PRO . 14.2 tp -97.32 153.29 18.15 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.353 -0.842 . . . . 0.0 109.774 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.602 ' CZ ' ' HA ' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -140.96 109.6 5.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.98 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.816 ' HG2' HD22 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -97.77 137.77 36.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.355 -0.84 . . . . 0.0 109.402 179.614 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.595 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 78.73 46.68 8.41 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.602 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 38.1 Cg_endo -63.47 71.32 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.052 1.554 . . . . 0.0 111.041 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.552 ' HA2' HG22 ' A' ' 7' ' ' VAL . . . -46.43 95.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 40' ' ' PRO . 0.1 OUTLIER 46.13 40.44 7.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -1.137 . . . . 0.0 110.413 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.561 ' HB3' ' HB2' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -68.64 131.87 45.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.105 -0.997 . . . . 0.0 109.929 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.846 HD11 ' HG3' ' A' ' 4' ' ' MET . 23.3 mm -121.08 148.22 48.5 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.388 -0.82 . . . . 0.0 109.124 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.714 ' HD2' HG23 ' A' ' 44' ' ' ILE . 41.2 Cg_endo -67.85 75.03 0.64 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.689 1.363 . . . . 0.0 110.863 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 49' ' ' VAL . 13.0 ttt85 -66.84 143.47 56.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.424 -0.798 . . . . 0.0 109.895 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -41.25 -33.62 0.4 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.344 -0.848 . . . . 0.0 110.523 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -49.46 -50.89 39.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.157 -0.964 . . . . 0.0 109.95 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.675 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.4 m -133.0 173.51 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.353 -0.842 . . . . 0.0 109.408 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.48 132.77 44.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.088 -1.008 . . . . 0.0 110.56 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.732 ' HA ' HD12 ' A' ' 15' ' ' LEU . 9.4 p -54.41 143.53 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.041 -1.037 . . . . 0.0 108.232 178.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.714 HG23 ' HA ' ' A' ' 15' ' ' LEU . 13.0 t -123.33 -57.5 2.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.666 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.959 ' O ' HD13 ' A' ' 54' ' ' ILE . 31.1 mm-40 -135.35 167.36 21.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.393 -0.817 . . . . 0.0 110.092 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.959 HD13 ' O ' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -136.77 147.94 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.436 -0.79 . . . . 0.0 109.067 179.359 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.556 HD13 ' H ' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -142.12 136.08 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.072 -1.017 . . . . 0.0 110.791 -179.21 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.556 ' H ' HD13 ' A' ' 55' ' ' ILE . 90.2 mm-40 -91.91 174.13 7.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.403 -0.811 . . . . 0.0 109.887 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.837 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -97.97 127.45 43.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.95 . . . . 0.0 110.348 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER 172.18 91.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.325 -0.86 . . . . 0.0 110.535 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.804 HD13 ' CE1' ' A' ' 96' ' ' TYR . 0.0 OUTLIER 177.76 -50.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.03 -1.044 . . . . 0.0 110.569 179.605 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.622 HG22 ' N ' ' A' ' 61' ' ' ARG . 15.7 mm -117.97 -93.34 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.788 -1.195 . . . . 0.0 110.33 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.622 ' N ' HG22 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -178.8 -163.34 0.06 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.129 -0.982 . . . . 0.0 111.042 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.829 ' HB3' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -92.51 -72.27 0.6 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.307 -0.871 . . . . 0.0 110.671 -179.353 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.783 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 3.1 m-20 -41.84 -24.59 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.675 -0.641 . . . . 0.0 111.636 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.967 ' OE1' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -58.47 134.01 56.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.846 -1.159 . . . . 0.0 110.294 -179.51 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.078 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -109.21 138.95 44.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.949 . . . . 0.0 109.285 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.967 HD13 ' OE1' ' A' ' 64' ' ' GLN . 2.0 tp -126.25 111.7 14.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -0.991 . . . . 0.0 110.848 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.614 ' O ' HD12 ' A' ' 105' ' ' LEU . 1.1 tpp180 -89.42 123.31 33.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.242 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.603 HD23 ' HA ' ' A' ' 104' ' ' VAL . 13.2 mt -122.57 146.99 46.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.877 . . . . 0.0 111.264 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 13.5 ttp85 -114.41 165.01 13.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.577 -0.702 . . . . 0.0 109.365 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.879 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -83.59 161.21 21.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.956 -1.09 . . . . 0.0 111.278 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.486 ' HB3' ' O ' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -123.83 -35.91 2.8 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.479 ' HG3' ' CD1' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -125.44 151.25 46.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.511 -0.743 . . . . 0.0 109.463 179.091 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.514 ' OE1' HG23 ' A' ' 83' ' ' VAL . 20.3 tt0 -83.08 95.99 8.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.123 -0.985 . . . . 0.0 109.556 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 177.77 -27.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.18 -0.95 . . . . 0.0 110.719 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.577 ' HZ3' ' HB2' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -74.46 125.8 29.34 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.036 -1.04 . . . . 0.0 110.16 -179.671 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 77' ' ' ARG . 34.9 m-20 -94.73 119.53 33.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 109.536 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 76' ' ' ASP . 5.0 mtm180 -39.6 -55.91 1.77 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.456 -0.778 . . . . 0.0 110.821 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -118.42 -8.1 10.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.1 -1.0 . . . . 0.0 110.396 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.41 -20.52 2.96 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.431 ' O ' ' CG ' ' A' ' 76' ' ' ASP . 4.4 mttp -63.88 -132.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -1.083 . . . . 0.0 109.866 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.536 ' HB3' ' CG1' ' A' ' 29' ' ' VAL . 5.9 mp0 -142.65 120.85 12.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.942 -1.098 . . . . 0.0 110.077 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.468 ' HD3' ' HG2' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -132.51 178.14 7.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.93 . . . . 0.0 110.186 179.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.917 HG13 ' H ' ' A' ' 85' ' ' GLY . 7.7 p -107.86 179.95 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.378 -0.826 . . . . 0.0 110.267 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.879 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 8.8 t -70.24 -15.53 62.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 110.343 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.917 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -86.75 8.37 75.89 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.468 ' HG2' ' HD3' ' A' ' 82' ' ' ARG . 13.6 tp10 -91.14 162.96 14.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.24 -1.153 . . . . 0.0 109.888 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.468 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 12.5 pt-20 -153.5 156.95 39.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.949 -1.094 . . . . 0.0 110.359 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.577 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -139.51 147.53 41.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.762 179.894 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.951 HD13 ' N ' ' A' ' 90' ' ' VAL . 2.7 tm? -103.41 146.97 27.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -0.852 . . . . 0.0 109.493 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.951 ' N ' HD13 ' A' ' 89' ' ' LEU . 20.5 t -104.47 117.42 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.146 -0.971 . . . . 0.0 110.224 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.69 -0.18 8.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.576 -0.702 . . . . 0.0 109.909 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.52 171.41 15.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.425 -0.797 . . . . 0.0 110.112 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.829 HG13 ' HB3' ' A' ' 62' ' ' GLN . 11.1 t -86.43 166.6 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.131 -0.98 . . . . 0.0 110.019 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.781 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 144.02 -28.18 2.0 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 59' ' ' ILE . . . 58.34 14.25 2.8 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.337 -1.096 . . . . 0.0 110.921 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.804 ' CE1' HD13 ' A' ' 59' ' ' ILE . 6.7 t80 179.99 85.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.088 -1.008 . . . . 0.0 110.674 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.816 HD22 ' HG2' ' A' ' 38' ' ' GLU . 69.3 mt -129.45 81.63 69.54 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 109.54 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.869 ' O ' HD22 ' A' ' 36' ' ' LEU . 44.3 Cg_endo -71.8 141.48 37.42 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.076 1.566 . . . . 0.0 110.774 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -85.19 -164.85 1.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.41 -0.806 . . . . 0.0 109.941 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.473 HG11 ' HG2' ' A' ' 34' ' ' GLU . 18.7 t -109.47 -62.75 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.215 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.515 ' HB2' ' HB2' ' A' ' 75' ' ' TRP . 14.8 m-85 -97.6 -33.06 11.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.278 -0.889 . . . . 0.0 110.189 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.565 ' OE1' ' CH2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -80.95 154.03 27.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 110.243 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -128.79 172.18 11.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.91 . . . . 0.0 110.45 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.603 ' HA ' HD23 ' A' ' 68' ' ' LEU . 7.5 p -93.28 142.69 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.903 . . . . 0.0 110.644 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.711 ' H ' HD12 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -106.34 -19.81 13.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.477 -0.764 . . . . 0.0 109.608 179.755 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -174.63 156.24 2.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.497 -0.752 . . . . 0.0 109.944 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.437 HD23 HD11 ' A' ' 66' ' ' LEU . 3.3 mp -107.54 146.09 32.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.899 . . . . 0.0 110.356 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.078 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 8.9 p -134.41 159.52 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.139 -0.976 . . . . 0.0 109.848 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 110' ' ' ALA . 8.2 p-10 -110.36 125.71 53.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.122 -0.986 . . . . 0.0 110.114 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.783 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . -43.03 148.01 0.29 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.216 -0.928 . . . . 0.0 110.408 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.558 ' O ' HG22 ' A' ' 111' ' ' VAL . 13.9 p -157.41 44.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.258 -0.901 . . . . 0.0 110.377 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.421 ' O ' ' C ' ' A' ' 113' ' ' LEU . 1.9 tt -121.17 150.73 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.298 -0.876 . . . . 0.0 110.257 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 112' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.21 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 50.31 42.38 25.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.344 -1.092 . . . . 0.0 110.328 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.472 ' O ' ' HB3' ' A' ' 4' ' ' MET . 0.3 OUTLIER -171.92 110.77 0.28 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.177 -0.952 . . . . 0.0 110.194 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.707 ' SD ' HD11 ' A' ' 44' ' ' ILE . 15.3 ttt 62.32 153.37 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.361 -0.837 . . . . 0.0 110.333 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.462 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 1.8 mt-30 -130.83 176.05 8.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.357 -0.839 . . . . 0.0 109.867 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 8' ' ' LEU . 14.2 t -90.63 143.35 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.22 -0.925 . . . . 0.0 109.471 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.455 ' C ' ' O ' ' A' ' 6' ' ' VAL . 40.7 t -39.4 95.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.436 -0.79 . . . . 0.0 110.102 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 6' ' ' VAL . 0.9 OUTLIER -45.55 165.84 0.16 Allowed Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.451 -0.781 . . . . 0.0 110.167 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.69 -56.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 124.165 1.613 . . . . 0.0 110.648 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.775 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -166.75 26.01 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.084 -1.01 . . . . 0.0 110.588 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 7.2 p -103.58 171.76 7.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.171 -0.956 . . . . 0.0 109.655 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.834 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -141.42 160.4 40.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.858 -1.151 . . . . 0.0 110.689 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.097 ' CD2' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -129.59 155.18 46.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.103 -0.998 . . . . 0.0 109.927 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.613 ' CD2' ' N ' ' A' ' 14' ' ' HIS . 5.2 m170 -92.74 126.51 37.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 110.321 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.097 HD21 ' CD2' ' A' ' 13' ' ' LEU . 2.6 mm? -112.19 151.51 29.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.671 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.607 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 9.0 ttmt -119.58 117.0 27.2 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.953 -1.092 . . . . 0.0 109.362 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.962 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -77.93 120.33 22.64 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.271 -0.893 . . . . 0.0 110.335 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.499 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 0.5 OUTLIER -99.29 101.76 13.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.629 -0.669 . . . . 0.0 109.731 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.63 HD13 ' H ' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -159.04 141.04 13.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.327 -0.858 . . . . 0.0 110.04 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.63 ' H ' HD13 ' A' ' 19' ' ' LEU . 4.1 m-20 -90.07 103.6 16.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.856 . . . . 0.0 110.258 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.636 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -128.96 104.48 7.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.393 -0.817 . . . . 0.0 110.042 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -122.92 116.42 23.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.269 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -86.63 177.28 7.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -0.882 . . . . 0.0 110.345 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.5 tttp -79.96 -2.35 43.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.145 -0.972 . . . . 0.0 110.149 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -62.75 -30.54 71.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.195 -0.941 . . . . 0.0 110.188 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 27' ' ' ASP . . . 145.01 -30.09 1.8 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 26' ' ' GLY . 0.2 OUTLIER 170.91 141.84 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.297 -1.119 . . . . 0.0 109.939 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 1.0 OUTLIER -137.9 -99.73 0.19 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.098 -1.001 . . . . 0.0 110.427 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.636 HG22 ' CB ' ' A' ' 21' ' ' PHE . 1.5 m -112.08 137.41 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.035 -1.041 . . . . 0.0 109.752 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 30' ' ' VAL . 29.6 m -137.37 80.88 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.9 . . . . 0.0 110.026 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.499 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 47.91 68.62 0.64 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.891 . . . . 0.0 110.18 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.14 29.54 0.04 OUTLIER Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.362 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.962 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 38.1 m-20 -83.99 146.72 27.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.789 -1.418 . . . . 0.0 109.473 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.619 ' OE1' HG11 ' A' ' 100' ' ' VAL . 4.8 tt0 -144.22 147.34 33.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.099 -1.001 . . . . 0.0 111.056 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.619 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 11.5 p90 -156.7 164.41 38.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.465 -0.772 . . . . 0.0 110.188 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.527 ' HB2' ' HA ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -96.74 149.46 21.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.244 -0.91 . . . . 0.0 110.394 -179.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.57 ' HB3' HD23 ' A' ' 13' ' ' LEU . 2.9 t80 -131.55 110.74 11.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.233 -0.917 . . . . 0.0 110.502 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.594 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 2.3 tm-20 -85.75 125.12 32.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.652 -0.655 . . . . 0.0 110.001 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.594 ' N ' ' HD3' ' A' ' 40' ' ' PRO . . . 74.63 44.85 24.81 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.594 ' HD3' ' N ' ' A' ' 39' ' ' GLY . 55.9 Cg_endo -77.88 32.96 0.44 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.494 1.26 . . . . 0.0 111.222 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 5' ' ' GLN . . . -54.39 -59.53 9.95 Favored Glycine 0 N--CA 1.487 2.096 0 O-C-N 120.53 -1.356 . . . . 0.0 109.976 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 75.5 p -78.87 12.35 2.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -1.174 . . . . 0.0 111.501 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.615 ' OH ' HD12 ' A' ' 15' ' ' LEU . 3.2 t80 -72.99 130.6 40.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.851 -1.156 . . . . 0.0 110.078 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.707 HD11 ' SD ' ' A' ' 4' ' ' MET . 1.9 mt -118.66 143.11 32.81 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.982 . . . . 0.0 109.798 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.518 ' HD2' HG23 ' A' ' 44' ' ' ILE . 46.0 Cg_endo -72.58 107.17 2.24 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.971 1.511 . . . . 0.0 110.458 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 49' ' ' VAL . 1.2 mtt-85 -114.91 148.73 38.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.306 -0.871 . . . . 0.0 110.229 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 46' ' ' ARG . 0.3 OUTLIER -40.44 -45.95 2.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.353 -0.842 . . . . 0.0 110.847 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.426 ' C ' ' CG1' ' A' ' 49' ' ' VAL . 3.0 mt-10 -42.53 -39.06 2.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.407 -0.808 . . . . 0.0 110.875 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.63 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.6 m -145.96 174.09 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.15 -0.969 . . . . 0.0 110.549 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 49' ' ' VAL . 1.6 mm-40 -139.39 139.61 37.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.255 -0.903 . . . . 0.0 110.395 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.446 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . 5.0 m -55.23 130.98 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.147 -0.971 . . . . 0.0 110.223 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.607 ' CG2' ' HB2' ' A' ' 16' ' ' LYS . 3.7 t -104.12 -58.7 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.312 -0.867 . . . . 0.0 110.351 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.888 ' C ' HD13 ' A' ' 54' ' ' ILE . 3.7 mt-10 -143.36 171.06 14.64 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.097 -1.002 . . . . 0.0 110.4 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.888 HD13 ' C ' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -132.23 135.96 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.834 HG22 ' O ' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -129.91 143.86 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.913 -1.117 . . . . 0.0 111.694 -178.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.468 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 93.1 mm-40 -91.84 158.78 16.13 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.644 -0.66 . . . . 0.0 109.383 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.775 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -102.35 132.85 48.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.175 -0.953 . . . . 0.0 110.193 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 3.7 t 178.5 55.02 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.132 -0.98 . . . . 0.0 111.584 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.591 HG22 ' O ' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -157.42 -51.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.462 -1.398 . . . . 0.0 111.599 179.341 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.554 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 13.9 mm -70.05 157.42 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.616 -1.302 . . . . 0.0 110.644 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.438 ' O ' HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -90.43 179.58 5.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.35 -0.844 . . . . 0.0 110.004 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.981 ' HA ' HG12 ' A' ' 93' ' ' VAL . 4.4 mt-30 -83.42 -27.07 29.81 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.151 -0.968 . . . . 0.0 110.714 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.711 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 3.1 m120 -94.4 -34.94 12.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.129 -0.982 . . . . 0.0 110.526 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.429 ' NE2' ' O ' ' A' ' 108' ' ' VAL . 40.6 tp60 -58.69 129.3 41.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.115 -0.991 . . . . 0.0 111.146 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.103 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -108.3 143.5 37.09 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.557 ' O ' HD13 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -126.72 120.47 29.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.081 -1.012 . . . . 0.0 110.578 -179.194 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.705 ' O ' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -89.69 141.87 28.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.489 -0.757 . . . . 0.0 109.462 179.591 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.705 HD22 ' O ' ' A' ' 67' ' ' ARG . 1.8 mm? -125.41 125.74 43.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.15 -0.969 . . . . 0.0 111.081 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.9 ' HB2' HD11 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -105.41 159.31 16.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.461 -0.774 . . . . 0.0 109.615 179.433 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.3 151.33 46.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.212 -0.93 . . . . 0.0 110.878 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -116.01 -30.16 6.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.434 -0.791 . . . . 0.0 109.589 179.322 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -149.43 130.21 14.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.304 -0.873 . . . . 0.0 109.802 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.46 ' N ' ' HD3' ' A' ' 72' ' ' LYS . 0.3 OUTLIER -56.57 90.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.176 -0.953 . . . . 0.0 109.903 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 72' ' ' LYS . 37.5 t -176.0 -29.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.384 -0.822 . . . . 0.0 110.442 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.584 ' CE3' ' HG2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -73.89 120.88 20.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.147 -0.971 . . . . 0.0 110.005 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.423 ' OD2' ' O ' ' A' ' 79' ' ' GLY . 3.5 m-20 -80.02 113.85 18.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.354 -0.841 . . . . 0.0 110.051 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.477 ' HB2' ' OE2' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -55.65 -54.7 40.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 110.355 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.68 -13.94 12.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.363 -0.836 . . . . 0.0 110.411 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.423 ' O ' ' OD2' ' A' ' 76' ' ' ASP . . . 143.42 -22.03 2.22 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.8 mmtt -85.77 157.51 20.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.524 -0.986 . . . . 0.0 109.741 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.521 ' HB3' HG11 ' A' ' 29' ' ' VAL . 37.8 mm-40 -69.37 126.5 29.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 110.161 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.473 ' HD2' ' OE1' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -122.2 175.23 6.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.493 -0.754 . . . . 0.0 110.702 -179.541 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.633 HG22 ' N ' ' A' ' 84' ' ' THR . 4.8 p -119.35 171.8 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.417 -0.802 . . . . 0.0 110.423 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.633 ' N ' HG22 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -54.78 -170.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.105 -0.997 . . . . 0.0 108.789 178.746 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 86' ' ' GLU . . . 70.77 -55.88 0.98 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.626 ' HG3' ' N ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -44.76 156.37 0.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.171 -1.193 . . . . 0.0 109.11 179.335 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.626 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 12.9 pt-20 -155.61 145.06 21.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.656 -1.278 . . . . 0.0 111.148 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -112.3 160.39 17.71 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 90' ' ' VAL . 0.1 OUTLIER -115.33 127.72 55.61 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.966 -1.084 . . . . 0.0 111.221 -178.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.64 ' N ' HD12 ' A' ' 89' ' ' LEU . 25.0 t -92.64 108.3 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.394 -0.816 . . . . 0.0 109.705 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.0 m -128.19 46.12 2.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.967 . . . . 0.0 110.829 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.453 ' CG2' ' ND2' ' A' ' 10' ' ' ASN . 53.2 m -107.8 131.3 54.61 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.15 -0.969 . . . . 0.0 110.149 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.981 HG12 ' HA ' ' A' ' 62' ' ' GLN . 27.5 m -66.9 150.29 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.253 -0.904 . . . . 0.0 110.477 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.618 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 41.08 82.03 0.02 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.712 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . . . -159.63 147.08 16.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -1.151 . . . . 0.0 110.207 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.567 ' O ' ' CG ' ' A' ' 96' ' ' TYR . 14.9 t80 -133.49 59.27 1.74 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.379 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.685 HD21 ' HB1' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -117.55 99.91 52.51 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 120.911 -1.118 . . . . 0.0 109.783 178.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.727 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 47.3 Cg_endo -77.56 18.08 0.87 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 124.111 1.585 . . . . 0.0 111.854 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 98' ' ' PRO . . . 70.1 -178.59 0.22 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.81 -1.181 . . . . 0.0 110.426 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.619 HG11 ' OE1' ' A' ' 34' ' ' GLU . 2.6 t -102.57 -61.72 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 109.793 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.537 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 22.0 m-85 -107.73 47.92 0.87 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.27 -0.894 . . . . 0.0 109.925 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.646 ' HB2' HD12 ' A' ' 68' ' ' LEU . 17.8 mt-10 -138.85 158.67 43.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.904 -1.122 . . . . 0.0 111.611 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.63 ' O ' HD13 ' A' ' 68' ' ' LEU . 9.9 mt-10 -132.49 167.53 19.81 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.606 -0.684 . . . . 0.0 109.395 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.521 ' C ' HD13 ' A' ' 105' ' ' LEU . 3.8 m -90.75 146.89 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.937 -1.102 . . . . 0.0 110.263 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.9 HD11 ' HB2' ' A' ' 69' ' ' ARG . 0.8 OUTLIER -102.28 -11.24 18.86 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.405 -0.809 . . . . 0.0 109.351 179.315 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 0.5 OUTLIER 162.46 127.71 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.61 -0.682 . . . . 0.0 110.098 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.1 mp -76.45 121.86 23.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 109.598 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.103 HG13 ' HB3' ' A' ' 65' ' ' ALA . 9.1 p -111.31 153.98 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.094 -1.004 . . . . 0.0 110.467 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.778 ' OD2' HD11 ' A' ' 112' ' ' ILE . 1.5 t0 -110.91 120.17 41.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -0.874 . . . . 0.0 109.821 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . -50.16 -82.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.007 -1.058 . . . . 0.0 110.216 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 111' ' ' VAL . 9.6 p -162.72 135.33 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.379 -0.826 . . . . 0.0 110.019 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.778 HD11 ' OD2' ' A' ' 109' ' ' ASP . 3.8 mt -130.44 -140.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.216 -0.928 . . . . 0.0 109.712 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.512 ' H ' HG22 ' A' ' 112' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.004 -1.06 . . . . 0.0 110.303 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.519 ' O ' ' CD2' ' A' ' 3' ' ' HIS . 0.3 OUTLIER -77.68 -41.0 39.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.283 -1.128 . . . . 0.0 110.116 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.519 ' CD2' ' O ' ' A' ' 2' ' ' SER . 1.6 m170 -151.5 164.59 36.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.203 -0.936 . . . . 0.0 109.999 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.697 ' HG3' HD11 ' A' ' 44' ' ' ILE . 0.5 OUTLIER 57.22 111.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.261 -0.9 . . . . 0.0 110.187 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 2.4 mt-30 -95.33 146.44 24.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.251 -0.906 . . . . 0.0 110.188 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.0 t -77.26 155.89 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.932 . . . . 0.0 110.37 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 74.9 t -45.21 106.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.321 -0.862 . . . . 0.0 110.217 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.761 HD23 ' OG1' ' A' ' 11' ' ' THR . 3.5 mp -49.83 164.72 0.34 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.7 -57.13 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.992 1.522 . . . . 0.0 110.498 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.68 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 3.2 m120 -163.41 31.11 0.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -0.904 . . . . 0.0 110.011 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.761 ' OG1' HD23 ' A' ' 8' ' ' LEU . 55.2 p -112.62 171.82 7.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.316 -0.865 . . . . 0.0 110.37 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -137.74 165.96 25.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.177 -0.952 . . . . 0.0 110.029 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.855 HD23 ' CG ' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -133.95 155.63 49.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.149 -0.969 . . . . 0.0 111.032 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.628 ' C ' HD23 ' A' ' 15' ' ' LEU . 52.8 m80 -99.06 132.74 44.14 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.288 -0.883 . . . . 0.0 110.474 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.856 HD21 ' HB2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -137.06 156.76 48.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.997 -1.064 . . . . 0.0 109.984 178.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 3.4 mtpt -107.94 123.56 48.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.358 -0.839 . . . . 0.0 110.742 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.087 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -82.1 119.68 24.33 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.314 -0.866 . . . . 0.0 110.157 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.861 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 2.8 mm? -101.06 101.18 11.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.581 -0.699 . . . . 0.0 109.865 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.487 HD13 ' HA ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -160.99 147.15 14.74 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.102 -0.999 . . . . 0.0 110.502 -179.679 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -88.75 113.26 24.12 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.672 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -130.6 142.89 50.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.081 -1.012 . . . . 0.0 111.733 -178.27 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -102.16 123.69 46.45 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.442 -0.786 . . . . 0.0 109.548 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -89.33 164.36 14.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.077 -1.014 . . . . 0.0 110.669 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -32.57 59.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.384 -0.822 . . . . 0.0 110.065 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -65.77 -27.85 68.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 110.215 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.85 26.41 5.02 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 28' ' ' LYS . 0.4 OUTLIER -103.27 -43.04 5.55 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.204 -1.174 . . . . 0.0 110.126 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 21' ' ' PHE . 37.5 tttt 58.08 133.69 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.635 -0.666 . . . . 0.0 110.888 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.672 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -95.35 147.4 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.223 -0.923 . . . . 0.0 109.027 179.207 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 30' ' ' VAL . 16.7 m -130.99 85.61 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.961 -1.087 . . . . 0.0 110.98 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.861 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 42.16 68.76 0.43 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.409 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.88 23.51 0.09 OUTLIER Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.445 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 1.087 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 10.5 m-20 -85.72 154.22 21.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.818 -1.401 . . . . 0.0 109.734 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 78.7 tt0 -155.93 138.71 15.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.294 -0.879 . . . . 0.0 110.312 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.667 ' CH2' HD12 ' A' ' 15' ' ' LEU . 3.8 p90 -157.77 177.14 11.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.164 -0.96 . . . . 0.0 110.523 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.654 HD22 ' O ' ' A' ' 98' ' ' PRO . 39.7 tp -90.43 165.56 13.76 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.433 -0.792 . . . . 0.0 110.824 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.856 ' HB2' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -135.73 110.84 8.91 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.58 -0.7 . . . . 0.0 109.467 179.554 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -86.22 131.31 34.26 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.193 -0.942 . . . . 0.0 110.441 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.597 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 54.98 45.99 79.15 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.855 ' CG ' HD23 ' A' ' 13' ' ' LEU . 39.5 Cg_endo -67.03 -60.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.918 1.483 . . . . 0.0 110.338 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 5' ' ' GLN . . . 37.83 -86.81 0.01 OUTLIER Glycine 0 N--CA 1.497 2.72 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.617 ' N ' ' O ' ' A' ' 40' ' ' PRO . 1.2 p -54.4 -7.65 0.17 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.337 -1.096 . . . . 0.0 112.008 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.599 ' CD2' HD21 ' A' ' 13' ' ' LEU . 6.6 t80 -67.37 130.09 41.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.61 -1.307 . . . . 0.0 110.096 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.697 HD11 ' HG3' ' A' ' 4' ' ' MET . 34.1 mt -119.56 147.78 44.4 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.51 -0.744 . . . . 0.0 109.639 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.695 ' HD2' HG23 ' A' ' 44' ' ' ILE . 40.4 Cg_endo -68.48 87.62 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.841 1.442 . . . . 0.0 110.462 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 49' ' ' VAL . 18.3 mmt85 -95.91 157.73 15.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.402 -0.811 . . . . 0.0 110.112 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -53.66 -19.84 4.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.177 -0.952 . . . . 0.0 110.107 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.489 ' C ' ' CG1' ' A' ' 49' ' ' VAL . 1.8 tp10 -62.65 -36.51 83.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.283 -0.885 . . . . 0.0 109.752 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.489 ' CG1' ' C ' ' A' ' 48' ' ' GLU . 0.9 OUTLIER -150.05 173.92 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.393 -0.817 . . . . 0.0 109.521 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 52' ' ' VAL . 6.3 mt-10 -130.88 125.59 33.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.043 -1.036 . . . . 0.0 110.507 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 51' ' ' VAL . 2.6 p -54.21 124.84 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.098 -1.001 . . . . 0.0 109.139 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.877 HG12 ' HG2' ' A' ' 53' ' ' GLU . 47.1 t -104.37 -61.79 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.106 -0.996 . . . . 0.0 111.1 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.95 ' O ' HD13 ' A' ' 54' ' ' ILE . 4.5 mm-40 -134.84 174.09 10.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.071 -1.018 . . . . 0.0 110.612 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.95 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.1 mm -135.24 131.76 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.486 HG13 ' HG2' ' A' ' 98' ' ' PRO . 0.3 OUTLIER -121.13 137.31 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.106 -0.996 . . . . 0.0 111.269 -178.583 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.495 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 6.8 mp0 -95.37 169.24 10.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.505 -0.747 . . . . 0.0 110.543 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.888 ' HB1' ' HB3' ' A' ' 95' ' ' ALA . . . -96.85 118.99 34.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.821 . . . . 0.0 110.282 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 58' ' ' THR . 8.1 t -176.91 78.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.053 -1.03 . . . . 0.0 110.726 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.79 HG21 ' CD1' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -179.12 -59.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.944 -1.098 . . . . 0.0 111.104 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.697 HG13 HG22 ' A' ' 59' ' ' ILE . 1.7 mt -92.75 -139.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 120.295 -1.503 . . . . 0.0 109.695 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.503 ' H ' HG22 ' A' ' 60' ' ' ILE . 14.7 mtt85 -155.53 -162.02 1.26 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.077 -1.014 . . . . 0.0 110.092 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.834 ' CB ' HG12 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -83.06 -72.28 0.46 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.944 . . . . 0.0 111.109 -179.171 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.563 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 9.6 p30 -45.41 -41.1 8.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -0.918 . . . . 0.0 111.304 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.85 136.87 51.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.877 -1.139 . . . . 0.0 111.14 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.989 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -121.96 142.65 50.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.515 -0.741 . . . . 0.0 109.296 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.936 HD22 ' C ' ' A' ' 65' ' ' ALA . 4.4 mm? -125.85 112.8 16.43 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.962 -1.086 . . . . 0.0 110.668 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.494 ' O ' ' HG3' ' A' ' 67' ' ' ARG . 3.5 ptp180 -90.91 126.98 36.21 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.031 -1.043 . . . . 0.0 110.362 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.789 HD23 ' HA ' ' A' ' 104' ' ' VAL . 17.2 mt -123.02 137.82 54.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.363 -0.836 . . . . 0.0 110.678 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -98.79 154.09 18.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.313 -0.867 . . . . 0.0 109.953 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.905 ' HB2' ' HG3' ' A' ' 86' ' ' GLU . . . -67.92 140.35 56.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.378 -0.826 . . . . 0.0 111.6 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 101' ' ' PHE . 15.1 tpp85 -104.38 -38.46 6.82 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.5 ' HB2' ' HB3' ' A' ' 101' ' ' PHE . 2.0 mmtt -113.81 155.96 24.75 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.453 ' OE2' ' OD1' ' A' ' 27' ' ' ASP . 12.5 pt-20 -86.82 27.76 0.96 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.988 -1.07 . . . . 0.0 110.275 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.6 -20.97 4.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.211 -0.93 . . . . 0.0 110.689 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.6 ' HB2' ' CD2' ' A' ' 101' ' ' PHE . 13.7 t90 -73.99 107.27 6.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.155 -0.965 . . . . 0.0 110.426 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 82' ' ' ARG . 8.3 m-20 -112.75 122.96 49.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.353 -0.842 . . . . 0.0 110.157 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.5 ' NH2' ' OD2' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -88.01 -20.41 25.85 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.265 -0.897 . . . . 0.0 110.256 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.5 ' OD2' ' NH2' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -96.16 6.98 47.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.208 -0.933 . . . . 0.0 110.032 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.07 9.33 86.83 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 76' ' ' ASP . 2.0 mmmt -117.88 135.61 53.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -1.189 . . . . 0.0 110.406 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.75 125.77 7.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -0.865 . . . . 0.0 110.159 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.504 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 1.5 mtt-85 -137.36 142.88 41.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.89 . . . . 0.0 110.115 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.556 HG13 ' H ' ' A' ' 85' ' ' GLY . 11.4 p -78.62 170.72 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.912 . . . . 0.0 110.215 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.754 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -55.44 -17.51 5.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.513 -0.742 . . . . 0.0 110.384 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.556 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -72.74 -12.2 78.1 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.905 ' HG3' ' HB2' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -67.3 170.97 6.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.969 -1.312 . . . . 0.0 109.848 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -159.59 145.61 16.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.15 -0.969 . . . . 0.0 110.277 179.66 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.596 ' CZ2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -132.08 133.69 44.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.22 -0.925 . . . . 0.0 110.016 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.073 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -107.06 138.72 42.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 110.018 179.737 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 1.073 ' N ' HD22 ' A' ' 89' ' ' LEU . 63.5 t -93.91 101.35 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.343 -0.848 . . . . 0.0 110.137 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.868 ' HB ' HD11 ' A' ' 89' ' ' LEU . 1.5 t -119.64 0.2 10.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.596 -0.69 . . . . 0.0 109.717 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 93' ' ' VAL . 98.9 m -88.06 114.44 24.68 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.429 -0.794 . . . . 0.0 110.259 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.834 HG12 ' CB ' ' A' ' 62' ' ' GLN . 16.6 m -41.31 124.7 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.453 -0.78 . . . . 0.0 109.753 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' A' ' 96' ' ' TYR . . . -174.93 34.78 0.1 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.888 ' HB3' ' HB1' ' A' ' 57' ' ' ALA . . . 45.58 -80.83 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.758 -0.848 . . . . 0.0 111.627 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.79 ' CD1' HG21 ' A' ' 59' ' ' ILE . 3.8 t80 -125.12 159.76 30.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.625 -1.297 . . . . 0.0 110.06 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -173.28 69.07 0.36 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.131 -0.98 . . . . 0.0 110.555 -179.441 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.654 ' O ' HD22 ' A' ' 36' ' ' LEU . 45.1 Cg_endo -74.89 145.27 31.68 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.839 1.441 . . . . 0.0 109.938 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.786 ' HB3' ' CG ' ' A' ' 102' ' ' GLU . . . -104.95 -141.67 0.37 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.038 -1.039 . . . . 0.0 111.15 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.512 ' CG2' ' HA ' ' A' ' 35' ' ' TRP . 0.9 OUTLIER -121.29 -58.42 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.136 -0.978 . . . . 0.0 111.819 -178.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.6 ' CD2' ' HB2' ' A' ' 75' ' ' TRP . 9.7 m-30 -111.35 55.6 0.66 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.161 -1.587 . . . . 0.0 111.492 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.786 ' CG ' ' HB3' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -141.2 143.83 34.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.592 -1.317 . . . . 0.0 110.815 179.218 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.407 ' O ' ' CD1' ' A' ' 105' ' ' LEU . 12.5 tp10 -118.56 128.31 54.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.586 -0.696 . . . . 0.0 110.171 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.789 ' HA ' HD23 ' A' ' 68' ' ' LEU . 4.9 p -65.28 148.53 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.389 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 1.6 mp -105.19 -45.56 4.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.354 -0.841 . . . . 0.0 109.944 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.11 133.14 2.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.878 . . . . 0.0 109.963 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.855 ' C ' HD22 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -76.06 142.65 41.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.939 . . . . 0.0 111.119 -179.499 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.989 HG13 ' HB3' ' A' ' 65' ' ' ALA . 3.4 p -128.03 149.88 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.993 -1.067 . . . . 0.0 109.709 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.2 119.58 39.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.058 -1.026 . . . . 0.0 110.544 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 63' ' ' ASN . . . -81.82 -173.59 4.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.028 -1.045 . . . . 0.0 109.862 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.73 HG12 HG23 ' A' ' 112' ' ' ILE . 86.8 t -74.78 -89.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.169 -0.957 . . . . 0.0 110.439 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.73 HG23 HG12 ' A' ' 111' ' ' VAL . 3.0 pt -119.86 -24.81 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.083 -1.011 . . . . 0.0 110.039 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.557 ' OXT' HD23 ' A' ' 113' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.142 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.561 ' O ' ' CD2' ' A' ' 3' ' ' HIS . 79.8 p -63.27 -49.24 74.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -1.112 . . . . 0.0 110.086 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.561 ' CD2' ' O ' ' A' ' 2' ' ' SER . 1.5 m-70 174.49 -33.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.168 -0.958 . . . . 0.0 110.41 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.42 ' HA ' HD11 ' A' ' 44' ' ' ILE . 1.5 mtt -98.31 137.63 36.75 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.179 -0.951 . . . . 0.0 110.462 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.513 ' CB ' ' O ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -97.4 -173.94 2.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.311 -0.868 . . . . 0.0 110.071 179.714 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.522 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 3.5 t -123.29 160.09 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.243 -0.91 . . . . 0.0 109.954 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.471 ' O ' ' O ' ' A' ' 8' ' ' LEU . 10.6 t -57.06 81.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.374 -0.828 . . . . 0.0 110.837 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.798 ' C ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -45.62 171.38 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.43 -0.794 . . . . 0.0 110.113 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.632 ' N ' HD22 ' A' ' 8' ' ' LEU . 51.3 Cg_endo -75.44 -99.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.524 1.276 . . . . 0.0 111.955 -178.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.963 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 0.8 OUTLIER -112.38 83.94 1.89 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.761 -1.212 . . . . 0.0 110.934 -178.711 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.744 HG23 HD23 ' A' ' 8' ' ' LEU . 1.7 p -156.16 169.6 24.13 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.204 -0.935 . . . . 0.0 110.17 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.909 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -145.9 167.37 23.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 108.883 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.813 HD23 ' HG3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -134.55 153.75 51.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.826 -1.171 . . . . 0.0 111.137 179.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 1.04 ' CD2' HD13 ' A' ' 36' ' ' LEU . 14.3 m-70 -98.5 135.63 39.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -0.858 . . . . 0.0 109.261 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.951 HD13 ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -139.11 165.53 26.91 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.128 -0.983 . . . . 0.0 110.172 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 1.6 tttt -114.51 120.91 41.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 111.108 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.0 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -81.56 112.53 18.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.416 -0.802 . . . . 0.0 109.696 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.809 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -100.47 101.6 12.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.395 -0.816 . . . . 0.0 110.124 -179.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.581 HD23 ' HG3' ' A' ' 48' ' ' GLU . 0.1 OUTLIER -162.27 139.18 8.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 110.208 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.577 ' H ' HD13 ' A' ' 19' ' ' LEU . 33.9 p-10 -78.83 101.53 7.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.687 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.883 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -121.62 104.91 9.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.27 -0.894 . . . . 0.0 110.53 -179.46 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 2.3 pt-20 -119.79 115.89 24.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.401 -0.812 . . . . 0.0 109.819 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.75 175.17 6.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.176 -0.952 . . . . 0.0 110.44 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -65.24 -13.44 58.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.426 -0.796 . . . . 0.0 110.176 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.4 -25.87 68.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 110.057 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.78 -66.44 0.48 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -148.13 134.22 19.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.304 -1.115 . . . . 0.0 110.168 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.3 tptt -125.15 -90.47 0.55 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.126 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.883 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -106.63 143.32 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.681 -1.262 . . . . 0.0 109.416 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.613 ' O ' HG23 ' A' ' 30' ' ' VAL . 29.1 m -138.59 88.58 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.024 -1.047 . . . . 0.0 110.676 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.809 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 41.55 65.32 0.86 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.372 -0.83 . . . . 0.0 110.55 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -175.17 26.02 0.07 OUTLIER Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.501 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 1.0 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 10.0 m-20 -86.7 154.53 20.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.893 -1.357 . . . . 0.0 109.833 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.724 ' OE2' HG21 ' A' ' 52' ' ' VAL . 3.8 tt0 -153.59 131.27 11.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.251 -0.906 . . . . 0.0 110.176 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.776 ' CZ3' ' HB2' ' A' ' 17' ' ' ALA . 6.8 p90 -151.94 165.17 35.43 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.062 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 1.04 HD13 ' CD2' ' A' ' 14' ' ' HIS . 51.6 tp -91.44 161.86 14.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -0.834 . . . . 0.0 110.173 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.612 ' CE2' ' HB2' ' A' ' 43' ' ' TYR . 0.9 OUTLIER -136.78 111.99 9.09 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.366 -0.834 . . . . 0.0 109.89 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.648 ' HB2' HD21 ' A' ' 97' ' ' LEU . 2.4 tm-20 -84.31 140.68 31.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.683 -0.635 . . . . 0.0 109.803 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.609 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 59.05 40.77 95.97 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.813 ' HG3' HD23 ' A' ' 13' ' ' LEU . 49.2 Cg_endo -75.2 -51.14 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.375 1.197 . . . . 0.0 109.535 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.588 ' N ' HD12 ' A' ' 8' ' ' LEU . . . 41.63 -94.08 0.01 OUTLIER Glycine 0 N--CA 1.486 1.967 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 40' ' ' PRO . 1.8 t -78.23 19.9 0.42 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.425 -1.044 . . . . 0.0 112.05 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.612 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 1.6 t80 -67.61 111.05 3.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.675 -1.266 . . . . 0.0 109.006 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.457 HG23 ' HD2' ' A' ' 45' ' ' PRO . 51.1 mm -90.11 142.14 28.42 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.295 -0.878 . . . . 0.0 110.609 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.653 ' HB3' HG23 ' A' ' 51' ' ' VAL . 48.3 Cg_endo -74.74 106.5 2.27 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.184 1.623 . . . . 0.0 110.467 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.428 ' O ' ' N ' ' A' ' 48' ' ' GLU . 0.7 OUTLIER -84.95 147.85 26.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 109.789 179.699 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -43.71 -25.82 0.2 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.163 -0.96 . . . . 0.0 109.933 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.581 ' HG3' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -62.15 -46.45 88.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -0.863 . . . . 0.0 110.51 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.641 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -124.03 173.17 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.183 -0.948 . . . . 0.0 110.418 -179.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.416 ' O ' HG23 ' A' ' 52' ' ' VAL . 3.0 mm-40 -135.1 137.12 42.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 110.22 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.653 HG23 ' HB3' ' A' ' 45' ' ' PRO . 12.2 t -56.98 138.79 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 109.234 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.724 HG21 ' OE2' ' A' ' 34' ' ' GLU . 39.4 t -121.86 -51.27 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.031 -1.043 . . . . 0.0 110.799 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.822 ' O ' HD13 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -145.6 166.89 24.45 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.977 -1.077 . . . . 0.0 110.147 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.822 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -134.29 131.24 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.335 -0.853 . . . . 0.0 109.245 179.185 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.909 HG22 ' O ' ' A' ' 12' ' ' ALA . 8.0 tt -117.03 145.93 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.061 -1.024 . . . . 0.0 111.44 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.452 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 14.4 mp0 -105.79 -179.51 3.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.618 -0.676 . . . . 0.0 109.837 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.963 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -97.16 136.06 38.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.159 -0.963 . . . . 0.0 111.17 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 4.7 t 176.23 57.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.443 -0.786 . . . . 0.0 111.134 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.621 HG21 ' CG ' ' A' ' 96' ' ' TYR . 0.5 OUTLIER -173.77 -48.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.507 -1.371 . . . . 0.0 112.33 179.389 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.602 HG22 ' N ' ' A' ' 61' ' ' ARG . 70.7 mt -75.69 172.63 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.577 -1.327 . . . . 0.0 110.333 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.602 ' N ' HG22 ' A' ' 60' ' ' ILE . 29.7 mtt-85 -117.81 -174.31 2.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.035 -1.04 . . . . 0.0 110.256 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.798 ' CA ' HG13 ' A' ' 93' ' ' VAL . 5.6 tt0 -79.16 -30.22 43.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.17 -0.956 . . . . 0.0 110.96 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 7.2 p30 -105.94 -21.87 13.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.009 -1.057 . . . . 0.0 110.625 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 109' ' ' ASP . 5.5 tp-100 -58.39 135.0 57.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.873 -1.142 . . . . 0.0 110.699 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.106 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -112.96 135.47 53.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.487 -0.758 . . . . 0.0 109.324 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.592 ' O ' HD22 ' A' ' 89' ' ' LEU . 1.3 mp -124.82 117.23 23.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.192 -0.942 . . . . 0.0 111.173 -179.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.496 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 1.7 ttp180 -96.34 126.13 41.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 108.965 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.017 ' CD2' HG12 ' A' ' 104' ' ' VAL . 17.8 mt -118.89 133.18 56.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.01 -1.056 . . . . 0.0 110.582 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 5.4 ttt85 -114.85 150.63 35.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -0.847 . . . . 0.0 110.13 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.523 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -70.32 123.45 21.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.83 . . . . 0.0 110.752 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -81.8 -38.67 25.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.947 . . . . 0.0 108.931 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.636 ' CG ' ' CD2' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -136.35 143.25 43.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.535 -0.728 . . . . 0.0 109.239 179.099 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 74' ' ' CYS . 0.0 OUTLIER -55.46 -161.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.983 . . . . 0.0 110.58 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 7.3 m 78.88 -40.97 0.27 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.587 -0.696 . . . . 0.0 110.54 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.603 ' CD1' ' HB2' ' A' ' 35' ' ' TRP . 20.6 t90 -73.38 104.36 4.36 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.769 -1.207 . . . . 0.0 110.099 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.452 ' OD1' ' HA ' ' A' ' 81' ' ' GLU . 65.1 m-20 -84.1 113.72 21.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.853 . . . . 0.0 110.136 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.459 ' HB2' ' CH2' ' A' ' 75' ' ' TRP . 21.8 tpt180 -87.45 -8.55 56.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.316 -0.865 . . . . 0.0 110.489 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.02 3.04 9.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 110.199 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.69 -2.9 64.98 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.85 144.27 48.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -1.114 . . . . 0.0 110.047 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.65 ' CB ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -46.16 110.67 0.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -0.929 . . . . 0.0 110.408 -179.762 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.35 179.44 3.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.212 -0.93 . . . . 0.0 109.947 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.654 HG13 ' H ' ' A' ' 85' ' ' GLY . 12.5 p -116.85 172.87 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.995 -1.066 . . . . 0.0 110.503 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.597 ' N ' HG22 ' A' ' 83' ' ' VAL . 7.5 t -57.55 -16.35 9.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.303 -0.873 . . . . 0.0 109.96 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.654 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -71.38 -14.25 74.34 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.437 ' HB3' ' O ' ' A' ' 83' ' ' VAL . 5.1 tp10 -75.63 147.75 39.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.406 -1.055 . . . . 0.0 109.67 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 68' ' ' LEU . 4.8 tt0 -157.38 162.44 39.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.212 -0.93 . . . . 0.0 109.981 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.576 ' CZ2' ' HB ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -153.34 142.04 20.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.17 -0.956 . . . . 0.0 110.232 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.859 HD13 ' O ' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -100.25 119.42 38.35 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.497 -0.752 . . . . 0.0 109.98 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.599 ' N ' HD22 ' A' ' 89' ' ' LEU . 5.3 p -97.99 150.72 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -0.925 . . . . 0.0 110.749 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.1 t -148.98 51.06 0.97 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.453 -0.779 . . . . 0.0 109.903 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.649 HG22 ' OD1' ' A' ' 10' ' ' ASN . 9.2 m -82.95 139.82 33.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -0.917 . . . . 0.0 110.459 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.798 HG13 ' CA ' ' A' ' 62' ' ' GLN . 8.1 t -75.4 128.75 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.168 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.705 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 48.69 84.32 0.02 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.588 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . . . -177.61 151.46 0.74 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.111 -1.229 . . . . 0.0 110.953 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.621 ' CG ' HG21 ' A' ' 59' ' ' ILE . 1.2 t80 -116.88 112.57 21.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.021 -1.049 . . . . 0.0 110.419 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -124.94 76.71 66.62 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.183 -0.948 . . . . 0.0 110.249 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.414 ' HD3' ' CD1' ' A' ' 96' ' ' TYR . 52.8 Cg_endo -77.18 6.67 4.15 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.009 1.531 . . . . 0.0 110.967 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.589 ' CB ' ' CG ' ' A' ' 102' ' ' GLU . . . 52.41 -161.47 0.1 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.002 -1.062 . . . . 0.0 110.084 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.67 HG11 ' HG2' ' A' ' 34' ' ' GLU . 3.4 t -115.0 -62.01 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.07 -1.019 . . . . 0.0 111.19 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.636 ' CD2' ' CG ' ' A' ' 72' ' ' LYS . 4.5 m-30 -93.71 -29.65 15.3 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.767 -1.208 . . . . 0.0 111.214 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.589 ' CG ' ' CB ' ' A' ' 99' ' ' ALA . 8.6 pt-20 -80.37 161.15 25.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.965 -1.084 . . . . 0.0 110.899 -178.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.478 ' OE2' ' CD2' ' A' ' 105' ' ' LEU . 0.8 OUTLIER -136.05 164.18 28.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.364 -0.835 . . . . 0.0 110.018 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 1.017 HG12 ' CD2' ' A' ' 68' ' ' LEU . 3.9 m -76.25 139.85 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.909 . . . . 0.0 110.43 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.735 ' N ' HD23 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -94.0 -10.34 33.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.329 -0.857 . . . . 0.0 109.145 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.505 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER 166.35 -174.66 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.548 -0.72 . . . . 0.0 109.871 179.677 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 107' ' ' LEU . 4.4 mp -133.54 127.47 33.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.3 -0.875 . . . . 0.0 109.762 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.106 HG13 ' HB3' ' A' ' 65' ' ' ALA . 9.4 p -124.51 113.72 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.951 -1.093 . . . . 0.0 111.004 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -70.01 134.95 48.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.184 -0.947 . . . . 0.0 109.941 179.405 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . -88.68 53.59 2.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.423 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 110' ' ' ALA . 55.3 t -153.43 120.47 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 110.178 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.2 tt -118.49 141.56 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.227 -0.921 . . . . 0.0 110.146 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.144 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.3 m -87.63 139.54 30.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.208 -1.172 . . . . 0.0 110.19 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.474 ' O ' ' O ' ' A' ' 4' ' ' MET . 0.5 OUTLIER -44.38 131.67 6.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.344 -0.848 . . . . 0.0 110.367 -179.828 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.474 ' O ' ' O ' ' A' ' 3' ' ' HIS . 0.0 OUTLIER 58.48 120.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.186 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.454 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . 7.1 tt0 -117.84 168.17 10.72 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.211 -0.931 . . . . 0.0 110.205 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.551 ' C ' ' HA3' ' A' ' 41' ' ' GLY . 7.1 p -118.4 139.51 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.157 -0.964 . . . . 0.0 109.991 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.708 HG23 ' CA ' ' A' ' 39' ' ' GLY . 2.2 p -38.85 120.45 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.31 -0.869 . . . . 0.0 111.118 -178.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.659 HD23 ' OG1' ' A' ' 11' ' ' THR . 0.0 OUTLIER -67.99 171.54 5.41 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.817 -0.552 . . . . 0.0 109.766 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 38.1 Cg_endo -64.67 73.8 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.593 1.312 . . . . 0.0 109.969 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.944 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 9.2 m-20 64.1 33.29 12.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.873 -0.517 . . . . 0.0 111.558 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.659 ' OG1' HD23 ' A' ' 8' ' ' LEU . 1.2 p -106.16 169.07 8.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.76 -1.213 . . . . 0.0 109.369 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.572 ' HB2' ' HA ' ' A' ' 38' ' ' GLU . . . -148.75 158.67 44.32 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.008 -1.057 . . . . 0.0 110.496 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.049 HD13 HD11 ' A' ' 15' ' ' LEU . 1.4 pp -127.57 156.94 41.44 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.294 -0.879 . . . . 0.0 110.896 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.621 ' CD2' ' N ' ' A' ' 14' ' ' HIS . 6.6 m170 -93.39 127.17 38.89 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.526 -0.734 . . . . 0.0 110.622 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.049 HD11 HD13 ' A' ' 13' ' ' LEU . 1.1 mm? -114.21 144.66 42.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.487 -0.758 . . . . 0.0 110.151 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.553 ' HB2' HG22 ' A' ' 52' ' ' VAL . 4.2 tttp -107.75 116.54 32.13 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.241 -0.983 . . . . 0.0 109.339 178.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.024 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -79.39 120.85 24.39 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 110.074 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.752 HD12 ' OE1' ' A' ' 50' ' ' GLU . 70.6 mt -105.98 101.21 10.72 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.883 -0.511 . . . . 0.0 109.638 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.841 HD13 ' N ' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -164.04 144.1 8.14 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.074 -1.016 . . . . 0.0 110.608 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.841 ' N ' HD13 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -84.9 103.4 13.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.343 -0.848 . . . . 0.0 109.146 178.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.8 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -115.39 111.66 21.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.0 110.542 -179.067 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.554 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 7.8 tt0 -91.98 126.71 37.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.349 -0.844 . . . . 0.0 110.272 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -108.88 146.59 33.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.143 -0.973 . . . . 0.0 110.109 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.08 3.48 20.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.286 -0.884 . . . . 0.0 110.435 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.61 1.65 46.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.221 -0.925 . . . . 0.0 110.356 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.34 -17.76 54.65 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -101.0 90.41 4.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.334 -1.098 . . . . 0.0 109.72 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -107.31 164.46 12.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.24 -0.913 . . . . 0.0 110.463 -179.547 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.8 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -110.73 141.87 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.215 -0.928 . . . . 0.0 109.032 179.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 30' ' ' VAL . 23.1 m -131.53 90.31 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.997 -1.064 . . . . 0.0 110.686 -179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.576 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 39.98 58.34 2.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.468 -0.77 . . . . 0.0 110.74 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.91 28.05 0.22 Allowed Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.58 -1.295 . . . . 0.0 110.04 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 1.024 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 7.4 m-20 -91.98 148.35 22.27 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.08 -1.247 . . . . 0.0 110.075 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.746 ' OE1' HG11 ' A' ' 52' ' ' VAL . 5.3 tt0 -147.63 131.7 17.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.016 -1.053 . . . . 0.0 110.603 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.589 ' HH2' HG21 ' A' ' 49' ' ' VAL . 10.3 p90 -140.64 172.92 12.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.188 -0.945 . . . . 0.0 110.3 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.763 HD21 ' HB2' ' A' ' 97' ' ' LEU . 17.1 tp -106.16 156.78 18.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.488 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.499 ' N ' ' HG ' ' A' ' 36' ' ' LEU . 1.5 t80 -142.89 115.52 8.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.239 -0.913 . . . . 0.0 110.913 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.572 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 4.3 tm-20 -84.53 141.58 30.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.532 -0.73 . . . . 0.0 109.273 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.708 ' CA ' HG23 ' A' ' 7' ' ' VAL . . . 63.43 47.73 84.76 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.771 ' HB2' HD21 ' A' ' 13' ' ' LEU . 47.1 Cg_endo -68.99 7.06 0.85 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 124.187 1.625 . . . . 0.0 112.071 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.551 ' HA3' ' C ' ' A' ' 6' ' ' VAL . . . -49.67 -57.03 10.05 Favored Glycine 0 N--CA 1.486 2.0 0 C-N-CA 119.321 -1.418 . . . . 0.0 109.56 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 61.4 p -71.93 -4.45 28.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.479 -1.012 . . . . 0.0 110.789 -179.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.778 ' OH ' HD12 ' A' ' 15' ' ' LEU . 4.3 t80 -82.67 111.5 18.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.042 -1.036 . . . . 0.0 109.732 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.538 HG23 ' HD2' ' A' ' 45' ' ' PRO . 18.2 mm -102.48 144.56 28.86 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.255 -0.903 . . . . 0.0 109.787 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.538 ' HD2' HG23 ' A' ' 44' ' ' ILE . 42.2 Cg_endo -67.8 96.3 0.43 Allowed 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.033 1.543 . . . . 0.0 111.474 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.1 147.71 23.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 109.482 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.471 ' HG3' ' N ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -50.72 -30.95 15.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.161 -0.962 . . . . 0.0 110.474 -179.572 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.471 ' N ' ' HG3' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -52.25 -25.49 9.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.129 -0.982 . . . . 0.0 110.668 -179.796 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.613 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.5 m -149.18 173.29 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.885 . . . . 0.0 109.615 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.752 ' OE1' HD12 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -132.74 134.79 45.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.052 -1.03 . . . . 0.0 110.595 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.434 HG23 ' H ' ' A' ' 51' ' ' VAL . 9.0 t -54.79 130.78 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 109.128 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.879 HG12 ' OE2' ' A' ' 53' ' ' GLU . 5.3 t -104.54 -62.24 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.366 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.967 ' O ' HD13 ' A' ' 54' ' ' ILE . 2.4 mm-40 -146.29 173.72 12.0 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.189 -1.005 . . . . 0.0 110.547 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.967 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.3 mm -133.68 145.88 32.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.503 HD13 ' N ' ' A' ' 56' ' ' GLN . 0.4 OUTLIER -136.71 139.05 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.914 -1.116 . . . . 0.0 110.923 -178.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.515 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 2.8 mp0 -88.75 159.63 17.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.574 -0.704 . . . . 0.0 109.939 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.944 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -94.84 138.06 33.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.286 -0.884 . . . . 0.0 110.222 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 1.7 t 178.48 58.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.988 -1.07 . . . . 0.0 111.903 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.58 HG22 ' O ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER -166.04 -52.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.605 -1.31 . . . . 0.0 111.201 178.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.574 ' N ' ' CG2' ' A' ' 59' ' ' ILE . 10.5 mt -62.45 161.23 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.655 -1.278 . . . . 0.0 109.552 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.469 ' HB2' ' HB2' ' A' ' 64' ' ' GLN . 1.0 OUTLIER -96.38 -168.43 1.73 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.1 -1.0 . . . . 0.0 110.818 -179.37 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.81 ' HA ' HG13 ' A' ' 93' ' ' VAL . 7.5 tt0 -89.03 -17.5 29.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.323 -0.861 . . . . 0.0 111.116 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.93 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 2.4 p-10 -115.96 -36.34 4.17 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 110.266 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.469 ' HB2' ' HB2' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -55.54 132.05 47.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 111.175 -179.596 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.007 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -109.9 149.71 29.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.384 -0.823 . . . . 0.0 109.381 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.715 ' O ' HG12 ' A' ' 90' ' ' VAL . 0.7 OUTLIER -119.01 123.9 45.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.831 -1.168 . . . . 0.0 110.948 -179.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.603 ' HG2' HD22 ' A' ' 105' ' ' LEU . 7.9 ttt180 -91.5 120.91 32.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 109.255 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.626 HD13 ' C ' ' A' ' 103' ' ' GLU . 2.5 mm? -112.66 137.49 50.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.186 -0.946 . . . . 0.0 111.256 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.58 ' CB ' HD11 ' A' ' 105' ' ' LEU . 7.5 ttt180 -128.12 150.53 49.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.539 -0.725 . . . . 0.0 109.466 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.769 ' HB2' ' HG2' ' A' ' 86' ' ' GLU . . . -62.84 136.76 58.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.053 -1.029 . . . . 0.0 110.603 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.504 ' HG3' ' HD2' ' A' ' 72' ' ' LYS . 34.8 tpt85 -107.52 -26.3 10.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.252 -0.905 . . . . 0.0 110.022 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.646 ' HG3' ' CD2' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -143.83 34.7 1.26 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.22 -0.925 . . . . 0.0 110.332 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.57 ' O ' ' CB ' ' A' ' 74' ' ' CYS . 1.1 pt-20 38.76 -162.13 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.585 -0.697 . . . . 0.0 110.447 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.57 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER 77.43 -35.21 0.21 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.382 -0.824 . . . . 0.0 111.156 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.578 ' CB ' ' HB2' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -73.87 113.13 10.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.91 -1.119 . . . . 0.0 109.665 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 79' ' ' GLY . 11.0 t0 -78.17 109.96 12.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.345 -0.847 . . . . 0.0 110.839 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.56 ' HB2' ' CZ2' ' A' ' 75' ' ' TRP . 1.4 tpm_? -88.68 -41.8 12.37 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.281 -0.887 . . . . 0.0 109.79 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -102.95 -9.07 20.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.356 -0.84 . . . . 0.0 110.128 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.498 ' N ' ' OD1' ' A' ' 76' ' ' ASP . . . 103.56 -4.6 47.21 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 81' ' ' GLU . 2.1 mttt -103.63 2.13 32.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -1.167 . . . . 0.0 110.132 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.466 ' OE2' ' OD2' ' A' ' 33' ' ' ASP . 43.5 mm-40 57.32 110.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 110.083 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.44 ' HB2' ' CD ' ' A' ' 86' ' ' GLU . 1.5 mmm-85 -113.8 179.87 3.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.465 -0.772 . . . . 0.0 110.641 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.929 HG13 ' H ' ' A' ' 85' ' ' GLY . 5.8 p -87.56 169.91 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.415 -0.803 . . . . 0.0 110.653 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.679 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -48.55 -23.03 0.86 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.304 -0.873 . . . . 0.0 110.138 179.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.929 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -64.66 -34.58 90.29 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.769 ' HG2' ' HB2' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -50.19 162.51 0.21 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.171 -1.193 . . . . 0.0 109.727 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.459 ' HB3' ' HG3' ' A' ' 69' ' ' ARG . 7.8 pt-20 -159.13 151.22 21.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.145 -0.972 . . . . 0.0 110.655 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.521 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -133.0 148.44 52.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.431 -0.793 . . . . 0.0 109.106 179.579 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.928 HD23 ' H ' ' A' ' 90' ' ' VAL . 1.1 tt -109.3 162.23 14.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.176 -0.952 . . . . 0.0 110.15 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.928 ' H ' HD23 ' A' ' 89' ' ' LEU . 14.3 p -137.0 117.78 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.156 -0.965 . . . . 0.0 110.556 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.66 38.27 3.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.396 -0.815 . . . . 0.0 109.789 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.52 ' CG2' ' OD1' ' A' ' 10' ' ' ASN . 2.2 m -88.62 133.78 34.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.848 . . . . 0.0 110.568 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.81 HG13 ' HA ' ' A' ' 62' ' ' GLN . 76.5 t -76.8 147.46 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.317 -0.865 . . . . 0.0 109.871 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.653 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 44.97 82.35 0.03 OUTLIER Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.703 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . . . -165.31 145.84 7.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.33 -1.1 . . . . 0.0 110.393 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.573 ' O ' ' CD1' ' A' ' 96' ' ' TYR . 3.2 t80 -124.81 -13.59 6.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.598 -0.689 . . . . 0.0 110.859 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.763 ' HB2' HD21 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -40.87 98.93 0.19 Allowed Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.151 -0.968 . . . . 0.0 110.185 -179.708 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.712 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 50.2 Cg_endo -86.88 11.63 3.21 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.169 1.615 . . . . 0.0 111.018 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 98' ' ' PRO . . . 67.99 -158.97 0.21 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.027 -1.046 . . . . 0.0 110.111 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.478 HG21 ' HG2' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -123.93 -55.45 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.061 -1.025 . . . . 0.0 110.897 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.646 ' CD2' ' HG3' ' A' ' 72' ' ' LYS . 7.5 m-85 -98.68 -4.54 33.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.869 -1.145 . . . . 0.0 110.159 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.563 ' HG2' ' CH2' ' A' ' 75' ' ' TRP . 6.9 mt-10 -91.05 121.93 33.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.293 -0.88 . . . . 0.0 110.733 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.626 ' C ' HD13 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -102.19 143.32 32.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.411 -0.806 . . . . 0.0 109.975 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 104' ' ' VAL . 3.6 m -71.39 134.08 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.062 -1.024 . . . . 0.0 110.426 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.603 HD22 ' HG2' ' A' ' 67' ' ' ARG . 3.0 mp -84.83 -16.02 42.78 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.447 -0.783 . . . . 0.0 109.168 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 3.2 p30 160.85 -165.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.456 ' HB3' ' NE2' ' A' ' 64' ' ' GLN . 3.4 mp -123.1 109.76 14.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.35 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.007 HG13 ' HB3' ' A' ' 65' ' ' ALA . 10.0 p -97.19 161.55 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.474 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 110' ' ' ALA . 8.8 p-10 -104.65 131.78 51.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.852 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.93 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . -38.4 148.73 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.476 -0.765 . . . . 0.0 110.942 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.629 ' O ' HG22 ' A' ' 111' ' ' VAL . 2.4 p -131.12 79.73 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -0.866 . . . . 0.0 109.951 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.409 ' H ' HG23 ' A' ' 112' ' ' ILE . 0.9 OUTLIER -60.04 163.49 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.9 . . . . 0.0 110.09 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.697 HD13 ' C ' ' A' ' 113' ' ' LEU . 3.1 tm? . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.048 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 0.7 OUTLIER -137.95 -163.3 1.42 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.269 -1.136 . . . . 0.0 110.18 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' A' ' 2' ' ' SER . 2.6 m170 58.93 149.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 110.144 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.469 ' O ' ' O ' ' A' ' 3' ' ' HIS . 1.1 mtp 54.12 107.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.302 -0.874 . . . . 0.0 110.058 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.492 ' NE2' HD11 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -99.29 164.76 11.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.143 -0.973 . . . . 0.0 110.757 -179.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.509 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 55.6 t -97.82 157.5 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.381 -0.825 . . . . 0.0 109.524 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.527 ' HA ' ' CA ' ' A' ' 41' ' ' GLY . 48.7 t -38.06 102.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.51 -0.744 . . . . 0.0 110.766 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.903 HD22 ' CG ' ' A' ' 40' ' ' PRO . 1.6 mp -47.73 137.49 9.91 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 110.288 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.672 ' O ' HG23 ' A' ' 11' ' ' THR . 48.4 Cg_endo -73.87 85.05 1.38 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.986 1.519 . . . . 0.0 110.618 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.888 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 9.4 m-20 56.64 48.36 16.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.214 -0.929 . . . . 0.0 110.578 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 9' ' ' PRO . 61.3 p -143.56 170.89 14.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.079 -1.013 . . . . 0.0 110.696 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.866 ' HB2' HD21 ' A' ' 97' ' ' LEU . . . -146.31 159.79 42.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.495 -0.753 . . . . 0.0 110.107 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.877 HD23 ' HG3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -133.3 152.71 51.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 109.983 179.493 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 1.02 ' C ' HD13 ' A' ' 15' ' ' LEU . 32.2 m80 -92.71 133.85 35.61 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.157 -0.964 . . . . 0.0 111.521 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.092 HD21 ' HB2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -124.21 153.85 41.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.419 -0.801 . . . . 0.0 109.274 178.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.547 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 8.5 ttmt -107.65 117.1 33.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.984 -1.073 . . . . 0.0 109.277 178.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.006 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -78.6 110.84 14.09 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.318 -0.864 . . . . 0.0 110.123 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 48' ' ' GLU . 82.6 mt -98.53 101.13 12.46 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.365 0.602 . . . . 0.0 109.72 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.544 HD13 ' N ' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -163.87 136.54 5.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.202 -0.936 . . . . 0.0 110.081 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.544 ' N ' HD13 ' A' ' 19' ' ' LEU . 80.3 m-20 -78.43 104.36 8.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 0.0 109.702 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.676 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -127.36 126.3 42.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.147 -0.97 . . . . 0.0 110.587 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -120.32 126.05 49.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.385 -0.822 . . . . 0.0 110.02 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.517 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -67.05 167.39 11.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.188 -0.945 . . . . 0.0 110.439 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.68 -24.85 23.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.328 -0.857 . . . . 0.0 110.229 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.76 -27.07 68.47 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.396 -0.815 . . . . 0.0 110.197 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 22' ' ' GLU . . . 146.01 -54.29 0.55 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.418 ' HA ' ' CB ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -155.7 148.58 24.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.223 -1.163 . . . . 0.0 110.238 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . 5.3 tptp -147.14 -73.66 0.21 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 110.459 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.845 HG12 ' HG2' ' A' ' 81' ' ' GLU . 2.0 m -103.54 139.79 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.206 -0.934 . . . . 0.0 109.653 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.67 ' O ' HG23 ' A' ' 30' ' ' VAL . 35.7 m -142.0 84.93 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 110.482 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 47.55 67.37 0.82 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.482 -0.761 . . . . 0.0 110.481 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -179.26 26.44 0.05 OUTLIER Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.592 -1.289 . . . . 0.0 110.587 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 1.006 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 15.7 m-20 -87.99 150.42 23.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.821 -1.4 . . . . 0.0 110.217 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 80.4 tt0 -145.3 130.8 18.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.134 -0.979 . . . . 0.0 110.052 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.873 ' CE2' HD23 ' A' ' 15' ' ' LEU . 8.0 p90 -143.03 166.01 25.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.042 -1.036 . . . . 0.0 110.715 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.584 HD13 ' NE2' ' A' ' 14' ' ' HIS . 56.2 tp -90.17 153.72 20.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.454 -0.779 . . . . 0.0 109.942 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 1.092 ' HB2' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -119.98 109.62 15.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.763 -1.211 . . . . 0.0 110.38 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.527 ' HB2' ' CD2' ' A' ' 97' ' ' LEU . 0.4 OUTLIER -90.71 127.0 36.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.422 -0.799 . . . . 0.0 110.186 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.57 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 57.98 46.86 92.03 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.903 ' CG ' HD22 ' A' ' 8' ' ' LEU . 37.8 Cg_endo -62.85 -21.65 73.26 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.87 1.458 . . . . 0.0 110.095 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.527 ' CA ' ' HA ' ' A' ' 7' ' ' VAL . . . 30.97 -92.09 0.01 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.712 ' O ' HD12 ' A' ' 44' ' ' ILE . 30.2 p -86.21 34.78 0.63 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.38 -1.07 . . . . 0.0 111.666 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.485 ' CE2' HD11 ' A' ' 13' ' ' LEU . 14.4 t80 -69.45 111.36 5.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.772 -1.205 . . . . 0.0 109.592 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.712 HD12 ' O ' ' A' ' 42' ' ' THR . 2.5 mp -103.57 142.58 24.88 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 109.839 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.578 ' HD2' HG23 ' A' ' 44' ' ' ILE . 44.4 Cg_endo -70.96 109.6 2.59 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.007 1.53 . . . . 0.0 110.801 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 49' ' ' VAL . 80.4 mtt180 -111.85 143.81 42.2 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.364 -0.835 . . . . 0.0 110.015 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 46' ' ' ARG . 14.4 pttp -43.55 -38.28 2.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.099 -1.0 . . . . 0.0 110.094 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 8.8 mt-10 -44.89 -43.83 9.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.171 -0.956 . . . . 0.0 110.231 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.748 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.6 m -136.49 173.33 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.326 -0.859 . . . . 0.0 109.99 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -136.06 139.82 43.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.098 -1.001 . . . . 0.0 110.526 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 51' ' ' VAL . 17.1 t -54.74 130.58 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.186 -0.946 . . . . 0.0 109.587 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 15' ' ' LEU . 16.9 t -109.73 -62.39 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.267 -0.896 . . . . 0.0 110.396 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.858 ' O ' HD13 ' A' ' 54' ' ' ILE . 3.2 mt-10 -139.03 173.08 11.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.035 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.858 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.4 mm -131.72 150.55 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 12' ' ' ALA . 0.4 OUTLIER -143.55 144.95 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.84 -1.163 . . . . 0.0 110.883 -179.025 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.459 ' HA ' HG22 ' A' ' 11' ' ' THR . 13.6 mp0 -115.88 169.77 8.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.524 -0.735 . . . . 0.0 109.767 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.888 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -89.11 139.09 30.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 110.078 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.452 ' O ' HG12 ' A' ' 59' ' ' ILE . 2.6 t -169.97 51.4 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 110.261 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.735 HG22 HG13 ' A' ' 60' ' ' ILE . 7.1 mm -146.83 -82.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.085 -1.009 . . . . 0.0 110.631 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.886 HD13 ' HG2' ' A' ' 64' ' ' GLN . 13.3 mt -111.88 -102.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.803 -1.186 . . . . 0.0 110.704 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.535 ' N ' ' HA ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER -175.99 -144.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.848 -1.158 . . . . 0.0 110.822 -179.633 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.963 ' HB2' HG13 ' A' ' 93' ' ' VAL . 6.1 tt0 -87.98 -66.41 0.92 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.511 -0.743 . . . . 0.0 110.884 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.506 ' HA ' ' HB3' ' A' ' 110' ' ' ALA . 3.3 m-20 -31.25 -58.7 0.24 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.299 0.571 . . . . 0.0 110.786 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.886 ' HG2' HD13 ' A' ' 60' ' ' ILE . 2.8 tp-100 -59.87 129.22 40.79 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.224 -0.923 . . . . 0.0 109.66 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.674 ' C ' HD22 ' A' ' 66' ' ' LEU . . . -108.15 146.73 32.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.969 -1.082 . . . . 0.0 110.264 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.708 HD12 HG21 ' A' ' 104' ' ' VAL . 4.0 mm? -121.27 116.34 24.67 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.134 -0.979 . . . . 0.0 109.89 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.687 ' O ' HD23 ' A' ' 68' ' ' LEU . 16.3 ttp180 -90.14 132.47 35.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.064 -1.022 . . . . 0.0 110.01 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 67' ' ' ARG . 12.6 mt -124.14 143.27 50.58 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.522 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.513 ' HG3' ' HB3' ' A' ' 87' ' ' GLU . 2.5 ttt180 -117.62 138.88 51.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.714 -0.616 . . . . 0.0 109.577 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -58.33 152.67 17.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.223 -0.923 . . . . 0.0 110.359 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.81 ' C ' HG22 ' A' ' 84' ' ' THR . 8.8 ttt180 -143.48 -11.79 0.7 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.158 -0.964 . . . . 0.0 111.778 -179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.597 ' HG2' ' CE1' ' A' ' 101' ' ' PHE . 5.4 tppt? -114.57 -4.92 12.78 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.635 -1.29 . . . . 0.0 111.021 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.523 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 7.8 tt0 54.55 69.64 0.7 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.892 -1.13 . . . . 0.0 109.689 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 2.6 t -172.81 -31.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.308 -0.87 . . . . 0.0 110.261 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.594 ' CB ' ' HB2' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -74.16 126.76 31.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.146 -0.972 . . . . 0.0 110.118 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.538 ' HB3' ' N ' ' A' ' 81' ' ' GLU . 39.3 p-10 -101.08 110.34 22.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.156 -0.965 . . . . 0.0 109.905 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.568 ' HB2' ' CZ2' ' A' ' 75' ' ' TRP . 2.3 tpm_? -80.05 -38.08 32.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.391 -0.818 . . . . 0.0 110.032 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.35 24.05 13.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.296 -0.878 . . . . 0.0 110.108 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.92 9.71 80.23 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 81' ' ' GLU . 30.4 mtpt -130.12 87.97 2.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -1.076 . . . . 0.0 110.038 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.845 ' HG2' HG12 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -43.2 118.48 1.32 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.918 . . . . 0.0 109.58 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.551 ' HB3' ' CB ' ' A' ' 86' ' ' GLU . 1.4 ttm180 -117.23 179.67 3.97 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 0.0 110.779 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.608 HG22 ' N ' ' A' ' 84' ' ' THR . 7.4 p -82.51 172.36 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.507 -0.745 . . . . 0.0 110.628 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.81 HG22 ' C ' ' A' ' 71' ' ' ARG . 45.7 p -52.65 -26.39 13.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.353 -0.842 . . . . 0.0 109.99 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -55.96 -43.71 87.83 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.551 ' CB ' ' HB3' ' A' ' 82' ' ' ARG . 12.4 tp10 -55.96 153.52 8.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.403 -1.057 . . . . 0.0 109.527 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.513 ' HB3' ' HG3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -159.47 156.18 27.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.064 -1.022 . . . . 0.0 110.602 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.49 ' CZ2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -142.58 151.12 41.22 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.283 -0.886 . . . . 0.0 109.604 179.679 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.894 HD23 ' H ' ' A' ' 90' ' ' VAL . 1.8 tt -102.21 154.01 19.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.325 -0.86 . . . . 0.0 109.901 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.894 ' H ' HD23 ' A' ' 89' ' ' LEU . 49.4 t -114.2 107.95 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.385 -0.822 . . . . 0.0 110.396 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 91' ' ' THR . 28.9 m -121.47 25.85 9.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.923 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.511 HG21 ' HG3' ' A' ' 38' ' ' GLU . 12.2 t -76.85 171.36 14.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.381 -0.824 . . . . 0.0 110.403 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.963 HG13 ' HB2' ' A' ' 62' ' ' GLN . 3.9 t -92.22 75.81 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 0.0 110.027 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.472 ' HA2' ' HB3' ' A' ' 10' ' ' ASN . . . -128.01 -85.82 0.5 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.712 ' HB1' ' H ' ' A' ' 59' ' ' ILE . . . -177.18 -38.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.362 -1.081 . . . . 0.0 109.707 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.608 ' CD1' ' HB ' ' A' ' 59' ' ' ILE . 3.4 p90 179.92 40.81 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.697 -0.627 . . . . 0.0 109.94 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.866 HD21 ' HB2' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -41.68 103.97 0.33 Allowed Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.281 -0.887 . . . . 0.0 110.155 -179.73 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.718 ' O ' ' HB2' ' A' ' 99' ' ' ALA . 46.7 Cg_endo -72.09 -98.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.08 1.569 . . . . 0.0 110.277 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.718 ' HB2' ' O ' ' A' ' 98' ' ' PRO . . . 169.11 -156.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.769 -1.207 . . . . 0.0 110.156 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.514 HG23 ' CD2' ' A' ' 14' ' ' HIS . 0.3 OUTLIER -128.31 -32.03 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 110.806 -179.563 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.597 ' CE1' ' HG2' ' A' ' 72' ' ' LYS . 1.7 m-85 -130.48 -6.86 4.19 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.75 -1.219 . . . . 0.0 110.897 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.58 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . 1.2 pt-20 -110.86 157.73 19.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.013 -1.055 . . . . 0.0 110.675 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.57 166.06 13.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.355 -0.841 . . . . 0.0 109.846 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.708 HG21 HD12 ' A' ' 66' ' ' LEU . 11.5 p -95.63 152.61 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.142 -0.974 . . . . 0.0 110.469 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.834 ' N ' HD22 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -102.55 -34.71 9.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.367 -0.833 . . . . 0.0 109.508 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -164.97 -163.88 0.74 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.557 -0.715 . . . . 0.0 109.63 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.897 ' N ' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -136.93 163.71 30.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 110.578 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 64' ' ' GLN . 33.7 t -138.95 150.48 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.843 . . . . 0.0 110.169 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.455 ' CG ' ' O ' ' A' ' 109' ' ' ASP . 1.7 p-10 -111.67 115.13 28.61 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.882 -1.136 . . . . 0.0 109.81 178.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.506 ' HB3' ' HA ' ' A' ' 63' ' ' ASN . . . -78.02 177.2 8.48 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.981 -1.074 . . . . 0.0 110.595 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.44 160.49 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.335 -0.853 . . . . 0.0 109.843 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.5 mm -72.11 137.4 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.292 -0.88 . . . . 0.0 110.271 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.265 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.436 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.11 -69.04 0.34 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -1.193 . . . . 0.0 110.227 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.453 ' O ' ' HB3' ' A' ' 4' ' ' MET . 77.5 m80 -92.47 125.42 37.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.176 -0.952 . . . . 0.0 110.262 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.504 ' CG ' ' N ' ' A' ' 5' ' ' GLN . 5.6 ttp 57.33 168.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.933 . . . . 0.0 110.074 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.504 ' N ' ' CG ' ' A' ' 4' ' ' MET . 0.0 OUTLIER 176.49 -173.91 0.1 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.148 -0.97 . . . . 0.0 110.384 179.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.51 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 41.5 t -113.47 160.04 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 0.0 109.718 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.495 ' CA ' ' HA3' ' A' ' 41' ' ' GLY . 21.5 t -35.56 99.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.65 -0.656 . . . . 0.0 110.855 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.79 HD23 ' OG1' ' A' ' 11' ' ' THR . 2.5 mp -47.45 147.23 2.96 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.458 -0.776 . . . . 0.0 110.865 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 10' ' ' ASN . 50.4 Cg_endo -76.98 69.0 7.17 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.134 1.597 . . . . 0.0 110.462 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.661 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 0.9 OUTLIER 67.68 49.0 1.0 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.21 -0.931 . . . . 0.0 110.741 179.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.79 ' OG1' HD23 ' A' ' 8' ' ' LEU . 33.1 p -137.13 171.35 14.62 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.278 -0.889 . . . . 0.0 109.792 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.741 ' HB2' HD21 ' A' ' 97' ' ' LEU . . . -144.3 161.97 37.59 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.954 -1.091 . . . . 0.0 110.785 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.749 HD11 HD11 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -134.04 152.2 51.74 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.244 -0.91 . . . . 0.0 110.419 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.826 ' CD2' HD13 ' A' ' 36' ' ' LEU . 9.1 m170 -88.03 128.19 35.4 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.143 -0.973 . . . . 0.0 110.727 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.749 HD11 HD11 ' A' ' 13' ' ' LEU . 2.7 mm? -115.99 148.0 40.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.497 -0.752 . . . . 0.0 110.579 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.708 ' HB2' HG22 ' A' ' 52' ' ' VAL . 1.7 ttmt -114.16 116.85 29.75 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.239 -0.984 . . . . 0.0 108.889 177.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.082 ' HB3' ' HB3' ' A' ' 33' ' ' ASP . . . -80.43 121.95 26.37 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.954 -1.091 . . . . 0.0 109.936 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 69.3 mt -98.66 99.89 11.05 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.493 0.663 . . . . 0.0 109.711 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.501 HD13 ' N ' ' A' ' 20' ' ' ASP . 0.4 OUTLIER -166.73 130.06 1.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.503 -0.748 . . . . 0.0 109.669 -179.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.501 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -71.62 101.34 2.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.083 -1.011 . . . . 0.0 110.019 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.749 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -129.51 71.38 1.44 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.903 . . . . 0.0 109.969 -179.88 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.496 ' HA ' ' HB3' ' A' ' 28' ' ' LYS . 4.7 tt0 -102.39 114.92 29.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.273 -0.892 . . . . 0.0 110.381 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -81.36 177.39 9.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 110.064 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.7 4.01 12.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 110.35 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.95 -25.44 68.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.317 -0.865 . . . . 0.0 110.166 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.16 -37.75 1.89 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.57 96.56 0.05 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.297 -1.119 . . . . 0.0 110.472 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.565 ' HG2' HG13 ' A' ' 29' ' ' VAL . 3.1 tptt -99.67 -107.71 0.21 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.166 -0.959 . . . . 0.0 109.892 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.749 HG22 ' CB ' ' A' ' 21' ' ' PHE . 1.7 m -112.03 137.04 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.767 -1.208 . . . . 0.0 109.189 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.667 ' O ' HG23 ' A' ' 30' ' ' VAL . 29.6 m -138.85 90.18 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.135 -0.978 . . . . 0.0 110.545 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 46.75 51.61 12.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.864 . . . . 0.0 110.436 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -176.7 25.37 0.06 OUTLIER Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.152 -1.499 . . . . 0.0 111.061 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 1.082 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -66.66 149.84 49.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.508 -1.584 . . . . 0.0 109.011 179.091 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.635 ' CG ' ' CZ ' ' A' ' 101' ' ' PHE . 1.2 pm0 -148.47 138.66 22.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.557 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.418 ' HB2' ' CD1' ' A' ' 75' ' ' TRP . 10.1 p90 -158.86 164.68 35.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.335 -0.853 . . . . 0.0 109.816 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.826 HD13 ' CD2' ' A' ' 14' ' ' HIS . 60.6 tp -90.82 156.14 18.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.004 -1.06 . . . . 0.0 109.66 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.731 ' HB2' HD23 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -126.1 114.13 17.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.055 -1.028 . . . . 0.0 110.183 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -84.77 129.38 34.83 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.275 0.559 . . . . 0.0 109.983 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.61 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 64.77 44.33 94.95 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.731 ' HG2' HD22 ' A' ' 8' ' ' LEU . 55.8 Cg_endo -77.48 17.74 0.89 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.604 1.318 . . . . 0.0 110.875 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.578 ' HA2' HD13 ' A' ' 8' ' ' LEU . . . -49.21 -41.99 31.59 Favored Glycine 0 N--CA 1.488 2.114 0 O-C-N 120.755 -1.216 . . . . 0.0 110.367 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.8 p -93.73 19.74 8.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.038 -1.272 . . . . 0.0 110.974 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.61 ' C ' HD12 ' A' ' 44' ' ' ILE . 21.8 t80 -85.45 133.36 34.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.124 -0.985 . . . . 0.0 110.019 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.61 HD12 ' C ' ' A' ' 43' ' ' TYR . 1.5 mp -119.73 145.31 39.02 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.359 -0.838 . . . . 0.0 109.006 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.52 ' HD2' HG23 ' A' ' 44' ' ' ILE . 40.9 Cg_endo -66.89 109.53 1.71 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.869 1.457 . . . . 0.0 110.713 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -111.59 149.58 31.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.462 -0.774 . . . . 0.0 110.246 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -53.07 -29.1 28.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.859 . . . . 0.0 110.312 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.486 ' C ' ' CG1' ' A' ' 49' ' ' VAL . 20.4 tt0 -59.81 -21.69 61.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.173 -0.954 . . . . 0.0 110.512 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.553 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.9 m -150.92 170.8 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.292 -0.88 . . . . 0.0 110.33 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -131.54 138.0 48.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.198 -0.939 . . . . 0.0 110.099 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.434 HG23 ' H ' ' A' ' 51' ' ' VAL . 6.6 t -58.63 125.55 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.716 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.708 HG22 ' HB2' ' A' ' 16' ' ' LYS . 2.8 t -102.27 -63.32 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.276 -0.89 . . . . 0.0 110.291 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.591 ' O ' HD13 ' A' ' 54' ' ' ILE . 3.4 mt-10 -144.01 166.49 24.82 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.18 -0.95 . . . . 0.0 110.252 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.591 HD13 ' O ' ' A' ' 53' ' ' GLU . 2.6 mm -128.71 148.65 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.725 HD11 ' OH ' ' A' ' 96' ' ' TYR . 0.5 OUTLIER -141.6 130.39 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.591 -1.318 . . . . 0.0 111.59 -178.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.45 ' HA ' ' HB ' ' A' ' 11' ' ' THR . 23.1 mp0 -94.8 176.0 6.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.589 -0.694 . . . . 0.0 109.708 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.818 ' HB1' ' HB2' ' A' ' 95' ' ' ALA . . . -102.02 144.61 30.4 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.159 -0.963 . . . . 0.0 110.63 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER 170.61 59.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.156 -0.965 . . . . 0.0 111.984 179.53 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.662 HG23 ' H ' ' A' ' 60' ' ' ILE . 1.2 tt -172.71 -60.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.277 -1.515 . . . . 0.0 112.649 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.662 ' H ' HG23 ' A' ' 59' ' ' ILE . 18.8 mm -80.81 169.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.36 -1.463 . . . . 0.0 110.835 -178.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.449 ' N ' HG22 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -109.33 -159.7 0.69 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.474 -0.766 . . . . 0.0 110.326 -179.773 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.987 ' HB2' HG13 ' A' ' 93' ' ' VAL . 2.9 tt0 -91.14 -68.64 0.78 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.327 -0.858 . . . . 0.0 110.295 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.651 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 2.1 m-20 -38.23 -50.97 1.46 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.75 -0.594 . . . . 0.0 110.97 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.486 ' NE2' ' O ' ' A' ' 108' ' ' VAL . 7.9 tp60 -59.69 137.4 58.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.082 -1.011 . . . . 0.0 110.852 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.969 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -127.41 148.95 50.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.412 -0.805 . . . . 0.0 110.069 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.656 HD11 HG21 ' A' ' 60' ' ' ILE . 2.6 mp -127.05 118.13 23.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.318 -0.864 . . . . 0.0 110.152 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.599 ' O ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -91.66 128.26 37.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.002 -1.061 . . . . 0.0 110.029 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.752 HD11 HG21 ' A' ' 90' ' ' VAL . 15.6 mt -120.33 139.85 52.15 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.05 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -120.02 157.54 28.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.483 -0.761 . . . . 0.0 109.754 179.329 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.877 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -68.95 124.58 24.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 111.353 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -84.33 -23.09 30.37 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.503 ' HG2' ' HB3' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -156.73 146.56 20.89 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.552 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 74' ' ' CYS . 1.9 pt-20 -56.96 -156.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.036 -1.04 . . . . 0.0 110.341 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 6.6 m 77.34 -43.45 0.42 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.525 -0.734 . . . . 0.0 110.889 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.718 ' HZ3' ' HB2' ' A' ' 70' ' ' ALA . 8.3 t90 -74.15 110.94 8.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.793 -1.192 . . . . 0.0 110.353 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 76' ' ' ASP . 2.4 p30 -91.2 127.05 36.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.205 -0.934 . . . . 0.0 110.003 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -86.08 -40.5 15.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 110.039 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.01 -28.79 25.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.166 -0.959 . . . . 0.0 110.275 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 80' ' ' LYS . . . 139.86 -52.29 0.71 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -61.05 -131.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -1.179 . . . . 0.0 109.741 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.535 ' CD ' HG11 ' A' ' 29' ' ' VAL . 15.0 mm-40 -136.97 121.78 18.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.826 -1.171 . . . . 0.0 110.464 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.36 173.26 8.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.535 -0.728 . . . . 0.0 109.888 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.62 HG13 ' H ' ' A' ' 85' ' ' GLY . 13.5 p -88.87 173.03 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 0.0 110.568 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.877 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 10.1 t -67.45 -12.53 60.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.863 . . . . 0.0 110.006 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.62 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -63.49 -14.65 55.2 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.635 ' HG3' ' CZ3' ' A' ' 75' ' ' TRP . 8.4 pt-20 -79.25 166.42 22.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.417 -1.049 . . . . 0.0 109.526 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.496 ' HA ' ' OE2' ' A' ' 102' ' ' GLU . 5.8 pt-20 -157.9 153.55 26.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.808 -1.183 . . . . 0.0 110.774 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.509 ' CE2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -128.38 144.24 51.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.392 -0.817 . . . . 0.0 109.716 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.897 HD23 ' H ' ' A' ' 90' ' ' VAL . 1.4 tt -106.2 158.42 16.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.211 -0.931 . . . . 0.0 110.123 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.897 ' H ' HD23 ' A' ' 89' ' ' LEU . 16.6 t -122.23 136.65 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 0.0 110.571 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.587 HG23 ' C ' ' A' ' 90' ' ' VAL . 61.0 p -155.72 60.26 0.61 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 109.641 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.686 HG21 ' HB3' ' A' ' 95' ' ' ALA . 14.6 t -85.29 167.93 15.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.399 -0.813 . . . . 0.0 110.627 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.987 HG13 ' HB2' ' A' ' 62' ' ' GLN . 3.3 t -108.18 67.17 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.385 -0.822 . . . . 0.0 109.768 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 60' ' ' ILE . . . 110.04 62.85 0.52 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.818 ' HB2' ' HB1' ' A' ' 57' ' ' ALA . . . -174.72 -153.14 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.332 -1.099 . . . . 0.0 110.426 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.725 ' OH ' HD11 ' A' ' 55' ' ' ILE . 2.3 p90 176.46 119.11 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.741 HD21 ' HB2' ' A' ' 12' ' ' ALA . 2.6 mp -106.19 95.65 11.7 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 111.457 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.488 ' O ' ' O ' ' A' ' 99' ' ' ALA . 47.0 Cg_endo -74.94 87.19 1.34 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.9 1.474 . . . . 0.0 108.887 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.597 ' HB3' ' HB2' ' A' ' 102' ' ' GLU . . . -50.05 -172.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.404 -0.81 . . . . 0.0 111.261 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 t -99.47 -66.33 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.433 -0.792 . . . . 0.0 110.496 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.635 ' CZ ' ' CG ' ' A' ' 34' ' ' GLU . 21.5 m-30 -100.15 22.23 11.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.936 -1.102 . . . . 0.0 110.57 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.597 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 2.4 mm-40 -111.56 120.29 41.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.964 -1.085 . . . . 0.0 110.397 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -100.13 156.26 17.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.352 -0.843 . . . . 0.0 110.188 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.649 HG12 HD22 ' A' ' 68' ' ' LEU . 3.5 m -81.87 138.39 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 110.26 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.592 ' CD1' ' N ' ' A' ' 105' ' ' LEU . 3.0 mp -97.14 -9.58 27.62 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.318 -0.864 . . . . 0.0 109.197 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.57 ' CB ' ' O ' ' A' ' 105' ' ' LEU . 0.4 OUTLIER 159.94 -160.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.791 -0.568 . . . . 0.0 109.622 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.875 ' C ' HD22 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -138.42 150.13 46.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.941 . . . . 0.0 110.341 178.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.969 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 14.7 p -134.07 140.66 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.128 -0.982 . . . . 0.0 110.167 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.17 117.84 35.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.881 -1.137 . . . . 0.0 110.003 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . -54.21 -78.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 110.014 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.3 t -142.35 147.1 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.357 -0.839 . . . . 0.0 110.273 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.518 HG22 ' N ' ' A' ' 113' ' ' LEU . 3.0 mt -112.83 170.93 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.346 -0.846 . . . . 0.0 109.679 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.518 ' N ' HG22 ' A' ' 112' ' ' ILE . 11.8 mt . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.093 -1.004 . . . . 0.0 110.126 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 84.8 p -115.22 83.67 1.96 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.331 -1.099 . . . . 0.0 110.206 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -164.38 128.4 2.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.907 . . . . 0.0 110.335 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.453 ' HG2' ' N ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -112.49 152.83 28.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 110.213 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.453 ' N ' ' HG2' ' A' ' 4' ' ' MET . 0.5 OUTLIER -122.22 -170.71 2.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.151 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.507 ' O ' HD12 ' A' ' 8' ' ' LEU . 9.8 p -126.61 147.24 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.163 -0.961 . . . . 0.0 110.089 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.47 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 83.4 t -41.18 107.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 110.337 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.975 HD23 ' OG1' ' A' ' 11' ' ' THR . 5.4 mp -63.24 163.94 16.21 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.391 -0.818 . . . . 0.0 110.079 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.411 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 47.3 Cg_endo -73.19 -56.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.913 1.48 . . . . 0.0 110.451 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.825 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 63.2 m-80 -158.42 31.77 0.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 110.174 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.975 ' OG1' HD23 ' A' ' 8' ' ' LEU . 43.9 p -106.41 171.56 7.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.342 -0.849 . . . . 0.0 110.2 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.496 ' O ' HG22 ' A' ' 55' ' ' ILE . . . -147.24 162.46 38.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.193 -0.942 . . . . 0.0 109.93 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.776 HD11 ' HE2' ' A' ' 43' ' ' TYR . 0.6 OUTLIER -130.25 155.79 45.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.021 . . . . 0.0 110.642 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.696 ' C ' HD23 ' A' ' 15' ' ' LEU . 2.4 m170 -96.93 129.16 44.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.341 -0.849 . . . . 0.0 109.08 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.838 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -126.2 162.28 25.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.703 -1.248 . . . . 0.0 109.48 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.537 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . 1.2 ttpt -113.44 118.58 34.91 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.576 -0.85 . . . . 0.0 111.029 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.118 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -73.9 113.18 10.77 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.922 0.868 . . . . 0.0 108.782 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.875 HD23 ' O ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -106.95 106.73 17.4 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.486 0.66 . . . . 0.0 110.655 -178.677 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.86 HD13 ' HG3' ' A' ' 48' ' ' GLU . 5.1 tp -166.72 146.2 5.6 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.564 -0.71 . . . . 0.0 109.903 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.3 105.0 15.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 109.827 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.882 ' HB2' HG22 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -125.14 118.52 26.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.212 -0.93 . . . . 0.0 110.318 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.54 114.98 27.25 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.141 -0.975 . . . . 0.0 110.149 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.35 145.41 48.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.158 -0.964 . . . . 0.0 110.224 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -80.57 -9.04 59.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.909 . . . . 0.0 110.207 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.2 -14.08 59.6 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.266 -0.896 . . . . 0.0 110.169 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.27 -5.42 30.12 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.18 29.09 1.11 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.117 -1.225 . . . . 0.0 110.027 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.6 ttpp -66.78 116.0 7.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.356 -0.84 . . . . 0.0 110.37 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.882 HG22 ' HB2' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -109.0 146.76 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.262 -0.899 . . . . 0.0 109.65 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 30' ' ' VAL . 27.0 m -132.41 81.37 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.07 -1.019 . . . . 0.0 109.764 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 41.31 67.47 0.54 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.617 -0.677 . . . . 0.0 110.295 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -168.47 20.26 0.08 OUTLIER Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.114 -1.517 . . . . 0.0 111.263 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 1.118 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 1.3 m-20 -88.34 150.6 23.13 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.437 -1.625 . . . . 0.0 109.406 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.506 ' HG3' HG21 ' A' ' 52' ' ' VAL . 16.5 tt0 -151.46 139.07 19.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.089 -1.007 . . . . 0.0 110.461 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.662 ' CZ2' HD12 ' A' ' 15' ' ' LEU . 8.7 p90 -154.44 177.63 10.96 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.147 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.553 HD21 ' CE1' ' A' ' 14' ' ' HIS . 0.5 OUTLIER -90.33 158.69 17.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 0.0 110.969 -179.062 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.761 ' HB2' HD21 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -141.99 110.77 6.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.386 -0.821 . . . . 0.0 109.565 179.252 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.472 ' HG2' ' HB2' ' A' ' 12' ' ' ALA . 4.1 tm-20 -93.94 149.44 21.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.205 -0.934 . . . . 0.0 111.001 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.588 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 55.91 45.52 86.2 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.615 ' HG2' HD22 ' A' ' 8' ' ' LEU . 41.8 Cg_endo -70.68 -60.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.757 1.398 . . . . 0.0 109.844 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.492 ' HA3' ' C ' ' A' ' 6' ' ' VAL . . . 41.87 -89.92 0.01 OUTLIER Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 40' ' ' PRO . 19.8 p -66.9 1.32 1.95 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.33 -1.1 . . . . 0.0 111.559 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.776 ' HE2' HD11 ' A' ' 13' ' ' LEU . 6.8 t80 -68.78 124.15 22.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.643 -1.286 . . . . 0.0 110.408 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.65 HG23 ' HD2' ' A' ' 45' ' ' PRO . 6.2 mt -115.52 145.59 34.78 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 109.064 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.65 ' HD2' HG23 ' A' ' 44' ' ' ILE . 42.6 Cg_endo -67.57 109.19 1.78 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.764 1.402 . . . . 0.0 110.751 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -102.37 144.64 30.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.4 -0.812 . . . . 0.0 109.999 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.786 ' O ' HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -37.34 -45.66 0.7 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.572 -0.705 . . . . 0.0 111.062 -179.582 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.86 ' HG3' HD13 ' A' ' 19' ' ' LEU . 11.4 tt0 -49.07 -49.07 43.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -0.964 . . . . 0.0 110.98 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.535 HG12 ' HA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -133.44 142.58 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.915 -1.115 . . . . 0.0 110.741 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -108.62 137.51 46.45 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.323 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.431 HG13 ' HB3' ' A' ' 45' ' ' PRO . 31.3 m -54.01 145.29 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.168 -0.957 . . . . 0.0 109.252 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.734 HG23 ' HA ' ' A' ' 15' ' ' LEU . 31.7 t -117.48 -58.65 3.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.048 -1.033 . . . . 0.0 110.407 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.936 ' O ' HD13 ' A' ' 54' ' ' ILE . 1.9 mt-10 -136.09 172.85 12.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.144 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.936 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.2 mm -136.18 130.73 48.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.322 -0.861 . . . . 0.0 108.828 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.638 HD13 ' H ' ' A' ' 56' ' ' GLN . 0.4 OUTLIER -125.85 144.93 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.214 -0.929 . . . . 0.0 111.162 -178.591 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.638 ' H ' HD13 ' A' ' 55' ' ' ILE . 40.7 mm-40 -100.4 174.28 6.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.468 -0.77 . . . . 0.0 109.779 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.825 ' HB2' ' O ' ' A' ' 10' ' ' ASN . . . -102.25 125.68 49.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.132 -0.98 . . . . 0.0 109.96 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 3.2 t 179.29 63.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.012 -1.055 . . . . 0.0 111.872 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.533 HG21 ' CD1' ' A' ' 96' ' ' TYR . 0.1 OUTLIER -169.68 -37.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.549 -1.344 . . . . 0.0 111.323 179.107 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 95' ' ' ALA . 9.4 mm -78.1 158.41 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.785 -1.197 . . . . 0.0 110.44 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.513 ' HB2' ' HB3' ' A' ' 64' ' ' GLN . 9.1 mtt180 -62.8 -168.84 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.283 -0.886 . . . . 0.0 110.413 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.842 ' HA ' HG13 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -91.63 -19.92 22.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.334 -0.854 . . . . 0.0 110.701 -179.435 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 2.7 p30 -127.97 -19.2 4.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.905 -1.122 . . . . 0.0 110.907 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.513 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 6.4 tp-100 -51.34 126.88 18.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.031 -1.043 . . . . 0.0 111.646 -179.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.016 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . . . -108.54 142.37 39.06 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.492 HD23 HD12 ' A' ' 107' ' ' LEU . 1.8 mp -127.59 115.04 18.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.837 -1.165 . . . . 0.0 111.882 -178.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . 4.3 ttm180 -91.36 119.6 31.51 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.71 ' CD2' HG23 ' A' ' 104' ' ' VAL . 21.6 mt -113.74 161.25 17.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 111.396 -178.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.591 ' HB2' HD21 ' A' ' 105' ' ' LEU . 15.7 mtp180 -126.57 161.88 26.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.371 -0.83 . . . . 0.0 110.179 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.888 ' HB3' ' O ' ' A' ' 84' ' ' THR . . . -82.63 152.37 25.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.202 -0.936 . . . . 0.0 111.415 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.518 ' HG3' ' N ' ' A' ' 72' ' ' LYS . 9.4 ptt180 -125.31 -27.7 3.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.453 -0.779 . . . . 0.0 109.819 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.518 ' N ' ' HG3' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -124.49 118.46 26.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.283 -0.885 . . . . 0.0 109.762 179.575 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.524 ' N ' ' HB ' ' A' ' 84' ' ' THR . 4.3 pt-20 -54.51 106.82 0.23 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.202 -0.937 . . . . 0.0 110.723 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.507 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER 168.5 -43.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.285 -0.884 . . . . 0.0 110.151 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.779 ' CZ3' ' HB2' ' A' ' 70' ' ' ALA . 2.7 t90 -74.98 104.43 5.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.284 -0.885 . . . . 0.0 110.182 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.482 ' OD2' ' N ' ' A' ' 80' ' ' LYS . 3.4 t70 -96.82 122.04 39.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -0.978 . . . . 0.0 110.226 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.452 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -85.03 -0.38 54.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.886 . . . . 0.0 110.365 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.55 -4.99 8.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.954 . . . . 0.0 110.365 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 101.21 -47.25 1.21 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.482 ' N ' ' OD2' ' A' ' 76' ' ' ASP . 9.1 mmtp -69.54 98.63 1.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -1.14 . . . . 0.0 110.012 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.748 ' OE2' HG21 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -34.17 135.15 0.16 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.718 -0.614 . . . . 0.0 110.913 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.16 179.77 7.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 110.533 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.599 HG22 ' N ' ' A' ' 84' ' ' THR . 10.8 p -77.84 174.02 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.4 -0.813 . . . . 0.0 110.553 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.888 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 2.3 t -73.95 -3.52 29.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.815 . . . . 0.0 110.099 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.572 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -72.88 -13.35 78.84 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.451 ' HG3' ' CZ3' ' A' ' 75' ' ' TRP . 8.3 pt-20 -70.79 172.24 9.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -1.083 . . . . 0.0 110.058 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.452 ' HB3' ' HG2' ' A' ' 69' ' ' ARG . 5.4 pm0 -159.06 172.59 17.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 110.444 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.549 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -155.96 153.66 29.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.342 -0.849 . . . . 0.0 109.795 -179.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.974 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -122.25 124.97 45.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.117 -0.99 . . . . 0.0 109.954 179.558 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.974 ' N ' HD22 ' A' ' 89' ' ' LEU . 4.5 p -105.6 138.92 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.429 -0.795 . . . . 0.0 110.263 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.7 t -141.93 49.78 1.56 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.272 -0.892 . . . . 0.0 110.415 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.524 ' CG2' ' HB3' ' A' ' 10' ' ' ASN . 51.6 m -91.28 138.66 31.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -0.937 . . . . 0.0 110.281 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.842 HG13 ' HA ' ' A' ' 62' ' ' GLN . 17.5 t -71.13 140.39 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.147 -0.971 . . . . 0.0 110.15 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.563 ' O ' ' HB1' ' A' ' 57' ' ' ALA . . . 43.27 80.75 0.04 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.587 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . . . -156.38 154.01 29.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -1.149 . . . . 0.0 110.861 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.539 ' O ' ' CG ' ' A' ' 96' ' ' TYR . 4.9 t80 -117.69 25.69 10.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.502 -0.749 . . . . 0.0 109.961 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 96' ' ' TYR . 2.0 mm? -34.34 91.87 0.05 OUTLIER Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.827 -0.546 . . . . 0.0 111.408 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.518 ' N ' ' O ' ' A' ' 96' ' ' TYR . 48.5 Cg_endo -91.32 115.8 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.827 1.435 . . . . 0.0 110.395 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.747 ' HB1' ' HB3' ' A' ' 102' ' ' GLU . . . -69.76 171.92 8.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.213 -0.929 . . . . 0.0 110.32 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.615 HG21 ' HA ' ' A' ' 35' ' ' TRP . 1.7 t -99.33 -58.5 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.352 -0.843 . . . . 0.0 109.447 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.655 ' HB2' ' HB3' ' A' ' 75' ' ' TRP . 22.8 m-30 -117.6 38.9 3.46 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.156 -0.965 . . . . 0.0 109.257 178.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.747 ' HB3' ' HB1' ' A' ' 99' ' ' ALA . 13.6 tt0 -132.11 133.23 44.07 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.124 -0.985 . . . . 0.0 110.879 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -105.08 171.22 7.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.389 -0.819 . . . . 0.0 110.193 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.71 HG23 ' CD2' ' A' ' 68' ' ' LEU . 7.7 p -101.31 144.56 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.172 -0.955 . . . . 0.0 110.306 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.844 ' N ' HD22 ' A' ' 105' ' ' LEU . 1.6 mm? -103.14 -40.07 6.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -0.968 . . . . 0.0 110.118 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.901 ' C ' HD13 ' A' ' 107' ' ' LEU . 1.8 p30 -161.29 171.58 18.11 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.868 . . . . 0.0 109.963 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.901 HD13 ' C ' ' A' ' 106' ' ' ASP . 0.3 OUTLIER -121.96 142.55 50.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.175 -0.953 . . . . 0.0 110.367 -179.855 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.016 ' CG1' ' HB3' ' A' ' 65' ' ' ALA . 12.6 p -125.49 157.84 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.398 -0.814 . . . . 0.0 109.499 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.405 ' O ' ' CG ' ' A' ' 109' ' ' ASP . 8.6 p-10 -110.91 121.27 44.93 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.92 -1.113 . . . . 0.0 110.704 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 63' ' ' ASN . . . -75.93 172.2 13.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 109.951 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.6 m -129.4 -29.54 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.951 -1.093 . . . . 0.0 110.876 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.417 ' O ' HG23 ' A' ' 112' ' ' ILE . 0.6 OUTLIER -144.94 27.89 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.928 -1.108 . . . . 0.0 110.69 -179.7 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.34 -179.978 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.3 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.445 ' OG ' ' HG3' ' A' ' 45' ' ' PRO . 74.6 m 45.47 -165.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.259 -1.142 . . . . 0.0 110.424 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.472 ' O ' ' CB ' ' A' ' 4' ' ' MET . 0.4 OUTLIER 60.28 13.55 4.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 0.0 110.161 -179.798 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.472 ' CB ' ' O ' ' A' ' 3' ' ' HIS . 0.2 OUTLIER 67.46 128.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.902 . . . . 0.0 110.368 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.605 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 0.6 OUTLIER -133.38 86.01 2.26 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.282 -0.886 . . . . 0.0 109.836 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.505 ' O ' ' O ' ' A' ' 5' ' ' GLN . 12.0 p -38.0 165.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.349 -0.844 . . . . 0.0 111.927 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.571 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 43.7 t -30.83 150.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 CA-C-O 121.586 0.708 . . . . 0.0 111.973 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.659 HD23 ' OG1' ' A' ' 11' ' ' THR . 6.0 mp -106.29 171.23 4.96 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.569 -0.707 . . . . 0.0 109.634 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 8' ' ' LEU . 44.5 Cg_endo -71.35 -39.44 3.8 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.72 1.379 . . . . 0.0 110.401 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.471 ' ND2' HG21 ' A' ' 93' ' ' VAL . 3.1 m-20 172.19 37.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.338 -0.851 . . . . 0.0 109.681 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.659 ' OG1' HD23 ' A' ' 8' ' ' LEU . 69.9 p -114.58 162.72 16.38 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.329 -0.857 . . . . 0.0 110.957 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.714 ' HB3' ' HG ' ' A' ' 97' ' ' LEU . . . -135.57 161.13 36.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.378 -0.826 . . . . 0.0 109.96 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.982 HD23 ' CG ' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -133.28 153.65 51.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.167 -0.958 . . . . 0.0 110.553 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.802 ' C ' HD13 ' A' ' 15' ' ' LEU . 30.7 m80 -96.58 136.35 37.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.0 109.642 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.913 HD13 ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -135.67 167.18 21.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.126 -0.984 . . . . 0.0 110.561 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 3.2 ttmt -119.04 117.58 29.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.17 -0.956 . . . . 0.0 110.049 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.044 ' HB3' ' HB2' ' A' ' 33' ' ' ASP . . . -75.76 117.54 17.61 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.311 -0.868 . . . . 0.0 109.864 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 61.4 mt -108.62 100.94 10.13 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.188 0.518 . . . . 0.0 109.963 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.729 HD13 ' HG2' ' A' ' 48' ' ' GLU . 9.3 tp -163.79 144.74 8.83 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.157 -0.964 . . . . 0.0 110.294 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -85.2 110.78 19.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.379 -0.826 . . . . 0.0 109.061 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.757 ' CB ' HG22 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -128.23 112.55 14.63 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.103 -0.998 . . . . 0.0 111.103 -178.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -94.26 113.84 25.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.348 -0.845 . . . . 0.0 109.265 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.87 163.82 19.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.363 -0.836 . . . . 0.0 110.503 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.78 -31.45 18.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.297 -0.877 . . . . 0.0 110.234 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.35 -11.5 10.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.347 -0.846 . . . . 0.0 110.33 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.457 ' O ' ' CB ' ' A' ' 27' ' ' ASP . . . -87.1 5.06 85.85 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER 66.17 10.73 7.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.329 -1.101 . . . . 0.0 110.372 179.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 29.6 ttpt 55.94 112.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.275 -0.891 . . . . 0.0 110.391 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.757 HG22 ' CB ' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -90.15 150.08 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.154 -0.967 . . . . 0.0 109.794 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.561 ' O ' HG23 ' A' ' 30' ' ' VAL . 25.2 m -133.39 81.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 0.0 110.336 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . . . 42.36 66.87 0.67 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 110.189 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.52 20.18 0.09 OUTLIER Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.373 -1.394 . . . . 0.0 110.895 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 1.044 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -89.09 152.39 21.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.478 -1.601 . . . . 0.0 108.984 179.191 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 15' ' ' LEU . 23.0 tt0 -155.23 140.12 17.25 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.907 -1.12 . . . . 0.0 110.498 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.729 ' CZ3' ' HB2' ' A' ' 17' ' ' ALA . 5.2 p90 -162.94 172.78 14.56 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.661 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.745 HD13 ' NE2' ' A' ' 14' ' ' HIS . 16.9 tp -90.53 159.93 16.23 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.394 0.616 . . . . 0.0 110.733 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.655 ' HB2' HD11 ' A' ' 15' ' ' LEU . 0.6 OUTLIER -135.38 114.77 12.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.321 -0.862 . . . . 0.0 109.952 179.629 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.476 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -86.96 135.47 33.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.515 -0.741 . . . . 0.0 110.369 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.596 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 54.02 44.31 72.77 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.982 ' CG ' HD23 ' A' ' 13' ' ' LEU . 52.9 Cg_endo -77.03 42.76 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.492 1.259 . . . . 0.0 110.959 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 5' ' ' GLN . . . -65.1 -25.12 70.77 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.525 ' O ' HD12 ' A' ' 44' ' ' ILE . 9.6 p -101.63 12.95 36.32 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.831 -1.394 . . . . 0.0 109.77 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.464 ' HB3' ' HB2' ' A' ' 40' ' ' PRO . 16.6 t80 -86.88 122.53 30.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.393 -0.817 . . . . 0.0 109.556 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.657 HG23 ' HD2' ' A' ' 45' ' ' PRO . 3.7 mp -116.98 145.25 35.17 Favored Pre-proline 0 C--N 1.3 -1.562 0 O-C-N 121.224 -0.922 . . . . 0.0 109.508 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.657 ' HD2' HG23 ' A' ' 44' ' ' ILE . 43.0 Cg_endo -69.56 83.44 0.66 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.874 1.46 . . . . 0.0 110.172 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -95.72 152.93 18.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.414 -0.804 . . . . 0.0 110.697 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -41.55 -42.97 2.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.352 -0.843 . . . . 0.0 110.69 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.729 ' HG2' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -42.55 -47.94 5.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.856 . . . . 0.0 110.434 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.6 HG12 ' HA ' ' A' ' 17' ' ' ALA . 1.2 m -136.15 173.85 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.313 -0.867 . . . . 0.0 110.332 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -133.16 142.02 48.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.388 -0.82 . . . . 0.0 110.206 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' A' ' 45' ' ' PRO . 47.7 t -62.56 130.36 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.229 -0.919 . . . . 0.0 109.833 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.735 HG23 ' HA ' ' A' ' 15' ' ' LEU . 28.2 t -107.82 -61.32 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 110.588 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.775 ' O ' HD13 ' A' ' 54' ' ' ILE . 7.8 mm-40 -139.89 168.08 20.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.168 -0.958 . . . . 0.0 110.293 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.775 HD13 ' O ' ' A' ' 53' ' ' GLU . 1.4 mm -128.89 152.48 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.319 -0.863 . . . . 0.0 109.191 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -149.65 152.25 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.952 -1.092 . . . . 0.0 110.697 -179.698 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.536 ' HA ' ' CB ' ' A' ' 11' ' ' THR . 0.2 OUTLIER -123.94 177.89 5.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.432 -0.792 . . . . 0.0 110.078 179.542 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.532 ' CA ' ' HA ' ' A' ' 95' ' ' ALA . . . -87.25 130.02 34.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.186 -0.946 . . . . 0.0 110.727 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 57' ' ' ALA . 1.5 t 177.41 52.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 111.018 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.86 HG22 HG13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -157.09 -59.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.608 -1.308 . . . . 0.0 111.591 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.86 HG13 HG22 ' A' ' 59' ' ' ILE . 2.3 mt -92.51 -174.46 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 120.14 -1.6 . . . . 0.0 110.8 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.699 ' H ' HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -101.25 169.43 8.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.4 -0.812 . . . . 0.0 110.114 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.634 ' CG ' HG13 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -67.3 -72.69 0.16 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.203 -0.935 . . . . 0.0 111.974 -179.006 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.565 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 5.7 p30 -39.62 -24.1 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.297 -0.877 . . . . 0.0 112.07 -178.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.507 ' NE2' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -57.22 167.98 0.81 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.609 -1.307 . . . . 0.0 112.206 -178.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.01 ' HB3' HG13 ' A' ' 108' ' ' VAL . . . -150.35 131.25 14.22 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.552 ' HG ' ' CG1' ' A' ' 90' ' ' VAL . 2.5 pp -129.3 127.42 41.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.513 -1.367 . . . . 0.0 112.395 -178.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . 12.5 ttt180 -103.64 130.01 51.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.784 -0.572 . . . . 0.0 109.553 178.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.49 HD23 ' O ' ' A' ' 67' ' ' ARG . 35.2 mt -117.76 149.53 40.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.18 -0.95 . . . . 0.0 111.007 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.443 ' C ' ' HG2' ' A' ' 102' ' ' GLU . 22.7 ttp180 -114.53 139.89 49.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.537 -0.727 . . . . 0.0 109.883 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.567 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -60.45 147.6 40.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.144 -0.973 . . . . 0.0 110.376 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -107.05 -44.1 4.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 109.874 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.592 ' HD2' ' CE2' ' A' ' 101' ' ' PHE . 15.2 ptpt -122.41 134.79 54.6 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.269 -0.894 . . . . 0.0 109.809 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.511 ' N ' ' HB ' ' A' ' 84' ' ' THR . 2.4 pt-20 -57.16 96.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.205 -0.935 . . . . 0.0 110.644 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.52 -42.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 110.443 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.596 ' CB ' ' HB2' ' A' ' 101' ' ' PHE . 2.5 t90 -74.64 120.34 20.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.214 -0.929 . . . . 0.0 110.701 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -117.19 110.21 17.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -0.923 . . . . 0.0 109.401 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.559 ' HB3' ' CZ2' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -59.38 -23.06 62.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 110.219 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.462 ' OD2' ' HE2' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -88.57 -21.44 24.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 110.14 179.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.26 16.37 27.69 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.462 ' HE2' ' OD2' ' A' ' 78' ' ' ASP . 25.1 mttm -110.39 -137.89 0.37 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.218 -1.166 . . . . 0.0 110.147 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.729 ' CG ' HG11 ' A' ' 29' ' ' VAL . 7.9 mp0 -134.98 105.42 6.36 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.03 -1.043 . . . . 0.0 110.327 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.75 179.54 5.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.224 -0.922 . . . . 0.0 110.68 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.594 HG13 ' H ' ' A' ' 85' ' ' GLY . 13.3 p -91.67 174.45 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.422 -0.799 . . . . 0.0 110.79 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.58 ' N ' HG22 ' A' ' 83' ' ' VAL . 4.6 t -72.01 -6.53 42.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.318 -0.864 . . . . 0.0 110.361 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.594 ' H ' HG13 ' A' ' 83' ' ' VAL . . . -80.03 -19.27 70.29 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.44 ' OE2' ' NH1' ' A' ' 77' ' ' ARG . 8.0 tp10 -66.94 160.61 25.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.462 -1.022 . . . . 0.0 110.053 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.416 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 6.1 pt-20 -154.87 168.12 27.98 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.38 -0.825 . . . . 0.0 110.05 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.592 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -147.5 143.94 28.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.127 -0.983 . . . . 0.0 109.979 179.587 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.851 HD22 ' N ' ' A' ' 90' ' ' VAL . 0.6 OUTLIER -115.46 124.46 51.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.108 -0.995 . . . . 0.0 110.208 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.851 ' N ' HD22 ' A' ' 89' ' ' LEU . 8.5 p -107.05 132.37 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.313 -0.867 . . . . 0.0 110.518 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.836 HG23 HD11 ' A' ' 89' ' ' LEU . 3.5 p -115.4 29.37 8.05 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.488 0.661 . . . . 0.0 109.25 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.585 HG22 ' N ' ' A' ' 93' ' ' VAL . 20.1 m -74.65 171.81 13.21 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.417 -0.802 . . . . 0.0 109.55 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.634 HG13 ' CG ' ' A' ' 62' ' ' GLN . 1.5 t -47.37 172.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.99 -1.069 . . . . 0.0 109.006 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.563 ' O ' ' HB3' ' A' ' 95' ' ' ALA . . . -45.24 -88.87 0.01 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 94' ' ' GLY . . . 60.84 -167.79 0.18 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.569 -0.959 . . . . 0.0 110.213 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.516 ' CD2' ' CD1' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -120.76 -65.46 1.14 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.711 -0.618 . . . . 0.0 109.827 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.714 ' HG ' ' HB3' ' A' ' 12' ' ' ALA . 0.3 OUTLIER 46.23 71.37 1.59 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.559 -0.713 . . . . 0.0 110.695 179.584 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.404 ' HD2' HG21 ' A' ' 55' ' ' ILE . 49.5 Cg_endo -78.15 120.53 5.0 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.939 1.494 . . . . 0.0 110.092 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.844 ' HB1' ' HB2' ' A' ' 102' ' ' GLU . . . -73.55 138.82 45.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.21 -0.931 . . . . 0.0 110.275 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.568 HG23 ' N ' ' A' ' 101' ' ' PHE . 30.5 m -69.65 -51.72 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.157 -0.965 . . . . 0.0 110.754 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.596 ' HB2' ' CB ' ' A' ' 75' ' ' TRP . 19.5 m-30 -112.78 26.4 10.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.732 -1.23 . . . . 0.0 110.464 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.844 ' HB2' ' HB1' ' A' ' 99' ' ' ALA . 1.1 tt0 -121.63 141.95 50.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.011 -1.056 . . . . 0.0 110.464 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.03 152.26 36.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.418 -0.801 . . . . 0.0 110.333 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.772 ' C ' HD13 ' A' ' 105' ' ' LEU . 12.4 p -94.45 133.06 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.259 -0.9 . . . . 0.0 110.075 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.772 HD13 ' C ' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -102.76 -21.98 13.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.308 -0.87 . . . . 0.0 110.209 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -174.44 136.31 0.46 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.937 . . . . 0.0 110.396 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.4 pp -99.1 153.25 19.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.89 . . . . 0.0 109.965 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.01 HG13 ' HB3' ' A' ' 65' ' ' ALA . 2.5 p -130.93 147.25 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.083 -1.01 . . . . 0.0 110.605 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -107.19 126.29 52.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.857 . . . . 0.0 110.004 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 63' ' ' ASN . . . -66.96 139.13 57.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.927 . . . . 0.0 110.526 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 111' ' ' VAL . 47.7 t -141.89 91.45 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.414 -0.804 . . . . 0.0 109.811 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 71.8 mt -125.81 142.69 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.197 -0.939 . . . . 0.0 110.33 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.675 ' OXT' HD13 ' A' ' 113' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.168 -179.934 . . . . . . . . 2 2 . 1 stop_ save_